<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="other" dtd-version="1.1" specific-use="sps-1.9" xml:lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Arq Bras Cardiol</journal-id>
      <journal-id journal-id-type="publisher-id">abc</journal-id>
      <journal-title-group>
        <journal-title>Arquivos Brasileiros de Cardiologia</journal-title>
        <abbrev-journal-title abbrev-type="publisher">Arq. Bras. Cardiol.</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0066-782X</issn>
      <issn pub-type="epub">1678-4170</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Cardiologia - SBC</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v3">496q4yHnGXqhqRPzxpz7X7L</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v2">S0066-782X2019001101006</article-id>
      <article-id pub-id-type="doi">10.5935/abc.20190205</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Guidelines</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Guideline of the Brazilian Society of Cardiology on Telemedicine in Cardiology - 2019</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">0000-0003-1253-1514</contrib-id>
          <name>
            <surname>Lopes</surname>
            <given-names>Marcelo Ant&#244;nio Cartaxo Queiroga</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Oliveira</surname>
            <given-names>Gl&#225;ucia Maria Moraes de</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ribeiro</surname>
            <given-names>Antonio Luiz Pinho</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pinto</surname>
            <given-names>Fausto J.</given-names>
          </name>
          <xref ref-type="aff" rid="aff4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rey</surname>
            <given-names>Helena Cramer Veiga</given-names>
          </name>
          <xref ref-type="aff" rid="aff5">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zimerman</surname>
            <given-names>Leandro Ioschpe</given-names>
          </name>
          <xref ref-type="aff" rid="aff6">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rochitte</surname>
            <given-names>Carlos Eduardo</given-names>
          </name>
          <xref ref-type="aff" rid="aff7">7</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bacal</surname>
            <given-names>Fernando</given-names>
          </name>
          <xref ref-type="aff" rid="aff7">7</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Polanczyk</surname>
            <given-names>Carisi Anne</given-names>
          </name>
          <xref ref-type="aff" rid="aff6">6</xref>
          <xref ref-type="aff" rid="aff8">8</xref>
          <xref ref-type="aff" rid="aff9">9</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Halperin</surname>
            <given-names>Cidio</given-names>
          </name>
          <xref ref-type="aff" rid="aff10">10</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ara&#250;jo</surname>
            <given-names>Edson Correia</given-names>
          </name>
          <xref ref-type="aff" rid="aff11">11</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mesquita</surname>
            <given-names>Evandro Tinoco</given-names>
          </name>
          <xref ref-type="aff" rid="aff12">12</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Arruda</surname>
            <given-names>Jos&#233; Airton</given-names>
          </name>
          <xref ref-type="aff" rid="aff13">13</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rohde</surname>
            <given-names>Luis Eduardo Paim</given-names>
          </name>
          <xref ref-type="aff" rid="aff6">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Grinberg</surname>
            <given-names>Max</given-names>
          </name>
          <xref ref-type="aff" rid="aff7">7</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Moretti</surname>
            <given-names>Miguel</given-names>
          </name>
          <xref ref-type="aff" rid="aff7">7</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Caramori</surname>
            <given-names>Paulo Ricardo Avancini</given-names>
          </name>
          <xref ref-type="aff" rid="aff14">14</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Botelho</surname>
            <given-names>Roberto Vieira</given-names>
          </name>
          <xref ref-type="aff" rid="aff15">15</xref>
          <xref ref-type="aff" rid="aff16">16</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Brand&#227;o</surname>
            <given-names>Andr&#233;a Ara&#250;jo</given-names>
          </name>
          <xref ref-type="aff" rid="aff17">17</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hajjar</surname>
            <given-names>Ludhmila Abrah&#227;o</given-names>
          </name>
          <xref ref-type="aff" rid="aff7">7</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Santos</surname>
            <given-names>Alexandre Fonseca</given-names>
          </name>
          <xref ref-type="aff" rid="aff11">11</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Colafranceschi</surname>
            <given-names>Alexandre Siciliano</given-names>
          </name>
          <xref ref-type="aff" rid="aff18">18</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Etges</surname>
            <given-names>Ana Paula Beck da Silva</given-names>
          </name>
          <xref ref-type="aff" rid="aff9">9</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Marino</surname>
            <given-names>B&#225;rbara Campos Abreu</given-names>
          </name>
          <xref ref-type="aff" rid="aff19">19</xref>
          <xref ref-type="aff" rid="aff20">20</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zanotto</surname>
            <given-names>Bruna Stella</given-names>
          </name>
          <xref ref-type="aff" rid="aff8">8</xref>
          <xref ref-type="aff" rid="aff9">9</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Nascimento</surname>
            <given-names>Bruno Ramos</given-names>
          </name>
          <xref ref-type="aff" rid="aff21">21</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Medeiros</surname>
            <given-names>Cesar Rocha</given-names>
          </name>
          <xref ref-type="aff" rid="aff22">22</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Santos</surname>
            <given-names>Daniel Vitor de Vasconcelos</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cook</surname>
            <given-names>Daniela Matos Arrowsmith</given-names>
          </name>
          <xref ref-type="aff" rid="aff18">18</xref>
          <xref ref-type="aff" rid="aff23">23</xref>
          <xref ref-type="aff" rid="aff24">24</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Antoniolli</surname>
            <given-names>Eduardo</given-names>
          </name>
          <xref ref-type="aff" rid="aff25">25</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Souza</surname>
            <given-names>Erito Marques de</given-names>
            <suffix>Filho</suffix>
          </name>
          <xref ref-type="aff" rid="aff12">12</xref>
          <xref ref-type="aff" rid="aff26">26</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fernandes</surname>
            <given-names>F&#225;bio</given-names>
          </name>
          <xref ref-type="aff" rid="aff27">27</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gandour</surname>
            <given-names>Fabio</given-names>
          </name>
          <xref ref-type="aff" rid="aff28">28</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fernandez</surname>
            <given-names>Francisco</given-names>
          </name>
          <xref ref-type="aff" rid="aff16">16</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Souza</surname>
            <given-names>Germano Emilio Concei&#231;&#227;o</given-names>
          </name>
          <xref ref-type="aff" rid="aff29">29</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Weigert</surname>
            <given-names>Guilherme de Souza</given-names>
          </name>
          <xref ref-type="aff" rid="aff30">30</xref>
          <xref ref-type="aff" rid="aff31">31</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Castro</surname>
            <given-names>Iran</given-names>
          </name>
          <xref ref-type="aff" rid="aff32">32</xref>
          <xref ref-type="aff" rid="aff33">33</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cade</surname>
            <given-names>Jamil Ribeiro</given-names>
          </name>
          <xref ref-type="aff" rid="aff34">34</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Figueiredo</surname>
            <given-names>Jos&#233; Albuquerque de</given-names>
            <suffix>Neto</suffix>
          </name>
          <xref ref-type="aff" rid="aff35">35</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fernandes</surname>
            <given-names>Juliano de Lara</given-names>
          </name>
          <xref ref-type="aff" rid="aff36">36</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hadlich</surname>
            <given-names>Marcelo Souza</given-names>
          </name>
          <xref ref-type="aff" rid="aff37">37</xref>
          <xref ref-type="aff" rid="aff38">38</xref>
          <xref ref-type="aff" rid="aff39">39</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Oliveira</surname>
            <given-names>Marco Antonio Pra&#231;a</given-names>
          </name>
          <xref ref-type="aff" rid="aff29">29</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Alkmim</surname>
            <given-names>Maria Beatriz</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">3</xref>
          <xref ref-type="aff" rid="aff21">21</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Paix&#227;o</surname>
            <given-names>Maria Cristina da</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Prudente</surname>
            <given-names>Maur&#237;cio Lopes</given-names>
          </name>
          <xref ref-type="aff" rid="aff40">40</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Aguiar</surname>
            <given-names>Miguel A. S.</given-names>
            <suffix>Netto</suffix>
          </name>
          <xref ref-type="aff" rid="aff41">41</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Marcolino</surname>
            <given-names>Milena Soriano</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Oliveira</surname>
            <given-names>Monica Amorim de</given-names>
          </name>
          <xref ref-type="aff" rid="aff5">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Simonelli</surname>
            <given-names>Osvaldo</given-names>
          </name>
          <xref ref-type="aff" rid="aff42">42</xref>
          <xref ref-type="aff" rid="aff43">43</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lemos</surname>
            <given-names>Pedro A.</given-names>
            <suffix>Neto</suffix>
          </name>
          <xref ref-type="aff" rid="aff44">44</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rosa</surname>
            <given-names>Priscila Raupp da</given-names>
          </name>
          <xref ref-type="aff" rid="aff44">44</xref>
          <xref ref-type="aff" rid="aff45">45</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Figueira</surname>
            <given-names>Renato Minelli</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cury</surname>
            <given-names>Roberto Caldeira</given-names>
          </name>
          <xref ref-type="aff" rid="aff46">46</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Almeida</surname>
            <given-names>Rodrigo Coelho</given-names>
          </name>
          <xref ref-type="aff" rid="aff47">47</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lima</surname>
            <given-names>Sandra Regina Franco</given-names>
          </name>
          <xref ref-type="aff" rid="aff48">48</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Barberato</surname>
            <given-names>Silvio Henrique</given-names>
          </name>
          <xref ref-type="aff" rid="aff49">49</xref>
          <xref ref-type="aff" rid="aff50">50</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Constancio</surname>
            <given-names>Thiago Inoc&#234;ncio</given-names>
          </name>
          <xref ref-type="aff" rid="aff51">51</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rezende</surname>
            <given-names>Wladimir Fernandes de</given-names>
          </name>
          <xref ref-type="aff" rid="aff52">52</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1">
        <label>1</label>
        <institution content-type="orgname">Hospital Alberto Urquiza Wanderley</institution>
        <addr-line>
          <city>Jo&#227;o Pessoa</city>
          <state>PB</state>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">Hospital Alberto Urquiza Wanderley, Jo&#227;o Pessoa, PB - Brazil</institution>
      </aff>
      <aff id="aff2">
        <label>2</label>
        <institution content-type="orgname">Universidade Federal do Rio de Janeiro</institution>
        <addr-line>
          <city>Rio de Janeiro</city>
          <state>RJ</state>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ - Brazil</institution>
      </aff>
      <aff id="aff3">
        <label>3</label>
        <institution content-type="orgname">Universidade Federal de Minas Gerais</institution>
        <addr-line>
          <city>Belo Horizonte</city>
          <state>MG</state>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MG - Brazil</institution>
      </aff>
      <aff id="aff4">
        <label>4</label>
        <institution content-type="orgname">Universidade de Lisboa</institution>
        <addr-line>
          <city>Lisboa</city>
        </addr-line>
        <country country="PT">Portugal</country>
        <institution content-type="original">Universidade de Lisboa, Lisboa - Portugal</institution>
      </aff>
      <aff id="aff5">
        <label>5</label>
        <institution content-type="orgname">Instituto Nacional de Cardiologia do Rio de Janeiro</institution>
        <addr-line>
          <city>Rio de Janeiro</city>
          <state>RJ</state>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">Instituto Nacional de Cardiologia do Rio de Janeiro, Rio de Janeiro, RJ - Brazil</institution>
      </aff>
      <aff id="aff6">
        <label>6</label>
        <institution content-type="orgname">Hospital de Cl&#237;nicas de Porto Alegre</institution>
        <addr-line>
          <city>Porto Alegre</city>
          <state>RS</state>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">Hospital de Cl&#237;nicas de Porto Alegre, Porto Alegre, RS - Brazil</institution>
      </aff>
      <aff id="aff7">
        <label>7</label>
        <institution content-type="orgname">Universidade de S&#227;o Paulo</institution>
        <institution content-type="orgdiv1">Faculdade de Medicina</institution>
        <institution content-type="orgdiv2">Hospital das Cl&#237;nicas</institution>
        <addr-line>
          <city>S&#227;o Paulo</city>
          <state>SP</state>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">Instituto do Cora&#231;&#227;o (InCor) do Hospital das Cl&#237;nicas da Faculdade de Medicina da Universidade de S&#227;o Paulo (USP), S&#227;o Paulo, SP - Brazil</institution>
      </aff>
      <aff id="aff8">
        <label>8</label>
        <institution content-type="orgname">Universidade Federal do Rio Grande do Sul</institution>
        <addr-line>
          <city>Porto Alegre</city>
          <state>RS</state>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS - Brazil</institution>
      </aff>
      <aff id="aff9">
        <label>9</label>
        <institution content-type="orgname">Instituto de Avalia&#231;&#227;o de Tecnologias em Sa&#250;de</institution>
        <addr-line>
          <city>Porto Alegre</city>
          <state>RS</state>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">Instituto de Avalia&#231;&#227;o de Tecnologias em Sa&#250;de (IATS), Porto Alegre, RS - Brazil</institution>
      </aff>
      <aff id="aff10">
        <label>10</label>
        <institution content-type="orgname">Hospital Ernesto Dornelles</institution>
        <addr-line>
          <city>Porto Alegre</city>
          <state>RS</state>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">Hospital Ernesto Dornelles, Porto Alegre, RS - Brazil</institution>
      </aff>
      <aff id="aff11">
        <label>11</label>
        <institution content-type="orgname">Banco Mundial</institution>
        <addr-line>
          <city>Bras&#237;lia</city>
          <state>DF</state>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">Banco Mundial, Bras&#237;lia, DF - Brazil</institution>
      </aff>
      <aff id="aff12">
        <label>12</label>
        <institution content-type="orgname">Universidade Federal Fluminense</institution>
        <addr-line>
          <city>Rio de Janeiro</city>
          <state>RJ</state>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">Universidade Federal Fluminense (UFF), Rio de Janeiro, RJ - Brazil</institution>
      </aff>
      <aff id="aff13">
        <label>13</label>
        <institution content-type="orgname">Universidade Federal do Esp&#237;rito Santo</institution>
        <addr-line>
          <city>Vit&#243;ria</city>
          <state>ES</state>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">Universidade Federal do Esp&#237;rito Santo (UFES), Vit&#243;ria, ES - Brazil</institution>
      </aff>
      <aff id="aff14">
        <label>14</label>
        <institution content-type="orgname">Universidade Cat&#243;lica do Rio Grande do Sul</institution>
        <institution content-type="orgdiv1">Hospital S&#227;o Lucas da Pontif&#237;cia</institution>
        <addr-line>
          <city>Porto Alegre</city>
          <state>RS</state>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">Hospital S&#227;o Lucas da Pontif&#237;cia Universidade Cat&#243;lica do Rio Grande do Sul (PUCRS), Porto Alegre , RS - Brazil</institution>
      </aff>
      <aff id="aff15">
        <label>15</label>
        <institution content-type="orgname">Instituto do Cora&#231;&#227;o do Tri&#226;ngulo</institution>
        <addr-line>
          <city>Uberl&#226;ndia</city>
          <state>MG</state>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">Instituto do Cora&#231;&#227;o do Tri&#226;ngulo (ICT), Uberl&#226;ndia, MG - Brazil</institution>
      </aff>
      <aff id="aff16">
        <label>16</label>
        <institution content-type="orgname">International Telemedical Systems do Brasil</institution>
        <addr-line>
          <city>Uberl&#226;ndia</city>
          <state>MG</state>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">International Telemedical Systems do Brasil (ITMS), Uberl&#226;ndia, MG - Brazil</institution>
      </aff>
      <aff id="aff17">
        <label>17</label>
        <institution content-type="orgname">Universidade do Estado do Rio de Janeiro</institution>
        <addr-line>
          <city>Rio de Janeiro</city>
          <state>RJ</state>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">Universidade do Estado do Rio de Janeiro (UERJ), Rio de Janeiro, RJ - Brazil</institution>
      </aff>
      <aff id="aff18">
        <label>18</label>
        <institution content-type="orgname">Hospital Pr&#243;-Card&#237;aco</institution>
        <addr-line>
          <city>Rio de Janeiro</city>
          <state>RJ</state>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">Hospital Pr&#243;-Card&#237;aco, Rio de Janeiro, RJ - Brazil</institution>
      </aff>
      <aff id="aff19">
        <label>19</label>
        <institution content-type="orgname">Hospital Madre Teresa</institution>
        <addr-line>
          <city>Belo Horizonte</city>
          <state>MG</state>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">Hospital Madre Teresa, Belo Horizonte, MG - Brazil</institution>
      </aff>
      <aff id="aff20">
        <label>20</label>
        <institution content-type="orgname">Pontif&#237;cia Universidade Cat&#243;lica de Minas Gerais</institution>
        <addr-line>
          <city>Belo Horizonte</city>
          <state>MG</state>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">Pontif&#237;cia Universidade Cat&#243;lica de Minas Gerais (PUCMG), Belo Horizonte, MG - Brazil</institution>
      </aff>
      <aff id="aff21">
        <label>21</label>
        <institution content-type="orgname">Universidade Federal de Minas Gerais</institution>
        <institution content-type="orgdiv1">Hospital das Cl&#237;nicas</institution>
        <addr-line>
          <city>Belo Horizonte</city>
          <state>MG</state>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">Hospital das Cl&#237;nicas da Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MG - Brazil</institution>
      </aff>
      <aff id="aff22">
        <label>22</label>
        <institution content-type="orgname">Hospital Copa D'Or</institution>
        <addr-line>
          <city>Rio de Janeiro</city>
          <state>RJ</state>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">Hospital Copa D'Or, Rio de Janeiro, RJ - Brazil</institution>
      </aff>
      <aff id="aff23">
        <label>23</label>
        <institution content-type="orgname">Hospital Copa Star</institution>
        <addr-line>
          <city>Rio de Janeiro</city>
          <state>RJ</state>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">Hospital Copa Star, Rio de Janeiro, RJ - Brazil</institution>
      </aff>
      <aff id="aff24">
        <label>24</label>
        <institution content-type="orgname">Hospital dos Servidores do Estado do Rio de Janeiro</institution>
        <addr-line>
          <city>Rio de Janeiro</city>
          <state>RJ</state>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">Hospital dos Servidores do Estado do Rio de Janeiro, Rio de Janeiro, RJ - Brazil</institution>
      </aff>
      <aff id="aff25">
        <label>25</label>
        <institution content-type="orgname">Hospital Santa Ana</institution>
        <addr-line>
          <city>Porto Alegre</city>
          <state>RS</state>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">Hospital Santa Ana, Porto Alegre, RS - Brazil</institution>
      </aff>
      <aff id="aff26">
        <label>26</label>
        <institution content-type="orgname">Universidade Federal Rural do Rio de Janeiro</institution>
        <addr-line>
          <city>Serop&#233;dica</city>
          <state>RJ</state>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">Universidade Federal Rural do Rio de Janeiro, Serop&#233;dica, RJ - Brazil</institution>
      </aff>
      <aff id="aff27">
        <label>27</label>
        <institution content-type="orgname">UMC Imagem</institution>
        <addr-line>
          <city>Uberl&#226;ndia</city>
          <state>MG</state>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">UMC Imagem, Uberl&#226;ndia, MG - Brazil</institution>
      </aff>
      <aff id="aff28">
        <label>28</label>
        <institution content-type="orgname">Universidade de Bras&#237;lia</institution>
        <addr-line>
          <city>Bras&#237;lia</city>
          <state>DF</state>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">Universidade de Bras&#237;lia (UnB), Bras&#237;lia, DF - Brazil</institution>
      </aff>
      <aff id="aff29">
        <label>29</label>
        <institution content-type="orgname">Universidade de S&#227;o Paulo</institution>
        <addr-line>
          <city>S&#227;o Paulo</city>
          <state>SP</state>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">Universidade de S&#227;o Paulo (USP), S&#227;o Paulo, SP - Brazil</institution>
      </aff>
      <aff id="aff30">
        <label>30</label>
        <institution content-type="orgname">Americas Medical City</institution>
        <addr-line>
          <city>Rio de Janeiro</city>
          <state>RJ</state>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">Americas Medical City, Rio de Janeiro, RJ - Brazil </institution>
      </aff>
      <aff id="aff31">
        <label>31</label>
        <institution content-type="orgname">Conexa Sa&#250;de</institution>
        <addr-line>
          <city>Rio de Janeiro</city>
          <state>RJ</state>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">Conexa Sa&#250;de, Rio de Janeiro, RJ - Brazil</institution>
      </aff>
      <aff id="aff32">
        <label>32</label>
        <institution content-type="orgname">Instituto de Cardiologia do Rio Grande do Sul</institution>
        <addr-line>
          <city>Porto Alegre</city>
          <state>RS</state>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">Instituto de Cardiologia do Rio Grande do Sul, Porto Alegre, RS - Brazil </institution>
      </aff>
      <aff id="aff33">
        <label>33</label>
        <institution content-type="orgname">Funda&#231;&#227;o Universit&#225;ria de Cardiologia</institution>
        <addr-line>
          <city>Porto Alegre</city>
          <state>RS</state>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">Funda&#231;&#227;o Universit&#225;ria de Cardiologia, Porto Alegre, RS - Brazil </institution>
      </aff>
      <aff id="aff34">
        <label>34</label>
        <institution content-type="orgname">Hospital Santa Marcelina</institution>
        <addr-line>
          <city>S&#227;o Paulo</city>
          <state>SP</state>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">Hospital Santa Marcelina, S&#227;o Paulo, SP - Brazil</institution>
      </aff>
      <aff id="aff35">
        <label>35</label>
        <institution content-type="orgname">Universidade Federal do Maranh&#227;o</institution>
        <addr-line>
          <city>S&#227;o Lu&#237;s</city>
          <state>MA</state>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">Universidade Federal do Maranh&#227;o, S&#227;o Lu&#237;s, MA - Brazil</institution>
      </aff>
      <aff id="aff36">
        <label>36</label>
        <institution content-type="orgname">Instituto de Ensino e Pesquisa Jos&#233; Michel Kalaf</institution>
        <addr-line>
          <city>Campina</city>
          <state>SP</state>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">Instituto de Ensino e Pesquisa Jos&#233; Michel Kalaf, Campina, SP - Brazil</institution>
      </aff>
      <aff id="aff37">
        <label>37</label>
        <institution content-type="orgname">Fleury Medicina e Sa&#250;de</institution>
        <addr-line>
          <city>Rio de Janeiro</city>
          <state>RJ</state>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">Fleury Medicina e Sa&#250;de, Rio de Janeiro, RJ - Brazil</institution>
      </aff>
      <aff id="aff38">
        <label>38</label>
        <institution content-type="orgname">Rede D'Or</institution>
        <addr-line>
          <city>Rio de Janeiro</city>
          <state>RJ</state>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">Rede D'Or, Rio de Janeiro, RJ - Brazil</institution>
      </aff>
      <aff id="aff39">
        <label>39</label>
        <institution content-type="orgname">Unimed-Rio</institution>
        <addr-line>
          <city>Rio de Janeiro</city>
          <state>RJ</state>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">Unimed-Rio, Rio de Janeiro, RJ - Brazil</institution>
      </aff>
      <aff id="aff40">
        <label>40</label>
        <institution content-type="orgname">Hospital ENCORE</institution>
        <addr-line>
          <city>Goi&#226;nia</city>
          <state>GO</state>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">Hospital ENCORE, Goi&#226;nia, GO - Brazil</institution>
      </aff>
      <aff id="aff41">
        <label>41</label>
        <institution content-type="orgname">BrasilSa&#250;de Cia de Seguros</institution>
        <addr-line>
          <city>Rio de Janeiro</city>
          <state>RJ</state>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">BrasilSa&#250;de Cia de Seguros, Rio de Janeiro, RJ - Brazil</institution>
      </aff>
      <aff id="aff42">
        <label>42</label>
        <institution content-type="orgname">Conselho Regional de Medicina do Estado de S&#227;o Paulo</institution>
        <addr-line>
          <city>S&#227;o Paulo</city>
          <state>SP</state>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">Conselho Regional de Medicina do Estado de S&#227;o Paulo, S&#227;o Paulo, SP - Brazil</institution>
      </aff>
      <aff id="aff43">
        <label>43</label>
        <institution content-type="orgname">Instituto Paulista de Direito M&#233;dico e da Sa&#250;de</institution>
        <addr-line>
          <city>Ribeir&#227;o Preto</city>
          <state>SP</state>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">Instituto Paulista de Direito M&#233;dico e da Sa&#250;de (IPDMS), Ribeir&#227;o Preto, SP - Brazil</institution>
      </aff>
      <aff id="aff44">
        <label>44</label>
        <institution content-type="orgname">Hospital Israelita Albert Einstein</institution>
        <addr-line>
          <city>S&#227;o Paulo</city>
          <state>SP</state>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">Hospital Israelita Albert Einstein, S&#227;o Paulo, SP - Brazil </institution>
      </aff>
      <aff id="aff45">
        <label>45</label>
        <institution content-type="orgname">Hospital S&#237;rio Liban&#234;s</institution>
        <addr-line>
          <city>S&#227;o Paulo</city>
          <state>SP</state>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">Hospital S&#237;rio Liban&#234;s, S&#227;o Paulo, SP - Brazil</institution>
      </aff>
      <aff id="aff46">
        <label>46</label>
        <institution content-type="orgname">DASA</institution>
        <addr-line>
          <city>S&#227;o Paulo</city>
          <state>SP</state>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">DASA, S&#227;o Paulo, SP - Brazil</institution>
      </aff>
      <aff id="aff47">
        <label>47</label>
        <institution content-type="orgname">Medportal</institution>
        <addr-line>
          <city>Rio de Janeiro</city>
          <state>RJ</state>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">Medportal, Rio de Janeiro, RJ - Brazil</institution>
      </aff>
      <aff id="aff48">
        <label>48</label>
        <institution content-type="orgname">Sfranco Consultoria Jur&#237;dica</institution>
        <addr-line>
          <city>S&#227;o Jos&#233; dos Campos</city>
          <state>SP</state>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">Sfranco Consultoria Jur&#237;dica, S&#227;o Jos&#233; dos Campos, SP - Brazil</institution>
      </aff>
      <aff id="aff49">
        <label>49</label>
        <institution content-type="orgname">CardioEco-Centro de Diagn&#243;stico Cardiovascular</institution>
        <addr-line>
          <city>Curitiba</city>
          <state>PR</state>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">CardioEco-Centro de Diagn&#243;stico Cardiovascular, Curitiba, PR - Brazil</institution>
      </aff>
      <aff id="aff50">
        <label>50</label>
        <institution content-type="orgname">Quanta Diagn&#243;stico e Terapia</institution>
        <addr-line>
          <city>Curitiba</city>
          <state>PR</state>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">Quanta Diagn&#243;stico e Terapia, Curitiba, PR - Brazil</institution>
      </aff>
      <aff id="aff51">
        <label>51</label>
        <institution content-type="orgname">Funda&#231;&#227;o Oswaldo Cruz</institution>
        <addr-line>
          <city>Rio de Janeiro</city>
          <state>RJ</state>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">Funda&#231;&#227;o Oswaldo Cruz (Fiocruz), Rio de Janeiro, RJ - Brazil</institution>
      </aff>
      <aff id="aff52">
        <label>52</label>
        <institution content-type="orgname">UMC Tecnologia</institution>
        <addr-line>
          <city>S&#227;o Paulo</city>
          <state>SP</state>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">UMC Tecnologia, S&#227;o Paulo, SP - Brazil</institution>
      </aff>
      <author-notes>
        <corresp id="c1"><bold>Correspondence:</bold> Sociedade Brasileira de Cardiologia - Av. Marechal C&#226;mara, 360/330 - Centro - Rio de Janeiro - Postal Code: 20020-907. E-mail: <email>diretrizes@cardiol.br</email>
				</corresp>
      </author-notes>
      <pub-date date-type="pub" publication-format="electronic">
        <day>02</day>
        <month>12</month>
        <year>2019</year>
      </pub-date>
      <pub-date date-type="collection" publication-format="electronic">
        <month>11</month>
        <year>2019</year>
      </pub-date>
      <volume>113</volume>
      <issue>5</issue>
      <fpage>1006</fpage>
      <lpage>1056</lpage>
      <permissions>
        <license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/" xml:lang="en">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited</license-p>
        </license>
      </permissions>
    </article-meta>
  </front>
  <body>
    <table-wrap id="t1">
      <caption>
        <title>Grades of recommendation and levels of evidence in this update were applied according to the following standards: </title>
      </caption>
      <table frame="hsides" rules="groups">
        <colgroup>
          <col width="20%"/>
          <col width="80%"/>
        </colgroup>
        <thead>
          <tr>
            <th align="center" colspan="2">Classes (grades) of recommendation</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td align="left">Grade I</td>
            <td align="center">Conditions for which there is conclusive evidence or, in the absence of conclusive evidence, a general consensus that the procedure is safe and useful/effective.</td>
          </tr>
          <tr>
            <td align="left">Grade IIa</td>
            <td align="center">Conditions for which there is conflicting evidence and/or divergent opinions regarding the procedure's safety and usefulness/effectiveness. Weight or evidence/opinion in favor of the procedure. Received approval by most studies/experts.</td>
          </tr>
          <tr>
            <td align="left">Grade IIb</td>
            <td align="center">Conditions for which there is conflicting evidence and/or divergent opinions regarding the procedure's safety and usefulness/effectiveness. Safety and usefulness/effectiveness are less well established, with no prevailing opinions in favor.</td>
          </tr>
          <tr>
            <td align="left">Grade III</td>
            <td align="center">Conditions for which there is evidence and/or consensus that the procedure is not useful/effective and in some cases may be potentially harmful.</td>
          </tr>
        </tbody>
      </table>
    </table-wrap>
    <table-wrap id="t2">
      <table frame="hsides" rules="groups">
        <colgroup>
          <col width="20%"/>
          <col width="80%"/>
        </colgroup>
        <thead>
          <tr>
            <th align="center" colspan="2">Levels of evidence</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td align="left">Level A</td>
            <td align="center">Data obtained from multiple, concordant, large randomized trials, and/or robust meta-analysis of randomized clinical trials.</td>
          </tr>
          <tr>
            <td align="left">Level B</td>
            <td align="center">Data obtained from less robust meta-analysis, from a single randomized trial, or from nonrandomized (observational) trials.</td>
          </tr>
          <tr>
            <td align="left">Level C</td>
            <td align="center">Data obtained through a consensus of expert opinions.</td>
          </tr>
        </tbody>
      </table>
    </table-wrap>
    <table-wrap id="t3">
      <table frame="hsides" rules="groups">
        <colgroup>
          <col width="12%"/>
          <col width="12%"/>
          <col width="12%"/>
          <col width="12%"/>
          <col width="12%"/>
          <col width="12%"/>
          <col width="12%"/>
          <col width="12%"/>
        </colgroup>
        <thead>
          <tr style="border-bottom-width:thin;border-bottom-style:solid">
            <th align="center" colspan="8">Declaration of potential conflict of interests of authors/collaborators of theGuideline of the Brazilian Society of Cardiology on Telemedicine in Cardiology - 2019<break/>If, within the last 3 years, the author/collaborator of the guideline:</th>
          </tr>
          <tr>
            <th align="left">Names of guideline collaborators</th>
            <th align="center">Participated in clinical and/or experimental studies sponsored by pharmaceutical or equipment companies related to this guideline</th>
            <th align="center">Spoke at events or activities sponsored by industry related to this guideline</th>
            <th align="center">Was (is) a member of a board of advisors or a board of directors of a pharmaceutical or equipment industry</th>
            <th align="center">Participated in normative committees of scientific research sponsored by industry</th>
            <th align="center">Received personal or institutional funding from industry</th>
            <th align="center">Wrote scientific papers in journals sponsored by industry</th>
            <th align="center">Owns stocks in industry</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td align="left">Alexandre Fonseca Santos</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
          </tr>
          <tr>
            <td align="left">Alexandre Siciliano Colafranceschi</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
          </tr>
          <tr>
            <td align="left">Ana Paula Beck da Silva Etges</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
          </tr>
          <tr>
            <td align="left">Andr&#233;a Ara&#250;jo Brand&#227;o</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
          </tr>
          <tr>
            <td align="left">Antonio Luiz Pinho Ribeiro</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
          </tr>
          <tr>
            <td align="left">B&#225;rbara Campos Abreu Marino</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
          </tr>
          <tr>
            <td align="left">Bruna Stella Zanotto</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
          </tr>
          <tr>
            <td align="left">Bruno Ramos Nascimento</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
          </tr>
          <tr>
            <td align="left">Carisi Anne Polanczyk</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
          </tr>
          <tr>
            <td align="left">Carlos Eduardo Rochitte</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
          </tr>
          <tr>
            <td align="left">Cesar Rocha Medeiros</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
          </tr>
          <tr>
            <td align="left">Cidio Halperin</td>
            <td align="center">Apple</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
          </tr>
          <tr>
            <td align="left">Daniel Vitor de Vasconcelos Santos</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
          </tr>
          <tr>
            <td align="left">Daniela Matos Arrowsmith Cook</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
          </tr>
          <tr>
            <td align="left">Edson Correia Ara&#250;jo</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
          </tr>
          <tr>
            <td align="left">Eduardo Antoniolli</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
          </tr>
          <tr>
            <td align="left">Erito Marques de Souza Filho</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
          </tr>
          <tr>
            <td align="left">Evandro Tinoco Mesquita</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
          </tr>
          <tr>
            <td align="left">F&#225;bio Fernandes</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
          </tr>
          <tr>
            <td align="left">Fabio Gandour</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
          </tr>
          <tr>
            <td align="left">Fausto J. Pinto</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
          </tr>
          <tr>
            <td align="left">Fernando Bacal</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
          </tr>
          <tr>
            <td align="left">Francisco Fernandez</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
          </tr>
          <tr>
            <td align="left">Germano Emilio Concei&#231;&#227;o Souza</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
          </tr>
          <tr>
            <td align="left">Gl&#225;ucia Maria Moraes de Oliveira</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
          </tr>
          <tr>
            <td align="left">Guilherme de Souza Weigert</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">Conexa Sa&#250;de</td>
            <td align="center">No</td>
            <td align="center">Conexa Sa&#250;de</td>
            <td align="center">No</td>
            <td align="center">Conexa Sa&#250;de</td>
          </tr>
          <tr>
            <td align="left">Helena Cramer Veiga Rey</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
          </tr>
          <tr>
            <td align="left">Iran Castro</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
          </tr>
          <tr>
            <td align="left">Jamil Ribeiro Cade</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No </td>
            <td align="center">No</td>
            <td align="center">No</td>
          </tr>
          <tr>
            <td align="left">Jos&#233; Airton de Arruda</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
          </tr>
          <tr>
            <td align="left">Jos&#233; Albuquerque de Figueiredo Neto</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
          </tr>
          <tr>
            <td align="left">Juliano Lara Fernandes</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">Hypera Pharma, Grupo Biotoscana</td>
          </tr>
          <tr>
            <td align="left">Leandro Ioschpe Zimerman</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">Pfizer</td>
            <td align="center">Bayer, Pfizer, Biotronik</td>
            <td align="center">No</td>
            <td align="center">No</td>
          </tr>
          <tr>
            <td align="left">Ludhmila Abrah&#227;o Hajjar</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
          </tr>
          <tr>
            <td align="left">Luis Eduardo Paim Rohde</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
          </tr>
          <tr>
            <td align="left">Marcelo Ant&#244;nio Cartaxo Queiroga Lopes</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
          </tr>
          <tr>
            <td align="left">Marcelo Souza Hadlich</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
          </tr>
          <tr>
            <td align="left">Marco Antonio Pra&#231;a Oliveira</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
          </tr>
          <tr>
            <td align="left">Maria Beatriz Alkmim</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
          </tr>
          <tr>
            <td align="left">Maria Cristina da Paix&#227;o</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
          </tr>
          <tr>
            <td align="left">Maur&#237;cio Lopes Prudente</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
          </tr>
          <tr>
            <td align="left">Max Grinberg</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
          </tr>
          <tr>
            <td align="left">Miguel A. S. Aguiar Netto</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
          </tr>
          <tr>
            <td align="left">Miguel Antonio Moretti</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
          </tr>
          <tr>
            <td align="left">Milena Soriano Marcolino</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
          </tr>
          <tr>
            <td align="left">Monica Amorim de Oliveira</td>
            <td align="center">No </td>
            <td align="center">No </td>
            <td align="center">No </td>
            <td align="center">No </td>
            <td align="center">No </td>
            <td align="center">No </td>
            <td align="center">No </td>
          </tr>
          <tr>
            <td align="left">Osvaldo Simonelli</td>
            <td align="center">No </td>
            <td align="center">No </td>
            <td align="center">No </td>
            <td align="center">No </td>
            <td align="center">No </td>
            <td align="center">No </td>
            <td align="center">No </td>
          </tr>
          <tr>
            <td align="left">Paulo Ricardo Avancini Caramori</td>
            <td align="center">No </td>
            <td align="center">No </td>
            <td align="center">Medtronic</td>
            <td align="center">SciTech, Biotronik</td>
            <td align="center">No </td>
            <td align="center">No </td>
            <td align="center">No </td>
          </tr>
          <tr>
            <td align="left">Pedro A. Lemos Neto</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
          </tr>
          <tr>
            <td align="left">Priscila Raupp da Rosa</td>
            <td align="center">No</td>
            <td align="center">Aruba/Kapersky</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
          </tr>
          <tr>
            <td align="left">Renato Minelli Figueira</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
          </tr>
          <tr>
            <td align="left">Roberto Caldeira Cury</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
          </tr>
          <tr>
            <td align="left">Roberto Vieira Botelho</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
          </tr>
          <tr>
            <td align="left">Rodrigo Coelho de Almeida</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
          </tr>
          <tr>
            <td align="left">Sandra Regina Franco Lima</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
          </tr>
          <tr>
            <td align="left">Silvio Henrique Barberato </td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
          </tr>
          <tr>
            <td align="left">Thiago Inoc&#234;ncio Constancio</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
          </tr>
          <tr>
            <td align="left">Wladimir Fernandes de Rezende</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
            <td align="center">No</td>
          </tr>
        </tbody>
      </table>
    </table-wrap>
    <sec>
      <title>Presentation</title>
      <p>In due time, the Brazilian Society of Cardiology decided to create a guideline on telemedicine applied to cardiology, also known as telecardiology. According to the Pan American Health Organization (PAHO) and the World Health Organization (WHO), telemedicine is &#8220;The delivery of health care services, where distance is a critical factor, by all health care professionals using information and communication technologies for the exchange of valid information for diagnosis, treatment, and prevention of disease and injuries, research and evaluation, and for the continuing education of health care providers, all in the interests of advancing the health of individuals and their communities.&#8221; Such a seemingly simple and altruistic definition carries a wide range of potential implications at various levels, from an ethical point of view to a potential impact on clinical practice and outcomes. Hence, the importance of guidelines, organized by the medical community through scientific societies, in offering to all of those involved in the process a reference based, as much as possible, on expert opinion, current scientific evidence, and on respect for medical ethical and deontological values.</p>
      <p>Considering that cardiovascular diseases are the main cause of morbidity and mortality in the 21st century in Brazil and worldwide, the opportunity to use instruments to allow more effective actions in the prevention, diagnosis, treatment, and follow-up of these diseases paves the way to very relevant perspectives of better care for the populations and communities that we serve. At the same time, bioethical aspects and consequences should never be neglected, as they can (and should) undermine programs that, disguised as &#8220;medical,&#8221; fail to meet these ethical requirements. Therefore, regulated operating models based on guidelines organized by medical-scientific authorities are fundamental in striking a balance.</p>
      <p>The introduction and implementation of new digital technologies are favoring the emergence of new methodologies (many still experimental) aimed at improving the capacity of intervention on individual patients and allowing for more customized care. We are experiencing what Eric Topol<xref ref-type="bibr" rid="B1">1</xref> in his latest book, &#8220;Deep Medicine: How Artificial Intelligence Can Make Healthcare Human Again,&#8221; called the &#8220;Fourth Industrial Age&#8221; comprising artificial intelligence, robotics, and big data that will have a great impact on the way we live and see ourselves as human beings. If this is very positive at first sight, it is also true that it is not devoid of risk, particularly in the way that we approach or will approach the patient. Therefore, one must not forget the Hippocratic principle: &#8220;It is far more important to know what person the disease has than what disease the person has.&#8221; In fact, when we are sick, we all want to have our doctor - and not a computer - taking care of us and offering us a word of comfort and confidence.</p>
      <p>Therefore, we must think smartly about how to apply to human benefit this impressive array of elements that have opened up frontiers that were unfathomable just a few years ago. Telemedicine - or telecardiology - can indeed play a very important role, particularly when this may be the only available resource. However, its use must be properly delineated to prevent abuse and misuse. The present document and guideline was prepared for this purpose. This complete document offers a detailed review of the regulation of telemedicine in Brazil, defines the meaning of a geographically remote area, and describes the fundamentals of telemedicine and the secure grounds for its transmission.</p>
      <p>This document also offers up-to-date information on current evidence and applications of so-called teleconsultation, telediagnosis, and telemonitoring, and reflects on how telemedicine can provide technology-based medical services, with artificial intelligence playing a key role. The document also includes the economic assessment and budgetary impact of incorporating telemedicine in cardiology in Brazil and telemedicine in supplementary health, and - in one of the most important chapters - presents the ethical and legal aspects of telemedicine. Finally, the document includes a set of recommendations intended to be practical and adapted to the Brazilian perspective.</p>
      <p>The result is a guideline perfectly aligned with the WHO guidelines on the principle that the implementation of telemedicine must be properly planned and should predict situations like the feasibility of network coverage for technology access in remote locations, construction of a legal and judicial structure for the implementation, budgetary impact and cost-effectiveness assessment of the implementation of each stage of the project, and development of indicators of the clinical continuum of applicability for user safety. As the president-elect of the World Heart Federation, I see this as a model document in terms of how it was planned and implemented, as well as in its content, reflecting the current evidence and perspective of the main scientific players in the area. As such, I think it will become a historical document, a milestone in the responsible introduction of telemedicine-telecardiology in clinical practice, in this case, applied to Brazil, but which can serve as an example for others globally, contributing to decrease the burden of cardiovascular diseases worldwide.</p>
      <p>Lisbon, June 2019.</p>
      <p>
        <bold>Prof. Fausto J. Pinto, FESC, FACC</bold>
      </p>
      <p>President-elect, World Heart Federation (WHF)</p>
      <p>Past President, European Society of Cardiology (ESC)</p>
      <p>University of Lisbon, Portugal</p>
    </sec>
    <sec sec-type="intro">
      <title>Introduction</title>
      <p>For more than 26 years now, starting after the publication of the Consensus on Severe Heart Disease in 1993,<xref ref-type="bibr" rid="B2">2</xref>the Brazilian Society of Cardiology (SBC) has been regularly issuing guidelines on most diverse topics, guiding the practice of cardiology in Brazil. In 1999, the Brazilian Federal Council of Medicine (CFM)<xref ref-type="bibr" rid="B3">3</xref>partnered with the Brazilian Medical Association (AMB) and, aiming to support medical decision making and optimize patient care, started a process along with specialty societies for the development of Medical Guidelines based on current scientific evidence. Thus, the commitment of SBC precedes the initiative by AMB and fulfills one of the society&#8217;s objectives, described in the society&#8217;s bylaws.</p>
      <p>Resolution 1.642/2002,<xref ref-type="bibr" rid="B4">4</xref>passed by the CFM to preserve the autonomy of the physician, defined that, in their relationship with physicians and beneficiaries, health insurance and group medical companies, medical cooperatives, self-management companies, and other companies offering direct care or care mediated by medical-hospital services should only adopt medical guidelines or protocols prepared by Brazilian specialty societies along with the AMB. Within this context,<xref ref-type="bibr" rid="B5">5</xref>the CFM initiated discussions in 2018 to update the regulations of telemedicine.</p>
      <p>Telemedicine can be defined as the application of information and communication technologies to health care with the goal of offering, in a broad concept, health-related services ranging from primary care to robotic surgery and education, expanding coverage to remote areas in a country with continental dimensions.</p>
      <p>The Pan American Health Organization (PAHO) and the WHO define telemedicine as &#8220;The delivery of health care services, where distance is a critical factor, by all health care professionals using information and communication technologies for the exchange of valid information for diagnosis, treatment, and prevention of disease and injuries, research and evaluation, and for the continuing education of health care providers, all in the interests of advancing the health of individuals and their communities.&#8221; The PAHO estimates that one third of the population in the Americas has no access to health care and that 800,000 additional health care professionals would be needed to meet the needs in the region.<xref ref-type="bibr" rid="B6">6</xref>If applied in its broad context, telemedicine could allow access and reduce inequality for this population by providing supposedly cost-effective quality services, especially considering the increased prevalence and mortality from chronic noncommunicable diseases (NCDs) in low- and middle-income countries like Brazil. Added to this context is the aging and increasing disease rate of the Brazilian population, which makes telemedicine an ideal tool to face the contemporary challenges of universal health care systems.<xref ref-type="bibr" rid="B7">7</xref>
			</p>
      <p>Beyond the vast possibilities and applications of telemedicine, rigorous evaluations of telemedicine projects must be undertaken, not only because all health care systems face financial sustainability challenges beyond investments in health care interventions, but also because of the limited clinical evidence available, especially in the current order of value-based medicine. This topic of utmost importance has been the subject of several publications by the WHO. Examples of that include the Digital Health Atlas,<xref ref-type="bibr" rid="B8">8</xref> a global virtual platform to support governments in monitoring and coordinating digital health activities; &#8220;BeHe@lthy, BeMobile&#8221; (BHBM),<xref ref-type="bibr" rid="B9">9</xref>for the prevention and control of NCDs; and mHealth Assessment and Planning for Scale (MAPS), a manual for digital health monitoring and evaluation<xref ref-type="bibr" rid="B10">10</xref>to enhance digital health research and implementation; among others. These documents culminated in the publication by the WHO of the first guideline on digital health interventions on April 17, 2019.<xref ref-type="bibr" rid="B11">11</xref>
			</p>
      <p>In addition to updating the guideline on telemedicine applicable to cardiology published in 2015, the main objective of the present guideline is to answer the following questions: Is there legal and ethical support for the application of telemedicine in Brazil? Are there technical conditions for the application of telemedicine in the country? What is the priority of incorporating telemedicine into the health care system? For which modalities is there good quality scientific evidence to support this practice? For modalities supported by solid evidence, does cost effectiveness justify this application? What would be the budgetary impact? Is the Brazilian health care system prepared to provide comprehensive care?</p>
      <p>This guideline, which is in line with the WHO guidelines,<xref ref-type="bibr" rid="B11">11</xref> advocates that the implementation of telemedicine should be a planned process that provides feasibility of the network coverage in remote locations, elaboration of the legal and judicial bases for its implementation, budgetary impact and cost-effectiveness assessment of each stage of the project, and development of clinical continuum indicators of the applicability for the safety of the beneficiaries. Telemedicine can be a potential tool in improving health care services but is not exempt from risks and challenges related to its implementation and from the evaluation of the real impact of its benefits.</p>
      <p>In the final chapter, the authors present a summary of recommendations based on current evidence, in an attempt to guide the discussions that will certainly permeate the democratization of comprehensive health care services, especially the actions involving telemedicine as a tool to expand the universality and integrality of the Brazilian Unified Health System (SUS), recommendations that also extend to supplementary health care.</p>
      <p>Brazil, June 2019.</p>
      <p>
        <bold>Dr. Marcelo Ant&#244;nio Cartaxo Queiroga, FESC, TEC-SBC</bold>
      </p>
      <p>President-elect of the Brazilian Society of Cardiology (Sociedade Brasileira de Cardiologia - SBC)</p>
      <p>Director of the Department of Interventional Cardiology, Alberto Urquiza Wanderley Hospital, Jo&#227;o Pessoa, PB, Brazil Member of the Para&#237;ba State Academy of Medicine</p>
      <p>
        <bold>Dr. Gl&#225;ucia Maria Moraes de Oliveira, FACC, FESC, TEC-SBC</bold>
      </p>
      <p>Associate Professor of Cardiology at the Federal University of Rio de Janeiro (Universidade Federal do Rio de Janeiro - UFRJ) </p>
      <p>Coordinator of the Postgraduate Cardiology Program at UFRJ, Rio de Janeiro, RJ, Brazil</p>
      <p>President of the Federation of the Cardiology Societies of the Portuguese-Speaking Countries (2015-2016)</p>
    </sec>
    <sec>
      <title>1. Fundamentals of Telemedicine: Concepts, Bioethical Aspects, Legislation and Regulation, Applicability in Brazil, and Artificial Intelligence</title>
      <sec>
        <title>1.1. Fundamentals of Telemedicine</title>
        <p>In May 2005, Ministers of Health from 192 countries members of the World Health Organization (WHO) approved the Resolution on eHealth,<xref ref-type="bibr" rid="B12">12</xref> which recognized for the first time the importance of information and communication technologies (ICTs) applied to health - digital health or eHealth - &#8220;reinforcing the fundamental human rights by increasing and improving equity, solidarity, quality of life, and quality of care.&#8221;</p>
        <p>The Brazilian Ministry of Health defines the following areas of telehealth application:<xref ref-type="bibr" rid="B13">13</xref>
				</p>
        <p>
          <bold>Innovation in digital health and telehealth</bold>
        </p>
        <p>Innovation in digital health is transversal to telehealth initiatives and seeks to explore via ICT new ideas to solve chronic problems with difficult solutions by usual methods. It must start with the population&#8217;s health care needs.</p>
        <p>
          <bold>Teleconsulting</bold>
        </p>
        <p>Registered consultation between health care workers, professionals, and managers using two-way telecommunication instruments in order to answer questions about clinical procedures, health care actions, and suggestions related to the work process in health care. Teleconsulting can occur in real time or by offline messaging.</p>
        <p>
          <bold>Telediagnosis</bold>
        </p>
        <p>Autonomous service using ICT to deliver diagnostic support services (<italic>e.g.,</italic> remote evaluation of diagnostic tests) to facilitate access to specialized services. The use of telediagnosis seeks to reduce the time to diagnosis by enabling treatment for predictable complications through early diagnosis.</p>
        <p>
          <bold>Telemonitoring</bold>
        </p>
        <p>Remote monitoring of patients&#8217; health and/or disease parameters through ICT. Monitoring may include clinical data collection, transmission, processing, and management by a health care professional using an electronic system.</p>
        <p>
          <bold>Teleregulation</bold>
        </p>
        <p>Set of actions in regulatory systems for evaluation of adequate responses to existing demands, promoting equity and access to services, and enabling health care access. Teleregulation also includes the evaluation and planning of actions to provide regulatory operational intelligence to management teams. The objective of teleregulation is to potentiate primary health care services, thus enabling the qualification and reduction of wait for specialized care.</p>
        <p>
          <bold>Tele-education</bold>
        </p>
        <p>Availability of interactive educational materials on health-related topics delivered remotely through ICT and focused on professional education across activity areas.</p>
      </sec>
      <sec>
        <title>1.2. Types of Intervention in Telehealth</title>
        <p>Synchronous video conference: modality of remote interaction via live conference between primary care and medical specialty services.</p>
        <p>Asynchronous video conference (&#8220;store and forward&#8221;): use of a storage system to forward diagnostic images, vital signs, and/or video clips along with patients&#8217; data for later review by a specialist. Provides diagnostic and treatment support for the primary care system.</p>
        <p>Remote monitoring: use of equipment to remotely collect and forward patients&#8217; data to a hospital or monitoring center for interpretation. These (wearable) devices monitor remotely a variety of indicators ranging from specific vital signs (heart rate, blood pressure [BP], and blood glucose) to other indicators.</p>
        <p>Mobile health (mHealth): defined as a medical and public health care practice supported by mobile devices like cell phones, monitoring devices, personal digital assistants (PDAs), and other wireless devices.<xref ref-type="bibr" rid="B14">14</xref>
				</p>
        <p>The goals of telemedicine include:</p>
        <p> Remote assistance: teleconsultation, telediagnosis or diagnostic telemonitoring, remote patient monitoring and/or treatment;</p>
        <p> Administrative management of patient care: request of diagnostic tests, medical prescriptions, and actions related to service reimbursement;</p>
        <p> Remote qualification of human resources to facilitate continuing education programs;</p>
        <p> Network collaborative clinical research: use of ICT to share and disseminate best practices and generate knowledge.</p>
      </sec>
      <sec>
        <title>1.3. Safe Bases for Data Transmission</title>
        <p>Information safety is fundamental for data transmission, and two immediate effects must be considered: a) understanding of the critical value of data storage and use, and b) possible implications for individuals and organizations of violating safety and compliance standards.</p>
        <p>The European General Data Protection Regulation (GDPR) and the Brazilian General Data Protection Act (<italic>Lei Geral de Prote&#231;&#227;o de Dados</italic>, LGPD) impose heavy fines and sanctions for improper access to information under their custody.</p>
        <p>The following sections list the main requirements for establishing appropriate safety policies.<xref ref-type="bibr" rid="B15">15</xref>
				</p>
      </sec>
      <sec>
        <title>1.4. Data Protection and Confidentiality</title>
        <p>For proper information protection, the safety of the systems must be ensured, reducing vulnerabilities and preventing improper access and breach of confidentiality. Authorizations and hierarchical levels for access to information must be clearly determined.<xref ref-type="bibr" rid="B16">16</xref>
				</p>
        <p>The policy related to information access and confidentiality must be reported in a document signed by the users defining the a) scope of data that can be accessed and b) legal implications and sanctions eventually applied to users in case of violation of the agreed rules.</p>
        <p>Misuse of technological installations is directly related to the safety of the environments under the responsibility of ICT teams. Strict policies must be adopted in terms of access to physical facilities, data networks, operating systems, and databases and their applications. A valuable framework to provide an understanding of the control of these environments can be found in the document &#8220;Access Control Example Policy&#8221; (Health and Social Care Information Centre, 2017).<xref ref-type="bibr" rid="B16">16</xref>
				</p>
        <p>The recommended standard for data transmission in Brazil follows the set of rules determined by the Health Insurance Portability and Accountability Act (HIPAA).17 This set of norms has proven robust enough to ensure the safety of the transferred data and is recommended as the benchmark for data transfer practices. The CFM Resolution 2.227/2018, now revoked, set the standard that would meet the desirable requirements: &#8220;Use of a proprietary or an open-source electronic/digital information registration system that captures, stores, presents, transfers, or prints digitally identifiable health information and is fully compliant with the requirements of Safety Assurance Level 2 (<italic>N&#237;vel de Garantia de Seguran&#231;a 2</italic>, NGS2) and the ICP-Brazil standard.&#8221;</p>
        <p>According to these standards, stored data (&#8220;at rest&#8221;; &#8220;in transit&#8221;) must be encrypted for transfer. One of the essential practices for data security is to maintain the tools required to encrypt and decrypt information in environments other than the original storage locations.<xref ref-type="bibr" rid="B18">18</xref><sup>-</sup><xref ref-type="bibr" rid="B20">20</xref>
				</p>
        <p>In addition to ensuring information security, HIPAA rules offer extensive documentation for data encryption and transfer, facilitating the work of development teams. Of note, national public data cannot be stored in cloud systems hosted outside the country.<xref ref-type="bibr" rid="B21">21</xref><sup>-</sup><xref ref-type="bibr" rid="B22">22</xref>
				</p>
      </sec>
      <sec>
        <title>1.5. Bioethical Aspects</title>
        <p>Initiatives to provide remote health care through telemedicine date back to the 19th century. Cardiology was a pioneer in this initiative, with the description by Einthoven in 1906 of a transtelephonic electrocardiographic transmission from the academic hospital to the physiology laboratory at Leiden University, a few miles away.<xref ref-type="bibr" rid="B23">23</xref> The big boost in the development of telemetry was by the North American Space Agency (NASA) in astronaut monitoring.<xref ref-type="bibr" rid="B24">24</xref><sup>,</sup><xref ref-type="bibr" rid="B25">25</xref>
				</p>
        <p>However, the incorporation of telemedicine, as currently conceived, is contemporaneous<xref ref-type="bibr" rid="B24">24</xref><sup>-</sup><xref ref-type="bibr" rid="B29">29</xref> and linked to the traditional notion that the preservation of the social value of medicine depends on content flow. Any modality of telecommunication holds both constructive and destructive potentials that trigger contradictions in terms of values and rules of moral code related to bedside medical practice. Ambivalence is welcome in medicine, which according to Osler (1849-1919), is the science of uncertainty and the art of probability.<xref ref-type="bibr" rid="B28">28</xref> Telemedicine is not immune to the pendular movements of the variety of methods addressing health needs.</p>
        <p>Bedside practice faces dilemmas inherent to the diversity of the human condition.<xref ref-type="bibr" rid="B30">30</xref> Physicians and patients face external and/or internal challenges without a single and simple solution. Any option to be considered must be judiciously expressed, clarified, and adjusted to be validated for the conceptual and individual context of the clinical circumstance.</p>
        <p>Applied technology has attributed a sense of real progress to medicine.<xref ref-type="bibr" rid="B31">31</xref> The contemporary emphasis on ICTs in health care must be critically observed by society. Bioethics has the required competence to evaluate the effects of telemedicine on the integration of health sciences, health care professionals, patients/relatives, health institutions, and health care system.</p>
        <p>The benefit of telemedicine should be considered more as a non-presential complementation of usual care rather than a replacement for face-to-face care. Telemedicine should be practiced with security and for a period relevant to the clinical circumstance (expiration dates proportional to the legitimate interests involved).<xref ref-type="bibr" rid="B32">32</xref><sup>,</sup><xref ref-type="bibr" rid="B33">33</xref>
				</p>
        <p>An additional ethical aspect is that certain unavoidable perspectives of abuse of a technique should not adversely affect the beneficial use of the technique. Therefore, any ethical and legal considerations regarding the still young telemedicine, especially for application in a continental, multiethnic, and multicultural country like Brazil, cannot fail to recognize that it is difficult for a health care professional to define comprehensively and in depth his or her set of responsibilities, considering that the scope of telemedicine demands an A-to-Z range of intertwining requirements, decisions, and provisions regarding:</p>
        <p>
          <list list-type="alpha-lower">
            <list-item>
              <p> involvement with fundamentals of current ethics, prudence, and zeal regarding complex issues like elderly care, comfort of vulnerable individuals, decrease in hospitalizations, and prompt guidance;</p>
            </list-item>
            <list-item>
              <p> impartial judgment about covering the patient&#8217;s real needs and constraint of secondary gains and conflicts of interest, including the potential for political (mis)use and power;</p>
            </list-item>
            <list-item>
              <p> sense of beneficence;</p>
            </list-item>
            <list-item>
              <p> avoidance of maleficence;</p>
            </list-item>
            <list-item>
              <p> commitment to the biological safety of the patient;</p>
            </list-item>
            <list-item>
              <p> respect for equity;</p>
            </list-item>
            <list-item>
              <p> definition about the complementary function of the &#8220;presential&#8221; and its substitute;</p>
            </list-item>
            <list-item>
              <p> awareness about the consequences of the &#8220;non-presential&#8221; on clinical reasoning;</p>
            </list-item>
            <list-item>
              <p> clarity about the range of use variations;</p>
            </list-item>
            <list-item>
              <p> training on roles, responsibilities, and skills in equipment management with continuous improvement;</p>
            </list-item>
            <list-item>
              <p> development of a friendly connection to the patients&#8217; records;</p>
            </list-item>
            <list-item>
              <p> respect for the patient&#8217;s right to autonomy expressed through free, informed, renewable, and revocable consent;</p>
            </list-item>
            <list-item>
              <p> imperative appreciation of human values;</p>
            </list-item>
            <list-item>
              <p> critical appreciation of cost effectiveness;</p>
            </list-item>
            <list-item>
              <p> appreciation of the value of face-to-face relationships immediately or long before the online connection;</p>
            </list-item>
            <list-item>
              <p> creation of a mood of confidence despite the distance;</p>
            </list-item>
            <list-item>
              <p> conceptual and event-driven alerts about non-presential limitations;</p>
            </list-item>
            <list-item>
              <p> individual assessment of the level of competence for the required care at the moment;</p>
            </list-item>
            <list-item>
              <p> assessment of the completeness of the required information;</p>
            </list-item>
            <list-item>
              <p> concern with the continuity of the care provided;</p>
            </list-item>
            <list-item>
              <p> promotion of adherence to the recommended management; </p>
            </list-item>
            <list-item>
              <p> respect for professional confidentiality;</p>
            </list-item>
            <list-item>
              <p> &#8220;passport adjustments&#8221; related to the state geographical limitation of the physician&#8217;s registration in the medical council;</p>
            </list-item>
            <list-item>
              <p> continued research for reliable evidence of advantages and disadvantages;</p>
            </list-item>
            <list-item>
              <p> interface with consumerism in health care, including due and undue expectations about the possibility of immediate care;</p>
            </list-item>
            <list-item>
              <p> valuing the contribution of bioethics to the harmonization between classic, innovative, and novelty.</p>
            </list-item>
          </list>
        </p>
        <p>Therefore, in light of the existing ethical-normative bases of the current legislation and the bioethical principles that guide physician-patient relationships, we can establish the following guidelines for the use of telemedicine in cardiology:</p>
        <p> Cardiologists should use caution, and prior to using telemedicine applied to cardiology (or simply telecardiology), they should maintain a fruitful relationship with their patients based on the Code of Medical Ethics.</p>
        <p> The free and informed consent form is the document that obtains authorization from the patient for the use of telecardiology when the alternative of direct teleconsultation is considered.</p>
        <p> Procedures for the remote monitoring of vital signs should be previously consented by the patient, with proper guidance and training regarding its use.</p>
        <p> Medical companies providing telecardiology services must be registered with the Regional Medical Council (<italic>Conselho Regional de Medicina</italic>, CRM) and have a cardiologist as a technical manager, who will be in charge of overseeing the procedures performed, especially regarding the technological tools available to professionals.</p>
        <p> Respect for the patients&#8217; autonomy of will and protection of privacy regarding health data are the basis of telemedicine applied to cardiology.</p>
      </sec>
      <sec>
        <title>1.6. Legislation and Regulation in Brazil</title>
        <p>The Brazilian Internet Civil Framework (Federal Law No. 12.965, dated April 23, 2014)<xref ref-type="bibr" rid="B34">34</xref> and the General Data Protection Law (LGPD; Federal Law No. 13.709, dated August 14 2018)<xref ref-type="bibr" rid="B35">35</xref> are the main normative instruments with direct impact on telemedicine in Brazil, even though they are not specific for this purpose. The main authorities regulating telemedicine in Brazil are the Ministry of Health, the National Sanitary Surveillance Agency (Anvisa), the National Supplementary Health Agency (ANS), and the CFM.</p>
        <sec>
          <title>1.6.1. The Brazilian Internet Civil Framework</title>
          <p>The Brazilian Internet Civil Framework (Decree 8.771, dated May 11, 2016)<xref ref-type="bibr" rid="B34">34</xref> establishes the principles, guarantees, rights, and duties of users of the World Wide Web in Brazil.</p>
          <p>The Brazilian Internet Civil Framework recognized legal relations in the virtual world and their effects on Brazilian order. In addition to establishing the neutrality of the web, it also excelled in safeguarding freedom of expression and privacy protection but failed to address important aspects related to personal data, leading to the development of the LGPD.34</p>
        </sec>
        <sec>
          <title>1.6.2. General Law Data Protection Law</title>
          <p>Federal Law No. 13.709,<xref ref-type="bibr" rid="B35">35</xref> dated August 14, 2018 (LGPD) deals with the processing of personal data, including digital information, by an individual or entity governed by public or private law, with the purpose of protecting the fundamental rights of freedom and privacy and the free development of the personality of the natural individual.</p>
          <p>An important contribution of the LGPD<xref ref-type="bibr" rid="B35">35</xref> is the clear definition of the concept of data:</p>
          <p>
            <list list-type="roman-upper">
              <list-item>
                <p> Personal data - information related to an identified or identifiable natural individual;</p>
              </list-item>
              <list-item>
                <p> Anonymized data - data related to a holder that cannot be identified by reasonable technical means available at the time of processing;</p>
              </list-item>
              <list-item>
                <p> Sensitive personal data - racial or ethnic origin; religious belief; political opinion; union affiliation or membership in religious, philosophical, or political organizations; health- or sex-related data; and genetic or biometric data, when linked to a natural individual.</p>
              </list-item>
            </list>
          </p>
          <p>According to the legislation, access to the Internet is essential to the exercise of citizenship, and inviolability of intimacy, privacy, and communications established through the Internet must be ensured to users.</p>
          <p>Safety and confidentiality measures and procedures must be clearly informed by the service provider and should meet the standards set by regulations, respecting the right of confidentiality related to business privacy.</p>
          <p>Regarding telemedicine, the need to deal with a large amount of sensitive data (patient registration, health complaints, prior and current disease history, test requests and results, diagnostic hypotheses, therapeutic plan, clinical follow-up, and opinions, among others) makes LGPD an object of significant interest.</p>
          <p>In 2007, the Brazilian Ministry of Health established the National Telehealth Program to improve the quality of primary health care in the Unified Health System (SUS) and support the Family Health Strategy program. Ordinance 2.546, dated October 2011, expanded, redefined, and renamed the program to Brazilian National Telehealth Network Program, which governs the services of synchronous or asynchronous teleconsultation, telediagnosis, second formative opinion, and health tele-education.<xref ref-type="bibr" rid="B36">36</xref>
					</p>
        </sec>
        <sec>
          <title>1.6.3. Regulation of Telemedicine by the Federal Council of Medicine</title>
          <p>According to CFM Resolution 1.643/2002,<xref ref-type="bibr" rid="B37">37</xref>telemedicine is the practice of medicine through the use of interactive audiovisual and data communication methodologies, with the objective of health care, education, and research. Additionally, the following relevant aspects should be highlighted:</p>
          <p>
            <list list-type="bullet">
              <list-item>
                <p> The services provided must have appropriate technological infrastructure and should comply with the CFM technical standards related to data storage, handling, transfer, confidentiality, and privacy, and must ensure professional secrecy.</p>
              </list-item>
              <list-item>
                <p> The professional responsibility for the care lies with the patient&#8217;s attending physician. Others involved in the process will be jointly liable to the extent to which they contribute to the eventual damage.</p>
              </list-item>
              <list-item>
                <p> Entities providing telemedicine services must be registered in the Entities Register of the Regional Council of Medicine of the state of their location along with a physician regularly registered in the Council assigned as a technical manager and a list of all physicians participating as staff members.</p>
              </list-item>
            </list>
          </p>
          <p>Since then, technological innovations and the democratization of Internet access have allowed several innovations that still lack proper regulation, such as:</p>
          <p>
            <list list-type="bullet">
              <list-item>
                <p> new means of physician-patient relationship;</p>
              </list-item>
              <list-item>
                <p> emergence of data and service agents and providers;</p>
              </list-item>
              <list-item>
                <p> discussion of a new format for the free and informed consent form under strict safety rules to guarantee information confidentiality and integrity.</p>
              </list-item>
            </list>
          </p>
          <p>This scenario prompted a need to update the regulation of telemedicine practice in Brazil. Based on that, the CFM issued Resolution 2.227/2018, which was later repealed. However, an update of the Resolution is urgently needed to provide legal security within the perspective of telemedicine emerging as a vector of health transformation.<xref ref-type="bibr" rid="B38">38</xref>
					</p>
          <p>In this guideline, we adopt the denomination of the services offered within the scope of telemedicine, according to the Ministry of Health Ordinance 2.546, dated October 2011, and current CFM regulation.</p>
        </sec>
      </sec>
      <sec>
        <title>1.7. Applicability in Brazil</title>
        <p>In a country with continental proportions like Brazil, telemedicine represents a perspective to ensure the implementation of public policies conceived when the SUS was established, which have not been entirely fulfilled due to existing unassisted or remote areas lacking health care professionals, among other reasons. Thus, infrastructure conditions must be established to deliver available resources using health-related ICTs to these areas. To understand the applicability of telemedicine in Brazil, it is important to discuss concepts related to remote areas and to know the country&#8217;s medical demography.</p>
        <sec>
          <title>1.7.1. Concept of Urban and Rural Territories and Remote Area</title>
          <p>The definition of territory goes beyond that of physical space since it generally has a strong relationship with the sociocultural context of the area. The division between urban and rural spaces is not abrupt; both have flexible boundaries and similar characteristics.<xref ref-type="bibr" rid="B39">39</xref> Territorial occupation is evidently unequal in many regions, as it is also the access to goods and services offered in different forms of human settlements. In general, modes of transport and accessibility to urban and rural areas differ from one location to another, thus the importance of defining a classification for urban and rural concepts.<xref ref-type="bibr" rid="B40">40</xref>
					</p>
          <p>According to the Organization for Economic Cooperation and Development (OECD), spaces are classified according to the population density, the proportion of the population living in large centers, and accessibility, defined as the commuting time between urban centers and rural areas. A rural area is classified as remote by the OECD when 50% of the local population requires at least 45 to 60 minutes of travel in motor vehicle to reach a center with a population of at least 50,000 inhabitants.<xref ref-type="bibr" rid="B41">41</xref>
					</p>
          <p>In Brazil, the classification of occupied rural or urban spaces was established in 1938 by Decree No. 311/1938. The 2014 Territorial Base Manual, by the Brazilian Institute of Geography and Statistics (IBGE),<xref ref-type="bibr" rid="B42">42</xref>considers the access by national road or waterway network from rural areas to urban centers to classify rural areas according to their degree of proximity and access to large urban centers, creating a sense of isolation. The 2014 Transportation Logistics Map classified municipalities as adjacent or remote if the travel time from the municipal headquarters to a center of influence was longer or shorter, respectively, than the national average.</p>
          <p><xref ref-type="table" rid="t4">Table 1.1</xref> shows the distribution of municipalities across the national territory based on the classification of isolation by IBGE.<xref ref-type="bibr" rid="B43">43</xref>
					</p>
          <table-wrap id="t4">
            <label>Table 1.1</label>
            <caption>
              <title>Classification of isolation of Brazilian municipalities according to region and population<xref ref-type="bibr" rid="B43">43</xref>
							</title>
            </caption>
            <table frame="hsides" rules="rows">
              <colgroup>
                <col width="12%"/>
                <col width="12%"/>
                <col width="12%"/>
                <col width="12%"/>
                <col width="12%"/>
                <col width="12%"/>
                <col width="12%"/>
                <col width="12%"/>
              </colgroup>
              <thead>
                <tr>
                  <th align="left" colspan="2">Classification of isolation (IBGE)</th>
                  <th align="center">Brazil</th>
                  <th align="center">North</th>
                  <th align="center">Northeast</th>
                  <th align="center">Southeast</th>
                  <th align="center">South</th>
                  <th align="center">Midwest</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left" rowspan="4">Adjacent</td>
                  <td align="center">Number of municipalities</td>
                  <td align="center">5,126</td>
                  <td align="center">277</td>
                  <td align="center">1,683</td>
                  <td align="center">1,637</td>
                  <td align="center">1,180</td>
                  <td align="center">349</td>
                </tr>
                <tr>
                  <td align="center">% of municipalities in relation to the large region</td>
                  <td align="center">92.11</td>
                  <td align="center">61.69</td>
                  <td align="center">93.81</td>
                  <td align="center">98.14</td>
                  <td align="center">99.33</td>
                  <td align="center">74.89</td>
                </tr>
                <tr>
                  <td align="center">Total population<break/>2010 Census)</td>
                  <td align="center">183,820,219</td>
                  <td align="center">12,610,201</td>
                  <td align="center">51,780,322</td>
                  <td align="center">79,982,805</td>
                  <td align="center">27,099,304</td>
                  <td align="center">12,347,587</td>
                </tr>
                <tr>
                  <td align="center">% of the population </td>
                  <td align="center">96.37</td>
                  <td align="center">79.49</td>
                  <td align="center">97.56</td>
                  <td align="center">99.53</td>
                  <td align="center">98.95</td>
                  <td align="center">87.83</td>
                </tr>
                <tr>
                  <td align="left" rowspan="4">Remote</td>
                  <td align="center">Number of municipalities</td>
                  <td align="center">439</td>
                  <td align="center">172</td>
                  <td align="center">111</td>
                  <td align="center">31</td>
                  <td align="center">8</td>
                  <td align="center">117</td>
                </tr>
                <tr>
                  <td align="center">% of municipalities in relation to the large region</td>
                  <td align="center">7.89</td>
                  <td align="center">38.31</td>
                  <td align="center">6.19</td>
                  <td align="center">1.86</td>
                  <td align="center">0.67</td>
                  <td align="center">25.11</td>
                </tr>
                <tr>
                  <td align="center">Total population (2010 Census)</td>
                  <td align="center">6,927,512</td>
                  <td align="center">3,254,253</td>
                  <td align="center">1,293,560</td>
                  <td align="center">381,605</td>
                  <td align="center">287,587</td>
                  <td align="center">1,710,507</td>
                </tr>
                <tr>
                  <td align="center">% of the population</td>
                  <td align="center">3.63</td>
                  <td align="center">20.51</td>
                  <td align="center">2.44</td>
                  <td align="center">0.47</td>
                  <td align="center">1.05</td>
                  <td align="center">12.17</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <attrib>Source: IBGE. Classification and Characterization of Rural and Urban Spaces in Brazil.<xref ref-type="bibr" rid="B43">43</xref>
							</attrib>
            </table-wrap-foot>
          </table-wrap>
          <p>More than 65% of the municipalities considered to be remote are located in the North and Midwest regions of the country. These two regions concentrate 5 million inhabitants or 72% of the country&#8217;s residents living in remote municipalities (almost 7 million individuals live in areas considered remote by the IBGE). Also in the North and Midwest regions, the population in remote municipalities represents 20% and 12% of the total population, respectively. <xref ref-type="fig" rid="f1">Figure 1.1</xref> shows the proportion of urban population in Brazilian municipalities.</p>
          <p>
            <fig id="f1">
              <label>Figure 1.1</label>
              <caption>
                <title>Proportion of urban population in Brazilian municipalities, 2010 census.<xref ref-type="bibr" rid="B44">44</xref>
								</title>
              </caption>
              <attrib>Source: IBGE &#8211; 2010 census.<xref ref-type="bibr" rid="B44">44</xref>
							</attrib>
              <graphic xlink:href="1678-4170-abc-113-05-1006-90205-gf01.jpg"/></fig>
          </p>
        </sec>
        <sec>
          <title>1.7.2. Medical Demography</title>
          <p>The ratio of physicians per inhabitant in Brazil (2.1 physicians per thousand inhabitants) is significantly lower than the average ratio in OECD countries (3.4 physicians per thousand inhabitants). In addition to the absolute shortage of professionals, the country also has relative shortages due to large regional inequalities in the distribution of the existing medical workforce. Recent studies point out to a large concentration of medical professionals in the South and Southeast, with the proportion of specialists following this trend.<xref ref-type="bibr" rid="B45">45</xref>
						<xref ref-type="table" rid="t5">Table 1.2</xref> shows the distribution of physicians by country region, divided according to specialization as generalists, with some type of specialty (specialists), ratio per thousand inhabitants, and distribution of cardiologists by region and per inhabitant.</p>
          <table-wrap id="t5">
            <label>Table 1.2</label>
            <caption>
              <title>Distribution of physicians by region of the country, disaggregated by specialization and region, grouped as generalists or specialists</title>
            </caption>
            <table frame="hsides" rules="rows">
              <colgroup>
                <col width="12%"/>
                <col width="12%"/>
                <col width="12%"/>
                <col width="12%"/>
                <col width="12%"/>
                <col width="12%"/>
                <col width="12%"/>
                <col width="12%"/>
              </colgroup>
              <thead>
                <tr>
                  <th align="left">Region</th>
                  <th align="center">Physicians</th>
                  <th align="center">Generalists</th>
                  <th align="center">Specialists</th>
                  <th align="center">Population </th>
                  <th align="center">Cardiology</th>
                  <th align="center">Cardiology/1,000 inhabs.</th>
                  <th align="center">Physician/1,000 inhabs.</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left">North</td>
                  <td align="center">20,884</td>
                  <td align="center">10,128</td>
                  <td align="center">10,766</td>
                  <td align="center">17,936,201</td>
                  <td align="center">441</td>
                  <td align="center">0.025</td>
                  <td align="center">1.16</td>
                </tr>
                <tr>
                  <td align="left">Northeast</td>
                  <td align="center">80,623</td>
                  <td align="center">34,461</td>
                  <td align="center">46,162</td>
                  <td align="center">57,254,159</td>
                  <td align="center">2,534</td>
                  <td align="center">0.044</td>
                  <td align="center">1.41</td>
                </tr>
                <tr>
                  <td align="left">Midwest</td>
                  <td align="center">37,536</td>
                  <td align="center">12,828</td>
                  <td align="center">24,708</td>
                  <td align="center">15,875,907</td>
                  <td align="center">1,464</td>
                  <td align="center">0.092</td>
                  <td align="center">2.36</td>
                </tr>
                <tr>
                  <td align="left">Southeast</td>
                  <td align="center">244,304</td>
                  <td align="center">91,124</td>
                  <td align="center">153,180</td>
                  <td align="center">86,949,714</td>
                  <td align="center">8,383</td>
                  <td align="center">0.096</td>
                  <td align="center">2.81</td>
                </tr>
                <tr>
                  <td align="left">South</td>
                  <td align="center">68,430</td>
                  <td align="center">20,948</td>
                  <td align="center">47,482</td>
                  <td align="center">29,644,948</td>
                  <td align="center">2,694</td>
                  <td align="center">0.091</td>
                  <td align="center">2.31</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <attrib>Source: Scheffer M, Cassenote A, Guilloux AGA, Mioto BA, Mainardi GM. Medical Demography in Brazil 2018. S&#227;o Paulo: FMUSP, CFM, Cremesp; 2018.<xref ref-type="bibr" rid="B45">45</xref>
							</attrib>
              <fn id="TFN1">
                <p>*Population estimated by IBGE in 2017.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p>In the North and Northeast regions, some Federation units have a physician/inhabitant ratio below 1.00, like Par&#225; and Maranh&#227;o, where the ratios are 0.97 and 0.87, respectively. The most recent Brazilian Medical Demographic Report (2018) also pointed to a significant inequality in the distribution of physicians between predominantly urban and rural municipalities, with a high concentration of the medical workforce in large urban centers.<xref ref-type="bibr" rid="B45">45</xref>
					</p>
          <p>Data from the National Register of Health Establishments (<italic>Cadastro Nacional de Estabelecimentos de Sa&#250;de,</italic> CNES), provided by the Ministry of Health,<xref ref-type="bibr" rid="B46">46</xref> show the same trend of concentration of medical professionals in the South and Southeast regions in February 2019, as seen in <xref ref-type="fig" rid="f2">Figure 1.2</xref>.<xref ref-type="bibr" rid="B46">46</xref>
					</p>
          <p>
            <fig id="f2">
              <label>Figure 1.2</label>
              <caption>
                <title>Distribution of physicians per thousand inhabitants in Brazilian municipalities &#8211; CNES, February 2019.<xref ref-type="bibr" rid="B46">46</xref>
								</title>
              </caption>
              <attrib>Source: National Register of Health Facilities (CNES/DATASUS/MS).<xref ref-type="bibr" rid="B46">46</xref>
							</attrib>
              <graphic xlink:href="1678-4170-abc-113-05-1006-90205-gf02.jpg"/></fig>
          </p>
        </sec>
        <sec>
          <title>1.7.3. eHealth Strategy</title>
          <p>The International Telecommunication Union (ITU),<xref ref-type="bibr" rid="B47">47</xref> an agency of the United Nations (UN), has been working in collaboration with the WHO to create a global environment for eHealth strategy implementation, especially in telemedicine.<xref ref-type="bibr" rid="B47">47</xref><sup>,</sup><xref ref-type="bibr" rid="B48">48</xref>
					</p>
          <p>The eHealth strategy is particularly important in the control of chronic noncommunicable diseases like hypertension, diabetes, heart diseases, and age-related diseases. The implementation of eHealth and telemedicine has progressed substantially in recent years,<xref ref-type="bibr" rid="B49">49</xref> but a recent systematic review on the cost effectiveness of eHealth implementation found shortage of studies and could not assess the impact of the strategy on health systems or social aspects, although most studies showed the strategy to be efficacious and cost effective.<xref ref-type="bibr" rid="B49">49</xref>
					</p>
        </sec>
        <sec>
          <title>1.7.4. Telecommunications and Data Infrastructure</title>
          <p>Up to 95% of the world&#8217;s population is estimated to have access to mobile telephony; in Brazil, this coverage may exceed 98%. Access to mobile phone services has progressed remarkably in Brazil, and the use of mobile phone equipment per inhabitant has increased from 2009 to 2019,<xref ref-type="bibr" rid="B50">50</xref><sup>,</sup><xref ref-type="bibr" rid="B51">51</xref>followed by a downward trend since then (<xref ref-type="fig" rid="f3">Figure 1.3</xref>). <xref ref-type="fig" rid="f4">Figure 1.4</xref> shows the distribution of cell phones per 100 inhabitants and the ratio between cardiologists and cell phones per 1,000 inhabitants in Brazil in 2018.</p>
          <p>
            <fig id="f3">
              <label>Figure 1.3</label>
              <caption>
                <title>Density of access to mobile phones in Brazil and regions, March 2009 to 2019.<xref ref-type="bibr" rid="B50">50</xref>
								</title>
              </caption>
              <attrib>Source: ANATEL.<xref ref-type="bibr" rid="B50">50</xref>
							</attrib>
              <graphic xlink:href="1678-4170-abc-113-05-1006-90205-gf03.jpg"/></fig>
          </p>
          <p>
            <fig id="f4">
              <label>Figure 1.4</label>
              <caption>
                <title>Distribution of cell phones and cardiologists, Brazil. a) Ratio cardiologists/1,000 inhabitants (2017), b) Density of cell phone density/100 inhabitants (2019).<xref ref-type="bibr" rid="B51">51</xref>
								</title>
              </caption>
              <attrib>Source: Scheffer M, Cassenote A, Guilloux AGA, Mioto BA, Mainardi GM. Medical Demographics in Brazil 2018. S&#227;o Paulo: FMUSP, CFM, Cremesp; 2018.<xref ref-type="bibr" rid="B45">45</xref>
							</attrib>
              <graphic xlink:href="1678-4170-abc-113-05-1006-90205-gf04.jpg"/></fig>
          </p>
          <p>In terms of optical fiber coverage, the concentration is also greater in the Brazilian South and Southeast regions. <xref ref-type="fig" rid="f5">Figure 1.5</xref> shows the distribution of optical fiber backhaul in Brazilian municipalities. Backhaul is the portion of a hierarchical network (like cellular mobile communication networks) that is responsible for connecting the main network and the subnets. As shown in the map in <xref ref-type="fig" rid="f5">figure 1.5</xref>, the concentration of optical fiber networks is lower in municipalities of the North region, which also concentrates the largest proportion of isolated municipalities.</p>
          <p>
            <fig id="f5">
              <label>Figure 1.5</label>
              <caption>
                <title>Municipalities with optical fiber backhaul and other technologies, February 2019.</title>
              </caption>
              <attrib>Source: ANATEL.<xref ref-type="bibr" rid="B50">50</xref>
							</attrib>
              <graphic xlink:href="1678-4170-abc-113-05-1006-90205-gf05.jpg"/></fig>
          </p>
          <p>Data from <xref ref-type="fig" rid="f4">figures 1.4</xref> and <xref ref-type="fig" rid="f5">1.5</xref> show a trend of concentration of cardiologists in areas with a higher concentration of enabled mobile devices. The correlation coefficient of this relationship is 0.67, which indicates that the availability of cardiologists correlates highly with access to mobile phones. These data indicate a greater challenge to the implementation of telemedicine in remote areas, considering that the shortage of physicians follows the same distribution of the deficient telecommunications infrastructure in Brazil. A detailed analysis of the costs and benefits of this expansion should direct incentives to this area.</p>
        </sec>
      </sec>
      <sec>
        <title>1.8. Artificial Intelligence</title>
        <p>Artificial intelligence (AI) is a complex framework of sophisticated mathematical-computational models that allows the construction of algorithms to emulate various human tasks. AI encompasses an increasing number of subareas translating into different combined or complementary methodologies and approaches. Some examples include artificial neural networks (particularly deep learning models and convolutional networks), support vector machines, evolutionary algorithms, and natural language processing. The elaboration of analytical algorithms derived from large databases allows for interactive interpretation and apprehension, recognition of hidden patterns of combined information not obtained with traditional statistical methods, and assistance in more accurate decision making.</p>
        <p>The availability of this huge amount of data and new analytical techniques - big data analytics - opens up new scientific possibilities and AI applications, such as machine learning and data mining, which are already widely applied in telecardiology to diagnose combinations of multiple modalities of images, biobanks, electronic cohorts, on-site and distance clinical monitoring sensors, electronic health records, genomes and other molecular techniques, among others.<xref ref-type="bibr" rid="B52">52</xref><sup>-</sup><xref ref-type="bibr" rid="B54">54</xref>
				</p>
        <p>The implementation of these applications in clinical cardiology has grown exponentially<xref ref-type="bibr" rid="B55">55</xref> and has prognostic features, like the use of an algorithm derived from magnetic resonance based on three-dimensional patterns of right ventricular systolic function to assess with high accuracy the outcomes in pulmonary arterial hypertension,<xref ref-type="bibr" rid="B56">56</xref> identification of phenotypic patterns in heart failure with preserved ejection fraction and unfavorable prognosis confirmed by heterogeneous patterns of ventricular repolarization on electrocardiogram,<xref ref-type="bibr" rid="B57">57</xref> prediction of cardiovascular risk in large cohorts,<xref ref-type="bibr" rid="B58">58</xref> and prediction of urgent revascularization in emergency patients with chest pain,<xref ref-type="bibr" rid="B59">59</xref> among others. However, AI studies are generally based on observational data from administrative databases or clinical records, which potentially have different types of biases and confounding factors.<xref ref-type="bibr" rid="B54">54</xref>
				</p>
        <p>AI applications in telemedicine are promising but still very limited.<xref ref-type="bibr" rid="B60">60</xref> In the area of telediagnosis, efforts for automated classification and diagnosis in electrocardiography and cardiovascular imaging<xref ref-type="bibr" rid="B61">61</xref> are promising but still incipient. As for cardiovascular interventions, a recent review<xref ref-type="bibr" rid="B62">62</xref> found 8 studies incorporating machine learning in a real-life research setting, of which only three were evaluated in a randomized controlled trial. Of the 8 interventions, 6 (75%) showed statistical significance (at a p level of 0.05) in health outcomes. Some of these interventions are directly related to telecardiology and assessed interventions for weight loss, stress control, smoking cessation, and personalized nutrition based on glycemic response. Most studies had small sample sizes and short duration, reflecting a need for investments and further studies exploring the potentialities in the area.</p>
        <p>In a recent review, Topol<xref ref-type="bibr" rid="B63">63</xref> highlighted the presuppositions that will guide the future of AI in medicine: the patient must be considered the center for the implementation of any new technology, the incorporation of these new technologies for diagnosis and treatment should occur after robust validation of their clinical effectiveness, the use of digital tools and decision algorithms by patients should be an option for those who feel empowered to do so, and interdisciplinary training must involve health care professionals, engineers, computer scientists, and bioinformaticians. These minimum conditions presuppose the steps to incorporate AI into clinical practice and minimize implementation challenges.</p>
        <p>However, many aspects of health care practice will continue to depend on other dimensions, such as political, economic, and cultural ones, and on the ability of the health care professionals to interact with patients and community so that AI can truly benefit the patients, given that the issue of unequal access to health care is still critical in Brazil and will require large investments and reorganization of the health care system.<xref ref-type="bibr" rid="B54">54</xref>
				</p>
        <p>Thus, potential strategies for incorporation and planning of implementation and adoption must be aligned with the possibility and challenges of offering cardiology care centered on the patient and the final value aggregated to the line of cardiology care. There is a need to identify the best technology to incorporate and define in which part of the medical work process such technology can add value to both the process and the patient&#8217;s health. Additionally, it is necessary to plan the incorporation and design the journey of digital transformation in cardiology to ensure a high technological level.</p>
        <p>The incorporation of these technologies into clinical practice must, at first, involve rigorous evaluation of their performance and their ultimate value for the patient. This evaluation should respect and follow the current evaluation process of incorporation of new health technologies by the Ministry of Health, considering all aspects, norms, and regulations. The incorporation should also be based on scientific evidence on the generation of ultimate value to the patient&#8217;s health from the perspective of an individual exposed to technology.</p>
        <p>It should be made clear that AI, once incorporated, works by increasing the professionals&#8217; capabilities and never by replacing them, and that all civil and criminal responsibilities, as well as all responsibilities related to the patient and his or her health problem, remain with the attending physician.<xref ref-type="bibr" rid="B64">64</xref>
				</p>
        <p>Training should be multiprofessional, interdisciplinary, and focused on building services dedicated to generating the ultimate value for the patient. The medical curriculum in the cardiology area should include contents related to technical knowledge, competence development, and use of AI techniques, while cardiology services should structure a continuous program for professional qualification and human resources training in managing incorporation, training, and adoption of new digital health technologies.</p>
        <p>At present, there is no specific regulation on the use of AI in health care, although countries like Canada, United Kingdom, and the United States have begun the first phases of planning and implementing AI regulation in this area. Also, the European Union has published a document on the ethical aspects of AI in health care.<xref ref-type="bibr" rid="B63">63</xref> The fast-paced digital transformation has led to reflections on how to balance the adoption of technology and emerging digital systems with ethical, moral, emotional, and social values, particularly values related to patients&#8217; safety.</p>
      </sec>
    </sec>
    <sec>
      <title>2. Uses and Application of Telemedicine in Cardiology</title>
      <sec>
        <title>2.1 Telemedicine in Brazil</title>
        <p>With the development of the Information Society in the late 20<sup>th</sup> century as a result of globalization and widespread use of ICT, the emergence of organizational, social, political, and economic innovations of the society became pressing issues, requiring new ways to learn, teach, and work. The world began to worry about the principles of equal opportunity, participation, and integration so that everyone could access and benefit from the applications of the Information Society. In health care, telemedicine has made substantial progress worldwide, as it is classically viewed as a set of actions with great potential to improve access to health care services and to care quality and effectiveness at a lower cost.<xref ref-type="bibr" rid="B65">65</xref>
				</p>
        <p>As a mark of the new millennium, we highlight the aging of the population, the increase in chronic noncommunicable diseases, and the consequent need to provide health care services for a longer time, which increases health-related costs. Therefore, it is essential to incorporate innovative, efficient, and effective solutions like telemedicine and biotechnology to promote universality and comprehensiveness in health care.</p>
        <p>Several actions in telemedicine are currently present in all continents and must be planned according to local needs in order to be successful. According to Bashshur et al.,<xref ref-type="bibr" rid="B66">66</xref> the success of these actions depends on three pillars: access, quality, and cost.<xref ref-type="bibr" rid="B66">66</xref> In developed countries, telemedicine is an alternative to traditional methods and is already present as an option to supplementary health or to address gaps in the health care system, but always aiming at integral care. In developing countries, access is the main pillar, since telemedicine can be the only option in regions where traditional specialized care is not available.</p>
        <p>In Brazil, the systematic development of telemedicine and telehealth in the public health system started in 2006, with investments from the Ministry of Health, State Health Secretariats, and Municipal Health Secretariats. The main objective was to support primary care, particularly the Family Health Strategy in remote municipalities, through teleconsulting, telediagnosis, and tele-education. If applied on a large scale, these strategies could decrease the referral of patients to large centers and consequently improve the population&#8217;s access to specialized care and reduce health care costs.<xref ref-type="bibr" rid="B67">67</xref> Therefore, telemedicine in the Brazilian public system has been anchored from the outset in the basic principles of universality, equity, and integrality of the SUS. Based on the universality principle, health is everyone&#8217;s right, and it is up to the state to ensure it. Equity targets the reduction of inequalities or increased investment in areas where it&#8217;s most needed. Integrality considers the individual as a whole to meet all his or her needs.<xref ref-type="bibr" rid="B68">68</xref>
				</p>
        <p>Telecardiology, one of the most developed domains in telemedicine, has multiple actions in promoting health, disease prevention, diagnosis, treatment, and rehabilitation with an impact on the quality of life. It can be considered an important ally of the public, supplementary, or private health care system in promoting comprehensive and high-quality health care.</p>
      </sec>
      <sec>
        <title>2.2. In Primary Care</title>
        <p>Primary Health Care (PHC) involves integrated and multidisciplinary care and is the foundation to achieve universal health, according to the PAHO, which also advocates for other health determinants like education, food, housing, financial protection, clean water, and safe environments.<xref ref-type="bibr" rid="B69">69</xref> To achieve universal health, health care systems must be transformed, especially by making PHC efficient, integrated, and organized, placing the patient at the center of the system. The PAHO also estimates that about one third of the population in the Americas has no access to health care and that 800,000 additional health care professionals would be necessary to meet the needs in the region.</p>
        <p>Telemedicine plays an important role in the qualification of the PHC, with clinical, human, organizational, educational, administrative, technical, and social benefits.<xref ref-type="bibr" rid="B70">70</xref> The application of telemedicine to support PHC brings benefits to the population served, including (i) improved access to specialized services, (ii) increased solvability to the basic level, (iii) decreased number of patients referred to other municipalities for specialized care, (iv) more qualified referrals and faster hospitalization decisions, (v) better training of local health care professionals, with consequently better qualified clinical care, (vi) reduced time to diagnosis, with decreased risk of complications, (vii) diagnosis of diseases at earlier stages, (viii) cost and time savings for the patient, (ix) improved quality of life, (x) fewer hospitalizations and visits to emergency units, (xi) improved clinical care continuum, (xii) reduced risk factors and complications from chronic diseases, and (xiii) savings for the health care system.<xref ref-type="bibr" rid="B70">70</xref><sup>-</sup><xref ref-type="bibr" rid="B74">74</xref>
				</p>
        <sec>
          <title>2.2.1. Applications in Health Promotion and Prevention</title>
          <p>In cardiology, health promoting actions and primary and secondary prevention of cardiovascular diseases translate into significant cost savings by reducing specialized consultations, hospitalizations for clinical complications, and admissions to the emergency room.<xref ref-type="bibr" rid="B71">71</xref> Telemedicine can be useful in controlling risk factors for coronary artery disease; improving blood pressure control;<xref ref-type="bibr" rid="B75">75</xref><sup>-</sup><xref ref-type="bibr" rid="B78">78</xref> reducing glycosylated hemoglobin levels in patients with diabetes mellitus;<xref ref-type="bibr" rid="B79">79</xref><sup>-</sup><xref ref-type="bibr" rid="B81">81</xref> improving lipid profile;<xref ref-type="bibr" rid="B82">82</xref><sup>,</sup><xref ref-type="bibr" rid="B83">83</xref> reducing weight, body mass index (BMI), or waist circumference in obese individuals;<xref ref-type="bibr" rid="B77">77</xref><sup>,</sup><xref ref-type="bibr" rid="B84">84</xref><sup>-</sup><xref ref-type="bibr" rid="B86">86</xref> and increasing the success of smoking cessation programs.<xref ref-type="bibr" rid="B87">87</xref>
					</p>
          <p>Several modalities of telemedicine can be applied in this regard, including cell phone text/audio messaging systems, which have positive results in improving medication adherence, changing eating habits, and increasing physical activity among patients with hypertension, diabetes, and obesity, or after acute myocardial infarction (AMI).<xref ref-type="bibr" rid="B86">86</xref><sup>,</sup><xref ref-type="bibr" rid="B88">88</xref> 24-hour monitoring systems on cell phones or monitoring center services have become more frequent due to the development of specialized equipment with direct communication with telemedicine systems such as stethoscopes, scales, thermometers, digital devices, blood pressure equipment, remote monitoring of vital signs and implantable electronic devices.<xref ref-type="bibr" rid="B89">89</xref><sup>,</sup><xref ref-type="bibr" rid="B90">90</xref> Simple watches have been transformed into monitoring systems equipped with technology to report heart rate, stress level (skin humidity and temperature), optical BP, and physical activity, among other parameters.<xref ref-type="bibr" rid="B91">91</xref><sup>-</sup><xref ref-type="bibr" rid="B92">92</xref> Several applications are available to guide the health care team and/or patients, including applications focused on self-care.<xref ref-type="bibr" rid="B89">89</xref>
					</p>
        </sec>
        <sec>
          <title>2.2.2. Decision Support Systems</title>
          <p>Clinical decision support systems (DSSs) provide knowledge and information from individual patients to physicians and other health care professionals, or to the patients themselves, to improve care quality and clinical outcomes. These systems are recommended by the Community Preventive Services Task Force (CPSTF) in the prevention of cardiovascular diseases despite being based on moderate- to poor-quality evidence.93 Applications that have shown benefits include those improving screening for cardiovascular risk factors, prescription of aspirin for primary prevention, and counseling on healthy diet, physical activity, and smoking cessation.94 Due to that, these applications may have wide applicability in PHC. Still, they have shown no evidence of reducing emergency visits, hospitalizations, or cardiovascular events, although additional studies are still needed. A study reported a lower mortality rate with an educational strategy for health care professionals associated with DSS alerts compared with educational strategy alone.<xref ref-type="bibr" rid="B95">95</xref>
					</p>
          <p>DSSs have been evaluated in pilot studies in Brazilian Basic Health Units (<italic>Unidades B&#225;sicas de Sa&#250;de,</italic> UBS) in multifaceted interventions. This tool was proven feasible in PHC in patients with hypertension and diabetes and for cardiovascular risk management, with good satisfaction reported by the professionals and perceived ease of use,<xref ref-type="bibr" rid="B96">96</xref><sup>,</sup><xref ref-type="bibr" rid="B97">97</xref> although the number of questionnaire fields filled in by the professionals was low.<xref ref-type="bibr" rid="B96">96</xref> This may be related to the incipient implantation of electronic medical records in UBSs, generating duplicate work, a factor that was inversely related to the successful implementation of the DSS.<xref ref-type="bibr" rid="B98">98</xref> New initiatives are underway to assess the impact on clinical outcomes of the control of patients with hypertension and diabetes in the Mucuri Valley, in Minas Gerais, and the management of patients on warfarin, still the most widely used anticoagulant in the SUS.</p>
        </sec>
        <sec>
          <title>2.2.3. Teleconsulting</title>
          <p>Teleconsulting systems have great applicability in PHC in terms of supporting health care professionals in remote areas and qualifying and reducing the time to diagnosis and treatment. As a tool with the important potential of increasing PHC solvability, teleconsulting should be incorporated into the care process in health care units as an integral part of the regulatory process of the municipality. This is an efficient way to reduce the long wait for in-person consultations with a cardiologist. Although teleconsultation has been extensively studied in our country,<xref ref-type="bibr" rid="B99">99</xref> only a few studies have evaluated in our population the impact of teleconsultation on traditional health outcomes, like risk and mortality. A systematic review by Liddy et al.<xref ref-type="bibr" rid="B100">100</xref> reported that teleconsulting systems were highly accepted by patients and health care professionals and improved access to specialized care. A randomized trial in cardiology assessed adverse events (including death, AMI, urgent or emergent cardiac catheterization and/or angioplasty, and emergency room visits) in patients referred to teleconsultation versus patients receiving a traditional referral. The group referred to teleconsultation was more likely to have an appointment with the cardiologist and had fewer visits to the emergency department.<xref ref-type="bibr" rid="B101">101</xref>
					</p>
        </sec>
        <sec>
          <title>2.2.4. Teleregulation</title>
          <p>The demand for specialized care has been growing worldwide and surpassing the supply of services while meeting limited access to specialists and long waiting times.<xref ref-type="bibr" rid="B101">101</xref> Interventions in telehealth, particularly involving teleconsultation for regulation, have shown a great impact in reducing waiting time with the qualification of access to specialists, avoiding unnecessary referrals, and at a lower cost. In Brazil, the experience of teleconsultation for regulation (or teleregulation) has also reduced the waiting time for specialized consultation, qualifying the access and optimizing the use of resources, in addition to providing users with greater comfort and lower impact on their routine.<xref ref-type="bibr" rid="B102">102</xref>-<xref ref-type="bibr" rid="B104">104</xref> Teleregulation also enables the classification of the risk of the demand for specialized care. Protocols to guide health care have been established, and the final decision regarding referral is defined along with the attending and teleconsulting physicians. In addition to the mentioned gains from the user&#8217;s perspective, there is the process of continuing education and professional qualification, increasing solvability in primary care.<xref ref-type="bibr" rid="B101">101</xref><sup>-</sup><xref ref-type="bibr" rid="B104">104</xref>
					</p>
        </sec>
        <sec>
          <title>2.2.5. Telediagnosis</title>
          <p>Tele-electrocardiography, the most common activity in telecardiology, is a simple and low-cost technology for easy transfer of a small file using an Internet connection with limited bandwidth. Thus, it can be easily incorporated into the PHC routine for its great applicability and suitability for the infrastructure of PHC facilities in remote and poor areas.<xref ref-type="bibr" rid="B105">105</xref><sup>,</sup><xref ref-type="bibr" rid="B106">106</xref> Tele-electrocardiography is widespread in both public and private settings in Brazil, with several companies in the country delivering reports around the clock. In 2017, the Ministry of Health launched the National Offer of Telediagnosis Project (<italic>Projeto Oferta Nacional de Telediagn&#243;stico,</italic> ONTD) to expand the diagnostic services of tests conducted remotely in the most deprived areas of the country. Tele-electrocardiography was the first modality of telediagnosis offered nationwide by a telehealth team specialized in telecardiology. This project is an innovation in the management of a large-scale national telemedicine project model, and the good results obtained have shown its easy applicability and suitability for remote areas.<xref ref-type="bibr" rid="B107">107</xref> The application of AI to the large databases of diagnostic tests improves the ease of the process of reporting and increases the accuracy of the tests.<xref ref-type="bibr" rid="B61">61</xref><sup>,</sup><xref ref-type="bibr" rid="B108">108</xref>
					</p>
          <p>In telecardiology, tele-echocardiography is a promising strategy for rationalization of the access to complementary propaedeutics, early diagnosis, prioritization of referrals, and organization of waiting lists. Initial evidence of tele-echocardiography application derive from population-based screening studies, for example, a study conducted in rural India, where more than 1,000 echocardiograms were performed in about 11 hours and transferred to a cloud computing system for expert analysis using telemedicine.<xref ref-type="bibr" rid="B109">109</xref> The strategy proved feasible and showed good agreement between preliminary field diagnoses and the reports by experts (k = 0.85), and an alarming 16% rate of major abnormalities (including 32.9% of valvular defects). Even in high-income regions like the UK, evidence has shown echocardiographic screening in primary care by nonspecialists to be an attractive strategy, with clinically significant (moderate to severe) valvular disease observed in 6.4% of the asymptomatic population aged &#8805; 65 years and associated with socioeconomic factors.<xref ref-type="bibr" rid="B110">110</xref> The strategy may be especially useful in Brazil, which has a presumably high burden of undiagnosed cardiovascular disease and limitations in the provision of specialized tests, including conventional echocardiography.</p>
          <p>The tele-echocardiography strategy was first tested in Brazil in a program for screening of rheumatic heart disease (the Rheumatic Valvular Disease Screening Program study; <italic>Programa de RastreamentO da VAlvopatia Reum&#225;tica</italic> - PROVAR). The study established, at a research level, a routine for the acquisition of simplified imaging protocols using portable and ultraportable devices by non-physicians (nurses and technologists), which were uploaded to dedicated cloud computing systems for storage and remote expert interpretation.<xref ref-type="bibr" rid="B111">111</xref><sup>,</sup><xref ref-type="bibr" rid="B112">112</xref> In addition to remote diagnosis, telemedicine was also used to train health care professionals on basic echocardiographic principles through interactive online modules. After training, health care professionals with different backgrounds were able to diagnose rheumatic heart disease with accuracy.<xref ref-type="bibr" rid="B111">111</xref> The project reported a high prevalence of subclinical rheumatic heart disease (4.2%), which is quite significant considering the current impact of the disease on public health.<xref ref-type="bibr" rid="B113">113</xref>
					</p>
          <p>A similar strategy was subsequently applied in primary care. Professionals (physicians, nurses, nurse technicians) from health care centers located in low-income regions of metropolitan areas of Belo Horizonte and Montes Claros received online and in-person training for the acquisition of a simplified echocardiographic protocol with ultraportable devices and support by the project&#8217;s field team. Echocardiography was performed in asymptomatic individuals of three age groups (17-20, 35-40, and 60-65 years) as a screening method and in patients on a waiting list to undergo echocardiography or who had this test requested by the family health care team. The results showed that a) the strategy is feasible for the conditions found in Brazil and has the potential to be expanded to other scenarios; b) the prevalence of echocardiographic abnormalities in asymptomatic populations was high (above 20%) in general; c) among patients on a waiting list for echocardiography, more than 50% had no significant abnormalities on screening echocardiography; and d) the correlation with conventional echocardiography was satisfactory.<xref ref-type="bibr" rid="B112">112</xref> A prediction score was developed from these findings, incorporating clinical data and variables from the simplified echocardiogram.<xref ref-type="bibr" rid="B114">114</xref>Thus, tele-echocardiography may be a strategy for early diagnosis but is mainly an instrument to prioritize and organize waiting lists in health care systems with limited availability of tests and specialized consultations. However, the incorporation of this model into Brazilian health policies depends on broad regulatory discussions involving authorities, professional councils, and medical societies - especially regarding simplified image acquisition by non-physicians.</p>
          <p>The adoption of tele-echocardiography (<xref ref-type="table" rid="t6">Table 2.1</xref>) for the care of disadvantaged remote communities has potential advantages, but this method still lacks robust scientific validation with prospective controlled studies confirming its benefits to patients&#8217; health and cost-effectiveness, among other challenges.</p>
          <table-wrap id="t6">
            <label>Table 2.1</label>
            <caption>
              <title>Potential advantages and challenges for the adoption of tele-echocardiography in Brazil</title>
            </caption>
            <table frame="hsides" rules="groups">
              <colgroup>
                <col width="50%"/>
                <col width="50%"/>
              </colgroup>
              <thead>
                <tr>
                  <th align="left">Advantages</th>
                  <th align="center">Challenges</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left">Allow access to the method at remote locations</td>
                  <td align="center">Lack of standardization of the components of tele-echocardiography </td>
                </tr>
                <tr>
                  <td align="left">Optimization of clinical outcomes</td>
                  <td align="center">Absence of scientific evidence confirming the impact on clinical outcomes </td>
                </tr>
                <tr>
                  <td align="left">Reduction in the cost of transporting human resources to geographically distant areas </td>
                  <td align="center">Absence of scientific evidence confirming cost-effectiveness; questions about reimbursement and system costs </td>
                </tr>
                <tr>
                  <td align="left">Reduction in the cost of transporting patients to tertiary centers</td>
                  <td align="center">Uncertainty about adherence by local health care professionals</td>
                </tr>
                <tr>
                  <td align="left" rowspan="4">Reduction in the number of unnecessary echocardiograms</td>
                  <td align="center">Veto of the Brazilian legislation to the work of non-medical operators (sonographers)</td>
                </tr>
                <tr>
                  <td align="center">Lack of guidelines for training of operators </td>
                </tr>
                <tr>
                  <td align="center">Medical-legal uncertainties</td>
                </tr>
                <tr>
                  <td align="center">Legislative issues related to licensing, data storage, privacy, and confidentiality </td>
                </tr>
              </tbody>
            </table>
          </table-wrap>
        </sec>
        <sec>
          <title>2.2.6. Tele-Education</title>
          <p>Remote educational activities in cardiology for health care professionals, offering courses, lectures, and learning tools on clinical issues and care management, have the added benefit of improving the quality of care. Educational activities for patients should be encouraged for their health empowerment.</p>
          <p>In remote municipalities with small populations, PHC is often the only level of local health care, while their health care units receive patients with acute cardiovascular diseases. Thus, telecardiology in PHC not only should qualify the care of chronic diseases but should also support urgent care for ischemic diseases and arrhythmias.</p>
          <p>Due to the myriad of applications of simple telemedicine tools, cardiology can be considered one of the specialties most sensitive to the use of ICTs. The triad teleconsulting, telediagnosis, and tele-education integrally applied to PHC and associated with tools like DSS can make a difference in the quality of care for cardiovascular diseases, especially hypertension, atrial fibrillation, heart failure, and AMI. Finally, teleregulation can offer support to PHC, in terms of solvability at this level, improving access to specialty care.</p>
        </sec>
      </sec>
      <sec>
        <title>2.7. In Specialized Care</title>
        <sec>
          <title>2.7.1. Heart Failure</title>
          <p>Extensive literature has examined the use of telemedicine strategies to monitor patients with heart failure with the objective of reducing hospitalizations associated with increased morbidity, mortality, and costs and improving patients&#8217; adherence and participation. The interventions range from the application of traditional technologies like structured telephone support, telemonitoring using innovative technologies with implantable or wearable devices, DSS, and machine learning to predict complications.<xref ref-type="bibr" rid="B115">115</xref><sup>,</sup><xref ref-type="bibr" rid="B116">116</xref><sup>,</sup><xref ref-type="bibr" rid="B117">117</xref> The results are variable, but most demonstrate benefits. However, the use of these strategies in clinical practice is still very limited due to regulatory, logistics, and financial issues.<xref ref-type="bibr" rid="B118">118</xref>
					</p>
          <p>Telemonitoring may be invasive or noninvasive. Sensors are tools capable of detecting, recording, and responding to specific information, <italic>e.g.,</italic> patients&#8217; vital signs, and are increasingly embedded in smartphones and other mobile devices. Sensor logging can generate large data sets that may be transmitted in real time to health care professionals.<xref ref-type="bibr" rid="B119">119</xref> Since multiprofessional intervention programs often have geographical, economic, and bureaucratic barriers, telemonitoring can be a solution to promote care for patients with heart failure.<xref ref-type="bibr" rid="B115">115</xref>
					</p>
          <p>Evidence about structured telephone support and noninvasive telemonitoring in patients with heart failure has been summarized in a Cochrane systematic review of 41 studies. Structured telephone support reduced all-cause mortality (RR 0.87, 95%CI 0.77-0.98; n = 9,222) and heart failure-related hospitalizations (RR 0.85, 95%CI 0.77-0.93; n = 7,030), both with moderate-quality evidence. Telemonitoring reduced all-cause mortality (RR 0.80, 95%CI 0.68-0.94; n = 3,740) and heart failure-related hospitalizations (RR 0.71, 95%CI 0.60-0.83; n = 2,148), both with moderate-quality evidence.<xref ref-type="bibr" rid="B119">119</xref>
					</p>
          <p>Another meta-analysis<xref ref-type="bibr" rid="B120">120</xref> of 26 studies with 2,506 patients undergoing telemonitoring (including the transmission of vital signs) observed a time-dependent effect. Short-term follow-up (up to 180 days) had better results for hard outcomes (like mortality), which were not maintained during longer follow-up (1 year). Regardless of the follow-up duration, the strategy was unable to reduce hospitalization. An increase in emergency visits in the telemonitoring group raises the question of how an intervention that does not reduce hospitalization could reduce the mortality rate. Perhaps the early detection of signs of decompensation encourages a more frequent search for care and prompt treatment with diuretics and vasodilators without requiring intensive therapy.</p>
          <p>In the publication of one of its Clinical Protocols and Guidelines on Heart Failure,<xref ref-type="bibr" rid="B121">121</xref>the Ministry of Health analyzed several studies evaluating the benefits of telemonitoring based on telephone follow-up, recommending for health care services to consider follow-up using telephone support for patients with New York Heart Association (NYHA) functional class III to IV heart failure after hospital discharge. The analysis showed an 18% reduction in overall mortality with remote monitoring compared with usual care (RR 0.82, 95%CI 0.73-0.93). Telemonitoring also reduced by 23% (RR 0.77, 95%CI 0.68-0.88) the risk of hospitalization due to heart failure. Of note, this recommendation should be directed to patients with the potential of most benefits. There is no consensus on the intensity and frequency of monitoring, but they should be performed focused on clinical and educational guidance.</p>
          <p>Evidence regarding the duration of hospital stay is more fragile and controversial. Of seven studies on structured telephone support and nine on telemonitoring, only one on each type of intervention reported significantly decreased hospital stay. Additionally, nine of 11 studies on structured telephone support and five of 11 studies on telemonitoring reported significant improvements in quality of life. Three of nine studies on structured telephone support and one of six studies on telemonitoring reported reductions in cost, while two studies on telemonitoring reported increased costs due to expenses related to the intervention and increased medical management. Seven of the nine studies that assessed heart failure knowledge and self-care noted significant improvements. Despite acceptance by 76-97% of the participants, decreased adherence to the intervention over time can be challenging, and was reported in the review at 55.1-65.8% with structured telephone support and 75-98.5% with telemonitoring.<xref ref-type="bibr" rid="B119">119</xref>
					</p>
          <p>Machine learning techniques can be potentially valuable in remote monitoring of patients at high risk of heart failure. Individual characteristics of these patients obtained from the analysis of a large number of electronic medical records may help identify those at greatest risk of unfavorable outcomes who could benefit from individualized medical treatment.<xref ref-type="bibr" rid="B122">122</xref> The Seattle Heart Failure Model (SHFM), for example, is a machine learning framework for the calculation of mortality risk in heart failure. The model considers various clinical aspects obtained from electronic medical records to predict the prognosis of the disease and incorporates the potential impact of therapies on patients&#8217; outcomes. This DSS was shown to be potentially useful in identifying patients with heart failure at higher risk of unfavorable outcomes, but met implementation barriers, as it was time consuming, expensive, required familiarity of the physician with computers, and failed to take into account other clinical variables that were not included in the collected data.<xref ref-type="bibr" rid="B123">123</xref>
					</p>
          <p>Evidence of the benefits of telemonitoring in heart failure has been recently confirmed with the publication of the Telemedical Interventional Management in Heart Failure II (TIM-HF2) study. This was a prospective, randomized, multicenter clinical trial including 1,571 patients with NYHA class II or III heart failure hospitalized due to heart failure within 12 months before the randomization and with an ejection fraction of 45% or lower. The patients were then randomized to remote management or usual care and followed up for up to 393 days.<xref ref-type="bibr" rid="B124">124</xref>
					</p>
          <p>The percentage of days lost due to unplanned cardiovascular hospitalizations and death from all causes was 4.88% in the remote patient management group and 6.64% in the usual care group (p = 0.04). Patients assigned to remote management lost an average of 17.8 days/year compared with 24.2 days/year among patients assigned to usual care. The hazard ratio (HR) for all-cause mortality was 0.70 (95%CI 0.50-0.96; p = 0.0280) in favor of the teleconsultation group, but cardiovascular mortality was not significantly different between both groups (HR 0.671, 95%CI 0.45-1.01; p = 0.0560).<xref ref-type="bibr" rid="B124">124</xref>
					</p>
          <p>New devices to monitor intracardiac pressure present the most compelling evidence for the application of telemonitoring and use more advanced technologies. CardioMEMS is a device that is percutaneously implanted in the pulmonary artery to transmit central pressure values to a platform. When the pressure levels of the pulmonary artery rise above a certain threshold, the physician receives an alert and a statement indicating congestion or low output. Other devices for implantation in the right ventricle are being used experimentally. The study CHAMPION (CardioMEMS Heart Sensor Allows Monitoring of Pressure to Improve Outcomes in NYHA Class III Heart Failure Patients)<xref ref-type="bibr" rid="B125">125</xref> evaluated patients with NYHA functional class III heart failure across 64 centers in the US. The patients were randomized by a centralized electronic system to a group of management by CardioMEMS or to a control group.</p>
          <p>In the monitoring group, the physicians used daily data from pulmonary artery pressure measurements to guide treatment. After a follow-up of 15 months, the monitoring group had a 37% reduction in hospitalizations related to heart failure compared with the control group. The long-term follow-up of this study, in which the control group was switched to receive pulmonary pressure monitoring, showed that these results remained significant and clinically relevant over time.<xref ref-type="bibr" rid="B126">126</xref>
					</p>
        </sec>
        <sec>
          <title>2.7.2. In Hypertension</title>
          <p>Telemonitoring strategies can also be applied for BP control, but they overlap the self- monitoring approach. In the TASMINH4 trial, 1,182 patients were randomized (1:1:1) to general titration of antihypertensive medication based on clinical readings by a generalist (usual care group), self-monitoring (self-monitoring group), or self-monitoring along with telemonitoring (telemonitoring group). The study found that the use of BP self-monitoring to titrate antihypertensive therapy in poorly controlled hypertension in primary care resulted in lower systolic BP without increasing the workload of the clinical team. After 1 year, patients who had the medications adjusted based on self-monitoring with or without telemonitoring had significantly lower systolic BP than those who had the treatment adjusted based on BP measured during consultations. The BP values in the telemonitoring group that received medication titration became lower faster (at 6 months) than in those in the self-monitoring group, an effect that is likely to further reduce cardiovascular events and improve long-term control.<xref ref-type="bibr" rid="B127">127</xref><sup>,</sup><xref ref-type="bibr" rid="B128">128</xref>
					</p>
          <p>Several studies also show that strategies for hypertension telemonitoring involving a clinical pharmacist lead to a beneficial impact on BP control in the short and medium term. Margolis et al.<xref ref-type="bibr" rid="B129">129</xref> evaluated the durability of the effect of such intervention after a follow-up of 54 months in a randomized cluster study among 16 primary care clinics and 450 patients (228 receiving telemonitoring and 222 on usual care). Intensive intervention based on telemonitoring maintained the effects for up to 24 months (12 months after the end of the intervention), but lost efficacy in the long term.<xref ref-type="bibr" rid="B129">129</xref>
					</p>
          <p>A prospective observational cohort study monitored the BP levels before and after an educational intervention and introduction to home BP monitoring (HBPM). In the intervention group, 484 patients were instructed to track their BP levels using a smartphone three to seven times a week. The mean BP levels improved from 42% to 67% among patients on HBPM compared with 59% to 67% among controls (p &lt; 0.01).<xref ref-type="bibr" rid="B130">130</xref>
					</p>
          <p>The INTERACT study was a randomized clinical trial in which 303 patients using BP and/or lipid-lowering medications were randomized to receive or not receive text messages. The group that received text messages improved medication adherence at 6 months compared with the group that did not receive messages. The overall improvement in medication adherence was 16%.<xref ref-type="bibr" rid="B129">129</xref><sup>,</sup><xref ref-type="bibr" rid="B131">131</xref>
					</p>
          <p>A Cochrane systematic review<xref ref-type="bibr" rid="B132">132</xref> sought to establish the effectiveness of mobile phone-based interventions in improving adherence to medications prescribed for primary prevention of cardiovascular disease in adults. The participants in the trials were recruited from community-based primary care or outpatient clinics in high-income (Canada, Spain) and upper- to middle-income countries (South Africa, China), but the interventions varied widely. One trial evaluated an intervention focused on adherence to BP medication delivered exclusively by text messaging, while another trial involved BP monitoring combined with feedback delivered via smartphone. The authors considered the body of evidence for the effect of cell phone-based interventions on objective outcomes (BP and cholesterol) having a low quality. Of two studies that evaluated medication adherence along with other lifestyle modifications, one reported a small beneficial effect on lowering low-density lipoprotein cholesterol while the other found no benefit. Another trial (1,372 participants) on an intervention based on text messaging showed a small reduction in systolic BP in a group that delivered information-only text messages, but uncertain evidence of benefit in a second intervention group that provided additional interactivity. One study examined the effect of BP monitoring combined with smartphone text messaging and reported moderate intervention benefits to systolic and diastolic BP. There was conflicting evidence from trials targeting medication adherence along with lifestyle advice using multicomponent interventions. Another study found large benefits on BP levels, while another study showed no such effect. The authors of this Cochrane review concluded that there is low-quality evidence related to the effects of interventions delivered via mobile phone in increasing adherence to medications prescribed for primary prevention. The conclusion based on this review is that there is current uncertainty about the effectiveness of such interventions.</p>
        </sec>
        <sec>
          <title>2.7.3. Emergency Services</title>
          <p>Brazil has a geographically distributed health care system in which UBSs, emergency care units (ECUs), secondary hospitals, and ambulances are scattered across the country, often at remote locations. Specialized centers are located in advanced care units, like tertiary hospitals, located in major cities. In this context, telemedicine tools can improve emergency management.<xref ref-type="bibr" rid="B133">133</xref>
					</p>
          <p>Telemedicine has different applications in emergency services, ranging from electrocardiographic transmissions associated or not with synchronous teleconsultations to assist in the early diagnosis and management of cases of acute coronary syndrome (ACS); clinical DSSs to help with the diagnosis, management, and prediction of cardiac complications in patients with ACS;<xref ref-type="bibr" rid="B133">133</xref> transmission of bedside ultrasonographic images before hospital admissions;<xref ref-type="bibr" rid="B134">134</xref> and image transmission and support in the diagnosis and management of patients with acute stroke.<xref ref-type="bibr" rid="B135">135</xref> The use of DSSs could increase the adherence to guideline recommendations in the management of patients with ACS, but evidence on its impact on clinical outcomes in this context is still limited.<xref ref-type="bibr" rid="B135">135</xref>
					</p>
        </sec>
        <sec>
          <title>2.7.4. In Systems of Care for Acute Myocardial Infarction</title>
          <p>Systems of care for AMI integrate preadmission services, hospitals, and hemodynamic services comprising the care of patients with AMI in a given region in order to optimize the management of clinically suspected patients. The proposal of these systems is to delineate the patients&#8217; care flow involving early diagnosis, preadmission care, initial treatment, use of thrombolytic agents, referral to a specialized hospital, and post-event follow-up. They target high-quality, effective, safe care for patients with AMI by optimizing resources and reducing disparities in their access to care.<xref ref-type="bibr" rid="B133">133</xref><sup>,</sup><xref ref-type="bibr" rid="B136">136</xref>
					</p>
          <p>Telemedicine services may play a crucial role in AMI systems of care, as they facilitate the communication between a physician in an emergency unit, low-complexity hospital, or pre-hospital admission with cardiologists at the hub or hospital with a hemodynamic center that will receive the patient. Cardiologists can assist in (i) analyzing and interpreting electrocardiograms for accurate and early diagnosis of ST-segment elevation AMI,<xref ref-type="bibr" rid="B132">132</xref><sup>,</sup><xref ref-type="bibr" rid="B137">137</xref> (ii) guiding the best course of action, including the administration or not of thrombolytic agents and other medications, through synchronous teleconsultations, <italic>i.e.</italic>, real-time communication between the on-site professional and the remote specialist,<xref ref-type="bibr" rid="B137">137</xref><sup>,</sup><xref ref-type="bibr" rid="B138">138</xref> and (iii) monitoring the patient&#8217;s clinical condition through telemonitoring, with synchronous data transmission.<xref ref-type="bibr" rid="B137">137</xref>
					</p>
          <p>The incorporation of telemedicine strategies in systems of care for AMI is a worldwide trend. A recent meta-analysis including studies conducted in Europe (11), North America (8), South America (5), Asia (9), and Australia (2), with a total of 16,960 patients, found consistent moderate-quality evidence that telemedicine strategies associated with usual care in this context reduce in-hospital mortality by 37% (RR 0.63, 95%CI 0.55-0.72), with a number needed to treat (NNT) of 29 (95%CI 23-40) when compared with usual care without telemedicine. The study also found poor quality evidence that this intervention can reduce door-to-balloon time (mean difference 28 minutes, 95%CI -35 to -20 minutes) and 30-day (RR 0.62, 95%CI 0.43-0.85) and long-term (RR 0.61 95%CI 0.40-0.92) mortality.<xref ref-type="bibr" rid="B138">138</xref>
					</p>
          <p>In Brazil, Belo Horizonte, Campinas, Salvador, S&#227;o Paulo, and the Northern Region of Minas Gerais (encompassing 89 municipalities) have published initiatives in this area.<xref ref-type="bibr" rid="B137">137</xref><sup>,</sup><xref ref-type="bibr" rid="B139">139</xref><sup>-</sup><xref ref-type="bibr" rid="B143">143</xref> Decreased system delays and increased reperfusion rates have been observed in cases of ST-segment elevation AMI, with evidence of reduced hospital mortality.<xref ref-type="bibr" rid="B139">139</xref><sup>,</sup><xref ref-type="bibr" rid="B143">143</xref><sup>,</sup><xref ref-type="bibr" rid="B144">144</xref>
					</p>
          <p>A typical telemedicine system comprises a specialized center (hub) and multiple remote care units distributed within a geographic region (spoke centers) connected bidirectionally by a communication channel. The specialized center may be a referral hospital in cardiology, the operation center of an Emergency Mobile Care Service (<italic>Servi&#231;o de Atendimento M&#243;vel de Urg&#234;ncia</italic>, SAMU), or a telemedicine center. Some systems of care for AMI comprise more than one specialized center, each with specific remote units for regional coverage.<xref ref-type="bibr" rid="B145">145</xref> The 2015 Telemecardiology Guideline for the Care of Patients with Acute Coronary Syndrome and Other Heart Diseases details models of care using telemedicine systems for the care of patients with ACS.<xref ref-type="bibr" rid="B133">133</xref>
					</p>
        </sec>
        <sec>
          <title>2.7.5. In Controlling the Use of Anticoagulants</title>
          <p>The strategy of self-management of anticoagulants has been associated with a significantly lower risk of ischemic stroke and all-cause mortality compared with direct treatment with oral anticoagulants, while no significant differences were observed for major bleeding and mortality. However, decreased surveillance is a potential problem for the detection of patients who are unable to take care of their own treatment. A structured education program is required for patients and/or caregivers and for involved professionals in health care and quality control.<xref ref-type="bibr" rid="B146">146</xref><sup>-</sup><xref ref-type="bibr" rid="B148">148</xref>
					</p>
        </sec>
        <sec>
          <title>2.7.6. Cardiac Rehabilitation</title>
          <p>Guidelines recommend that patients should undergo cardiac rehabilitation after AMI, percutaneous coronary intervention (PCI), or myocardial revascularization. However, rehabilitation is still underused, with participation of only 14-31% of all eligible patients. Patients&#8217; inability to attend the sessions and costs are important barriers.<xref ref-type="bibr" rid="B149">149</xref> Telehealth interventions using ICTs to enable remote rehabilitation programs can overcome common barriers to rehabilitation access while preserving clinical supervision and prescription of individualized exercise.<xref ref-type="bibr" rid="B150">150</xref>
					</p>
          <p>In a systematic review of 11 studies, the types of intervention were variable and included the use of mobile or computer applications, biosensors, and interventions delivered by landline phone lines. The interventions involved prescription and/or monitoring of the participants&#8217; performance and adherence. All interventions included feedback, education, psychosocial support, and/or behavioral changes via landline phone communications, mobile messaging, e-mail, website use, online tutorial, or online chat.<xref ref-type="bibr" rid="B151">151</xref>
					</p>
          <p>The level of physical activity was higher in the intervention group compared with the usual care group. Compared with face-to-face rehabilitation, the intervention with telehealth was more effective in improving the level of physical activity, exercise adherence, diastolic BP, and LDL-cholesterol, with poor- to moderate-quality evidence. Telehealth rehabilitation was similar to face-to-face rehabilitation in maximal aerobic exercise capacity and other modifiable cardiovascular risk factors.<xref ref-type="bibr" rid="B151">151</xref>
					</p>
          <p>The Telehab III study was a prospective, randomized, multicenter controlled trial with patients undergoing cardiac rehabilitation. In all, 140 patients were randomized to a conventional rehabilitation group or a 24-week Internet-based telerehabilitation group associated with conventional rehabilitation. The additional telerehabilitation program showed improvement in physical fitness and quality of life and induced persistent health benefits.<xref ref-type="bibr" rid="B152">152</xref>
					</p>
          <p>A clinical trial conducted in China randomized 98 patients with NYHA I-III functional class heart failure to an 8-week home-based teleconsultation exercise training program or usual outpatient follow-up. Statistically significant improvements were observed in the experimental group in terms of quality of life and result in the 6-minute walking distance test compared with the control group. These results confirm that physical training via teleconsultation is an effective alternative method for cardiac rehabilitation.<xref ref-type="bibr" rid="B153">153</xref>
					</p>
          <p>The noninferiority, randomized controlled trial REMOTE-CR tested the effects and costs of cardiac rehabilitation by real-time teleconsultation in 162 patients with heart failure and demonstrated this to be a cost-effective alternative that can enhance the scope of rehabilitation.<xref ref-type="bibr" rid="B154">154</xref>
					</p>
          <p>Home-based cardiac rehabilitation is an alternative to increase patients&#8217; engagement in the program by presenting greater flexibility and activity options, offering choices based on the patients&#8217; values and preferences, and allowing the implementation according to the patients&#8217; daily routine.<xref ref-type="bibr" rid="B155">155</xref> The association of cardiac rehabilitation with conventional rehabilitation has been shown to be more effective and efficient compared with a conventional rehabilitation program alone, as it reduced the rates of readmission due to cardiovascular causes and improved quality of life during the study period.<xref ref-type="bibr" rid="B156">156</xref>
					</p>
        </sec>
        <sec>
          <title>2.7.7. Remote Monitoring by Implantable Devices</title>
          <p>Pacemaker telemonitoring has not significantly improved quality of life and number of cardiovascular events, but provided early detection and treatment of events, reducing hospital admissions and visits (routine and emergency) at lower costs compared with hospital follow-up.<xref ref-type="bibr" rid="B157">157</xref>
					</p>
          <p>Implantable cardiac defibrillators (ICDs) or resynchronization defibrillators are another type of implantable monitoring systems. Some of these devices may be equipped with software for multiparametric monitoring of, for example, thoracic impedance and right ventricular filling pressure with measurements captured by a right ventricular lead. A groundbreaking study published in 2008 showed their clinical benefits in patients with NYHA functional class III heart failure.<xref ref-type="bibr" rid="B158">158</xref> The IN-TIME trial later tested a similar strategy using multiparametric monitoring devices (ICDs and resynchronization defibrillators). The parameters evaluated in the trial included events like ventricular and atrial tachyarrhythmia, low percentage of biventricular pacing, increased frequency of ventricular extrasystoles, decreased patient activity, and abnormal intracardiac electrogram. Abnormalities in these parameters triggered a structured phone contact. The group allocated to telemonitoring had a significant reduction in combined clinical outcomes and total mortality.<xref ref-type="bibr" rid="B159">159</xref> Other similar studies have also shown a reduction in combined clinical outcomes, often related to a decreased need for face-to-face visits.<xref ref-type="bibr" rid="B160">160</xref> Results from an unselected population cohort study also indicated benefits of remote monitoring with information from ICD/cardiac resynchronization therapy (CRT) on mortality.<xref ref-type="bibr" rid="B161">161</xref> However, a meta-analysis<xref ref-type="bibr" rid="B162">162</xref> of 11 randomized trials evaluating 5,703 patients showed no consistent results on clinical outcomes. The meta-analysis showed that device telemonitoring was associated with a reduction in the total number of planned, unplanned, and emergency room visits (RR 0.56, 95%CI 0.43-0.73, p &lt; 0.001). However, rates of cardiac-related hospitalization (RR 0.96, 95%CI 0.82-1.12, p = 0.60), the composite endpoints of emergency visits, unplanned hospital visits, or hospitalizations (RR 0.99, 95%CI 0.68-1.43, p = 0.96), and total and cardiac mortality were also similar between groups.<xref ref-type="bibr" rid="B162">162</xref>
					</p>
        </sec>
        <sec>
          <title>2.7.8. Atrial Fibrillation</title>
          <p>Patients with atrial fibrillation (AFib) comprise a special group, considering that, among other things, AFib has been accounted for approximately 60% of pacemaker and CRT/defibrillator (CRT-Ds) alerts and nearly 10% of all ICD alerts in a worldwide database.<xref ref-type="bibr" rid="B163">163</xref> Remote monitoring has excellent sensitivity (95%) in detecting AFib, a feature that becomes even more important, considering that 90% of the detected episodes were asymptomatic.<xref ref-type="bibr" rid="B164">164</xref><sup>,</sup><xref ref-type="bibr" rid="B165">165</xref> The potential benefits of remote monitoring include detection and early reaction (<italic>e.g.</italic>, drug therapy, device reprogramming, or electrical cardioversion) to prevent atrial remodeling and serious adverse events related to AFib. The IMPACT trial has shown that the detection of asymptomatic AFib via remote monitoring considerably shortened the time to anticoagulation initiation (3 days versus 54 days) but was not associated with reduced rates of stroke, systemic embolism, and bleeding.<xref ref-type="bibr" rid="B166">166</xref>
					</p>
          <p>In the preclinical phase of an arrhythmia, telemedicine screening may detect asymptomatic AFib.<xref ref-type="bibr" rid="B89">89</xref> In a pilot study, the daily transmission of electrocardiographic data by phone facilitated the diagnosis of asymptomatic paroxysmal AFib.<xref ref-type="bibr" rid="B90">90</xref> In large cohorts, telecardiology services improved the management of patients with AFib and detected new cases of arrhythmia.<xref ref-type="bibr" rid="B167">167</xref>
					</p>
          <p>Support by telemedicine can improve the diagnosis of silent AFib.<xref ref-type="bibr" rid="B168">168</xref> Bilgi et al.<xref ref-type="bibr" rid="B169">169</xref> demonstrated that home-based electrocardiographic assessment supported by telecardiology increased the sensitivity of the diagnosis of AFib in elderly individuals and was useful in identifying individuals with AFib and atypical symptoms at home.<xref ref-type="bibr" rid="B169">169</xref> The electrocardiogram (ECG) was recorded and transmitted by a smartphone to a 24/7 telecardiology center and evaluated by a cardiologist. The telecardiology support increased two times (40 years), four times (60 years), and seven times (70 years) the rate of AFib diagnosed at home.</p>
          <p>The SEARCH-AF study has shown that the use of an ECG lead (DI) on an iPhone ECG (iECG, AliveCor KardiaMobile) accurately diagnosed AFib, making this technology feasible for the screening of subclinical AFib in primary care and in the community.<xref ref-type="bibr" rid="B170">170</xref> In the REHEARSE-AF study, a randomized trial of AFib screening involving 1,001 participants aged &#8805; 65 years and with CHA<xref ref-type="bibr" rid="B2">2</xref>DS2-VASc &#8805; 2,<xref ref-type="bibr" rid="B171">171</xref> the participants were randomized to screening with AliveCor KardiaMobile (iECG) twice a week for 12 months (and additional ECG in case of symptoms) or usual routine. The use of iECG increased by almost four times the diagnosis of AFib (HR 3.9, p = 0.007).</p>
          <p>Smartphones, apps, and cloud storage technology have the potential to change the practice of medicine and the way decisions are made. On smartphone platforms, medical or health care applications can analyze a range of vital signs through built-in sensors, interconnected devices, or peripherals.171 The transfer of ECG images by multimedia messaging can be a practical, low-cost procedure in telecardiology.<xref ref-type="bibr" rid="B172">172</xref> These new technologies may increase the detection of arrhythmias, but the real value of these new methods has yet to be evaluated in rigorously conducted studies.</p>
        </sec>
        <sec>
          <title>2.7.9. Channelopathies</title>
          <p>Inherited electrical syndromes are less frequent indications for ICD implantation. However, their management can be challenging because these devices are then implanted in patients who are often younger and less likely to comply with the required follow-up.<xref ref-type="bibr" rid="B174">174</xref> Electrical abnormalities may occur in these diseases, predisposing the patient to unnecessary shocks and requiring careful programming.<xref ref-type="bibr" rid="B175">175</xref> The pediatric population, which often has implanted epicardial electrodes, is specifically more vulnerable. In such patients, telemonitoring may be particularly useful for surveillance, early detection, and preventive programming.<xref ref-type="bibr" rid="B176">176</xref> In the multicenter Brugada registry, the number of outpatient visits was significantly lower in a telemonitoring group compared with a control group (p &lt; 0.001), and there was a trend suggesting that the number of inappropriate shocks was also reduced.<xref ref-type="bibr" rid="B177">177</xref>
					</p>
        </sec>
        <sec>
          <title>2.7.10. Tachycardia and Ventricular Fibrillation</title>
          <p>Remote patient monitoring can be valuable for prompt assessment of the appropriateness of the detection and the efficacy of the administered therapy. If shock is appropriate, and clinical condition is stable, the physician can reassure the patient without requiring a hospital visit. In a multicenter pilot study, 81% of the episodes of ventricular tachyarrhythmia were analyzed remotely, and in 85% of the cases, no further action was required.<xref ref-type="bibr" rid="B178">178</xref> The TRUST study demonstrated that remote monitoring allows early detection of ventricular tachyarrhythmias compared with standard follow-up (1 day versus 36 days for ventricular fibrillation and 1 day versus 28 days for ventricular tachycardia, p &lt; 0.001).<xref ref-type="bibr" rid="B179">179</xref> Other potential benefits of remote monitoring include the prevention of inadequate shocks and appropriate but unnecessary shocks. Inadequate detection due to supraventricular tachyarrhythmias (or T-wave oversensing) may lead to the patient receiving a notification for in-hospital reprogramming or other interventions.<xref ref-type="bibr" rid="B180">180</xref> Proper delivery of ICD shock for slow, stable ventricular tachycardia may lead to device reprogramming with broader use of painless antitachycardia therapies. Recurrent and self-limited asymptomatic rapid ventricular tachycardia occurring in the ventricular fibrillation window (triggering alerts in some systems, regardless of the administered therapy), can be detected early and, with appropriate intervention, be programmed to prevent electrical storms. In addition, timely treatment of tachycardias may prevent early battery depletion caused by recurrent loads and shock administration.<xref ref-type="bibr" rid="B176">176</xref><sup>,</sup><xref ref-type="bibr" rid="B181">181</xref>
					</p>
        </sec>
        <sec>
          <title>2.7.11. Congenital Heart Disease</title>
          <p>Tele-echocardiography can establish an early diagnosis of congenital heart diseases to guide therapeutic management.<xref ref-type="bibr" rid="B182">182</xref> A North American multicenter study in 338 paired infants (with and without access to telemedicine) with or without minor heart disease showed a statistically significant reduction in the percentage of infants transferred to a tertiary hospital (10% versus 5%), as well as in total hospital stay and intensive care unit (ICU) stay.<xref ref-type="bibr" rid="B183">183</xref> Telemedicine increases the ability of pediatric cardiologists to provide higher quality care to a greater number of patients, although high-quality studies evaluating the impact of this intervention are still limited.</p>
        </sec>
      </sec>
      <sec>
        <title>2.8. Cardiovascular Teletomography and Teleresonance</title>
        <p>Despite the apparent similarity between teleimaging and local diagnostic services, divergences between both occur in one fifth of the cases. Specifically, divergences with clinical impact occur in up to 1 to 3% of the cases. We can hypothesize that the reasons for these divergences may be inadequate imaging quality, unavailability of patients&#8217; clinical data (like current and past history and physical examination), limited access to patients&#8217; laboratory tests and other imaging evaluations, fatigue, and simple interobserver variation.</p>
        <p>The workflow of imaging diagnosis in local hospitals and in telediagnosis may be difficult to distinguish. Generated images are stored in imaging systems (picture archiving and communication system - PACS, for example) and then analyzed by the radiology department (and other specialties working with imaging tests, like cardiology and obstetrics). In teleimaging, the image is transmitted to an external center and analyzed the same way that it would be done locally. Further studies are needed to compare the diagnostic performance of teleimaging versus local imaging. Both may even be assumed to have the same performance, but evidence is critical to confirm our assumptions and can determine not only whether teleimaging can be performed, but also the optimal conditions to be carried out safely and cost-effectively without harm to the patient.</p>
        <sec>
          <title>2.8.1. DICOM Standard</title>
          <p>A new group of services developed in previous years was introduced in 1993, the Digital Imaging and Communications in Medicine (DICOM) standard. The objective was to standardize data and information obtained by imaging methods, normalizing the rules for transmission and storage of medical information. This group of services uses a digital format that associates images with metadata-type information with the ability to optimize search and exchange of information and the use of images by specific software programs. DICOM specifications are updated from time to time without losing sight of previously established functionalities.<xref ref-type="bibr" rid="B184">184</xref><sup>,</sup><xref ref-type="bibr" rid="B185">185</xref>
					</p>
        </sec>
        <sec>
          <title>2.8.2. MRI, CT, and Telemedicine</title>
          <p>Contrast-enhanced magnetic resonance imaging (MRI) and computed tomography (CT) scanning bear additional complexities, requiring specific care at centers performing these tests. These range from the scheduling of the tests - in which there is a need to define its precise indication, <italic>e.g.</italic>, pharmacological stress test (dipyridamole, adenosine, dobutamine), evaluation of myocardial ischemia, viability, valvular heart disease, specific cardiomyopathies, among others - to the need of on-site physicians due to frequent use of contrast and medications, nursing technicians to obtain an adequate venous access, and biomedical doctors and technologists with specific training and experience in the acquisition and postprocessing of MRI and CT scan images using software dedicated for these analyses.</p>
          <p>The images should be read by experienced specialized physicians with specific training in that particular area of diagnostic imaging. Such training usually requires 2 years and is not widely available nationwide, limiting the number of trained specialists for appropriate MRI and CT scanning.</p>
          <p>The complexity of performing MRI and CT scans with remote guidance and reading, together with the need for specialists to analyze the images and the possibility of the test being performed at any given time, depending on the clinical indication, makes telemedicine increasingly important for this activity.</p>
        </sec>
        <sec>
          <title>2.8.3. The Federal Council of Medicine and Tele-CT/Tele-MRI</title>
          <p>In 2014, the CFM updated the rules for tele-CT/tele-MRI practice in Brazil.<xref ref-type="bibr" rid="B186">186</xref> These rules are valid for the transmission of patients&#8217; images between different locations to produce a medical report, a second expert opinion, or a clinical imaging review. The rules related to the topic of this document are listed below:</p>
          <p>
            <list list-type="bullet">
              <list-item>
                <p> Clinical data - The transmission of tests by tele-CT/tele-MRI should be accompanied by necessary clinical data of the patient, collected by the requesting physician, for the preparation of the report.</p>
              </list-item>
              <list-item>
                <p> Patient authorization - The patient must authorize on an informed consent form the transmission of images and data.</p>
              </list-item>
              <list-item>
                <p> Local and remote specialist - The responsibility for the remote transmission of tests and reports must be assigned to a specialist in MRI and CT scanning.</p>
              </list-item>
              <list-item>
                <p> Limits for remote practice - In the case of noncontrast imaging (<italic>e.g.</italic>, calcium score - CS), and in the absence of a specialist physician at the health care facility, the attending physician may ask the specialist for appropriate remote diagnostic support.</p>
              </list-item>
              <list-item>
                <p> Specialist required - A specialist physician must be present in centers where contrast imaging tests - including MRI and CT scans - are performed. </p>
              </list-item>
              <list-item>
                <p> Shared responsibility - The professional responsibility for the care lies with the specialist physician caring for the patient undergoing the test. The specialist issuing the remote report shares this responsibility.</p>
              </list-item>
              <list-item>
                <p> Headquarters in Brazilian territory - Legal entities providing services in tele-CT/tele-MRI must be headquartered in Brazilian territory and be registered with the CRM of their jurisdiction. If the provider is an individual, he or she must be a physician trained in MRI and CT scanning.</p>
              </list-item>
              <list-item>
                <p> Operating standards - This is beyond the scope of this document, but specific information can be found in another document on operating standards and minimum requirements for the transmission and handling of remote imaging diagnostic reports.</p>
              </list-item>
              <list-item>
                <p> Image compression and transmission - Communication protocols, file formats, and compression algorithms should comply with current DICOM and HL7 standards. The specialist physician is responsible for evaluating the compression ratio.</p>
              </list-item>
              <list-item>
                <p> Image visualization and processing - The specialist physician is responsible for ensuring the technical characteristics of remote workstations, monitors, and ergonomic conditions in order to avoid compromising the diagnosis.</p>
              </list-item>
              <list-item>
                <p> Safety and privacy - Computerized systems used for the transmission and handling of clinical data and diagnostic imaging reports and for sharing of image and information must comply with CFM regulations. Specifically, tele-CT/tele-MRI, systems must meet the mandatory requirements of the &#8220;Level of Safety Assurance 2 (<italic>N&#237;vel de Ga</italic>rantia de Seguran&#231;a 2, NGS2)&#8221; established in the current Certification Manual for Electronic Health Registration Systems issued by the CFM and the Brazilian Society of Health Informatics (<italic>Sociedade Brasileira de Inform&#225;tica em Sa&#250;de</italic>, SBIS).</p>
              </list-item>
            </list>
          </p>
        </sec>
        <sec>
          <title>2.8.4. Imaging Transmission</title>
          <p>Imaging transmission must comply with CFM standards regarding quality and security. However, MRI and CT images are generally larger, requiring an infrastructure with adequate data bandwidth for transmission. Importantly, the specialist physician responsible for the report must download the images. Thus, the choice of important sequences after image acquisition and the method of compression are fundamental for a smooth flow.</p>
        </sec>
        <sec>
          <title>2.8.5. Postprocessing Software and Workstations</title>
          <p>Ranging from ECG images to three-dimensional coronary angiotomography (TCA) images and the wide variety of MRI sequences, several imaging parameters must be evaluated, most requiring specific software.</p>
          <p><italic>Assessment of CS -</italic> CS is assessed with software programs installed in workstations, which are usually purchased with the CT equipment, or with other independent programs or plug-ins. The report usually informs the amount of calcification in each artery along with the total CS value and percentile for the patient&#8217;s gender and age, based on several population studies, of which the most used and recommended is the MESA (MultiEthnic Study of Atherosclerosis) study.<xref ref-type="bibr" rid="B187">187</xref><sup>,</sup><xref ref-type="bibr" rid="B188">188</xref> Other data such as arterial age and the patient&#8217;s overall cardiovascular risk variation based on the ECG can also be described.</p>
          <p><italic>Evaluation of TCA -</italic> After the appropriate acquisition phase, aiming at the best temporal and spatial resolution of the coronary arteries, and editing of the ECG, which is usually done directly in the CT equipment, other applications are helpful in establishing a diagnosis.</p>
          <p>Until the requesting physician is able to obtain a clear view, the interpretation of the findings may be helped by software programs that extend the coronary arteries in a single plane (curved planar reconstruction - CPR), visualization of three-dimensional rendered images (using a 3D-volume-rendering technique), visualization of bidimensional images with multiple oblique planes (multiplanar reconstruction - MPR), and the characterization of coronary plaques, as well as the objective measurement of stenoses.<xref ref-type="bibr" rid="B189">189</xref>
					</p>
          <p><italic>Evaluation with MRI -</italic> As one of the most versatile imaging methods available, MRI is able to produce images of almost any anatomical plane and provide a wide range of pulse sequences to generate images with specific characteristics, allowing assessments that range from the evaluation of ventricular function to myocardial tissue characterization.<xref ref-type="bibr" rid="B190">190</xref> Several software applications are available for this purpose, including applications for: </p>
          <p>
            <list list-type="bullet">
              <list-item>
                <p> assessment of volume, ventricular mass, and right and left cardiac function; </p>
              </list-item>
              <list-item>
                <p> analysis of intracardiac flow to measure QP-QS, shunts, and valvular dysfunction; </p>
              </list-item>
              <list-item>
                <p> magnetic resonance angiography postprocessing with measurement of vascular diameters; </p>
              </list-item>
              <list-item>
                <p> tissue characterization to quantify perfusion, necrotic/fibrotic mass, iron deposition by T2* evaluation, and parametric maps of T1, T2, and T2* values.</p>
              </list-item>
            </list>
          </p>
          <p>The strategy of using software programs in MRI and CT imaging is strongly recommended and can improve the time required to read the images, the accuracy of the reading, and the clarity of the report of the findings.</p>
        </sec>
        <sec>
          <title>2.8.6. Database, Communication, and Image Archiving</title>
          <p>The integration between radiological information system (RIS) and PACS enables the assignment of a unique registration for each patient. This optimizes the information by combining images with clinical data and making the process faster and more secure. This format has been increasingly used in health care centers and often enables remote access, facilitating the use of tele-CT/tele-MRI and improving administrative procedures and communication.</p>
          <p>Several solutions are available in this regard, including cloud-based web solutions. Remote access to images and the ability to distribute reports via a standard universal system are helpful for the workflow.</p>
          <p>A report is nothing more than a type of communication with the main objective of transmitting the assessment of images analyzed by an expert to another physician who needs such information to make decisions. The more complete and clear the transmitted information is, the more important the requested test becomes. The development of structured reports linking written information to tables, figures, and photos to make the information as clear and accurate as possible is an ongoing trend.</p>
          <p>As described earlier, reports may be made available through advanced systems like RIS, but other forms of transmission, including instant messaging applications like WhatsApp, may be used. According to the CFM,<xref ref-type="bibr" rid="B191">191</xref> WhatsApp and similar platforms can be used for communication between physicians and patients, as well as privately between physicians for transmission of data or questions, or in closed group chats between specialists or clinical staff of an institution or chair, provided that all information transmitted is absolutely confidential, remain within the group, and is not circulated to recreational groups, even if these are composed only of physicians.</p>
        </sec>
        <sec>
          <title>2.8.7. Clinical Indications for MRI and CT</title>
          <p>Interestingly, no studies in the literature have assessed the clinical impact of the application of tele-MRI or tele-CT. Thus, clinical recommendations in this guideline are based on level C evidence, including expert consensuses, and in the absence of studies evaluating cost-effective outcomes. Aware of this limitation, we cite at the end of this document the main indications for the application of tele-CT/tele-MRI in this subarea of cardiovascular imaging.<xref ref-type="bibr" rid="B192">192</xref>
					</p>
          <p>The use of MRI and CT imaging has been increasing, and characteristics of these imaging methods make their use very interesting in telemedicine, particularly in countries with continental proportions like Brazil and in those with a limited number of available MRI/CT specialists. The possibility of having a specialist potentially accessible at any moment can be helpful in patient management and in lowering health care costs by optimizing the time of available specialists and expediting reports of hospitalized patients, which can shorten their hospital stay, and in other applications related to this medical progress.</p>
        </sec>
      </sec>
    </sec>
    <sec>
      <title>3. Telerobotics Applied to Cardiology</title>
      <sec>
        <title>3.1. Robotic Telesurgery</title>
        <p>The concept of telesurgery was introduced in the early 1970s by NASA.<xref ref-type="bibr" rid="B193">193</xref> The objective of the original project was to provide medical care to astronauts during remote missions.</p>
        <p>Robotic telesurgery devices are applications in which the surgeon controls remotely a robot that executes the surgical procedure. The da Vinci&#174; system (da Vinci&#174; surgical system; Intuitive Surgical, Sunnyvale, CA, USA), the most widely used robotics platform today, follows this approach. The surgeon works on a console separated from the surgical field, and the movement of his or her hands is perceived and transmitted to the instruments close to the patient. This technique yields great ergonomic benefit to the surgeon, incorporates functions like hand tremor cancellation, and broadens (in three dimensions) the view of the field that the surgeon is interested in. However, these platforms lack much automation and require continuous involvement of a human operator (surgeon) for regulatory reasons.</p>
        <p>ARTEMIS was the first surgical robot used for cardiac procedures.<xref ref-type="bibr" rid="B194">194</xref>Designed as a telesurgery and telepresence system for cardiac procedures, it was used for training and planning and to perform minimally invasive procedures.</p>
        <p>Currently, robotic cardiac surgery has been used primarily for mitral valve repair and myocardial revascularization, following approval by the Food and Drug Administration (FDA) in 2002 and 2000, respectively. Newer techniques assist in cardiac manipulation procedures by compensating heart movements. However, large-scale implementation of this technique is hampered by its high cost<xref ref-type="bibr" rid="B195">195</xref> and the absence of randomized studies demonstrating its superiority over traditional minimally invasive techniques, with or without hybrid procedures.<xref ref-type="bibr" rid="B196">196</xref>
				</p>
        <p>The first robotic mitral valve heart surgery was performed in 1998 by Carpentier, in France, and Mohr, in Germany. That same year, Carpentier conducted the first coronary artery bypass surgery in Paris, while Reichenspurner performed revascularization surgery with the voice-controlled ZEUS Robotic Surgical System (Computer Motion, Goleta, CA) in Munich.<xref ref-type="bibr" rid="B196">196</xref>,<xref ref-type="bibr" rid="B197">197</xref> Since then, this technique has become popular as it is associated with less surgical aggression, reduced cardiopulmonary bypass and aortic clamping duration, and shorter hospital stay compared with the conventional open technique.<xref ref-type="bibr" rid="B197">197</xref>
				</p>
        <p>The da Vinci&#174; robotic system has allowed improved visualization of the surgical field with three-dimensional capture and ten-fold magnification, resulting in greater precision in the surgical procedure and smaller incisions following a learning curve.<xref ref-type="bibr" rid="B198">198</xref><sup>,</sup><xref ref-type="bibr" rid="B199">199</xref> It has also reduced the rates of all complications (particularly infection), blood transfusion, and time to return to work activities, with an impact on the total costs of the procedure. This has been observed especially among patients at high risk (like elderly individuals) and those with ejection fraction lower than 20%, diabetes of difficult control, and severe chronic obstructive pulmonary disease.<xref ref-type="bibr" rid="B200">200</xref> This robotics system has also benefited hybrid surgeries, angioplasty, and minimally invasive procedures in patients with multilateral obstructive coronary artery disease.<xref ref-type="bibr" rid="B201">201</xref>
				</p>
        <p>Both computer-integrated surgery and telemedicine are becoming popular in the developed world. Advancements in robotic technology and information technology, like the Internet of Things, allow robotic arms to be controlled remotely, enabling robotic telesurgery. With telesurgery, surgeons can perform surgical procedures in remote locations, away from the patients, improving the access to medical treatment and, potentially, the quality of the treatment.</p>
        <p>As with other telemedicine applications, telesurgery can broaden the access to interventions in remote areas or centers where specialists in particular types of surgery are not present, for example. The importance of telemedicine, telesurgery, and remote surgery is not restricted to their ability to perform medical procedures in areas where these procedures are not available and can be extended to telementoring, which involves the training of medical professionals to perform these procedures.<xref ref-type="bibr" rid="B202">202</xref> In this area, telesurgery could also benefit patients requiring infrequent, highly complex interventions, in which the medical-surgical expertise is not widely available. The acquisition of new technology expertise by specialists has been accompanied by mentoring programs (proctors). In robotic surgery, telemedicine can provide training with remotely connected proctors (telementoring), expanding the access to innovative technologies.<xref ref-type="bibr" rid="B203">203</xref><sup>,</sup><xref ref-type="bibr" rid="B204">204</xref>
				</p>
        <p>Outcomes of robotic surgeries still lack long-term analyses of hard outcomes like all-cause mortality, cardiovascular death, fatal AMI, stroke, need for repeat revascularization, and vascular graft patency. As in traditional surgeries, patient selection is essential, and the goal should be complete revascularization, bearing in mind that CO<sub>2</sub> insufflation decreases venous return by increasing intrathoracic pressure and may compromise hemodynamic parameters in patients with left ventricular dysfunction and in those with chronic obstructive disease, who would benefit more from minimally invasive surgery. Case series have been reported totaling about 110 patients and showing 90% of surgical success within 30 days without open surgery and a maximum follow-up of 5 years.<xref ref-type="bibr" rid="B205">205</xref><sup>-</sup><xref ref-type="bibr" rid="B207">207</xref>
				</p>
        <p>The largest experience in this area has been published by Cavallaro et al.,<xref ref-type="bibr" rid="B208">208</xref> who reported rates of morbidity and mortality with robotic myocardial revascularization surgery in 2,582 patients between 2008 and 2010. The authors reported lower rates of postoperative complications in selected patients but concluded that these benefits decreased in patients requiring multiple bypass grafts.<xref ref-type="bibr" rid="B208">208</xref>
				</p>
        <p>Approximately 1,700 robotic heart surgeries are performed annually in the US, including 35.5% for mitral valve repairs.<xref ref-type="bibr" rid="B209">209</xref> In 2011, the FDA introduced a post-marketing surveillance plan known as the Medical Device Epidemiology Network initiative, leveraging AI to real-world data analysis, including international registries and electronic medical record data, to bridge the gap in evidence gathering concurrent with the implementation of technological innovation without compromising patient safety.<xref ref-type="bibr" rid="B210">210</xref>
				</p>
        <p>In Brazil, none of the robotic surgical techniques have been included in the public policy list or in the List of Procedures and Events in Health of the National Health Agency.<xref ref-type="bibr" rid="B210">210</xref> In this sense, the CFM, through Resolution 2.227/2018, which was later repealed, had regulated robotic telesurgery, precisely anticipating the expansion of the benefits of the technique and facilitating the follow-up of the learning curve by proctors in remote locations. Thus, robotic surgery in Brazil can be remotely assisted by a specialist at a large center in another country. Although the CFM allowed the use of robotic telesurgery in Brazil, it restricted the method to professionals qualified to practice medicine in the country.<xref ref-type="bibr" rid="B39">39</xref> Of note, mentoring/proctoring programs in Brazil have not been widely regulated, except in the State of Para&#237;ba, where the CRM, through Resolution CRM-PB 182/2018, defined rules that regulate and legally secure the practice to the medical act.<xref ref-type="bibr" rid="B39">39</xref>
				</p>
        <p>In addition to the information presented above, synchronization between the vast potential of these technologies and the existing ethical and legal apparatus is also lacking. Unlike a comprehensive national policy, there is a general scenario of fragmentation characterized by different norms and standards issued by different agencies and with a different focus.<xref ref-type="bibr" rid="B7">7</xref> Even if a single instrument could hardly achieve these objectives, fragmentation would be yet another obstacle to overcome to reach the potential that telemedicine and telesurgery have in our country. </p>
        <p>Among other barriers to their practical use are the scarcity of resources and technical knowledge, as well as infrastructure issues. Brazil is a country of unequal regional distribution in terms of broadband availability.<xref ref-type="bibr" rid="B7">7</xref> This means that the infrastructure of the broadband data network is one of the most limiting factors for the expansion of telemedicine in general and telesurgery in particular, especially in rural areas of the country.</p>
      </sec>
      <sec>
        <title>3.2. Robotic Angioplasty</title>
        <p>PCI can be considered a highly predictable, safe, and minimally invasive therapy. However, this manual and operator-dependent procedure must be executed in person, demanding physical action by the physician. Full proficiency can only be achieved in high-volume environments with scenarios involving highly complex and technological interventions. Coronary angioplasty also exposes both professional and patient to ionizing radiation. As a result, the potential risks are high for occupational health damage arising not only from the radiation but also from the need of individual protection<xref ref-type="bibr" rid="B211">211</xref><sup>-</sup><xref ref-type="bibr" rid="B213">213</xref>e.g., a 7-kg lead apron).</p>
        <p>Robot-assisted coronary interventions have recently been developed as an alternative to reduce the reliance on manual operation,<xref ref-type="bibr" rid="B214">214</xref><sup>-</sup><xref ref-type="bibr" rid="B224">224</xref> potentially reducing damage from radiation exposure.<xref ref-type="bibr" rid="B225">225</xref> Clinical studies have demonstrated the safety and efficacy of the robotic system, which has already been approved for routine application in the US and the European Union. Even though the current set of scientific evidence is encouraging, it is also recent and limited to the number of patients treated, hindering further consideration of possible risks and benefits of the technique, especially when it comes to particularities of its application in subgroups of clinical interest.</p>
      </sec>
    </sec>
    <sec sec-type="supplementary-material">
      <title>4. Telemedicine for Provision of Services and in Supplementary Health</title>
      <sec>
        <title>4.1. Provision of Services</title>
        <p>Over 60% of all health care facilities and between 40-50% of all US hospitals are currently estimated to use some form of digital data transmission.<xref ref-type="bibr" rid="B226">226</xref> In 2016, a US health care facility reported that communication of digital health data (e-mail, phone, and video) exceeded the number of in-person consultations.<xref ref-type="bibr" rid="B227">227</xref>
				</p>
        <p>However, it is important to note that despite new modes and means of communication transmission between physicians and patients, ethical and legal responsibilities remain the same as those governing the traditional physician-patient relationship.<xref ref-type="bibr" rid="B228">228</xref> Cardiologists must inform their patients about telemedicine services and their limitations, the possibility of late follow-up, by encouraging regular reporting to their attending physicians, and how they can receive electronic health-promoting information.</p>
        <p>Reimbursement is a key determinant of the success of clinical interventions. The movement toward value-based reimbursement rather than payment for service, which provides incentives for care in lower-cost settings, along with the identification and interaction with high-risk individuals before disease onset, and the efficient use of integrated care teams, provide incentives for telemedicine expansion. Understanding the effect of reimbursement within the context of alternative payment models is a priority.</p>
        <p>While the path of value-based reimbursement is uncertain, the efficiency of care will inevitably be a priority in any scenario. Ensuring that these technologies are used for patients who meet the appropriate clinical requirements is also an important related topic. In the US, reimbursement for medical services by telemedicine has gradually expanded from coverage of services provided in rural settings to a broader program (Medicare Access and CHIP Reauthorization Act).<xref ref-type="bibr" rid="B229">229</xref> Training and development projects have been created in Brazil, along with a continuing medical education with special attention to the SAMU/UPA care model, developed by the Ministry of Health and private hospitals.<xref ref-type="bibr" rid="B230">230</xref>
				</p>
        <p>Regarding the payment for telemedicine and telehealth services in Brazil, as already mentioned, it should be considered that the main source of funds has been the public sector:<xref ref-type="bibr" rid="B231">231</xref><sup>-</sup><xref ref-type="bibr" rid="B233">233</xref>
				</p>
        <p>
          <list list-type="bullet">
            <list-item>
              <p> public communications from national (such as the National Council for Scientific and Technological Development - CNPq - and the Financier of Studies and Projects - FINEP) and regional research and innovation funding agencies (state research supporting foundations);</p>
            </list-item>
            <list-item>
              <p> agreements or direct transfer of funds to universities and health departments, within the scope of the program <italic>Telessa&#250;de Brasil</italic>, then <italic>Telessa&#250;de Brasil Redes</italic>;</p>
            </list-item>
            <list-item>
              <p> service providing agreements between public administrators and telehealth centers at university centers;<xref ref-type="bibr" rid="B232">232</xref>
							</p>
            </list-item>
            <list-item>
              <p> projects within hospitals receiving tax waiving by the PRO-ADI SUS program from the Ministry of Health.<xref ref-type="bibr" rid="B215">215</xref>
							</p>
            </list-item>
          </list>
        </p>
        <p>Many of these investments occurred at an early stage of technological development in the country, and only some of the fostered nuclei became active, sustainable services.<xref ref-type="bibr" rid="B232">232</xref> There is a clear need for inclusion of telehealth procedures in the list of procedures paid by the SUS in order to regulate and encourage their routine use in the health system.</p>
        <p>Supplementary health, in turn, lacks formal mechanisms of payment and reimbursement for telehealth activities, so telemedicine actions in this sector have been focused on optimizing care and reducing costs, and are often associated with specific conditions like stroke.<xref ref-type="bibr" rid="B231">231</xref>
				</p>
        <p>Of note, the Ministry of Health Secretariat of Science, Technology, and Strategic Inputs, through Ordinance 26, of August 2, 2017, made public the decision to incorporate remote monitoring technology for the evaluation of patients with cardiac implantable electronic devices (CIEDs) within the scope of the SUS. This is an unprecedented incorporation of remote monitoring technology as a result of industry demand. The requester assessed the budgetary impact of the technology over 5 years, considering only direct expenses with the purchase of the remote monitoring device and the provision of conventional monitoring in a base case. A second scenario analyzed a model of dynamic transition state to account for opportunity costs of both technologies, exploring the advantages and disadvantages of each strategy. With the decision, the technology should have been included in the SUS within 180 days from the publication of the incorporation order by the Secretary of Science, Technology, and Strategic Inputs, but to date, the Clinical Protocol and Therapeutic Guidelines making this technology available in the SUS have still not been published.<xref ref-type="bibr" rid="B234">234</xref>
				</p>
        <p>Unfortunately, there are still several gaps in the process of recognizing medical services in telemedicine for the purpose of reimbursement. The example above is the only one deliberated for public health. The process of coding hierarchical classifications or other payment modalities for the various telemedicine services has not yet been properly structured.</p>
        <p>A more complete and structured set of codes would also provide more accurate data to address the scarcity of systematic economic evaluation of the benefits of telemedicine in both pay-per-service and value-based models.<xref ref-type="bibr" rid="B235">235</xref> Bridging this gap is essential to guiding public and private health care providers and technology buyers and investors on decisions about investment returns in this field.</p>
      </sec>
      <sec>
        <title>4.2. Telemedicine in Supplementary Health</title>
        <p>In 1988, Brazil opted for the establishment of a universal health care system free and fully accessible, pursuant to art. 196 of the Federal Constitution. However, health care is available to private initiative, as established in the Magna Carta (Paragraph 1 of Art. 199) pertaining to the scope of participation of the private initiative: &#8220;Private institutions may participate in a complementary way in the SUS, according to its guidelines, by means of a contract of public law or agreement, with preference given to philanthropic and nonprofit entities.&#8221;<xref ref-type="bibr" rid="B236">236</xref>
				</p>
        <p>Supplementary health assists over 47 million beneficiaries in Brazil and is governed by its own legislation, regulated by the National Health Agency. This is a health care system with its own characteristics and regulatory framework guided by specific legislation (Law No. 9.656/1998). The benefits gained from the remarkable development of ICT also apply to supplementary health. However, it should be noted that, due to particularities of laws governing the sector, health care plan operators are required to offer a myriad of procedures included in the List of Procedures and Events in Health of the National Health Agency.<xref ref-type="bibr" rid="B237">237</xref>
				</p>
        <p>Also worthy of note is the fact that when one buys a health care plan, priority is given to access to physicians and therapies that supplement the list of policies offered by the SUS. Most of the supplementary health beneficiaries live in large centers, with over 35 million beneficiaries in the Southeast (28,650,281) and South (6,912,748) regions and more than 18 million in capital cities. An analysis of the intersection of demographic data of supplementary health beneficiaries and Brazilian physicians, including cardiologists, shows that the proportion of physicians per inhabitant (beneficiaries of supplementary health) in these regions is different from the one observed in public health, where truly remote areas receive no coverage. It is imperative to consider that the in-person relationship between physician and patient is the rule in supplementary health, which does not hinder the possibility of making telemedicine resources available.<xref ref-type="bibr" rid="B238">238</xref>
				</p>
        <p>Accordingly, the various services provided by telemedicine are fully applicable to supplementary health. However, the provision of face-to-face consultations with experts rather than their &#8220;tele&#8221; versions is a legal demand. ICT resources should not be offered to replace face-to-face interaction but should be an option to improve care also in the context of supplementary health.</p>
        <p>Increased efficiency in health care requires quality improvements and costs savings.<xref ref-type="bibr" rid="B239">239</xref> The integration of telemedicine into outpatient clinics and hospitals, including supplementary health, can help achieve both goals.<xref ref-type="bibr" rid="B240">240</xref>
				</p>
        <p>Medical care is, without question, one of the most (if not the most) complex sectors in the economy. Considerable financial investment and years of persistence are required to build an effective telemedicine system. The widespread adoption of this type of practice also requires behavioral adaptations by many physicians, organizations, and patients.<xref ref-type="bibr" rid="B241">241</xref> The industry in this area still requires better regulation.</p>
        <p>Telemedicine can be an affordable alternative to meet the health needs of vulnerable populations with multiple comorbidities requiring frequent care.<xref ref-type="bibr" rid="B242">242</xref> Improving patient engagement, telemedicine can provide an effective platform for patients to engage in their own decisions.<xref ref-type="bibr" rid="B243">243</xref> For example, the US Veterans Health Administration introduced a national telemedicine program named Care Coordination/Home Telehealth. This model allows patients to manage their own conditions,<xref ref-type="bibr" rid="B244">244</xref> and some important studies have reported that the shared-decision model has reduced hospitalization rates.<xref ref-type="bibr" rid="B245">245</xref>
				</p>
        <p>Unequal access to health, even in supplementary health, is persistent in Brazil and requires major investments to improve the organization of health care systems. Even when health care services and evidence-based guidelines are available for common and relevant conditions like hypertension and diabetes, the implementation gap is vast, and best practices are not absorbed by health care professionals, or recommended measures are not followed by patients and their relatives. The science of implementation has proved to be as important as data analysis in recent decades for the recognition of bottlenecks preventing full use of preventive and therapeutic measures to ensure benefits for patients who can live longer and better by taking advantage of all available knowledge,<xref ref-type="bibr" rid="B246">246</xref> reducing costs and increasing the efficiency of private health care systems.</p>
        <p>Direct physician-patient teleconsultation, not yet regulated in Brazil, is the most frequently used model. A US report showed that telecardiology was useful for evaluating both new and recent postoperative referrals, with the potential benefit of knowledge transfer to local primary care. In Canada, teleconsultation has been useful for the evaluation of new patients with syncope and supraventricular tachycardia.<xref ref-type="bibr" rid="B247">247</xref> In the United Kingdom, a wide range of inpatient and outpatient telecardiology services is available at district hospitals using various technologies.<xref ref-type="bibr" rid="B248">248</xref> This approach has improved access, was cost neutral, and increased patient satisfaction. The authors emphasized that it complemented but did not replace regular consultations.</p>
        <p>The demand for home care using web-based applications directed to consumers, including tablet and smartphone applications, is growing exponentially.<xref ref-type="bibr" rid="B249">249</xref> Many health care providers worldwide are adopting this technology as a way to provide low-cost care for common problems that could result in a visit to the emergency department.<xref ref-type="bibr" rid="B250">250</xref> Most of these applications rely solely on video and audio connections with additional software for scheduling, billing, sharing of still images, and documentation. Also, some peripherals, such as smartphone-compatible heart rate sensing devices,<xref ref-type="bibr" rid="B251">251</xref> are available for purchase at decreasing prices.</p>
        <p>Limited financial availability for the acquisition and maintenance of telemedicine equipment and infrastructure remains a barrier to the widespread deployment of telemedicine.<xref ref-type="bibr" rid="B252">252</xref> This is particularly true for many health care providers or small systems that may lack the required resources and often have conflicting demands for available funds. Other costs associated with telemedicine programs include salary, administrative support and supplies, software and application development and upgrade costs, training programs, and initiatives to promote the program to patients.<xref ref-type="bibr" rid="B253">253</xref> With increased mobile connectivity, smartphones, and video compression, the costs to implement simple telemedicine interactions have decreased.</p>
        <p>Currently, none of the procedures used in telemedicine are included in the Supplementary Health List of Procedures and Events in Health, <italic>i.e.</italic>, a regulatory vacuum current places telemedicine in a field of conjecture and frustrated expectations dissociated from the interest of the regulated sector. There is also no concrete scientific evidence available to support the formal use of this technology.<xref ref-type="bibr" rid="B38">38</xref>
				</p>
        <p>Telemedicine is a disruptive innovation with the potential to change health, and its influence is likely to increase rapidly. Guided by what is best for patients, telemedicine, if properly applied, will help usher in a new age for health care that will be built by patients and physicians, identifying new ways of care, increasing quality and rationalizing costs also in supplementary care.<xref ref-type="bibr" rid="B240">240</xref>
				</p>
      </sec>
    </sec>
    <sec>
      <title>5. Economic Evaluation and Budgetary Impact of the Incorporation of Telemedicine in Cardiology in Brazil</title>
      <sec>
        <title>5.1. Concepts of Economic Evaluation in Telemedicine</title>
        <p>The implementation of telemedicine services seeks to provide accessible and quality health care at a low cost.<xref ref-type="bibr" rid="B254">254</xref> Since the 1990s, as technological communication capabilities advanced, telemedicine services became more prevalent.<xref ref-type="bibr" rid="B255">255</xref>
				</p>
        <p>The emergence of new telemedicine-related capabilities and their integration into care systems offers opportunities to enhance value-based clinical care, promote health, and prevent diseases.<xref ref-type="bibr" rid="B256">256</xref>
				</p>
        <p>The values associated with the adoption of telemedicine services include the collaboration with the agile accessibility of patients to highly complex centers,<xref ref-type="bibr" rid="B257">257</xref> along with a reduction in mortality<xref ref-type="bibr" rid="B258">258</xref> and frequency of hospitalizations.<xref ref-type="bibr" rid="B259">259</xref>
				</p>
        <p>In cardiology, recent publications portray telemedicine and teleconsultation services as effective in the management of patients with chronic heart failure,<xref ref-type="bibr" rid="B260">260</xref><sup>,</sup><xref ref-type="bibr" rid="B261">261</xref> preparation of ECG reports, guidance of patients through mobile applications,<xref ref-type="bibr" rid="B262">262</xref> and cardiac rehabilitation,<xref ref-type="bibr" rid="B263">263</xref> among others.</p>
        <p>From reported experiences, telemedicine is universally seen as offering interesting benefits for improving accessibility and quality of health.<xref ref-type="bibr" rid="B264">264</xref> However, scientific and financial investments required to introduce these technologies into the health care system are high,<xref ref-type="bibr" rid="B265">265</xref> which potentiates the importance of accurate studies on economic analysis to guide decisions upon implementation of telemedicine services.<xref ref-type="bibr" rid="B265">265</xref><sup>,</sup><xref ref-type="bibr" rid="B266">266</xref>
				</p>
        <p>Economic analysis is one of the pillars of health care assessment that aims to support and guide decision making. For a new technology to be applied to a process, it must replace existing alternatives with equal or better results. That is, it must be effective. In addition, the results thus obtained should be less expensive than the alternatives or present reasonable values related to benefits, i.e., it must be cost effective.</p>
        <p>However, the economic evaluation of telemedicine strategies has some specificities: constant change of technology, lack of an adequate study design to manage undersized samples, inadequacy of conventional economic assessment techniques, and health outcome assessment problems not directly related to health.<xref ref-type="bibr" rid="B267">267</xref> As a consequence, different types of cost analysis have gained an important role in the evaluation of telemedicine services.</p>
      </sec>
      <sec>
        <title>5.2. Applied Economic Methods</title>
        <p>Different approaches have been used to assess the economic impact of telemedicine services with varying levels of acceptability. Basically, five methods are available for calculation of cost effectiveness between conventional and telemedicine interventions: cost-minimization analysis, cost-benefit analysis, cost-effectiveness analysis, and cost-utility analysis. Additionally, return on investment has been used in telemedicine projects.<xref ref-type="bibr" rid="B268">268</xref>
				</p>
        <p>Cost-minimization analyses assume that both alternatives (conventional and telemedicine) are equally effective in health outcomes but differ in cost. A cost-minimization analysis considers changes but keeps health outcomes unaltered. For example, telecardiology for ECG reports assumes the same result but with different costs. Consequently, managers have to consider only differences in costs when deciding which alternative is less expensive.<xref ref-type="bibr" rid="B269">269</xref>
				</p>
        <p>Cost-benefit analysis recognizes that different projects are equally effective, but results and costs change. Changes in health costs and outcomes are considered simultaneously and attribute a monetary or numerical value not only to costs but also to health outcomes in order to express the nondimensional cost/benefit ratio. However, the idea of attributing monetary values to health outcomes, such as years of life, is not always acceptable to health decision makers.</p>
        <p>Cost-effectiveness analysis appears as a solution when costs and results are considered simultaneously, without attributing monetary values to results. Each outcome is defined according to its specific unit so that the final indices demonstrate a relationship between economic and health outcomes. Therefore, the final decision depends on the relationship that the decision maker considers best. This ratio (incremental cost-effectiveness ratio, ICER) represents the cost for each additional result unit.<xref ref-type="bibr" rid="B252">252</xref>
				</p>
        <p>Cost-utility analyses consider individuals&#8217; quality of life and the time of life that they will obtain as a result of an intervention. This is a particular case of cost effectiveness in which results are measured in terms of full-life lived years, usually expressed in quality-adjusted life-years (QALYs) or disability-adjusted life-years (DALY). The WHO recommends a value for DALY equivalent to three times the gross domestic product per capita.</p>
        <p>Return on investment is a nondimensional relationship between the monetary value invested and the monetary gain resulting from these investments, and measures the efficiency of the investment.<xref ref-type="bibr" rid="B270">270</xref>
				</p>
      </sec>
      <sec>
        <title>
				</title>
      </sec>
      <sec>
        <title>5.3. Literature Review</title>
        <p>A systematic literature review of cost-benefit review studies on the adoption of telemedicine services was conducted by the Federal University of Minas Gerais (UFMG) in 2016, gathering publications from 2000 to 2016.<xref ref-type="bibr" rid="B105">105</xref> Considering the keywords employed in the study, a search was performed on the PubMed database with the inclusion criterion being only studies related to cardiology. Other reviews manually searched in databases and/or journals of the area were also added. Thus, the search included literature review articles on the assessment of the incorporation of telemedicine in cardiology from 2000 to April 2019.</p>
        <p>Variables related to the economic analysis method, purpose of telemedicine in cardiology, clinical effectiveness, and cost reduction were extracted from the studies. For effectiveness, the impact on the reduction of mortality and hospitalizations, improvement of medication management, and anticipation of diagnosis were evaluated.</p>
        <p>From the search and application of exclusion criteria, 35 articles were fully analyzed by two researchers (A.E. and B.Z.) for the collection of variables. <xref ref-type="fig" rid="f6">Figure 5.1</xref> presents the flowchart of the selection of the articles.</p>
        <p>
          <fig id="f6">
            <label>Figure 5.1</label>
            <caption>
              <title>Flowchart of selection of articles on economic analysis of Telemedicine applied to cardiology.</title>
            </caption>
            <graphic xlink:href="1678-4170-abc-113-05-1006-90205-gf06.jpg"/></fig>
        </p>
        <p>The number of studies focusing on telemedicine, especially the monitoring of chronic diseases, has increased over the last decade. Of the 35 studies identified, 19 were published after 2015. <xref ref-type="table" rid="t7">Table 5.1</xref> summarizes the characteristics of the articles.</p>
        <table-wrap id="t7">
          <label>Table 5.1</label>
          <caption>
            <title>Studies on economic evaluations of telemedicine in cardiology</title>
          </caption>
          <table frame="hsides" rules="rows">
            <colgroup>
              <col width="11%"/>
              <col width="11%"/>
              <col width="11%"/>
              <col width="11%"/>
              <col width="11%"/>
              <col width="11%"/>
              <col width="11%"/>
              <col width="11%"/>
              <col width="11%"/>
            </colgroup>
            <tbody>
              <tr>
                <td align="left">
                  <bold>#ID</bold>
                </td>
                <td align="center">
                  <bold>Authors</bold>
                </td>
                <td align="center">
                  <bold>Year</bold>
                </td>
                <td align="center">
                  <bold>Number of papers assessed</bold>
                </td>
                <td align="center">
                  <bold>Category of telemedicine services</bold>
                </td>
                <td align="center">
                  <bold>Service focus</bold>
                </td>
                <td align="center">
                  <bold>Reduction in mortality</bold>
                </td>
                <td align="center">
                  <bold>Reduction in hospitalizations</bold>
                </td>
                <td align="center">
                  <bold>Reduction in hospital stay</bold>
                </td>
              </tr>
              <tr>
                <td align="left">1</td>
                <td align="center">L&#243;pez-Villegas A, Catal&#225;n-Matamoros D, Mart&#237;n-Saborido C, Villegas-Tripiana I, Robles-Musso E.<xref ref-type="bibr" rid="B284">284</xref>
								</td>
                <td align="center">2016</td>
                <td align="center">7</td>
                <td align="center">Telemonitoring (mHealth)</td>
                <td align="center">Heart failure</td>
                <td align="center">N/A</td>
                <td align="center">N/A</td>
                <td align="center">Yes</td>
              </tr>
              <tr>
                <td align="left">2</td>
                <td align="center">Cajita MI, Gleason KT, Han HR.<xref ref-type="bibr" rid="B271">271</xref>
								</td>
                <td align="center">2016</td>
                <td align="center">10</td>
                <td align="center">Telemonitoring (mHealth)</td>
                <td align="center">Heart failure</td>
                <td align="center">N/A</td>
                <td align="center">N/A</td>
                <td align="center">N/A</td>
              </tr>
              <tr>
                <td align="left">3</td>
                <td align="center">Louis AA Turner T Gretton M Baksh A Cleland JG.<xref ref-type="bibr" rid="B270">270</xref>
								</td>
                <td align="center">2003</td>
                <td align="center">24</td>
                <td align="center">Telemonitoring (mHealth)</td>
                <td align="center">Heart failure</td>
                <td align="center">Yes</td>
                <td align="center">Yes</td>
                <td align="center">Yes</td>
              </tr>
              <tr>
                <td align="left">4</td>
                <td align="center">Kassavou A, Sutton S.<xref ref-type="bibr" rid="B254">254</xref>
								</td>
                <td align="center">2018</td>
                <td align="center">17</td>
                <td align="center">Mobile and automated communication</td>
                <td align="center">Guidance on medication use</td>
                <td align="center">N/A</td>
                <td align="center">N/A</td>
                <td align="center">N/A</td>
              </tr>
              <tr>
                <td align="left">5</td>
                <td align="center">Lin MH, Yuan WL, Huang TC, Zhang HF, Mai JT, Wang JF.<xref ref-type="bibr" rid="B264">264</xref>
								</td>
                <td align="center">2017</td>
                <td align="center">39</td>
                <td align="center">Telemonitoring (mHealth)</td>
                <td align="center">Chronic heart failure</td>
                <td align="center">Yes</td>
                <td align="center">Yes</td>
                <td align="center">Yes</td>
              </tr>
              <tr>
                <td align="left">6</td>
                <td align="center">Kotb A Cameron C Hsieh S Wells G.<xref ref-type="bibr" rid="B285">285</xref>
								</td>
                <td align="center">2015</td>
                <td align="center">30</td>
                <td align="center">Comparison between telephone teleconsultation services</td>
                <td align="center">Heart failure</td>
                <td align="center">Yes</td>
                <td align="center">Yes</td>
                <td align="center">Yes</td>
              </tr>
              <tr>
                <td align="left">7</td>
                <td align="center">Yun JE, Park JE, Park HY, Lee HY, Park DA.<xref ref-type="bibr" rid="B286">286</xref>
								</td>
                <td align="center">2018</td>
                <td align="center">37</td>
                <td align="center">Telemonitoring (mHealth)</td>
                <td align="center">Heart failure</td>
                <td align="center">Yes</td>
                <td align="center">Yes</td>
                <td align="center">N/A </td>
              </tr>
              <tr>
                <td align="left">8</td>
                <td align="center">Seto E.<xref ref-type="bibr" rid="B269">269</xref>
								</td>
                <td align="center">2008</td>
                <td align="center">9</td>
                <td align="center">Telemonitoring (mHealth)</td>
                <td align="center">Heart failure</td>
                <td align="center">N/A</td>
                <td align="center">N/A</td>
                <td align="center">N/A</td>
              </tr>
              <tr>
                <td align="left">9</td>
                <td align="center">Grustam AS, Severens JL, van Nijnatten J, Koymans R, Vrijhoef HJ.<xref ref-type="bibr" rid="B260">260</xref>
								</td>
                <td align="center">2014</td>
                <td align="center">22</td>
                <td align="center">Telemedicine</td>
                <td align="center">Chronic heart failure</td>
                <td align="center">Yes</td>
                <td align="center">Yes</td>
                <td align="center">N/A</td>
              </tr>
              <tr>
                <td align="left">10</td>
                <td align="center">Lee M, Wang M, Liu J, Holbrook A.<xref ref-type="bibr" rid="B287">287</xref>
								</td>
                <td align="center">2018</td>
                <td align="center">7</td>
                <td align="center">Teleconsulting</td>
                <td align="center">Guidance on medication use</td>
                <td align="center">Yes</td>
                <td align="center">N/A</td>
                <td align="center">N/A</td>
              </tr>
              <tr>
                <td align="left">11</td>
                <td align="center">Klersy C, De Silvestri A, Gabutti G, Raisaro A, Curti M, Regoli F, et al.<xref ref-type="bibr" rid="B288">288</xref>
								</td>
                <td align="center">2011</td>
                <td align="center">17</td>
                <td align="center">Telemonitoring (mHealth)</td>
                <td align="center">Heart failure</td>
                <td align="center">N/A</td>
                <td align="center">Sim</td>
                <td align="center">N&#227;o</td>
              </tr>
              <tr>
                <td align="left">12</td>
                <td align="center">Conway A Inglis SC Clark RA.;<xref ref-type="bibr" rid="B289">289</xref>
								</td>
                <td align="center">2014</td>
                <td align="center">25</td>
                <td align="center">Telemonitoring (mHealth)</td>
                <td align="center">Hypertension</td>
                <td align="center">Yes</td>
                <td align="center">Yes</td>
                <td align="center">Yes</td>
              </tr>
              <tr>
                <td align="left">13</td>
                <td align="center">Duan Y, Xie Z, Dong F, Wu Z, Lin Z, Sun N, Xu J.<xref ref-type="bibr" rid="B290">290</xref>
								</td>
                <td align="center">2017</td>
                <td align="center">46</td>
                <td align="center">Telemonitoring (mHealth)</td>
                <td align="center">Hypertension</td>
                <td align="center">N/A</td>
                <td align="center">Yes</td>
                <td align="center">N/A</td>
              </tr>
              <tr>
                <td align="left">14</td>
                <td align="center">Kitsiou S Par&#233; G Jaana M.;<xref ref-type="bibr" rid="B291">291</xref>
								</td>
                <td align="center">2015</td>
                <td align="center">15</td>
                <td align="center">Telemonitoring (mHealth)</td>
                <td align="center">Chronic heart failure</td>
                <td align="center">Yes</td>
                <td align="center">N/A</td>
                <td align="center">N/A</td>
              </tr>
              <tr>
                <td align="left">
                  <bold>#ID</bold>
                </td>
                <td align="center">
                  <bold>Reduction in hospital stay</bold>
                </td>
                <td align="center">
                  <bold>Early diagnosis</bold>
                </td>
                <td align="center">
                  <bold>Increased adherence to therapy</bold>
                </td>
                <td align="center">
                  <bold>Not conclusive</bold>
                </td>
                <td align="center">
                  <bold>Cost reduction</bold>
                </td>
                <td align="center" colspan="3">
                  <bold>Most frequent economic analysis method among the articles</bold>
                </td>
              </tr>
              <tr>
                <td align="left">1</td>
                <td align="center">Yes</td>
                <td align="center">Yes</td>
                <td align="center">N/A</td>
                <td align="center">N/A</td>
                <td align="center">Yes</td>
                <td align="center" colspan="3">Cost-effectiveness</td>
              </tr>
              <tr>
                <td align="left">2</td>
                <td align="center">N/A</td>
                <td align="center">N/A</td>
                <td align="center">N/A</td>
                <td align="center">Yes</td>
                <td align="center">N/A</td>
                <td align="center" colspan="3">N/A</td>
              </tr>
              <tr>
                <td align="left">3</td>
                <td align="center">Yes</td>
                <td align="center">Yes</td>
                <td align="center">N/A</td>
                <td align="center">N/A</td>
                <td align="center">Yes</td>
                <td align="center" colspan="3">Cost-effectiveness</td>
              </tr>
              <tr>
                <td align="left">4</td>
                <td align="center">N/A</td>
                <td align="center">N/A</td>
                <td align="center">Yes</td>
                <td align="center">N/A</td>
                <td align="center">N/A</td>
                <td align="center" colspan="3">N/A</td>
              </tr>
              <tr>
                <td align="left">5</td>
                <td align="center">Yes</td>
                <td align="center">N/A</td>
                <td align="center">N/A</td>
                <td align="center">N/A</td>
                <td align="center">N/A</td>
                <td align="center" colspan="3">N/A</td>
              </tr>
              <tr>
                <td align="left">6</td>
                <td align="center">Yes</td>
                <td align="center">N/A</td>
                <td align="center">N/A</td>
                <td align="center">N/A</td>
                <td align="center">N/A</td>
                <td align="center" colspan="3">N/A</td>
              </tr>
              <tr>
                <td align="left">7</td>
                <td align="center">N/A</td>
                <td align="center">N/A</td>
                <td align="center">Yes</td>
                <td align="center">N/A</td>
                <td align="center">N/A</td>
                <td align="center" colspan="3">N/A</td>
              </tr>
              <tr>
                <td align="left">8</td>
                <td align="center">N/A</td>
                <td align="center">N/A</td>
                <td align="center">N/A</td>
                <td align="center">N/A</td>
                <td align="center">Yes</td>
                <td align="center" colspan="3">Cost-minimization</td>
              </tr>
              <tr>
                <td align="left">9</td>
                <td align="center">N/A</td>
                <td align="center">N/A</td>
                <td align="center">N/A</td>
                <td align="center">N/A</td>
                <td align="center">Yes</td>
                <td align="center" colspan="3">Cost-effectiveness</td>
              </tr>
              <tr>
                <td align="left">10</td>
                <td align="center">N/A</td>
                <td align="center">Yes</td>
                <td align="center">N/A</td>
                <td align="center">N/A</td>
                <td align="center">N/A</td>
                <td align="center" colspan="3">N/A</td>
              </tr>
              <tr>
                <td align="left">11</td>
                <td align="center">No</td>
                <td align="center">N/A</td>
                <td align="center">N/A</td>
                <td align="center">N/A</td>
                <td align="center">Yes</td>
                <td align="center" colspan="3">Cost-effectiveness</td>
              </tr>
              <tr>
                <td align="left">12</td>
                <td align="center">Yes</td>
                <td align="center">N/A</td>
                <td align="center">N/A</td>
                <td align="center">N/A</td>
                <td align="center">N/A</td>
                <td align="center" colspan="3">N/A</td>
              </tr>
              <tr>
                <td align="left">13</td>
                <td align="center">N/A</td>
                <td align="center">Yes</td>
                <td align="center">N/A</td>
                <td align="center">N/A</td>
                <td align="center">N/A</td>
                <td align="center" colspan="3">N/A</td>
              </tr>
              <tr>
                <td align="left">14</td>
                <td align="center">N/A</td>
                <td align="center">N/A</td>
                <td align="center">N/A</td>
                <td align="center">N/A</td>
                <td align="center">Yes</td>
                <td align="center" colspan="3">N/A</td>
              </tr>
              <tr>
                <td align="left">15</td>
                <td align="center">Polisena J Tran K Cimon K Hutton B McGill S Palmer K<xref ref-type="bibr" rid="B292">292</xref>
								</td>
                <td align="center">2010</td>
                <td align="center">21</td>
                <td align="center">Telemonitoring (mHealth)</td>
                <td align="center">Congestive heart failure</td>
                <td align="center">Yes</td>
                <td align="center">Yes</td>
                <td align="center">Yes</td>
              </tr>
              <tr>
                <td align="left">16</td>
                <td align="center">Pandor A Thokala P Gomersall T Baalbaki H Stevens JW Wang J.<xref ref-type="bibr" rid="B266">266</xref>
								</td>
                <td align="center">2013</td>
                <td align="center">2</td>
                <td align="center">Telemonitoring (mHealth)</td>
                <td align="center">Heart failure</td>
                <td align="center">Yes</td>
                <td align="center">Yes</td>
                <td align="center">N/A</td>
              </tr>
              <tr>
                <td align="left">17</td>
                <td align="center">Inglis SC Conway A Clark RA.; Cleland JG<xref ref-type="bibr" rid="B285">285</xref>
								</td>
                <td align="center">2015</td>
                <td align="center">27</td>
                <td align="center">Teleconsulting</td>
                <td align="center">Heart failure</td>
                <td align="center">Yes</td>
                <td align="center">Yes</td>
                <td align="center">N/A</td>
              </tr>
              <tr>
                <td align="left">18</td>
                <td align="center">Liu S, Feng W, Chhatbar PY, Liu Y, Ji X, Ovbiagele B.<xref ref-type="bibr" rid="B286">286</xref>
								</td>
                <td align="center">2015</td>
                <td align="center">13</td>
                <td align="center">Telemonitoring (mHealth)</td>
                <td align="center">Risk of stroke</td>
                <td align="center">Yes</td>
                <td align="center">N/A</td>
                <td align="center">N/A</td>
              </tr>
              <tr>
                <td align="left">19</td>
                <td align="center">Knox L, Rahman RJ, Beedie C.<xref ref-type="bibr" rid="B287">287</xref>
								</td>
                <td align="center">2017</td>
                <td align="center">26</td>
                <td align="center">Telemonitoring (mHealth)</td>
                <td align="center">Chronic heart failure</td>
                <td align="center">Yes</td>
                <td align="center">Yes</td>
                <td align="center">Yes</td>
              </tr>
              <tr>
                <td align="left">20</td>
                <td align="center">Pandor A Gomersall T Stevens JW Wang J Al-Mohammad A Bakhai A.<xref ref-type="bibr" rid="B288">288</xref>
								</td>
                <td align="center">2013</td>
                <td align="center">21</td>
                <td align="center">Telemonitoring (mHealth)</td>
                <td align="center">Heart failure</td>
                <td align="center">N/A</td>
                <td align="center">Yes</td>
                <td align="center">N/A</td>
              </tr>
              <tr>
                <td align="left">21</td>
                <td align="center">Hamilton SJ, Mills B, Birch EM, Thompson SC.<xref ref-type="bibr" rid="B255">255</xref>
								</td>
                <td align="center">2018</td>
                <td align="center">9</td>
                <td align="center">Telemonitoring (mHealth)</td>
                <td align="center">Cardiac rehabilitation and heart failure</td>
                <td align="center">N/A</td>
                <td align="center">N/A</td>
                <td align="center">N/A</td>
              </tr>
              <tr>
                <td align="left">22</td>
                <td align="center">Inglis SC Clark RA Dierckx R Prieto-Merino D Cleland JG.<xref ref-type="bibr" rid="B289">289</xref>
								</td>
                <td align="center">2015</td>
                <td align="center">25</td>
                <td align="center">Telemonitoring (mHealth)</td>
                <td align="center">Heart failure</td>
                <td align="center">Yes</td>
                <td align="center">Yes</td>
                <td align="center">N/A</td>
              </tr>
              <tr>
                <td align="left">23</td>
                <td align="center">Par&#233; G Jaana M Sicotte C.;<xref ref-type="bibr" rid="B290">290</xref>
								</td>
                <td align="center">2007</td>
                <td align="center">16</td>
                <td align="center">Telemonitoring (mHealth)</td>
                <td align="center">Hypertension and heart disease</td>
                <td align="center">N/A</td>
                <td align="center">Yes</td>
                <td align="center">Yes</td>
              </tr>
              <tr>
                <td align="left">24</td>
                <td align="center">Shah A Clarke M Sharma U.;<xref ref-type="bibr" rid="B291">291</xref>
								</td>
                <td align="center">2011</td>
                <td align="center">13</td>
                <td align="center">Telemonitoring (mHealth)</td>
                <td align="center">Congestive heart failure</td>
                <td align="center">N/A</td>
                <td align="center">No</td>
                <td align="center">No</td>
              </tr>
              <tr>
                <td align="left">25</td>
                <td align="center">Rawstorn JC, Gant N, Direito A, Beckmann C, Maddison R.<xref ref-type="bibr" rid="B151">151</xref>
								</td>
                <td align="center">2016</td>
                <td align="center">11</td>
                <td align="center">Teleconsulting</td>
                <td align="center">Cardiac rehabilitation</td>
                <td align="center">Yes</td>
                <td align="center">N/A</td>
                <td align="center">N/A</td>
              </tr>
              <tr>
                <td align="left">26</td>
                <td align="center">Neubeck L Redfern J Fernandez R Briffa T Bauman A.<xref ref-type="bibr" rid="B292">292</xref>
								</td>
                <td align="center">2009</td>
                <td align="center">11</td>
                <td align="center">Telemonitoring (mHealth)</td>
                <td align="center">Coronary disease</td>
                <td align="center">Yes</td>
                <td align="center">N/A</td>
                <td align="center">N/A</td>
              </tr>
              <tr>
                <td align="left">
                  <bold>#ID</bold>
                </td>
                <td align="center">
                  <bold>Early diagnosis</bold>
                </td>
                <td align="center" colspan="2">
                  <bold>Increased adherence to therapy</bold>
                </td>
                <td align="center" colspan="2">
                  <bold>Not conclusive</bold>
                </td>
                <td align="center">
                  <bold>Cost reduction</bold>
                </td>
                <td align="center" colspan="2">
                  <bold>Most frequent economic analysis method among articles</bold>
                </td>
              </tr>
              <tr>
                <td align="left">15</td>
                <td align="center">N/A</td>
                <td align="center" colspan="2">N/A</td>
                <td align="center" colspan="2">N/A</td>
                <td align="center">N/A</td>
                <td align="center" colspan="2">N/A</td>
              </tr>
              <tr>
                <td align="left">16</td>
                <td align="center">N/A</td>
                <td align="center" colspan="2">N/A</td>
                <td align="center" colspan="2">N/A</td>
                <td align="center">Yes</td>
                <td align="center" colspan="2">Cost-effectiveness</td>
              </tr>
              <tr>
                <td align="left">17</td>
                <td align="center">N/A</td>
                <td align="center" colspan="2">N/A</td>
                <td align="center" colspan="2">N/A</td>
                <td align="center">N/A</td>
                <td align="center" colspan="2">N/A</td>
              </tr>
              <tr>
                <td align="left">18</td>
                <td align="center">Yes</td>
                <td align="center" colspan="2">NA</td>
                <td align="center" colspan="2">NA</td>
                <td align="center">N/A</td>
                <td align="center" colspan="2">N/A</td>
              </tr>
              <tr>
                <td align="left">19</td>
                <td align="center">Yes</td>
                <td align="center" colspan="2">N/A</td>
                <td align="center" colspan="2">N/A</td>
                <td align="center">N/A</td>
                <td align="center" colspan="2">N/A</td>
              </tr>
              <tr>
                <td align="left">20</td>
                <td align="center">N/A</td>
                <td align="center" colspan="2">N/A</td>
                <td align="center" colspan="2">N/A</td>
                <td align="center">N/A</td>
                <td align="center" colspan="2">N/A</td>
              </tr>
              <tr>
                <td align="left">21</td>
                <td align="center">Yes</td>
                <td align="center" colspan="2">Yes</td>
                <td align="center" colspan="2">N/A</td>
                <td align="center">N/A</td>
                <td align="center" colspan="2">Cost-effectiveness</td>
              </tr>
              <tr>
                <td align="left">22</td>
                <td align="center">Yes</td>
                <td align="center" colspan="2">N/A</td>
                <td align="center" colspan="2">N/A</td>
                <td align="center">No</td>
                <td align="center" colspan="2">N/A</td>
              </tr>
              <tr>
                <td align="left">23</td>
                <td align="center">Yes</td>
                <td align="center" colspan="2">N/A</td>
                <td align="center" colspan="2">N/A</td>
                <td align="center">No</td>
                <td align="center" colspan="2">N/A</td>
              </tr>
              <tr>
                <td align="left">24</td>
                <td align="center">NA</td>
                <td align="center" colspan="2">N/A</td>
                <td align="center" colspan="2">N/A</td>
                <td align="center">Yes</td>
                <td align="center" colspan="2">N/A</td>
              </tr>
              <tr>
                <td align="left">25</td>
                <td align="center">Yes</td>
                <td align="center" colspan="2">N/A</td>
                <td align="center" colspan="2">N/A</td>
                <td align="center">N/A</td>
                <td align="center" colspan="2">N/A</td>
              </tr>
              <tr>
                <td align="left">26</td>
                <td align="center">Yes</td>
                <td align="center" colspan="2">N/A</td>
                <td align="center" colspan="2">N/A</td>
                <td align="center">Yes</td>
                <td align="center" colspan="2">N/A</td>
              </tr>
              <tr>
                <td align="left">27</td>
                <td align="center">Huang K Liu W He D Huang B Xiao D Peng Y.<xref ref-type="bibr" rid="B301">301</xref>
								</td>
                <td align="center">2015</td>
                <td align="center">9</td>
                <td align="center">Teleconsulting</td>
                <td align="center">Coronary disease</td>
                <td align="center">Yes</td>
                <td align="center">NA</td>
                <td align="center">NA</td>
              </tr>
              <tr>
                <td align="left">28</td>
                <td align="center">Purcell R McInnes S Halcomb EJ.<xref ref-type="bibr" rid="B302">302</xref>
								</td>
                <td align="center">2014</td>
                <td align="center">13</td>
                <td align="center">Telemonitoring (mHealth)</td>
                <td align="center">Chronic heart failure</td>
                <td align="center">Yes</td>
                <td align="center">Yes</td>
                <td align="center">NA</td>
              </tr>
              <tr>
                <td align="left">29</td>
                <td align="center">Chaudhry SI Phillips CO Stewart SS Riegel B Mattera JA Jerant AF Krumholz HM.<xref ref-type="bibr" rid="B303">303</xref>
								</td>
                <td align="center">2007</td>
                <td align="center">9</td>
                <td align="center">Telemonitoring (mHealth)</td>
                <td align="center">Heart failure</td>
                <td align="center">NA</td>
                <td align="center">Yes</td>
                <td align="center">Yes</td>
              </tr>
              <tr>
                <td align="left">30</td>
                <td align="center">Pfaeffli Dale L, Dobson R, Whittaker R, Maddison R.<xref ref-type="bibr" rid="B304">304</xref>
								</td>
                <td align="center">2016</td>
                <td align="center">7</td>
                <td align="center">Telemonitoring (mHealth)</td>
                <td align="center">Cardiovascular diseases</td>
                <td align="center">NA</td>
                <td align="center">NA</td>
                <td align="center">NA</td>
              </tr>
              <tr>
                <td align="left">31</td>
                <td align="center">Rush KL Hatt L Janke R Burton L Ferrier M Tetrault M.;<xref ref-type="bibr" rid="B262">262</xref>
								</td>
                <td align="center">2018</td>
                <td align="center">16</td>
                <td align="center">Tele-education</td>
                <td align="center">Chronic heart failure</td>
                <td align="center">NA</td>
                <td align="center">Yes</td>
                <td align="center">Yes</td>
              </tr>
              <tr>
                <td align="left">32</td>
                <td align="center">Hameed AS, Sauermann S, Schreier G.<xref ref-type="bibr" rid="B305">305</xref>
								</td>
                <td align="center">2014</td>
                <td align="center">9</td>
                <td align="center">Comparison between telephone teleconsultation services</td>
                <td align="center">Heart failure</td>
                <td align="center">NA</td>
                <td align="center">NA</td>
                <td align="center">NA</td>
              </tr>
              <tr>
                <td align="left">33</td>
                <td align="center">Feltner C Jones CD Feltner C Zheng ZJ Sueta CA Coker-Schwimmer EJ Arvanitis M.<xref ref-type="bibr" rid="B259">259</xref>
								</td>
                <td align="center">2014</td>
                <td align="center">47</td>
                <td align="center">Telemonitoring (mHealth)</td>
                <td align="center">Heart failure</td>
                <td align="center">NA</td>
                <td align="center">Yes</td>
                <td align="center">NA</td>
              </tr>
              <tr>
                <td align="left">34</td>
                <td align="center">Beatty AL, Fukuoka Y, Whooley MA.<xref ref-type="bibr" rid="B150">150</xref>
								</td>
                <td align="center">2013</td>
                <td align="center">3</td>
                <td align="center">Telemonitoring (mHealth)</td>
                <td align="center">Cardiac rehabilitation</td>
                <td align="center">NA</td>
                <td align="center">NA</td>
                <td align="center">NA</td>
              </tr>
              <tr>
                <td align="left">35</td>
                <td align="center">Driscoll A, Meagher S, Kennedy R, Hay M, Banerji J, Campbell D, Cox N, Gascard D, Hare D, Page K, Nadurata V, Sanders R, Patsamanis H.<xref ref-type="bibr" rid="B258">258</xref>
								</td>
                <td align="center">2016</td>
                <td align="center">29</td>
                <td align="center">Telemonitoring (mHealth)</td>
                <td align="center">Heart failure</td>
                <td align="center">Yes</td>
                <td align="center">Yes</td>
                <td align="center">Yes</td>
              </tr>
              <tr>
                <td align="left">
                  <bold>#ID</bold>
                </td>
                <td align="center">
                  <bold>Early diagnosis</bold>
                </td>
                <td align="center" colspan="2">
                  <bold>Increased adherence to therapy</bold>
                </td>
                <td align="center" colspan="2">
                  <bold>Not conclusive</bold>
                </td>
                <td align="center">
                  <bold>Cost reduction</bold>
                </td>
                <td align="center" colspan="2">
                  <bold>Most frequent economic analysis method among the articles</bold>
                </td>
              </tr>
              <tr>
                <td align="left">27</td>
                <td align="center">Yes</td>
                <td align="center" colspan="2">N/A</td>
                <td align="center" colspan="2">N/A</td>
                <td align="center">N/A</td>
                <td align="center" colspan="2">N/A</td>
              </tr>
              <tr>
                <td align="left">28</td>
                <td align="center">Yes</td>
                <td align="center" colspan="2">N/A</td>
                <td align="center" colspan="2">N/A</td>
                <td align="center">Yes</td>
                <td align="center" colspan="2">N/A</td>
              </tr>
              <tr>
                <td align="left">29</td>
                <td align="center">N/A</td>
                <td align="center" colspan="2">N/A</td>
                <td align="center" colspan="2">N/A</td>
                <td align="center">Yes</td>
                <td align="center" colspan="2">Cost-effectiveness</td>
              </tr>
              <tr>
                <td align="left">30</td>
                <td align="center">N/A</td>
                <td align="center" colspan="2">Yes</td>
                <td align="center" colspan="2">N/A</td>
                <td align="center">Yes</td>
                <td align="center" colspan="2">N/A</td>
              </tr>
              <tr>
                <td align="left">31</td>
                <td align="center">Yes</td>
                <td align="center" colspan="2">Yes</td>
                <td align="center" colspan="2">N/A</td>
                <td align="center">Yes</td>
                <td align="center" colspan="2">N/A</td>
              </tr>
              <tr>
                <td align="left">32</td>
                <td align="center">Yes</td>
                <td align="center" colspan="2">Yes</td>
                <td align="center" colspan="2">N/A</td>
                <td align="center">No</td>
                <td align="center" colspan="2">N/A</td>
              </tr>
              <tr>
                <td align="left">33</td>
                <td align="center">N/A</td>
                <td align="center" colspan="2">N/A</td>
                <td align="center" colspan="2">N/A</td>
                <td align="center">N/A</td>
                <td align="center" colspan="2">N/A</td>
              </tr>
              <tr>
                <td align="left">34</td>
                <td align="center">Yes</td>
                <td align="center" colspan="2">Yes</td>
                <td align="center" colspan="2">N/A</td>
                <td align="center">N/A</td>
                <td align="center" colspan="2">N/A</td>
              </tr>
              <tr>
                <td align="left">35</td>
                <td align="center">N/A</td>
                <td align="center" colspan="2">N/A</td>
                <td align="center" colspan="2">N/A</td>
                <td align="center">N/A</td>
                <td align="center" colspan="2">N/A</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>Among the studies, 26 evaluated the telemedicine telemonitoring service mHealth as primary intervention versus usual face-to-face treatment. According to the authors, the ease of use of mobile phones, through the use of applications for remote monitoring and quick communication with patients, was the most common.<xref ref-type="bibr" rid="B271">271</xref>
				</p>
        <p>The most common outcomes in the evaluated studies were a reduction in mortality rate (54% of the reviews) and in the number of hospital readmissions (57% of the reviews), with at least one of these outcomes appearing in 26 studies. Other expected results were reduced hospitalization, early diagnosis, and better medication adherence.</p>
        <p>On the other hand, economic evaluations were less frequent. Only 16 reviews found conclusive results with cost analyses, of which 13 concluded that telemedicine provided savings to the paying source by reducing costs. Eight reviews included the economic evaluation of incorporating telemedicine in cardiology, with cost effectiveness being the most frequent evaluation (seven studies), while cost minimization was included in a single study. One study suggested that the few existing economic assessments have low methodological rigor, not allowing an assertive conclusion about the economic viability of the implementation.<xref ref-type="bibr" rid="B264">264</xref><sup>,</sup><xref ref-type="bibr" rid="B271">271</xref>
				</p>
        <p>Briefly, studies on heart failure telemonitoring have shown that support strategies (video conferencing or telephone) are cost effective, meaning, they have a potential for financial return. Studies evaluating monitoring by cardiac devices showed an incremental cost-effective ratio of US$ 13,979 per QALYs. In a meta-analysis, device telemonitoring was related to a 44% reduction in hospital visits, with no effect on mortality, but a 15-50% reduction in direct health costs.<xref ref-type="bibr" rid="B272">272</xref> The economic results of noninvasive telemonitoring are even more heterogeneous. Some clinical trials have shown neutral results, while one showed a significant reduction in heart failure readmissions and a direct total cost reduction of &#8364; 3,546 per patient for 6 months of follow-up.<xref ref-type="bibr" rid="B273">273</xref> In a Dutch clinical trial, the TEHAF trial, the likelihood of cost-effectiveness for remote monitoring was 48% (&#8364; 50,000/QALY threshold), probably due to differences between institutions. One of the most detailed studies was developed for the UK health system perspective using a Markov model comparing usual treatment, telephone support, or remote telemonitoring for patients with heart failure after hospital discharge. Assuming monthly costs of &#163; 27 for standard care, &#163; 179 for telephone support, and &#163; 175 for telemonitoring during business hours, the most cost-effective strategy was telemonitoring, with values below &#163; 20,000 per QALY. The telephone support strategy was very unfavorable, with an ICER of &#163; 228,035/QALY compared with telemonitoring.<xref ref-type="bibr" rid="B274">274</xref>
				</p>
        <p>Variables evaluating effectiveness repeat across the studies, notably the reduction in mortality and in hospitalization frequency. However, accurate cost collection methods, definition of which cost variables should be collected, and the application of economic models still lack standard recommendations in the literature. More than 70% of the studies did not consider at least one category: health care costs, patient and family expenses, or lost productivity. Many failed to include salaries and benefits, training time, amortized capital investments, data and follow-up operations, and overhead costs. Moreover, an important constraint in these economic analyses has been the great heterogeneity of technology (intervention) and even the control group (alternatives). Technologies supporting telemedicine services advance at an impressive pace and range from complex structures and large investments less than 10 years ago to cost-effective solutions based on cell phones and mobile devices.<xref ref-type="bibr" rid="B256">256</xref><sup>,</sup><xref ref-type="bibr" rid="B263">263</xref> These are distinct services requiring a high initial investment, but most data point to a return on investment over time due to the volume of patients who then do not require the use of the traditional health care system.<xref ref-type="bibr" rid="B260">260</xref><sup>,</sup><xref ref-type="bibr" rid="B269">269</xref> Economic assessment methods must, therefore, track the service over time, including the outcomes of patients receiving care or monitored by the telemedicine services. Given the diversity of the benefits gained, the applied cost methodology - dedicated data reflecting conditions of the local health care system - must be evaluated for a proper understanding of the cost effectiveness of these technologies.</p>
      </sec>
      <sec>
        <title>5.4. Economic Evaluations of Telemedicine in Brazil</title>
        <p>These new technologies are being gradually introduced in the routine of hospitals, clinics, and offices in the private and public sectors in Brazil. The first of these technologies to be applied was the transmission of ECG data for remotely reporting. In 1994, the company Telecardio started using this technology, transmitting the tests by telephone, and in 1995, the <italic>Instituto do Cora&#231;&#227;o</italic> (InCor) created a service called ECG-FAX. Later, in 2005, a telecardiology system or Minas Telecardio project was implemented at UFMG&#8217;s Clinics Hospital.<xref ref-type="bibr" rid="B275">275</xref> In 2007, the Ministry of Health, aiming to develop actions to support primary care teams through permanent education and virtual technologies, created the <italic>Telessa&#250;de Brasil</italic> program, later renamed <italic>Telessa&#250;de Brasil Redes</italic>. Nine Brazilian Telehealth Centers (<italic>N&#250;cleos de Telessa&#250;de no Brasil</italic>) were initially established, offering teleconsulting (consultation between professionals) and telediagnosis (ECG) in the public sector. Currently, several companies offer remote reporting of ambulatory BP monitoring (ABPM), Holter, and remote echocardiography and imaging analysis. AI is currently used in teleconsulting and is at an advanced stage in the preparation of diagnostic test reports. Telemonitoring of patients with heart failure is also ongoing in Brazil.</p>
        <p>The routine use of these technologies in Brazil is an indirect indication of their effectiveness, and the continuing operation of companies in this sector is an indirect measure of cost-effectiveness, although there are few formal studies on this subject in Brazil.</p>
        <p>At least two initiatives for the application of new technologies in cardiology in Brazil focused on these cost-effectiveness studies: 1) the telemedicine service and remote patient monitoring of InCor at the University of S&#227;o Paulo Medical School and 2) the telediagnosis and teleconsultation system of the Minas Gerais Teleasssistance Network (RTMG) of the Clinics Hospital at UFMG.</p>
        <p>In addition to the results from telecardiology services, an analysis of savings estimates for the state of Rio Grande do Sul through the <italic>Telessa&#250;deRS</italic> project, which offers 20 clinical specialty teleconsultation services, was conducted and are presented in this chapter as a third approach to an economic evaluation of telemedicine in Brazil.</p>
      </sec>
      <sec>
        <title>5.5. InCor-FMUSP Telemedicine and Patient Monitoring Service</title>
        <p>Stevens et al. evaluated the economic burden and impact on patients&#8217; disability of four main heart conditions - heart failure, AMI, AFib, and hypertension - in 2015 in Brazil.<xref ref-type="bibr" rid="B276">276</xref> Specifically for hypertension, the authors assessed the cost effectiveness of conventional care versus telemedicine and structured telephone support over a 30-year time horizon after 2015. A summary of the results found in the study is shown in <xref ref-type="table" rid="t8">Table 5.2</xref>.</p>
        <table-wrap id="t8">
          <label>Table 5.2</label>
          <caption>
            <title>Results of comparison: treatment of hypertensive patients with conventional care through Telemedicine and through a structured telephone support system over a 30-year timeframe from 2015</title>
          </caption>
          <table frame="hsides" rules="rows">
            <colgroup>
              <col width="25%"/>
              <col width="25%"/>
              <col width="25%"/>
              <col width="25%"/>
            </colgroup>
            <thead>
              <tr>
                <th align="left">
								</th>
                <th align="center">Conventional care</th>
                <th align="center">Telemedicine</th>
                <th align="center">Structured telephone support</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left">Total cost (R$)</td>
                <td align="center">5,832</td>
                <td align="center">55,930</td>
                <td align="center">49,870</td>
              </tr>
              <tr>
                <td align="left">Incremental cost (R$)</td>
                <td align="center">
								</td>
                <td align="center">50,098</td>
                <td align="center">44,038</td>
              </tr>
              <tr>
                <td align="left">Additional life-years<sup><xref ref-type="table-fn" rid="TFN2">1</xref></sup></td>
                <td align="center">
								</td>
                <td align="center">1.89</td>
                <td align="center">1.61</td>
              </tr>
              <tr>
                <td align="left">Cost per additional life-year (R$/year)</td>
                <td align="center">
								</td>
                <td align="center">26,437</td>
                <td align="center">27,281</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="TFN2">
              <label>1</label>
              <p>Additional life-years reflect the impact of longevity on the patient's quality of life.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p>Both technologies were considered cost effective by the authors, assuming the standard defined by the WHO of an intervention being considered cost effective when having a cost per life-year between one and three times the gross domestic product per capita per QALY. However, the Brazilian health authorities have not yet defined the country&#8217;s ICER. Thus, safe inferences cannot be made on whether the procedures applied in telemedicine within the SUS would be cost effective or not within these scenarios. According to Brazilian law, products, medications, or procedures included in SUS&#8217; protocols must be evaluated for safety, efficacy, effectiveness, and cost effectiveness. Therefore, an effective reference is still needed to validate the economic assessment in question.<xref ref-type="bibr" rid="B277">277</xref>
				</p>
      </sec>
      <sec>
        <title>5.6. Telediagnosis and Teleconsultation System of the Minas Gerais Teleassistance Network (Rede de Teleassist&#234;ncia de Minas Gerais, RTMG) at the Clinics Hospital of UFMG</title>
        <p>The Telehealth Center (<italic>Centro de Telessa&#250;de</italic>, CTS HC/UFMG) coordinates the RTMG, a collaborative network established in 2005 by seven public universities in Minas Gerais: UFMG, Federal University of Uberl&#226;ndia (UFU), Federal University of Tri&#226;ngulo Mineiro (UFTM), Federal University of Juiz de Fora (UFJF), Federal University of S&#227;o Jo&#227;o Del Rei (UFSJ), State University of Montes Claros (Unimontes), and Federal University of Jequitinhonha and Mucuri Valleys (UFVJM).</p>
        <p>Telecare activities include teleconsultation and telediagnosis. Teleconsultations are mostly asynchronous through regulatory calls in medicine, nursing, dentistry, physiotherapy, pharmacy, psychology, nutrition, and speech therapy. Telediagnosis consists of the analysis and reports of ECGs, ABPM, Holter, and retinography, along with synchronous cardiology teleconsultations to support critical clinical cases. The service is registered in the CRM of the State of Minas Gerais.</p>
        <p>The RTMG activity was initiated with the research project Minas Telecardio in 2006, implementing a telecardiology service with ECG reports and teleconsultation in 82 municipalities in Minas Gerais. The RTMG activities expanded over time and currently connects 814 municipalities with more than 1,000 telehealth units in Minas Gerais. Within the ONTD project of the Ministry of Health, it began to offer nationwide telecardiology services on September 2017, and currently serves 90 municipalities in the states of Acre, Bahia, Cear&#225;, Mato Grosso and Roraima. This expansion was partly the result of studies proving the cost effectiveness of the system for the main RTMG funders (Ministry of Health and Minas Gerais State Department of Health).</p>
        <p>Using the results of the Minas Telecardio Project, Andrade et al.<xref ref-type="bibr" rid="B278">278</xref> compared the cost-benefit ratio of remote ECG reporting, considering the hypothesis of economic benefit in performing ECGs in the telecardiology project compared with the referral of the patient to perform ECG examination at another location.<xref ref-type="bibr" rid="B278">278</xref> The study was conducted between June 2006 and November 2008 in 82 municipalities in rural areas of the state of Minas Gerais. Each municipality received a microcomputer with a digital electrocardiograph machine and had the possibility of forwarding the ECG recordings and establishing communication with the cardiology department at university hospitals of the RTMG. The costs of the project were divided into two categories: related to the implementation and related to the maintenance of the telecardiology system. The cost of moving patients was assessed, including the cost of transportation (using city-provided resources), the cost of food during their absence from home, and the cost of a missed working day (both paid by the patient). The cost-benefit without inclusion (perspective of the public health service) and with inclusion (perspective of the society) of the patients&#8217; costs were evaluated. For the face-to-face scenario, the cost of ECG and cost of the consultation were added (R$ 5.15 and R$ 10.00, respectively, based on the SUS&#8217; reference table). The sources of data for the analysis were mainly the National Household Sample Survey (<italic>Pesquisa Nacional de Amostra de Domic&#237;lios</italic>, PNAD), SIA-SUS Ambulatory Information System, and CNES.</p>
        <p>Considering the cost of implementation and maintenance of the project of R$ 1,818,282.87 and the number of examinations performed in the 30-month period (62,865 examinations from August 2006 to December 2008), the unit cost of each remote report was R$ 28.92. A summary of the results is shown in <xref ref-type="table" rid="t9">Table 5.3</xref>.</p>
        <table-wrap id="t9">
          <label>Table 5.3</label>
          <caption>
            <title>Comparison of costs between the alternatives remote report and face-to-face report in the Minas Telecardio Project<xref ref-type="bibr" rid="B278">278</xref>
						</title>
          </caption>
          <table frame="hsides" rules="rows">
            <colgroup>
              <col width="33%"/>
              <col width="33%"/>
              <col width="33%"/>
            </colgroup>
            <thead>
              <tr>
                <th align="left">Scenario</th>
                <th align="center">Cost (R$)</th>
                <th align="center">Difference (R$)</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left">1. Remote report</td>
                <td align="center">28.92</td>
                <td align="center">
								</td>
              </tr>
              <tr>
                <td align="left">2. Face-to-face report without costs of patient displacement</td>
                <td align="center">30.91</td>
                <td align="center">1.99</td>
              </tr>
              <tr>
                <td align="left">3. Face-to-face report with costs of patient displacement</td>
                <td align="center">49.83</td>
                <td align="center">20.91</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>A sensitivity analysis showed that the results are sensitive to patient travel costs, particularly related to the driver&#8217;s salary and number of patients per vehicle. Given the small difference between scenarios 1 and 2, it can be concluded that, in some situations, telecardiology may not be more economical from the point of view of public health service.</p>
        <p>At that time, the system had a relatively low output and, since the activities have a high fixed cost, resulted in a high cost for the remote report. With the expansion of the system to other municipalities, the cost of the activities reduced, increasing the cost effectiveness of the system.</p>
        <p>In 2007, the Ministry of Health, with resources from PAHO, engaged the CTS HC/UFMG in the project &#8220;Analysis of the Financial Management of Telehealth Services Applied to Primary Care.&#8221; In the project, the analysis of the economic sustainability of the application of telehealth in primary care was based on a comparison of costs between two scenarios:</p>
        <p>
          <list list-type="roman-upper">
            <list-item>
              <p> Face-to-face care: when the patient is treated in primary care and requires to be subsequently referred to secondary level care;</p>
            </list-item>
            <list-item>
              <p> Remote care: when the primary care physician receives remote support through a telehealth service, and this support avoids the referral of the patient.</p>
            </list-item>
          </list>
        </p>
        <p>The results refer to 20 municipalities participating in the National Telehealth Project with reliable data, located in the North/Northeast regions and Jequitinhonha Valley in Minas Gerais, considered one of the poorest regions of the state. The main results of the project are shown in <xref ref-type="table" rid="t10">table 5.4</xref>.<xref ref-type="bibr" rid="B279">279</xref><sup>,</sup><xref ref-type="bibr" rid="B280">280</xref>
				</p>
        <table-wrap id="t10">
          <label>Table 5.4</label>
          <caption>
            <title>Comparison of average costs (R$/month/municipality) between face-to-face and remote care in the project "Analysis of Financial Management of Telehealth Services Applied in Primary Care"<xref ref-type="bibr" rid="B279">279</xref><sup>,</sup><xref ref-type="bibr" rid="B280">280</xref>
						</title>
          </caption>
          <table frame="hsides" rules="rows">
            <colgroup>
              <col width="33%"/>
              <col width="33%"/>
              <col width="33%"/>
            </colgroup>
            <thead>
              <tr>
                <th align="left">Cost item (R$/month)</th>
                <th align="center">Face-to-face care</th>
                <th align="center">Remote care</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left">Patients referral</td>
                <td align="center">2,399.58</td>
                <td align="center">697.78</td>
              </tr>
              <tr>
                <td align="left">System implementation</td>
                <td align="center">
								</td>
                <td align="center">56.03</td>
              </tr>
              <tr>
                <td align="left">Equipment depreciation in the municipality</td>
                <td align="center">
								</td>
                <td align="center">101.97</td>
              </tr>
              <tr>
                <td align="left">Equipment maintenance in the municipality</td>
                <td align="center">
								</td>
                <td align="center">40.79</td>
              </tr>
              <tr>
                <td align="left">Capital cost of equipment</td>
                <td align="center">
								</td>
                <td align="center">51.92</td>
              </tr>
              <tr>
                <td align="left">Activities of remote care<xref ref-type="table-fn" rid="TFN3">*</xref>
								</td>
                <td align="center">
								</td>
                <td align="center">210.80</td>
              </tr>
              <tr>
                <td align="left">Total</td>
                <td align="center">2,398.58</td>
                <td align="center">1,159.29</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="TFN3">
              <label>*</label>
              <p>ECG report, case discussion and teleconsultation.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p>This project presented more realistic results compared with the previous one, as it collected information about the cost of patient referral directly in the municipalities. However, it maintained the sample of the participating municipalities concentrated in the same region of the state, the Jequitinhonha Valley, which has a low human development index (HDI). In 2009, the Minas Telecardio Expansion project expanded the service to higher HDI regions for a final sample of 66 other municipalities. The results were similar to those of the previous project and are shown in <xref ref-type="table" rid="t11">table 5.5</xref>.<xref ref-type="bibr" rid="B281">281</xref><sup>-</sup><xref ref-type="bibr" rid="B283">283</xref>
				</p>
        <table-wrap id="t11">
          <label>Table 5.5</label>
          <caption>
            <title>"Economic Analysis and Impact of the Application of Telehealth Services in Primary Care in Municipalities of Minas Gerais"<xref ref-type="bibr" rid="B282">282</xref>
						</title>
          </caption>
          <table frame="hsides" rules="rows">
            <colgroup>
              <col width="80%"/>
              <col width="20%"/>
            </colgroup>
            <tbody>
              <tr>
                <td align="left">Average cost of each telehealth activity in 2010</td>
                <td align="center">R$ 10.68</td>
              </tr>
              <tr>
                <td align="left">Average fixed cost of patient referral</td>
                <td align="center">R$ 41.77</td>
              </tr>
              <tr>
                <td align="left">Savings to the municipality by avoided referral</td>
                <td align="center">R$ 71.11</td>
              </tr>
              <tr>
                <td align="left">Minimum monthly number of referrals reduction per municipality to enable the system</td>
                <td align="center">4.28</td>
              </tr>
              <tr>
                <td align="left">Minimum monthly number of activities per municipality to enable the system</td>
                <td align="center">5.5</td>
              </tr>
              <tr>
                <td align="left">Average monthly number of activities by municipality in 2010</td>
                <td align="center">28.5</td>
              </tr>
              <tr>
                <td align="left">Investment by SES/MG (2005-2009)</td>
                <td align="center">R$ 11,599,638.00</td>
              </tr>
              <tr>
                <td align="left">Savings for the health care system (from June 2006 to July 2011)</td>
                <td align="center">R$ 31,970,549.13</td>
              </tr>
              <tr>
                <td align="left">Return on Investment (ROI) (savings:investment)</td>
                <td align="center">2.76:1</td>
              </tr>
              <tr>
                <td align="left">% of referrals avoided</td>
                <td align="center">78%</td>
              </tr>
              <tr>
                <td align="left">Minimum referral distance for system viability (approximate)</td>
                <td align="center">54 Km</td>
              </tr>
              <tr>
                <td align="left">Average cost of each telehealth activity in 2010<xref ref-type="table-fn" rid="TFN4">*</xref>
								</td>
                <td align="center">R$ 10.68</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="TFN4">
              <label>*</label>
              <p>ECG report, case discussion and teleconsultation.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p>Recently, a study (pending publication) was conducted to assess the cost effectiveness of the ONTD. The ONTD is a project of the Ministry of Health to offer telecardiology services (ECG reports and teleconsultations) to all Brazilian states, for which the CTS HC/UFMG was chosen as Specialist Center, that is, the service provider. State Telehealth Centers receive funding from the Ministry of Health to train and implement care in municipalities of their state, previously agreed with the State Health Departments, which may forward 24/7 their test requests and teleconsultations to the Expert Center. The requests may be elective or urgent. The report is available on a platform, and, when necessary, local physicians can ask questions as part of teleconsultation. An alert system informs physicians and nurses about critically emergent situations. The effectiveness of the system has been proven by performance indicators (time to submit tests, waiting time for analysis of urgent/elective reports, time to the first analysis of the report, number of tests requested by the municipality, etc.), and user satisfaction. The results proved the effectiveness of the system by replacing alternatives previously available to obtain the test/report (referral of the patient, periodic visits of the cardiologist to the municipality, and outsourcing of tests to private companies/clinics). In terms of these alternatives, the cost of the test by the ONTD is about five times lower, demonstrating cost effectiveness.</p>
      </sec>
      <sec>
        <title>5.7. Analysis of the Economic Impact of the Telessa&#250;deRS Teleconsulting Service</title>
        <p>An economic analysis of the Telessa&#250;deRS service was performed to evaluate the financial results of the service generated to the state. Teleconsultations are offered for various specialties, in addition to the contribution to the regulation of waiting lists for the state of Rio Grande do Sul. Teleconsultations in endocrinology, gastroenterology, proctology, rheumatology, and urology were selected as samples.</p>
        <p>The cost per teleconsultation (R$ 110.29) was evaluated considering data from 8 months of service and included costs of the physical structure of the service (rent, energy, depreciation, server capacity, among others) and payment of professionals. As a premise, all teleconsultations and regulations that resulted in the cancellation of the face-to-face consultation would represent, for the state, savings in patient transportation to Porto Alegre (which is variable according to the municipality of origin) and payment of face-to-face consultation to the municipality (R$ 100.00). Estimated savings were calculated as the difference between the cost of performing canceled teleconsultations and the cost of face-to-face care.</p>
        <p>The analysis identified that over 21 months (October 2016 to June 2018), the state saved R$ 2,287,121.78, of which 47% were related to consultations and 53% to transportation services. For teleconsultation, the service was found to be attractive up to the amount of payment per consultation of R$ 38.95, considering the average cost of transportation. The municipalities with the greatest distances from Porto Alegre had higher savings, except for four municipalities neighboring Porto Alegre, which had a higher number of avoided teleconsultations than the others&#8217; average.</p>
        <p>Of note, a comparison of these results with those of other states and services should consider that the services of Telessa&#250;de are provided by scholars and &#8220;CLT&#8221; professionals (employees following the Brazilian Labor Laws); therefore, Telessa&#250;de can operate at a lower cost per teleconsultation. The operation of a similar service including only &#8220;CLT&#8221; employees would increase the cost per each teleconsultation and require additional economic analysis.</p>
        <p>The WHO considers cost effective those interventions with ICER between 1 and 3 times the gross domestic product per capita per life-year, unless adjusted for QALY. </p>
      </sec>
    </sec>
    <sec>
      <title>6. Recommendations</title>
      <p>The Brazilian Society of Cardiology, due to the growing interest in the use of telemedicine for the expansion of health care, particularly in the area of cardiology, prepared this guideline to inform the medical category and society in general on the scientific and technological basis of telemedicine applications considering the current scenario.</p>
      <p>Even though there is growing enthusiasm for the democratization of information and communication technologies, it is important to point out that barriers to implementation persist across the country and must be addressed. The most significant ones are:</p>
      <p>
        <list list-type="bullet">
          <list-item>
            <p> update of laws and regulations applicable by the health authorities and CFM;</p>
          </list-item>
          <list-item>
            <p> provision of minimum telecommunications infrastructure in health care facilities, especially in remote areas;</p>
          </list-item>
          <list-item>
            <p> cost of technology;</p>
          </list-item>
          <list-item>
            <p> need for qualification and training of human resources;</p>
          </list-item>
          <list-item>
            <p> incorporation of technologies in the SUS&#8217; public policy list and in the List of Procedures and Events in Health of the National Health Agency.</p>
          </list-item>
        </list>
      </p>
      <p>By bringing to light the discussion about telemedicine applications, in addition to its media repercussion, we seek to provide scientific and technical support for the elaboration of health care policies consistent with the use of this technology. In this sense, we must formally incorporate, after due evaluation by the CONITEC, the various possibilities available today linked to the respective clinical protocols and therapeutic guidelines (PCDT). Also, in the context of supplementary health, it is necessary to include in the List of Procedures and Events in Health of the National Health Agency those with scientific recognition and authorized for current use in the country. </p>
      <p>As discussed in this guideline, with rare exceptions, there is no provision in the Brazilian Hierarchical Classification of Medical Procedures (which is a condition for inclusion in the NHA coverage list) for common procedures in telemedicine. Generic coding is used, with descriptions that are broad in nature and allow for likelihood use, such as code 2.01.01.20-1 (clinical and electronic evaluation of a patient with a cardiac pacemaker or resynchronization defibrillator or defibrillator). However, the reimbursement of this service will depend on the health care provider&#8217;s sole decision. This fact limits the applicability of telemedicine in the field of supplementary health, with the related consequences.</p>
      <p>In 2015, the Brazilian Society of Cardiology, through the Telecardiology Guideline for the Care of Patients with Acute Coronary Syndrome and other Heart Diseases,<xref ref-type="bibr" rid="B133">133</xref> made recommendations on this topic. However, the current version of the broader guideline addresses new applications for telecardiology, especially those already incorporated into the health care system. It still deals with future perspectives, such as the use of telerobotics and AI. The authors, focusing on current scientific evidence and cost effectiveness, have updated the recommendations to guide public and private health care providers on judicious use of telemedicine applications in Brazil.</p>
      <p><xref ref-type="table" rid="t12">Table 6.1</xref> summarizes the recommendations outlined in this guideline.</p>
      <table-wrap id="t12">
        <label>Table 6.1</label>
        <caption>
          <title>Recommendations for the practice of Telemedicine in Brazil</title>
        </caption>
        <table frame="hsides" rules="rows">
          <colgroup>
            <col width="40%"/>
            <col width="20%"/>
            <col width="20%"/>
            <col width="20%"/>
          </colgroup>
          <thead>
            <tr>
              <th align="left">Clinical indication</th>
              <th align="center">Class of indication</th>
              <th align="center">Level of evidence</th>
              <th align="center">references</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left">
                <bold>Teleconsultation</bold>
              </td>
              <td align="center">
							</td>
              <td align="center">
							</td>
              <td align="center">
							</td>
            </tr>
            <tr>
              <td align="left">Teleconsultation assists general practitioners from remote areas in the clinical evaluation of patients with suspected or established cardiovascular disease, being cost-effective from the SUS perspective</td>
              <td align="center">IIa</td>
              <td align="center">B</td>
              <td align="center">
                <xref ref-type="bibr" rid="B76">76</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B99">99</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B100">100</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B101">101</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B278">278</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B279">279</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B280">280</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B281">281</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B282">282</xref>
              </td>
            </tr>
            <tr>
              <td align="left">Teleconsultation assists physicians working in emergency care in the management of cases of acute cardiovascular diseases</td>
              <td align="center">IIa</td>
              <td align="center">C</td>
              <td align="center">
                <xref ref-type="bibr" rid="B133">133</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B134">134</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B137">137</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B138">138</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B139">139</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B140">140</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B141">141</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B142">142</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B143">143</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B144">144</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B145">145</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B149">149</xref>
              </td>
            </tr>
            <tr>
              <td align="left">Teleconsultation assists in regulating access to specialized care in patients with suspected or established cardiovascular disease</td>
              <td align="center">IIa</td>
              <td align="center">C</td>
              <td align="center">
                <xref ref-type="bibr" rid="B101">101</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B102">102</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B103">103</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B104">104</xref>
              </td>
            </tr>
            <tr>
              <td align="left">
                <bold>Telediagnosis</bold>
              </td>
              <td align="center">
							</td>
              <td align="center">
							</td>
              <td align="center">
							</td>
            </tr>
            <tr>
              <td align="left">Tele-electrocardiography is a feasible and effective alternative to offer electrocardiography in health care systems, and is particularly useful and cost effective in primary care and remote locations</td>
              <td align="center">I</td>
              <td align="center">B</td>
              <td align="center">
                <xref ref-type="bibr" rid="B61">61</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B105">105</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B106">106</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B107">107</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B278">278</xref>
              </td>
            </tr>
            <tr>
              <td align="left">Telemedicine with transmission of electrocardiographic report in pre-hospital care of patients with suspected acute myocardial infarction reduces cardiovascular outcomes and early and late mortality</td>
              <td align="center">I</td>
              <td align="center">B</td>
              <td align="center">
                <xref ref-type="bibr" rid="B87">87</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B137">137</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B138">138</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B139">139</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B140">140</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B141">141</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B142">142</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B143">143</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B144">144</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B145">145</xref>
                <sup>,</sup>
              </td>
            </tr>
            <tr>
              <td align="left">Tele-echocardiography with teleconsultation is effective in the early detection of congenital heart disease in newborns</td>
              <td align="center">IIa</td>
              <td align="center">B</td>
              <td align="center">
                <xref ref-type="bibr" rid="B182">182</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B183">183</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B306">306</xref>
              </td>
            </tr>
            <tr>
              <td align="left">Tele-echocardiography allows the early detection of subclinical cases of rheumatic heart disease in children and adolescents</td>
              <td align="center">IIa</td>
              <td align="center">B</td>
              <td align="center">
                <xref ref-type="bibr" rid="B111">111</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B112">112</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B307">307</xref>
              </td>
            </tr>
            <tr>
              <td align="left">Tele-echocardiography in primary care allows early detection of cases of heart disease and may help prioritize referrals to specialized care.</td>
              <td align="center">IIb</td>
              <td align="center">C</td>
              <td align="center">
                <xref ref-type="bibr" rid="B109">109</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B110">110</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B112">112</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B114">114</xref>
              </td>
            </tr>
            <tr>
              <td align="left" colspan="2">Transmission of tomography and cardiac resonance imaging by telemedicine can be performed:</td>
              <td align="center">
							</td>
              <td align="center">
							</td>
            </tr>
            <tr>
              <td align="left">- to obtain a second opinion</td>
              <td align="center">IIa</td>
              <td align="center">C</td>
              <td align="center">
                <xref ref-type="bibr" rid="B190">190</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B192">192</xref>
              </td>
            </tr>
            <tr>
              <td align="left">- for discussion in "Heart Teams"</td>
              <td align="center">IIa</td>
              <td align="center">C</td>
              <td align="center">
                <xref ref-type="bibr" rid="B190">190</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B192">192</xref>
              </td>
            </tr>
            <tr>
              <td align="left">- for remote support in emergency cases</td>
              <td align="center">IIa</td>
              <td align="center">C</td>
              <td align="center">
                <xref ref-type="bibr" rid="B190">190</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B192">192</xref>
              </td>
            </tr>
            <tr>
              <td align="left">- in sporadic routine cases</td>
              <td align="center">IIa</td>
              <td align="center">C</td>
              <td align="center">
                <xref ref-type="bibr" rid="B190">190</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B192">192</xref>
              </td>
            </tr>
            <tr>
              <td align="left">- for routine transmission of all cardiovascular imaging tests to specialized centers or groups</td>
              <td align="center">IIb</td>
              <td align="center">C</td>
              <td align="center">
                <xref ref-type="bibr" rid="B190">190</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B192">192</xref>
              </td>
            </tr>
            <tr>
              <td align="left">
                <bold>Telemonitoring</bold>
              </td>
              <td align="center">
							</td>
              <td align="center">
							</td>
              <td align="center">
							</td>
            </tr>
            <tr>
              <td align="left">Self-monitoring of blood pressure with telemonitoring helps in treatment control and adherence effective in reducing hospitalizations due to heart failure</td>
              <td align="center">IIa</td>
              <td align="center">B</td>
              <td align="center">
                <xref ref-type="bibr" rid="B75">75</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B77">77</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B78">78</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B127">127</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B128">128</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B129">129</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B130">130</xref>
              </td>
            </tr>
            <tr>
              <td align="left">Noninvasive telemonitoring strategies with structured telephone support are effective in reducing hospitalizations due to heart failure</td>
              <td align="center">I</td>
              <td align="center">A</td>
              <td align="center">
                <xref ref-type="bibr" rid="B115">115</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B116">116</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B118">118</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B119">119</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B120">120</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B123">123</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B124">124</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B125">125</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B126">126</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B158">158</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B159">159</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B161">161</xref>
              </td>
            </tr>
            <tr>
              <td align="left">Noninvasive telemonitoring strategies with structured telephone support are effective in reducing mortality in heart failure</td>
              <td align="center">IIa</td>
              <td align="center">A</td>
              <td align="center">
                <xref ref-type="bibr" rid="B115">115</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B116">116</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B118">118</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B119">119</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B120">120</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B123">123</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B124">124</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B125">125</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B126">126</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B158">158</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B159">159</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B161">161</xref>
              </td>
            </tr>
            <tr>
              <td align="left">Remote monitoring of patients with arrhythmias and implantable electrical devices, in addition to regular telemetric assessments, is effective in reducing outpatient visits and early detection of device dysfunction.</td>
              <td align="center">IIa</td>
              <td align="center">B</td>
              <td align="center">
                <xref ref-type="bibr" rid="B157">157</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B160">160</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B162">162</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B163">163</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B164">164</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B165">165</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B166">166</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B167">167</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B168">168</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B169">169</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B170">170</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B174">174</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B175">175</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B177">177</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B178">178</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B179">179</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B180">180</xref>
              </td>
            </tr>
            <tr>
              <td align="left">Telerehabilitation of eligible patients with heart failure, with or without left ventricular dysfunction, with NYHA functional class I-III, is effective in improving program adherence, quality of life and performance in the 6-minute walking distance test</td>
              <td align="center">IIa</td>
              <td align="center">B</td>
              <td align="center">
                <xref ref-type="bibr" rid="B148">148</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B149">149</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B150">150</xref>
                <xref ref-type="bibr" rid="B151">151</xref>
                <sup>,</sup>
                <xref ref-type="bibr" rid="B152">152</xref>
              </td>
            </tr>
            <tr>
              <td align="left">Private communication to send data or ask questions between physicians, in closed groups of specialists, or among the clinical staff of an institution or chair, safeguarding professional confidentiality</td>
              <td align="center">I</td>
              <td align="center">C</td>
              <td align="center">
                <xref ref-type="bibr" rid="B191">191</xref>
              </td>
            </tr>
            <tr>
              <td align="left">Private communication between physicians and patients through communication platforms to send data or ask questions, safeguarding professional confidentiality</td>
              <td align="center">IIa</td>
              <td align="center">C</td>
              <td align="center">
                <xref ref-type="bibr" rid="B191">191</xref>
              </td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="other">
        <p><bold>Note:</bold> This guideline is for information purposes and should not replace the clinical judgment of a physician, who must ultimately determine the appropriate treatment for each patient.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="B1">
        <label>1</label>
        <mixed-citation>1 Topol E. Deep medicine: how artificial intelligence can make healthcare human again. California: Bales &amp;Noble;2019.</mixed-citation>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Topol</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <source>Deep medicine: how artificial intelligence can make healthcare human again</source>
          <year>2019</year>
          <publisher-loc>California</publisher-loc>
          <publisher-name>Bales &amp;Noble</publisher-name>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <mixed-citation>2 Sociedade Brasileira de Cardiologia. Consenso Nacional sobre cardiopatia grave. Internet, [Acesso em 06 de junho 2019]. Dispon&#237;vel em: <ext-link ext-link-type="uri" xlink:href="http://publicacoes.cardiol.br/consenso/1993/61/cardiopatiaGrave.pdf">http://publicacoes.cardiol.br/consenso/1993/61/cardiopatiaGrave.pdf</ext-link>
				</mixed-citation>
        <element-citation publication-type="webpage">
          <person-group person-group-type="author">
            <collab>Sociedade Brasileira de Cardiologia</collab>
          </person-group>
          <source>onsenso Nacional sobre cardiopatia grave</source>
          <comment>Internet</comment>
          <date-in-citation content-type="access-date">06 de junho 2019</date-in-citation>
          <comment>Dispon&#237;vel em: <ext-link ext-link-type="uri" xlink:href="http://publicacoes.cardiol.br/consenso/1993/61/cardiopatiaGrave.pdf">http://publicacoes.cardiol.br/consenso/1993/61/cardiopatiaGrave.pdf</ext-link>
					</comment>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <mixed-citation>3 Conselho Federal de Medicina. Associa&#231;&#227;o M&#233;dica Brasileira. Projeto Diretrizes. Internet. [Acesso em 06 de junho 2019]. Dispon&#237;vel em: <ext-link ext-link-type="uri" xlink:href="http://www.portalmedico.org.br/diretrizes/100_diretrizes/Texto_Introdutorio.pdf">http://www.portalmedico.org.br/diretrizes/100_diretrizes/Texto_Introdutorio.pdf</ext-link>
				</mixed-citation>
        <element-citation publication-type="webpage">
          <person-group person-group-type="author">
            <collab>Conselho Federal de Medicina</collab>
            <collab>Associa&#231;&#227;o M&#233;dica Brasileira</collab>
          </person-group>
          <source>Projeto Diretrizes</source>
          <comment>Internet</comment>
          <date-in-citation content-type="access-date">6 de junho 2019</date-in-citation>
          <comment>Dispon&#237;vel em: <ext-link ext-link-type="uri" xlink:href="http://www.portalmedico.org.br/diretrizes/100_diretrizes/Texto_Introdutorio.pdf">http://www.portalmedico.org.br/diretrizes/100_diretrizes/Texto_Introdutorio.pdf</ext-link>
					</comment>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <mixed-citation>4 Conselho Federal de Medicina. Resolu&#231;&#245;es/CFM/2002/1642. Internet. [ Acesso em 06 de junho de 2019]. Dispon&#237;vel em: <ext-link ext-link-type="uri" xlink:href="http://www.portalmedico.org.br/resolucoes/CFM/2002/1642_2002.htm">http://www.portalmedico.org.br/resolucoes/CFM/2002/1642_2002.htm</ext-link>
				</mixed-citation>
        <element-citation publication-type="webpage">
          <person-group person-group-type="author">
            <collab>Conselho Federal de Medicina</collab>
          </person-group>
          <source>Resolu&#231;&#245;es/CFM/2002/1642</source>
          <comment>Internet</comment>
          <date-in-citation content-type="access-date">06 de junho de 2019</date-in-citation>
          <comment>Dispon&#237;vel em: <ext-link ext-link-type="uri" xlink:href="http://www.portalmedico.org.br/resolucoes/CFM/2002/1642_2002.htm">http://www.portalmedico.org.br/resolucoes/CFM/2002/1642_2002.htm</ext-link>
					</comment>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <mixed-citation>5 Conselho Federal de Medicina (CFM-Brasil). Resolu&#231;&#227;o CFM 2.227/2018: define e disciplina a telemedicina como forma de presta&#231;&#227;o de servi&#231;os m&#233;dicos mediados por tecnologia. [Acesso em 15 fevereiro 2019]. Dispon&#237;vel em: <ext-link ext-link-type="uri" xlink:href="https://portal.cfm.org.br/images/PDF/resolucao222718.pdf">https://portal.cfm.org.br/images/PDF/resolucao222718.pdf</ext-link>
				</mixed-citation>
        <element-citation publication-type="webpage">
          <person-group person-group-type="author">
            <collab>Conselho Federal de Medicina</collab>
          </person-group>
          <source>Resolu&#231;&#227;o CFM 2.227/2018: define e disciplina a telemedicina como forma de presta&#231;&#227;o de servi&#231;os m&#233;dicos mediados por tecnologia</source>
          <date-in-citation content-type="access-date">15 fevereiro 2019</date-in-citation>
          <comment>Dispon&#237;vel em: <ext-link ext-link-type="uri" xlink:href="https://portal.cfm.org.br/images/PDF/resolucao222718.pdf">https://portal.cfm.org.br/images/PDF/resolucao222718.pdf</ext-link>
					</comment>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <mixed-citation>6 Organizaci&#243;n Panamericana de la Salud. (OPS). Definici&#243;n de indicadores para proyectos de telemedicina como herramienta para la reducci&#243;n de las inequidades en salud: documento de an&#225;lisis y resultados de una comunidad de pr&#225;cticas. Washington, DC; 2016 [Acesso em 06 de junho de 2019). Dispon&#237;vel em: http://iris.paho.org/xmlui/handle/123456789/28563</mixed-citation>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <collab>Organizaci&#243;n Panamericana de la Salud</collab>
          </person-group>
          <source>Definici&#243;n de indicadores para proyectos de telemedicina como herramienta para la reducci&#243;n de las inequidades en salud: documento de an&#225;lisis y resultados de una comunidad de pr&#225;cticas</source>
          <year>2016</year>
          <publisher-loc>Washington</publisher-loc>
          <publisher-name>DC</publisher-name>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <mixed-citation>7 Maldonado JM, Marques AB, Cruz A. Telemedicina: desafios &#224; sua difus&#227;o no Brasil. Cad Sa&#250;de P&#250;blica. 2016;32(2): e00155615</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Maldonado</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Marques</surname>
              <given-names>AB</given-names>
            </name>
            <name>
              <surname>Cruz</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Telemedicina: desafios &#224; sua difus&#227;o no Brasil</article-title>
          <source>Cad Sa&#250;de P&#250;blica</source>
          <year>2016</year>
          <volume>32</volume>
          <issue>2</issue>
          <elocation-id>e00155615</elocation-id>
        </element-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <mixed-citation>8 Organiza&#231;&#227;o Mundial da sa&#250;de. (OMS). Digital Atlas Health. Internet.[ [Acessed in 2019 June 06] Available from: <ext-link ext-link-type="uri" xlink:href="https://digitalhealthatlas.org/en//">https://digitalhealthatlas.org/en//</ext-link>
				</mixed-citation>
        <element-citation publication-type="webpage">
          <person-group person-group-type="author">
            <collab>Organiza&#231;&#227;o Mundial da sa&#250;de</collab>
          </person-group>
          <source>Digital Atlas Health</source>
          <comment>Internet</comment>
          <date-in-citation content-type="access-date">2019 June 06</date-in-citation>
          <comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://digitalhealthatlas.org/en//">https://digitalhealthatlas.org/en//</ext-link>
					</comment>
        </element-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <mixed-citation>9 World Health Organization. (WHO). Be He@lthy, Be Mobile/OMS. Internet. [ Acessed in 2019 june 06]. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.who.int/ncds/prevention/be-healthy-be-mobile/en/">https://www.who.int/ncds/prevention/be-healthy-be-mobile/en/</ext-link>
				</mixed-citation>
        <element-citation publication-type="webpage">
          <person-group person-group-type="author">
            <collab>World Health Organization</collab>
          </person-group>
          <source>Be He@lthy, Be Mobile/OMS</source>
          <comment>Internet</comment>
          <date-in-citation content-type="access-date">2019 june 06</date-in-citation>
          <comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://www.who.int/ncds/prevention/be-healthy-be-mobile/en/">https://www.who.int/ncds/prevention/be-healthy-be-mobile/en/</ext-link>
					</comment>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <mixed-citation>10 World Health Organization. (WHO). The MAPS Toolkit mHealth Assessment and Planning for Scale. Internet. [Acessed in 2019 June 06]. Available from: <ext-link ext-link-type="uri" xlink:href="https://apps.who.int/iris/bitstream/handle/10665/185238/9789241509510_eng.pdf?sequence=1">https://apps.who.int/iris/bitstream/handle/10665/185238/9789241509510_eng.pdf?sequence=1</ext-link>
				</mixed-citation>
        <element-citation publication-type="webpage">
          <person-group person-group-type="author">
            <collab>World Health Organization</collab>
          </person-group>
          <source>The MAPS Toolkit mHealth Assessment and Planning for Scale</source>
          <comment>Internet</comment>
          <date-in-citation content-type="access-date">2019 June 06</date-in-citation>
          <comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://apps.who.int/iris/bitstream/handle/10665/185238/9789241509510_eng.pdf?sequence=1">https://apps.who.int/iris/bitstream/handle/10665/185238/9789241509510_eng.pdf?sequence=1</ext-link>
					</comment>
        </element-citation>
      </ref>
      <ref id="B11">
        <label>11</label>
        <mixed-citation>11 World Health Organization. (WHO) Guideline: recommendations on digital interventions for health system strengthening. Geneva;2019. ( Licence: CC BY-NC-SA 3.0 IGO)</mixed-citation>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <collab>World Health Organization</collab>
          </person-group>
          <source>Guideline: recommendations on digital interventions for health system strengthening</source>
          <publisher-loc>Geneva</publisher-loc>
          <year>2019</year>
          <comment>Licence: CC BY-NC-SA 3.0 IGO</comment>
        </element-citation>
      </ref>
      <ref id="B12">
        <label>12</label>
        <mixed-citation>12 World Health Organization. eHealth [Internet]. 58th World Health Assembly; 16-25 May 2005; Geneva, Switzerland. Geneva: WHO; 2005 (Resolution WHA58.28). [Acessed in 2016 February 19]. Available from: http://www.who.int/healthacademy/media/WHA58-28-en.pdf?ua=1</mixed-citation>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <collab>World Health Organization</collab>
          </person-group>
          <comment>eHealth [Internet]</comment>
          <source>58th World Health Assembly; 16-25 May 2005; Geneva, Switzerland</source>
          <year>2005</year>
          <publisher-loc>Geneva</publisher-loc>
          <publisher-name>WHO</publisher-name>
        </element-citation>
      </ref>
      <ref id="B13">
        <label>13</label>
        <mixed-citation>13 Minist&#233;rio da Sa&#250;de. Sa&#250;de Digital e Telessa&#250;de [acesso em 04 set 2019]. Dispon&#237;vel em: <ext-link ext-link-type="uri" xlink:href="http://www.saude.gov.br/component/content/article/1357-telessaude/43660-saude-digital-e-telessaude">http://www.saude.gov.br/component/content/article/1357-telessaude/43660-saude-digital-e-telessaude</ext-link>
				</mixed-citation>
        <element-citation publication-type="webpage">
          <person-group person-group-type="author">
            <collab>Minist&#233;rio da Sa&#250;de</collab>
          </person-group>
          <source>Sa&#250;de Digital e Telessa&#250;de</source>
          <date-in-citation content-type="access-date">04 set 2019</date-in-citation>
          <comment>Dispon&#237;vel em: <ext-link ext-link-type="uri" xlink:href="http://www.saude.gov.br/component/content/article/1357-telessaude/43660-saude-digital-e-telessaude">http://www.saude.gov.br/component/content/article/1357-telessaude/43660-saude-digital-e-telessaude</ext-link>
					</comment>
        </element-citation>
      </ref>
      <ref id="B14">
        <label>14</label>
        <mixed-citation>14 WHO Library Cataloguing-in-Publication Data mHealth: New horizons for health through mobile technologies: second global survey on eHealth. 1.Cellular phone - utilization. 2.Computers, Handheld - utilization. 3.Telemedicine. 4.Medical informatics. 5.Technology transfer. 6.Data collection. I.WHO Global Observatory for eHealth. ISBN 978 92 4 156425 0 (NLM classification: W 26.5) (c) World Health Organization 2011. Internet. [Acessed in 2019 June 06]. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.who.int/goe/publications/goe_mhealth_web.pdf">https://www.who.int/goe/publications/goe_mhealth_web.pdf</ext-link>
				</mixed-citation>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <collab>WHO</collab>
          </person-group>
          <source>Library Cataloguing-in-Publication Data mHealth: New horizons for health through mobile technologies: second global survey on eHealth. 1.Cellular phone - utilization. 2.Computers, Handheld - utilization. 3.Telemedicine. 4.Medical informatics. 5.Technology transfer. 6.Data collection. I.WHO Global Observatory for eHealth. ISBN 978 92 4 156425 0 (NLM classification: W 26.5) (c) World Health Organization</source>
          <year>2011</year>
          <comment>Internet</comment>
          <date-in-citation content-type="access-date">2019 June 06</date-in-citation>
          <comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://www.who.int/goe/publications/goe_mhealth_web.pdf">https://www.who.int/goe/publications/goe_mhealth_web.pdf</ext-link>
					</comment>
        </element-citation>
      </ref>
      <ref id="B15">
        <label>15</label>
        <mixed-citation>15 Konduto Blog. O Brasil &#233; o pa&#237;s mais vulner&#225;vel para o vazamento de dados. Internet. [Accesso em 04 outubro 2018.]. Dispon&#237;vel em: <ext-link ext-link-type="uri" xlink:href="https://blog.konduto.com/pt/2016/01/vazamento-dados-estudo-brasil">https://blog.konduto.com/pt/2016/01/vazamento-dados-estudo-brasil</ext-link>
				</mixed-citation>
        <element-citation publication-type="webpage">
          <person-group person-group-type="author">
            <collab>Konduto Blog</collab>
          </person-group>
          <source>O Brasil &#233; o pa&#237;s mais vulner&#225;vel para o vazamento de dados</source>
          <comment>Internet</comment>
          <date-in-citation content-type="access-date">04 outubro 2018</date-in-citation>
          <comment>Dispon&#237;vel em: <ext-link ext-link-type="uri" xlink:href="https://blog.konduto.com/pt/2016/01/vazamento-dados-estudo-brasil">https://blog.konduto.com/pt/2016/01/vazamento-dados-estudo-brasil</ext-link>
					</comment>
        </element-citation>
      </ref>
      <ref id="B16">
        <label>16</label>
        <mixed-citation>16 NHS Digital. Access Control Example Policy. Internet. [Accessed in 2019 Oct 04]. Available from: <ext-link ext-link-type="uri" xlink:href="https://digital.nhs.uk/data-and-information/looking-after-information/data-security-and-information-governance">https://digital.nhs.uk/data-and-information/looking-after-information/data-security-and-information-governance</ext-link>
				</mixed-citation>
        <element-citation publication-type="webpage">
          <person-group person-group-type="author">
            <collab>NHS Digital</collab>
          </person-group>
          <source>Access Control Example Policy</source>
          <comment>Internet</comment>
          <date-in-citation content-type="access-date">2019 Oct 04</date-in-citation>
          <comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://digital.nhs.uk/data-and-information/looking-after-information/data-security-and-information-governance">https://digital.nhs.uk/data-and-information/looking-after-information/data-security-and-information-governance</ext-link>
					</comment>
        </element-citation>
      </ref>
      <ref id="B17">
        <label>17</label>
        <mixed-citation>17 Health Insurance Portability and Accountability Act (HIPAA). Internet. [Accessed in 2019 Oct 04]. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.hhs.gov/sites/default/files/ocr/privacy/hipaa/understanding/summary/privacysummary.pdf">https://www.hhs.gov/sites/default/files/ocr/privacy/hipaa/understanding/summary/privacysummary.pdf</ext-link>
				</mixed-citation>
        <element-citation publication-type="webpage">
          <person-group person-group-type="author">
            <collab>Health Insurance Portability and Accountability Act</collab>
          </person-group>
          <source>Internet</source>
          <date-in-citation content-type="access-date">2019 Oct 04</date-in-citation>
          <comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://www.hhs.gov/sites/default/files/ocr/privacy/hipaa/understanding/summary/privacysummary.pdf">https://www.hhs.gov/sites/default/files/ocr/privacy/hipaa/understanding/summary/privacysummary.pdf</ext-link>
					</comment>
        </element-citation>
      </ref>
      <ref id="B18">
        <label>18</label>
        <mixed-citation>18 Scarfone K, Souppaya N, Sexton M. Guide to Storage Encryption Technologies for End User Devices Recommendations of the National Institute of Standards and Technology. Internet. [Accessed in 2018 Oct 04]. Available from: <ext-link ext-link-type="uri" xlink:href="https://ws680.nist.gov/publication/get_pdf.cfm?pub_id=51257">https://ws680.nist.gov/publication/get_pdf.cfm?pub_id=51257</ext-link>
				</mixed-citation>
        <element-citation publication-type="webpage">
          <person-group person-group-type="author">
            <name>
              <surname>Scarfone</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Souppaya</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Sexton</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <source>Guide to Storage Encryption Technologies for End User Devices Recommendations of the National Institute of Standards and Technology</source>
          <comment>Internet</comment>
          <date-in-citation content-type="access-date">2018 Oct 04</date-in-citation>
          <comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://ws680.nist.gov/publication/get_pdf.cfm?pub_id=51257">https://ws680.nist.gov/publication/get_pdf.cfm?pub_id=51257</ext-link>
					</comment>
        </element-citation>
      </ref>
      <ref id="B19">
        <label>19</label>
        <mixed-citation>19 Chernick CM, Edington III C, Fanto MJ, Rosenthal R. Internet. Guidelines for the Selection and Use of Transport Layer Security (TLS) Implementations. Internewt. [Accessed in 2018 Oct 04].Available from: <ext-link ext-link-type="uri" xlink:href="https://nvlpubs.nist.gov/nistpubs/Legacy/SP/nistspecialpublication800-52.pdf">https://nvlpubs.nist.gov/nistpubs/Legacy/SP/nistspecialpublication800-52.pdf</ext-link>
				</mixed-citation>
        <element-citation publication-type="webpage">
          <person-group person-group-type="author">
            <name>
              <surname>Chernick</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Edington</surname>
              <given-names>C</given-names>
              <suffix>III</suffix>
            </name>
            <name>
              <surname>Fanto</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Rosenthal</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <comment>Internet</comment>
          <source>Guidelines for the Selection and Use of Transport Layer Security (TLS) Implementations</source>
          <comment>Internewt</comment>
          <date-in-citation content-type="access-date">2018 Oct 04</date-in-citation>
          <comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://nvlpubs.nist.gov/nistpubs/Legacy/SP/nistspecialpublication800-52.pdf">https://nvlpubs.nist.gov/nistpubs/Legacy/SP/nistspecialpublication800-52.pdf</ext-link>
					</comment>
        </element-citation>
      </ref>
      <ref id="B20">
        <label>20</label>
        <mixed-citation>20 Frankel S, Hoffman P, Orebaugh A, Park R. Internet. Guide to SSL VPNs Recommendations of the National Institute of Standards and Technology. Internet. Accessed in 2018 Oct 04]. Available from: <ext-link ext-link-type="uri" xlink:href="https://nvlpubs.nist.gov/nistpubs/Legacy/SP/nistspecialpublication800-113.pdf">https://nvlpubs.nist.gov/nistpubs/Legacy/SP/nistspecialpublication800-113.pdf</ext-link>
				</mixed-citation>
        <element-citation publication-type="webpage">
          <person-group person-group-type="author">
            <name>
              <surname>Frankel</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hoffman</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Orebaugh</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <comment>Internet</comment>
          <source>Guide to SSL VPNs Recommendations of the National Institute of Standards and Technology</source>
          <comment>Internet</comment>
          <date-in-citation content-type="access-date">2018 Oct 04</date-in-citation>
          <comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://nvlpubs.nist.gov/nistpubs/Legacy/SP/nistspecialpublication800-113.pdf">https://nvlpubs.nist.gov/nistpubs/Legacy/SP/nistspecialpublication800-113.pdf</ext-link>
					</comment>
        </element-citation>
      </ref>
      <ref id="B21">
        <label>21</label>
        <mixed-citation>21 HIPAA. Arquitetura para seguran&#231;a e conformidade com a HIPAA na Amazon Web Service. Internet. Accessed in 2018 Nov 09]. Available from: <ext-link ext-link-type="uri" xlink:href="https://d1.awsstatic.com/whitepapers/compliance/AWS_HIPAA_Compliance_Whitepaper.pdf">https://d1.awsstatic.com/whitepapers/compliance/AWS_HIPAA_Compliance_Whitepaper.pdf</ext-link>
				</mixed-citation>
        <element-citation publication-type="webpage">
          <person-group person-group-type="author">
            <collab>HIPAA</collab>
          </person-group>
          <source>Arquitetura para seguran&#231;a e conformidade com a HIPAA na Amazon Web Service</source>
          <comment>Internet</comment>
          <date-in-citation content-type="access-date">2018 Nov 09</date-in-citation>
          <comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://d1.awsstatic.com/whitepapers/compliance/AWS_HIPAA_Compliance_Whitepaper.pdf">https://d1.awsstatic.com/whitepapers/compliance/AWS_HIPAA_Compliance_Whitepaper.pdf</ext-link>
					</comment>
        </element-citation>
      </ref>
      <ref id="B22">
        <label>22</label>
        <mixed-citation>22 Azure Security and Compliance HIPAA/HITRUST Blueprint. Solutions for a Health Insurance Portability and Accountability Act(HIPAA) and Health Informtion Trust Alliance (HITRUST) compliant workloads in Azure. Internet. Accessed in 2018 Nov 04. Available from: <ext-link ext-link-type="uri" xlink:href="https://servicetrust.microsoft.com/ViewPage/HIPAABlueprint">https://servicetrust.microsoft.com/ViewPage/HIPAABlueprint</ext-link>
				</mixed-citation>
        <element-citation publication-type="webpage">
          <person-group person-group-type="author">
            <collab>Azure Security and Compliance HIPAA/HITRUST Blueprint</collab>
          </person-group>
          <source>Solutions for a Health Insurance Portability and Accountability Act(HIPAA) and Health Informtion Trust Alliance (HITRUST) compliant workloads in Azure</source>
          <comment>Internet</comment>
          <date-in-citation content-type="access-date">2018 Nov 04</date-in-citation>
          <comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://servicetrust.microsoft.com/ViewPage/HIPAABlueprint">https://servicetrust.microsoft.com/ViewPage/HIPAABlueprint</ext-link>
					</comment>
        </element-citation>
      </ref>
      <ref id="B23">
        <label>23</label>
        <mixed-citation>23 Barold SS. Willem Einthoven and the birth of clinical electrocardiography a hundred years ago. Card Electrophysiol Rev. 2003;7(1): 99-104</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Barold</surname>
              <given-names>SS</given-names>
            </name>
          </person-group>
          <article-title>Willem Einthoven and the birth of clinical electrocardiography a hundred years ago</article-title>
          <source>Card Electrophysiol Rev</source>
          <year>2003</year>
          <volume>7</volume>
          <issue>1</issue>
          <fpage>99</fpage>
          <lpage>104</lpage>
        </element-citation>
      </ref>
      <ref id="B24">
        <label>24</label>
        <mixed-citation>24 Chaet D, Clearfield R, Sabin JE, Skimming K. Ethical practice in Telehealth and Telemedicine. Council on Ethical and Judicial Affairs American Medical Association. J Gen Intern Med. 2017;32(10): 1136-40.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chaet</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Clearfield</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Sabin</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Skimming</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Ethical practice in Telehealth and Telemedicine: Council on Ethical and Judicial Affairs American Medical Association</article-title>
          <source>J Gen Intern Med</source>
          <year>2017</year>
          <volume>32</volume>
          <issue>10</issue>
          <fpage>1136</fpage>
          <lpage>1140</lpage>
        </element-citation>
      </ref>
      <ref id="B25">
        <label>25</label>
        <mixed-citation>25 Combi C, Pozzani G, Pozzi G. Telemedicine for Developing Countries. A Survey and Some Design Issues. Appl Clin Inform. 2016;7(4): 1025-50</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Combi</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Pozzani</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Pozzi</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Telemedicine for Developing Countries: A Survey and Some Design Issues</article-title>
          <source>Appl Clin Inform</source>
          <year>2016</year>
          <volume>7</volume>
          <issue>4</issue>
          <fpage>1025</fpage>
          <lpage>1050</lpage>
        </element-citation>
      </ref>
      <ref id="B26">
        <label>26</label>
        <mixed-citation>26 Grigsby RK. Telemedicine. JAMA. 1995;274(6): 461-2</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Grigsby</surname>
              <given-names>RK</given-names>
            </name>
          </person-group>
          <article-title>Telemedicine</article-title>
          <source>JAMA</source>
          <year>1995</year>
          <volume>274</volume>
          <issue>6</issue>
          <fpage>461</fpage>
          <lpage>462</lpage>
        </element-citation>
      </ref>
      <ref id="B27">
        <label>27</label>
        <mixed-citation>27 Lerner EJ. Telemedicine. Slow in coming. N J Med. 1997;94(10): 71-2</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lerner</surname>
              <given-names>EJ</given-names>
            </name>
          </person-group>
          <article-title>Telemedicine: Slow in coming</article-title>
          <source>N J Med</source>
          <year>1997</year>
          <volume>94</volume>
          <issue>10</issue>
          <fpage>71</fpage>
          <lpage>72</lpage>
        </element-citation>
      </ref>
      <ref id="B28">
        <label>28</label>
        <mixed-citation>28 Ekeland AG, Bowes A, Flottorp S. Effectiveness of telemedicine: a systematic review of reviews. Int J Med Inform. 2010;79(11): 736-71</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ekeland</surname>
              <given-names>AG</given-names>
            </name>
            <name>
              <surname>Bowes</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Flottorp</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Effectiveness of telemedicine: a systematic review of reviews</article-title>
          <source>Int J Med Inform</source>
          <year>2010</year>
          <volume>79</volume>
          <issue>11</issue>
          <fpage>736</fpage>
          <lpage>771</lpage>
        </element-citation>
      </ref>
      <ref id="B29">
        <label>29</label>
        <mixed-citation>29 Ryan TJ. Osler and his teaching: relevant today. Postgrad Med J. 2015;91(1080): 540-1</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ryan</surname>
              <given-names>TJ</given-names>
            </name>
          </person-group>
          <article-title>Osler and his teaching: relevant today</article-title>
          <source>Postgrad Med J</source>
          <year>2015</year>
          <volume>91</volume>
          <issue>1080</issue>
          <fpage>540</fpage>
          <lpage>541</lpage>
        </element-citation>
      </ref>
      <ref id="B30">
        <label>30</label>
        <mixed-citation>30 Hill AV. The ethical dilemma of science. Nature. 1952;170(4323): 388-93.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hill</surname>
              <given-names>AV</given-names>
            </name>
          </person-group>
          <article-title>The ethical dilemma of science</article-title>
          <source>Nature</source>
          <year>1952</year>
          <volume>170</volume>
          <issue>4323</issue>
          <fpage>388</fpage>
          <lpage>393</lpage>
        </element-citation>
      </ref>
      <ref id="B31">
        <label>31</label>
        <mixed-citation>31 Perednia DA, Allen A. Telemedicine technology and clinical applications. JAMA. 1995;273(6): 483-8</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Perednia</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Allen</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Telemedicine technology and clinical applications</article-title>
          <source>JAMA</source>
          <year>1995</year>
          <volume>273</volume>
          <issue>6</issue>
          <fpage>483</fpage>
          <lpage>488</lpage>
        </element-citation>
      </ref>
      <ref id="B32">
        <label>32</label>
        <mixed-citation>32 Grinberg M, Lopes AS. Paternalism, autonomy and ontology. Arq Bras Cardiol. 2013;101(4): e83-5</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Grinberg</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lopes</surname>
              <given-names>AS</given-names>
            </name>
          </person-group>
          <article-title>Paternalism, autonomy and ontology</article-title>
          <source>Arq Bras Cardiol</source>
          <year>2013</year>
          <volume>101</volume>
          <issue>4</issue>
          <fpage>e83</fpage>
          <lpage>e85</lpage>
        </element-citation>
      </ref>
      <ref id="B33">
        <label>33</label>
        <mixed-citation>33 Kuehn BM. Telemedicine Helps Cardiologists Extend Their Reach. Circulation. 2016;134(16): 1189-91</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kuehn</surname>
              <given-names>BM</given-names>
            </name>
          </person-group>
          <article-title>Telemedicine Helps Cardiologists Extend Their Reach</article-title>
          <source>Circulation</source>
          <year>2016</year>
          <volume>134</volume>
          <issue>16</issue>
          <fpage>1189</fpage>
          <lpage>1191</lpage>
        </element-citation>
      </ref>
      <ref id="B34">
        <label>34</label>
        <mixed-citation>34 Brasil. Presid&#234;ncia da Rep&#250;blica. LEI N&#186; 12.965, DE 23 DE ABRIL DE 2014 - "Marco Civil da Internet". Internet. Acesso em 13 abr 2019. Dispon&#237;vel em <ext-link ext-link-type="uri" xlink:href="http://www.planalto.gov.br/ccivil_03/_ato2011-2014/2014/lei/l12965.htm">http://www.planalto.gov.br/ccivil_03/_ato2011-2014/2014/lei/l12965.htm</ext-link>.</mixed-citation>
        <element-citation publication-type="webpage">
          <person-group person-group-type="author">
            <collab>Brasil</collab>
            <collab>Presid&#234;ncia da Rep&#250;blica</collab>
          </person-group>
          <source>LEI N&#186; 12.965, DE 23 DE ABRIL DE 2014 - "Marco Civil da Internet"</source>
          <comment>Internet</comment>
          <date-in-citation content-type="access-date">13 abr 2019</date-in-citation>
          <comment>Dispon&#237;vel em <ext-link ext-link-type="uri" xlink:href="http://www.planalto.gov.br/ccivil_03/_ato2011-2014/2014/lei/l12965.htm">http://www.planalto.gov.br/ccivil_03/_ato2011-2014/2014/lei/l12965.htm</ext-link>
					</comment>
        </element-citation>
      </ref>
      <ref id="B35">
        <label>35</label>
        <mixed-citation>35 Brasil. Presid&#234;ncia da Rep&#250;blica. LEI N&#186; 13.709, DE 14 DE AGOSTO DE 2018. "Lei Geral de Prote&#231;&#227;o de Dados Pessoais". Internet. Acesso em 13 abr 2019. Dispon&#237;vel em <ext-link ext-link-type="uri" xlink:href="http://www.planalto.gov.br/ccivil_03/_Ato2015-2018/2018/Lei/L13709.htm">http://www.planalto.gov.br/ccivil_03/_Ato2015-2018/2018/Lei/L13709.htm</ext-link>
				</mixed-citation>
        <element-citation publication-type="webpage">
          <person-group person-group-type="author">
            <collab>Brasil</collab>
            <collab>Presid&#234;ncia da Rep&#250;blica</collab>
          </person-group>
          <source>LEI N&#186; 13.709, DE 14 DE AGOSTO DE 2018. "Lei Geral de Prote&#231;&#227;o de Dados Pessoais"</source>
          <comment>Internet</comment>
          <date-in-citation content-type="access-date">13 abr 2019</date-in-citation>
          <comment>Dispon&#237;vel em <ext-link ext-link-type="uri" xlink:href="http://www.planalto.gov.br/ccivil_03/_Ato2015-2018/2018/Lei/L13709.htm">http://www.planalto.gov.br/ccivil_03/_Ato2015-2018/2018/Lei/L13709.htm</ext-link>
					</comment>
        </element-citation>
      </ref>
      <ref id="B36">
        <label>36</label>
        <mixed-citation>36 Brasil. Minist&#233;rio da Sa&#250;de. SUS. Sistema &#218;nico da Sa&#250;de. Internet. Acesso em 10 jun 2019. Dispon&#237;vel em: Dispon&#237;vel em <ext-link ext-link-type="uri" xlink:href="http://portalms.saude.gov.br/sistema-unico-de-saude/principios-do-sus">http://portalms.saude.gov.br/sistema-unico-de-saude/principios-do-sus</ext-link>. Acessado em 16/06/2019</mixed-citation>
        <element-citation publication-type="webpage">
          <person-group person-group-type="author">
            <collab>Brasil</collab>
            <collab>Minist&#233;rio da Sa&#250;de</collab>
          </person-group>
          <source>SUS. Sistema &#218;nico da Sa&#250;de</source>
          <comment>Internet</comment>
          <comment>Dispon&#237;vel em: Dispon&#237;vel em <ext-link ext-link-type="uri" xlink:href="http://portalms.saude.gov.br/sistema-unico-de-saude/principios-do-sus">http://portalms.saude.gov.br/sistema-unico-de-saude/principios-do-sus</ext-link>
					</comment>
          <date-in-citation content-type="access-date">16/06/2019</date-in-citation>
        </element-citation>
      </ref>
      <ref id="B37">
        <label>37</label>
        <mixed-citation>37 Conselho Federal de Medicina (CFM). Resolu&#231;&#227;o CFM n&#186; 1.643/2002. Define e disciplina a presta&#231;&#227;o de servi&#231;os atrav&#233;s da Telemedicina. Internet. Acesso em 06 jun 2019. Dispon&#237;vel em http://www.portalmedico.org.br/resolucoes/cfm/2002/1643_2002.htm Lopes MA, Oliveira GM, Amaral J&#250;nior A, Pereira ES. Window to the Future or Door to Chaos? Arq Bras Cardiol. 2019;112(4): 461-5</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <collab>Conselho Federal de Medicina</collab>
          </person-group>
          <article-title>Resolu&#231;&#227;o CFM n&#186; 1: 643/2002. Define e disciplina a presta&#231;&#227;o de servi&#231;os atrav&#233;s da Telemedicina. Internet. Acesso em 06 jun 2019. Dispon&#237;vel em http://www.portalmedico.org.br/resolucoes/cfm/2002/1643_2002.htm Lopes MA, Oliveira GM, Amaral J&#250;nior A, Pereira ES. Window to the Future or Door to Chaos?</article-title>
          <source>Arq Bras Cardiol</source>
          <year>2019</year>
          <volume>112</volume>
          <issue>4</issue>
          <fpage>461</fpage>
          <lpage>465</lpage>
        </element-citation>
      </ref>
      <ref id="B38">
        <label>38</label>
        <mixed-citation>38 Lopes MA, Oliveira GM, Amaral Jr A, Pereira ES. Janela para o Futuro ou Porta para o Caos? Arq Bras Cardiol. 2019;112(4): 461-5</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lopes</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Oliveira</surname>
              <given-names>GM</given-names>
            </name>
            <name>
              <surname>Amaral</surname>
              <given-names>A</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Pereira</surname>
              <given-names>ES</given-names>
            </name>
          </person-group>
          <article-title>Janela para o Futuro ou Porta para o Caos</article-title>
          <source>Arq Bras Cardiol</source>
          <year>2019</year>
          <volume>112</volume>
          <issue>4</issue>
          <fpage>461</fpage>
          <lpage>465</lpage>
        </element-citation>
      </ref>
      <ref id="B39">
        <label>39</label>
        <mixed-citation>39 Davoudi S, Stead D. Urban-rural relationships: An introduction and brief history. Built Environment. 2002;28(4): 268-77</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Davoudi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Stead</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Urban-rural relationships: An introduction and brief history</article-title>
          <source>Built Environment</source>
          <year>2002</year>
          <volume>28</volume>
          <issue>4</issue>
          <fpage>268</fpage>
          <lpage>277</lpage>
        </element-citation>
      </ref>
      <ref id="B40">
        <label>40</label>
        <mixed-citation>40 Rogers H, Castree N, Kitchen R. A Dictionary of Human Geography. Oxford: Oxford University Press; 2013. Internet. [Accessed in 2019 Jun 06]. Available from: https://doi.org/10.1093/acref/9780199599868.001.0001</mixed-citation>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Rogers</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Castree</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Kitchen</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <source>A Dictionary of Human Geography</source>
          <year>2013</year>
          <publisher-loc>Oxford</publisher-loc>
          <publisher-name>Oxford University Press</publisher-name>
        </element-citation>
      </ref>
      <ref id="B41">
        <label>41</label>
        <mixed-citation>41 Brezzi M, Dijkstra L, Ruiz V. OECD Extended Regional Typology: The Economic Performance of Remote Rural Regions. In: OECD Regional Development Working Papers. Internet. [Accessed in 2018 Nov 10] Available from: <ext-link ext-link-type="uri" xlink:href="https://doi.org/dx.doi.org/10.1787/5kg6z83tw7f4-en">https://doi.org/dx.doi.org/10.1787/5kg6z83tw7f4-en</ext-link>
				</mixed-citation>
        <element-citation publication-type="webpage">
          <person-group person-group-type="author">
            <name>
              <surname>Brezzi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Dijkstra</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Ruiz</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <source>OECD Extended Regional Typology: The Economic Performance of Remote Rural Regions. In: OECD Regional Development Working Papers</source>
          <comment>Internet</comment>
          <date-in-citation content-type="access-date">2018 Nov 10</date-in-citation>
          <comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://doi.org/dx.doi.org/10.1787/5kg6z83tw7f4-en">https://doi.org/dx.doi.org/10.1787/5kg6z83tw7f4-en</ext-link>
					</comment>
        </element-citation>
      </ref>
      <ref id="B42">
        <label>42</label>
        <mixed-citation>42 Instituto Brasileiro de Geografia e Estat&#237;stica. (IBGE). Classifica&#231;&#227;o e caracteriza&#231;&#227;o dos espa&#231;os rurais e urbanos do Brasil; uma primeira aproxima&#231;&#227;o. Rio de Janeiro; 2017. (Estudos e Pesquisas - Informa&#231;&#227;o Geogr&#225;fica. N.11)</mixed-citation>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <collab>Instituto Brasileiro de Geografia e Estat&#237;stica</collab>
          </person-group>
          <source>Classifica&#231;&#227;o e caracteriza&#231;&#227;o dos espa&#231;os rurais e urbanos do Brasil; uma primeira aproxima&#231;&#227;o</source>
          <publisher-loc>Rio de Janeiro</publisher-loc>
          <year>2017</year>
          <comment>Estudos e Pesquisas - Informa&#231;&#227;o Geogr&#225;fica. N.11</comment>
        </element-citation>
      </ref>
      <ref id="B43">
        <label>43</label>
        <mixed-citation>43 Instituto Brasileiro de Geografia e Estat&#237;stica. (IBGE). Sistema de mapeamento para base territorial- SISMAI- Manual do Usu&#225;rio. Rio de Janeiro; 2010</mixed-citation>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <collab>Instituto Brasileiro de Geografia e Estat&#237;stica</collab>
          </person-group>
          <source>Sistema de mapeamento para base territorial- SISMAI- Manual do Usu&#225;rio</source>
          <publisher-loc>Rio de Janeiro</publisher-loc>
          <year>2010</year>
        </element-citation>
      </ref>
      <ref id="B44">
        <label>44</label>
        <mixed-citation>44 Instituto Brasileiro de Geografia e Estat&#237;stica. (IBGE). Censo IBGE 2010. Internet. [Acesso em 06 jun 2019]. Dispon&#237;vel em: ps: //censo2010.ibge.gov.br</mixed-citation>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <collab>Instituto Brasileiro de Geografia e Estat&#237;stica</collab>
          </person-group>
          <source>Censo IBGE</source>
          <year>2010</year>
          <comment>Internet</comment>
          <date-in-citation content-type="access-date">06 jun 2019</date-in-citation>
          <comment>//censo2010.ibge.gov.br</comment>
        </element-citation>
      </ref>
      <ref id="B45">
        <label>45</label>
        <mixed-citation>45 Scheffer M, Cassenote A, Guilloux AG, Miotto B, Mainardi GM, Matijasevich A, et al. Demografia M&#233;dica no Brasil 2018. Sao Paulo: FMUSP.2018: 1-286. Available from: <ext-link ext-link-type="uri" xlink:href="https://jornal.usp.br/wp-content/uploads/DemografiaMedica2018.pdf">https://jornal.usp.br/wp-content/uploads/DemografiaMedica2018.pdf</ext-link>
				</mixed-citation>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Scheffer</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Cassenote</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Guilloux</surname>
              <given-names>AG</given-names>
            </name>
            <name>
              <surname>Miotto</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Mainardi</surname>
              <given-names>GM</given-names>
            </name>
            <name>
              <surname>Matijasevich</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <source>Demografia M&#233;dica no Brasil 2018</source>
          <publisher-loc>Sao Paulo</publisher-loc>
          <publisher-name>FMUSP</publisher-name>
          <year>2018</year>
          <fpage>1</fpage>
          <lpage>286</lpage>
          <ext-link ext-link-type="uri" xlink:href="https://jornal.usp.br/wp-content/uploads/DemografiaMedica2018.pdf">https://jornal.usp.br/wp-content/uploads/DemografiaMedica2018.pdf</ext-link>
        </element-citation>
      </ref>
      <ref id="B46">
        <label>46</label>
        <mixed-citation>46 Brasil. Minist&#233;rio da Sa&#250;de. Cadastro Nacional de Estabelecimentos de Saude. Internet. [Acesso em 10 mar&#231;o 2019]. Dispon&#237;vel em: <ext-link ext-link-type="uri" xlink:href="http://cnes.datasus.gov.br/">http://cnes.datasus.gov.br/</ext-link>
				</mixed-citation>
        <element-citation publication-type="webpage">
          <person-group person-group-type="author">
            <collab>Brasil</collab>
            <collab>Minist&#233;rio da Sa&#250;de</collab>
          </person-group>
          <source>Cadastro Nacional de Estabelecimentos de Saude</source>
          <comment>Internet</comment>
          <date-in-citation content-type="access-date">10 mar&#231;o 2019</date-in-citation>
          <comment>Dispon&#237;vel em: <ext-link ext-link-type="uri" xlink:href="http://cnes.datasus.gov.br/">http://cnes.datasus.gov.br/</ext-link>
					</comment>
        </element-citation>
      </ref>
      <ref id="B47">
        <label>47</label>
        <mixed-citation>47 International Telecommunication Union. (ITU). Internet. Accessed in 2019 Feb 02]. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.itu.int/en/ITU-T/e-health/Pages/default.aspx">https://www.itu.int/en/ITU-T/e-health/Pages/default.aspx</ext-link>
				</mixed-citation>
        <element-citation publication-type="webpage">
          <person-group person-group-type="author">
            <collab>International Telecommunication Union</collab>
          </person-group>
          <comment>Internet</comment>
          <date-in-citation content-type="access-date">2019 Feb 02</date-in-citation>
          <comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://www.itu.int/en/ITU-T/e-health/Pages/default.aspx">https://www.itu.int/en/ITU-T/e-health/Pages/default.aspx</ext-link>
					</comment>
        </element-citation>
      </ref>
      <ref id="B48">
        <label>48</label>
        <mixed-citation>48 Pan American Health Organization. (PAHO). eHealth in the Region of the Americas: breaking down the barriers to implementation. Results of the World Health Organization's Third Global Survey on eHealth. Washington (DC); 2016.Habicht T, Reinap M, Kasekamp K, Sikkut R, Aaben, L, van Ginneken E. Estonia: Health System Review. Health Syst Transit. 2018;20(1): 1-189</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <collab>Pan American Health Organization</collab>
          </person-group>
          <article-title>eHealth in the Region of the Americas: breaking down the barriers to implementation</article-title>
          <source>Results of the World Health Organization's Third Global Survey on eHealth</source>
          <publisher-loc>Washington (DC)</publisher-loc>
          <year>2016</year>
          <comment>Habicht T, Reinap M, Kasekamp K, Sikkut R, Aaben, L, van Ginneken E. Estonia: Health System Review. Health Syst Transit. 2018;20(1): 1-189</comment>
        </element-citation>
      </ref>
      <ref id="B49">
        <label>49</label>
        <mixed-citation>49 Sanyal C, Stolee, P, Juzwishin, D, Husereau D. Economic evaluations of eHealth technologies: A systematic review. PLoS One. 2018;13(6): e0198112</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sanyal</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Stolee</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Juzwishin</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Husereau</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Economic evaluations of eHealth technologies: A systematic review</article-title>
          <source>PLoS One</source>
          <year>2018</year>
          <volume>13</volume>
          <issue>6</issue>
          <elocation-id>e0198112</elocation-id>
        </element-citation>
      </ref>
      <ref id="B50">
        <label>50</label>
        <mixed-citation>50 National Agency for Telecommunication. (ANATEL). Internet. [Acccessed in 2019 March 04]. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.anatel.gov.br">http://www.anatel.gov.br</ext-link>
				</mixed-citation>
        <element-citation publication-type="webpage">
          <source>National Agency for Telecommunication</source>
          <comment>ANATEL). Internet</comment>
          <date-in-citation content-type="access-date">2019 March 04</date-in-citation>
          <comment>Available from: <ext-link ext-link-type="uri" xlink:href="http://www.anatel.gov.br">http://www.anatel.gov.br</ext-link>
					</comment>
        </element-citation>
      </ref>
      <ref id="B51">
        <label>51</label>
        <mixed-citation>51 TELECO Blog. Celulares por Regi&#227;o SMP/SMC/Estado. Internet. [Acesso em 13 Mar 2019]. Dispon&#237;vel em: <ext-link ext-link-type="uri" xlink:href="http://www.teleco.com.br/nceluf.asp">http://www.teleco.com.br/nceluf.asp</ext-link>
				</mixed-citation>
        <element-citation publication-type="webpage">
          <person-group person-group-type="author">
            <collab>TELECO Blog</collab>
          </person-group>
          <source>Celulares por Regi&#227;o SMP/SMC/Estado</source>
          <comment>Internet</comment>
          <date-in-citation content-type="access-date">13 Mar 2019</date-in-citation>
          <comment>Dispon&#237;vel em: <ext-link ext-link-type="uri" xlink:href="http://www.teleco.com.br/nceluf.asp">http://www.teleco.com.br/nceluf.asp</ext-link>
					</comment>
        </element-citation>
      </ref>
      <ref id="B52">
        <label>52</label>
        <mixed-citation>52 Topol Review: Preparing the healthcare workforce to deliver the digital future, as parto f the draft health and care workforce strategy for England to 2027- facing the facts, shaping the future. Secretary of State for Health and Social Care. Internet. [Accessed in 2019 Feb 02]. Available from: <ext-link ext-link-type="uri" xlink:href="https://topol.hee.nhs.uk/wp-content/uploads/HEE-Topol-Review-2019.pdf">https://topol.hee.nhs.uk/wp-content/uploads/HEE-Topol-Review-2019.pdf</ext-link>
				</mixed-citation>
        <element-citation publication-type="webpage">
          <source>Topol Review: Preparing the healthcare workforce to deliver the digital future, as parto f the draft health and care workforce strategy for England to 2027- facing the facts, shaping the future. Secretary of State for Health and Social Care</source>
          <comment>Internet</comment>
          <date-in-citation content-type="access-date">2019 Feb 02</date-in-citation>
          <comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://topol.hee.nhs.uk/wp-content/uploads/HEE-Topol-Review-2019.pdf">https://topol.hee.nhs.uk/wp-content/uploads/HEE-Topol-Review-2019.pdf</ext-link>
					</comment>
        </element-citation>
      </ref>
      <ref id="B53">
        <label>53</label>
        <mixed-citation>53 Park SH, Han K. Methodologic Guide for Evaluating Clinical Performance and Effect of Artificial Intelligence Technology for Medical Diagnosis and Prediction. Radiology. 2018;286(3): 800-9</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Park</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Han</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Methodologic Guide for Evaluating Clinical Performance and Effect of Artificial Intelligence Technology for Medical Diagnosis and Prediction</article-title>
          <source>Radiology</source>
          <year>2018</year>
          <volume>286</volume>
          <issue>3</issue>
          <fpage>800</fpage>
          <lpage>809</lpage>
        </element-citation>
      </ref>
      <ref id="B54">
        <label>54</label>
        <mixed-citation>54 Ribeiro AL, Oliveira GM. Rumo a uma Cardiologia Centrada no Paciente e Guiada por Dados. Arq Bras Cardiol. 2019;112(4): 371-3</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ribeiro</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Oliveira</surname>
              <given-names>GM</given-names>
            </name>
          </person-group>
          <article-title>Rumo a uma Cardiologia Centrada no Paciente e Guiada por Dados</article-title>
          <source>Arq Bras Cardiol</source>
          <year>2019</year>
          <volume>112</volume>
          <issue>4</issue>
          <fpage>371</fpage>
          <lpage>373</lpage>
        </element-citation>
      </ref>
      <ref id="B55">
        <label>55</label>
        <mixed-citation>55 Johnson KW, Soto JT, Glicksberg BS, Shameer K, Miotto R, Ali M, et al. Artificial Intelligence in Cardiology. J Am Coll Cardiol. 2018;71(23): 2668-79</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Johnson</surname>
              <given-names>KW</given-names>
            </name>
            <name>
              <surname>Soto</surname>
              <given-names>JT</given-names>
            </name>
            <name>
              <surname>Glicksberg</surname>
              <given-names>BS</given-names>
            </name>
            <name>
              <surname>Shameer</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Miotto</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Ali</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Artificial Intelligence in Cardiology</article-title>
          <source>J Am Coll Cardiol</source>
          <year>2018</year>
          <volume>71</volume>
          <issue>23</issue>
          <fpage>2668</fpage>
          <lpage>2679</lpage>
        </element-citation>
      </ref>
      <ref id="B56">
        <label>56</label>
        <mixed-citation>56 Dawes TJW, de Marvao A, Shi W, Fletcher T, Watson GMJ, Wharton J, et al. Machine learning of three-dimensional right ventricular motion enables outcome prediction in pulmonary hypertension: a cardiac MR imaging study. Radiology. 2017;283(2): 381-90</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dawes</surname>
              <given-names>TJW</given-names>
            </name>
            <name>
              <surname>de Marvao</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Shi</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Fletcher</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Watson</surname>
              <given-names>GMJ</given-names>
            </name>
            <name>
              <surname>Wharton</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Machine learning of three-dimensional right ventricular motion enables outcome prediction in pulmonary hypertension: a cardiac MR imaging study</article-title>
          <source>Radiology</source>
          <year>2017</year>
          <volume>283</volume>
          <issue>2</issue>
          <fpage>381</fpage>
          <lpage>390</lpage>
        </element-citation>
      </ref>
      <ref id="B57">
        <label>57</label>
        <mixed-citation>57 Oskouie SK, Prenner SB, Shah SJ, Sauer AJ. Differences in repolarization heterogeneity among heart failure with preserved ejection fraction phenotypic subgroups. Am J Cardiol. 2017;120(4): 601-6.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Oskouie</surname>
              <given-names>SK</given-names>
            </name>
            <name>
              <surname>Prenner</surname>
              <given-names>SB</given-names>
            </name>
            <name>
              <surname>Shah</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Sauer</surname>
              <given-names>AJ</given-names>
            </name>
          </person-group>
          <article-title>Differences in repolarization heterogeneity among heart failure with preserved ejection fraction phenotypic subgroups</article-title>
          <source>Am J Cardiol</source>
          <year>2017</year>
          <volume>120</volume>
          <issue>4</issue>
          <fpage>601</fpage>
          <lpage>606</lpage>
        </element-citation>
      </ref>
      <ref id="B58">
        <label>58</label>
        <mixed-citation>58 Weng SF, Reps J, Kai J, Garibaldi JM, Qureshi N. Can machine-learning improve cardiovascular risk prediction using routine clinical data? PLoS One. 2017;12(4): e0174944</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Weng</surname>
              <given-names>SF</given-names>
            </name>
            <name>
              <surname>Reps</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Kai</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Garibaldi</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Qureshi</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Can machine-learning improve cardiovascular risk prediction using routine clinical data</article-title>
          <source>PLoS One</source>
          <year>2017</year>
          <volume>12</volume>
          <issue>4</issue>
          <elocation-id>e0174944</elocation-id>
        </element-citation>
      </ref>
      <ref id="B59">
        <label>59</label>
        <mixed-citation>59 Goto S, Kimura M, Katsumata Y, Goto S, Kamatani T, Ichihara G, et al. Artificial intelligence to predict needs for urgent revascularization from 12-leads electrocardiography in emergency patients. PLoS One. 2019;14(1): e0210103</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Goto</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kimura</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Katsumata</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Goto</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kamatani</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Ichihara</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Artificial intelligence to predict needs for urgent revascularization from 12-leads electrocardiography in emergency patients</article-title>
          <source>PLoS One</source>
          <year>2019</year>
          <volume>14</volume>
          <issue>1</issue>
          <elocation-id>e0210103</elocation-id>
        </element-citation>
      </ref>
      <ref id="B60">
        <label>60</label>
        <mixed-citation>60 Seetharam K, Kagiyama N, Sengupta PP. Application of mobile health, telemedicine and artificial intelligence to echocardiography. Echo Res Pract. 2019 Feb 1. pii: ERP-18-0081.R1. [Epub ahead of print]</mixed-citation>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Seetharam</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kagiyama</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Sengupta</surname>
              <given-names>PP</given-names>
            </name>
          </person-group>
          <source>Application of mobile health, telemedicine and artificial intelligence to echocardiography. Echo Res Pract</source>
          <day>01</day>
          <month>02</month>
          <year>2019</year>
          <pub-id pub-id-type="pii">ERP-18-0081.R1</pub-id>
          <comment>Epub ahead of print</comment>
        </element-citation>
      </ref>
      <ref id="B61">
        <label>61</label>
        <mixed-citation>61 Ribeiro AH, Ribeiro MH, Paix&#227;o G, Oliveira D, Gomes P. Canazart D, et al. Automatic diagnosis of the short-duration 12-lead ECG using a deep neural network the CODE study. Internet. [Accessed in 2019 Jun 06]. Available from: https:arxiv.org/abs/1904.01949</mixed-citation>
        <element-citation publication-type="webpage">
          <person-group person-group-type="author">
            <name>
              <surname>Ribeiro</surname>
              <given-names>AH</given-names>
            </name>
            <name>
              <surname>Ribeiro</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Paix&#227;o</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Oliveira</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Gomes</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Canazart</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <source>Automatic diagnosis of the short-duration 12-lead ECG using a deep neural network the CODE study</source>
          <comment>Internet</comment>
          <date-in-citation content-type="access-date">2019 Jun 06</date-in-citation>
          <comment>Available from: <ext-link ext-link-type="uri" xlink:href="https:arxiv.org/abs/1904.01949">https:arxiv.org/abs/1904.01949</ext-link>
					</comment>
        </element-citation>
      </ref>
      <ref id="B62">
        <label>62</label>
        <mixed-citation>62 Triantafyllidis AK, Tsanas A. Applications of Machine Learning in Real-Life Digital Health Interventions: Review of the Literature. J Med Internet Res. 2019;21(4): e12286</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Triantafyllidis</surname>
              <given-names>AK</given-names>
            </name>
            <name>
              <surname>Tsanas</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Applications of Machine Learning in Real-Life Digital Health Interventions: Review of the Literature</article-title>
          <source>J Med Internet Res</source>
          <year>2019</year>
          <volume>21</volume>
          <issue>4</issue>
          <elocation-id>e12286</elocation-id>
        </element-citation>
      </ref>
      <ref id="B63">
        <label>63</label>
        <mixed-citation>63 Topol EJ. The Topol Review. An independent report on behalf of the Secretary of State for Health and Social Care. Internet. [Accessed in 2019 Feb 02]. Available from: <ext-link ext-link-type="uri" xlink:href="https://topol.hee.nhs.uk/">https://topol.hee.nhs.uk/</ext-link>
				</mixed-citation>
        <element-citation publication-type="webpage">
          <person-group person-group-type="author">
            <name>
              <surname>Topol</surname>
              <given-names>EJ</given-names>
            </name>
          </person-group>
          <source>The Topol Review. An independent report on behalf of the Secretary of State for Health and Social Care</source>
          <comment>Internet</comment>
          <date-in-citation content-type="access-date">2019 Feb 02</date-in-citation>
          <comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://topol.hee.nhs.uk/">https://topol.hee.nhs.uk/</ext-link>
					</comment>
        </element-citation>
      </ref>
      <ref id="B64">
        <label>64</label>
        <mixed-citation>64 European Commission-Futurium - Independent high-level expert group on Artificial Intelligence. Ethics guidelines for trustworthy. Internet. [Accessed in 2019 Feb 03]. Available from: <ext-link ext-link-type="uri" xlink:href="https://ec.europa-eu/digital/-single-market/in/high-level-expert-group-artificial-intelligence">https://ec.europa-eu/digital/-single-market/in/high-level-expert-group-artificial-intelligence</ext-link>
				</mixed-citation>
        <element-citation publication-type="webpage">
          <person-group person-group-type="author">
            <collab>European Commission-Futurium</collab>
          </person-group>
          <source>Independent high-level expert group on Artificial Intelligence. Ethics guidelines for trustworthy</source>
          <comment>Internet</comment>
          <date-in-citation content-type="access-date">2019 Feb 03</date-in-citation>
          <comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://ec.europa-eu/digital/-single-market/in/high-level-expert-group-artificial-intelligence">https://ec.europa-eu/digital/-single-market/in/high-level-expert-group-artificial-intelligence</ext-link>
					</comment>
        </element-citation>
      </ref>
      <ref id="B65">
        <label>65</label>
        <mixed-citation>65 Granja C, Janssen W, Johansen MA. Factors Determining the Success and Failure of eHealth Interventions: Systematic Review of the Literature. J Med Internet Res. 2018;20(5): e10235</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Granja</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Janssen</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Johansen</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>Factors Determining the Success and Failure of eHealth Interventions: Systematic Review of the Literature</article-title>
          <source>J Med Internet Res</source>
          <year>2018</year>
          <volume>20</volume>
          <issue>5</issue>
          <elocation-id>e10235</elocation-id>
        </element-citation>
      </ref>
      <ref id="B66">
        <label>66</label>
        <mixed-citation>66 Bashshur RL, Shannon G, Krupinski EA, Grigsby J. Sustaining and realizing the promise of telemedicine. Telemed J E Health. 2013;19(5): 339-45</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bashshur</surname>
              <given-names>RL</given-names>
            </name>
            <name>
              <surname>Shannon</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Krupinski</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Grigsby</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Sustaining and realizing the promise of telemedicine</article-title>
          <source>Telemed J E Health</source>
          <year>2013</year>
          <volume>19</volume>
          <issue>5</issue>
          <fpage>339</fpage>
          <lpage>345</lpage>
        </element-citation>
      </ref>
      <ref id="B67">
        <label>67</label>
        <mixed-citation>67 Campos FE, Haddad AE, Wen CL, Alkmim MB. Telessa&#250;de em Apoio &#224; Aten&#231;&#227;o Prim&#225;ria &#224; Sa&#250;de no Brasil. In: Santos AF, et al (Org.). Telessa&#250;de Um Instrumento de Suporte Assistencial e Educa&#231;&#227;o Permanente. Belo Horizonte: UFMG. 2006; p.59-74</mixed-citation>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Campos</surname>
              <given-names>FE</given-names>
            </name>
            <name>
              <surname>Haddad</surname>
              <given-names>AE</given-names>
            </name>
            <name>
              <surname>Wen</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Alkmim</surname>
              <given-names>MB</given-names>
            </name>
          </person-group>
          <chapter-title>Telessa&#250;de em Apoio &#224; Aten&#231;&#227;o Prim&#225;ria &#224; Sa&#250;de no Brasil</chapter-title>
          <person-group person-group-type="author">
            <name>
              <surname>Santos</surname>
              <given-names>AF</given-names>
            </name>
            <etal/>
          </person-group>
          <source>Telessa&#250;de Um Instrumento de Suporte Assistencial e Educa&#231;&#227;o Permanente</source>
          <publisher-loc>Belo Horizonte</publisher-loc>
          <publisher-name>UFMG</publisher-name>
          <year>2006</year>
          <fpage>59</fpage>
          <lpage>74</lpage>
        </element-citation>
      </ref>
      <ref id="B68">
        <label>68</label>
        <mixed-citation>68 Brasil. Minist&#233;rio da Sa&#250;de.Internet. [Acesso em 04 abr 2019]. Dispon&#237;vel em: <ext-link ext-link-type="uri" xlink:href="http://portalms.saude.gov.br/sistema-unico-de-saude/princ&#237;pios-do-sus">http://portalms.saude.gov.br/sistema-unico-de-saude/princ&#237;pios-do-sus</ext-link>.</mixed-citation>
        <element-citation publication-type="webpage">
          <person-group person-group-type="author">
            <collab>Brasil</collab>
          </person-group>
          <source>Minist&#233;rio da Sa&#250;de</source>
          <comment>Internet</comment>
          <date-in-citation content-type="access-date">04 abr 2019</date-in-citation>
          <comment>Dispon&#237;vel em: <ext-link ext-link-type="uri" xlink:href="http://portalms.saude.gov.br/sistema-unico-de-saude/princ&#237;pios-do-sus">http://portalms.saude.gov.br/sistema-unico-de-saude/princ&#237;pios-do-sus</ext-link>
					</comment>
        </element-citation>
      </ref>
      <ref id="B69">
        <label>69</label>
        <mixed-citation>69 Pan American Health Organization. (PAHO). World Health Day: PAHO calls for equitable access to health care. Internet. [Accessed in 2019 Apr 09]. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.paho.org/">https://www.paho.org/</ext-link>
				</mixed-citation>
        <element-citation publication-type="webpage">
          <person-group person-group-type="author">
            <collab>Pan American Health Organization</collab>
          </person-group>
          <source>World Health Day: PAHO calls for equitable access to health care</source>
          <comment>Internet</comment>
          <date-in-citation content-type="access-date">2019 Apr 09</date-in-citation>
          <comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://www.paho.org/">https://www.paho.org/</ext-link>
					</comment>
        </element-citation>
      </ref>
      <ref id="B70">
        <label>70</label>
        <mixed-citation>70 Hjelm NM. Benefits and drawbacks of telemedicine. J Telemed Telecare. 2005;11(2): 60-70</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hjelm</surname>
              <given-names>NM</given-names>
            </name>
          </person-group>
          <article-title>Benefits and drawbacks of telemedicine</article-title>
          <source>J Telemed Telecare</source>
          <year>2005</year>
          <volume>11</volume>
          <issue>2</issue>
          <fpage>60</fpage>
          <lpage>70</lpage>
        </element-citation>
      </ref>
      <ref id="B71">
        <label>71</label>
        <mixed-citation>71 Bashshur RL, Howell JD, Krupinski EA, Harms KM, Bashshur N, Doarn CR. The Empirical Foundations of Telemedicine Interventions in Primary Care. Telemed J E Health. 2016;22(5): 342-75</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bashshur</surname>
              <given-names>RL</given-names>
            </name>
            <name>
              <surname>Howell</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Krupinski</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Harms</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Bashshur</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Doarn</surname>
              <given-names>CR</given-names>
            </name>
          </person-group>
          <article-title>The Empirical Foundations of Telemedicine Interventions in Primary Care</article-title>
          <source>Telemed J E Health</source>
          <year>2016</year>
          <volume>22</volume>
          <issue>5</issue>
          <fpage>342</fpage>
          <lpage>375</lpage>
        </element-citation>
      </ref>
      <ref id="B72">
        <label>72</label>
        <mixed-citation>72 Nerlich M, Balas EA, Schall T, Stieglitz SP, Filzmaier R, Asbach P, et al. Teleconsultation practice guidelines: report from G8 Global Health Applications Subproject 4. Telemed J E Health. 2002;8(4): 411-8</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nerlich</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Balas</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Schall</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Stieglitz</surname>
              <given-names>SP</given-names>
            </name>
            <name>
              <surname>Filzmaier</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Asbach</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Teleconsultation practice guidelines: report from G8 Global Health Applications Subproject 4</article-title>
          <source>Telemed J E Health</source>
          <year>2002</year>
          <volume>8</volume>
          <issue>4</issue>
          <fpage>411</fpage>
          <lpage>418</lpage>
        </element-citation>
      </ref>
      <ref id="B73">
        <label>73</label>
        <mixed-citation>73 Ohinmaa A, Hailey D, Roine R. Elements for assessment of telemedicine applications. Int J Technol Assess Health Care. 2001;17(2): 190-202</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ohinmaa</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hailey</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Roine</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Elements for assessment of telemedicine applications</article-title>
          <source>Int J Technol Assess Health Care</source>
          <year>2001</year>
          <volume>17</volume>
          <issue>2</issue>
          <fpage>190</fpage>
          <lpage>202</lpage>
        </element-citation>
      </ref>
      <ref id="B74">
        <label>74</label>
        <mixed-citation>74 Alkmim MB, Figueira RM, Marcolino MS, Cardoso CS, Pena de Abreu M, Cunha LR, et al. Improving patient access to specialized health care: the Telehealth Network of Minas Gerais, Brazil. Bull World Health Organ 2012;90(5): 373-8</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alkmim</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>Figueira</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Marcolino</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Cardoso</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Pena de Abreu</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Cunha</surname>
              <given-names>LR</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Improving patient access to specialized health care: the Telehealth Network of Minas Gerais, Brazil</article-title>
          <source>Bull World Health Organ</source>
          <year>2012</year>
          <volume>90</volume>
          <issue>5</issue>
          <fpage>373</fpage>
          <lpage>378</lpage>
        </element-citation>
      </ref>
      <ref id="B75">
        <label>75</label>
        <mixed-citation>75 McManus RJ, Mant J, Bray EP, Holder R, Jones MI, Greenfield S, et al. Telemonitoring and self-management in the control of hypertension (TASMINH2): a randomised controlled trial. Lancet 2010;376(9736): 163-72</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McManus</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Mant</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Bray</surname>
              <given-names>EP</given-names>
            </name>
            <name>
              <surname>Holder</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>MI</given-names>
            </name>
            <name>
              <surname>Greenfield</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Telemonitoring and self-management in the control of hypertension (TASMINH2): a randomised controlled trial</article-title>
          <source>Lancet</source>
          <year>2010</year>
          <volume>376</volume>
          <issue>9736</issue>
          <fpage>163</fpage>
          <lpage>172</lpage>
        </element-citation>
      </ref>
      <ref id="B76">
        <label>76</label>
        <mixed-citation>76 Nilsson M, Rasmark U, Nordgren H, Hallberg P, Sk&#246;nevik J, Westman G, et al. The physician at a distance: the use of videoconferencing in the treatment of patients with hypertension. J Telemed Telecare. 2009;15(8): 397-403</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nilsson</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Rasmark</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Nordgren</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Hallberg</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Sk&#246;nevik</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Westman</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The physician at a distance: the use of videoconferencing in the treatment of patients with hypertension</article-title>
          <source>J Telemed Telecare</source>
          <year>2009</year>
          <volume>15</volume>
          <issue>8</issue>
          <fpage>397</fpage>
          <lpage>403</lpage>
        </element-citation>
      </ref>
      <ref id="B77">
        <label>77</label>
        <mixed-citation>77 Park MJ, Kim HS, Kim KS. Cellular phone and Internet-based individual intervention on blood pressure and obesity in obese patients with hypertension. Int J Med Inform. 2009;78(10): 704-10</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Park</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>HS</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>KS</given-names>
            </name>
          </person-group>
          <article-title>Cellular phone and Internet-based individual intervention on blood pressure and obesity in obese patients with hypertension</article-title>
          <source>Int J Med Inform</source>
          <year>2009</year>
          <volume>78</volume>
          <issue>10</issue>
          <fpage>704</fpage>
          <lpage>710</lpage>
        </element-citation>
      </ref>
      <ref id="B78">
        <label>78</label>
        <mixed-citation>78 McKinstry B, Hanley J, Wild S, Pagliari C, Paterson M, Lewis S, et al. Telemonitoring based service redesign for the management of uncontrolled hypertension: multicentre randomised controlled trial. BMJ. 2013 May;346: f3030</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McKinstry</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Hanley</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Wild</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Pagliari</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Paterson</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lewis</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Telemonitoring based service redesign for the management of uncontrolled hypertension: multicentre randomised controlled trial</article-title>
          <source>BMJ</source>
          <year>2013</year>
          <month>05</month>
          <volume>346</volume>
          <fpage>f3030</fpage>
          <lpage>f3030</lpage>
        </element-citation>
      </ref>
      <ref id="B79">
        <label>79</label>
        <mixed-citation>79 Ralston JD, Hirsch IB, Hoath J, Mullen M, Cheadle A, Goldberg HI. Web-based collaborative care for type 2 diabetes: a pilot randomized trial. Diabetes Care. 2009;32(2): 234-9</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ralston</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Hirsch</surname>
              <given-names>IB</given-names>
            </name>
            <name>
              <surname>Hoath</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Mullen</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Cheadle</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Goldberg</surname>
              <given-names>HI</given-names>
            </name>
          </person-group>
          <article-title>Web-based collaborative care for type 2 diabetes: a pilot randomized trial</article-title>
          <source>Diabetes Care</source>
          <year>2009</year>
          <volume>32</volume>
          <issue>2</issue>
          <fpage>234</fpage>
          <lpage>239</lpage>
        </element-citation>
      </ref>
      <ref id="B80">
        <label>80</label>
        <mixed-citation>80 Charpentier G, Benhamou PY, Dardari D, Clergeot A, Franc S, Schaepelynck-Belicar P, et al. The Diabeo software enabling individualized insulin dose adjustments combined with telemedicine support improves HbA1c in poorly controlled type 1 diabetic patients: a 6-month, randomized, open-label, parallel-group, multicenter trial (TeleDiab 1 Study). Diabetes Care. 2011;34(3): 533-9</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Charpentier</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Benhamou</surname>
              <given-names>PY</given-names>
            </name>
            <name>
              <surname>Dardari</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Clergeot</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Franc</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Schaepelynck-Belicar</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The Diabeo software enabling individualized insulin dose adjustments combined with telemedicine support improves HbA1c in poorly controlled type 1 diabetic patients: a 6-month, randomized, open-label, parallel-group, multicenter trial (TeleDiab 1 Study)</article-title>
          <source>Diabetes Care</source>
          <year>2011</year>
          <volume>34</volume>
          <issue>3</issue>
          <fpage>533</fpage>
          <lpage>539</lpage>
        </element-citation>
      </ref>
      <ref id="B81">
        <label>81</label>
        <mixed-citation>81 Marcolino MS, Maia JX, Alkmim MB, Boersma E, Ribeiro AL. Telemedicine application in the care of diabetes patients: systematic review and meta-analysis. PLoS One. 2013;8(11): e79246</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Marcolino</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Maia</surname>
              <given-names>JX</given-names>
            </name>
            <name>
              <surname>Alkmim</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>Boersma</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Ribeiro</surname>
              <given-names>AL</given-names>
            </name>
          </person-group>
          <article-title>Telemedicine application in the care of diabetes patients: systematic review and meta-analysis</article-title>
          <source>PLoS One</source>
          <year>2013</year>
          <volume>8</volume>
          <issue>11</issue>
          <elocation-id>e79246</elocation-id>
        </element-citation>
      </ref>
      <ref id="B82">
        <label>82</label>
        <mixed-citation>82 Goulis DG, Giaglis GD, Boren SA, Lekka I, Bontis E, Balas EA, et al. Effectiveness of home-centered care through telemedicine applications for overweight and obese patients: a randomized controlled trial. Int J Obes Relat Metab Disord. 2004;28(11): 1391-8</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Goulis</surname>
              <given-names>DG</given-names>
            </name>
            <name>
              <surname>Giaglis</surname>
              <given-names>GD</given-names>
            </name>
            <name>
              <surname>Boren</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Lekka</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Bontis</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Balas</surname>
              <given-names>EA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Effectiveness of home-centered care through telemedicine applications for overweight and obese patients: a randomized controlled trial</article-title>
          <source>Int J Obes Relat Metab Disord</source>
          <year>2004</year>
          <volume>28</volume>
          <issue>11</issue>
          <fpage>1391</fpage>
          <lpage>1398</lpage>
        </element-citation>
      </ref>
      <ref id="B83">
        <label>83</label>
        <mixed-citation>83 Rodr&#237;guez-Id&#237;goras MI, Sep&#250;lveda-Mu&#241;oz J, S&#225;nchez-Garrido-Escudero R, Mart&#237;nez-Gonz&#225;lez JL, Escolar-Castell&#243; JL, Paniagua-G&#243;mez IM, et al. Telemedicine influence on the follow-up of type 2 diabetes patients. Diabetes Technol Ther. 2009;11(7): 431-7</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rodr&#237;guez-Id&#237;goras</surname>
              <given-names>MI</given-names>
            </name>
            <name>
              <surname>Sep&#250;lveda-Mu&#241;oz</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>S&#225;nchez-Garrido-Escudero</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Mart&#237;nez-Gonz&#225;lez</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Escolar-Castell&#243;</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Paniagua-G&#243;mez</surname>
              <given-names>IM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Telemedicine influence on the follow-up of type 2 diabetes patients</article-title>
          <source>Diabetes Technol Ther</source>
          <year>2009</year>
          <volume>11</volume>
          <issue>7</issue>
          <fpage>431</fpage>
          <lpage>437</lpage>
        </element-citation>
      </ref>
      <ref id="B84">
        <label>84</label>
        <mixed-citation>84 Appel LJ, Clark JM, Yeh HC, Wang NY, Coughlin JW, Daumit G, et al. Comparative effectiveness of weight-loss interventions in clinical practice. N Engl J Med. 2011;365(21): 1959-68</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Appel</surname>
              <given-names>LJ</given-names>
            </name>
            <name>
              <surname>Clark</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Yeh</surname>
              <given-names>HC</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>NY</given-names>
            </name>
            <name>
              <surname>Coughlin</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Daumit</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Comparative effectiveness of weight-loss interventions in clinical practice</article-title>
          <source>N Engl J Med</source>
          <year>2011</year>
          <volume>365</volume>
          <issue>21</issue>
          <fpage>1959</fpage>
          <lpage>1968</lpage>
        </element-citation>
      </ref>
      <ref id="B85">
        <label>85</label>
        <mixed-citation>85 Mu&#241;iz J, G&#243;mez-Doblas JJ, Santiago-P&#233;rez MI, Lekuona-Goya I, Murga-Eizagaetxebarr&#237;a N, de Teresa-Galv&#225;n SS E, et al. The effect of post-discharge educational intervention on patients in achieving objectives in modifiable risk factors six months after discharge following an episode of acute coronary syndrome, (CAM-2 Project): a randomized controlled trial. Health Qual Life Outcomes. 2010 Nov;8: 137</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mu&#241;iz</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>G&#243;mez-Doblas</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Santiago-P&#233;rez</surname>
              <given-names>MI</given-names>
            </name>
            <name>
              <surname>Lekuona-Goya</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Murga-Eizagaetxebarr&#237;a</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>de Teresa-Galv&#225;n SS</surname>
              <given-names>E</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The effect of post-discharge educational intervention on patients in achieving objectives in modifiable risk factors six months after discharge following an episode of acute coronary syndrome, (CAM-2 Project): a randomized controlled trial</article-title>
          <source>Health Qual Life Outcomes</source>
          <year>2010</year>
          <month>11</month>
          <volume>8</volume>
          <fpage>137</fpage>
          <lpage>137</lpage>
        </element-citation>
      </ref>
      <ref id="B86">
        <label>86</label>
        <mixed-citation>86 Gusm&#227;o LL, Ribeiro AL, Souza-Silva MVR, Gomes PR, Beleigoli AM, Cardoso CS, et al. Implementation of a text message intervention to promote behavioural change and weight loss among overweight and obese Brazilian primary care patients. J Telemed Telecare. 2018 Jan: 1357633X18782092</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gusm&#227;o</surname>
              <given-names>LL</given-names>
            </name>
            <name>
              <surname>Ribeiro</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Souza-Silva</surname>
              <given-names>MVR</given-names>
            </name>
            <name>
              <surname>Gomes</surname>
              <given-names>PR</given-names>
            </name>
            <name>
              <surname>Beleigoli</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Cardoso</surname>
              <given-names>CS</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Implementation of a text message intervention to promote behavioural change and weight loss among overweight and obese Brazilian primary care patients</article-title>
          <source>J Telemed Telecare</source>
          <year>2018</year>
          <month>01</month>
          <comment>1357633X18782092</comment>
        </element-citation>
      </ref>
      <ref id="B87">
        <label>87</label>
        <mixed-citation>87 Marcolino MS, Oliveira JA, D&#8217;Agostino M, Ribeiro AL, Alkmim MBM, Novillo-Ortiz D. The Impact of mHealth Interventions: Systematic Review of Systematic Reviews. JMIR Mhealth Uhealth. 2018;6(1): e23</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Marcolino</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Oliveira</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>D&#8217;Agostino</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ribeiro</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Alkmim</surname>
              <given-names>MBM</given-names>
            </name>
            <name>
              <surname>Novillo-Ortiz</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>The Impact of mHealth Interventions: Systematic Review of Systematic Reviews</article-title>
          <source>JMIR Mhealth Uhealth</source>
          <year>2018</year>
          <volume>6</volume>
          <issue>1</issue>
          <elocation-id>e23</elocation-id>
        </element-citation>
      </ref>
      <ref id="B88">
        <label>88</label>
        <mixed-citation>88 Chow CK, Redfern J, Hillis GS, Thakkar J, Santo K, Hackett ML, et al. Effect of Lifestyle-Focused Text Messaging on Risk Factor Modification in Patients With Coronary Heart Disease: A Randomized Clinical Trial. JAMA. 2015;314(12): 1255-63</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chow</surname>
              <given-names>CK</given-names>
            </name>
            <name>
              <surname>Redfern</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Hillis</surname>
              <given-names>GS</given-names>
            </name>
            <name>
              <surname>Thakkar</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Santo</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Hackett</surname>
              <given-names>ML</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Effect of Lifestyle-Focused Text Messaging on Risk Factor Modification in Patients With Coronary Heart Disease: A Randomized Clinical Trial</article-title>
          <source>JAMA</source>
          <year>2015</year>
          <volume>314</volume>
          <issue>12</issue>
          <fpage>1255</fpage>
          <lpage>1263</lpage>
        </element-citation>
      </ref>
      <ref id="B89">
        <label>89</label>
        <mixed-citation>89 Thangada ND, Garg N, Pandey A, Kumar N. The Emerging Role of Mobile-Health Applications in the Management of Hypertension. Curr Cardiol Rep. 2018;20(9): 78</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Thangada</surname>
              <given-names>ND</given-names>
            </name>
            <name>
              <surname>Garg</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Pandey</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kumar</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>The Emerging Role of Mobile-Health Applications in the Management of Hypertension</article-title>
          <source>Curr Cardiol Rep</source>
          <year>2018</year>
          <volume>20</volume>
          <issue>9</issue>
          <fpage>78</fpage>
          <lpage>78</lpage>
        </element-citation>
      </ref>
      <ref id="B90">
        <label>90</label>
        <mixed-citation>90 McConnell MV, Turakhia MP, Harrington RA, King AC, Ashley EA. Mobile Health Advances in Physical Activity, Fitness, and Atrial Fibrillation: Moving Hearts. J Am Coll Cardiol 2018;71(23): 2691-701</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McConnell</surname>
              <given-names>MV</given-names>
            </name>
            <name>
              <surname>Turakhia</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Harrington</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>King</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Ashley</surname>
              <given-names>EA</given-names>
            </name>
          </person-group>
          <article-title>Mobile Health Advances in Physical Activity, Fitness, and Atrial Fibrillation: Moving Hearts</article-title>
          <source>J Am Coll Cardiol</source>
          <year>2018</year>
          <volume>71</volume>
          <issue>23</issue>
          <fpage>2691</fpage>
          <lpage>2701</lpage>
        </element-citation>
      </ref>
      <ref id="B91">
        <label>91</label>
        <mixed-citation>91 Kumari P, Mathew L, Syal P. Increasing trend of wearables and multimodal interface for human activity monitoring: A review. Biosens Bioelectron. 2017 Apr;90: 298-307</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kumari</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Mathew</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Syal</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Increasing trend of wearables and multimodal interface for human activity monitoring: A review</article-title>
          <source>Biosens Bioelectron</source>
          <year>2017</year>
          <month>04</month>
          <volume>90</volume>
          <fpage>298</fpage>
          <lpage>307</lpage>
        </element-citation>
      </ref>
      <ref id="B92">
        <label>92</label>
        <mixed-citation>92 Riffenburg KM, Spartano NL. Physical activity and weight maintenance: the utility of wearable devices and mobile health technology in research and clinical settings. Curr Opin Endocrinol Diabetes Obes. 2018;25(5): 310-4</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Riffenburg</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Spartano</surname>
              <given-names>NL</given-names>
            </name>
          </person-group>
          <article-title>Physical activity and weight maintenance: the utility of wearable devices and mobile health technology in research and clinical settings</article-title>
          <source>Curr Opin Endocrinol Diabetes Obes</source>
          <year>2018</year>
          <volume>25</volume>
          <issue>5</issue>
          <fpage>310</fpage>
          <lpage>314</lpage>
        </element-citation>
      </ref>
      <ref id="B93">
        <label>93</label>
        <mixed-citation>93 Hopkins DP, Community Preventive Services Task F. Clinical Decision Support Systems Recommended to Prevent Cardiovascular Disease. Am J Prev Med. 2015;49(5): 796-9</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hopkins</surname>
              <given-names>DP</given-names>
            </name>
            <collab>Community Preventive Services Task F</collab>
          </person-group>
          <article-title>Clinical Decision Support Systems Recommended to Prevent Cardiovascular Disease</article-title>
          <source>Am J Prev Med</source>
          <year>2015</year>
          <volume>49</volume>
          <issue>5</issue>
          <fpage>796</fpage>
          <lpage>799</lpage>
        </element-citation>
      </ref>
      <ref id="B94">
        <label>94</label>
        <mixed-citation>94 Njie GJ, Proia KK, Thota AB, Finnie RK, Hopkins DP, Banks SM, Callahan DB, et al. Clinical Decision Support Systems and Prevention: A Community Guide Cardiovascular Disease Systematic Review. Am J Prev Med. 2015;49(5): 784-95</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Njie</surname>
              <given-names>GJ</given-names>
            </name>
            <name>
              <surname>Proia</surname>
              <given-names>KK</given-names>
            </name>
            <name>
              <surname>Thota</surname>
              <given-names>AB</given-names>
            </name>
            <name>
              <surname>Finnie</surname>
              <given-names>RK</given-names>
            </name>
            <name>
              <surname>Hopkins</surname>
              <given-names>DP</given-names>
            </name>
            <name>
              <surname>Banks</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Callahan</surname>
              <given-names>DB</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Clinical Decision Support Systems and Prevention: A Community Guide Cardiovascular Disease Systematic Review</article-title>
          <source>Am J Prev Med</source>
          <year>2015</year>
          <volume>49</volume>
          <issue>5</issue>
          <fpage>784</fpage>
          <lpage>795</lpage>
        </element-citation>
      </ref>
      <ref id="B95">
        <label>95</label>
        <mixed-citation>95 Roumie CL, Elasy TA, Greevy R, Griffin MR, Liu X, Stone WJ, et al. Improving blood pressure control through provider education, provider alerts, and patient education: a cluster randomized trial. Ann Intern Med. 2006;145(3): 165-75</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Roumie</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Elasy</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Greevy</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Griffin</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Stone</surname>
              <given-names>WJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Improving blood pressure control through provider education, provider alerts, and patient education: a cluster randomized trial</article-title>
          <source>Ann Intern Med</source>
          <year>2006</year>
          <volume>145</volume>
          <issue>3</issue>
          <fpage>165</fpage>
          <lpage>175</lpage>
        </element-citation>
      </ref>
      <ref id="B96">
        <label>96</label>
        <mixed-citation>96 Maia JX, de Sousa LA, Marcolino MS, Cardoso CS, da Silva JL, Alkmim MB, et al. The Impact of a Clinical Decision Support System in Diabetes Primary Care Patients in a Developing Country. Diabetes Technol Ther. 2016;18(4): 258-63</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Maia</surname>
              <given-names>JX</given-names>
            </name>
            <name>
              <surname>de Sousa</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Marcolino</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Cardoso</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>da Silva</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Alkmim</surname>
              <given-names>MB</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The Impact of a Clinical Decision Support System in Diabetes Primary Care Patients in a Developing Country</article-title>
          <source>Diabetes Technol Ther</source>
          <year>2016</year>
          <volume>18</volume>
          <issue>4</issue>
          <fpage>258</fpage>
          <lpage>263</lpage>
        </element-citation>
      </ref>
      <ref id="B97">
        <label>97</label>
        <mixed-citation>97 Silveira DV, Marcolino MS, Machado EL, Ferreira CG, Alkmim MBM, Resende ES, et al. Development and Evaluation of a Mobile Decision Support System for Hypertension Management in the Primary Care Setting in Brazil: Mixed-Methods Field Study on Usability, Feasibility, and Utility. JMIR Mhealth Uhealth. 2019;7(3): e9869</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Silveira</surname>
              <given-names>DV</given-names>
            </name>
            <name>
              <surname>Marcolino</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Machado</surname>
              <given-names>EL</given-names>
            </name>
            <name>
              <surname>Ferreira</surname>
              <given-names>CG</given-names>
            </name>
            <name>
              <surname>Alkmim</surname>
              <given-names>MBM</given-names>
            </name>
            <name>
              <surname>Resende</surname>
              <given-names>ES</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Development and Evaluation of a Mobile Decision Support System for Hypertension Management in the Primary Care Setting in Brazil: Mixed-Methods Field Study on Usability, Feasibility, and Utility</article-title>
          <source>JMIR Mhealth Uhealth</source>
          <year>2019</year>
          <volume>7</volume>
          <issue>3</issue>
          <elocation-id>e9869</elocation-id>
        </element-citation>
      </ref>
      <ref id="B98">
        <label>98</label>
        <mixed-citation>98 Lobach D, Sanders GD, Bright TJ, Wong A, Dhurjati R, Bristow E, et al. Enabling health care decisionmaking through clinical decision support and knowledge management. Evid Rep Technol Assess (Full Rep). 2012 Apr;203: 1-784</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lobach</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Sanders</surname>
              <given-names>GD</given-names>
            </name>
            <name>
              <surname>Bright</surname>
              <given-names>TJ</given-names>
            </name>
            <name>
              <surname>Wong</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Dhurjati</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Bristow</surname>
              <given-names>E</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Enabling health care decisionmaking through clinical decision support and knowledge management</article-title>
          <source>Evid Rep Technol Assess (Full Rep)</source>
          <year>2012</year>
          <month>04</month>
          <volume>203</volume>
          <fpage>1</fpage>
          <lpage>784</lpage>
        </element-citation>
      </ref>
      <ref id="B99">
        <label>99</label>
        <mixed-citation>99 Alkmim MB, Marcolino MS, Figueira RM, Sousa L, Nunes MS, Cardoso CS, et al. Factors associated with the use of a teleconsultation system in Brazilianprimary care. Telemed J E Health. 2015;21(6): 473-83</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alkmim</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>Marcolino</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Figueira</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Sousa</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Nunes</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Cardoso</surname>
              <given-names>CS</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Factors associated with the use of a teleconsultation system in Brazilianprimary care</article-title>
          <source>Telemed J E Health</source>
          <year>2015</year>
          <volume>21</volume>
          <issue>6</issue>
          <fpage>473</fpage>
          <lpage>483</lpage>
        </element-citation>
      </ref>
      <ref id="B100">
        <label>100</label>
        <mixed-citation>100 Liddy C, Moroz I, Mihan A, Nawar N, Keely E. A Systematic Review of Asynchronous, Provider-to-Provider, Electronic Consultation Services to Improve Access to Specialty Care Available Worldwide. Telemed J E Health. 2019;25(3): 184-98</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liddy</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Moroz</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Mihan</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Nawar</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Keely</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>A Systematic Review of Asynchronous, Provider-to-Provider, Electronic Consultation Services to Improve Access to Specialty Care Available Worldwide</article-title>
          <source>Telemed J E Health</source>
          <year>2019</year>
          <volume>25</volume>
          <issue>3</issue>
          <fpage>184</fpage>
          <lpage>198</lpage>
        </element-citation>
      </ref>
      <ref id="B101">
        <label>101</label>
        <mixed-citation>101 Olayiwola JN, Anderson D, Jepeal N, Aseltine R, Pickett C, Yan J, et al. Electronic Consultations to Improve the Primary Care-Specialty Care Interface for Cardiology in the Medically Underserved: A Cluster-Randomized Controlled Trial. Ann Fam Med. 2016;14(2): 133-40</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Olayiwola</surname>
              <given-names>JN</given-names>
            </name>
            <name>
              <surname>Anderson</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Jepeal</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Aseltine</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Pickett</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Yan</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Electronic Consultations to Improve the Primary Care-Specialty Care Interface for Cardiology in the Medically Underserved: A Cluster-Randomized Controlled Trial</article-title>
          <source>Ann Fam Med</source>
          <year>2016</year>
          <volume>14</volume>
          <issue>2</issue>
          <fpage>133</fpage>
          <lpage>140</lpage>
        </element-citation>
      </ref>
      <ref id="B102">
        <label>102</label>
        <mixed-citation>102 Caffery LJ, Farjian M, Smith AC. Telehealth interventions for reducing waiting lists and waiting times for specialist outpatient services: A scoping review. J Telemed Telecare. 2016;22(8): 504-12</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Caffery</surname>
              <given-names>LJ</given-names>
            </name>
            <name>
              <surname>Farjian</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>AC</given-names>
            </name>
          </person-group>
          <article-title>Telehealth interventions for reducing waiting lists and waiting times for specialist outpatient services: A scoping review</article-title>
          <source>J Telemed Telecare</source>
          <year>2016</year>
          <volume>22</volume>
          <issue>8</issue>
          <fpage>504</fpage>
          <lpage>512</lpage>
        </element-citation>
      </ref>
      <ref id="B103">
        <label>103</label>
        <mixed-citation>103 Maeyama MA, Calvo MC. A Integra&#231;&#227;o do telessa&#250;de nas centrais de regula&#231;&#227;o: a teleconsultoria como mediadora entre a aten&#231;&#227;o b&#225;sica e a aten&#231;&#227;o especializada. Rev Bras Educ Med. 2018;42(3): 63-72</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Maeyama</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Calvo</surname>
              <given-names>MC</given-names>
            </name>
          </person-group>
          <article-title>A Integra&#231;&#227;o do telessa&#250;de nas centrais de regula&#231;&#227;o: a teleconsultoria como mediadora entre a aten&#231;&#227;o b&#225;sica e a aten&#231;&#227;o especializada</article-title>
          <source>Rev Bras Educ Med</source>
          <year>2018</year>
          <volume>42</volume>
          <issue>3</issue>
          <fpage>63</fpage>
          <lpage>72</lpage>
        </element-citation>
      </ref>
      <ref id="B104">
        <label>104</label>
        <mixed-citation>104 Pfeil JN. Avalia&#231;&#227;o da regula&#231;&#227;o de consultas m&#233;dicas especializadas baseada em protocolo + teleconsultoria. [Disserta&#231;&#227;o]. Porto Alegre: Universidade Federal do Rio Grande do Sul; 2018.</mixed-citation>
        <element-citation publication-type="thesis">
          <person-group person-group-type="author">
            <name>
              <surname>Pfeil</surname>
              <given-names>JN</given-names>
            </name>
          </person-group>
          <source>Avalia&#231;&#227;o da regula&#231;&#227;o de consultas m&#233;dicas especializadas baseada em protocolo + teleconsultoria</source>
          <year>2018</year>
          <publisher-loc>Porto Alegre</publisher-loc>
          <publisher-name>Universidade Federal do Rio Grande do Sul</publisher-name>
        </element-citation>
      </ref>
      <ref id="B105">
        <label>105</label>
        <mixed-citation>105 Ribeiro AL, Alkmim MB, Cardoso CS, Carvalho GG, Caiaffa WT, Andrade MV, et al. Implementation of a telecardiology system in the state of Minas Gerais: the Minas Telecardio Project. Arq Bras Cardiol. 2010;95(1): 70-8</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ribeiro</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Alkmim</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>Cardoso</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Carvalho</surname>
              <given-names>GG</given-names>
            </name>
            <name>
              <surname>Caiaffa</surname>
              <given-names>WT</given-names>
            </name>
            <name>
              <surname>Andrade</surname>
              <given-names>MV</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Implementation of a telecardiology system in the state of Minas Gerais: the Minas Telecardio Project</article-title>
          <source>Arq Bras Cardiol</source>
          <year>2010</year>
          <volume>95</volume>
          <issue>1</issue>
          <fpage>70</fpage>
          <lpage>78</lpage>
        </element-citation>
      </ref>
      <ref id="B106">
        <label>106</label>
        <mixed-citation>106 Sparenberg AL, Russomano T, de Azevedo DF. Transmission of digital electrocardiogram (ECG) via modem connection in southern Brazil. Conf Proc IEEE. Eng Med Biol Soc. 2004 Mar;5: 3396-9</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sparenberg</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Russomano</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>de Azevedo</surname>
              <given-names>DF</given-names>
            </name>
          </person-group>
          <article-title>Transmission of digital electrocardiogram (ECG) via modem connection in southern Brazil: Conf Proc IEEE</article-title>
          <source>Eng Med Biol Soc</source>
          <year>2004</year>
          <month>03</month>
          <volume>5</volume>
          <fpage>3396</fpage>
          <lpage>3399</lpage>
        </element-citation>
      </ref>
      <ref id="B107">
        <label>107</label>
        <mixed-citation>107 Figueira RM, Alkmim MB, Vasconcelos-Santos DV, Marcolino MS, Pelico M, Silva LB, Ribeiro ALP. Oferta Nacional de Telediagn&#243;stico em Eletrocardiografia: relato de experi&#234;ncia do N&#250;cleo de Telessa&#250;de Minas Gerais, Hospital das Cl&#237;nicas/UFMG In: Global Summit Telemedicine &amp; Digital Health, S&#227;o Paulo, 3-6 de abril de 2019 [apresenta&#231;&#227;o oral].</mixed-citation>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Figueira</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Alkmim</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>Vasconcelos-Santos</surname>
              <given-names>DV</given-names>
            </name>
            <name>
              <surname>Marcolino</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Pelico</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Silva</surname>
              <given-names>LB</given-names>
            </name>
            <name>
              <surname>Ribeiro</surname>
              <given-names>ALP</given-names>
            </name>
          </person-group>
          <chapter-title>Oferta Nacional de Telediagn&#243;stico em Eletrocardiografia: relato de experi&#234;ncia do N&#250;cleo de Telessa&#250;de Minas Gerais, Hospital das Cl&#237;nicas/UFMG</chapter-title>
          <source>lobal Summit Telemedicine &amp; Digital Health</source>
          <publisher-loc>S&#227;o Paulo</publisher-loc>
          <day>06</day>
          <season>3-6de</season>
          <year>2019</year>
          <comment>apresenta&#231;&#227;o oral</comment>
        </element-citation>
      </ref>
      <ref id="B108">
        <label>108</label>
        <mixed-citation>108 Anderson KP. Artificial intelligence-augmented ECG assessment: The promise and the challenge. J Cardiovasc Electrophysiol. 2019;30(5): 675-8</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Anderson</surname>
              <given-names>KP</given-names>
            </name>
          </person-group>
          <article-title>Artificial intelligence-augmented ECG assessment: The promise and the challenge</article-title>
          <source>J Cardiovasc Electrophysiol</source>
          <year>2019</year>
          <volume>30</volume>
          <issue>5</issue>
          <fpage>675</fpage>
          <lpage>678</lpage>
        </element-citation>
      </ref>
      <ref id="B109">
        <label>109</label>
        <mixed-citation>109 Singh S, Bansal M, Maheshwari P, Adams D, Sengupta SP, Price R, et al. American Society of Echocardiography: Remote Echocardiography with Web-Based Assessments for Referrals at a Distance (ASE-REWARD) Study. J Am Soc Echocardiogr. 2013;26(3): 221-33</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Singh</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Bansal</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Maheshwari</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Adams</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Sengupta</surname>
              <given-names>SP</given-names>
            </name>
            <name>
              <surname>Price</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>American Society of Echocardiography: Remote Echocardiography with Web-Based Assessments for Referrals at a Distance (ASE-REWARD) Study</article-title>
          <source>J Am Soc Echocardiogr</source>
          <year>2013</year>
          <volume>26</volume>
          <issue>3</issue>
          <fpage>221</fpage>
          <lpage>233</lpage>
        </element-citation>
      </ref>
      <ref id="B110">
        <label>110</label>
        <mixed-citation>110 d&#8217;Arcy JL, Coffey S, Loudon MA, Kennedy A, Pearson-Stuttard J, Birks J, et al. Large-scale community echocardiographic screening reveals a major burden of undiagnosed valvular heart disease in older people: the OxVALVE Population Cohort Study. Eur Heart J. 2016;37(47): 3515-22</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>d&#8217;Arcy</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Coffey</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Loudon</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Kennedy</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Pearson-Stuttard</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Birks</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Large-scale community echocardiographic screening reveals a major burden of undiagnosed valvular heart disease in older people: the OxVALVE Population Cohort Study</article-title>
          <source>Eur Heart J</source>
          <year>2016</year>
          <volume>37</volume>
          <issue>47</issue>
          <fpage>3515</fpage>
          <lpage>3522</lpage>
        </element-citation>
      </ref>
      <ref id="B111">
        <label>111</label>
        <mixed-citation>111 Lopes EL, Beaton AZ, Nascimento BR, Tompsett A, Dos Santos JP, Perlman L, et al. Telehealth solutions to enable global collaboration in rheumatic heart disease screening. J Telemed Telecare. 2018;24(2): 101-9</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lopes</surname>
              <given-names>EL</given-names>
            </name>
            <name>
              <surname>Beaton</surname>
              <given-names>AZ</given-names>
            </name>
            <name>
              <surname>Nascimento</surname>
              <given-names>BR</given-names>
            </name>
            <name>
              <surname>Tompsett</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Dos Santos</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Perlman</surname>
              <given-names>L</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Telehealth solutions to enable global collaboration in rheumatic heart disease screening</article-title>
          <source>J Telemed Telecare</source>
          <year>2018</year>
          <volume>24</volume>
          <issue>2</issue>
          <fpage>101</fpage>
          <lpage>109</lpage>
        </element-citation>
      </ref>
      <ref id="B112">
        <label>112</label>
        <mixed-citation>112 Nascimento BR, Sable C, Nunes MC, Diamantino AC, Oliveira KK, Oliveira CM, et al. Comparison Between Different Strategies of Rheumatic Heart Disease Echocardiographic Screening in Brazil: Data From the PROVAR (Rheumatic Valve Disease Screening Program) Study. J Am Heart Assoc. 2018;7(4). pii: e008039</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nascimento</surname>
              <given-names>BR</given-names>
            </name>
            <name>
              <surname>Sable</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Nunes</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Diamantino</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Oliveira</surname>
              <given-names>KK</given-names>
            </name>
            <name>
              <surname>Oliveira</surname>
              <given-names>CM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Comparison Between Different Strategies of Rheumatic Heart Disease Echocardiographic Screening in Brazil: Data From the PROVAR (Rheumatic Valve Disease Screening Program) Study</article-title>
          <source>J Am Heart Assoc</source>
          <year>2018</year>
          <volume>7</volume>
          <issue>4</issue>
          <pub-id pub-id-type="pii">e008039</pub-id>
        </element-citation>
      </ref>
      <ref id="B113">
        <label>113</label>
        <mixed-citation>113 Nascimento BR, Beaton AZ, Nunes MC, Diamantino AC, Carmo GA, Oliveira KK, et al. Echocardiographic prevalence of rheumaticheart disease in Brazilian schoolchildren: Data from the PROVAR study. Int JCardiol. 2016 Sep;219: 439-45</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nascimento</surname>
              <given-names>BR</given-names>
            </name>
            <name>
              <surname>Beaton</surname>
              <given-names>AZ</given-names>
            </name>
            <name>
              <surname>Nunes</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Diamantino</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Carmo</surname>
              <given-names>GA</given-names>
            </name>
            <name>
              <surname>Oliveira</surname>
              <given-names>KK</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Echocardiographic prevalence of rheumaticheart disease in Brazilian schoolchildren: Data from the PROVAR study</article-title>
          <source>Int JCardiol</source>
          <year>2016</year>
          <month>09</month>
          <volume>219</volume>
          <fpage>439</fpage>
          <lpage>445</lpage>
        </element-citation>
      </ref>
      <ref id="B114">
        <label>114</label>
        <mixed-citation>114 Diamantino AC, Nunes MC, Sable C, Nascimento BR, Lima EM, Martins LN, et al. Use of screening echocardiography to improve healthcare in underserved areas of brazil: Data from the provar + Study. Circulation. 2018;138(1): A16989</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Diamantino</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Nunes</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Sable</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Nascimento</surname>
              <given-names>BR</given-names>
            </name>
            <name>
              <surname>Lima</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Martins</surname>
              <given-names>LN</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Use of screening echocardiography to improve healthcare in underserved areas of brazil: Data from the provar + Study</article-title>
          <source>Circulation</source>
          <year>2018</year>
          <volume>138</volume>
          <issue>1</issue>
          <fpage>A16989</fpage>
          <lpage>A16989</lpage>
        </element-citation>
      </ref>
      <ref id="B115">
        <label>115</label>
        <mixed-citation>115 Gensini GF, Alderighi C, Rasoini R, Mazzanti M, Casolo G. Value of Telemonitoring and Telemedicine in Heart Failure Management. Card Fail Rev. 2017;3(2): 116-21</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gensini</surname>
              <given-names>GF</given-names>
            </name>
            <name>
              <surname>Alderighi</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Rasoini</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Mazzanti</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Casolo</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Value of Telemonitoring and Telemedicine in Heart Failure Management</article-title>
          <source>Card Fail Rev</source>
          <year>2017</year>
          <volume>3</volume>
          <issue>2</issue>
          <fpage>116</fpage>
          <lpage>121</lpage>
        </element-citation>
      </ref>
      <ref id="B116">
        <label>116</label>
        <mixed-citation>116 Bashi N, Karunanithi M, Fatehi F, Ding H, Walters D. Remote Monitoring of Patients With Heart Failure: An Overview of Systematic Reviews.J Med Internet Res 2017;19(1): e18</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bashi</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Karunanithi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Fatehi</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Ding</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Walters</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Remote Monitoring of Patients With Heart Failure: An Overview of Systematic Reviews</article-title>
          <source>J Med Internet Res</source>
          <year>2017</year>
          <volume>19</volume>
          <issue>1</issue>
          <elocation-id>e18</elocation-id>
        </element-citation>
      </ref>
      <ref id="B117">
        <label>117</label>
        <mixed-citation>117 Ji Eun Yun, Jeong-Eun Park, Hyun-Young Park, Hae-Young Lee, Dong-Ah Park.Comparative Effectiveness of Telemonitoring Versus Usual Care for Heart Failure: A Systematic Review and Meta-analysis. J Card Fail. 2018;24(1): 19-28</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yun</surname>
              <given-names>Ji Eun</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>Jeong-Eun</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>Hyun-Young</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>Hae-Young</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>Dong-Ah</given-names>
            </name>
          </person-group>
          <article-title>Comparative Effectiveness of Telemonitoring Versus Usual Care for Heart Failure: A Systematic Review and Meta-analysis</article-title>
          <source>J Card Fail</source>
          <year>2018</year>
          <volume>24</volume>
          <issue>1</issue>
          <fpage>19</fpage>
          <lpage>28</lpage>
        </element-citation>
      </ref>
      <ref id="B118">
        <label>118</label>
        <mixed-citation>118 Fraiche AM, Eapen ZJ, McClellan MB. Moving Beyond the Walls of the Clinic: Opportunities and Challenges to the Future of Telehealth in Heart Failure. JACC Heart Fail. 2017;5(4): 297-304</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fraiche</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Eapen</surname>
              <given-names>ZJ</given-names>
            </name>
            <name>
              <surname>McClellan</surname>
              <given-names>MB</given-names>
            </name>
          </person-group>
          <article-title>Moving Beyond the Walls of the Clinic: Opportunities and Challenges to the Future of Telehealth in Heart Failure</article-title>
          <source>JACC Heart Fail</source>
          <year>2017</year>
          <volume>5</volume>
          <issue>4</issue>
          <fpage>297</fpage>
          <lpage>304</lpage>
        </element-citation>
      </ref>
      <ref id="B119">
        <label>119</label>
        <mixed-citation>119 Inglis SC, Clark RA, Dierckx R, Prieto-Merino D, Cleland JG. Structured telephone support or non-invasive telemonitoring for patients with heart failure. Cochrane Database Syst Rev. 2015;(10): CD007228</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Inglis</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Clark</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Dierckx</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Prieto-Merino</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Cleland</surname>
              <given-names>JG</given-names>
            </name>
          </person-group>
          <article-title>Structured telephone support or non-invasive telemonitoring for patients with heart failure</article-title>
          <source>Cochrane Database Syst Rev</source>
          <year>2015</year>
          <issue>10</issue>
          <fpage>CD007228</fpage>
          <lpage>CD007228</lpage>
        </element-citation>
      </ref>
      <ref id="B120">
        <label>120</label>
        <mixed-citation>120 Pekmezaris R, Tortez L, Williams M, Patel V, Makaryus A, Zeltser R, et al. Home Telemonitoring In Heart Failure: A Systematic Review And Meta-Analysis. Health Affairs (Millwood). 2018;37(12): 1983-9.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pekmezaris</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Tortez</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Williams</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Patel</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Makaryus</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Zeltser</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Home Telemonitoring In Heart Failure: A Systematic Review And Meta-Analysis</article-title>
          <source>Health Affairs (Millwood)</source>
          <year>2018</year>
          <volume>37</volume>
          <issue>12</issue>
          <fpage>1983</fpage>
          <lpage>1989</lpage>
        </element-citation>
      </ref>
      <ref id="B121">
        <label>121</label>
        <mixed-citation>121 Brasil. Minist&#233;rio da Sa&#250;de. Protocolos cl&#237;nicos e diretrizes terap&#234;uticas sobre insufici&#234;ncia card&#237;aca. Internet. [Acesso em 15 maio 2019]. Dispon&#237;vel em: <ext-link ext-link-type="uri" xlink:href="http://conitec.gov.br/images/Protocolos/Diretrizes/Relatrio_diretrizes_brasileiras_ICC.pdf">http://conitec.gov.br/images/Protocolos/Diretrizes/Relatrio_diretrizes_brasileiras_ICC.pdf</ext-link>
				</mixed-citation>
        <element-citation publication-type="webpage">
          <person-group person-group-type="author">
            <collab>Brasil</collab>
            <collab>Minist&#233;rio da Sa&#250;de</collab>
          </person-group>
          <source>Protocolos cl&#237;nicos e diretrizes terap&#234;uticas sobre insufici&#234;ncia card&#237;aca</source>
          <comment>Internet</comment>
          <date-in-citation content-type="access-date">15 maio 2019</date-in-citation>
          <comment>Dispon&#237;vel em: <ext-link ext-link-type="uri" xlink:href="http://conitec.gov.br/images/Protocolos/Diretrizes/Relatrio_diretrizes_brasileiras_ICC.pdf">http://conitec.gov.br/images/Protocolos/Diretrizes/Relatrio_diretrizes_brasileiras_ICC.pdf</ext-link>
					</comment>
        </element-citation>
      </ref>
      <ref id="B122">
        <label>122</label>
        <mixed-citation>122 Mortazavi BJ, Downing NS, Bucholz EM, Dharmarajan K, Manhapra A, Li SX, et al. Analysis of Machine Learning Techniques for Heart Failure Readmissions. Circ Cardiovasc Qual Outcomes. 2016;9(6): 629-40</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mortazavi</surname>
              <given-names>BJ</given-names>
            </name>
            <name>
              <surname>Downing</surname>
              <given-names>NS</given-names>
            </name>
            <name>
              <surname>Bucholz</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Dharmarajan</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Manhapra</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>SX</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Analysis of Machine Learning Techniques for Heart Failure Readmissions</article-title>
          <source>Circ Cardiovasc Qual Outcomes</source>
          <year>2016</year>
          <volume>9</volume>
          <issue>6</issue>
          <fpage>629</fpage>
          <lpage>640</lpage>
        </element-citation>
      </ref>
      <ref id="B123">
        <label>123</label>
        <mixed-citation>123 Levy WC, Mozaffarian D, Linker DT, Sutradhar SC, Anker SD, Cropp AB, et al. The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation. 2006;113(11): 1424-33</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Levy</surname>
              <given-names>WC</given-names>
            </name>
            <name>
              <surname>Mozaffarian</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Linker</surname>
              <given-names>DT</given-names>
            </name>
            <name>
              <surname>Sutradhar</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Anker</surname>
              <given-names>SD</given-names>
            </name>
            <name>
              <surname>Cropp</surname>
              <given-names>AB</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The Seattle Heart Failure Model: prediction of survival in heart failure</article-title>
          <source>Circulation</source>
          <year>2006</year>
          <volume>113</volume>
          <issue>11</issue>
          <fpage>1424</fpage>
          <lpage>1433</lpage>
        </element-citation>
      </ref>
      <ref id="B124">
        <label>124</label>
        <mixed-citation>124 Koehler F, Koehler K, Deckwart O, Prescher S, Wegscheider K, Kirwan BA, et al. Efficacy of telemedical interventional management in patients with heart failure (TIM-HF2): a randomised, controlled, parallel-group, unmasked trial. Lancet. 2018;392(10152): 1047-57</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Koehler</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Koehler</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Deckwart</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Prescher</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Wegscheider</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kirwan</surname>
              <given-names>BA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Efficacy of telemedical interventional management in patients with heart failure (TIM-HF2): a randomised, controlled, parallel-group, unmasked trial</article-title>
          <source>Lancet</source>
          <year>2018</year>
          <volume>392</volume>
          <issue>10152</issue>
          <fpage>1047</fpage>
          <lpage>1057</lpage>
        </element-citation>
      </ref>
      <ref id="B125">
        <label>125</label>
        <mixed-citation>125 Abraham WT, Adamson PB, Bourge RC, Aaron MF, Costanzo MR, Stevenson LW, et al. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet. 2011;377(9766): 658-66</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Abraham</surname>
              <given-names>WT</given-names>
            </name>
            <name>
              <surname>Adamson</surname>
              <given-names>PB</given-names>
            </name>
            <name>
              <surname>Bourge</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Aaron</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Costanzo</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Stevenson</surname>
              <given-names>LW</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial</article-title>
          <source>Lancet</source>
          <year>2011</year>
          <volume>377</volume>
          <issue>9766</issue>
          <fpage>658</fpage>
          <lpage>666</lpage>
        </element-citation>
      </ref>
      <ref id="B126">
        <label>126</label>
        <mixed-citation>126 Abraham WT, Stevenson LW, Bourge RC, Lindenfeld JA, Bauman JG, Adamson PB. Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial. Lancet. 2016;387(10017): 453-61</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Abraham</surname>
              <given-names>WT</given-names>
            </name>
            <name>
              <surname>Stevenson</surname>
              <given-names>LW</given-names>
            </name>
            <name>
              <surname>Bourge</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Lindenfeld</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Bauman</surname>
              <given-names>JG</given-names>
            </name>
            <name>
              <surname>Adamson</surname>
              <given-names>PB</given-names>
            </name>
          </person-group>
          <article-title>Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial</article-title>
          <source>Lancet</source>
          <year>2016</year>
          <volume>387</volume>
          <issue>10017</issue>
          <fpage>453</fpage>
          <lpage>461</lpage>
        </element-citation>
      </ref>
      <ref id="B127">
        <label>127</label>
        <mixed-citation>127 McManus RJ, Mant J, Franssen M, Nickless A, Schwartz C, Hodgkinson J, et al. Efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (TASMINH4): an unmasked randomized controlled trial. Lancet. 2018; 391(10124): 949-59</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McManus</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Mant</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Franssen</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Nickless</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Schwartz</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Hodgkinson</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (TASMINH4): an unmasked randomized controlled trial</article-title>
          <source>Lancet</source>
          <year>2018</year>
          <volume>391</volume>
          <issue>10124</issue>
          <fpage>949</fpage>
          <lpage>959</lpage>
        </element-citation>
      </ref>
      <ref id="B128">
        <label>128</label>
        <mixed-citation>128 Monahan M, Jowett S, Nickless A, Franssen M, Grant S, Greenfield S, et al. Cost-Effectiveness of Telemonitoring and Self-Monitoring of Blood Pressure for Antihypertensive Titration in Primary Care (TASMINH4). Hypertension. 2019;73(6): 1231-9</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Monahan</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Jowett</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Nickless</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Franssen</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Grant</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Greenfield</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cost-Effectiveness of Telemonitoring and Self-Monitoring of Blood Pressure for Antihypertensive Titration in Primary Care (TASMINH4)</article-title>
          <source>Hypertension</source>
          <year>2019</year>
          <volume>73</volume>
          <issue>6</issue>
          <fpage>1231</fpage>
          <lpage>1239</lpage>
        </element-citation>
      </ref>
      <ref id="B129">
        <label>129</label>
        <mixed-citation>129 Margolis KL, Asche SE, Dehmer SP, Bergdall AR, Green BB, Sperl-Hillen JM, et al. Long-term Outcomes of the Effects of Home Blood Pressure Telemonitoring and Pharmacist Management on Blood Pressure Among Adults With Uncontrolled Hypertension: Follow-up of a Cluster Randomized Clinical Trial. JAMA Netw Open. 2018;1(5): e181617</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Margolis</surname>
              <given-names>KL</given-names>
            </name>
            <name>
              <surname>Asche</surname>
              <given-names>SE</given-names>
            </name>
            <name>
              <surname>Dehmer</surname>
              <given-names>SP</given-names>
            </name>
            <name>
              <surname>Bergdall</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Green</surname>
              <given-names>BB</given-names>
            </name>
            <name>
              <surname>Sperl-Hillen</surname>
              <given-names>JM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Long-term Outcomes of the Effects of Home Blood Pressure Telemonitoring and Pharmacist Management on Blood Pressure Among Adults With Uncontrolled Hypertension: Follow-up of a Cluster Randomized Clinical Trial</article-title>
          <source>JAMA Netw Open</source>
          <year>2018</year>
          <volume>1</volume>
          <issue>5</issue>
          <elocation-id>e181617</elocation-id>
        </element-citation>
      </ref>
      <ref id="B130">
        <label>130</label>
        <mixed-citation>130 Ciemins EL, Arora A, Coombs NC, Holloway B, Mullette EJ, Garland R, et al. Improving Blood Pressure Control Using Smart Technology. Telemed J E Health. 2018;24(3): 222-8</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ciemins</surname>
              <given-names>EL</given-names>
            </name>
            <name>
              <surname>Arora</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Coombs</surname>
              <given-names>NC</given-names>
            </name>
            <name>
              <surname>Holloway</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Mullette</surname>
              <given-names>EJ</given-names>
            </name>
            <name>
              <surname>Garland</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Improving Blood Pressure Control Using Smart Technology</article-title>
          <source>Telemed J E Health</source>
          <year>2018</year>
          <volume>24</volume>
          <issue>3</issue>
          <fpage>222</fpage>
          <lpage>228</lpage>
        </element-citation>
      </ref>
      <ref id="B131">
        <label>131</label>
        <mixed-citation>131 Wald DS, Bestwick JP, Raiman L, Brendell R, Wald NJ. Randomised trial of text messaging on adherence to cardiovascular preventive treatment (INTERACT trial). PLoS One. 2014;9(12): e114268</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wald</surname>
              <given-names>DS</given-names>
            </name>
            <name>
              <surname>Bestwick</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Raiman</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Brendell</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Wald</surname>
              <given-names>NJ</given-names>
            </name>
          </person-group>
          <article-title>Randomised trial of text messaging on adherence to cardiovascular preventive treatment (INTERACT trial)</article-title>
          <source>PLoS One</source>
          <year>2014</year>
          <volume>9</volume>
          <issue>12</issue>
          <elocation-id>e114268</elocation-id>
        </element-citation>
      </ref>
      <ref id="B132">
        <label>132</label>
        <mixed-citation>132 Palmer MJ, Barnard S, Perel P, Free C. Mobile phone-based interventions for improving adherence to medication prescribed for the primary prevention of cardiovascular disease in adults. Cochrane Database of Syst Rev. 2018: 6: CD012675</mixed-citation>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Palmer</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Barnard</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Perel</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Free</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <chapter-title>Mobile phone-based interventions for improving adherence to medication prescribed for the primary prevention of cardiovascular disease in adults</chapter-title>
          <source>Cochrane Database of Syst Rev</source>
          <year>2018</year>
          <volume>6</volume>
          <comment>CD012675</comment>
        </element-citation>
      </ref>
      <ref id="B133">
        <label>133</label>
        <mixed-citation>133 Oliveira Junior MT, Canesin MF, Marcolino MS, Ribeiro AL, Carvalho AC, Reddy S, et al. Telemedicine guideline in Patient Care with Acute Coronary Syndrome and Other heart Diseases. Arq Bras Cardiol. 2015;104( 5 Suppl 1): 1-26</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Oliveira</surname>
              <given-names>MT</given-names>
              <suffix>Junior</suffix>
            </name>
            <name>
              <surname>Canesin</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Marcolino</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Ribeiro</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Carvalho</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Reddy</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Telemedicine guideline in Patient Care with Acute Coronary Syndrome and Other heart Diseases</article-title>
          <source>Arq Bras Cardiol</source>
          <year>2015</year>
          <volume>104</volume>
          <issue>5 Suppl 1</issue>
          <fpage>1</fpage>
          <lpage>26</lpage>
        </element-citation>
      </ref>
      <ref id="B134">
        <label>134</label>
        <mixed-citation>134 DeBusk RF, Miller NH, Raby L. Technical feasibility of an online decision support system for acute coronary syndromes. Circ Cardiovasc Qual Outcomes. 2010;3(6): 694-700</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>DeBusk</surname>
              <given-names>RF</given-names>
            </name>
            <name>
              <surname>Miller</surname>
              <given-names>NH</given-names>
            </name>
            <name>
              <surname>Raby</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Technical feasibility of an online decision support system for acute coronary syndromes</article-title>
          <source>Circ Cardiovasc Qual Outcomes</source>
          <year>2010</year>
          <volume>3</volume>
          <issue>6</issue>
          <fpage>694</fpage>
          <lpage>700</lpage>
        </element-citation>
      </ref>
      <ref id="B135">
        <label>135</label>
        <mixed-citation>135 Nelson BP, Chason K. Use of ultrasound by emergency medical services: a review. Int J Emerg Med. 2008;1(4): 253-9</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nelson</surname>
              <given-names>BP</given-names>
            </name>
            <name>
              <surname>Chason</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Use of ultrasound by emergency medical services: a review</article-title>
          <source>Int J Emerg Med</source>
          <year>2008</year>
          <volume>1</volume>
          <issue>4</issue>
          <fpage>253</fpage>
          <lpage>259</lpage>
        </element-citation>
      </ref>
      <ref id="B136">
        <label>136</label>
        <mixed-citation>136 Wechsler LR, Demaerschalk BM, Schwamm LH, Adeoye OM, Audebert HJ, Fanale CV, et al. Telemedicine Quality and Outcomes in Stroke: A Scientific Statement for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2017;48(1): e3-25</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wechsler</surname>
              <given-names>LR</given-names>
            </name>
            <name>
              <surname>Demaerschalk</surname>
              <given-names>BM</given-names>
            </name>
            <name>
              <surname>Schwamm</surname>
              <given-names>LH</given-names>
            </name>
            <name>
              <surname>Adeoye</surname>
              <given-names>OM</given-names>
            </name>
            <name>
              <surname>Audebert</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Fanale</surname>
              <given-names>CV</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Telemedicine Quality and Outcomes in Stroke: A Scientific Statement for Healthcare Professionals From the American Heart Association/American Stroke Association</article-title>
          <source>Stroke</source>
          <year>2017</year>
          <volume>48</volume>
          <issue>1</issue>
          <fpage>e3</fpage>
          <lpage>25</lpage>
        </element-citation>
      </ref>
      <ref id="B137">
        <label>137</label>
        <mixed-citation>137 Nascimento BR, Brant LC, Marino BC, Passaglia LG, Ribeiro AL. Implementing myocardial infarction systems of care in low/middle-income countries. Heart. 2019;105(1): 20-6</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nascimento</surname>
              <given-names>BR</given-names>
            </name>
            <name>
              <surname>Brant</surname>
              <given-names>LC</given-names>
            </name>
            <name>
              <surname>Marino</surname>
              <given-names>BC</given-names>
            </name>
            <name>
              <surname>Passaglia</surname>
              <given-names>LG</given-names>
            </name>
            <name>
              <surname>Ribeiro</surname>
              <given-names>AL</given-names>
            </name>
          </person-group>
          <article-title>Implementing myocardial infarction systems of care in low/middle-income countries</article-title>
          <source>Heart</source>
          <year>2019</year>
          <volume>105</volume>
          <issue>1</issue>
          <fpage>20</fpage>
          <lpage>26</lpage>
        </element-citation>
      </ref>
      <ref id="B138">
        <label>138</label>
        <mixed-citation>138 Marcolino MS, Maia LM, Oliveira JA, Melo LD, Pereira BL, Andrade-Junior DF, et al, et al. Impact of telemedicine interventions on mortality in patients with acute myocardial infarction: a systematic review and meta-analysis. Heart. 2019 Jun 28. pii: heartjnl-2018-314539. [Epub ahead of print]</mixed-citation>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Marcolino</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Maia</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Oliveira</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Melo</surname>
              <given-names>LD</given-names>
            </name>
            <name>
              <surname>Pereira</surname>
              <given-names>BL</given-names>
            </name>
            <name>
              <surname>Andrade-Junior</surname>
              <given-names>DF</given-names>
            </name>
            <etal/>
          </person-group>
          <chapter-title>Impact of telemedicine interventions on mortality in patients with acute myocardial infarction: a systematic review and meta-analysis</chapter-title>
          <source>Heart</source>
          <day>28</day>
          <month>06</month>
          <year>2019</year>
          <pub-id pub-id-type="pii">heartjnl-2018-314539</pub-id>
          <comment>Epub ahead of print</comment>
        </element-citation>
      </ref>
      <ref id="B139">
        <label>139</label>
        <mixed-citation>139 Farah S, Andr&#233;a BR, Silva RC, Monteiro A. Telecardiology on the Diagnostic Support of Chest Pain in Twenty-Two Emergency Care Units (UPA 24h) in The State of Rio de Janeiro. Int J Cardiovasc Sci. 2019;32(2): 158-62</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Farah</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Andr&#233;a</surname>
              <given-names>BR</given-names>
            </name>
            <name>
              <surname>Silva</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Monteiro</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Telecardiology on the Diagnostic Support of Chest Pain in Twenty-Two Emergency Care Units (UPA 24h) in The State of Rio de Janeiro</article-title>
          <source>Int J Cardiovasc Sci</source>
          <year>2019</year>
          <volume>32</volume>
          <issue>2</issue>
          <fpage>158</fpage>
          <lpage>162</lpage>
        </element-citation>
      </ref>
      <ref id="B140">
        <label>140</label>
        <mixed-citation>140 Marcolino MS, Brant LC, Araujo JG, Nascimento BR, Castro LR, Martins P, et al. Implementation of the myocardial infarction system of care in city of Belo Horizonte, Brazil. Arq Bras Cardiol. 2013;100(4): 307-14</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Marcolino</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Brant</surname>
              <given-names>LC</given-names>
            </name>
            <name>
              <surname>Araujo</surname>
              <given-names>JG</given-names>
            </name>
            <name>
              <surname>Nascimento</surname>
              <given-names>BR</given-names>
            </name>
            <name>
              <surname>Castro</surname>
              <given-names>LR</given-names>
            </name>
            <name>
              <surname>Martins</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Implementation of the myocardial infarction system of care in city of Belo Horizonte, Brazil</article-title>
          <source>Arq Bras Cardiol</source>
          <year>2013</year>
          <volume>100</volume>
          <issue>4</issue>
          <fpage>307</fpage>
          <lpage>314</lpage>
        </element-citation>
      </ref>
      <ref id="B141">
        <label>141</label>
        <mixed-citation>141 Solla DJ, Paiva Filho Ide M, Delisle JE, Braga AA, Moura JB, Moraes Xd Jr, et al. Integrated regional networks for ST-segment-elevation myocardial infarction care in developing countries: the experience of Salvador, Bahia, Brazil. Circ Cardiovasc Qual Outcomes. 2013;6(1): 9-17</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Solla</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Paiva Ide</surname>
              <given-names>M</given-names>
              <suffix>Filho</suffix>
            </name>
            <name>
              <surname>Delisle</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Braga</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Moura</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Xd</surname>
              <given-names>Moraes</given-names>
              <suffix>Jr</suffix>
            </name>
            <etal/>
          </person-group>
          <article-title>Integrated regional networks for ST-segment-elevation myocardial infarction care in developing countries: the experience of Salvador, Bahia, Brazil</article-title>
          <source>Circ Cardiovasc Qual Outcomes</source>
          <year>2013</year>
          <volume>6</volume>
          <issue>1</issue>
          <fpage>9</fpage>
          <lpage>17</lpage>
        </element-citation>
      </ref>
      <ref id="B142">
        <label>142</label>
        <mixed-citation>142 Matsuda CN, Cade JR, Janella BL, Pazolini VA, Cintra GF, Bourget M, et al. Implementa&#231;&#227;o da telemedicina no atendimento inicial do infarto agudo do mioc&#225;rdio com supradesnivelamento do segmento ST. J Transcat Intervent. 2018 Aug;26: 1-6</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Matsuda</surname>
              <given-names>CN</given-names>
            </name>
            <name>
              <surname>Cade</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Janella</surname>
              <given-names>BL</given-names>
            </name>
            <name>
              <surname>Pazolini</surname>
              <given-names>VA</given-names>
            </name>
            <name>
              <surname>Cintra</surname>
              <given-names>GF</given-names>
            </name>
            <name>
              <surname>Bourget</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Implementa&#231;&#227;o da telemedicina no atendimento inicial do infarto agudo do mioc&#225;rdio com supradesnivelamento do segmento ST</article-title>
          <source>J Transcat Intervent</source>
          <year>2018</year>
          <month>08</month>
          <volume>26</volume>
          <fpage>1</fpage>
          <lpage>6</lpage>
        </element-citation>
      </ref>
      <ref id="B143">
        <label>143</label>
        <mixed-citation>143 Marino BC, Ribeiro AL, Alkmim MB, Antunes AP, Boersma E, Marcolino MS. Coordinated regional care of myocardial infarction in a rural area in Brazil: Minas Telecardio Project 2. Eur Heart J Qual Care Clin Outcomes. 2016;2(3): 215-24</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Marino</surname>
              <given-names>BC</given-names>
            </name>
            <name>
              <surname>Ribeiro</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Alkmim</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>Antunes</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Boersma</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Marcolino</surname>
              <given-names>MS</given-names>
            </name>
          </person-group>
          <article-title>Coordinated regional care of myocardial infarction in a rural area in Brazil: Minas Telecardio Project 2</article-title>
          <source>Eur Heart J Qual Care Clin Outcomes</source>
          <year>2016</year>
          <volume>2</volume>
          <issue>3</issue>
          <fpage>215</fpage>
          <lpage>224</lpage>
        </element-citation>
      </ref>
      <ref id="B144">
        <label>144</label>
        <mixed-citation>144 Caluza AC, Barbosa AH, Goncalves I, Oliveira CA, Matos LN, Zeefried C, et al. ST-Elevation myocardial infarction network: systematization in 205 cases reduced clinical events in the public health care system. Arq Bras Cardiol. 2012;99(5): 1040-8</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Caluza</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Barbosa</surname>
              <given-names>AH</given-names>
            </name>
            <name>
              <surname>Goncalves</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Oliveira</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Matos</surname>
              <given-names>LN</given-names>
            </name>
            <name>
              <surname>Zeefried</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>ST-Elevation myocardial infarction network: systematization in 205 cases reduced clinical events in the public health care system</article-title>
          <source>Arq Bras Cardiol</source>
          <year>2012</year>
          <volume>99</volume>
          <issue>5</issue>
          <fpage>1040</fpage>
          <lpage>1048</lpage>
        </element-citation>
      </ref>
      <ref id="B145">
        <label>145</label>
        <mixed-citation>145 Filgueiras Filho NM, Feitosa Filho GS, Solla DJF, Arg&#244;lo FC, Guimar&#227;es PO, Paiva Filho IM, et al. Implementation of a Regional Network for ST-Segment-Elevation Myocardial Infarction (STEMI) Care and 30-Day Mortality in a Low- to Middle-Income City in Brazil: Findings From Salvador's STEMI Registry (RESISST). J Am Heart Assoc. 2018;7(14). pii: e008624</mixed-citation>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Filgueiras</surname>
              <given-names>NM</given-names>
              <suffix>Filho</suffix>
            </name>
            <name>
              <surname>Feitosa</surname>
              <given-names>GS</given-names>
              <suffix>Filho</suffix>
            </name>
            <name>
              <surname>Solla</surname>
              <given-names>DJF</given-names>
            </name>
            <name>
              <surname>Arg&#244;lo</surname>
              <given-names>FC</given-names>
            </name>
            <name>
              <surname>Guimar&#227;es</surname>
              <given-names>PO</given-names>
            </name>
            <name>
              <surname>Paiva</surname>
              <given-names>IM</given-names>
              <suffix>Filho</suffix>
            </name>
            <etal/>
          </person-group>
          <chapter-title>Implementation of a Regional Network for ST-Segment-Elevation Myocardial Infarction (STEMI) Care and 30-Day Mortality in a Low- to Middle-Income City in Brazil: Findings From Salvador's STEMI Registry (RESISST)</chapter-title>
          <source>J Am Heart Assoc</source>
          <year>2018</year>
          <volume>7</volume>
          <issue>14</issue>
          <pub-id pub-id-type="pii">e008624</pub-id>
        </element-citation>
      </ref>
      <ref id="B146">
        <label>146</label>
        <mixed-citation>146 Brasen CL, Madsen JS, Parkner T, Brandslund I. Home Management of Warfarin Treatment Through a Real-Time Supervised Telemedicine Solution: A Randomized Controlled Trial. Telemed J E Health. 2019;25(2): 109-15</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brasen</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Madsen</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Parkner</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Brandslund</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>Home Management of Warfarin Treatment Through a Real-Time Supervised Telemedicine Solution: A Randomized Controlled Trial</article-title>
          <source>Telemed J E Health</source>
          <year>2019</year>
          <volume>25</volume>
          <issue>2</issue>
          <fpage>109</fpage>
          <lpage>115</lpage>
        </element-citation>
      </ref>
      <ref id="B147">
        <label>147</label>
        <mixed-citation>147 Pozzi M, Mitchell J, Henaine AM, Hanna N, Safi O, Henaine R. International normalized ratio self-testing and self-management: improving patient outcomes. Vasc Health Risk Manag. 2016 Oct;12: 387-92</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pozzi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Mitchell</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Henaine</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Hanna</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Safi</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Henaine</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>International normalized ratio self-testing and self-management: improving patient outcomes</article-title>
          <source>Vasc Health Risk Manag</source>
          <year>2016</year>
          <month>10</month>
          <volume>12</volume>
          <fpage>387</fpage>
          <lpage>392</lpage>
        </element-citation>
      </ref>
      <ref id="B148">
        <label>148</label>
        <mixed-citation>148 Heneghan CJ, Garcia-Alamino JM, Spencer EA, Ward AM, Perera R, Bankhead C, et al. Self-monitoring and self-management of oral anticoagulation. Cochrane Database Syst Rev. 2016 Jul;7: CD003839</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Heneghan</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Garcia-Alamino</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Spencer</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Ward</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Perera</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Bankhead</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Self-monitoring and self-management of oral anticoagulation</article-title>
          <source>Cochrane Database Syst Rev</source>
          <year>2016</year>
          <month>07</month>
          <volume>7</volume>
          <fpage>CD003839</fpage>
          <lpage>CD003839</lpage>
        </element-citation>
      </ref>
      <ref id="B149">
        <label>149</label>
        <mixed-citation>149 Saia M, Mantoan D, Fonzo M, Bertoncello C, Soattin M, Sperotto M, et al. Impact of the Regional Network for AMI in the Management of STEMI on Care Processes, Outcomes and Health Inequities in the Veneto Region, Italy. Int J Environ Res Public Health. 2018;15(9). pii: E1980</mixed-citation>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Saia</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Mantoan</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Fonzo</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Bertoncello</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Soattin</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sperotto</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <chapter-title>Impact of the Regional Network for AMI in the Management of STEMI on Care Processes, Outcomes and Health Inequities in the Veneto Region, Italy</chapter-title>
          <source>Int J Environ Res Public Health</source>
          <year>2018</year>
          <volume>15</volume>
          <issue>9</issue>
          <pub-id pub-id-type="pii">E1980</pub-id>
        </element-citation>
      </ref>
      <ref id="B150">
        <label>150</label>
        <mixed-citation>150 Beatty AL, Fukuoka Y, Whooley MA. Using mobile technology for cardiac rehabilitation: a review and framework for development and evaluation. J Am Heart Assoc. 2013;2(6): e000568</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Beatty</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Fukuoka</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Whooley</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>Using mobile technology for cardiac rehabilitation: a review and framework for development and evaluation</article-title>
          <source>J Am Heart Assoc</source>
          <year>2013</year>
          <volume>2</volume>
          <issue>6</issue>
          <elocation-id>e000568</elocation-id>
        </element-citation>
      </ref>
      <ref id="B151">
        <label>151</label>
        <mixed-citation>151 Rawstorn JC, Gant N, Direito A, Beckmann C, Maddison R. Telehealth exercise-based cardiac rehabilitation: a systematic review and meta-analysis. Heart. 2016;102(15): 1183-92</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rawstorn</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Gant</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Direito</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Beckmann</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Maddison</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Telehealth exercise-based cardiac rehabilitation: a systematic review and meta-analysis</article-title>
          <source>Heart</source>
          <year>2016</year>
          <volume>102</volume>
          <issue>15</issue>
          <fpage>1183</fpage>
          <lpage>1192</lpage>
        </element-citation>
      </ref>
      <ref id="B152">
        <label>152</label>
        <mixed-citation>152 Frederix I, Hansen D, Coninx K, Vandervoort P, Vandijck D, Hens N, et al. Medium-Term Effectiveness of a Comprehensive Internet-Based and Patient-Specific Telerehabilitation Program With Text Messaging Support for Cardiac Patients: Randomized Controlled Trial. J Med Internet Res. 2015;17(7): e185</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Frederix</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Hansen</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Coninx</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Vandervoort</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Vandijck</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Hens</surname>
              <given-names>N</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Medium-Term Effectiveness of a Comprehensive Internet-Based and Patient-Specific Telerehabilitation Program With Text Messaging Support for Cardiac Patients: Randomized Controlled Trial</article-title>
          <source>J Med Internet Res</source>
          <year>2015</year>
          <volume>17</volume>
          <issue>7</issue>
          <elocation-id>e185</elocation-id>
        </element-citation>
      </ref>
      <ref id="B153">
        <label>153</label>
        <mixed-citation>153 Peng X, Su Y, Hu Z, Sun X, Li X, Dolansky MA, et al. Home-based telehealth exercise training program in Chinese patients with heart failure: A randomized controlled trial. Medicine (Baltimore). 2018;97(35): e12069</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Peng</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Su</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Hu</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Dolansky</surname>
              <given-names>MA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Home-based telehealth exercise training program in Chinese patients with heart failure: A randomized controlled trial</article-title>
          <source>Medicine (Baltimore)</source>
          <year>2018</year>
          <volume>97</volume>
          <issue>35</issue>
          <elocation-id>e12069</elocation-id>
        </element-citation>
      </ref>
      <ref id="B154">
        <label>154</label>
        <mixed-citation>154 Maddison R, Rawstorn JC, Stewart RAH, Benatar J, Whittaker R, Rolleston A, et al. Effects and costs of real-time cardiac telerehabilitation: randomised controlled non-inferiority trial. Heart. 2019;105(2): 122-9</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Maddison</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Rawstorn</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Stewart</surname>
              <given-names>RAH</given-names>
            </name>
            <name>
              <surname>Benatar</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Whittaker</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Rolleston</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Effects and costs of real-time cardiac telerehabilitation: randomised controlled non-inferiority trial</article-title>
          <source>Heart</source>
          <year>2019</year>
          <volume>105</volume>
          <issue>2</issue>
          <fpage>122</fpage>
          <lpage>129</lpage>
        </element-citation>
      </ref>
      <ref id="B155">
        <label>155</label>
        <mixed-citation>155 Taylor RS, Dalal H, Jolly K, Moxham T, Zawada A. Home-based versus centre-based cardiac rehabilitation. Cochrane Database Syst Rev. 2010(1): CD007130</mixed-citation>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Taylor</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Dalal</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Jolly</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Moxham</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Zawada</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <chapter-title>Home-based versus centre-based cardiac rehabilitation</chapter-title>
          <source>Cochrane Database Syst Rev</source>
          <year>2010</year>
          <issue>1</issue>
          <fpage>CD007130</fpage>
          <lpage>CD007130</lpage>
        </element-citation>
      </ref>
      <ref id="B156">
        <label>156</label>
        <mixed-citation>156 Frederix I, Hansen D, Coninx K, Vandervoort P, Vandijck D, Hens N, et al. Effect of comprehensive cardiac telerehabilitation on one-year cardiovascular rehospitalization rate, medical costs and quality of life: A cost-effectiveness analysis. Eur J Prev Cardiol. 2016;23(7): 674-82</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Frederix</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Hansen</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Coninx</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Vandervoort</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Vandijck</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Hens</surname>
              <given-names>N</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Effect of comprehensive cardiac telerehabilitation on one-year cardiovascular rehospitalization rate, medical costs and quality of life: A cost-effectiveness analysis</article-title>
          <source>Eur J Prev Cardiol</source>
          <year>2016</year>
          <volume>23</volume>
          <issue>7</issue>
          <fpage>674</fpage>
          <lpage>682</lpage>
        </element-citation>
      </ref>
      <ref id="B157">
        <label>157</label>
        <mixed-citation>157 Lopez-Villegas A, Catalan-Matamoros D, Martin-Saborido C, Villegas-Tripiana I, Robles-Musso E. A Systematic Review of Economic Evaluations of Pacemaker Telemonitoring Systems. Rev Esp Cardiol (Engl Ed). 2016;69(2): 125-33</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lopez-Villegas</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Catalan-Matamoros</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Martin-Saborido</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Villegas-Tripiana</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Robles-Musso</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>A Systematic Review of Economic Evaluations of Pacemaker Telemonitoring Systems</article-title>
          <source>Rev Esp Cardiol (Engl Ed)</source>
          <year>2016</year>
          <volume>69</volume>
          <issue>2</issue>
          <fpage>125</fpage>
          <lpage>133</lpage>
        </element-citation>
      </ref>
      <ref id="B158">
        <label>158</label>
        <mixed-citation>158 Bourge RC, Abraham WT, Adamson PB, Aaron MF, Aranda JM Jr, Magalski A, et al. Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS HF study. J Am Coll Cardiol. 2008;51(11): 1073-9</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bourge</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Abraham</surname>
              <given-names>WT</given-names>
            </name>
            <name>
              <surname>Adamson</surname>
              <given-names>PB</given-names>
            </name>
            <name>
              <surname>Aaron</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Aranda</surname>
              <given-names>JM</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Magalski</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS HF study</article-title>
          <source>J Am Coll Cardiol</source>
          <year>2008</year>
          <volume>51</volume>
          <issue>11</issue>
          <fpage>1073</fpage>
          <lpage>1079</lpage>
        </element-citation>
      </ref>
      <ref id="B159">
        <label>159</label>
        <mixed-citation>159 Hindricks G, Taborsky M, Glikson M, Heinrich U, Schumacher B, Katz A, et al. Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial. Lancet. 2014;384(9943): 583-90</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hindricks</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Taborsky</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Glikson</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Heinrich</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Schumacher</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Katz</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial</article-title>
          <source>Lancet</source>
          <year>2014</year>
          <volume>384</volume>
          <issue>9943</issue>
          <fpage>583</fpage>
          <lpage>590</lpage>
        </element-citation>
      </ref>
      <ref id="B160">
        <label>160</label>
        <mixed-citation>160 De Simone A, Leoni L, Luzi M, Amellone C, Stabile G, La Rocca V, et al. Remote monitoring improves outcome after ICD implantation: the clinical efficacy in the management of heart failure (EFFECT) study. Europace. 2015;17(8): 1267-75</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>De Simone</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Leoni</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Luzi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Amellone</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Stabile</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>La Rocca</surname>
              <given-names>V</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Remote monitoring improves outcome after ICD implantation: the clinical efficacy in the management of heart failure (EFFECT) study</article-title>
          <source>Europace</source>
          <year>2015</year>
          <volume>17</volume>
          <issue>8</issue>
          <fpage>1267</fpage>
          <lpage>1275</lpage>
        </element-citation>
      </ref>
      <ref id="B161">
        <label>161</label>
        <mixed-citation>161 Kurek A, Tajstra M, Gadula-Gacek E, Buchta P, Skrzypek M, Pyka L, et al. Impact of remote monitoring on long-term prognosis in heart failure patients in a real-world cohort: results from all-comers COMMIT HF trial. J Cardiovasc Electrophysiol. 2017;28(4): 425-31</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kurek</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Tajstra</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Gadula-Gacek</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Buchta</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Skrzypek</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Pyka</surname>
              <given-names>L</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Impact of remote monitoring on long-term prognosis in heart failure patients in a real-world cohort: results from all-comers COMMIT HF trial</article-title>
          <source>J Cardiovasc Electrophysiol</source>
          <year>2017</year>
          <volume>28</volume>
          <issue>4</issue>
          <fpage>425</fpage>
          <lpage>431</lpage>
        </element-citation>
      </ref>
      <ref id="B162">
        <label>162</label>
        <mixed-citation>162 Klersy C, Boriani G, De Silvestri A, Mairesse GH, Braunschweig F, Scotti V, et al. Effect of telemonitoring of cardiac implantable electronic devices on health care utilization: a meta-analysis of randomized controlled trials in patients with heart failure. Eur J Heart Fail. 2016;18(2): 195-204</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Klersy</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Boriani</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>De Silvestri</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Mairesse</surname>
              <given-names>GH</given-names>
            </name>
            <name>
              <surname>Braunschweig</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Scotti</surname>
              <given-names>V</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Effect of telemonitoring of cardiac implantable electronic devices on health care utilization: a meta-analysis of randomized controlled trials in patients with heart failure</article-title>
          <source>Eur J Heart Fail</source>
          <year>2016</year>
          <volume>18</volume>
          <issue>2</issue>
          <fpage>195</fpage>
          <lpage>204</lpage>
        </element-citation>
      </ref>
      <ref id="B163">
        <label>163</label>
        <mixed-citation>163 Lazarus A. Remote, wireless, ambulatory monitoring of implantable pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy systems: analysis of a worldwide database. PacingClin. Electrophysiol. 2007;30(Suppl1): S2-12</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lazarus</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Remote, wireless, ambulatory monitoring of implantable pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy systems: analysis of a worldwide database. PacingClin</article-title>
          <source>Electrophysiol</source>
          <year>2007</year>
          <volume>30</volume>
          <issue>Suppl1</issue>
          <fpage>S2</fpage>
          <lpage>12</lpage>
        </element-citation>
      </ref>
      <ref id="B164">
        <label>164</label>
        <mixed-citation>164 Ricci RP, Morichelli L, Santini M. Remote control of implanted devices through Home Monitoringtechnology improves detection and clinical management of atrial fibrillation. Europace. 2009;11(1): 54-61</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ricci</surname>
              <given-names>RP</given-names>
            </name>
            <name>
              <surname>Morichelli</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Santini</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Remote control of implanted devices through Home Monitoringtechnology improves detection and clinical management of atrial fibrillation</article-title>
          <source>Europace</source>
          <year>2009</year>
          <volume>11</volume>
          <issue>1</issue>
          <fpage>54</fpage>
          <lpage>61</lpage>
        </element-citation>
      </ref>
      <ref id="B165">
        <label>165</label>
        <mixed-citation>165 Ricci RP, Morichelli L, D'Onofrio A, Calo L, Vaccari D, Zanotto G, et al. Effectiveness of remote monitoring of CIEDs in detection and treatment of clinical and device-related cardiovascular events in daily practice: the Home Guide Registry. Europace. 2013;15(7): 970-7</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ricci</surname>
              <given-names>RP</given-names>
            </name>
            <name>
              <surname>Morichelli</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>D'Onofrio</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Calo</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Vaccari</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Zanotto</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Effectiveness of remote monitoring of CIEDs in detection and treatment of clinical and device-related cardiovascular events in daily practice: the Home Guide Registry</article-title>
          <source>Europace</source>
          <year>2013</year>
          <volume>15</volume>
          <issue>7</issue>
          <fpage>970</fpage>
          <lpage>977</lpage>
        </element-citation>
      </ref>
      <ref id="B166">
        <label>166</label>
        <mixed-citation>166 Martin DT, Bersohn MM, Waldo AL, Wathen MS, Choucair WK, Lip GY, et al. Randomized trial of atrial arrhythmia monitoring to guide anticoagulation in patients with implanted defibrillator and cardiac resynchronization devices. Eur Heart J. 2015;36(26): 1660-8</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Martin</surname>
              <given-names>DT</given-names>
            </name>
            <name>
              <surname>Bersohn</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Waldo</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Wathen</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Choucair</surname>
              <given-names>WK</given-names>
            </name>
            <name>
              <surname>Lip</surname>
              <given-names>GY</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Randomized trial of atrial arrhythmia monitoring to guide anticoagulation in patients with implanted defibrillator and cardiac resynchronization devices</article-title>
          <source>Eur Heart J</source>
          <year>2015</year>
          <volume>36</volume>
          <issue>26</issue>
          <fpage>1660</fpage>
          <lpage>1668</lpage>
        </element-citation>
      </ref>
      <ref id="B167">
        <label>167</label>
        <mixed-citation>167 Halcox JPJ, Wareham K, Cardew A, Gilmore M, Barry JP, Phillips C, et al. Assessment of Remote Heart Rhythm Sampling Using the AliveCor Heart Monitor to Screen for Atrial Fibrillation: The REHEARSE-AF Study. Circulation. 2017;136(19): 1784-94</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Halcox</surname>
              <given-names>JPJ</given-names>
            </name>
            <name>
              <surname>Wareham</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Cardew</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Gilmore</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Barry</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Phillips</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Assessment of Remote Heart Rhythm Sampling Using the AliveCor Heart Monitor to Screen for Atrial Fibrillation: The REHEARSE-AF Study</article-title>
          <source>Circulation</source>
          <year>2017</year>
          <volume>136</volume>
          <issue>19</issue>
          <fpage>1784</fpage>
          <lpage>1794</lpage>
        </element-citation>
      </ref>
      <ref id="B168">
        <label>168</label>
        <mixed-citation>168 Bruining N, Caiani E, Chronaki C, Guzik P, van der Velde E. Acquisition and analysis of cardiovascular signals on smartphones: potential, pitfalls and perspectives: by the Task Force of the e-Cardiology Working Group of European Society of Cardiology. Eur J Prev Cardiol. 2014;21(2 Suppl): 4-13</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bruining</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Caiani</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Chronaki</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Guzik</surname>
              <given-names>P</given-names>
            </name>
            <collab>van der Velde E</collab>
          </person-group>
          <article-title>Acquisition and analysis of cardiovascular signals on smartphones: potential, pitfalls and perspectives: by the Task Force of the e-Cardiology Working Group of European Society of Cardiology</article-title>
          <source>Eur J Prev Cardiol</source>
          <year>2014</year>
          <volume>21</volume>
          <issue>2 Suppl</issue>
          <fpage>4</fpage>
          <lpage>13</lpage>
        </element-citation>
      </ref>
      <ref id="B169">
        <label>169</label>
        <mixed-citation>169 Bilgi M, Gulalp B, Erol T, Gullu H, Karagun O, Altay H, et al. Interpretation of electrocardiogram images sent through the mobile phone multimedia messaging service. Telemed J E Health. 2012;18(2): 126-31</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bilgi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Gulalp</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Erol</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Gullu</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Karagun</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Altay</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Interpretation of electrocardiogram images sent through the mobile phone multimedia messaging service</article-title>
          <source>Telemed J E Health</source>
          <year>2012</year>
          <volume>18</volume>
          <issue>2</issue>
          <fpage>126</fpage>
          <lpage>131</lpage>
        </element-citation>
      </ref>
      <ref id="B170">
        <label>170</label>
        <mixed-citation>170 Lowres N, Neubeck L, Salkeld G, Krass I, McLachlan AJ, Redfern J, et al. Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies. The SEARCH-AF study. Thromb Haemost. 2014;111(6): 1167-76</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lowres</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Neubeck</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Salkeld</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Krass</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>McLachlan</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Redfern</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies: The SEARCH-AF study</article-title>
          <source>Thromb Haemost</source>
          <year>2014</year>
          <volume>111</volume>
          <issue>6</issue>
          <fpage>1167</fpage>
          <lpage>1176</lpage>
        </element-citation>
      </ref>
      <ref id="B171">
        <label>171</label>
        <mixed-citation>171 Halcox JPJ, Wareham K, Cardew A, Gilmore M, Barry JP, Phillips C, et al. Assessment of Remote Heart Rhythm Sampling Using the AliveCor Heart Monitor to Screen for Atrial Fibrillation: The REHEARSE-AF Study. Circulation. 2017;136(19): 1784-1794</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Halcox</surname>
              <given-names>JPJ</given-names>
            </name>
            <name>
              <surname>Wareham</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Cardew</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Gilmore</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Barry</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Phillips</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Assessment of Remote Heart Rhythm Sampling Using the AliveCor Heart Monitor to Screen for Atrial Fibrillation: The REHEARSE-AF Study</article-title>
          <source>Circulation</source>
          <year>2017</year>
          <volume>136</volume>
          <issue>19</issue>
          <fpage>1784</fpage>
          <lpage>1794</lpage>
        </element-citation>
      </ref>
      <ref id="B172">
        <label>172</label>
        <mixed-citation>172 Zungsontiporn N, Link MS. Newer technologies for detection of atrial fibrillation. BMJ. 2018 Oct;363: k3946</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zungsontiporn</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Link</surname>
              <given-names>MS</given-names>
            </name>
          </person-group>
          <article-title>Newer technologies for detection of atrial fibrillation</article-title>
          <source>BMJ</source>
          <year>2018</year>
          <month>10</month>
          <volume>363</volume>
          <fpage>k3946</fpage>
          <lpage>k3946</lpage>
        </element-citation>
      </ref>
      <ref id="B173">
        <label>173</label>
        <mixed-citation>173 Stanford Medicine. Apple Heart Study. [acesso em 04 set 2019]. Dispon&#237;vel em: <ext-link ext-link-type="uri" xlink:href="https://med.stanford.edu/appleheartstudy.html">https://med.stanford.edu/appleheartstudy.html</ext-link>
				</mixed-citation>
        <element-citation publication-type="webpage">
          <person-group person-group-type="author">
            <collab>Stanford Medicine</collab>
          </person-group>
          <source>Apple Heart Study</source>
          <date-in-citation content-type="access-date">04 set 2019</date-in-citation>
          <comment>Dispon&#237;vel em: <ext-link ext-link-type="uri" xlink:href="https://med.stanford.edu/appleheartstudy.html">https://med.stanford.edu/appleheartstudy.html</ext-link>
					</comment>
        </element-citation>
      </ref>
      <ref id="B174">
        <label>174</label>
        <mixed-citation>174 Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA, Freedman RA, Gettes LS, et al.2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2013;61(3): e6-75</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Epstein</surname>
              <given-names>AE</given-names>
            </name>
            <name>
              <surname>DiMarco</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Ellenbogen</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Estes</surname>
              <given-names>NA</given-names>
            </name>
            <name>
              <surname>Freedman</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Gettes</surname>
              <given-names>LS</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society</article-title>
          <source>J Am Coll Cardiol</source>
          <year>2013</year>
          <volume>61</volume>
          <issue>3</issue>
          <fpage>e6</fpage>
          <lpage>75</lpage>
        </element-citation>
      </ref>
      <ref id="B175">
        <label>175</label>
        <mixed-citation>175 De Asmundis C, Ricciardi D, Namdar M, Chierchia GB, Sarkozy A, Brugada P. Role of homemonitoring in children with implantable cardioverter defibrillators for Brugada syndrome. Europace. 2013;15(Suppl 1): i17-25</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>De Asmundis</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Ricciardi</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Namdar</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Chierchia</surname>
              <given-names>GB</given-names>
            </name>
            <name>
              <surname>Sarkozy</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Brugada</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Role of homemonitoring in children with implantable cardioverter defibrillators for Brugada syndrome</article-title>
          <source>Europace</source>
          <year>2013</year>
          <volume>15</volume>
          <issue>Suppl 1</issue>
          <fpage>i17</fpage>
          <lpage>i25</lpage>
        </element-citation>
      </ref>
      <ref id="B176">
        <label>176</label>
        <mixed-citation>176 Varma N, Michalski J, Epstein AE, Schweikert R. Automatic remote monitoring of implantable cardioverter-defibrillator lead and generator performance: the Lumos-T Safely Reduces Routine Office Device Follow-up (TRUST) Trial. Circ Arrhythm Electrophysiol. 2010;3(5): 428-36</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Varma</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Michalski</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Epstein</surname>
              <given-names>AE</given-names>
            </name>
            <name>
              <surname>Schweikert</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Automatic remote monitoring of implantable cardioverter-defibrillator lead and generator performance: the Lumos-T Safely Reduces Routine Office Device Follow-up (TRUST) Trial</article-title>
          <source>Circ Arrhythm Electrophysiol</source>
          <year>2010</year>
          <volume>3</volume>
          <issue>5</issue>
          <fpage>428</fpage>
          <lpage>436</lpage>
        </element-citation>
      </ref>
      <ref id="B177">
        <label>177</label>
        <mixed-citation>177 Sacher F, Probst V, Bessouet M, Wright M, Maluski A, Abbey S, et al. Remote implantable cardioverter defibrillator monitoring in a Brugada syndrome population. Europace. 2009;11(4): 489-94</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sacher</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Probst</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Bessouet</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wright</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Maluski</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Abbey</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Remote implantable cardioverter defibrillator monitoring in a Brugada syndrome population</article-title>
          <source>Europace</source>
          <year>2009</year>
          <volume>11</volume>
          <issue>4</issue>
          <fpage>489</fpage>
          <lpage>494</lpage>
        </element-citation>
      </ref>
      <ref id="B178">
        <label>178</label>
        <mixed-citation>178 Slotwiner D, Varma N, Akar JG, Annas G, Beardsall M, Fogel RI, et al. HRS expert consensus statement on remote interrogation and monitoring for cardiovascular implantable electronic devices. Heart Rhythm. 2015;12(7): e69-100</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Slotwiner</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Varma</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Akar</surname>
              <given-names>JG</given-names>
            </name>
            <name>
              <surname>Annas</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Beardsall</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Fogel</surname>
              <given-names>RI</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>HRS expert consensus statement on remote interrogation and monitoring for cardiovascular implantable electronic devices</article-title>
          <source>Heart Rhythm</source>
          <year>2015</year>
          <volume>12</volume>
          <issue>7</issue>
          <fpage>e69</fpage>
          <lpage>100</lpage>
        </element-citation>
      </ref>
      <ref id="B179">
        <label>179</label>
        <mixed-citation>179 Santini M, Ricci RP, Lunati M, Landolina M, Perego GB, Marzegalli M, et al. Remote monitoring of patients with biventricular defibrillators through the CareLink system improves clinical management of arrhythmias and heart failure episodes. J Interv Card Electrophysiol. 2009;24(1): 53-61</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Santini</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ricci</surname>
              <given-names>RP</given-names>
            </name>
            <name>
              <surname>Lunati</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Landolina</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Perego</surname>
              <given-names>GB</given-names>
            </name>
            <name>
              <surname>Marzegalli</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Remote monitoring of patients with biventricular defibrillators through the CareLink system improves clinical management of arrhythmias and heart failure episodes</article-title>
          <source>J Interv Card Electrophysiol</source>
          <year>2009</year>
          <volume>24</volume>
          <issue>1</issue>
          <fpage>53</fpage>
          <lpage>61</lpage>
        </element-citation>
      </ref>
      <ref id="B180">
        <label>180</label>
        <mixed-citation>180 Varma N, Epstein A, Irimpen A, Schweikert R, Shah J, Love CJ, et al. Efficacy and safety of automatic remote monitoring for ICD Follow-Up: the TRUST trial. Circulation. 2010;122(4): 325-32</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Varma</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Epstein</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Irimpen</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Schweikert</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Shah</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Love</surname>
              <given-names>CJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Efficacy and safety of automatic remote monitoring for ICD Follow-Up: the TRUST trial</article-title>
          <source>Circulation</source>
          <year>2010</year>
          <volume>122</volume>
          <issue>4</issue>
          <fpage>325</fpage>
          <lpage>332</lpage>
        </element-citation>
      </ref>
      <ref id="B181">
        <label>181</label>
        <mixed-citation>181 Varma N, Johnson MA. Prevalence of cancelled shock therapy and relationship to shock delivery in recipients of implantable cardioverter-defibrillators assessed by remote monitoring. Pacing Clin Electrophysiol. 2009;32(Suppl 1): S42-6</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Varma</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>Prevalence of cancelled shock therapy and relationship to shock delivery in recipients of implantable cardioverter-defibrillators assessed by remote monitoring</article-title>
          <source>Pacing Clin Electrophysiol</source>
          <year>2009</year>
          <volume>32</volume>
          <issue>Suppl 1</issue>
          <fpage>S42</fpage>
          <lpage>S46</lpage>
        </element-citation>
      </ref>
      <ref id="B182">
        <label>182</label>
        <mixed-citation>182 Grant B, Morgan GJ, McCrossan BA, Crealey GE, Sands AJ, Craig B, et al. Remote diagnosis of congenital heart disease: the impact of telemedicine. Arch Dis Child. 2010;95(4): 276-80</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Grant</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Morgan</surname>
              <given-names>GJ</given-names>
            </name>
            <name>
              <surname>McCrossan</surname>
              <given-names>BA</given-names>
            </name>
            <name>
              <surname>Crealey</surname>
              <given-names>GE</given-names>
            </name>
            <name>
              <surname>Sands</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Craig</surname>
              <given-names>B</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Remote diagnosis of congenital heart disease: the impact of telemedicine</article-title>
          <source>Arch Dis Child</source>
          <year>2010</year>
          <volume>95</volume>
          <issue>4</issue>
          <fpage>276</fpage>
          <lpage>280</lpage>
        </element-citation>
      </ref>
      <ref id="B183">
        <label>183</label>
        <mixed-citation>183 Webb CL, Waugh CL, Grigsby J, Busenbark D, Berdusis K, Sahn DJ, et al. American Society of Echocardiography Telemedicine Collaborators' Group. Impact of telemedicine on hospital transport, length of stay, and medical outcomes in infants with suspected heart disease: a multicenter study. J Am Soc Echocardiogr. 2013;26(9): 1090-8</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Webb</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Waugh</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Grigsby</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Busenbark</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Berdusis</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Sahn</surname>
              <given-names>DJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>American Society of Echocardiography Telemedicine Collaborators' Group: Impact of telemedicine on hospital transport, length of stay, and medical outcomes in infants with suspected heart disease: a multicenter study</article-title>
          <source>J Am Soc Echocardiogr</source>
          <year>2013</year>
          <volume>26</volume>
          <issue>9</issue>
          <fpage>1090</fpage>
          <lpage>1098</lpage>
        </element-citation>
      </ref>
      <ref id="B184">
        <label>184</label>
        <mixed-citation>184 Graham RN, Perriss RW and Scarsbrook AF. DICOM demystified: a review of digital file formats and their use in radiological practice. Clin Radiol. 2005;60(11): 1133-40</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Graham</surname>
              <given-names>RN</given-names>
            </name>
            <name>
              <surname>Perriss</surname>
              <given-names>RW</given-names>
            </name>
            <name>
              <surname>Scarsbrook</surname>
              <given-names>AF</given-names>
            </name>
          </person-group>
          <article-title>DICOM demystified: a review of digital file formats and their use in radiological practice</article-title>
          <source>Clin Radiol</source>
          <year>2005</year>
          <volume>60</volume>
          <issue>11</issue>
          <fpage>1133</fpage>
          <lpage>1140</lpage>
        </element-citation>
      </ref>
      <ref id="B185">
        <label>185</label>
        <mixed-citation>185 Pianykh O. Digital imaging and communications in medicine (DICOM): a practical introduction and survival guide. 1st ed: Springer; 2008</mixed-citation>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Pianykh</surname>
              <given-names>O</given-names>
            </name>
          </person-group>
          <source>Digital imaging and communications in medicine (DICOM): a practical introduction and survival guide. 1st</source>
          <year>2008</year>
          <edition> 1st ed </edition>
          <publisher-name>Springer</publisher-name>
        </element-citation>
      </ref>
      <ref id="B186">
        <label>186</label>
        <mixed-citation>186 Soares AH. Telerradiologia - Resolu&#231;&#227;o Consleho Federal de Medicina, n&#186; 2.107/2014. 2014</mixed-citation>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Soares</surname>
              <given-names>AH</given-names>
            </name>
          </person-group>
          <source>Telerradiologia - Resolu&#231;&#227;o Consleho Federal de Medicina</source>
          <issue>2.107/2014</issue>
          <year>2014</year>
        </element-citation>
      </ref>
      <ref id="B187">
        <label>187</label>
        <mixed-citation>187 Blaha MJ, Cainzos-Achirica M, Greenland P, McEvoy JW, Blankstein R, Budoff MJ, et al. Role of Coronary Artery Calcium Score of Zero and Other Negative Risk Markers for Cardiovascular Disease: The Multi-Ethnic Study of Atherosclerosis (MESA). Circulation. 2016;133(9): 849-58</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Blaha</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Cainzos-Achirica</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Greenland</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>McEvoy</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Blankstein</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Budoff</surname>
              <given-names>MJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Role of Coronary Artery Calcium Score of Zero and Other Negative Risk Markers for Cardiovascular Disease: The Multi-Ethnic Study of Atherosclerosis (MESA)</article-title>
          <source>Circulation</source>
          <year>2016</year>
          <volume>133</volume>
          <issue>9</issue>
          <fpage>849</fpage>
          <lpage>858</lpage>
        </element-citation>
      </ref>
      <ref id="B188">
        <label>188</label>
        <mixed-citation>188 McClelland RL, Jorgensen NW, Budoff M, Blaha MJ, Post WS, Kronmal RA, et al. 10-Year Coronary Heart Disease Risk Prediction Using Coronary Artery Calcium and Traditional Risk Factors: Derivation in the MESA (Multi-Ethnic Study of Atherosclerosis) With Validation in the HNR (Heinz Nixdorf Recall) Study and the DHS (Dallas Heart Study). J Am Coll Cardiol. 2015;66(15): 1643-53.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McClelland</surname>
              <given-names>RL</given-names>
            </name>
            <name>
              <surname>Jorgensen</surname>
              <given-names>NW</given-names>
            </name>
            <name>
              <surname>Budoff</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Blaha</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Post</surname>
              <given-names>WS</given-names>
            </name>
            <name>
              <surname>Kronmal</surname>
              <given-names>RA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>10-Year Coronary Heart Disease Risk Prediction Using Coronary Artery Calcium and Traditional Risk Factors: Derivation in the MESA (Multi-Ethnic Study of Atherosclerosis) With Validation in the HNR (Heinz Nixdorf Recall) Study and the DHS (Dallas Heart Study)</article-title>
          <source>J Am Coll Cardiol</source>
          <year>2015</year>
          <volume>66</volume>
          <issue>15</issue>
          <fpage>1643</fpage>
          <lpage>1653</lpage>
        </element-citation>
      </ref>
      <ref id="B189">
        <label>189</label>
        <mixed-citation>189 Leipsic J, Abbara S, Achenbach S, Cury R, Earls JP, Mancini GJ, et al. SCCT guidelines for the interpretation and reporting of coronary CT angiography: a report of the Society of Cardiovascular Computed Tomography Guidelines Committee. J Cardiovasc Comput Tomogr. 2014;8(5): 342-58</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Leipsic</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Abbara</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Achenbach</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Cury</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Earls</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Mancini</surname>
              <given-names>GJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>SCCT guidelines for the interpretation and reporting of coronary CT angiography: a report of the Society of Cardiovascular Computed Tomography Guidelines Committee</article-title>
          <source>J Cardiovasc Comput Tomogr</source>
          <year>2014</year>
          <volume>8</volume>
          <issue>5</issue>
          <fpage>342</fpage>
          <lpage>358</lpage>
        </element-citation>
      </ref>
      <ref id="B190">
        <label>190</label>
        <mixed-citation>190 Schulz-Menger J, Bluemke DA, Bremerich J, Flamm SD, Fogel MA, Friedrich MG, et al. Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) board of trustees task force on standardized post processing. J Cardiovasc Magn Reson. 2013 May;15: 35</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schulz-Menger</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Bluemke</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Bremerich</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Flamm</surname>
              <given-names>SD</given-names>
            </name>
            <name>
              <surname>Fogel</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Friedrich</surname>
              <given-names>MG</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) board of trustees task force on standardized post processing</article-title>
          <source>J Cardiovasc Magn Reson</source>
          <year>2013</year>
          <month>05</month>
          <volume>15</volume>
          <fpage>35</fpage>
          <lpage>35</lpage>
        </element-citation>
      </ref>
      <ref id="B191">
        <label>191</label>
        <mixed-citation>191 Cavalcanti EFS. Uso do whatsApp em ambiente hospitalar - Parecer Conselho Federal de Medicina, n&#186;14/2017. Internet. [Acesso em 04 abr 2018]. Dispon&#237;vel em: <ext-link ext-link-type="uri" xlink:href="https://sbpt.org.br/wp-content/uploads/2017/CFM-whatsapp.pdf">https://sbpt.org.br/wp-content/uploads/2017/CFM-whatsapp.pdf</ext-link>
				</mixed-citation>
        <element-citation publication-type="webpage">
          <person-group person-group-type="author">
            <name>
              <surname>Cavalcanti</surname>
              <given-names>EFS</given-names>
            </name>
          </person-group>
          <source>Uso do whatsApp em ambiente hospitalar - Parecer Conselho Federal de Medicina, n&#186;14/2017</source>
          <comment>Internet</comment>
          <date-in-citation content-type="access-date">04 abr 2018</date-in-citation>
          <comment>Dispon&#237;vel em: <ext-link ext-link-type="uri" xlink:href="https://sbpt.org.br/wp-content/uploads/2017/CFM-whatsapp.pdf">https://sbpt.org.br/wp-content/uploads/2017/CFM-whatsapp.pdf</ext-link>
					</comment>
        </element-citation>
      </ref>
      <ref id="B192">
        <label>192</label>
        <mixed-citation>192 Sara L, Szarf G, Tachibana A, Shiozaki AA, Villa AV, Oliveira AC, et al. II Diretriz de Resson&#226;ncia Magn&#233;tica e Tomografia Computadorizada Cardiovascular da Sociedade Brasileira de Cardiologia e do Col&#233;gio Brasileiro de Radiologia. Arq Bras Cardiol. 2014;103(6 Suppl 3): 1-86</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sara</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Szarf</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Tachibana</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Shiozaki</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Villa</surname>
              <given-names>AV</given-names>
            </name>
            <name>
              <surname>Oliveira</surname>
              <given-names>AC</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>II Diretriz de Resson&#226;ncia Magn&#233;tica e Tomografia Computadorizada Cardiovascular da Sociedade Brasileira de Cardiologia e do Col&#233;gio Brasileiro de Radiologia</article-title>
          <source>Arq Bras Cardiol</source>
          <year>2014</year>
          <volume>103</volume>
          <issue>6 Suppl 3</issue>
          <fpage>1</fpage>
          <lpage>86</lpage>
        </element-citation>
      </ref>
      <ref id="B193">
        <label>193</label>
        <mixed-citation>193 Alexander AD. "Impacts of Telemation on Modern Society" in On Theory and Practice of Robots and Manipulators, Springer Berlin Heidelberg, 1972, p.121-36</mixed-citation>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Alexander</surname>
              <given-names>AD</given-names>
            </name>
          </person-group>
          <source>"Impacts of Telemation on Modern Society" in On Theory and Practice of Robots and Manipulators, Springer Berlin Heidelberg</source>
          <year>1972</year>
          <fpage>121</fpage>
          <lpage>136</lpage>
        </element-citation>
      </ref>
      <ref id="B194">
        <label>194</label>
        <mixed-citation>194 Rininsland H. ARTEMIS. A telemanipulator for cardiac surgery. Eur J Cardiothorac Surg. 1999;16(Suppl 2): S106-11</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rininsland</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>ARTEMIS: A telemanipulator for cardiac surgery</article-title>
          <source>Eur J Cardiothorac Surg</source>
          <year>1999</year>
          <volume>16</volume>
          <issue>Suppl 2</issue>
          <fpage>S106</fpage>
          <lpage>S111</lpage>
        </element-citation>
      </ref>
      <ref id="B195">
        <label>195</label>
        <mixed-citation>195 Canale LS, Colafranceschi AS. Is robotic mitral valve surgery more expensive than its conventional counterpart? Interact Cardiovasc Thorac Surg. 2015;20(6): 844-7</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Canale</surname>
              <given-names>LS</given-names>
            </name>
            <name>
              <surname>Colafranceschi</surname>
              <given-names>AS</given-names>
            </name>
          </person-group>
          <article-title>Is robotic mitral valve surgery more expensive than its conventional counterpart</article-title>
          <source>Interact Cardiovasc Thorac Surg</source>
          <year>2015</year>
          <volume>20</volume>
          <issue>6</issue>
          <fpage>844</fpage>
          <lpage>847</lpage>
        </element-citation>
      </ref>
      <ref id="B196">
        <label>196</label>
        <mixed-citation>196 Sepehripour AH, Garas G, Athanasiou T, Casula R. Robotics in cardiac surgery. Ann R Coll Surg Engl. 2018;100(Suppl 7): 22-33</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sepehripour</surname>
              <given-names>AH</given-names>
            </name>
            <name>
              <surname>Garas</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Athanasiou</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Casula</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Robotics in cardiac surgery</article-title>
          <source>Ann R Coll Surg Engl</source>
          <year>2018</year>
          <volume>100</volume>
          <issue>Suppl 7</issue>
          <fpage>22</fpage>
          <lpage>33</lpage>
        </element-citation>
      </ref>
      <ref id="B197">
        <label>197</label>
        <mixed-citation>197 Lee JD, Srivastava M, Bonatti J. History and current status of robotic totally endoscopic coronary artery bypass. Circ J. 2012;76(9): 2058-65</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Srivastava</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Bonatti</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>History and current status of robotic totally endoscopic coronary artery bypass</article-title>
          <source>Circ J</source>
          <year>2012</year>
          <volume>76</volume>
          <issue>9</issue>
          <fpage>2058</fpage>
          <lpage>2065</lpage>
        </element-citation>
      </ref>
      <ref id="B198">
        <label>198</label>
        <mixed-citation>198 Poston RS, Tran R, Collins M, Reynolds M, Connerney I, Reicher B, et al. Comparison of economic and patient outcomes with minimally invasive vs. traditional off-pump CABG techniques. Ann Surg. 2008;248(4): 638-46</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Poston</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Tran</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Collins</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Reynolds</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Connerney</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Reicher</surname>
              <given-names>B</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Comparison of economic and patient outcomes with minimally invasive vs: traditional off-pump CABG techniques</article-title>
          <source>Ann Surg</source>
          <year>2008</year>
          <volume>248</volume>
          <issue>4</issue>
          <fpage>638</fpage>
          <lpage>646</lpage>
        </element-citation>
      </ref>
      <ref id="B199">
        <label>199</label>
        <mixed-citation>199 Bonatti J, Schachner T, Bonaros N, Oehlinger A, Ruetzler E, Friedrich G, et al. How to improve performance of robotic totally endoscopic coronary artery bypass grafting. Am J Surg. 2008;195(5): 711-6</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bonatti</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Schachner</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Bonaros</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Oehlinger</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ruetzler</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Friedrich</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>How to improve performance of robotic totally endoscopic coronary artery bypass grafting</article-title>
          <source>Am J Surg</source>
          <year>2008</year>
          <volume>195</volume>
          <issue>5</issue>
          <fpage>711</fpage>
          <lpage>716</lpage>
        </element-citation>
      </ref>
      <ref id="B200">
        <label>200</label>
        <mixed-citation>200 Desai HP, Tran R, Steinwagner T, Poston RS. Challenges of telerobotics in coronary bypass surgery. Expert Rev Med Devices. 2010;7(2): 165-8</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Desai</surname>
              <given-names>HP</given-names>
            </name>
            <name>
              <surname>Tran</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Steinwagner</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Poston</surname>
              <given-names>RS</given-names>
            </name>
          </person-group>
          <article-title>Challenges of telerobotics in coronary bypass surgery</article-title>
          <source>Expert Rev Med Devices</source>
          <year>2010</year>
          <volume>7</volume>
          <issue>2</issue>
          <fpage>165</fpage>
          <lpage>168</lpage>
        </element-citation>
      </ref>
      <ref id="B201">
        <label>201</label>
        <mixed-citation>201 Reicher B, Poston RS, Mehra MR, et al. Simultaneous 'hybrid' percutaneous coronary intervention and minimally invasive surgical bypass grafting: feasibility, safety, and clinical outcomes. Am Heart J. 2008;155(4): 661-7</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reicher</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Poston</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Mehra</surname>
              <given-names>MR</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Simultaneous 'hybrid' percutaneous coronary intervention and minimally invasive surgical bypass grafting: feasibility, safety, and clinical outcomes</article-title>
          <source>Am Heart J</source>
          <year>2008</year>
          <volume>155</volume>
          <issue>4</issue>
          <fpage>661</fpage>
          <lpage>667</lpage>
        </element-citation>
      </ref>
      <ref id="B202">
        <label>202</label>
        <mixed-citation>202 Saceanu SM, Angelescu C, Valeriu S, Patrascu A. Telesurgery and Robotic Surgery: Ethical and Legal Aspect. J Community Med Health Educ. 2015;5(3): 355</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Saceanu</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Angelescu</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Valeriu</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Patrascu</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Telesurgery and Robotic Surgery: Ethical and Legal Aspect</article-title>
          <source>J Community Med Health Educ</source>
          <year>2015</year>
          <volume>5</volume>
          <issue>3</issue>
          <fpage>355</fpage>
          <lpage>355</lpage>
        </element-citation>
      </ref>
      <ref id="B203">
        <label>203</label>
        <mixed-citation>203 Ghezzi TL, Campos Corleta O C. 30 Years of Robotic Surgery. World J Surg. 2016;40(10): 2550-7</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ghezzi</surname>
              <given-names>TL</given-names>
            </name>
            <collab>Campos Corleta O C</collab>
          </person-group>
          <article-title>30 Years of Robotic Surgery</article-title>
          <source>World J Surg</source>
          <year>2016</year>
          <volume>40</volume>
          <issue>10</issue>
          <fpage>2550</fpage>
          <lpage>2557</lpage>
        </element-citation>
      </ref>
      <ref id="B204">
        <label>204</label>
        <mixed-citation>204 Silva V, McGregor T, Rayman R, Luke PP. Telementoring and Telesurgery: Future or Fiction? Robot Surgery. Seung Hyuk Baik: IntechOpen. 2010.p.272. [Available from: <ext-link ext-link-type="uri" xlink:href="https://www.intechopen.com/books/robot-surgery/telementoring-and-telesurgery-future-or-fiction-]">https://www.intechopen.com/books/robot-surgery/telementoring-and-telesurgery-future-or-fiction-]</ext-link>
				</mixed-citation>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Silva</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>McGregor</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Rayman</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Luke</surname>
              <given-names>PP</given-names>
            </name>
          </person-group>
          <source>Telementoring and Telesurgery: Future or Fiction? Robot Surgery</source>
          <publisher-loc>Seung Hyuk Baik</publisher-loc>
          <publisher-name>IntechOpen</publisher-name>
          <year>2010</year>
          <fpage>272</fpage>
          <lpage>272</lpage>
          <ext-link ext-link-type="uri" xlink:href="https://www.intechopen.com/books/robot-surgery/telementoring-and-telesurgery-future-or-fiction-]">https://www.intechopen.com/books/robot-surgery/telementoring-and-telesurgery-future-or-fiction-]</ext-link>
        </element-citation>
      </ref>
      <ref id="B205">
        <label>205</label>
        <mixed-citation>205 Nifong LW, Chu VF, Bailey BM, Maziarz DM, Sorrell VL, Holbert D, et al. Robotic mitral valve repair: experience with the da Vinci system. Ann Thorac Surg. 2003;75(2): 438-42</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nifong</surname>
              <given-names>LW</given-names>
            </name>
            <name>
              <surname>Chu</surname>
              <given-names>VF</given-names>
            </name>
            <name>
              <surname>Bailey</surname>
              <given-names>BM</given-names>
            </name>
            <name>
              <surname>Maziarz</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Sorrell</surname>
              <given-names>VL</given-names>
            </name>
            <name>
              <surname>Holbert</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Robotic mitral valve repair: experience with the da Vinci system</article-title>
          <source>Ann Thorac Surg</source>
          <year>2003</year>
          <volume>75</volume>
          <issue>2</issue>
          <fpage>438</fpage>
          <lpage>442</lpage>
        </element-citation>
      </ref>
      <ref id="B206">
        <label>206</label>
        <mixed-citation>206 Nifong LW, Chitwood WR, Pappas PS, Smith CR, Argenziano M, Starnes VA, et al. Robotic mitral valve surgery: a United States multicenter trial. J Thorac Cardiovasc Surg. 2005;129(6): 1395-404</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nifong</surname>
              <given-names>LW</given-names>
            </name>
            <name>
              <surname>Chitwood</surname>
              <given-names>WR</given-names>
            </name>
            <name>
              <surname>Pappas</surname>
              <given-names>PS</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>Argenziano</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Starnes</surname>
              <given-names>VA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Robotic mitral valve surgery: a United States multicenter trial</article-title>
          <source>J Thorac Cardiovasc Surg</source>
          <year>2005</year>
          <volume>129</volume>
          <issue>6</issue>
          <fpage>1395</fpage>
          <lpage>1404</lpage>
        </element-citation>
      </ref>
      <ref id="B207">
        <label>207</label>
        <mixed-citation>207 Deeba S, Aggarwal R, Sains P, Martin S, Athanasiou T, Casula R, et al. Cardiac robotics: a review and St Mary's experience. Int J Med Robot. 2006;2(1): 16-20</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Deeba</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Aggarwal</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Sains</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Athanasiou</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Casula</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cardiac robotics: a review and St Mary's experience</article-title>
          <source>Int J Med Robot</source>
          <year>2006</year>
          <volume>2</volume>
          <issue>1</issue>
          <fpage>16</fpage>
          <lpage>20</lpage>
        </element-citation>
      </ref>
      <ref id="B208">
        <label>208</label>
        <mixed-citation>208 Cavallaro P, Rhee AJ, Chiang Y, Itagaki S, Seigerman M, Chikwe J. In-hospital mortality and morbidity after robotic coronary artery surgery. J Cardiothorac Vasc Anesth. 2015;29(1): 27-31</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cavallaro</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Rhee</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Chiang</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Itagaki</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Seigerman</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Chikwe</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>In-hospital mortality and morbidity after robotic coronary artery surgery</article-title>
          <source>J Cardiothorac Vasc Anesth</source>
          <year>2015</year>
          <volume>29</volume>
          <issue>1</issue>
          <fpage>27</fpage>
          <lpage>31</lpage>
        </element-citation>
      </ref>
      <ref id="B209">
        <label>209</label>
        <mixed-citation>209 Wright JD. Robotic-assisted surgery: Robotics in cardiac surgery balancing evidence and implementation. JAMA. 2017;318(16): 1545-7</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wright</surname>
              <given-names>JD</given-names>
            </name>
          </person-group>
          <article-title>Robotic-assisted surgery: Robotics in cardiac surgery balancing evidence and implementation</article-title>
          <source>JAMA</source>
          <year>2017</year>
          <volume>318</volume>
          <issue>16</issue>
          <fpage>1545</fpage>
          <lpage>1547</lpage>
        </element-citation>
      </ref>
      <ref id="B210">
        <label>210</label>
        <mixed-citation>210 Sedrakyan A, Marinac-Dabic D, Holmes DR. The international registry infrastructure for cardiovascular device evaluation and surveillance. JAMA. 2013;310(3): 257-9</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sedrakyan</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Marinac-Dabic</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Holmes</surname>
              <given-names>DR</given-names>
            </name>
          </person-group>
          <article-title>The international registry infrastructure for cardiovascular device evaluation and surveillance</article-title>
          <source>JAMA</source>
          <year>2013</year>
          <volume>310</volume>
          <issue>3</issue>
          <fpage>257</fpage>
          <lpage>259</lpage>
        </element-citation>
      </ref>
      <ref id="B211">
        <label>211</label>
        <mixed-citation>211 Afshar AE and Parikh PB. Prevention of Contrast and Radiation Injury During Coronary Angiography and Percutaneous Coronary Intervention. Curr Treat Options Cardiovasc Med. 2018;20(4): 32</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Afshar</surname>
              <given-names>AE</given-names>
            </name>
            <name>
              <surname>Parikh</surname>
              <given-names>PB</given-names>
            </name>
          </person-group>
          <article-title>Prevention of Contrast and Radiation Injury During Coronary Angiography and Percutaneous Coronary Intervention</article-title>
          <source>Curr Treat Options Cardiovasc Med</source>
          <year>2018</year>
          <volume>20</volume>
          <issue>4</issue>
          <fpage>32</fpage>
          <lpage>32</lpage>
        </element-citation>
      </ref>
      <ref id="B212">
        <label>212</label>
        <mixed-citation>212 Plourde G, Pancholy SB, Nolan J, Jolly S, Rao SV, Amhed I, et al. Radiation exposure in relation to the arterial access site used for diagnostic coronary angiography and percutaneous coronary intervention: a systematic review and meta-analysis. Lancet. 2015;386(10009): 2192-203</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Plourde</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Pancholy</surname>
              <given-names>SB</given-names>
            </name>
            <name>
              <surname>Nolan</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Jolly</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Rao</surname>
              <given-names>SV</given-names>
            </name>
            <name>
              <surname>Amhed</surname>
              <given-names>I</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Radiation exposure in relation to the arterial access site used for diagnostic coronary angiography and percutaneous coronary intervention: a systematic review and meta-analysis</article-title>
          <source>Lancet</source>
          <year>2015</year>
          <volume>386</volume>
          <issue>10009</issue>
          <fpage>2192</fpage>
          <lpage>2203</lpage>
        </element-citation>
      </ref>
      <ref id="B213">
        <label>213</label>
        <mixed-citation>213 Smilowitz NR, Balter S, Weisz G. Occupational hazards of interventional cardiology. Cardiovasc Revasc Med. 2013;14(4): 223-8</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Smilowitz</surname>
              <given-names>NR</given-names>
            </name>
            <name>
              <surname>Balter</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Weisz</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Occupational hazards of interventional cardiology</article-title>
          <source>Cardiovasc Revasc Med</source>
          <year>2013</year>
          <volume>14</volume>
          <issue>4</issue>
          <fpage>223</fpage>
          <lpage>228</lpage>
        </element-citation>
      </ref>
      <ref id="B214">
        <label>214</label>
        <mixed-citation>214 Bezerra HG, Mehanna E, G WV, A Costa M, Weisz G. Longitudinal Geographic Miss (LGM) in Robotic Assisted Versus Manual Percutaneous Coronary Interventions. J Interv Cardiol. 2015;28(5): 449-55</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bezerra</surname>
              <given-names>HG</given-names>
            </name>
            <name>
              <surname>Mehanna</surname>
              <given-names>E G WV</given-names>
            </name>
            <name>
              <surname> Costa</surname>
              <given-names>A M</given-names>
            </name>
            <name>
              <surname>Weisz</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Longitudinal Geographic Miss (LGM) in Robotic Assisted Versus Manual Percutaneous Coronary Interventions</article-title>
          <source>J Interv Cardiol</source>
          <year>2015</year>
          <volume>28</volume>
          <issue>5</issue>
          <fpage>449</fpage>
          <lpage>455</lpage>
        </element-citation>
      </ref>
      <ref id="B215">
        <label>215</label>
        <mixed-citation>215 Lo N, Gutierrez JA, Swaminathan RV. Robotic-Assisted Percutaneous Coronary Intervention. Curr Treat Options Cardiovasc Med. 2018;20(2): 14</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lo</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Gutierrez</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Swaminathan</surname>
              <given-names>RV</given-names>
            </name>
          </person-group>
          <article-title>Robotic-Assisted Percutaneous Coronary Intervention</article-title>
          <source>Curr Treat Options Cardiovasc Med</source>
          <year>2018</year>
          <volume>20</volume>
          <issue>2</issue>
          <fpage>14</fpage>
          <lpage>14</lpage>
        </element-citation>
      </ref>
      <ref id="B216">
        <label>216</label>
        <mixed-citation>216 Mangels DR, Giri J, Hirshfeld J, Wilensky RL. Robotic-assisted percutaneous coronary intervention. Catheter Cardiovasc Interv. 2017;90(6): 948-55</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mangels</surname>
              <given-names>DR</given-names>
            </name>
            <name>
              <surname>Giri</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Hirshfeld</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Wilensky</surname>
              <given-names>RL</given-names>
            </name>
          </person-group>
          <article-title>Robotic-assisted percutaneous coronary intervention</article-title>
          <source>Catheter Cardiovasc Interv</source>
          <year>2017</year>
          <volume>90</volume>
          <issue>6</issue>
          <fpage>948</fpage>
          <lpage>955</lpage>
        </element-citation>
      </ref>
      <ref id="B217">
        <label>217</label>
        <mixed-citation>217 Smitson CC, Ang L, Pourdjabbar A, Reeves R, Patel M, Mahmud E. Safety and Feasibility of a Novel, Second-Generation Robotic-Assisted System for Percutaneous Coronary Intervention: First-in-Human Report. J Invasive Cardiol. 2018;30(4): 152-6</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Smitson</surname>
              <given-names>CC</given-names>
            </name>
            <name>
              <surname>Ang</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Pourdjabbar</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Reeves</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Patel</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Mahmud</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Safety and Feasibility of a Novel, Second-Generation Robotic-Assisted System for Percutaneous Coronary Intervention: First-in-Human Report</article-title>
          <source>J Invasive Cardiol</source>
          <year>2018</year>
          <volume>30</volume>
          <issue>4</issue>
          <fpage>152</fpage>
          <lpage>156</lpage>
        </element-citation>
      </ref>
      <ref id="B218">
        <label>218</label>
        <mixed-citation>218 Swaminathan RV, Rao SV. Robotic-assisted transradial diagnostic coronary angiography. Catheter Cardiovasc Interv. 2018;92(1): 54-7</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Swaminathan</surname>
              <given-names>RV</given-names>
            </name>
            <name>
              <surname>Rao</surname>
              <given-names>SV</given-names>
            </name>
          </person-group>
          <article-title>Robotic-assisted transradial diagnostic coronary angiography</article-title>
          <source>Catheter Cardiovasc Interv</source>
          <year>2018</year>
          <volume>92</volume>
          <issue>1</issue>
          <fpage>54</fpage>
          <lpage>57</lpage>
        </element-citation>
      </ref>
      <ref id="B219">
        <label>219</label>
        <mixed-citation>219 Maor E, Eleid MF, Gulati R, Lerman A, Sandhu GS. Current and Future Use of Robotic Devices to Perform Percutaneous Coronary Interventions: A Review. J Am Heart Assoc. 2017;6(7). pii: e006239</mixed-citation>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Maor</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Eleid</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Gulati</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Lerman</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sandhu</surname>
              <given-names>GS</given-names>
            </name>
          </person-group>
          <chapter-title>Current and Future Use of Robotic Devices to Perform Percutaneous Coronary Interventions: A Review</chapter-title>
          <source>J Am Heart Assoc</source>
          <year>2017</year>
          <volume>6</volume>
          <issue>7</issue>
          <pub-id pub-id-type="pii">e006239</pub-id>
        </element-citation>
      </ref>
      <ref id="B220">
        <label>220</label>
        <mixed-citation>220 Mahmud E, Naghi J, Ang L, Harrison J, Behnamfar O, Pourdjabbar A, et al. Demonstration of the Safety and Feasibility of Robotically Assisted Percutaneous Coronary Intervention in Complex Coronary Lesions: Results of the CORA-PCI Study (Complex Robotically Assisted Percutaneous Coronary Intervention). JACC Cardiovasc Interv. 2017;10(13): 1320-7</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mahmud</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Naghi</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Ang</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Harrison</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Behnamfar</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Pourdjabbar</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Demonstration of the Safety and Feasibility of Robotically Assisted Percutaneous Coronary Intervention in Complex Coronary Lesions: Results of the CORA-PCI Study (Complex Robotically Assisted Percutaneous Coronary Intervention)</article-title>
          <source>JACC Cardiovasc Interv</source>
          <year>2017</year>
          <volume>10</volume>
          <issue>13</issue>
          <fpage>1320</fpage>
          <lpage>1327</lpage>
        </element-citation>
      </ref>
      <ref id="B221">
        <label>221</label>
        <mixed-citation>221 Mahmud E, Schmid F, Kalmar P, Deutschmann H, Hafner F, Rief P, et al. Feasibility and Safety of Robotic Peripheral Vascular Interventions: Results of the RAPID Trial. JACC Cardiovasc Interv. 2016;9(19): 2058-64</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mahmud</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Schmid</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Kalmar</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Deutschmann</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Hafner</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Rief</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Feasibility and Safety of Robotic Peripheral Vascular Interventions: Results of the RAPID Trial</article-title>
          <source>JACC Cardiovasc Interv</source>
          <year>2016</year>
          <volume>9</volume>
          <issue>19</issue>
          <fpage>2058</fpage>
          <lpage>2064</lpage>
        </element-citation>
      </ref>
      <ref id="B222">
        <label>222</label>
        <mixed-citation>222 Smilowitz NR, Moses JW, Sosa FA, Lerman B, Qureshi Y, Dalton KE, et al. Robotic-Enhanced PCI Compared to the Traditional Manual Approach. J Invasive Cardiol. 2014;26(7): 318-21</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Smilowitz</surname>
              <given-names>NR</given-names>
            </name>
            <name>
              <surname>Moses</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Sosa</surname>
              <given-names>FA</given-names>
            </name>
            <name>
              <surname>Lerman</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Qureshi</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Dalton</surname>
              <given-names>KE</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Robotic-Enhanced PCI Compared to the Traditional Manual Approach</article-title>
          <source>J Invasive Cardiol</source>
          <year>2014</year>
          <volume>26</volume>
          <issue>7</issue>
          <fpage>318</fpage>
          <lpage>321</lpage>
        </element-citation>
      </ref>
      <ref id="B223">
        <label>223</label>
        <mixed-citation>223 Weisz G, Smilowitz NR, Metzger DC, Caputo R, Delgado J, Marshall JJ, et al. The association between experience and proficiency with robotic-enhanced coronary intervention-insights from the PRECISE multi-center study. Acute Card Care. 2014;16(2): 37-40</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Weisz</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Smilowitz</surname>
              <given-names>NR</given-names>
            </name>
            <name>
              <surname>Metzger</surname>
              <given-names>DC</given-names>
            </name>
            <name>
              <surname>Caputo</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Delgado</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Marshall</surname>
              <given-names>JJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The association between experience and proficiency with robotic-enhanced coronary intervention-insights from the PRECISE multi-center study</article-title>
          <source>Acute Card Care</source>
          <year>2014</year>
          <volume>16</volume>
          <issue>2</issue>
          <fpage>37</fpage>
          <lpage>40</lpage>
        </element-citation>
      </ref>
      <ref id="B224">
        <label>224</label>
        <mixed-citation>224 Weisz G, Metzger DC, Caputo RP, Delgado JA, Marshall JJ, Vetrovec GW, et al. Safety and feasibility of robotic percutaneous coronary intervention: PRECISE (Percutaneous Robotically-Enhanced Coronary Intervention) Study. J Am Coll Cardiol. 2013;61(15): 1596-600</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Weisz</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Metzger</surname>
              <given-names>DC</given-names>
            </name>
            <name>
              <surname>Caputo</surname>
              <given-names>RP</given-names>
            </name>
            <name>
              <surname>Delgado</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Marshall</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Vetrovec</surname>
              <given-names>GW</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Safety and feasibility of robotic percutaneous coronary intervention: PRECISE (Percutaneous Robotically-Enhanced Coronary Intervention) Study</article-title>
          <source>J Am Coll Cardiol</source>
          <year>2013</year>
          <volume>61</volume>
          <issue>15</issue>
          <fpage>1596</fpage>
          <lpage>1600</lpage>
        </element-citation>
      </ref>
      <ref id="B225">
        <label>225</label>
        <mixed-citation>225 Madder RD, VanOosterhout S, Mulder A, Elmore M, Campbell J, Borgman A, et al. Impact of robotics and a suspended lead suit on physician radiation exposure during percutaneous coronary intervention. Cardiovasc Revasc Med. 2017;18(3): 190-6</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Madder</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>VanOosterhout</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Mulder</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Elmore</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Campbell</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Borgman</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Impact of robotics and a suspended lead suit on physician radiation exposure during percutaneous coronary intervention</article-title>
          <source>Cardiovasc Revasc Med</source>
          <year>2017</year>
          <volume>18</volume>
          <issue>3</issue>
          <fpage>190</fpage>
          <lpage>196</lpage>
        </element-citation>
      </ref>
      <ref id="B226">
        <label>226</label>
        <mixed-citation>226 Healthcare Information and Management Systems Society Announces the Alliance for Nursing Informatics Selection of 2016-2017 Emerging Leaders: Nurses and Mentors Linked Through Informatics Professional Development Program. Comput Inform Nurs. 2016;34(5): 196</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <collab>Healthcare Information and Management Systems</collab>
          </person-group>
          <article-title>Society Announces the Alliance for Nursing Informatics Selection of 2016-2017 Emerging Leaders: Nurses and Mentors Linked Through Informatics Professional Development Program</article-title>
          <source>Comput Inform Nurs</source>
          <year>2016</year>
          <volume>34</volume>
          <issue>5</issue>
          <fpage>196</fpage>
        </element-citation>
      </ref>
      <ref id="B227">
        <label>227</label>
        <mixed-citation>227 Advisory Board. A milestone: Kaiser now interacts more with patients virtually than in-person. Daily Briefing, October 13, 2016. Internet. [Accessed in 2019 May 10]. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.advisory.com/daily-briefing/2016/10/13/kaiser-telehealth">https://www.advisory.com/daily-briefing/2016/10/13/kaiser-telehealth</ext-link>
				</mixed-citation>
        <element-citation publication-type="book">
          <source>Advisory Board. A milestone: Kaiser now interacts more with patients virtually than in-person. Daily Briefing</source>
          <day>13</day>
          <month>10</month>
          <year>2016</year>
          <comment>Internet</comment>
          <date-in-citation content-type="access-date">2019 May 10</date-in-citation>
          <comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://www.advisory.com/daily-briefing/2016/10/13/kaiser-telehealth">https://www.advisory.com/daily-briefing/2016/10/13/kaiser-telehealth</ext-link>
					</comment>
        </element-citation>
      </ref>
      <ref id="B228">
        <label>228</label>
        <mixed-citation>228 Conselho Federal de Medicina. (CFM). C&#243;digo de &#201;tica M&#233;dica, Resolu&#231;&#227;o CFM N&#186; 2217, de 27 de setembro de 2018, modificado pelas resolu&#231;&#245;es n.2.222/2018 e 2.226/2019. [Internet]. [Acesso em 06 junho 2019]. Dispon&#237;vel em: <ext-link ext-link-type="uri" xlink:href="http://portal.cfm.org.br">http://portal.cfm.org.br</ext-link>
				</mixed-citation>
        <element-citation publication-type="webpage">
          <person-group person-group-type="author">
            <collab>Conselho Federal de Medicina</collab>
          </person-group>
          <source>C&#243;digo de &#201;tica M&#233;dica, Resolu&#231;&#227;o CFM N&#186; 2217, de 27 de setembro de 2018, modificado pelas resolu&#231;&#245;es n.2.222/2018 e 2.226/2019</source>
          <comment>Internet</comment>
          <date-in-citation content-type="access-date">06 junho 2019</date-in-citation>
          <comment>Dispon&#237;vel em: <ext-link ext-link-type="uri" xlink:href="http://portal.cfm.org.br">http://portal.cfm.org.br</ext-link>
					</comment>
        </element-citation>
      </ref>
      <ref id="B229">
        <label>229</label>
        <mixed-citation>229 H.R.2 - 114th Congress (2015-2016). Public Law N.114-10-(04/16/2015) an Act. MedicareAccessand CHIP Reauthorization Act of 2015. Internet. [Accessed in 2018 May 12]. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.congress.gov/114/plaws/publ10/PLAW-114publ10.pdf">https://www.congress.gov/114/plaws/publ10/PLAW-114publ10.pdf</ext-link>
				</mixed-citation>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <collab>H.R.2 - 114th Congress</collab>
          </person-group>
          <year>2016</year>
          <source>Public Law N.114-10-(04/16/2015) an Act. MedicareAccessand CHIP Reauthorization Act of 2015</source>
          <comment>Internet</comment>
          <date-in-citation content-type="access-date">2018 May 12</date-in-citation>
          <comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://www.congress.gov/114/plaws/publ10/PLAW-114publ10.pdf">https://www.congress.gov/114/plaws/publ10/PLAW-114publ10.pdf</ext-link>
					</comment>
        </element-citation>
      </ref>
      <ref id="B230">
        <label>230</label>
        <mixed-citation>230 Brasil. Minist&#233;rio da Sa&#250;de.Secretaria de Aten&#231;ao &#224; Sa&#250;de. SUS. Relat&#243;rio de Gest&#227;o. Internet. [Acesso em 05 fev 2018]. Dispon&#237;vel em: <ext-link ext-link-type="uri" xlink:href="https://www.relat--rio-de-Gest-oda-SAS-2015-Final.pdf">https://www.relat--rio-de-Gest-oda-SAS-2015-Final.pdf</ext-link>
				</mixed-citation>
        <element-citation publication-type="webpage">
          <person-group person-group-type="author">
            <collab>Brasil</collab>
            <collab>Minist&#233;rio da Sa&#250;de</collab>
          </person-group>
          <source>Secretaria de Aten&#231;ao &#224; Sa&#250;de. SUS. Relat&#243;rio de Gest&#227;o</source>
          <comment>Internet</comment>
          <date-in-citation content-type="access-date">05 fev 2018</date-in-citation>
          <comment>Dispon&#237;vel em: <ext-link ext-link-type="uri" xlink:href="https://www.relat--rio-de-Gest-oda-SAS-2015-Final.pdf">https://www.relat--rio-de-Gest-oda-SAS-2015-Final.pdf</ext-link>
					</comment>
        </element-citation>
      </ref>
      <ref id="B231">
        <label>231</label>
        <mixed-citation>231 Brasil. Minist&#233;rio da Sa&#250;de. Guia de avalia&#231;&#227;o, implanta&#231;&#227;o e monitoramento de programas e servi&#231;os em telemedicina e telessa&#250;de. 2018. Internet. [Acesso em 25 maio 2018]. Dispon&#237;vel em: <ext-link ext-link-type="uri" xlink:href="http://rebrats.saude.gov.br/images/MenuPrincipal/Guia_Avaliacao_telessaude_telemedicina.pdf">http://rebrats.saude.gov.br/images/MenuPrincipal/Guia_Avaliacao_telessaude_telemedicina.pdf</ext-link>
				</mixed-citation>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <collab>Brasil</collab>
            <collab>Minist&#233;rio da Sa&#250;de</collab>
          </person-group>
          <source>Guia de avalia&#231;&#227;o, implanta&#231;&#227;o e monitoramento de programas e servi&#231;os em telemedicina e telessa&#250;de</source>
          <year>2018</year>
          <comment>Internet</comment>
          <date-in-citation content-type="access-date">25 maio 2018</date-in-citation>
          <comment>Dispon&#237;vel em: <ext-link ext-link-type="uri" xlink:href="http://rebrats.saude.gov.br/images/MenuPrincipal/Guia_Avaliacao_telessaude_telemedicina.pdf">http://rebrats.saude.gov.br/images/MenuPrincipal/Guia_Avaliacao_telessaude_telemedicina.pdf</ext-link>
					</comment>
        </element-citation>
      </ref>
      <ref id="B232">
        <label>232</label>
        <mixed-citation>232 Figueira RM, Cunha LR, Neves DS, Alkmim MBM. From a Research Project to a Regular Telehealth Service: redefining objectives and strategies. Med-e-Tel 2013 The International Educational and Networking Forum for e-Health, Telemedicine and Health ICT, 2013 Luxembourg - Global Telemedicine and e-Health Updates: Knowledge Resources. 2013; 6: 264-7</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Figueira</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Cunha</surname>
              <given-names>LR</given-names>
            </name>
            <name>
              <surname>Neves</surname>
              <given-names>DS</given-names>
            </name>
            <name>
              <surname>Alkmim</surname>
              <given-names>MBM</given-names>
            </name>
          </person-group>
          <article-title>From a Research Project to a Regular Telehealth Service: redefining objectives and strategies</article-title>
          <source>Med-e-Tel 2013 The International Educational and Networking Forum for e-Health, Telemedicine and Health ICT, 2013 Luxembourg - Global Telemedicine and e-Health Updates: Knowledge Resources</source>
          <year>2013</year>
          <volume>6</volume>
          <fpage>264</fpage>
          <lpage>267</lpage>
        </element-citation>
      </ref>
      <ref id="B233">
        <label>233</label>
        <mixed-citation>233 Maldonado JM, Marques AB, Cruz A. Telemedicina: desafios &#224; sua difus&#227;o no Brasil. Cad Sa&#250;de P&#250;blica. 2016;32(Suppl 2): e00155615</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Maldonado</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Marques</surname>
              <given-names>AB</given-names>
            </name>
            <name>
              <surname>Cruz</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Telemedicina: desafios &#224; sua difus&#227;o no Brasil</article-title>
          <source>Cad Sa&#250;de P&#250;blica</source>
          <year>2016</year>
          <volume>32</volume>
          <issue>Suppl 2</issue>
          <elocation-id>e00155615</elocation-id>
        </element-citation>
      </ref>
      <ref id="B234">
        <label>234</label>
        <mixed-citation>234 Brasil. Minist&#233;rio da Sa&#250;de. Portaria n&#186; 26, de 02 de agosto de 2017. Torna p&#250;blica a decis&#227;o de incorporar a tecnologia de monitoramento remoto para avalia&#231;&#227;o de pacientes portadores de dispositivos card&#237;acos eletr&#244;nicos Implant&#225;veis (DCEI) no &#226;mbito do Sistema &#218;nico de Sa&#250;de - SUS. Bras&#237;lia; 2019. Internet. [Acesso em 16 junho 2019]. Dispon&#237;vel em: <ext-link ext-link-type="uri" xlink:href="http://www.downloads/portarias_SCTIE_26-27-29-30_consulta_publica_33-34-35-36%20(2).pdf">http://www.downloads/portarias_SCTIE_26-27-29-30_consulta_publica_33-34-35-36%20(2).pdf</ext-link>
				</mixed-citation>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <collab>Brasil</collab>
            <collab>Minist&#233;rio da Sa&#250;de</collab>
          </person-group>
          <source>Portaria n&#186; 26, de 02 de agosto de 2017. Torna p&#250;blica a decis&#227;o de incorporar a tecnologia de monitoramento remoto para avalia&#231;&#227;o de pacientes portadores de dispositivos card&#237;acos eletr&#244;nicos Implant&#225;veis (DCEI) no &#226;mbito do Sistema &#218;nico de Sa&#250;de - SUS</source>
          <publisher-loc>Bras&#237;lia</publisher-loc>
          <year>2019</year>
          <comment>Internet</comment>
          <date-in-citation content-type="access-date">16 junho 2019</date-in-citation>
          <comment>Dispon&#237;vel em: <ext-link ext-link-type="uri" xlink:href="http://www.downloads/portarias_SCTIE_26-27-29-30_consulta_publica_33-34-35-36%20(2).pdf">http://www.downloads/portarias_SCTIE_26-27-29-30_consulta_publica_33-34-35-36%20(2).pdf</ext-link>
					</comment>
        </element-citation>
      </ref>
      <ref id="B235">
        <label>235</label>
        <mixed-citation>235 Dinesen B, Nonnecke B, Lindeman D, Toft E, Kidholm K, Jethwani K, et al. Personalized Telehealth in the future: A Global Research Agenda. J Med Internet Res. 2016;18(3): e53</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dinesen</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Nonnecke</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Lindeman</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Toft</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Kidholm</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Jethwani</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Personalized Telehealth in the future: A Global Research Agenda</article-title>
          <source>J Med Internet Res</source>
          <year>2016</year>
          <volume>18</volume>
          <issue>3</issue>
          <elocation-id>e53</elocation-id>
        </element-citation>
      </ref>
      <ref id="B236">
        <label>236</label>
        <mixed-citation>236 Brasil. Constitui&#231;&#227;o 1988. Constitui&#231;&#227;o da Rep&#250;blica Federativa de Brasil. Bras&#237;lia: Gr&#225;fica do Senado; 1988</mixed-citation>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <collab>Brasil</collab>
          </person-group>
          <source>Constitui&#231;&#227;o 1988. Constitui&#231;&#227;o da Rep&#250;blica Federativa de Brasil</source>
          <year>1988</year>
          <publisher-loc>Bras&#237;lia</publisher-loc>
          <publisher-name>Gr&#225;fica do Senado</publisher-name>
        </element-citation>
      </ref>
      <ref id="B237">
        <label>237</label>
        <mixed-citation>237 Dallari SG, Nunes Jr VS. Direito sanit&#225;rio. S&#227;o Paulo: Verbatim; 2010. p 68.</mixed-citation>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Dallari</surname>
              <given-names>SG</given-names>
            </name>
            <name>
              <surname>Nunes</surname>
              <given-names>VS</given-names>
              <suffix>Jr</suffix>
            </name>
          </person-group>
          <source>Direito sanit&#225;rio</source>
          <year>2010</year>
          <publisher-loc>S&#227;o Paulo</publisher-loc>
          <publisher-name>Verbatim</publisher-name>
        </element-citation>
      </ref>
      <ref id="B238">
        <label>238</label>
        <mixed-citation>238 Resende NF. A amplitude da express&#227;o sa&#250;de no marco normativo brasileiro. In: Bliancheriene AC, Santos JS (orgs). Direito&#224; vida e &#224; sa&#250;de: impactos or&#231;ament&#225;rios e judicial. S&#227;o Paulo. Atlas; 2010</mixed-citation>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Resende</surname>
              <given-names>NF</given-names>
            </name>
          </person-group>
          <chapter-title>A amplitude da express&#227;o sa&#250;de no marco normativo brasileiro</chapter-title>
          <person-group person-group-type="compiler">
            <name>
              <surname>Bliancheriene</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Santos</surname>
              <given-names>JS</given-names>
            </name>
          </person-group>
          <source>Direito&#224; vida e &#224; sa&#250;de: impactos or&#231;ament&#225;rios e judicial</source>
          <publisher-loc>S&#227;o Paulo</publisher-loc>
          <publisher-name>Atlas</publisher-name>
          <year>2010</year>
        </element-citation>
      </ref>
      <ref id="B239">
        <label>239</label>
        <mixed-citation>239 Porter ME. What is value in healthcare? N Engl J Med. 2010;363(26): 2477-81</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Porter</surname>
              <given-names>ME</given-names>
            </name>
          </person-group>
          <article-title>What is value in healthcare</article-title>
          <source>N Engl J Med</source>
          <year>2010</year>
          <volume>363</volume>
          <issue>26</issue>
          <fpage>2477</fpage>
          <lpage>2481</lpage>
        </element-citation>
      </ref>
      <ref id="B240">
        <label>240</label>
        <mixed-citation>240 Schwamm LH. Telehealth: seven strategies to successfully implement disruptive technology and transform health care. Health Aff (Millwood). 2014;33(2): 200-6</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schwamm</surname>
              <given-names>LH</given-names>
            </name>
          </person-group>
          <article-title>Telehealth: seven strategies to successfully implement disruptive technology and transform health care</article-title>
          <source>Health Aff (Millwood)</source>
          <year>2014</year>
          <volume>33</volume>
          <issue>2</issue>
          <fpage>200</fpage>
          <lpage>206</lpage>
        </element-citation>
      </ref>
      <ref id="B241">
        <label>241</label>
        <mixed-citation>241 Institute of Medicine. Crossing the quality chasm: a new health system for the 21st century. Washington (DC): National Academies Press; 2001</mixed-citation>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <collab>Institute of Medicine</collab>
          </person-group>
          <source>Crossing the quality chasm: a new health system for the 21st century</source>
          <year>2001</year>
          <publisher-loc>Washington (DC)</publisher-loc>
          <publisher-name>National Academies Press</publisher-name>
        </element-citation>
      </ref>
      <ref id="B242">
        <label>242</label>
        <mixed-citation>242 Pan E, Cusack C, Hook J, Vincent A, Kaelber DC, Bates DW, et al. The value of provider-to-provider telehealth. Telemed J E Health. 2008;14(5): 446-53</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pan</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Cusack</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Hook</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Vincent</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kaelber</surname>
              <given-names>DC</given-names>
            </name>
            <name>
              <surname>Bates</surname>
              <given-names>DW</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The value of provider-to-provider telehealth</article-title>
          <source>Telemed J E Health</source>
          <year>2008</year>
          <volume>14</volume>
          <issue>5</issue>
          <fpage>446</fpage>
          <lpage>453</lpage>
        </element-citation>
      </ref>
      <ref id="B243">
        <label>243</label>
        <mixed-citation>243 Kang HG, Mahoney DF, Hoenig H, Hirth VA, Bonato P, Hajjar I, et al. In situ monitoring of health in older adults: technologies and issues. J Am Geriatr Soc. 2010;58(8): 1579-86</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kang</surname>
              <given-names>HG</given-names>
            </name>
            <name>
              <surname>Mahoney</surname>
              <given-names>DF</given-names>
            </name>
            <name>
              <surname>Hoenig</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Hirth</surname>
              <given-names>VA</given-names>
            </name>
            <name>
              <surname>Bonato</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Hajjar</surname>
              <given-names>I</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>In situ monitoring of health in older adults: technologies and issues</article-title>
          <source>J Am Geriatr Soc</source>
          <year>2010</year>
          <volume>58</volume>
          <issue>8</issue>
          <fpage>1579</fpage>
          <lpage>1586</lpage>
        </element-citation>
      </ref>
      <ref id="B244">
        <label>244</label>
        <mixed-citation>244 Barnett TE, Chumbler NR, Vogel WB, Beyth RJ, Qin H, Kobb R. The effectiveness of a care coordination home telehealth program for veterans with diabetes mellitus: a 2-year follow-up. Am J Manag Care. 2006;12(8): 467-74</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Barnett</surname>
              <given-names>TE</given-names>
            </name>
            <name>
              <surname>Chumbler</surname>
              <given-names>NR</given-names>
            </name>
            <name>
              <surname>Vogel</surname>
              <given-names>WB</given-names>
            </name>
            <name>
              <surname>Beyth</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Qin</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kobb</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>The effectiveness of a care coordination home telehealth program for veterans with diabetes mellitus: a 2-year follow-up</article-title>
          <source>Am J Manag Care</source>
          <year>2006</year>
          <volume>12</volume>
          <issue>8</issue>
          <fpage>467</fpage>
          <lpage>474</lpage>
        </element-citation>
      </ref>
      <ref id="B245">
        <label>245</label>
        <mixed-citation>245 Jia H, Chuang HC, Wu SS, Wang X, Chumbler NR. Long-term effect of home telehealth services on preventable hospitalization use. J Rehabil Res Dev. 2009;46(5): 557-66</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jia</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Chuang</surname>
              <given-names>HC</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Chumbler</surname>
              <given-names>NR</given-names>
            </name>
          </person-group>
          <article-title>Long-term effect of home telehealth services on preventable hospitalization use</article-title>
          <source>J Rehabil Res Dev</source>
          <year>2009</year>
          <volume>46</volume>
          <issue>5</issue>
          <fpage>557</fpage>
          <lpage>566</lpage>
        </element-citation>
      </ref>
      <ref id="B246">
        <label>246</label>
        <mixed-citation>246 Chan WV, Pearson TA, Bennett GC, Cushman WC, Gaziano TA, Gorman PN, et al. ACC/AHA Special Report: Clinical Implementation Strategies: A Summary of Systematic Reviews by the NHLBI Implementation Science Work Group: A Report of the American College of Cardiology Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2017;135(9): e122-37</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chan</surname>
              <given-names>WV</given-names>
            </name>
            <name>
              <surname>Pearson</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Bennett</surname>
              <given-names>GC</given-names>
            </name>
            <name>
              <surname>Cushman</surname>
              <given-names>WC</given-names>
            </name>
            <name>
              <surname>Gaziano</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Gorman</surname>
              <given-names>PN</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>ACC/AHA Special Report: Clinical Implementation Strategies: A Summary of Systematic Reviews by the NHLBI Implementation Science Work Group: A Report of the American College of Cardiology Heart Association Task Force on Clinical Practice Guidelines</article-title>
          <source>Circulation</source>
          <year>2017</year>
          <volume>135</volume>
          <issue>9</issue>
          <fpage>e122</fpage>
          <lpage>e137</lpage>
        </element-citation>
      </ref>
      <ref id="B247">
        <label>247</label>
        <mixed-citation>247 Cloutier A, Finley J. Telepediatric cardiology practice in Canada. Telemed J E Health. 2004;10(1): 33-7</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cloutier</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Finley</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Telepediatric cardiology practice in Canada</article-title>
          <source>Telemed J E Health</source>
          <year>2004</year>
          <volume>10</volume>
          <issue>1</issue>
          <fpage>33</fpage>
          <lpage>37</lpage>
        </element-citation>
      </ref>
      <ref id="B248">
        <label>248</label>
        <mixed-citation>248 Dowie R, Mistry H, Young TA, Weatherburn GC, Gardiner HM, Rigby M, et al. Telemedicine in pediatric and perinatal cardiology: economic evaluation of a service in English hospitals. Int J Technol Assess Health Care. 2007;23(1): 116-25</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dowie</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Mistry</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Young</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Weatherburn</surname>
              <given-names>GC</given-names>
            </name>
            <name>
              <surname>Gardiner</surname>
              <given-names>HM</given-names>
            </name>
            <name>
              <surname>Rigby</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Telemedicine in pediatric and perinatal cardiology: economic evaluation of a service in English hospitals</article-title>
          <source>Int J Technol Assess Health Care</source>
          <year>2007</year>
          <volume>23</volume>
          <issue>1</issue>
          <fpage>116</fpage>
          <lpage>125</lpage>
        </element-citation>
      </ref>
      <ref id="B249">
        <label>249</label>
        <mixed-citation>249 Uscher-Pines L, Mulcahy A, Cowling D, Hunter G, Burns R, Mehrotra A. Access and quality of care in direct-to-consumer telemedicine. Telemed J E Health. 2016;22(4): 282-7</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Uscher-Pines</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Mulcahy</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Cowling</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Hunter</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Burns</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Mehrotra</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Access and quality of care in direct-to-consumer telemedicine</article-title>
          <source>Telemed J E Health</source>
          <year>2016</year>
          <volume>22</volume>
          <issue>4</issue>
          <fpage>282</fpage>
          <lpage>287</lpage>
        </element-citation>
      </ref>
      <ref id="B250">
        <label>250</label>
        <mixed-citation>250 UnitedHealthcare. UnitedHealthcare covers virtual care physician visits, expanding consumers' access to affordable health care options. Internet. [Accessed in 2016 July 16]. Availablke from: <ext-link ext-link-type="uri" xlink:href="http://www.uhc.com/news-room/2015-news-releasearchive/Unitedhealthcare-covers-virtual-care-physician-visitsMuhlestein">http://www.uhc.com/news-room/2015-news-releasearchive/Unitedhealthcare-covers-virtual-care-physician-visitsMuhlestein</ext-link> JB, Le V, Albert D, Moreno FL, Anderson JL, Yanowitz F, et al. Smartphone ECG for evaluation of STEMI: results of the ST LEUIS pilot study. J Electrocardiol. 2015;48(2): 249-59</mixed-citation>
        <element-citation publication-type="webpage">
          <person-group person-group-type="author">
            <collab>UnitedHealthcare</collab>
          </person-group>
          <source>UnitedHealthcare covers virtual care physician visits, expanding consumers' access to affordable health care options</source>
          <comment>Internet</comment>
          <date-in-citation content-type="access-date">2016 July 16</date-in-citation>
          <comment>Availablke from: <ext-link ext-link-type="uri" xlink:href="http://www.uhc.com/news-room/2015-news-releasearchive/Unitedhealthcare-covers-virtual-care-physician-visitsMuhlestein">http://www.uhc.com/news-room/2015-news-releasearchive/Unitedhealthcare-covers-virtual-care-physician-visitsMuhlestein</ext-link>
					</comment>
          <comment>JB, Le V, Albert D, Moreno FL, Anderson JL, Yanowitz F, et al. Smartphone ECG for evaluation of STEMI: results of the ST LEUIS pilot study. J Electrocardiol. 2015;48(2): 249-59</comment>
        </element-citation>
      </ref>
      <ref id="B251">
        <label>251</label>
        <mixed-citation>251 Muhlestein JB, Le V, Albert D, Moreno FL, Anderson JL, Yanowitz F, et al. Smartphone ECG for evaluation of STEMI: results of the ST LEUIS pilot study. J Electrocardiol. 2015;48(2): 249-59</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Muhlestein</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Le</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Albert</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Moreno</surname>
              <given-names>FL</given-names>
            </name>
            <name>
              <surname>Anderson</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Yanowitz</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Smartphone ECG for evaluation of STEMI: results of the ST LEUIS pilot study</article-title>
          <source>J Electrocardiol</source>
          <year>2015</year>
          <volume>48</volume>
          <issue>2</issue>
          <fpage>249</fpage>
          <lpage>259</lpage>
        </element-citation>
      </ref>
      <ref id="B252">
        <label>252</label>
        <mixed-citation>252 Rogove HJ, McArthur D, Demaerschalk BM, Vespa PM. Barriers to telemedicine: survey of current users in acute care units. Telemed J E Health. 2012;18(1): 48-53</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rogove</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>McArthur</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Demaerschalk</surname>
              <given-names>BM</given-names>
            </name>
            <name>
              <surname>Vespa</surname>
              <given-names>PM</given-names>
            </name>
          </person-group>
          <article-title>Barriers to telemedicine: survey of current users in acute care units</article-title>
          <source>Telemed J E Health</source>
          <year>2012</year>
          <volume>18</volume>
          <issue>1</issue>
          <fpage>48</fpage>
          <lpage>53</lpage>
        </element-citation>
      </ref>
      <ref id="B253">
        <label>253</label>
        <mixed-citation>253 D&#225;valos ME, French MT, Burdick AE, Simmons SC. Economic evaluation of telemedicine: review of the literature and research guidelines for benefit-cost analysis. Telemed J E Health. 2009;15(10): 933-48</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>D&#225;valos</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>French</surname>
              <given-names>MT</given-names>
            </name>
            <name>
              <surname>Burdick</surname>
              <given-names>AE</given-names>
            </name>
            <name>
              <surname>Simmons</surname>
              <given-names>SC</given-names>
            </name>
          </person-group>
          <article-title>Economic evaluation of telemedicine: review of the literature and research guidelines for benefit-cost analysis</article-title>
          <source>Telemed J E Health</source>
          <year>2009</year>
          <volume>15</volume>
          <issue>10</issue>
          <fpage>933</fpage>
          <lpage>948</lpage>
        </element-citation>
      </ref>
      <ref id="B254">
        <label>254</label>
        <mixed-citation>254 Kassavou A, Sutton S. Automated telecommunication interventions to promote adherence to cardio-metabolic medications: meta-analysis of effectiveness and meta-regression of behaviour change techniques. Health Psychol Rev. 2018;12(1): 25-42</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kassavou</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sutton</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Automated telecommunication interventions to promote adherence to cardio-metabolic medications: meta-analysis of effectiveness and meta-regression of behaviour change techniques</article-title>
          <source>Health Psychol Rev</source>
          <year>2018</year>
          <volume>12</volume>
          <issue>1</issue>
          <fpage>25</fpage>
          <lpage>42</lpage>
        </element-citation>
      </ref>
      <ref id="B255">
        <label>255</label>
        <mixed-citation>255 Field MJ. Telecommunications in medicine-Evaluation. Committee on Evaluating Clinical Applications of Telemedicine. United States; Division of Health Care Services/Institute of Medicine;1996</mixed-citation>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Field</surname>
              <given-names>MJ</given-names>
            </name>
          </person-group>
          <source>Telecommunications in medicine-Evaluation. Committee on Evaluating Clinical Applications of Telemedicine</source>
          <publisher-loc>United States</publisher-loc>
          <publisher-name>Division of Health Care Services/Institute of Medicine</publisher-name>
          <year>1996</year>
        </element-citation>
      </ref>
      <ref id="B256">
        <label>256</label>
        <mixed-citation>256 Tuckson RV, Edmunds M, Hodgkins ML. Telehealth. N Engl J Med. 2017;377(16): 1585-92</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tuckson</surname>
              <given-names>RV</given-names>
            </name>
            <name>
              <surname>Edmunds</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hodgkins</surname>
              <given-names>ML</given-names>
            </name>
          </person-group>
          <article-title>Telehealth: N Engl</article-title>
          <source>J Med</source>
          <year>2017</year>
          <volume>377</volume>
          <issue>16</issue>
          <fpage>1585</fpage>
          <lpage>1592</lpage>
        </element-citation>
      </ref>
      <ref id="B257">
        <label>257</label>
        <mixed-citation>257 Flodgren G, Rachas A, Farmer AJ, Inzitari M, Shepperd S. Interactive telemedicine: effects on professional practice and health care outcomes. Cochrane Database Syst Rev. 2015;(9): CD002098</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Flodgren</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Rachas</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Farmer</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Inzitari</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Shepperd</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Interactive telemedicine: effects on professional practice and health care outcomes</article-title>
          <source>Cochrane Database Syst Rev</source>
          <year>2015</year>
          <issue>9</issue>
          <fpage>CD002098</fpage>
          <lpage>CD002098</lpage>
        </element-citation>
      </ref>
      <ref id="B258">
        <label>258</label>
        <mixed-citation>258 Driscoll A, Meagher S, Kennedy R, Hay M, Banerji J, Campbell D, et al. What is the impact of systems of care for heart failure on patients diagnosed with heart failure: a systematic review. BMC Cardiovasc Disord. 2016;16(1): 195</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Driscoll</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Meagher</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kennedy</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Hay</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Banerji</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Campbell</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>What is the impact of systems of care for heart failure on patients diagnosed with heart failure: a systematic review</article-title>
          <source>BMC Cardiovasc Disord</source>
          <year>2016</year>
          <volume>16</volume>
          <issue>1</issue>
          <fpage>195</fpage>
          <lpage>195</lpage>
        </element-citation>
      </ref>
      <ref id="B259">
        <label>259</label>
        <mixed-citation>259 Feltner C, Jones CD, Cen&#233; CW, Zheng ZJ, Sueta CA, Coker-Schwimmer EJ, et al. Transitional Care Interventions to Prevent Readmissions for Persons with Heart Failure. Ann Intern Med. 2014;160(11): 774-84</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Feltner</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>CD</given-names>
            </name>
            <name>
              <surname>Cen&#233;</surname>
              <given-names>CW</given-names>
            </name>
            <name>
              <surname>Zheng</surname>
              <given-names>ZJ</given-names>
            </name>
            <name>
              <surname>Sueta</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Coker-Schwimmer</surname>
              <given-names>EJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Transitional Care Interventions to Prevent Readmissions for Persons with Heart Failure</article-title>
          <source>Ann Intern Med</source>
          <year>2014</year>
          <volume>160</volume>
          <issue>11</issue>
          <fpage>774</fpage>
          <lpage>784</lpage>
        </element-citation>
      </ref>
      <ref id="B260">
        <label>260</label>
        <mixed-citation>260 Grustam AS, Severens JL, van Nijnatten J, Koymans R, Vrijhoef HJ. Cost-effectiveness of telehealth interventions for chronic heart failure patients: a literature review. Int J Technol Assess Health Care. 2014;30(1): 59-68</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Grustam</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Severens</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>van Nijnatten</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Koymans</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Vrijhoef</surname>
              <given-names>HJ</given-names>
            </name>
          </person-group>
          <article-title>Cost-effectiveness of telehealth interventions for chronic heart failure patients: a literature review</article-title>
          <source>Int J Technol Assess Health Care</source>
          <year>2014</year>
          <volume>30</volume>
          <issue>1</issue>
          <fpage>59</fpage>
          <lpage>68</lpage>
        </element-citation>
      </ref>
      <ref id="B261">
        <label>261</label>
        <mixed-citation>261 Gensini GF, Alderighi C, Rasoini R, Mazzanti M, Casolo G. Value of Telemonitoring and Telemedicine in Heart Failure Management. Card Fail Rev. 2017;3(2): 116-21</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gensini</surname>
              <given-names>GF</given-names>
            </name>
            <name>
              <surname>Alderighi</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Rasoini</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Mazzanti</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Casolo</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Value of Telemonitoring and Telemedicine in Heart Failure Management</article-title>
          <source>Card Fail Rev</source>
          <year>2017</year>
          <volume>3</volume>
          <issue>2</issue>
          <fpage>116</fpage>
          <lpage>121</lpage>
        </element-citation>
      </ref>
      <ref id="B262">
        <label>262</label>
        <mixed-citation>262 Rush KL, Hatt L, Janke R, Burton L, Ferrier M, Tetrault M. The efficacy of telehealth delivered educational approaches for patients with chronic diseases: A systematic review. Patient Educ Couns. 2018;101(8): 1310-21</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rush</surname>
              <given-names>KL</given-names>
            </name>
            <name>
              <surname>Hatt</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Janke</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Burton</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Ferrier</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Tetrault</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>The efficacy of telehealth delivered educational approaches for patients with chronic diseases: A systematic review</article-title>
          <source>Patient Educ Couns</source>
          <year>2018</year>
          <volume>101</volume>
          <issue>8</issue>
          <fpage>1310</fpage>
          <lpage>1321</lpage>
        </element-citation>
      </ref>
      <ref id="B263">
        <label>263</label>
        <mixed-citation>263 Hamilton SJ, Mills B, Birch EM, Thompson SC. Smartphones in the secondary prevention of cardiovascular disease: a systematic review. BMC Cardiovasc Disord. 2018;18(1): 25</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hamilton</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Mills</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Birch</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Thompson</surname>
              <given-names>SC</given-names>
            </name>
          </person-group>
          <article-title>Smartphones in the secondary prevention of cardiovascular disease: a systematic review</article-title>
          <source>BMC Cardiovasc Disord</source>
          <year>2018</year>
          <volume>18</volume>
          <issue>1</issue>
          <fpage>25</fpage>
          <lpage>25</lpage>
        </element-citation>
      </ref>
      <ref id="B264">
        <label>264</label>
        <mixed-citation>264 Lin MH, Yuan WL, Huang TC, Zhang HF, Mai JT, Wang JF. Clinical effectiveness of telemedicine for chronic heart failure: a systematic review and meta-analysis. J Investig Med. 2017;65(5): 899-911</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lin</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Yuan</surname>
              <given-names>WL</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>TC</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>HF</given-names>
            </name>
            <name>
              <surname>Mai</surname>
              <given-names>JT</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>JF</given-names>
            </name>
          </person-group>
          <article-title>Clinical effectiveness of telemedicine for chronic heart failure: a systematic review and meta-analysis</article-title>
          <source>J Investig Med</source>
          <year>2017</year>
          <volume>65</volume>
          <issue>5</issue>
          <fpage>899</fpage>
          <lpage>911</lpage>
        </element-citation>
      </ref>
      <ref id="B265">
        <label>265</label>
        <mixed-citation>265 Le Goff-Pronost M, Sicotte C. The added value of thorough economic evaluation of telemedicine networks. Eur J Health Econ. 2010;11(1): 45-55</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Le Goff-Pronost</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sicotte</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>The added value of thorough economic evaluation of telemedicine networks</article-title>
          <source>Eur J Health Econ</source>
          <year>2010</year>
          <volume>11</volume>
          <issue>1</issue>
          <fpage>45</fpage>
          <lpage>55</lpage>
        </element-citation>
      </ref>
      <ref id="B266">
        <label>266</label>
        <mixed-citation>266 Iribarren SJ, Cato K, Falzon L, Stone PW. What is the economic evidence for mHealth? A systematic review of economic evaluations of mHealth solutions. PLoS One. 2017;12(2): e0170581</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Iribarren</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Cato</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Falzon</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Stone</surname>
              <given-names>PW</given-names>
            </name>
          </person-group>
          <article-title>What is the economic evidence for mHealth: A systematic review of economic evaluations of mHealth solutions</article-title>
          <source>PLoS One</source>
          <year>2017</year>
          <volume>12</volume>
          <issue>2</issue>
          <elocation-id>e0170581</elocation-id>
        </element-citation>
      </ref>
      <ref id="B267">
        <label>267</label>
        <mixed-citation>267 Mistry H. Systematic review of studies of the cost-effectiveness of telemedicine and telecare: changes in the economic evidence over twenty years. J Telemed Telecare. 2012;18(1): 1-6</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mistry</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Systematic review of studies of the cost-effectiveness of telemedicine and telecare: changes in the economic evidence over twenty years</article-title>
          <source>J Telemed Telecare</source>
          <year>2012</year>
          <volume>18</volume>
          <issue>1</issue>
          <fpage>1</fpage>
          <lpage>6</lpage>
        </element-citation>
      </ref>
      <ref id="B268">
        <label>268</label>
        <mixed-citation>268 Rojas SV, Gagnon MP. A systematic review of the key indicators for assessing tele homecare cost-effectiveness. Telemed J E Health. 2008;14(9): 896-904</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rojas</surname>
              <given-names>SV</given-names>
            </name>
            <name>
              <surname>Gagnon</surname>
              <given-names>MP</given-names>
            </name>
          </person-group>
          <article-title>A systematic review of the key indicators for assessing tele homecare cost-effectiveness</article-title>
          <source>Telemed J E Health</source>
          <year>2008</year>
          <volume>14</volume>
          <issue>9</issue>
          <fpage>896</fpage>
          <lpage>904</lpage>
        </element-citation>
      </ref>
      <ref id="B269">
        <label>269</label>
        <mixed-citation>269 Seto E. Cost Comparison Between Telemonitoring and Usual Care of Heart Failure: A Systematic Review. Telemed J E Health. 2008;14(7): 679-86</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Seto</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Cost Comparison Between Telemonitoring and Usual Care of Heart Failure: A Systematic Review</article-title>
          <source>Telemed J E Health</source>
          <year>2008</year>
          <volume>14</volume>
          <issue>7</issue>
          <fpage>679</fpage>
          <lpage>686</lpage>
        </element-citation>
      </ref>
      <ref id="B270">
        <label>270</label>
        <mixed-citation>270 Louis AA, Turner T, Gretton M, Baksh A, Cleland JG. A systematic review of telemonitoring for the management of heart failure. Eur J Heart Fail. 2003;5(5): 583-90</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Louis</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Turner</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Gretton</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Baksh</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Cleland</surname>
              <given-names>JG</given-names>
            </name>
          </person-group>
          <article-title>A systematic review of telemonitoring for the management of heart failure</article-title>
          <source>Eur J Heart Fail</source>
          <year>2003</year>
          <volume>5</volume>
          <issue>5</issue>
          <fpage>583</fpage>
          <lpage>590</lpage>
        </element-citation>
      </ref>
      <ref id="B271">
        <label>271</label>
        <mixed-citation>271 Cajita MI, Gleason KT, Han HR. A Systematic Review of mHealth-Based Heart Failure Interventions. J Cardiovasc Nurs. 2016;31(3): E10-22</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cajita</surname>
              <given-names>MI</given-names>
            </name>
            <name>
              <surname>Gleason</surname>
              <given-names>KT</given-names>
            </name>
            <name>
              <surname>Han</surname>
              <given-names>HR</given-names>
            </name>
          </person-group>
          <article-title>A Systematic Review of mHealth-Based Heart Failure Interventions</article-title>
          <source>J Cardiovasc Nurs</source>
          <year>2016</year>
          <volume>31</volume>
          <issue>3</issue>
          <fpage>E10</fpage>
          <lpage>E22</lpage>
        </element-citation>
      </ref>
      <ref id="B272">
        <label>272</label>
        <mixed-citation>272 Eurlings CG, Boyne JJ, de Boer RA, Brunner-La Rocca HP. Telemedicine in heart failure-more than nice to have? Neth Heart J. 2019;27(1): 5-15</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eurlings</surname>
              <given-names>CG</given-names>
            </name>
            <name>
              <surname>Boyne</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>de Boer</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Brunner-La Rocca</surname>
              <given-names>HP</given-names>
            </name>
          </person-group>
          <article-title>Telemedicine in heart failure-more than nice to have</article-title>
          <source>Neth Heart J</source>
          <year>2019</year>
          <volume>27</volume>
          <issue>1</issue>
          <fpage>5</fpage>
          <lpage>15</lpage>
        </element-citation>
      </ref>
      <ref id="B273">
        <label>273</label>
        <mixed-citation>273 Com&#237;n-Colet J, Enjuanes C, Verd&#250;-Rotellar JM, Linas A, Ruiz-Rodriguez P, Gonz&#225;lez-Robledo G, et al. Impact on clinical events and healthcare costs of adding telemedicine to multidisciplinary disease management programmes for heart failure: Results of a randomized controlled trial. J Telemed Telecare. 2016;22(5): 282-95</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Com&#237;n-Colet</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Enjuanes</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Verd&#250;-Rotellar</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Linas</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ruiz-Rodriguez</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Gonz&#225;lez-Robledo</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Impact on clinical events and healthcare costs of adding telemedicine to multidisciplinary disease management programmes for heart failure: Results of a randomized controlled trial</article-title>
          <source>J Telemed Telecare</source>
          <year>2016</year>
          <volume>22</volume>
          <issue>5</issue>
          <fpage>282</fpage>
          <lpage>295</lpage>
        </element-citation>
      </ref>
      <ref id="B274">
        <label>274</label>
        <mixed-citation>274 Pandor A, Thokala P, Gomersall T, Baalbaki H, Stevens JW, Wang J, et al. Home telemonitoring or structured telephone support programmes after recent discharge in patients with heart failure: systematic review and economic evaluation. Health Technol Assess. 2013;17(32): 256p</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pandor</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Thokala</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Gomersall</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Baalbaki</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Stevens</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Home telemonitoring or structured telephone support programmes after recent discharge in patients with heart failure: systematic review and economic evaluation</article-title>
          <source>Health Technol Assess</source>
          <year>2013</year>
          <volume>17</volume>
          <issue>32</issue>
          <fpage>256p</fpage>
          <lpage>256p</lpage>
        </element-citation>
      </ref>
      <ref id="B275">
        <label>275</label>
        <mixed-citation>275 Ribeiro ALP, Alkmin MB, Marcolino MS, Figueira RM, Reis ZS, Oliveira JAQ, et al. A systematic review on cost and benefits of the implementation of eHealth strategies. Relat&#243;rio encaminhado &#224; OPAS - Organiza&#231;&#227;o Pan-Americana da Sa&#250;de.2016.168p. Internet. [Acesso em 06 junho 2019]. Dispon&#237;vel em: eHealth_OPAS_0109...168pDOCX</mixed-citation>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Ribeiro</surname>
              <given-names>ALP</given-names>
            </name>
            <name>
              <surname>Alkmin</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>Marcolino</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Figueira</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Reis</surname>
              <given-names>ZS</given-names>
            </name>
            <name>
              <surname>Oliveira</surname>
              <given-names>JAQ</given-names>
            </name>
            <etal/>
          </person-group>
          <source>A systematic review on cost and benefits of the implementation of eHealth strategies. Relat&#243;rio encaminhado &#224; OPAS - Organiza&#231;&#227;o Pan-Americana da Sa&#250;de</source>
          <year>2016</year>
          <size units="pages">168p</size>
          <comment>Internet</comment>
          <date-in-citation content-type="access-date">06 junho 2019</date-in-citation>
          <comment>eHealth_OPAS_0109...168pDOCX</comment>
        </element-citation>
      </ref>
      <ref id="B276">
        <label>276</label>
        <mixed-citation>276 Stevens B, Pezzullo L, Verdian L, Tomlinson J, George A, Bacal F. The Economic Burden of Heart Conditions in Brazil. Arq Bras Cardiol. 2018;111(1): 29-36</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stevens</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Pezzullo</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Verdian</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Tomlinson</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>George</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Bacal</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>The Economic Burden of Heart Conditions in Brazil</article-title>
          <source>Arq Bras Cardiol</source>
          <year>2018</year>
          <volume>111</volume>
          <issue>1</issue>
          <fpage>29</fpage>
          <lpage>36</lpage>
        </element-citation>
      </ref>
      <ref id="B277">
        <label>277</label>
        <mixed-citation>277 Pinto M, Marisa Santos M, Anete Trajman A. Limiar de custo-efetividade: uma necessidade para o Brasil? J Bras Econ Sa&#250;de 2016;8(1): 58-60, Minist&#233;rio da Sa&#250;de. Departamento de Ci&#234;ncia, Tecnologia e Insumos Estrat&#233;gicos, Diretrizes metodol&#243;gicas: estudos de avalia&#231;&#227;o econ&#244;mica de tecnologias em sa&#250;de. Bras&#237;lia: Minist&#233;rio da Sa&#250;de; 2014. (S&#233;rie A. Normas e Manuais T&#233;cnicos).</mixed-citation>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Pinto</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Marisa Santos</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Anete Trajman</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <source>Limiar de custo-efetividade: uma necessidade para o Brasil? J Bras Econ Sa&#250;de 2016;8(1): 58-60, Minist&#233;rio da Sa&#250;de. Departamento de Ci&#234;ncia, Tecnologia e Insumos Estrat&#233;gicos, Diretrizes metodol&#243;gicas: estudos de avalia&#231;&#227;o econ&#244;mica de tecnologias em sa&#250;de</source>
          <year>2014</year>
          <publisher-loc>Bras&#237;lia</publisher-loc>
          <publisher-name>Minist&#233;rio da Sa&#250;de</publisher-name>
        </element-citation>
      </ref>
      <ref id="B278">
        <label>278</label>
        <mixed-citation>278 Andrade MV, Maia AC, Cardoso CS, Alkmim MB, Ribeiro AL. Cost-benefit of the telecardiology service in the state of Minas Gerais: Minas Telecardio Project. Arq Bras Cardiol. 2011;97(4): 307-16</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Andrade</surname>
              <given-names>MV</given-names>
            </name>
            <name>
              <surname>Maia</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Cardoso</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Alkmim</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>Ribeiro</surname>
              <given-names>AL</given-names>
            </name>
          </person-group>
          <article-title>Cost-benefit of the telecardiology service in the state of Minas Gerais: Minas Telecardio Project</article-title>
          <source>Arq Bras Cardiol</source>
          <year>2011</year>
          <volume>97</volume>
          <issue>4</issue>
          <fpage>307</fpage>
          <lpage>316</lpage>
        </element-citation>
      </ref>
      <ref id="B279">
        <label>279</label>
        <mixed-citation>279 Figueira RM, Alkmin MBM, Ribeiro ALP, Abreu MP, Campos FE. Implementation and maintenance costs for a telehealth system in Brazil. In: Med-e-Tel 2008 The International Educational and Networking Forum for eHealth, Telemedicine and Health ICT, 2008, Luxemburgo. Global Telemedicine and eHeallth Updates: Knowledge Resources. Luxemburgo Luxexpo.2008;1: 354-8</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Figueira</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Alkmin</surname>
              <given-names>MBM</given-names>
            </name>
            <name>
              <surname>Ribeiro</surname>
              <given-names>ALP</given-names>
            </name>
            <name>
              <surname>Abreu</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Campos</surname>
              <given-names>FE</given-names>
            </name>
          </person-group>
          <article-title>Implementation and maintenance costs for a telehealth system in Brazil: In: Med-e-Tel 2008 The International Educational and Networking Forum for eHealth, Telemedicine and Health ICT, 2008, Luxemburgo. Global Telemedicine and eHeallth Updates: Knowledge Resources</article-title>
          <source>Luxemburgo Luxexpo</source>
          <year>2008</year>
          <volume>1</volume>
          <fpage>354</fpage>
          <lpage>358</lpage>
        </element-citation>
      </ref>
      <ref id="B280">
        <label>280</label>
        <mixed-citation>280 Figueira RM, Alkmin EM, Alkmin MBM, Abreu MP, Ribeiro ALP, Campos FE. Cost Estructure in a telecardiology service in Brazil. In: Med-e-Tel 2009 The International Educational and Networking Forum for eHealth, Telemedicine and Health ICT, 2009, Luxemburgo. MedeTel 2009 Global Telemedicine and eHealth Updates: Knowledge Resources. Luxemburgo: Luxexpo.2009;2: 84-88</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Figueira</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Alkmin</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Alkmin</surname>
              <given-names>MBM</given-names>
            </name>
            <name>
              <surname>Abreu</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Ribeiro</surname>
              <given-names>ALP</given-names>
            </name>
            <name>
              <surname>Campos</surname>
              <given-names>FE</given-names>
            </name>
          </person-group>
          <article-title>Cost Estructure in a telecardiology service in Brazil: In: Med-e-Tel 2009 The International Educational and Networking Forum for eHealth, Telemedicine and Health ICT, 2009, Luxemburgo. MedeTel 2009 Global Telemedicine and eHealth Updates: Knowledge Resources</article-title>
          <source>Luxemburgo: Luxexpo</source>
          <year>2009</year>
          <volume>2</volume>
          <fpage>84</fpage>
          <lpage>88</lpage>
        </element-citation>
      </ref>
      <ref id="B281">
        <label>281</label>
        <mixed-citation>281 Alkmin MB, Leles FAG, Abreu MP, Alfenas V, Figueira RM, Ribeiro ALP. Developing a low cost and high effectiveness telehealth implementatioin methodology in Minas Gerais, Brazil. In: MedeTel2010, 2010, Luxemburgo. Global Telemedicine and eHealth Updates. Luxemburgo.2010;3: 46-50</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alkmin</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>Leles</surname>
              <given-names>FAG</given-names>
            </name>
            <name>
              <surname>Abreu</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Alfenas</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Figueira</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Ribeiro</surname>
              <given-names>ALP</given-names>
            </name>
          </person-group>
          <article-title>Developing a low cost and high effectiveness telehealth implementatioin methodology in Minas Gerais, Brazil: In: MedeTel2010, 2010, Luxemburgo. Global Telemedicine and eHealth Updates</article-title>
          <source>Luxemburgo</source>
          <year>2010</year>
          <volume>3</volume>
          <fpage>46</fpage>
          <lpage>50</lpage>
        </element-citation>
      </ref>
      <ref id="B282">
        <label>282</label>
        <mixed-citation>282 Figueira RM, Alkmin MBM. An&#225;lise econ&#244;mica e de impacto da aplica&#231;&#227;o de servi&#231;os de telessa&#250;de na aten&#231;&#227;o b&#225;sica em munic&#237;pios de Minas Gerais - Relat&#243;rio Final, Secretaria de Estado da Sa&#250;de de Minas Gerais;2011. Internet. [Acesso em 06 junho 2019]. Dispon&#237;vel em: os: //telesaude.hc.ufmg.br</mixed-citation>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Figueira</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Alkmin</surname>
              <given-names>MBM</given-names>
            </name>
          </person-group>
          <source>An&#225;lise econ&#244;mica e de impacto da aplica&#231;&#227;o de servi&#231;os de telessa&#250;de na aten&#231;&#227;o b&#225;sica em munic&#237;pios de Minas Gerais - Relat&#243;rio Final, Secretaria de Estado da Sa&#250;de de Minas Gerais</source>
          <year>2011</year>
          <comment>Internet</comment>
          <date-in-citation content-type="access-date">06 junho 2019</date-in-citation>
          <comment>os: //telesaude.hc.ufmg.br</comment>
        </element-citation>
      </ref>
      <ref id="B283">
        <label>283</label>
        <mixed-citation>283 Alkmin MBM, Cardoso CS, Caiaffa WT, Resente ES, Ribeiro ALP, et al. Incorporaci&#243;n de la telesalud en el sistema p&#250;blico de salud de Minas Gerais, Brasil. Documento de proyecto. Comisi&#243;n Econ&#243;mica para Am&#233;rica Latina y el Caribe (CEPAL). Santiago do Chile, 2012. Internet. [Acesso em 06 de junho de 2019]. Dispon&#237;vel em: os: //telesaude.hc.ufmg.br</mixed-citation>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Alkmin</surname>
              <given-names>MBM</given-names>
            </name>
            <name>
              <surname>Cardoso</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Caiaffa</surname>
              <given-names>WT</given-names>
            </name>
            <name>
              <surname>Resente</surname>
              <given-names>ES</given-names>
            </name>
            <name>
              <surname>Ribeiro</surname>
              <given-names>ALP</given-names>
            </name>
            <etal/>
          </person-group>
          <source>Incorporaci&#243;n de la telesalud en el sistema p&#250;blico de salud de Minas Gerais, Brasil. Documento de proyecto. Comisi&#243;n Econ&#243;mica para Am&#233;rica Latina y el Caribe (CEPAL)</source>
          <publisher-loc>Santiago do Chile</publisher-loc>
          <year>2012</year>
          <comment>Internet</comment>
          <date-in-citation content-type="access-date">06 de junho de 2019</date-in-citation>
          <comment>os: //telesaude.hc.ufmg.br</comment>
        </element-citation>
      </ref>
      <ref id="B284">
        <label>284</label>
        <mixed-citation>284 L&#243;pez-Villegas A, Catal&#225;n-Matamoros D, Mart&#237;n-Saborido C, Villegas-Tripiana I, Robles-Musso E. A Systematic Review of Economic Evaluations of Pacemaker Telemonitoring Systems. Rev Esp Cardiol (Engl Ed). 2016;69(2): 125-33</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>L&#243;pez-Villegas</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Catal&#225;n-Matamoros</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Mart&#237;n-Saborido</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Villegas-Tripiana</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Robles-Musso</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>A Systematic Review of Economic Evaluations of Pacemaker Telemonitoring Systems</article-title>
          <source>Rev Esp Cardiol (Engl Ed)</source>
          <year>2016</year>
          <volume>69</volume>
          <issue>2</issue>
          <fpage>125</fpage>
          <lpage>133</lpage>
        </element-citation>
      </ref>
      <ref id="B285">
        <label>285</label>
        <mixed-citation>285 Kotb A, Cameron C, Hsieh S, Wells G. Comparative Effectiveness of Different Forms f Telemedicine for Individuals with Heart Failure (HF): A Systematic Review and Network Meta-Analysis. PLoS One. 2015;10(2): e0118681</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kotb</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Cameron</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Hsieh</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Wells</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Comparative Effectiveness of Different Forms f Telemedicine for Individuals with Heart Failure (HF): A Systematic Review and Network Meta-Analysis</article-title>
          <source>PLoS One</source>
          <year>2015</year>
          <volume>10</volume>
          <issue>2</issue>
          <elocation-id>e0118681</elocation-id>
        </element-citation>
      </ref>
      <ref id="B286">
        <label>286</label>
        <mixed-citation>286 Yun JE, Park JE, Park HY, Lee HY, Park DA. Comparative Effectiveness of Telemonitoring Versus Usual Care for Heart Failure: a Systematic Review and Meta-Analysis. J Card Fail. 2018;24(1): 19-28</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yun</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>HY</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>HY</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>DA</given-names>
            </name>
          </person-group>
          <article-title>Comparative Effectiveness of Telemonitoring Versus Usual Care for Heart Failure: a Systematic Review and Meta-Analysis</article-title>
          <source>J Card Fail</source>
          <year>2018</year>
          <volume>24</volume>
          <issue>1</issue>
          <fpage>19</fpage>
          <lpage>28</lpage>
        </element-citation>
      </ref>
      <ref id="B287">
        <label>287</label>
        <mixed-citation>287 Lee M, Wang M, Liu J, Holbrook A. Do telehealth interventions improve oral anticoagulation management? A systematic review and meta-analysis. J Thromb Thrombolysis. 2018;45(3): 325-36</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Holbrook</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Do telehealth interventions improve oral anticoagulation management: A systematic review and meta-analysis</article-title>
          <source>J Thromb Thrombolysis</source>
          <year>2018</year>
          <volume>45</volume>
          <issue>3</issue>
          <fpage>325</fpage>
          <lpage>336</lpage>
        </element-citation>
      </ref>
      <ref id="B288">
        <label>288</label>
        <mixed-citation>288 Klersy C, De Silvestri A, Gabutti G, Raisaro A, Curti M, Regoli F, et al. Economic impact of remote patient monitoring: an integrated economic model derived from a meta-analysis of randomized controlled trials in heart failure. Eur J Heart Fail. 2011;13(4): 450-9</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Klersy</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>De Silvestri</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Gabutti</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Raisaro</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Curti</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Regoli</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Economic impact of remote patient monitoring: an integrated economic model derived from a meta-analysis of randomized controlled trials in heart failure</article-title>
          <source>Eur J Heart Fail</source>
          <year>2011</year>
          <volume>13</volume>
          <issue>4</issue>
          <fpage>450</fpage>
          <lpage>459</lpage>
        </element-citation>
      </ref>
      <ref id="B289">
        <label>289</label>
        <mixed-citation>289 Conway A, Inglis SC, Clark RA. Effective Technologies for Noninvasive Remote Monitoring in Heart Failure. Telemed J E Health. 2014;20(6): 531-8</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Conway</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Inglis</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Clark</surname>
              <given-names>RA</given-names>
            </name>
          </person-group>
          <article-title>Effective Technologies for Noninvasive Remote Monitoring in Heart Failure</article-title>
          <source>Telemed J E Health</source>
          <year>2014</year>
          <volume>20</volume>
          <issue>6</issue>
          <fpage>531</fpage>
          <lpage>538</lpage>
        </element-citation>
      </ref>
      <ref id="B290">
        <label>290</label>
        <mixed-citation>290 Duan Y, Xie Z, Dong F, Wu Z, Lin Z, Sun N, et al. Effectiveness of home blood pressure telemonitoring: a systematic review and meta-analysis of randomised controlled studies. J Hum Hypertens. 2017;31(7): 427-37</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Duan</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Xie</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Dong</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>N</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Effectiveness of home blood pressure telemonitoring: a systematic review and meta-analysis of randomised controlled studies</article-title>
          <source>J Hum Hypertens</source>
          <year>2017</year>
          <volume>31</volume>
          <issue>7</issue>
          <fpage>427</fpage>
          <lpage>437</lpage>
        </element-citation>
      </ref>
      <ref id="B291">
        <label>291</label>
        <mixed-citation>291 Kitsiou S, Par&#233; G, Jaana M. Effects of Home Telemonitoring Interventions on Patients With Chronic Heart Failure: An Overview of Systematic Reviews. J Med Internet Res. 2015;17(3): e63</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kitsiou</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Par&#233;</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Jaana</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Effects of Home Telemonitoring Interventions on Patients With Chronic Heart Failure: An Overview of Systematic Reviews</article-title>
          <source>J Med Internet Res</source>
          <year>2015</year>
          <volume>17</volume>
          <issue>3</issue>
          <elocation-id>e63</elocation-id>
        </element-citation>
      </ref>
      <ref id="B292">
        <label>292</label>
        <mixed-citation>292 Polisena J, Tran K, Cimon K, Hutton B, McGill S, Palmer K, et al. Home telemonitoring for congestive heart failure: a systematic review and meta-analysis. J Telemed Telecare. 2010;16(2): 68-76</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Polisena</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Tran</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Cimon</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Hutton</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>McGill</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Palmer</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Home telemonitoring for congestive heart failure: a systematic review and meta-analysis</article-title>
          <source>J Telemed Telecare</source>
          <year>2010</year>
          <volume>16</volume>
          <issue>2</issue>
          <fpage>68</fpage>
          <lpage>76</lpage>
        </element-citation>
      </ref>
      <ref id="B293">
        <label>293</label>
        <mixed-citation>293 Inglis SC, Conway A, Cleland JG, Clark RA. Is age a factor in the success or failure of remote monitoring in heart failure? Telemonitoring and structured telephone support in elderly heart failure patients. Eur J Cardiovasc Nurs. 2015;14(3): 248-55</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Inglis</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Conway</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Cleland</surname>
              <given-names>JG</given-names>
            </name>
            <name>
              <surname>Clark</surname>
              <given-names>RA</given-names>
            </name>
          </person-group>
          <article-title>Is age a factor in the success or failure of remote monitoring in heart failure: Telemonitoring and structured telephone support in elderly heart failure patients</article-title>
          <source>Eur J Cardiovasc Nurs</source>
          <year>2015</year>
          <volume>14</volume>
          <issue>3</issue>
          <fpage>248</fpage>
          <lpage>255</lpage>
        </element-citation>
      </ref>
      <ref id="B294">
        <label>294</label>
        <mixed-citation>294 Liu S, Feng W, Chhatbar PY, Liu Y, Ji X, Ovbiagele B. Mobile health as a viable strategy to enhance stroke risk factor control: A systematic review and meta-analysis. J Neurol Sci. 2017 Jul;378: 140-5</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liu</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Feng</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Chhatbar</surname>
              <given-names>PY</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Ji</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Ovbiagele</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Mobile health as a viable strategy to enhance stroke risk factor control: A systematic review and meta-analysis</article-title>
          <source>J Neurol Sci</source>
          <year>2017</year>
          <month>07</month>
          <volume>378</volume>
          <fpage>140</fpage>
          <lpage>145</lpage>
        </element-citation>
      </ref>
      <ref id="B295">
        <label>295</label>
        <mixed-citation>295 Knox L, Rahman RJ, Beedie C. Quality of life in patients receiving telemedicine enhanced chronic heart failure disease management: A meta-analysis. J Telemed Telecare. 2017;23(7): 639-49</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Knox</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Rahman</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Beedie</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Quality of life in patients receiving telemedicine enhanced chronic heart failure disease management: A meta-analysis</article-title>
          <source>J Telemed Telecare</source>
          <year>2017</year>
          <volume>23</volume>
          <issue>7</issue>
          <fpage>639</fpage>
          <lpage>649</lpage>
        </element-citation>
      </ref>
      <ref id="B296">
        <label>296</label>
        <mixed-citation>296 Pandor A, Gomersall T, Stevens JW, Wang J, Al-Mohammad A, Bakhai A, et al. Remote monitoring after recent hospital discharge in patients with heart failure: a systematic review and network meta-analysis. Heart. 2013;99(23): 1717-26</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pandor</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Gomersall</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Stevens</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Al-Mohammad</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Bakhai</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Remote monitoring after recent hospital discharge in patients with heart failure: a systematic review and network meta-analysis</article-title>
          <source>Heart</source>
          <year>2013</year>
          <volume>99</volume>
          <issue>23</issue>
          <fpage>1717</fpage>
          <lpage>1726</lpage>
        </element-citation>
      </ref>
      <ref id="B297">
        <label>297</label>
        <mixed-citation>297 Inglis SC, Clark RA, Dierckx R, Prieto-Merino D, Cleland JG. Structured telephone support or non-invasive telemonitoring for patients with heart failure. Cochrane Database Syst Rev. 2015 Oct;(10): CD007228</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Inglis</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Clark</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Dierckx</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Prieto-Merino</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Cleland</surname>
              <given-names>JG</given-names>
            </name>
          </person-group>
          <article-title>Structured telephone support or non-invasive telemonitoring for patients with heart failure</article-title>
          <source>Cochrane Database Syst Rev</source>
          <year>2015</year>
          <month>10</month>
          <issue>10</issue>
          <fpage>CD007228</fpage>
        </element-citation>
      </ref>
      <ref id="B298">
        <label>298</label>
        <mixed-citation>298 Par&#233; G, Jaana M, Sicotte C. Systematic Review of Home Telemonitoring for Chronic Diseases: The Evidence Base. J Am Med Inform Assoc. 2007;14(3): 269-77</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Par&#233;</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Jaana</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sicotte</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Systematic Review of Home Telemonitoring for Chronic Diseases: The Evidence Base</article-title>
          <source>J Am Med Inform Assoc</source>
          <year>2007</year>
          <volume>14</volume>
          <issue>3</issue>
          <fpage>269</fpage>
          <lpage>277</lpage>
        </element-citation>
      </ref>
      <ref id="B299">
        <label>299</label>
        <mixed-citation>299 Clarke M, Shah A, Sharma U. Systematic review of studies on telemonitoring of patients with congestive heart failure: a meta-analysis.// J Telemed Telecare. 2011;17(1): 7-14</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Clarke</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Shah</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sharma</surname>
              <given-names>U</given-names>
            </name>
          </person-group>
          <article-title>Systematic review of studies on telemonitoring of patients with congestive heart failure: a meta-analysis.// J Telemed</article-title>
          <source>Telecare</source>
          <year>2011</year>
          <volume>17</volume>
          <issue>1</issue>
          <fpage>7</fpage>
          <lpage>14</lpage>
        </element-citation>
      </ref>
      <ref id="B300">
        <label>300</label>
        <mixed-citation>300 Neubeck L, Redfern J, Fernandez R, Briffa T, Bauman A, Freedman SB. Telehealth interventions for the secondary prevention of coronary heart disease: a systematic review. Eur J Cardiovasc Prev Rehabil. 2009;16(3): 281-9</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Neubeck</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Redfern</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Fernandez</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Briffa</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Bauman</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Freedman</surname>
              <given-names>SB</given-names>
            </name>
          </person-group>
          <article-title>Telehealth interventions for the secondary prevention of coronary heart disease: a systematic review</article-title>
          <source>Eur J Cardiovasc Prev Rehabil</source>
          <year>2009</year>
          <volume>16</volume>
          <issue>3</issue>
          <fpage>281</fpage>
          <lpage>289</lpage>
        </element-citation>
      </ref>
      <ref id="B301">
        <label>301</label>
        <mixed-citation>301 Huang K, Liu W, He D, Huang B, Xiao D, Peng Y, et al. Telehealth interventions versus center-based cardiac rehabilitation of coronary artery disease: A systematic review and meta-analysis. Eur J Prev Cardiol. 2015;22(8): 959-71</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Huang</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>He</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Xiao</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Peng</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Telehealth interventions versus center-based cardiac rehabilitation of coronary artery disease: A systematic review and meta-analysis</article-title>
          <source>Eur J Prev Cardiol</source>
          <year>2015</year>
          <volume>22</volume>
          <issue>8</issue>
          <fpage>959</fpage>
          <lpage>971</lpage>
        </element-citation>
      </ref>
      <ref id="B302">
        <label>302</label>
        <mixed-citation>302 Purcell R, McInnes S, Halcomb EJ. Telemonitoring can assist in managing cardiovascular disease in primary care: a systematic review of systematic reviews. BMC Fam Pract. 2014 Mar;15: 43</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Purcell</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>McInnes</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Halcomb</surname>
              <given-names>EJ</given-names>
            </name>
          </person-group>
          <article-title>Telemonitoring can assist in managing cardiovascular disease in primary care: a systematic review of systematic reviews</article-title>
          <source>BMC Fam Pract</source>
          <year>2014</year>
          <month>03</month>
          <volume>15</volume>
          <fpage>43</fpage>
          <lpage>43</lpage>
        </element-citation>
      </ref>
      <ref id="B303">
        <label>303</label>
        <mixed-citation>303 Chaudhry SI, Phillips CO, Stewart SS, Riegel B, Mattera JA, Jerant AF, et al. Telemonitoring for Patients with Chronic Heart Failure: A Systematic Review. J Card Fail. 2007;13(1): 56-62</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chaudhry</surname>
              <given-names>SI</given-names>
            </name>
            <name>
              <surname>Phillips</surname>
              <given-names>CO</given-names>
            </name>
            <name>
              <surname>Stewart</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Riegel</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Mattera</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Jerant</surname>
              <given-names>AF</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Telemonitoring for Patients with Chronic Heart Failure: A Systematic Review</article-title>
          <source>J Card Fail</source>
          <year>2007</year>
          <volume>13</volume>
          <issue>1</issue>
          <fpage>56</fpage>
          <lpage>62</lpage>
        </element-citation>
      </ref>
      <ref id="B304">
        <label>304</label>
        <mixed-citation>304 Pfaeffli Dale L, Dobson R, Whittaker R, Maddison R. The effectiveness of mobile-health behavior change interventions for cardiovascular disease self-management: A systematic review. Eur J Prev Cardiol. 2016;23(8): 801-17</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pfaeffli Dale</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Dobson</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Whittaker</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Maddison</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>The effectiveness of mobile-health behavior change interventions for cardiovascular disease self-management: A systematic review</article-title>
          <source>Eur J Prev Cardiol</source>
          <year>2016</year>
          <volume>23</volume>
          <issue>8</issue>
          <fpage>801</fpage>
          <lpage>817</lpage>
        </element-citation>
      </ref>
      <ref id="B305">
        <label>305</label>
        <mixed-citation>305 Hameed AS, Sauermann S, Schreier G. The impact of adherence on costs and effectiveness oftelemedical patient management in heart failure: A systematic review. Appl Clin Inform. 2014;5(3): 612-20</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hameed</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Sauermann</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Schreier</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>The impact of adherence on costs and effectiveness oftelemedical patient management in heart failure: A systematic review</article-title>
          <source>Appl Clin Inform</source>
          <year>2014</year>
          <volume>5</volume>
          <issue>3</issue>
          <fpage>612</fpage>
          <lpage>620</lpage>
        </element-citation>
      </ref>
      <ref id="B306">
        <label>306</label>
        <mixed-citation>306 Satou GM, Rheuban K, Alverson D, Lewin M, Mahnke C, Marcin J, et al. Telemedicine in Pediatric Cardiology: A Scientific Statement From the American Heart Association. Circulation. 2017;135(11): e648-78</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Satou</surname>
              <given-names>GM</given-names>
            </name>
            <name>
              <surname>Rheuban</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Alverson</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Lewin</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Mahnke</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Marcin</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Telemedicine in Pediatric Cardiology: A Scientific Statement From the American Heart Association</article-title>
          <source>Circulation</source>
          <year>2017</year>
          <volume>135</volume>
          <issue>11</issue>
          <fpage>e648</fpage>
          <lpage>e678</lpage>
        </element-citation>
      </ref>
      <ref id="B307">
        <label>307</label>
        <mixed-citation>307 Ploutz M, Lu JC, Scheel J, Webb C, Ensing GJ, Aliku T, et al. Handheld echocardiographic screening for rheumatic heart disease by non-experts. Heart. 2016;102(1): 35-9</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ploutz</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lu</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Scheel</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Webb</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Ensing</surname>
              <given-names>GJ</given-names>
            </name>
            <name>
              <surname>Aliku</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Handheld echocardiographic screening for rheumatic heart disease by non-experts</article-title>
          <source>Heart</source>
          <year>2016</year>
          <volume>102</volume>
          <issue>1</issue>
          <fpage>35</fpage>
          <lpage>39</lpage>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <sub-article article-type="translation" id="s1" xml:lang="pt">
    <front-stub>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Articles</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Diretriz da Sociedade Brasileira de Cardiologia sobre Telemedicina na Cardiologia &#8211; 2019</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">0000-0003-1253-1514</contrib-id>
          <name>
            <surname>Lopes</surname>
            <given-names>Marcelo Ant&#244;nio Cartaxo Queiroga</given-names>
          </name>
          <xref ref-type="aff" rid="aff53">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Oliveira</surname>
            <given-names>Gl&#225;ucia Maria Moraes de</given-names>
          </name>
          <xref ref-type="aff" rid="aff54">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ribeiro</surname>
            <given-names>Antonio Luiz Pinho</given-names>
          </name>
          <xref ref-type="aff" rid="aff55">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pinto</surname>
            <given-names>Fausto J.</given-names>
          </name>
          <xref ref-type="aff" rid="aff56">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rey</surname>
            <given-names>Helena Cramer Veiga</given-names>
          </name>
          <xref ref-type="aff" rid="aff57">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zimerman</surname>
            <given-names>Leandro Ioschpe</given-names>
          </name>
          <xref ref-type="aff" rid="aff58">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rochitte</surname>
            <given-names>Carlos Eduardo</given-names>
          </name>
          <xref ref-type="aff" rid="aff59">7</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bacal</surname>
            <given-names>Fernando</given-names>
          </name>
          <xref ref-type="aff" rid="aff59">7</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Polanczyk</surname>
            <given-names>Carisi Anne</given-names>
          </name>
          <xref ref-type="aff" rid="aff58">6</xref>
          <xref ref-type="aff" rid="aff60">8</xref>
          <xref ref-type="aff" rid="aff61">9</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Halperin</surname>
            <given-names>Cidio</given-names>
          </name>
          <xref ref-type="aff" rid="aff62">10</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ara&#250;jo</surname>
            <given-names>Edson Correia</given-names>
          </name>
          <xref ref-type="aff" rid="aff63">11</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mesquita</surname>
            <given-names>Evandro Tinoco</given-names>
          </name>
          <xref ref-type="aff" rid="aff64">12</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Arruda</surname>
            <given-names>Jos&#233; Airton</given-names>
          </name>
          <xref ref-type="aff" rid="aff65">13</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rohde</surname>
            <given-names>Luis Eduardo Paim</given-names>
          </name>
          <xref ref-type="aff" rid="aff58">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Grinberg</surname>
            <given-names>Max</given-names>
          </name>
          <xref ref-type="aff" rid="aff59">7</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Moretti</surname>
            <given-names>Miguel</given-names>
          </name>
          <xref ref-type="aff" rid="aff59">7</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Caramori</surname>
            <given-names>Paulo Ricardo Avancini</given-names>
          </name>
          <xref ref-type="aff" rid="aff66">14</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Botelho</surname>
            <given-names>Roberto Vieira</given-names>
          </name>
          <xref ref-type="aff" rid="aff67">15</xref>
          <xref ref-type="aff" rid="aff68">16</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Brand&#227;o</surname>
            <given-names>Andr&#233;a Ara&#250;jo</given-names>
          </name>
          <xref ref-type="aff" rid="aff69">17</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hajjar</surname>
            <given-names>Ludhmila Abrah&#227;o</given-names>
          </name>
          <xref ref-type="aff" rid="aff59">7</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Santos</surname>
            <given-names>Alexandre Fonseca</given-names>
          </name>
          <xref ref-type="aff" rid="aff63">11</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Colafranceschi</surname>
            <given-names>Alexandre Siciliano</given-names>
          </name>
          <xref ref-type="aff" rid="aff70">18</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Etges</surname>
            <given-names>Ana Paula Beck da Silva</given-names>
          </name>
          <xref ref-type="aff" rid="aff61">9</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Marino</surname>
            <given-names>B&#225;rbara Campos Abreu</given-names>
          </name>
          <xref ref-type="aff" rid="aff71">19</xref>
          <xref ref-type="aff" rid="aff72">20</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zanotto</surname>
            <given-names>Bruna Stella</given-names>
          </name>
          <xref ref-type="aff" rid="aff60">8</xref>
          <xref ref-type="aff" rid="aff61">9</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Nascimento</surname>
            <given-names>Bruno Ramos</given-names>
          </name>
          <xref ref-type="aff" rid="aff73">21</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Medeiros</surname>
            <given-names>Cesar Rocha</given-names>
          </name>
          <xref ref-type="aff" rid="aff74">22</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Santos</surname>
            <given-names>Daniel Vitor de Vasconcelos</given-names>
          </name>
          <xref ref-type="aff" rid="aff55">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cook</surname>
            <given-names>Daniela Matos Arrowsmith</given-names>
          </name>
          <xref ref-type="aff" rid="aff70">18</xref>
          <xref ref-type="aff" rid="aff75">23</xref>
          <xref ref-type="aff" rid="aff76">24</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Antoniolli</surname>
            <given-names>Eduardo</given-names>
          </name>
          <xref ref-type="aff" rid="aff77">25</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Souza</surname>
            <given-names>Erito Marques de</given-names>
            <suffix>Filho</suffix>
          </name>
          <xref ref-type="aff" rid="aff64">12</xref>
          <xref ref-type="aff" rid="aff78">26</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fernandes</surname>
            <given-names>F&#225;bio</given-names>
          </name>
          <xref ref-type="aff" rid="aff79">27</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gandour</surname>
            <given-names>Fabio</given-names>
          </name>
          <xref ref-type="aff" rid="aff80">28</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fernandez</surname>
            <given-names>Francisco</given-names>
          </name>
          <xref ref-type="aff" rid="aff68">16</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Souza</surname>
            <given-names>Germano Emilio Concei&#231;&#227;o</given-names>
          </name>
          <xref ref-type="aff" rid="aff81">29</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Weigert</surname>
            <given-names>Guilherme de Souza</given-names>
          </name>
          <xref ref-type="aff" rid="aff82">30</xref>
          <xref ref-type="aff" rid="aff83">31</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Castro</surname>
            <given-names>Iran</given-names>
          </name>
          <xref ref-type="aff" rid="aff84">32</xref>
          <xref ref-type="aff" rid="aff85">33</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cade</surname>
            <given-names>Jamil Ribeiro</given-names>
          </name>
          <xref ref-type="aff" rid="aff86">34</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Figueiredo</surname>
            <given-names>Jos&#233; Albuquerque de</given-names>
            <suffix>Neto</suffix>
          </name>
          <xref ref-type="aff" rid="aff87">35</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fernandes</surname>
            <given-names>Juliano de Lara</given-names>
          </name>
          <xref ref-type="aff" rid="aff88">36</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hadlich</surname>
            <given-names>Marcelo Souza</given-names>
          </name>
          <xref ref-type="aff" rid="aff89">37</xref>
          <xref ref-type="aff" rid="aff90">38</xref>
          <xref ref-type="aff" rid="aff91">39</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Oliveira</surname>
            <given-names>Marco Antonio Pra&#231;a</given-names>
          </name>
          <xref ref-type="aff" rid="aff73">29</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Alkmim</surname>
            <given-names>Maria Beatriz</given-names>
          </name>
          <xref ref-type="aff" rid="aff55">3</xref>
          <xref ref-type="aff" rid="aff73">21</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Paix&#227;o</surname>
            <given-names>Maria Cristina da</given-names>
          </name>
          <xref ref-type="aff" rid="aff55">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Prudente</surname>
            <given-names>Maur&#237;cio Lopes</given-names>
          </name>
          <xref ref-type="aff" rid="aff92">40</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Aguiar</surname>
            <given-names>Miguel A. S.</given-names>
            <suffix>Netto</suffix>
          </name>
          <xref ref-type="aff" rid="aff93">41</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Marcolino</surname>
            <given-names>Milena Soriano</given-names>
          </name>
          <xref ref-type="aff" rid="aff55">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Oliveira</surname>
            <given-names>Monica Amorim de</given-names>
          </name>
          <xref ref-type="aff" rid="aff57">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Simonelli</surname>
            <given-names>Osvaldo</given-names>
          </name>
          <xref ref-type="aff" rid="aff94">42</xref>
          <xref ref-type="aff" rid="aff95">43</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lemos</surname>
            <given-names>Pedro A.</given-names>
            <suffix>Neto</suffix>
          </name>
          <xref ref-type="aff" rid="aff96">44</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rosa</surname>
            <given-names>Priscila Raupp da</given-names>
          </name>
          <xref ref-type="aff" rid="aff9">44</xref>
          <xref ref-type="aff" rid="aff97">45</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Figueira</surname>
            <given-names>Renato Minelli</given-names>
          </name>
          <xref ref-type="aff" rid="aff55">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cury</surname>
            <given-names>Roberto Caldeira</given-names>
          </name>
          <xref ref-type="aff" rid="aff98">46</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Almeida</surname>
            <given-names>Rodrigo Coelho</given-names>
          </name>
          <xref ref-type="aff" rid="aff99">47</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lima</surname>
            <given-names>Sandra Regina Franco</given-names>
          </name>
          <xref ref-type="aff" rid="aff100">48</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Barberato</surname>
            <given-names>Silvio Henrique</given-names>
          </name>
          <xref ref-type="aff" rid="aff101">49</xref>
          <xref ref-type="aff" rid="aff102">50</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Constancio</surname>
            <given-names>Thiago Inoc&#234;ncio</given-names>
          </name>
          <xref ref-type="aff" rid="aff103">51</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rezende</surname>
            <given-names>Wladimir Fernandes de</given-names>
          </name>
          <xref ref-type="aff" rid="aff104">52</xref>
        </contrib>
      </contrib-group>
      <aff id="aff53">
        <label>1</label>
        <institution content-type="original">Hospital Alberto Urquiza Wanderley, Jo&#227;o Pessoa, PB - Brazil</institution>
      </aff>
      <aff id="aff54">
        <label>2</label>
        <institution content-type="original">Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ - Brazil</institution>
      </aff>
      <aff id="aff55">
        <label>3</label>
        <institution content-type="original">Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MG - Brazil</institution>
      </aff>
      <aff id="aff56">
        <label>4</label>
        <institution content-type="original">Universidade de Lisboa, Lisboa - Portugal</institution>
      </aff>
      <aff id="aff57">
        <label>5</label>
        <institution content-type="original">Instituto Nacional de Cardiologia do Rio de Janeiro, Rio de Janeiro, RJ - Brazil</institution>
      </aff>
      <aff id="aff58">
        <label>6</label>
        <institution content-type="original">Hospital de Cl&#237;nicas de Porto Alegre, Porto Alegre, RS - Brazil</institution>
      </aff>
      <aff id="aff59">
        <label>7</label>
        <institution content-type="original">Instituto do Cora&#231;&#227;o (InCor) do Hospital das Cl&#237;nicas da Faculdade de Medicina da Universidade de S&#227;o Paulo (USP), S&#227;o Paulo, SP - Brazil</institution>
      </aff>
      <aff id="aff60">
        <label>8</label>
        <institution content-type="original">Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS - Brazil</institution>
      </aff>
      <aff id="aff61">
        <label>9</label>
        <institution content-type="original">Instituto de Avalia&#231;&#227;o de Tecnologias em Sa&#250;de (IATS), Porto Alegre, RS - Brazil</institution>
      </aff>
      <aff id="aff62">
        <label>10</label>
        <institution content-type="original">Hospital Ernesto Dornelles, Porto Alegre, RS - Brazil</institution>
      </aff>
      <aff id="aff63">
        <label>11</label>
        <institution content-type="original">Banco Mundial, Bras&#237;lia, DF - Brazil</institution>
      </aff>
      <aff id="aff64">
        <label>12</label>
        <institution content-type="original">Universidade Federal Fluminense (UFF), Rio de Janeiro, RJ - Brazil</institution>
      </aff>
      <aff id="aff65">
        <label>13</label>
        <institution content-type="original">Universidade Federal do Esp&#237;rito Santo (UFES), Vit&#243;ria, ES - Brazil</institution>
      </aff>
      <aff id="aff66">
        <label>14</label>
        <institution content-type="original">Hospital S&#227;o Lucas da Pontif&#237;cia Universidade Cat&#243;lica do Rio Grande do Sul (PUCRS), Porto Alegre, RS - Brazil</institution>
      </aff>
      <aff id="aff67">
        <label>15</label>
        <institution content-type="original">Instituto do Cora&#231;&#227;o do Tri&#226;ngulo (ICT), Uberl&#226;ndia, MG - Brazil</institution>
      </aff>
      <aff id="aff68">
        <label>16</label>
        <institution content-type="original">International Telemedical Systems do Brasil (ITMS), Uberl&#226;ndia, MG - Brazil</institution>
      </aff>
      <aff id="aff69">
        <label>17</label>
        <institution content-type="original">Universidade do Estado do Rio de Janeiro (UERJ), Rio de Janeiro, RJ - Brazil</institution>
      </aff>
      <aff id="aff70">
        <label>18</label>
        <institution content-type="original">Hospital Pr&#243;-Card&#237;aco, Rio de Janeiro, RJ - Brazil</institution>
      </aff>
      <aff id="aff71">
        <label>19</label>
        <institution content-type="original">Hospital Madre Teresa, Belo Horizonte, MG - Brazil</institution>
      </aff>
      <aff id="aff72">
        <label>20</label>
        <institution content-type="original">Pontif&#237;cia Universidade Cat&#243;lica de Minas Gerais (PUCMG), Belo Horizonte, MG - Brazil</institution>
      </aff>
      <aff id="aff73">
        <label>21</label>
        <institution content-type="original">Hospital das Cl&#237;nicas da Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MG - Brazil</institution>
      </aff>
      <aff id="aff74">
        <label>22</label>
        <institution content-type="original">Hospital Copa D'Or, Rio de Janeiro, RJ - Brazil</institution>
      </aff>
      <aff id="aff75">
        <label>23</label>
        <institution content-type="original">Hospital Copa Star, Rio de Janeiro, RJ - Brazil</institution>
      </aff>
      <aff id="aff76">
        <label>24</label>
        <institution content-type="original">Hospital dos Servidores do Estado do Rio de Janeiro, Rio de Janeiro, RJ - Brazil</institution>
      </aff>
      <aff id="aff77">
        <label>25</label>
        <institution content-type="original">Hospital Santa Ana, Porto Alegre, RS - Brazil</institution>
      </aff>
      <aff id="aff78">
        <label>26</label>
        <institution content-type="original">Universidade Federal Rural do Rio de Janeiro, Serop&#233;dica, RJ - Brazil</institution>
      </aff>
      <aff id="aff79">
        <label>27</label>
        <institution content-type="original">UMC Imagem, Uberl&#226;ndia, MG - Brazil</institution>
      </aff>
      <aff id="aff80">
        <label>28</label>
        <institution content-type="original">Universidade de Bras&#237;lia (UnB), Bras&#237;lia, DF - Brazil</institution>
      </aff>
      <aff id="aff81">
        <label>29</label>
        <institution content-type="original">Universidade de S&#227;o Paulo (USP), S&#227;o Paulo, SP - Brazil</institution>
      </aff>
      <aff id="aff82">
        <label>30</label>
        <institution content-type="original">Americas Medical City, Rio de Janeiro, RJ - Brazil </institution>
      </aff>
      <aff id="aff83">
        <label>31</label>
        <institution content-type="original">Conexa Sa&#250;de, Rio de Janeiro, RJ - Brazil</institution>
      </aff>
      <aff id="aff84">
        <label>32</label>
        <institution content-type="original">Instituto de Cardiologia do Rio Grande do Sul, Porto Alegre, RS - Brazil </institution>
      </aff>
      <aff id="aff85">
        <label>33</label>
        <institution content-type="original">Funda&#231;&#227;o Universit&#225;ria de Cardiologia, Porto Alegre, RS - Brazil </institution>
      </aff>
      <aff id="aff86">
        <label>34</label>
        <institution content-type="original">Hospital Santa Marcelina, S&#227;o Paulo, SP - Brazil</institution>
      </aff>
      <aff id="aff87">
        <label>35</label>
        <institution content-type="original">Universidade Federal do Maranh&#227;o, S&#227;o Lu&#237;s, MA - Brazil</institution>
      </aff>
      <aff id="aff88">
        <label>36</label>
        <institution content-type="original">Instituto de Ensino e Pesquisa Jos&#233; Michel Kalaf, Campina, SP - Brazil</institution>
      </aff>
      <aff id="aff89">
        <label>37</label>
        <institution content-type="original">Fleury Medicina e Sa&#250;de, Rio de Janeiro, RJ - Brazil</institution>
      </aff>
      <aff id="aff90">
        <label>38</label>
        <institution content-type="original">Rede D'Or, Rio de Janeiro, RJ - Brazil</institution>
      </aff>
      <aff id="aff91">
        <label>39</label>
        <institution content-type="original">Unimed-Rio, Rio de Janeiro, RJ - Brazil</institution>
      </aff>
      <aff id="aff92">
        <label>40</label>
        <institution content-type="original">Hospital ENCORE, Goi&#226;nia, GO - Brazil</institution>
      </aff>
      <aff id="aff93">
        <label>41</label>
        <institution content-type="original">BrasilSa&#250;de Cia de Seguros, Rio de Janeiro, RJ - Brazil</institution>
      </aff>
      <aff id="aff94">
        <label>42</label>
        <institution content-type="original">Conselho Regional de Medicina do Estado de S&#227;o Paulo, S&#227;o Paulo, SP - Brazil</institution>
      </aff>
      <aff id="aff95">
        <label>43</label>
        <institution content-type="original">Instituto Paulista de Direito M&#233;dico e da Sa&#250;de (IPDMS), Ribeir&#227;o Preto, SP - Brazil</institution>
      </aff>
      <aff id="aff96">
        <label>44</label>
        <institution content-type="original">Hospital Israelita Albert Einstein, S&#227;o Paulo, SP - Brazil </institution>
      </aff>
      <aff id="aff97">
        <label>45</label>
        <institution content-type="original">Hospital S&#237;rio Liban&#234;s, S&#227;o Paulo, SP - Brazil</institution>
      </aff>
      <aff id="aff98">
        <label>46</label>
        <institution content-type="original">DASA, S&#227;o Paulo, SP - Brazil</institution>
      </aff>
      <aff id="aff99">
        <label>47</label>
        <institution content-type="original">Medportal, Rio de Janeiro, RJ - Brazil</institution>
      </aff>
      <aff id="aff100">
        <label>48</label>
        <institution content-type="original">Sfranco Consultoria Jur&#237;dica, S&#227;o Jos&#233; dos Campos, SP - Brazil</institution>
      </aff>
      <aff id="aff101">
        <label>49</label>
        <institution content-type="original">CardioEco-Centro de Diagn&#243;stico Cardiovascular, Curitiba, PR - Brazil</institution>
      </aff>
      <aff id="aff102">
        <label>50</label>
        <institution content-type="original">Quanta Diagn&#243;stico e Terapia, Curitiba, PR - Brazil</institution>
      </aff>
      <aff id="aff103">
        <label>51</label>
        <institution content-type="original">Funda&#231;&#227;o Oswaldo Cruz (Fiocruz), Rio de Janeiro, RJ - Brazil</institution>
      </aff>
      <aff id="aff104">
        <label>52</label>
        <institution content-type="original">UMC Tecnologia, S&#227;o Paulo, SP - Brazil</institution>
      </aff>
      <author-notes>
        <corresp id="c2">
          <bold>
            <italic>Correspond&#234;ncia: Sociedade Brasileira de Cardiologia - Av. Marechal C&#226;mara, 360/330 - Centro - Rio de Janeiro - CEP: 20020-907. E-mail: diretrizes@cardiol.br</italic>
          </bold>
        </corresp>
        <fn fn-type="conflict">
          <p><bold>Nota:</bold> estas Diretrizes se prestam a informar e n&#227;o a substituir o julgamento cl&#237;nico do m&#233;dico que, em &#250;ltima an&#225;lise, deve determinar o tratamento apropriado para seus pacientes.</p>
        </fn>
      </author-notes>
    </front-stub>
    <body>
      <table-wrap id="t13">
        <caption>
          <title>As tabelas de classes de recomenda&#231;&#227;o e n&#237;veis de evid&#234;ncia desta atualiza&#231;&#227;o foram realizadas conforme a padroniza&#231;&#227;o a seguir:</title>
        </caption>
        <table frame="hsides" rules="groups">
          <colgroup>
            <col width="20%"/>
            <col width="80%"/>
          </colgroup>
          <thead>
            <tr>
              <th align="center" colspan="2">Classes (graus) de recomenda&#231;&#227;o</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left">Classe I</td>
              <td align="center">Condi&#231;&#245;es para as quais h&#225; evid&#234;ncias conclusivas, ou, na sua falta, consenso geral de que o procedimento &#233; seguro, e &#250;til/eficaz</td>
            </tr>
            <tr>
              <td align="left">Classe IIa</td>
              <td align="center">Condi&#231;&#245;es para as quais h&#225; evid&#234;ncias conflitantes e/ou diverg&#234;ncia de opini&#227;o sobre seguran&#231;a, e utilidade/efic&#225;cia do procedimento. Peso ou evid&#234;ncia/opini&#227;o a favor do procedimento. A maioria dos estudos/especialistas aprova</td>
            </tr>
            <tr>
              <td align="left">Classe IIb</td>
              <td align="center">Condi&#231;&#245;es para as quais h&#225; evid&#234;ncias conflitantes e/ou diverg&#234;ncia de opini&#227;o sobre seguran&#231;a, e utilidade/efic&#225;cia do procedimento. Seguran&#231;a e utilidade/efic&#225;cia menos bem estabelecida, n&#227;o havendo predom&#237;nio de opini&#245;es a favor</td>
            </tr>
            <tr>
              <td align="left">Classe III</td>
              <td align="center">Condi&#231;&#245;es para as quais h&#225; evid&#234;ncias e/ou consenso de que o procedimento n&#227;o &#233; &#250;til/eficaz e, em alguns casos, pode ser prejudicial</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <table-wrap id="t14">
        <table frame="hsides" rules="groups">
          <colgroup>
            <col width="20%"/>
            <col width="80%"/>
          </colgroup>
          <thead>
            <tr>
              <th align="center" colspan="2">N&#237;veis de evid&#234;ncia</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left">N&#237;vel A</td>
              <td align="center">Dados obtidos a partir de m&#250;ltiplos estudos randomizados de bom porte, concordantes e/ou de metan&#225;lise robusta de estudos cl&#237;nicos randomizados</td>
            </tr>
            <tr>
              <td align="left">N&#237;vel B</td>
              <td align="center">Dados obtidos a partir de meta-an&#225;lise menos robusta, a partir de um &#250;nico estudo randomizado ou de estudos n&#227;o randomizados (observacionais)</td>
            </tr>
            <tr>
              <td align="left">N&#237;vel C</td>
              <td align="center">Dados obtidos de opini&#245;es consensuais de especialistas</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <table-wrap id="t15">
        <table frame="hsides" rules="groups">
          <colgroup>
            <col width="12%"/>
            <col width="12%"/>
            <col width="12%"/>
            <col width="12%"/>
            <col width="12%"/>
            <col width="12%"/>
            <col width="12%"/>
            <col width="12%"/>
          </colgroup>
          <thead>
            <tr style="border-bottom-width:thin;border-bottom-style:solid">
              <th align="center" colspan="8">Declara&#231;&#227;o de potencial conflito de interesses dos autores/colaboradores da<break/>Diretriz da Sociedade Brasileira de Cardiologia sobre Telemedicina na Cardiologia - 2019Se nos &#250;ltimos 3 anos o autor/colaborador das Diretrizes:</th>
            </tr>
            <tr>
              <th align="left">Nomes Integrantes<break/>da Diretriz</th>
              <th align="center">Participou de estudos cl&#237;nicos e/ou experimentais subvencionados pela ind&#250;stria farmac&#234;utica ou de equipamentos relacionados &#224; diretriz em quest&#227;o</th>
              <th align="center">Foi palestrante em eventos ou atividades patrocinadas pela ind&#250;stria relacionados &#224; diretriz em quest&#227;o</th>
              <th align="center">Foi (&#233;) membro do conselho consultivo ou diretivo da ind&#250;stria farmac&#234;utica ou de equipamentos</th>
              <th align="center">Participou de comit&#234;s normativos de estudos cient&#237;ficos patrocinados pela ind&#250;stria</th>
              <th align="center">Recebeu aux&#237;lio pessoal ou institucional da ind&#250;stria</th>
              <th align="center">Elaborou textos cient&#237;ficos em peri&#243;dicos patrocinados pela ind&#250;stria</th>
              <th align="center">Tem a&#231;&#245;es da ind&#250;stria</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left">Alexandre Fonseca Santos</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
            </tr>
            <tr>
              <td align="left">Alexandre Siciliano Colafranceschi</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
            </tr>
            <tr>
              <td align="left">Ana Paula Beck da Silva Etges</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
            </tr>
            <tr>
              <td align="left">Andr&#233;a Ara&#250;jo Brand&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
            </tr>
            <tr>
              <td align="left">Antonio Luiz Pinho Ribeiro</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
            </tr>
            <tr>
              <td align="left">B&#225;rbara Campos Abreu Marino</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
            </tr>
            <tr>
              <td align="left">Bruna Stella Zanotto</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
            </tr>
            <tr>
              <td align="left">Bruno Ramos Nascimento</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
            </tr>
            <tr>
              <td align="left">Carisi Anne Polanczyk</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
            </tr>
            <tr>
              <td align="left">Carlos Eduardo Rochitte</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
            </tr>
            <tr>
              <td align="left">Cesar Rocha Medeiros</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
            </tr>
            <tr>
              <td align="left">Cidio Halperin</td>
              <td align="center">Apple</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
            </tr>
            <tr>
              <td align="left">Daniel Vitor de Vasconcelos Santos</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
            </tr>
            <tr>
              <td align="left">Daniela Matos Arrowsmith Cook</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
            </tr>
            <tr>
              <td align="left">Edson Correia Ara&#250;jo</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
            </tr>
            <tr>
              <td align="left">Eduardo Antoniolli</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
            </tr>
            <tr>
              <td align="left">Erito Marques de Souza Filho</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
            </tr>
            <tr>
              <td align="left">Evandro Tinoco Mesquita</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
            </tr>
            <tr>
              <td align="left">F&#225;bio Fernandes</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
            </tr>
            <tr>
              <td align="left">Fabio Gandour</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
            </tr>
            <tr>
              <td align="left">Fausto J. Pinto</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
            </tr>
            <tr>
              <td align="left">Fernando Bacal</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
            </tr>
            <tr>
              <td align="left">Francisco Fernandez</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
            </tr>
            <tr>
              <td align="left">Germano Emilio Concei&#231;&#227;o Souza</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
            </tr>
            <tr>
              <td align="left">Gl&#225;ucia Maria Moraes de Oliveira</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
            </tr>
            <tr>
              <td align="left">Guilherme de Souza Weigert</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">Conexa Sa&#250;de</td>
              <td align="center">N&#227;o</td>
              <td align="center">Conexa Sa&#250;de</td>
              <td align="center">N&#227;o</td>
              <td align="center">Conexa Sa&#250;de</td>
            </tr>
            <tr>
              <td align="left">Helena Cramer Veiga Rey</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
            </tr>
            <tr>
              <td align="left">Iran Castro</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
            </tr>
            <tr>
              <td align="left">Jamil Ribeiro Cade</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o </td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
            </tr>
            <tr>
              <td align="left">Jos&#233; Airton de Arruda</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
            </tr>
            <tr>
              <td align="left">Jos&#233; Albuquerque de Figueiredo Neto</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
            </tr>
            <tr>
              <td align="left">Juliano Lara Fernandes</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">Hypera Pharma, Grupo Biotoscana</td>
            </tr>
            <tr>
              <td align="left">Leandro Ioschpe Zimerman</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">Pfizer</td>
              <td align="center">Bayer, Pfizer, Biotronik</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
            </tr>
            <tr>
              <td align="left">Ludhmila Abrah&#227;o Hajjar</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
            </tr>
            <tr>
              <td align="left">Luis Eduardo Paim Rohde</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
            </tr>
            <tr>
              <td align="left">Marcelo Ant&#244;nio Cartaxo Queiroga Lopes</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
            </tr>
            <tr>
              <td align="left">Marcelo Souza Hadlich</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
            </tr>
            <tr>
              <td align="left">Marco Antonio Pra&#231;a Oliveira</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
            </tr>
            <tr>
              <td align="left">Maria Beatriz Alkmim</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
            </tr>
            <tr>
              <td align="left">Maria Cristina da Paix&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
            </tr>
            <tr>
              <td align="left">Maur&#237;cio Lopes Prudente</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
            </tr>
            <tr>
              <td align="left">Max Grinberg</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
            </tr>
            <tr>
              <td align="left">Miguel A. S. Aguiar Netto</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
            </tr>
            <tr>
              <td align="left">Miguel Antonio Moretti</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
            </tr>
            <tr>
              <td align="left">Milena Soriano Marcolino</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
            </tr>
            <tr>
              <td align="left">Monica Amorim de Oliveira</td>
              <td align="center">N&#227;o </td>
              <td align="center">N&#227;o </td>
              <td align="center">N&#227;o </td>
              <td align="center">N&#227;o </td>
              <td align="center">N&#227;o </td>
              <td align="center">N&#227;o </td>
              <td align="center">N&#227;o </td>
            </tr>
            <tr>
              <td align="left">Osvaldo Simonelli</td>
              <td align="center">N&#227;o </td>
              <td align="center">N&#227;o </td>
              <td align="center">N&#227;o </td>
              <td align="center">N&#227;o </td>
              <td align="center">N&#227;o </td>
              <td align="center">N&#227;o </td>
              <td align="center">N&#227;o </td>
            </tr>
            <tr>
              <td align="left">Paulo Ricardo Avancini Caramori</td>
              <td align="center">N&#227;o </td>
              <td align="center">N&#227;o </td>
              <td align="center">Medtronic</td>
              <td align="center">SciTech, Biotronik</td>
              <td align="center">N&#227;o </td>
              <td align="center">N&#227;o </td>
              <td align="center">N&#227;o </td>
            </tr>
            <tr>
              <td align="left">Pedro A. Lemos Neto</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
            </tr>
            <tr>
              <td align="left">Priscila Raupp da Rosa</td>
              <td align="center">N&#227;o</td>
              <td align="center">Aruba/Kapersky - ind&#250;stria de seguran&#231;a cibern&#233;tica</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
            </tr>
            <tr>
              <td align="left">Renato Minelli Figueira</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
            </tr>
            <tr>
              <td align="left">Roberto Caldeira Cury</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
            </tr>
            <tr>
              <td align="left">Roberto Vieira Botelho</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
            </tr>
            <tr>
              <td align="left">Rodrigo Coelho de Almeida</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
            </tr>
            <tr>
              <td align="left">Sandra Regina Franco Lima</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
            </tr>
            <tr>
              <td align="left">Silvio Henrique Barberato </td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
            </tr>
            <tr>
              <td align="left">Thiago Inoc&#234;ncio Constancio</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
            </tr>
            <tr>
              <td align="left">Wladimir Fernandes de Rezende</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
              <td align="center">N&#227;o</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <sec>
        <title>Apresenta&#231;&#227;o</title>
        <p>Em boa hora, decidiu a Sociedade Brasileira de Cardiologia (SBC) fazer uma diretriz em telemedicina aplicada &#224; cardiologia, tamb&#233;m designada telecardiologia. A Organiza&#231;&#227;o Pan-americana de Sa&#250;de (OPAS) e a Organiza&#231;&#227;o Mundial de Sa&#250;de (OMS) definem Telemedicina como &#8220;a presta&#231;&#227;o de servi&#231;os de sa&#250;de remotos na promo&#231;&#227;o, preven&#231;&#227;o, diagn&#243;stico, tratamento e reabilita&#231;&#227;o pelos profissionais de sa&#250;de que utilizam as tecnologias de informa&#231;&#227;o e comunica&#231;&#227;o, que lhes permitem trocar dados, com o objetivo de facilitar o acesso e a oportunidade na presta&#231;&#227;o de servi&#231;os &#224; popula&#231;&#227;o que tem limita&#231;&#245;es de fornecimento, e acesso a servi&#231;os, ou ambos, em sua &#225;rea geogr&#225;fica&#8221;. Tal defini&#231;&#227;o, aparentemente simples e altru&#237;sta &#224; partida, traz consigo um conjunto vasto de potenciais implica&#231;&#245;es aos mais diversos n&#237;veis, desde o ponto de vista &#233;tico, mas tamb&#233;m com potencial impacto na pr&#225;tica cl&#237;nica e nos seus resultados. Da&#237; a import&#226;ncia de a comunidade m&#233;dica, atrav&#233;s das sociedades cient&#237;ficas, organizar diretrizes que ajudem todos os intervenientes no processo a terem uma refer&#234;ncia, que dever&#225; ser alicer&#231;ada na opini&#227;o de peritos, tanto quanto poss&#237;vel, baseada na evid&#234;ncia cient&#237;fica ao momento, bem como no respeito pelos valores da &#233;tica e deontologia m&#233;dicas.</p>
        <p>Considerando que as doen&#231;as cardiovasculares constituem atualmente, em pleno s&#233;culo 21, a maior causa de mortalidade e morbilidade em n&#237;vel global, incluindo o Brasil, a possibilidade de utilizar instrumentos que permitam uma atua&#231;&#227;o mais eficaz na sua preven&#231;&#227;o, diagn&#243;stico, tratamento e acompanhamento abre perspectivas muito relevantes, com o intuito de prestar melhores cuidados &#224;s popula&#231;&#245;es e comunidades que servimos. Ao mesmo tempo, n&#227;o podem nunca ser negligenciados os aspectos e consequ&#234;ncias de natureza bio&#233;tica que, por si s&#243;, podem (e devem) p&#244;r em causa programas que, travestidos de uma &#237;ndole m&#233;dica, n&#227;o cumprem esses requisitos &#233;ticos b&#225;sicos. &#201;, pois, fundamental a exist&#234;ncia de modelos de funcionamento que sejam regulados e balizados em diretrizes organizadas por quem tem, no terreno, a autoridade cient&#237;fica-m&#233;dica para encontrar esses equil&#237;brios. </p>
        <p>A introdu&#231;&#227;o e implementa&#231;&#227;o de novas tecnologias digitais tem permitido o desenvolvimento de novas metodologias, muitas delas ainda em fase de experimenta&#231;&#227;o, com o intuito de melhorar a capacidade de interven&#231;&#227;o no paciente individual, de forma a permitir uma atua&#231;&#227;o mais personalizada. Estamos a viver aquilo que Eric Topol<xref ref-type="bibr" rid="B1">1</xref> no seu muito recente livro, &#8220;<italic>Deep Medicine: How Artificial Intelligence can Make Healthcare Human Again</italic>&#8221;, apelidada de Quarta Era ou Revolu&#231;&#227;o Industrial, onde se inclui a intelig&#234;ncia artificial (IA), rob&#243;tica e <italic>big data</italic>, a qual ter&#225; um impacto maior na forma como vivemos e at&#233; na forma como nos vemos como humanos. Se tal &#233;, &#224; primeira vista, algo de muito positivo, tamb&#233;m &#233; verdade que n&#227;o &#233; algo isento de riscos, nomeadamente na forma como abordamos ou passaremos a abordar o indiv&#237;duo doente. Importa, pois, n&#227;o esquecer o princ&#237;pio hipocr&#225;tico de que &#8220;&#233; mais importante saber que tipo de pessoa tem a doen&#231;a do que saber que tipo de doen&#231;a a pessoa tem&#8221;. De fato, todos queremos, quando doentes, ter o nosso m&#233;dico a cuidar de n&#243;s, a dar-nos aquela palavra de conforto e confian&#231;a, e n&#227;o propriamente um computador. </p>
        <p>Temos, pois, de ser inteligentes ao pensar em como podemos utilizar em benef&#237;cio do ser humano toda essa pan&#243;plia de elementos que hoje nos abrem fronteiras insond&#225;veis h&#225; poucos anos. A telemedicina ou telecardiologia pode, de fato, desempenhar um papel muito importante, nomeadamente em certas circunst&#226;ncias em que pode ser o &#250;nico recurso dispon&#237;vel. Mas &#233; fundamental que a sua utiliza&#231;&#227;o seja devidamente balizada a fim de impedir abusos e uso indevido. &#201; neste sentido que o presente documento e a diretriz aqui contida foram desenhados. Trata-se de um documento muito completo, em que se faz uma revis&#227;o detalhada da regula&#231;&#227;o da telemedicina no Brasil, se define o que &#233; &#225;rea geograficamente remota, bem como se descrevem os seus fundamentos e as bases seguras para a sua transmiss&#227;o. </p>
        <p>O documento cont&#233;m, ainda, informa&#231;&#227;o muito atualizada sobre as evid&#234;ncias atuais e as aplica&#231;&#245;es da chamada teleconsultoria, bem como do telediagn&#243;stico e telemonitoramento, fazendo uma reflex&#227;o sobre como a telemedicina pode prestar servi&#231;os m&#233;dicos baseados na tecnologia, tendo aqui a IA um grande papel. Completam o documento uma avalia&#231;&#227;o econ&#244;mica e o impacto or&#231;ament&#225;rio da incorpora&#231;&#227;o da telemedicina na cardiologia no Brasil e da telemedicina na sa&#250;de suplementar, e um dos cap&#237;tulos mais importantes, sobre aspectos &#233;ticos e legais. Finalmente, um conjunto de recomenda&#231;&#245;es que se pretendem pr&#225;ticas e adapt&#225;veis &#224; realidade brasileira. </p>
        <p>Assim, temos como resultado uma diretriz perfeitamente alinhada com as orienta&#231;&#245;es da OMS no que se refere ao princ&#237;pio de que a implementa&#231;&#227;o da telemedicina deve ser um processo devidamente planejado e que preveja um conjunto de situa&#231;&#245;es que incluem: viabilidade da cobertura da rede para acesso da tecnologia a lugares remotos, a constru&#231;&#227;o da base legal e jur&#237;dica para sua efetiva&#231;&#227;o, o impacto or&#231;ament&#225;rio e a avalia&#231;&#227;o de custo-efetividade de execu&#231;&#227;o de cada etapa do projeto, e a elabora&#231;&#227;o de indicadores do <italic>continuum</italic> cl&#237;nico da aplicabilidade para seguran&#231;a dos usu&#225;rios. &#201; neste sentido que, como Presidente Eleito da <italic>World Heart Federation</italic>, vejo este documento como algo exemplar, quer na forma como foi planejado e efetivado, quer nos seus conte&#250;dos, refletindo o que &#233; a evid&#234;ncia atual e a perspectiva dos principais atores cient&#237;ficos nesta &#225;rea. Como tal, penso que ser&#225;, desde j&#225;, um documento hist&#243;rico, um <italic>milestone</italic> na introdu&#231;&#227;o respons&#225;vel da telemedicina-telecardiologia na pr&#225;tica cl&#237;nica, neste caso aplicada ao Brasil, mas que pode servir de exemplo para outras latitudes, globalmente, contribuindo para a redu&#231;&#227;o do peso das doen&#231;as cardiovasculares no mundo em que vivemos.</p>
        <p>Lisboa, junho de 2019.</p>
        <p>
          <bold>Prof. Fausto J. Pinto, FESC, FACC</bold>
        </p>
        <p>Presidente-Eleito, World Heart Federation (WHF)</p>
        <p>Ex-Presidente, European Society of Cardiology (ESC)</p>
        <p>Universidade de Lisboa, Portugal </p>
      </sec>
      <sec sec-type="intro">
        <title>Introdu&#231;&#227;o</title>
        <p>H&#225; mais de 26 anos, a SBC, com a publica&#231;&#227;o do Consenso sobre Cardiopatia Grave 1993,<xref ref-type="bibr" rid="B2">2</xref> edita regularmente diretrizes sobre os mais diversos temas da especialidade que norteiam a pr&#225;tica da cardiologia no Brasil. Em 1999, o Conselho Federal de Medicina (CFM),<xref ref-type="bibr" rid="B3">3</xref> em conjunto com a Associa&#231;&#227;o M&#233;dica Brasileira (AMB), com o objetivo de auxiliar na decis&#227;o m&#233;dica e, consequentemente, otimizar o cuidado aos pacientes, desencadearam um processo junto &#224;s Sociedades de Especialidade para a elabora&#231;&#227;o de Diretrizes M&#233;dicas baseadas nas evid&#234;ncias cient&#237;ficas dispon&#237;veis na atualidade. Portanto, o compromisso da SBC antecede a iniciativa da pr&#243;pria AMB, constituindo um dos objetivos societ&#225;rios, inclusive expresso em seu estatuto social. </p>
        <p>O CFM, por interm&#233;dio da Resolu&#231;&#227;o CFM n&#186; 1.642/2002,<xref ref-type="bibr" rid="B4">4</xref> &#224; guisa de preservar a autonomia dos m&#233;dicos, definiu que as empresas de seguro-sa&#250;de, de Medicina de grupo, cooperativas de trabalho m&#233;dico, empresas de autogest&#227;o ou outras que atuem sob a forma de presta&#231;&#227;o direta ou intermedia&#231;&#227;o dos servi&#231;os m&#233;dico-hospitalares devem, em seu relacionamento com m&#233;dicos e usu&#225;rios, adotar diretrizes ou protocolos m&#233;dicos somente quando estes forem elaborados pelas sociedades brasileiras de especialidades, em conjunto com a AMB. Nesse contexto,<xref ref-type="bibr" rid="B5">5</xref> em 2018, iniciaram-se as discuss&#245;es sobre a atualiza&#231;&#227;o da regulamenta&#231;&#227;o da Telemedicina pelo CFM.</p>
        <p>A Telemedicina pode ser contextualizada como o emprego de tecnologias de informa&#231;&#227;o e comunica&#231;&#227;o (TIC) na sa&#250;de com o objetivo de ofertar servi&#231;os relacionados com a sa&#250;de em sua concep&#231;&#227;o ampla, desde a aten&#231;&#227;o prim&#225;ria &#224;s cirurgias rob&#243;ticas, passando pela educa&#231;&#227;o, atrav&#233;s da amplia&#231;&#227;o da aten&#231;&#227;o da cobertura, em &#225;reas remotas de um pa&#237;s continental. </p>
        <p>A OPAS e a OMS definiram a Telemedicina como &#8220;a presta&#231;&#227;o de servi&#231;os de sa&#250;de remotos nos componentes de promo&#231;&#227;o, preven&#231;&#227;o, diagn&#243;stico, tratamento e reabilita&#231;&#227;o, pelos profissionais de sa&#250;de que utilizam as tecnologias de informa&#231;&#227;o e comunica&#231;&#227;o, que lhes permitem trocar dados com o objetivo de facilitar o acesso e a oportunidade na presta&#231;&#227;o de servi&#231;os &#224; popula&#231;&#227;o que tem limita&#231;&#245;es de fornecimento e acesso a servi&#231;os, ou ambos, em sua &#225;rea geogr&#225;fica&#8221;. A OPAS estimou que um ter&#231;o da popula&#231;&#227;o das am&#233;ricas n&#227;o tem acesso a cuidados de sa&#250;de e que seriam necess&#225;rios 800 mil profissionais de sa&#250;de adicionais para atender &#224;s necessidades dos sistemas de sa&#250;de na regi&#227;o.<xref ref-type="bibr" rid="B6">6</xref> A Telemedicina, se aplicada em seu contexto amplo, poderia permitir o acesso e reduzir a iniquidade para essas popula&#231;&#245;es, ofertando servi&#231;os de qualidade com suposto custo-efetividade, especialmente pelo aumento da preval&#234;ncia e da mortalidade das doen&#231;as cr&#244;nicas n&#227;o transmiss&#237;veis (DCNT) nos pa&#237;ses de baixa e m&#233;dia renda, dentre os quais o Brasil est&#225; situado. Acrescenta-se ainda, nesse contexto, o envelhecimento e adoecimento da popula&#231;&#227;o brasileira, o que transforma a Telemedicina em uma ferramenta importante que permitiria o enfrentamento dos desafios contempor&#226;neos dos sistemas de sa&#250;de universais.<xref ref-type="bibr" rid="B7">7</xref>
				</p>
        <p>Para al&#233;m das grandes possibilidades e aplica&#231;&#245;es da telemedicina, &#233; necess&#225;rio que avalia&#231;&#245;es rigorosas de projetos de telemedicina sejam realizadas n&#227;o s&#243; porque todos os sistemas de sa&#250;de enfrentam desafios de sustentabilidade financeira que n&#227;o se restringem somente aos investimentos nas interven&#231;&#245;es de sa&#250;de, mas tamb&#233;m pela pouca evid&#234;ncia cl&#237;nica dispon&#237;vel, especialmente nos ditames atuais da medicina baseada em valor. Esse tema se reveste de grande import&#226;ncia sendo motivo de v&#225;rias publica&#231;&#245;es da OMS. Como exemplo, o Digital Health Atlas,<xref ref-type="bibr" rid="B8">8</xref> um reposit&#243;rio global virtual para apoiar os governos no monitoramento e coordena&#231;&#227;o de investimentos digitais, o &#8220;BeHe@lthy, BeMobile&#8221; (BHBM)<xref ref-type="bibr" rid="B9">9</xref>, para preven&#231;&#227;o e controle das DCNT, o mHealth Assessment and Planning for Scale (MAPS), manual para Monitoramento e Avalia&#231;&#227;o da Sa&#250;de Digital<xref ref-type="bibr" rid="B10">10</xref> cujo objetivo &#233; fortalecer a pesquisa e implementa&#231;&#227;o da sa&#250;de digital, entre outros. Esses documentos culminaram na publica&#231;&#227;o, em 17 de abril de 2019, da primeira diretriz sobre interven&#231;&#245;es de sa&#250;de digital da OMS.<xref ref-type="bibr" rid="B11">11</xref>
				</p>
        <p>Esta diretriz de Telemedicina aplic&#225;vel &#224; cardiologia tem como principal objetivo, al&#233;m de atualizar a diretriz publicada sobre o tema em 2015, responder &#224;s seguintes quest&#245;es: Existe suporte legal e &#233;tico para o emprego da Telemedicina no Brasil? Existem condi&#231;&#245;es t&#233;cnicas para o emprego da Telemedicina no Pa&#237;s? Qual a prioridade para sua incorpora&#231;&#227;o no sistema de sa&#250;de? Para quais modalidades de emprego h&#225; evid&#234;ncia cient&#237;fica de qualidade para suportar sua pr&#225;tica? Nas modalidades onde existem evid&#234;ncias mais robustas para sustentar &#224; pr&#225;tica, o custo-efetividade justifica seu emprego? Qual seria o impacto or&#231;ament&#225;rio? A rede assistencial no Brasil tem capacidade de prover o atendimento de forma integral?</p>
        <p>Essa diretriz, em conson&#226;ncia com as orienta&#231;&#245;es da OMS,<xref ref-type="bibr" rid="B11">11</xref> preconiza que a implementa&#231;&#227;o da Telemedicina deve ser um processo planejado que preveja: a viabilidade da cobertura da rede para acesso a lugares remotos, a constru&#231;&#227;o do arcabou&#231;o legal e jur&#237;dico para sua efetiva&#231;&#227;o, o impacto or&#231;ament&#225;rio e a avalia&#231;&#227;o de custo-efetividade de execu&#231;&#227;o de cada etapa do projeto, al&#233;m da elabora&#231;&#227;o de indicadores do <italic>continuum</italic> cl&#237;nico da aplicabilidade para seguran&#231;a dos usu&#225;rios. A Telemedicina pode representar uma ferramenta potencial para melhorar a presta&#231;&#227;o de servi&#231;os de sa&#250;de, embora n&#227;o seja isenta de riscos e desafios para sua execu&#231;&#227;o e avali&#231;&#227;o do impacto real de seus benef&#237;cios.</p>
        <p>Desse modo, os autores apresentam uma s&#250;mula das recomenda&#231;&#245;es no cap&#237;tulo final, que foram baseadas nas evid&#234;ncias atuais, procurando nortear as discuss&#245;es que certamente ir&#227;o permear a democratiza&#231;&#227;o dos servi&#231;os de sa&#250;de integrais, especialmente das a&#231;&#245;es de Telemedicina como ferramenta para ampliar a universalidade e integralidade do Sistema &#218;nico de Sa&#250;de (SUS), recomenda&#231;&#245;es tamb&#233;m extensivas &#224; sa&#250;de suplementar.</p>
        <p>Brasil, junho de 2019.</p>
        <p>
          <bold>Dr. Marcelo Ant&#244;nio Cartaxo Queiroga, FESC, TEC-SBC</bold>
        </p>
        <p>Presidente-Eleito da Sociedade Brasileira de Cardiologia</p>
        <p>Diretor do Departamento de Cardiologia Intervencionista do Hospital Alberto Urquiza Wanderley, Jo&#227;o Pessoa, PB, Brasil</p>
        <p>Membro Titular da Academia de Medicina do Estado da Para&#237;ba</p>
        <p>
          <bold>Dra. Gl&#225;ucia Maria Moraes de Oliveira, FACC, FESC, TEC-SBC</bold>
        </p>
        <p>Professora Associada de Cardiologia da Universidade Federal do Rio de Janeiro (UFRJ)</p>
        <p>Coordenadora do Programa de P&#243;s-Gradua&#231;&#227;o de Cardiologia da UFRJ, Rio de Janeiro, RJ, Brasil</p>
        <p>Presidente da Federa&#231;&#227;o das Sociedades de Cardiologia de L&#237;ngua Portuguesa (2015-2016)</p>
      </sec>
      <sec>
        <title>1. Fundamentos da Telemedicina: Conceitos, Aspectos Bio&#233;ticos, Legisla&#231;&#227;o e Regulamenta&#231;&#227;o, Aplicabilidade no Brasil, e Intelig&#234;ncia Artificial</title>
        <sec>
          <title>1.1. Fundamentos de Telemedicina</title>
          <p>Em maio de 2005, ministros de Sa&#250;de dos 192 pa&#237;ses-membros da OMS aprovaram a resolu&#231;&#227;o sobre Cibersalud<xref ref-type="bibr" rid="B12">12</xref>, na qual, pela primeira vez, reconhecia-se a import&#226;ncia do emprego das tecnologias da informa&#231;&#227;o e comunica&#231;&#227;o (TIC) na sa&#250;de, a sa&#250;de digital ou e-Sa&#250;de &#8220;refor&#231;a os direitos humanos fundamentais, aumentando e melhorando a equidade, a solidariedade, a qualidade de vida e qualidade de atendimento&#8221;.</p>
          <p>O Minist&#233;rio da Sa&#250;de define os seguintes campos de atua&#231;&#227;o da telessa&#250;de:</p>
          <p>
            <bold>Inova&#231;&#227;o em sa&#250;de digital e telessa&#250;de</bold>
          </p>
          <p>A Inova&#231;&#227;o em Sa&#250;de Digital &#233; transversal &#224;s iniciativas de Telessa&#250;de e busca, nas TIC, explorar novas ideias para a resolu&#231;&#227;o de problemas cr&#244;nicos, de dif&#237;cil solu&#231;&#227;o pelos m&#233;todos usuais e devem partir de necessidades em sa&#250;de da popula&#231;&#227;o.</p>
          <p>
            <bold>Teleconcultoria</bold>
          </p>
          <p>Consultoria registrada e realizada entre os trabalhadores, profissionais e gestores da &#225;rea de sa&#250;de por meio de instrumentos de telecomunica&#231;&#227;o bidirecional com o fim de esclarecer d&#250;vidas sobre os procedimentos cl&#237;nicos, a&#231;&#245;es de sa&#250;de e quest&#245;es relativas ao processo de trabalho em sa&#250;de, podendo ser em tempo real ou por meio de mensagens offline.</p>
          <p>
            <bold>Telediagn&#243;stico</bold>
          </p>
          <p>Consiste em servi&#231;o aut&#244;nomo que utiliza as TIC para a realiza&#231;&#227;o de servi&#231;os de Apoio ao Diagn&#243;stico, como a avalia&#231;&#227;o de exames a dist&#226;ncia, facilitando o acesso a servi&#231;os especializados. Busca reduzir o tempo de diagn&#243;stico possibilitando tratamento para complica&#231;&#245;es previs&#237;veis por meio do diagn&#243;stico precoce.</p>
          <p>
            <bold>Telemonitoramento</bold>
          </p>
          <p>Monitoramento a dist&#226;ncia de par&#226;metros de sa&#250;de e/ou doen&#231;a de pacientes por meio das TIC. O monitoramento pode incluir a coleta de dados cl&#237;nicos, a transmiss&#227;o, o processamento e o manejo por um profissional de sa&#250;de utilizando sistema eletr&#244;nico.</p>
          <p>
            <bold>Telerregula&#231;&#227;o</bold>
          </p>
          <p>Conjunto de a&#231;&#245;es em sistemas de regula&#231;&#227;o com intuito de equacionar respostas adequadas &#224;s demandas existentes, promovendo acesso e equidade aos servi&#231;os, possibilitando o acesso &#224; sa&#250;de. Inclui tamb&#233;m a avalia&#231;&#227;o e o planejamento de a&#231;&#245;es, fornecendo &#224; gest&#227;o uma intelig&#234;ncia reguladora operarional. A telerregula&#231;&#227;o visa fortalecer o atendimento na Aten&#231;&#227;o Prim&#225;ria em Sa&#250;de, permitindo qualificar e reduzir as filas de espera no atendimento especializado. </p>
          <p>
            <bold>Teleduca&#231;&#227;o</bold>
          </p>
          <p>Disponibiliza&#231;&#227;o de objetos de de aprendizagem interativos sobre temas relacionados &#224; sa&#250;de, ministrados a dist&#226;ncia por meio de TIC, com foco na aprendizagem no trabalho, que, por sua vez, ocorre transversalmente em seus campos de atua&#231;&#227;o.</p>
        </sec>
        <sec>
          <title>1.2. Tipos de Interven&#231;&#227;o em Telessa&#250;de</title>
          <p>Videoconfer&#234;ncia s&#237;ncrona: modalidade de intera&#231;&#227;o por confer&#234;ncia ao vivo entre o atendimento prim&#225;rio e servi&#231;os m&#233;dicos especializados a dist&#226;ncia. </p>
          <p>Videoconfer&#234;ncia ass&#237;ncrona (<italic>Store and forward</italic>): utiliza o sistema de armazenamento e envio de imagens diagn&#243;sticas, sinais vitais e/ou v&#237;deo clipes em conjunto com os dados do paciente para uma revis&#227;o posterior por especialista. Fornece suporte ao sistema de atendimento prim&#225;rio no diagn&#243;stico e tratamento.</p>
          <p>Monitoramento remoto: utiliza equipamentos para coletar dados do paciente remotamente e enviar ao hospital ou centro de monitoramento para interpreta&#231;&#227;o. Esses dispositivos (<italic>weareables</italic>) monitoram desde um sinal vital espec&#237;fico (frequ&#234;ncia card&#237;aca, press&#227;o arterial - PA e aferi&#231;&#227;o dos n&#237;veis glic&#234;micos) at&#233; uma variedade de indicadores para o paciente a dist&#226;ncia. </p>
          <p><italic>Mobile health</italic> (<italic>mHealth</italic>): definida como pr&#225;tica m&#233;dica e de sa&#250;de p&#250;blica apoiada por dispositivos m&#243;veis, como telefones celulares, dispositivos de monitoramento, assistentes digitais pessoais (PDA) e outros dispositivos sem fio.<xref ref-type="bibr" rid="B14">14</xref>
					</p>
          <p>Entre os objetivos da Telemedicina que podemos listar:</p>
          <p>
            <list list-type="bullet">
              <list-item>
                <p> Assist&#234;ncia remota: teleconsultoria, telediagn&#243;stico ou telemonitoramento para diagn&#243;stico, acompanhamento e/ou tratamento a dist&#226;ncia do paciente; </p>
              </list-item>
              <list-item>
                <p> Gest&#227;o administrativa dos cuidados aos pacientes: solicita&#231;&#245;es de exames, prescri&#231;&#227;o m&#233;dica e aspectos relativos ao reembolso pela presta&#231;&#227;o de servi&#231;os; </p>
              </list-item>
              <list-item>
                <p> Qualifica&#231;&#227;o de recursos humanos a dist&#226;ncia para facilitar programas de educa&#231;&#227;o continuada; </p>
              </list-item>
              <list-item>
                <p> Pesquisa cl&#237;nica colaborativa em rede: utilizar as TIC para compartilhar e difundir boas pr&#225;ticas e gerar conhecimento.</p>
              </list-item>
            </list>
          </p>
        </sec>
        <sec>
          <title>1.3. Bases Seguras para Transmiss&#227;o de Dados</title>
          <p>A seguran&#231;a da informa&#231;&#227;o &#233; fundamental para a transmiss&#227;o de dados, e dois efeitos imediatos devem ser considerados: a) compreens&#227;o da criticidade da guarda e uso da informa&#231;&#227;o; b) poss&#237;veis implica&#231;&#245;es decorrentes da viola&#231;&#227;o dos padr&#245;es de seguran&#231;a e conformidade para indiv&#237;duos e organiza&#231;&#245;es.</p>
          <p>A legisla&#231;&#227;o europeia (GDPR) e a Lei Geral de Prote&#231;&#227;o de Dados Pessoais (LGPD) brasileira imp&#245;em pesadas multas e san&#231;&#245;es em caso de acesso indevido &#224;s informa&#231;&#245;es sob sua guarda. </p>
          <p>Nas se&#231;&#245;es seguintes, elencamos os requisitos principais para o estabelecimento de pol&#237;ticas adequadas de seguran&#231;a.<xref ref-type="bibr" rid="B15">15</xref>
					</p>
        </sec>
        <sec>
          <title>1.4. Prote&#231;&#227;o e Confidencialidade de Dados</title>
          <p>Para prote&#231;&#227;o adequada das informa&#231;&#245;es, &#233; necess&#225;rio garantir a seguran&#231;a dos sistemas, reduzindo eventuais vulnerabilidades, para evitar o acesso indevido e a quebra de confidencialidade. Deve haver determina&#231;&#227;o clara das autoriza&#231;&#245;es e n&#237;veis hier&#225;rquicos para o acesso &#224;s informa&#231;&#245;es.<xref ref-type="bibr" rid="B16">16</xref>
					</p>
          <p>A pol&#237;tica de acesso e confidencialidade da informa&#231;&#227;o deve constar de documento assinado pelos usu&#225;rios, definindo-se: a) escopo dos dados que podem ser acessados; b) implica&#231;&#245;es legais e san&#231;&#245;es que ser&#227;o eventualmente aplic&#225;veis aos usu&#225;rios em caso de viola&#231;&#227;o das normas acordadas.</p>
          <p>O uso indevido das instala&#231;&#245;es tecnol&#243;gicas est&#225; inversamente relacionado &#224; seguran&#231;a dos ambientes sob a responsabilidade das equipes de TIC. Devem ser adotadas pol&#237;ticas r&#237;gidas acerca do acesso &#224;s instala&#231;&#245;es f&#237;sicas, &#224;s redes de dados, aos sistemas operacionais, &#224;s bases de dados e suas aplica&#231;&#245;es. Um quadro valioso para a compreens&#227;o do controle desses ambientes pode ser encontrado no documento &#8220;<italic>Access Control Example Policy</italic>&#8221; (<italic>Health and Social Care Information Centre</italic>, 2017).<xref ref-type="bibr" rid="B16">16</xref>
					</p>
          <p>O padr&#227;o recomendado para transmiss&#227;o de dados no Brasil segue o conjunto de normas da Lei de Portabilidade e Responsabilidade de Seguro Sa&#250;de (<italic>Health Insurance Portability and Accountability Act, HIPAA</italic>).<xref ref-type="bibr" rid="B17">17</xref> Esse conjunto normativo se mostrou robusto o suficiente para garantir a seguran&#231;a dos dados transportados, e sua utiliza&#231;&#227;o como um balizador de pr&#225;ticas para o transporte de dados &#233; recomend&#225;vel. A Resolu&#231;&#227;o 2.227/2018<xref ref-type="bibr" rid="B5">5</xref> do CFM, embora revogada, preconizava o padr&#227;o que atenderia requisitos desej&#225;veis: &#8220;Deve ser utilizado um Sistema de Registro Eletr&#244;nico/Digital de informa&#231;&#227;o, propriet&#225;rio ou de co&#769;digo aberto, que capture, armazene, apresente, transmita ou imprima informa&#231;&#227;o digital e identificada em sa&#250;de, e que atenda integralmente aos requisitos do N&#237;vel de Garantia de Seguran&#231;a 2 (NGS2) e o padr&#227;o ICP-Brasil."</p>
          <p>Segundo essas normas, h&#225; a necessidade de que os dados armazenados (&#8220;<italic>at rest</italic>&#8221;) (&#8220;<italic>in transit</italic>&#8221;) estejam criptografados para a transmiss&#227;o. Uma das pr&#225;ticas essenciais para a seguran&#231;a dos dados &#233; a manuten&#231;&#227;o em ambientes distintos das ferramentas necess&#225;rias para criptografar e descriptografar informa&#231;&#245;es em ambientes diferentes dos locais de armazenamento originais.<xref ref-type="bibr" rid="B18">18</xref><sup>-</sup><xref ref-type="bibr" rid="B20">20</xref>
					</p>
          <p>As normas HIPAA para a criptografia e transporte de dados, al&#233;m de garantirem a seguran&#231;a das informa&#231;&#245;es, possuem farta documenta&#231;&#227;o dispon&#237;vel, facilitando o trabalho das equipes de desenvolvimento, por&#233;m os dados p&#250;blicos nacionais n&#227;o podem ser depositados em nuvens hospedadas fora do pa&#237;s.<xref ref-type="bibr" rid="B21">21</xref><sup>-</sup><xref ref-type="bibr" rid="B22">22</xref>
					</p>
        </sec>
        <sec>
          <title>1.5. Aspectos Bio&#233;ticos</title>
          <p>As iniciativas de ofertar assist&#234;ncia m&#233;dica a dist&#226;ncia, por meio de Telemedicina, remontam o s&#233;culo 19. A cardiologia &#233; pioneira, visto que, em 1906, Einthoven descreveu a transmiss&#227;o transtelef&#244;nica do eletrocardiograma do hospital acad&#234;mico at&#233; o laborat&#243;rio de fisiologia na Universidade de Leiden, alguns quil&#244;metros de dist&#226;ncia.<xref ref-type="bibr" rid="B23">23</xref> O grande impulso no desenvolvimento da telemetria foi dado pela Ag&#234;ncia Espacial Americana (NASA), para monitoramento de seus astronautas.<xref ref-type="bibr" rid="B24">24</xref><sup>,</sup><xref ref-type="bibr" rid="B25">25</xref>
					</p>
          <p>No entanto, a incorpora&#231;&#227;o da Telemedicina, na concep&#231;&#227;o atual, representa uma contemporaneidade.<xref ref-type="bibr" rid="B24">24</xref><sup>-</sup><xref ref-type="bibr" rid="B29">29</xref> Articula-se &#224; tradicional no&#231;&#227;o que a preserva&#231;&#227;o do valor social da Medicina est&#225; na depend&#234;ncia de um fluir de conte&#250;do. Qualquer modalidade de telecomunica&#231;&#227;o carrega potencialidades construtivas e destrutivas, e elas despertam contradi&#231;&#245;es em rela&#231;&#227;o aos valores e regras do c&#243;digo moral da pr&#225;tica m&#233;dica &#224; beira do leito. Ambival&#234;ncias s&#227;o bem-vindas na Medicina, que, segundo Osler (1849-1919), &#233; a ci&#234;ncia da incerteza e a arte da probabilidade.<xref ref-type="bibr" rid="B28">28</xref> A Telemedicina n&#227;o est&#225; imune aos movimentos pendulares da pluralidade de m&#233;todos na aten&#231;&#227;o &#224;s necessidades de sa&#250;de. </p>
          <p>&#192; beira do leito, convive-se com dilemas pr&#243;prios da diversidade da condi&#231;&#227;o humana.<xref ref-type="bibr" rid="B30">30</xref> M&#233;dicos e pacientes enfrentam desafios externos e/ou internos que n&#227;o permitem &#250;nica solu&#231;&#227;o. Qualquer op&#231;&#227;o cogitada precisa ser judiciosamente exposta, esclarecida e ajustada a fim de ganhar validade, quer para o contexto coletivo conceitual, quer para o individual da circunst&#226;ncia cl&#237;nica. </p>
          <p>A tecnologia aplicada adquiriu um sentido de real progresso para a Medicina.<xref ref-type="bibr" rid="B31">31</xref> O destaque contempor&#226;neo das tecnologias de informa&#231;&#227;o e comunica&#231;&#227;o na &#225;rea da sa&#250;de exige observat&#243;rios cr&#237;ticos da sociedade. A Bio&#233;tica tem as compet&#234;ncias necess&#225;rias para avaliar efeitos da Telemedicina sobre a integra&#231;&#227;o entre ci&#234;ncias da sa&#250;de, profissional da sa&#250;de, paciente/familiar, institui&#231;&#227;o de sa&#250;de e sistema de sa&#250;de.</p>
          <p>O benef&#237;cio da Telemedicina deve ser considerado mais na fun&#231;&#227;o de complementa&#231;&#227;o n&#227;o presencial do cuidado habitual do que uma substitui&#231;&#227;o do cuidado presencial. Deve ser praticada com seguran&#231;a e por per&#237;odo pertinente &#224; circunst&#226;ncia cl&#237;nica (prazos de validade proporcionais aos leg&#237;timos interesses envolvidos).<xref ref-type="bibr" rid="B32">32</xref><sup>,</sup><xref ref-type="bibr" rid="B33">33</xref>
					</p>
          <p>Aspecto &#233;tico adicional &#233; que certas perspectivas inevit&#225;veis de abuso de uma t&#233;cnica n&#227;o devem prejudicar o uso beneficente. Por isso, qualquer considera&#231;&#227;o de ordem &#233;tica e legal a respeito da ainda jovem Telemedicina, especialmente para aplica&#231;&#227;o a um Brasil continental, pluri&#233;tnico e multicultural n&#227;o pode deixar de reconhecer que &#233; dif&#237;cil para o profissional da sa&#250;de definir com abrang&#234;ncia e profundidade o conjunto de suas responsabilidades. Isso tendo em vista que o alcance da Telemedicina mobiliza uma gama A-Z de exig&#234;ncias, decis&#245;es e provid&#234;ncias que se entrela&#231;am acerca de: </p>
          <p>
            <list list-type="alpha-lower">
              <list-item>
                <p> envolvimento com fundamentos da &#233;tica vigente, a prud&#234;ncia e o zelo em rela&#231;&#227;o a temas complexos, como assist&#234;ncia ao idoso, comodidade ao vulner&#225;vel, redu&#231;&#227;o de hospitaliza&#231;&#245;es e presteza de orienta&#231;&#227;o; </p>
              </list-item>
              <list-item>
                <p> imparcialidade de ju&#237;zos sobre a cobertura das reais necessidades do paciente e conten&#231;&#227;o para acenos de ganhos secund&#225;rios e conflitos de interesse, passando pelo potencial de (mau) uso pol&#237;tico e do poder; </p>
              </list-item>
              <list-item>
                <p> sentido de benefic&#234;ncia;</p>
              </list-item>
              <list-item>
                <p> evita&#231;&#227;o da malefic&#234;ncia;</p>
              </list-item>
              <list-item>
                <p> compromisso com a seguran&#231;a biol&#243;gica do paciente;</p>
              </list-item>
              <list-item>
                <p> respeito &#224; equidade; </p>
              </list-item>
              <list-item>
                <p> defini&#231;&#227;o sobre a fun&#231;&#227;o de complementaridade do presencial ou de seu substituto; </p>
              </list-item>
              <list-item>
                <p> conscientiza&#231;&#227;o sobre consequ&#234;ncias do n&#227;o presencial sobre o racioc&#237;nio cl&#237;nico; </p>
              </list-item>
              <list-item>
                <p> clareza sobre a gama de varia&#231;&#245;es de uso; </p>
              </list-item>
              <list-item>
                <p> treinamento sobre pap&#233;is, responsabilidades e habilidades no manejo da aparelhagem em reentrantes aperfei&#231;oamentos; </p>
              </list-item>
              <list-item>
                <p> desenvolvimento de conex&#245;es amig&#225;veis com o prontu&#225;rio do paciente; </p>
              </list-item>
              <list-item>
                <p> respeito ao direito &#224; autonomia pelo paciente expresso por meio do consentimento livre, esclarecido, renov&#225;vel e revog&#225;vel; </p>
              </list-item>
              <list-item>
                <p> apre&#231;o imperioso pelos valores humanos; </p>
              </list-item>
              <list-item>
                <p> aprecia&#231;&#227;o cr&#237;tica sobre custo-efetividade; </p>
              </list-item>
              <list-item>
                <p> aprecia&#231;&#227;o sobre o valor da preced&#234;ncia da conex&#227;o <italic>on-line</italic> por uma rela&#231;&#227;o face a face em algum momento imediato ou remoto; </p>
              </list-item>
              <list-item>
                <p> clima de confian&#231;a apesar da dist&#226;ncia; </p>
              </list-item>
              <list-item>
                <p> alertas conceituais e provocados por acontecimentos sobre limita&#231;&#245;es do n&#227;o presencial;</p>
              </list-item>
              <list-item>
                <p> avalia&#231;&#227;o individual do n&#237;vel de compet&#234;ncia do momento para o cuidado requerido;</p>
              </list-item>
              <list-item>
                <p> avalia&#231;&#227;o do grau de completude das informa&#231;&#245;es devidas; </p>
              </list-item>
              <list-item>
                <p> preocupa&#231;&#227;o com a continuidade do cuidado prestado;</p>
              </list-item>
              <list-item>
                <p> promo&#231;&#227;o da ader&#234;ncia &#224; conduta recomendada;</p>
              </list-item>
              <list-item>
                <p> respeito ao sigilo profissional; </p>
              </list-item>
              <list-item>
                <p> &#8220;ajustes de passaporte&#8221; sobre a limita&#231;&#227;o geogr&#225;fica estadual da inscri&#231;&#227;o do m&#233;dico no conselho de Medicina; </p>
              </list-item>
              <list-item>
                <p> continuidade de pesquisas em busca de evid&#234;ncias confi&#225;veis sobre vantagens e desvantagens; </p>
              </list-item>
              <list-item>
                <p> interface com o consumerismo no cuidado com a sa&#250;de, incluindo expectativas devidas e indevidas quanto a possibilidades de haver atendimento imediato; </p>
              </list-item>
            </list>
          </p>
          <p>z. valoriza&#231;&#227;o da contribui&#231;&#227;o da Bio&#233;tica para a harmoniza&#231;&#227;o entre o cl&#225;ssico, a inova&#231;&#227;o e a novidade. </p>
          <p>Portanto, diante das bases &#233;tico-normativas existentes, da legisla&#231;&#227;o em vigor e dos princ&#237;pios bio&#233;ticos que norteiam a rela&#231;&#227;o entre o m&#233;dico e o paciente, podemos estabelecer as seguintes diretrizes para o uso da Telemedicina em cardiologia: </p>
          <p>
            <list list-type="order">
              <list-item>
                <p> O m&#233;dico cardiologista deve ter a cautela de, previamente &#224; utiliza&#231;&#227;o da Telemedicina aplicada &#224; cardiologia ou, simplesmente, telecardiologia, manter uma rela&#231;&#227;o prof&#237;cua com seu paciente, pautada pelas bases estabelecidas no C&#243;digo de &#201;tica M&#233;dica.</p>
              </list-item>
              <list-item>
                <p> O Termo de Consentimento Livre e Esclarecido &#233; o documento que obt&#233;m, do paciente, a autoriza&#231;&#227;o para a utiliza&#231;&#227;o da telecardiologia quando se vislumbra a alternativa de teleconsultoria direta. </p>
              </list-item>
              <list-item>
                <p> Procedimentos de monitoramento de sinais vitais a dist&#226;ncia deve ser previamente consentidos pelo paciente, com a devida orienta&#231;&#227;o e treinamento quanto &#224; sua utiliza&#231;&#227;o.</p>
              </list-item>
              <list-item>
                <p> As empresas m&#233;dicas que prestarem servi&#231;o na &#225;rea de telecardiologia dever&#227;o possuir inscri&#231;&#227;o junto ao Conselho Regional de Medicina (CRM), com um respons&#225;vel t&#233;cnico, m&#233;dico cardiologista, que ser&#225; o respons&#225;vel &#233;tico pela fiscaliza&#231;&#227;o dos procedimentos realizados, em especial quanto &#224;s ferramentas tecnol&#243;gicas disponibilizadas ao quadro de profissionais.</p>
              </list-item>
              <list-item>
                <p> O respeito &#224; autonomia de vontade do paciente e &#224; prote&#231;&#227;o da sua intimidade no que se relaciona com os dados de sa&#250;de s&#227;o a base da Telemedicina aplicada &#224; cardiologia.</p>
              </list-item>
            </list>
          </p>
        </sec>
        <sec>
          <title>1.6. Legisla&#231;&#227;o e Regulamenta&#231;&#227;o no Brasil</title>
          <p>O Marco Civil da Internet (Lei Federal n&#186;12.965, de 23 de abril de 2014)<xref ref-type="bibr" rid="B34">34</xref> e a Lei Geral de Prote&#231;&#227;o de Dados (LGPD) (Lei Federal n&#186;13.709, de 14 de agosto de 2018)<xref ref-type="bibr" rid="B35">35</xref> s&#227;o os principais instrumentos normativos, com repercuss&#227;o direta sobre a Telemedicina no Brasil, ainda que n&#227;o sejam espec&#237;ficos. As principais autoridades regulat&#243;rias s&#227;o: Minist&#233;rio da Sa&#250;de, Ag&#234;ncia Nacional de Vigil&#226;ncia Sanit&#225;ria (Anvisa), Ag&#234;ncia Nacional de Sa&#250;de Suplementar (ANS), e o CFM. </p>
          <sec>
            <title>1.6.1. Marco Civil da Internet</title>
            <p>O Marco Civil da Internet (Decreto 8.771 de 11/05/2016)<xref ref-type="bibr" rid="B34">34</xref> estabelece princ&#237;pios, garantias, direitos e deveres dos usu&#225;rios da rede mundial de computadores no Brasil.</p>
            <p>O Marco Civil da Internet reconheceu as rela&#231;&#245;es jur&#237;dicas no mundo virtual e seus efeitos no ordenamento brasileiro. Al&#233;m do estabelecimento da neutralidade da rede, destacou-se igualmente na salvaguarda da liberdade de express&#227;o e da prote&#231;&#227;o &#224; privacidade. N&#227;o contemplou, entretanto, importantes aspectos relativos aos dados pessoais, ensejando o advento da LGPD.<xref ref-type="bibr" rid="B34">34</xref>
						</p>
          </sec>
          <sec>
            <title>1.6.2. Lei Geral de Prote&#231;&#227;o de Dados (LGPD)</title>
            <p>A Lei Federal 13.709<xref ref-type="bibr" rid="B35">35</xref> de 14 de agosto de 2018 (LGPD), disp&#245;e sobre o tratamento de dados pessoais, inclusive nos meios digitais, por pessoa natural ou pessoa jur&#237;dica de direito p&#250;blico ou privado, com o objetivo de proteger os direitos fundamentais de liberdade e de privacidade e o livre desenvolvimento da personalidade da pessoa natural.</p>
            <p>Importante contribui&#231;&#227;o da LGPD<xref ref-type="bibr" rid="B35">35</xref> &#233; a clara enuncia&#231;&#227;o do conceito de dados: </p>
            <p>
              <list list-type="roman-upper">
                <list-item>
                  <p>I. Dado pessoal - informa&#231;&#227;o relacionada a pessoa natural identificada ou identific&#225;vel; </p>
                </list-item>
                <list-item>
                  <p>II. Dado anonimizado - dado relativo a titular que n&#227;o possa ser identificado, considerando a utiliza&#231;&#227;o de meios t&#233;cnicos razo&#225;veis e dispon&#237;veis na ocasi&#227;o de seu tratamento; </p>
                </list-item>
                <list-item>
                  <p>III. Dado pessoal sens&#237;vel - origem racial ou &#233;tnica; convic&#231;&#227;o religiosa; opini&#227;o pol&#237;tica; filia&#231;&#227;o a sindicato ou a organiza&#231;&#227;o de car&#225;ter religioso, filos&#243;fico ou pol&#237;tico; dado referente &#224; sa&#250;de ou &#224; vida sexual; e dado gen&#233;tico ou biom&#233;trico, quando vinculado a uma pessoa natural.</p>
                </list-item>
              </list>
            </p>
            <p>A legisla&#231;&#227;o define que o acesso &#224; internet &#233; essencial ao exerc&#237;cio da cidadania, e que devem ser assegurada aos usu&#225;rios a inviolabilidade da intimidade, da vida privada e das comunica&#231;&#245;es ali realizadas. </p>
            <p>As medidas e os procedimentos de seguran&#231;a e de sigilo devem ser informados pelo respons&#225;vel pela provis&#227;o de servi&#231;os de forma clara e atender a padr&#245;es definidos em regulamento, respeitado seu direito de confidencialidade quanto a segredos empresariais. </p>
            <p>Em rela&#231;&#227;o &#224; Telemedicina, a necessidade de tratamento de grandes volumes de dados sens&#237;veis (dados cadastrais de pacientes, queixas de sa&#250;de, antecedentes, hist&#243;rico de doen&#231;as, solicita&#231;&#245;es e resultados de exames, hip&#243;teses diagn&#243;sticas, plano terap&#234;utico, evolu&#231;&#227;o cl&#237;nica e pareceres, dentre outros) torna a LGPD objeto de denotado interesse.</p>
            <p>O Minist&#233;rio da Sa&#250;de instituiu em 2007 o Programa Nacional de Telessa&#250;de, expandindo-se com o objetivo de aperfei&#231;oar a qualidade do atendimento da Aten&#231;&#227;o Prim&#225;ria do SUS por meio do suporte &#224; Estrat&#233;gia de Sa&#250;de da Fam&#237;lia. Na Portaria 2.546 de outubro de 2011, o programa foi ampliado e redefinido, passando a ser denominado Programa Nacional Telessa&#250;de Brasil Rede, o qual disciplina os servi&#231;os de Teleconsultoria s&#237;ncrona ou ass&#237;ncrona; Telediagn&#243;stico; Segunda Opini&#227;o Formativa e Tele-educa&#231;&#227;o em Sa&#250;de.<xref ref-type="bibr" rid="B36">36</xref>
						</p>
          </sec>
          <sec>
            <title>1.6.3. Regulamenta&#231;&#227;o do Conselho Federal de Medicina sobre Telemedicina</title>
            <p>Conforme a Resolu&#231;&#227;o 1.643/2002<xref ref-type="bibr" rid="B37">37</xref> do CFM, a Telemedicina &#233; o exerc&#237;cio da Medicina mediante o emprego de metodologias interativas de comunica&#231;&#227;o audiovisual e de dados, com o objetivo de assist&#234;ncia, educa&#231;&#227;o e pesquisa em sa&#250;de. Al&#233;m destes, cumpre destacar os seguintes aspectos relevantes:</p>
            <p>
              <list list-type="bullet">
                <list-item>
                  <p> Os servi&#231;os prestados dever&#227;o contar com infraestrutura tecnol&#243;gica apropriada, assim como acatar as normas t&#233;cnicas do CFM pertinentes a guarda, manuseio, transmiss&#227;o de dados, confidencialidade, privacidade e garantia do sigilo profissional.</p>
                </list-item>
                <list-item>
                  <p> A responsabilidade profissional do atendimento cabe ao m&#233;dico assistente do paciente. Os demais envolvidos responder&#227;o solidariamente na propor&#231;&#227;o em que contribu&#237;rem por eventual dano ao mesmo.</p>
                </list-item>
                <list-item>
                  <p> As pessoas jur&#237;dicas que prestarem servi&#231;os de Telemedicina dever&#227;o inscrever-se no Cadastro de Pessoa Jur&#237;dica do Conselho Regional de Medicina do Estado onde residem, com a respectiva responsabilidade t&#233;cnica de um m&#233;dico regularmente inscrito no Conselho e a apresenta&#231;&#227;o da rela&#231;&#227;o dos m&#233;dicos que comp&#245;em seus quadros funcionais.</p>
                </list-item>
              </list>
            </p>
            <p>Desde ent&#227;o, inova&#231;&#245;es tecnol&#243;gicas e a democratiza&#231;&#227;o do acesso &#224; rede mundial de computadores permitiu diversas inova&#231;&#245;es as quais ainda carecem de regulamenta&#231;&#227;o adequada, tais como: </p>
            <p>
              <list list-type="bullet">
                <list-item>
                  <p> novos meios de relacionamento m&#233;dico-paciente;</p>
                </list-item>
                <list-item>
                  <p> exist&#234;ncia de agentes e provedores de dados e servi&#231;os;</p>
                </list-item>
                <list-item>
                  <p> discuss&#227;o de novo formato para o Termo de Consentimento Livre e Esclarecido (TCLE), sob r&#237;gidas normas de seguran&#231;a capazes de garantir a confidencialidade e integridade das informa&#231;&#245;es.</p>
                </list-item>
              </list>
            </p>
            <p>Nesse cen&#225;rio, surgiu a necessidade de atualizar a regulamenta&#231;&#227;o da pr&#225;tica da Telemedicina no Brasil. O CFM, nesse sentido, editou a Resolu&#231;&#227;o 2.227/2018, posteriormente revogada. No entanto, urge uma atualiza&#231;&#227;o dessa Resolu&#231;&#227;o, com a finalidade de oferecer seguran&#231;a jur&#237;dica dentro de uma perspectiva, em que a Telemedicina se apresenta como vetor de transforma&#231;&#227;o da sa&#250;de.<xref ref-type="bibr" rid="B38">38</xref>
						</p>
            <p>Nessa diretriz, adotaremos a denomina&#231;&#227;o dos servi&#231;os ofertados no &#226;mbito da Telemedicina conforme a portaria 2.546 do Minist&#233;rio da Sa&#250;de, de outubro de 2011, e regula&#231;&#227;o do CFM em vigor.</p>
          </sec>
        </sec>
        <sec>
          <title>1.7. Aplicabilidade no Brasil</title>
          <p>A Telemedicina em um pa&#237;s continental como o Brasil representa uma perspectiva de assegurar a consecu&#231;&#227;o de pol&#237;ticas p&#250;blicas concebidas &#224; &#233;poca da concep&#231;&#227;o do SUS, as quais n&#227;o foram plenamente satisfeitas em virtude da exist&#234;ncia de &#225;reas desassistidas ou remotas com exiguidade de profissionais de sa&#250;de, entre outras raz&#245;es. Assim, torna-se imperativa a exist&#234;ncia de condi&#231;&#245;es de infraestrutura capazes de fazer chegar na ponta os recursos dispon&#237;veis para emprego de TIC voltadas &#224; sa&#250;de. Discutir conceitos de &#225;reas remotas e conhecer a demografia m&#233;dica interessa para compreender a aplicabilidade da Telemedicina no Brasil.</p>
          <sec>
            <title>1.7.1. Conceito de Territ&#243;rio Urbano, Rural e &#193;rea Remota</title>
            <p>A defini&#231;&#227;o de territ&#243;rio ultrapassa o limite do espa&#231;o f&#237;sico, pois geralmente mant&#233;m forte rela&#231;&#227;o com o contexto sociocultural em que se insere. A divis&#227;o entre o espa&#231;o urbano e rural n&#227;o ocorre de forma abrupta, apresentando limites flex&#237;veis e com caracter&#237;sticas similares.<xref ref-type="bibr" rid="B39">39</xref> &#201; evidente que, em muitas regi&#245;es, a ocupa&#231;&#227;o territorial &#233; desigual, assim como o acesso aos bens e servi&#231;os ofertados nas diferentes formas de assentamentos humanos. Em geral, os meios de transporte e a acessibilidade &#224;s &#225;reas urbanas e rurais s&#227;o distintos de uma localidade para outra, retornando assim a import&#226;ncia da classifica&#231;&#227;o entre urbano e rural.<xref ref-type="bibr" rid="B40">40</xref>
						</p>
            <p>A Organiza&#231;&#227;o para Coopera&#231;&#227;o e Desenvolvimento Econ&#244;mico (OCDE) classifica os espa&#231;os de acordo com densidade populacional, propor&#231;&#227;o de popula&#231;&#227;o vivendo em grandes centros e acessibilidade, sendo esta &#250;ltima definida pelo tempo de deslocamento entre os centros urbanos e as &#225;reas rurais. Assim, a OCDE classifica uma &#225;rea rural em remota quando 50% da popula&#231;&#227;o local necessita de pelo menos 45 a 60 minutos de viagem em ve&#237;culo automotor para atingir um centro populacional com pelo menos 50 mil habitantes.<xref ref-type="bibr" rid="B41">41</xref>
						</p>
            <p>No Brasil, a classifica&#231;&#227;o dos espa&#231;os ocupados, rural ou urbano, foi estabelecida em 1938 por for&#231;a do Decreto n. 311/1938. O Manual da Base Territorial do Instituto Brasileiro de Geografia e Estat&#237;stica (IBGE)<xref ref-type="bibr" rid="B42">42</xref>, de 2014 considera o acesso por malha rodovi&#225;ria ou hidrovi&#225;ria nacional das &#225;reas rurais aos centros urbanos, o que permite sua classifica&#231;&#227;o quanto ao seu grau de proximidade e acesso aos grandes centros urbanos, criando uma no&#231;&#227;o de isolamento. A partir do Mapa de Log&#237;stica de Transporte de 2014, os munic&#237;pios foram classificados em adjacente e remotos, respectivamente, se o tempo de deslocamento da sede do munic&#237;pio a um centro de influ&#234;ncia fosse maior ou menor que a m&#233;dia nacional.</p>
            <p>A <xref ref-type="table" rid="t16">tabela 1.1</xref> apresenta a distribui&#231;&#227;o dos munic&#237;pios no territ&#243;rio nacional a partir da classifica&#231;&#227;o de isolamento do IBGE.<xref ref-type="bibr" rid="B43">43</xref>
						</p>
            <table-wrap id="t16">
              <label>Tabela 1.1</label>
              <caption>
                <title>Classifica&#231;&#227;o de isolamento dos munic&#237;pios brasileiros, por regi&#245;es e popula&#231;&#227;o<xref ref-type="bibr" rid="B43">43</xref>
								</title>
              </caption>
              <table frame="hsides" rules="rows">
                <colgroup>
                  <col width="12%"/>
                  <col width="12%"/>
                  <col width="12%"/>
                  <col width="12%"/>
                  <col width="12%"/>
                  <col width="12%"/>
                  <col width="12%"/>
                  <col width="12%"/>
                </colgroup>
                <thead>
                  <tr>
                    <th align="left" colspan="2">Classifica&#231;&#227;o de isolamento (IBGE)</th>
                    <th align="center">Brasil</th>
                    <th align="center">Norte</th>
                    <th align="center">Nordeste</th>
                    <th align="center">Sudeste</th>
                    <th align="center">Sul</th>
                    <th align="center">Cento-oeste</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td align="left" rowspan="4">Adjacente</td>
                    <td align="center">N&#250;mero de munic&#237;pios</td>
                    <td align="center">5.126</td>
                    <td align="center">277</td>
                    <td align="center">1.683</td>
                    <td align="center">1.637</td>
                    <td align="center">1.180</td>
                    <td align="center">349</td>
                  </tr>
                  <tr>
                    <td align="center">% de munic&#237;pios em rela&#231;&#227;o &#224; grande regi&#227;o</td>
                    <td align="center">92,11</td>
                    <td align="center">61,69</td>
                    <td align="center">93,81</td>
                    <td align="center">98,14</td>
                    <td align="center">99,33</td>
                    <td align="center">74,89</td>
                  </tr>
                  <tr>
                    <td align="center">Popula&#231;&#227;o total<break/>Censo 2010)</td>
                    <td align="center">183.820.219</td>
                    <td align="center">12.610.201</td>
                    <td align="center">51.780.322</td>
                    <td align="center">79.982.805</td>
                    <td align="center">27.099.304</td>
                    <td align="center">12.347.587</td>
                  </tr>
                  <tr>
                    <td align="center">% da popula&#231;&#227;o </td>
                    <td align="center">96,37</td>
                    <td align="center">79,49</td>
                    <td align="center">97,56</td>
                    <td align="center">99,53</td>
                    <td align="center">98,95</td>
                    <td align="center">87,83</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="4">Remoto</td>
                    <td align="center">N&#250;mero de munic&#237;pios</td>
                    <td align="center">439</td>
                    <td align="center">172</td>
                    <td align="center">111</td>
                    <td align="center">31</td>
                    <td align="center">8</td>
                    <td align="center">117</td>
                  </tr>
                  <tr>
                    <td align="center">% de munic&#237;pios em rela&#231;&#227;o &#224; grande regi&#227;o</td>
                    <td align="center">7,89</td>
                    <td align="center">38,31</td>
                    <td align="center">6,19</td>
                    <td align="center">1,86</td>
                    <td align="center">0,67</td>
                    <td align="center">25,11</td>
                  </tr>
                  <tr>
                    <td align="center">Popula&#231;&#227;o total<break/>Censo 2010)</td>
                    <td align="center">6.927.512</td>
                    <td align="center">3.254.253</td>
                    <td align="center">1.293.560</td>
                    <td align="center">381.605</td>
                    <td align="center">287.587</td>
                    <td align="center">1.710.507</td>
                  </tr>
                  <tr>
                    <td align="center">% da popula&#231;&#227;o </td>
                    <td align="center">3,63</td>
                    <td align="center">20,51</td>
                    <td align="center">2,44</td>
                    <td align="center">0,47</td>
                    <td align="center">1,05</td>
                    <td align="center">12,17</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <attrib>Fonte: IBGE. Classifica&#231;&#227;o e Caracteriza&#231;&#227;o dos Espa&#231;os Rurais e Urbanos do Brasil.<xref ref-type="bibr" rid="B43">43</xref>
								</attrib>
              </table-wrap-foot>
            </table-wrap>
            <p>Mais de 65% dos munic&#237;pios considerados remotos est&#227;o nas regi&#245;es Norte e Centro-oeste do pa&#237;s. Essas duas regi&#245;es concentram 5 milh&#245;es de habitantes, ou 72% dos residentes em munic&#237;pios remotos do pa&#237;s (quase 7 milh&#245;es de pessoas vivem em &#225;reas consideradas remotas pelo IBGE). Nas mesmas regi&#245;es Norte e Centro-oeste, a popula&#231;&#227;o em munic&#237;pios remotos representa 20% e 12% da popula&#231;&#227;o, respectivamente. A <xref ref-type="fig" rid="f7">figura 1.1</xref> apresenta a propor&#231;&#227;o da popula&#231;&#227;o urbana nos munic&#237;pios brasileiros.</p>
            <p>
              <fig id="f7">
                <label>Figura 1.1</label>
                <caption>
                  <title>Propor&#231;&#227;o da popula&#231;&#227;o urbana nos munic&#237;pios brasileiros, Censo de 2010.<xref ref-type="bibr" rid="B44">44</xref>
									</title>
                </caption>
                <attrib>Fonte: IBGE &#8211; Censo 2010.<xref ref-type="bibr" rid="B44">44</xref>
								</attrib>
                <graphic xlink:href="1678-4170-abc-113-05-1006-90205-gf01-pt.jpg"/></fig>
            </p>
          </sec>
          <sec>
            <title>1.7.2. Demografia M&#233;dica</title>
            <p>A raz&#227;o de m&#233;dicos por habitante no Brasil &#233; significativamente mais baixa (2,1 m&#233;dicos por mil habitantes) que a m&#233;dia dos pa&#237;ses da OCDE (3,4 m&#233;dicos por mil habitantes). Al&#233;m da escassez absoluta de profissionais, o pa&#237;s tamb&#233;m tem escassez relativa devido &#224;s grandes desigualdades regionais na distribui&#231;&#227;o da for&#231;a de trabalho m&#233;dico existente. Estudos recentes apontam para a grande concentra&#231;&#227;o de profissionais de Medicina nas regi&#245;es Sul e Sudeste, com a propor&#231;&#227;o de especialistas seguindo essa tend&#234;ncia.<xref ref-type="bibr" rid="B45">45</xref> A <xref ref-type="table" rid="t17">tabela 1.2</xref> mostra a distribui&#231;&#227;o de m&#233;dicos por regi&#227;o do pa&#237;s, desagregados segundo sua especializa&#231;&#227;o em generalistas, com alguma especialidade (especialistas) e a propor&#231;&#227;o m&#233;dico por mil habitantes, e a distribui&#231;&#227;o dos cardiologistas por regi&#245;es e por habitante.</p>
            <table-wrap id="t17">
              <label>Tabela 1.2</label>
              <caption>
                <title>Distribui&#231;&#227;o de m&#233;dicos por regi&#227;o do pa&#237;s, desagregados segundo sua especializa&#231;&#227;o e generalistas</title>
              </caption>
              <table frame="hsides" rules="rows">
                <colgroup>
                  <col width="12%"/>
                  <col width="12%"/>
                  <col width="12%"/>
                  <col width="12%"/>
                  <col width="12%"/>
                  <col width="12%"/>
                  <col width="12%"/>
                  <col width="12%"/>
                </colgroup>
                <thead>
                  <tr>
                    <th align="left">Regi&#227;o</th>
                    <th align="center">M&#233;dicos</th>
                    <th align="center">Generalistas</th>
                    <th align="center">Especialistas</th>
                    <th align="center">Popula&#231;&#227;o </th>
                    <th align="center">Cardiologia</th>
                    <th align="center">Cardiologista/1000 hab</th>
                    <th align="center">M&#233;dico/1000 hab</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td align="left">Norte</td>
                    <td align="center">20.884</td>
                    <td align="center">10.128</td>
                    <td align="center">10.766</td>
                    <td align="center">17.936.201</td>
                    <td align="center">441</td>
                    <td align="center">0,025</td>
                    <td align="center">1,16</td>
                  </tr>
                  <tr>
                    <td align="left">Nordeste</td>
                    <td align="center">80.623</td>
                    <td align="center">34.461</td>
                    <td align="center">46.162</td>
                    <td align="center">57.254.159</td>
                    <td align="center">2.534</td>
                    <td align="center">0,044</td>
                    <td align="center">1,41</td>
                  </tr>
                  <tr>
                    <td align="left">Centro-oeste</td>
                    <td align="center">37.536</td>
                    <td align="center">12.828</td>
                    <td align="center">24.708</td>
                    <td align="center">15.875.907</td>
                    <td align="center">1.464</td>
                    <td align="center">0,092</td>
                    <td align="center">2,36</td>
                  </tr>
                  <tr>
                    <td align="left">Sudeste</td>
                    <td align="center">244.304</td>
                    <td align="center">91.124</td>
                    <td align="center">153.180</td>
                    <td align="center">86.949.714</td>
                    <td align="center">8.383</td>
                    <td align="center">0,096</td>
                    <td align="center">2,81</td>
                  </tr>
                  <tr>
                    <td align="left">Sul</td>
                    <td align="center">68.430</td>
                    <td align="center">20.948</td>
                    <td align="center">47.482</td>
                    <td align="center">29.644.948</td>
                    <td align="center">2.694</td>
                    <td align="center">0,091</td>
                    <td align="center">2,31</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <attrib>Fonte: Scheffer M, Cassenote A, Guilloux AGA, Mioto BA, Mainardi GM. Demografia M&#233;dica no Brasil 2018. S&#227;o Paulo: FMUSP, CFM, Cremesp; 2018.<xref ref-type="bibr" rid="B45">45</xref>
								</attrib>
                <fn id="TFN5">
                  <p>*Popula&#231;&#227;o estimada pelo IBGE em 2017.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p>Nas regi&#245;es Norte e Nordeste, observa-se que em algumas unidades da federa&#231;&#227;o, a raz&#227;o m&#233;dico/habitante &#233; inferior a 1,00, como nos casos do Par&#225; e Maranh&#227;o com 0,97 e 0,87, respectivamente. O recente relat&#243;rio Demografia M&#233;dica no Brasil (2018) apontou, ainda, importante desigualdade na oferta de m&#233;dicos entre munic&#237;pios predominantemente urbanos e rurais, com elevada concentra&#231;&#227;o da for&#231;a de trabalho m&#233;dica nos grandes centros urbanos.<xref ref-type="bibr" rid="B45">45</xref>
						</p>
            <p>Os dados do Cadastro Nacional de Estabelecimentos de Sa&#250;de (CNES), disponibilizado pelo Minist&#233;rio da Sa&#250;de,<xref ref-type="bibr" rid="B46">46</xref> mostra a mesma tend&#234;ncia de concentra&#231;&#227;o de m&#233;dicos nas regi&#245;es Sul e Sudeste, no m&#234;s de fevereiro de 2019, como pode ser visto na <xref ref-type="fig" rid="f8">figura 1.2</xref>.<xref ref-type="bibr" rid="B46">46</xref>
						</p>
            <p>
              <fig id="f8">
                <label>Figura 1.2</label>
                <caption>
                  <title>Distribui&#231;&#227;o dos m&#233;dicos por mil habitantes nos munic&#237;pios brasileiros &#8211; CNES, fevereiro de 2019.<xref ref-type="bibr" rid="B46">46</xref>
									</title>
                </caption>
                <attrib>Fonte: Cadastro Nacional de Estabelecimentos de Sa&#250;de (CNES/DATASUS/MS).<xref ref-type="bibr" rid="B46">46</xref>
								</attrib>
                <graphic xlink:href="1678-4170-abc-113-05-1006-90205-gf02-pt.jpg"/></fig>
            </p>
          </sec>
          <sec>
            <title>1.7.3. A Estrat&#233;gia E-sa&#250;de</title>
            <p>A Uni&#227;o Internacional das Telecomunica&#231;&#245;es (UIT),<xref ref-type="bibr" rid="B47">47</xref> &#243;rg&#227;o ligado &#224; Organiza&#231;&#227;o das Na&#231;&#245;es Unidas (ONU), vem trabalhando em colabora&#231;&#227;o com a OMS, para cria&#231;&#227;o de um ambiente global para a implementa&#231;&#227;o da estrat&#233;gia e-sa&#250;de, especialmente em Telemedicina.<xref ref-type="bibr" rid="B47">47</xref><sup>,</sup><xref ref-type="bibr" rid="B48">48</xref>
						</p>
            <p>A estrat&#233;gia e-sa&#250;de &#233; particularmente importante para o controle de agravos cr&#244;nicos n&#227;o transmiss&#237;veis, como hipertens&#227;o arterial, diabetes, cardiopatias e doen&#231;as ligadas ao envelhecimento. Nos &#250;ltimos anos, tem-se observado grande avan&#231;o na aplica&#231;&#227;o de e-sa&#250;de e Telemedicina,<xref ref-type="bibr" rid="B49">49</xref> por&#233;m um estudo de revis&#227;o sistem&#225;tica recente, sobre rela&#231;&#227;o do custo-efetividade da aplica&#231;&#227;o de e-sa&#250;de, n&#227;o encontrou muitos estudos que possibilitassem analisar o impacto da estrat&#233;gia sobre os sistemas de sa&#250;de ou aspectos sociais, apesar de a maioria dos estudos demonstrarem efic&#225;cia e custo-efetividade.<xref ref-type="bibr" rid="B49">49</xref>
						</p>
          </sec>
          <sec>
            <title>1.7.4. Infraestrutura de Telecomunica&#231;&#245;es e Dados</title>
            <p>Estima-se que at&#233; 95% da popula&#231;&#227;o mundial tenha acesso &#224; telefonia m&#243;vel, sendo que no Brasil esses n&#250;meros podem passar de 98% de cobertura. A evolu&#231;&#227;o do acesso aos servi&#231;os de telefonia m&#243;vel no Brasil &#233; marcante e observa-se aumento na utiliza&#231;&#227;o equipamentos de telefonia m&#243;vel celular por habitante de 2009 a 2019,<xref ref-type="bibr" rid="B50">50</xref><sup>,</sup><xref ref-type="bibr" rid="B51">51</xref> seguido por uma tend&#234;ncia de queda na utiliza&#231;&#227;o de telefones m&#243;veis a partir de ent&#227;o (<xref ref-type="fig" rid="f9">Figura 1.3</xref>). Na <xref ref-type="fig" rid="f10">figura 1.4</xref>, podemos observar a distribui&#231;&#227;o de celulares/100 habitantes e a rela&#231;&#227;o entre os cardiologistas e celulares por 1000 habitantes no Brasil no ano de 2018.</p>
            <p>
              <fig id="f9">
                <label>Figura 1.3</label>
                <caption>
                  <title>Densidade de acesso a telefonia m&#243;vel no Brasil e regi&#245;es &#8211; mar&#231;o de 2009 a 2019.<xref ref-type="bibr" rid="B50">50</xref>
									</title>
                </caption>
                <attrib>Fonte: ANATEL.<xref ref-type="bibr" rid="B50">50</xref>
								</attrib>
                <graphic xlink:href="1678-4170-abc-113-05-1006-90205-gf03-pt.jpg"/></fig>
            </p>
            <p>
              <fig id="f10">
                <label>Figura 1.4</label>
                <caption>
                  <title>Distribui&#231;&#227;o de celulares e cardiologistas, Brasil. a) Raz&#227;o cardiologistas/1.000 habitantes (2017), b) Densidade de celulares/100 habitantes (2019).<xref ref-type="bibr" rid="B51">51</xref>
									</title>
                </caption>
                <attrib>Fonte: Scheffer M, Cassenote A, Guilloux AGA, Mioto BA, Mainardi GM. Demografia Medica no Brasil 2018. S&#227;o Paulo: FMUSP, CFM, Cremesp; 2018.<xref ref-type="bibr" rid="B45">45</xref>
								</attrib>
                <graphic xlink:href="1678-4170-abc-113-05-1006-90205-gf04-pt.jpg"/></fig>
            </p>
            <p>Em rela&#231;&#227;o &#224; cobertura de fibra &#243;tica, tamb&#233;m existe uma maior concentra&#231;&#227;o nas regi&#245;es Sul e Sudeste do Brasil. A <xref ref-type="fig" rid="f11">figura 1.5</xref> demostra a distribui&#231;&#227;o de <italic>backhaul</italic> em fibra &#243;tica nos munic&#237;pios brasileiros. <italic>Backhaul</italic> &#233; a por&#231;&#227;o de uma rede hier&#225;rquica, como a de comunica&#231;&#227;o por telefonia m&#243;vel celular, respons&#225;vel pela conex&#227;o da rede principal e as sub-redes. Nota-se, pelo mapa da <xref ref-type="fig" rid="f11">figura 1.5</xref>, que h&#225; menor concentra&#231;&#227;o de redes ligadas por fibras &#243;ticas em munic&#237;pios da regi&#227;o Norte, que tamb&#233;m concentra a maior propor&#231;&#227;o de munic&#237;pios isolados.</p>
            <p>
              <fig id="f11">
                <label>Figura 1.5</label>
                <caption>
                  <title>Munic&#237;pios com backhaul por fibra &#243;tica e outras tecnologias, fevereiro de 2019.</title>
                </caption>
                <attrib>Fonte: ANATEL.<xref ref-type="bibr" rid="B50">50</xref>
								</attrib>
                <graphic xlink:href="1678-4170-abc-113-05-1006-90205-gf05-pt.jpg"/></fig>
            </p>
            <p>Pelos dados apresentados nas <xref ref-type="fig" rid="f10">figuras 1.4</xref> e <xref ref-type="fig" rid="f11">1.5</xref>, observa-se tend&#234;ncia de concentra&#231;&#227;o de m&#233;dicos cardiologistas onde h&#225; maior concentra&#231;&#227;o de aparelhos de celular habilitados. O coeficiente de correla&#231;&#227;o dessa rela&#231;&#227;o &#233; de 0,67, o que indica que a oferta de m&#233;dicos cardiologistas &#233; altamente correlacionada ao acesso a telefones m&#243;veis. Estes dados indicam um maior desafio &#224; implanta&#231;&#227;o da Telemedicina em &#225;reas remotas, uma vez que a falta de m&#233;dicos segue a mesma distribui&#231;&#227;o da defici&#234;ncia de infraestrutura de telecomunica&#231;&#245;es no Brasil. Uma an&#225;lise detalhada dos custos e benef&#237;cios dessa expans&#227;o deveria guiar os incentivos nesta &#225;rea. </p>
          </sec>
        </sec>
        <sec>
          <title>1.8. Intelig&#234;ncia Artificial</title>
          <p>A IA engloba um complexo arcabou&#231;o de sofisticados modelos matem&#225;tico-computacionais que permitem a constru&#231;&#227;o de algoritmos utilizados para emular a realiza&#231;&#227;o de diversas tarefas humanas. Envolve um n&#250;mero crescente de sub&#225;reas que se traduzem em diferentes metodologias e abordagens, que podem atuar de forma combinada ou complementar. Alguns exemplos dessas ferramentas s&#227;o: redes neurais artificiais (em particular, os modelos de &#8220;<italic>deep learning</italic>&#8221; e redes &#8220;convolucionais&#8221;), m&#225;quinas de vetores-suporte, algoritmos evolucion&#225;rios e o processamento de linguagem natural. A elabora&#231;&#227;o de algoritmos anal&#237;ticos derivados de grandes bancos de dados permite interpretar e apreender de forma interativa, reconhecer padr&#245;es ocultos de combina&#231;&#227;o das informa&#231;&#245;es que n&#227;o s&#227;o obtidas com os m&#233;todos estat&#237;sticos tradicionais, e auxiliar na tomada de decis&#227;o com maior precis&#227;o. </p>
          <p>A disponibilidade desta enorme quantidade de dados e de novas t&#233;cnicas anal&#237;ticas - o <italic>big data analytics</italic> - abre novas possibilidades cient&#237;ficas e alternativas de IA, como <italic>machine learning</italic> e <italic>data mining</italic>, que j&#225; t&#234;m ampla aplica&#231;&#227;o na telecardiologia para diagn&#243;stico de combina&#231;&#245;es de m&#250;ltiplas modalidades de imagens, biobancos, coortes eletr&#244;nicas, sensores cl&#237;nicos presenciais e a dist&#226;ncia para monitora&#231;&#227;o, registros eletr&#244;nicos de sa&#250;de, genomas e outras t&#233;cnicas moleculares, entre outros.<xref ref-type="bibr" rid="B52">52</xref><sup>-</sup><xref ref-type="bibr" rid="B54">54</xref>
					</p>
          <p>A transposi&#231;&#227;o dessas aplica&#231;&#245;es para a pr&#225;tica cl&#237;nica em cardiologia tem crescido exponencialmente,<xref ref-type="bibr" rid="B55">55</xref> com caracter&#237;sticas progn&#243;sticas, como na utiliza&#231;&#227;o de algoritmo derivado da resson&#226;ncia nuclear magn&#233;tica baseado em padr&#245;es tridimensionais da fun&#231;&#227;o sist&#243;lica ventricular direita para avalia&#231;&#227;o de desfechos na hipertens&#227;o arterial pulmonar com acur&#225;cia elevada,<xref ref-type="bibr" rid="B56">56</xref> identifica&#231;&#227;o de padr&#245;es fenot&#237;picos para a insufici&#234;ncia card&#237;aca com fra&#231;&#227;o de eje&#231;&#227;o preservada com progn&#243;stico desfavor&#225;vel confirmados por padr&#245;es heterog&#234;neos da repolariza&#231;&#227;o ventricular no eletrocardiograma,<xref ref-type="bibr" rid="B57">57</xref> predi&#231;&#227;o de risco cardiovascular em grandes coortes,<xref ref-type="bibr" rid="B58">58</xref> predi&#231;&#227;o de revasculariza&#231;&#227;o urgente em pacientes com dor tor&#225;cica na emerg&#234;ncia,<xref ref-type="bibr" rid="B59">59</xref> entre outros. Por&#233;m, os estudos sobre IA geralmente se utilizam de dados observacionais, a partir de bases de dados administrativas ou de prontu&#225;rios cl&#237;nicos, com potencial de ocorr&#234;ncia de diferentes tipos de vieses e fatores de confundimento.<xref ref-type="bibr" rid="B54">54</xref>
					</p>
          <p>S&#227;o promissoras, mas ainda muito restritas, as aplica&#231;&#245;es desenvolvidas de IA em Telemedicina.<xref ref-type="bibr" rid="B60">60</xref> No campo do telediagn&#243;stico, os esfor&#231;os para classifica&#231;&#227;o e diagn&#243;stico automatizado no eletrocardiograma e das imagens cardiovasculares<xref ref-type="bibr" rid="B61">61</xref> s&#227;o promissores, mas ainda incipientes. Quanto &#224;s interven&#231;&#245;es cardiovasculares, uma revis&#227;o recente<xref ref-type="bibr" rid="B62">62</xref> encontrou oito estudos que incorporam a aprendizagem de m&#225;quina em um cen&#225;rio de pesquisa da vida real, dos quais apenas tr&#234;s foram avaliados em um estudo controlado randomizado. Das 8 interven&#231;&#245;es, 6 (75%) mostraram signific&#226;ncia estat&#237;stica (no n&#237;vel p = 0,05) em desfechos de sa&#250;de. Algumas dessas interven&#231;&#245;es s&#227;o diretamente relacionadas &#224; telecardiologia, avaliando interven&#231;&#245;es para perda de peso, controle do estresse, cessa&#231;&#227;o do tabagismo e nutri&#231;&#227;o personalizada com base na resposta glic&#234;mica. Os estudos s&#227;o, em geral, com amostras reduzidas e curta dura&#231;&#227;o, mostrando a necessidade de investimentos e novos estudos explorando as potencialidades da &#225;rea.</p>
          <p>Em recente revis&#227;o, Topol<xref ref-type="bibr" rid="B63">63</xref> salientou as premissas que nortear&#227;o a futuro da IA na Medicina: o paciente deve ser considerado o centro para a implementa&#231;&#227;o de qualquer nova tecnologia, a incorpora&#231;&#227;o dessas novas tecnologias para diagn&#243;stico e tratamento devem ocorrer quando houver uma robusta valida&#231;&#227;o de sua efic&#225;cia cl&#237;nica, o emprego de ferramentas digitais e algoritmos de decis&#227;o pelos pacientes deve ser mais uma op&#231;&#227;o para os que se sentirem habilitados, o treinamento interdisciplinar precisar&#225; ser realizado envolvendo profissionais de sa&#250;de, engenheiros, cientistas da computa&#231;&#227;o, e bioinform&#225;ticos. Essas condi&#231;&#245;es m&#237;nimas pressup&#245;em etapas para sua transposi&#231;&#227;o para a pr&#225;tica cl&#237;nica que ir&#227;o minimizar as dificuldades de sua implementa&#231;&#227;o.</p>
          <p>Entretanto, in&#250;meros aspectos da pr&#225;tica em sa&#250;de ainda continuar&#227;o a depender de outras dimens&#245;es, como a pol&#237;tica, a econ&#244;mica e a cultural, e da habilidade dos profissionais de sa&#250;de para interagirem com os pacientes e com a comunidade para que a IA possa de fato beneficiar os pacientes, dado que a quest&#227;o da desigualdade de acesso &#224; sa&#250;de ainda &#233; cr&#237;tica no Brasil, e exigir&#225; desde grandes investimentos at&#233; a melhoria da organiza&#231;&#227;o do sistema de sa&#250;de.<xref ref-type="bibr" rid="B54">54</xref>
					</p>
          <p>Dessa forma, as potenciais estrat&#233;gias de incorpora&#231;&#227;o, planejamento de implanta&#231;&#227;o e ado&#231;&#227;o devem estar alinhadas com a possibilidade e os desafios de oferecermos uma cardiologia centrada no paciente e no valor final agregado &#224; linha de cuidado em cardiologia. &#201; necess&#225;rio identificar a melhor tecnologia a ser incorporada, bem como definir em que parte do processo de trabalho m&#233;dico tal tecnologia pode agregar valor ao processo e &#224; sa&#250;de do paciente. Al&#233;m disso, faz-se necess&#225;rio planejar a incorpora&#231;&#227;o e desenhar a jornada de transforma&#231;&#227;o digital do servi&#231;o de cardiologia, buscando garantir um n&#237;vel elevado de ado&#231;&#227;o da tecnologia. </p>
          <p>A incorpora&#231;&#227;o dessas tecnologias na pr&#225;tica cl&#237;nica deve envolver, a priori, rigorosa avalia&#231;&#227;o de desempenho e o valor final para o paciente. Essa avalia&#231;&#227;o deve respeitar e seguir o processo vigente de avalia&#231;&#227;o de incorpora&#231;&#227;o de novas tecnologias em sa&#250;de liderado pelo Minist&#233;rio da Sa&#250;de, considerando todos os seus aspectos, normas e regulamenta&#231;&#245;es. A incorpora&#231;&#227;o deve ser baseada na evid&#234;ncia cient&#237;fica da gera&#231;&#227;o de valor final para a sa&#250;de do paciente, na perspectiva do indiv&#237;duo exposto &#224; tecnologia. </p>
          <p>Deve-se ter claro que a ferramenta de IA, uma vez incorporada, atua aumentando as capacidades do profissional, nunca o substituindo, e que as responsabilidades civis, criminais e em rela&#231;&#227;o ao paciente e seu problema de sa&#250;de, permanecem com o m&#233;dico assistente.<xref ref-type="bibr" rid="B64">64</xref>
					</p>
          <p>Recomenda-se que essa capacita&#231;&#227;o seja multiprofissional e interdisciplinar, voltada para a constru&#231;&#227;o de servi&#231;os devotados &#224; gera&#231;&#227;o de valor final para o paciente. Sugere-se que os curr&#237;culos m&#233;dicos de cardiologia contemplem a inser&#231;&#227;o de conte&#250;dos relacionados ao conhecimento t&#233;cnico, desenvolvimento de compet&#234;ncia e t&#233;cnicas de utiliza&#231;&#227;o de IA, e que os servi&#231;os de cardiologia estruturem um programa cont&#237;nuo de capacita&#231;&#227;o profissional e forma&#231;&#227;o de recursos humanos para gest&#227;o de incorpora&#231;&#227;o, treinamento e ado&#231;&#227;o de novas tecnologias digitais em sa&#250;de.</p>
          <p>No atual momento, n&#227;o h&#225; uma regula&#231;&#227;o espec&#237;fica sobre o uso da IA na &#225;rea da sa&#250;de, por&#233;m alguns pa&#237;ses como o Canad&#225;, o Reino Unido e os Estados Unidos iniciaram as primeiras fases para planejar e implementar a regulamenta&#231;&#227;o da IA na sa&#250;de. A Uni&#227;o Europeia publicou um documento sobre seus aspectos &#233;ticos.<xref ref-type="bibr" rid="B63">63</xref> A acelerada transforma&#231;&#227;o digital tem gerado reflex&#245;es sobre como equilibrar a ado&#231;&#227;o da tecnologia e dos sistemas digitais emergentes com valores &#233;ticos, morais, emocionais, sociais e, particularmente, ligados &#224; seguran&#231;a do paciente. </p>
        </sec>
      </sec>
      <sec>
        <title>2. Usos e Aplica&#231;&#227;o da Telemedicina em Cardiologia</title>
        <sec>
          <title>2.1. Telemedicina no Brasil</title>
          <p>Desde o advento da Sociedade da Informa&#231;&#227;o no final do s&#233;culo 20, fruto da globaliza&#231;&#227;o e da utiliza&#231;&#227;o em larga escala de TIC, tornou-se premente o surgimento de inova&#231;&#245;es organizacionais, sociais, pol&#237;ticas e econ&#244;micas da sociedade, que requerem nova forma de aprender, ensinar e exercer as profiss&#245;es. O mundo passou a se preocupar com os princ&#237;pios da igualdade de oportunidades, participa&#231;&#227;o e integra&#231;&#227;o para que todos pudessem ter acesso e se beneficiar das aplica&#231;&#245;es da sociedade da informa&#231;&#227;o. Na sa&#250;de, a Telemedicina teve importante avan&#231;o em todo o mundo, pois &#233; vista classicamente como um conjunto de a&#231;&#245;es com enorme potencial para melhorar o acesso aos servi&#231;os de sa&#250;de, a qualidade do cuidado e sua efetividade, com menor custo.<xref ref-type="bibr" rid="B65">65</xref>
					</p>
          <p>Como uma marca do novo mil&#234;nio, evidenciamos o envelhecimento da popula&#231;&#227;o, o aumento das DCNT e a consequente necessidade de prover servi&#231;os de sa&#250;de por um tempo maior, com aumento do custo da sa&#250;de. Torna-se, portanto, fundamental a incorpora&#231;&#227;o de solu&#231;&#245;es inovadoras, eficientes e eficazes como a Telemedicina e biotecnologia para promover a universalidade e integralidade do cuidado.</p>
          <p>As diversas a&#231;&#245;es de Telemedicina est&#227;o atualmente presentes em todos os continentes e, para seu sucesso, devem ser planejadas de acordo com a necessidade local. De acordo com Bashshur et al.,<xref ref-type="bibr" rid="B66">66</xref> o sucesso dessas a&#231;&#245;es depende de tr&#234;s pilares: acesso, qualidade e custo.<xref ref-type="bibr" rid="B66">66</xref> Nos pa&#237;ses desenvolvidos, representa uma alternativa aos m&#233;todos tradicionais, estando j&#225; presente como op&#231;&#227;o na sa&#250;de suplementar ou para resolver lacunas do sistema de sa&#250;de, mas sempre visando &#224; integralidade do cuidado. Nos pa&#237;ses em desenvolvimento, o acesso &#233; o principal pilar, pois muitas vezes a Telemedicina pode ser a &#250;nica op&#231;&#227;o em regi&#245;es onde n&#227;o est&#225; dispon&#237;vel o cuidado especializado tradicional.</p>
          <p>No Brasil, o desenvolvimento da Telemedicina e telessa&#250;de no sistema p&#250;blico de sa&#250;de iniciou sistematicamente a partir de 2006, com investimentos do Minist&#233;rio da Sa&#250;de, Secretarias de Estado da Sa&#250;de e Secretarias Municipais de Sa&#250;de. O principal objetivo era o fortalecimento da Aten&#231;&#227;o Prim&#225;ria, em especial a Estrat&#233;gia Sa&#250;de da Fam&#237;lia de munic&#237;pios remotos, por meio de teleconsultorias, telediagn&#243;stico e teleduca&#231;&#227;o. Se utilizados em larga escala, poderiam reduzir o encaminhamento de pacientes aos grandes centros, com consequente melhoria no acesso da popula&#231;&#227;o aos cuidados especializados e redu&#231;&#227;o dos custos com a sa&#250;de.<xref ref-type="bibr" rid="B67">67</xref> Portanto, desde o in&#237;cio, a Telemedicina p&#250;blica brasileira est&#225; ancorada nos princ&#237;pios b&#225;sicos do SUS de universalidade, equidade e integralidade. Pela universalidade, a sa&#250;de &#233; um direito de todos e cabe ao Estado assegur&#225;-lo. A equidade pretende diminuir desigualdades ou investir mais onde a car&#234;ncia &#233; maior. A integralidade considera as pessoas como um todo, atendendo a todas as suas necessidades.<xref ref-type="bibr" rid="B68">68</xref>
					</p>
          <p>A telecardiologia, um dos ramos mais desenvolvidos da Telemedicina, por meio de suas m&#250;ltiplas a&#231;&#245;es na promo&#231;&#227;o da sa&#250;de, preven&#231;&#227;o de doen&#231;as, diagn&#243;stico, tratamento e reabilita&#231;&#227;o, com impacto na melhora da qualidade de vida, pode ser considerada uma importante aliada do sistema de sa&#250;de, seja ele p&#250;blico, suplementar ou privado, para promover aten&#231;&#227;o &#224; sa&#250;de integral e com qualidade.</p>
        </sec>
        <sec>
          <title>2.2. Na Aten&#231;&#227;o Prim&#225;ria</title>
          <p>A Aten&#231;&#227;o Prim&#225;ria &#224; Sa&#250;de (APS) envolve cuidados integrados e multidisciplinares e &#233; a base para alcan&#231;ar a sa&#250;de universal, de acordo com a OPAS, que tamb&#233;m defende outros determinantes da sa&#250;de como a educa&#231;&#227;o, alimenta&#231;&#227;o, moradia, prote&#231;&#227;o financeira, &#225;gua pot&#225;vel e ambientes seguros.<xref ref-type="bibr" rid="B69">69</xref> Para alcan&#231;ar a sa&#250;de universal, &#233; necess&#225;rio transformar os sistemas de sa&#250;de, principalmente tornando a APS eficiente, integrada, organizada, com o paciente no centro do sistema. Ainda de acordo com a OPAS, estima-se que na regi&#227;o das Am&#233;ricas cerca de um ter&#231;o da popula&#231;&#227;o n&#227;o tem acesso a cuidados de sa&#250;de e que seriam necess&#225;rios 800 mil profissionais de sa&#250;de adicionais para atender &#224;s necessidades na Regi&#227;o. </p>
          <p>A Telemedicina tem importante papel na qualifica&#231;&#227;o da APS, com benef&#237;cios cl&#237;nicos, humanos, organizacionais, educacionais, administrativos, t&#233;cnicos e sociais.<xref ref-type="bibr" rid="B70">70</xref> A utiliza&#231;&#227;o da Telemedicina em apoio &#224; APS traz benef&#237;cios &#224; popula&#231;&#227;o atendida, como: (i) melhoria de acesso a servi&#231;os especializados, (ii) aumento da resolutividade do n&#237;vel b&#225;sico, (iii) diminui&#231;&#227;o do n&#250;mero de encaminhamentos de pacientes a outros munic&#237;pios para atendimento especializado, (iv) encaminhamentos mais qualificados e decis&#245;es mais r&#225;pidas por hospitaliza&#231;&#245;es, (v) profissionais de sa&#250;de locais mais capacitados, com consequente atendimento cl&#237;nico mais qualificado, (vi) redu&#231;&#227;o de tempo para o diagn&#243;stico, com diminui&#231;&#227;o do risco de complica&#231;&#245;es, (vii) doen&#231;as diagnosticadas em est&#225;gios mais precoces, (viii) economia de gastos e tempo para o paciente, (ix) melhoria da qualidade de vida, (x) redu&#231;&#227;o de interna&#231;&#245;es e utiliza&#231;&#227;o de unidades de urg&#234;ncia, (xi) melhoria na continuidade dos cuidados cl&#237;nicos, (xii) redu&#231;&#227;o de fatores de risco e complica&#231;&#245;es de doen&#231;as cr&#244;nicas e (xiii) economia para o sistema de sa&#250;de.<xref ref-type="bibr" rid="B70">70</xref><sup>-</sup><xref ref-type="bibr" rid="B74">74</xref>
					</p>
          <sec>
            <title>2.2.1. Aplica&#231;&#245;es de Promo&#231;&#227;o e Preven&#231;&#227;o &#224; Sa&#250;de</title>
            <p>Em cardiologia, a&#231;&#245;es de promo&#231;&#227;o da sa&#250;de e preven&#231;&#227;o prim&#225;ria e secund&#225;ria de doen&#231;as cardiovasculares representam significativa redu&#231;&#227;o de custos pela diminui&#231;&#227;o de consultas ao especialista, interna&#231;&#245;es por complica&#231;&#245;es cl&#237;nicas e entradas nas unidades de urg&#234;ncia.<xref ref-type="bibr" rid="B71">71</xref> A Telemedicina pode ser &#250;til: no controle dos fatores de risco para doen&#231;a arterial coronariana, na melhora do controle da PA,<xref ref-type="bibr" rid="B75">75</xref><sup>-</sup><xref ref-type="bibr" rid="B78">78</xref> na redu&#231;&#227;o da glicohemoglobina em pacientes diab&#233;ticos;<xref ref-type="bibr" rid="B79">79</xref><sup>-</sup><xref ref-type="bibr" rid="B81">81</xref> na melhora do perfil lip&#237;dico;<xref ref-type="bibr" rid="B82">82</xref><sup>,</sup><xref ref-type="bibr" rid="B83">83</xref> na redu&#231;&#227;o do peso, &#237;ndice de massa corporal (IMC) ou circunfer&#234;ncia da cintura em obesos<xref ref-type="bibr" rid="B77">77</xref><sup>,</sup><xref ref-type="bibr" rid="B84">84</xref><sup>-</sup><xref ref-type="bibr" rid="B86">86</xref> e no aumento do sucesso de programas de cessa&#231;&#227;o do tabagismo.<xref ref-type="bibr" rid="B87">87</xref>
						</p>
            <p>V&#225;rias modalidades de Telemedicina podem ser aplicadas nesse sentido, como sistemas de envio de mensagens de texto/&#225;udio em celulares, com resultados positivos na ades&#227;o &#224; medica&#231;&#227;o, mudan&#231;a de h&#225;bitos alimentares e aumento da atividade f&#237;sica em pacientes com hipertens&#227;o, diabetes, obesidade ou pacientes p&#243;s-infarto agudo do mioc&#225;rdio (IAM).<xref ref-type="bibr" rid="B86">86</xref><sup>,</sup><xref ref-type="bibr" rid="B88">88</xref> Sistemas de monitoramento 24 horas em celular ou servi&#231;os com centrais de monitoramento tornam-se mais frequentes pelo desenvolvimento de equipamentos especializados com comunica&#231;&#227;o direta com sistemas de Telemedicina, como estetosc&#243;pio, balan&#231;a, term&#244;metro digital, equipamentos para aferir PA, monitoramento remoto de sinais vitais e dispositivos eletr&#244;nicos implant&#225;veis.<xref ref-type="bibr" rid="B89">89</xref><sup>,</sup><xref ref-type="bibr" rid="B90">90</xref> Simples rel&#243;gios foram transformados em sistemas de monitoramento com tecnologia para informar a frequ&#234;ncia card&#237;aca, n&#237;vel de estresse (umidade e temperatura da pele), PA &#243;ptica e atividade f&#237;sica, entre outros par&#226;metros.<xref ref-type="bibr" rid="B91">91</xref><sup>,</sup><xref ref-type="bibr" rid="B92">92</xref> H&#225; diversos aplicativos dispon&#237;veis para orienta&#231;&#227;o da equipe de sa&#250;de e/ou pacientes, ou mesmo para autocuidado.<xref ref-type="bibr" rid="B89">89</xref>
						</p>
          </sec>
          <sec>
            <title>2.2.2. Sistemas de Suporte &#224; Decis&#227;o</title>
            <p>Os sistemas de suporte &#224; decis&#227;o (SSD) cl&#237;nica fornecem conhecimento e informa&#231;&#245;es espec&#237;ficas de um paciente individual a m&#233;dicos, a outros profissionais de sa&#250;de ou ao pr&#243;prio paciente, a fim de melhorar a qualidade do cuidado e os desfechos cl&#237;nicos. S&#227;o recomendados pela <italic>Community Preventive Services Task Force</italic> (CPSTF) na preven&#231;&#227;o de doen&#231;as cardiovasculares, apesar de baseados em evid&#234;ncias de qualidade moderada a fraca.<xref ref-type="bibr" rid="B93">93</xref> Entre as aplica&#231;&#245;es nas quais j&#225; se demonstrou benef&#237;cio, inclui-se o aumento do rastreamento de fatores de risco cardiovasculares, a prescri&#231;&#227;o de &#193;cido Acetilsalic&#237;lico para preven&#231;&#227;o prim&#225;ria e o aconselhamento acerca de dieta saud&#225;vel, da atividade f&#237;sica e da cessa&#231;&#227;o do tabagismo.<xref ref-type="bibr" rid="B94">94</xref> Portanto, pode ter grande aplicabilidade na APS. N&#227;o h&#225; evid&#234;ncias de redu&#231;&#227;o de atendimentos na emerg&#234;ncia, hospitaliza&#231;&#245;es e eventos cardiovasculares, mas estudos adicionais s&#227;o necess&#225;rios. Um estudo que avaliou estrat&#233;gia educacional para profissionais de sa&#250;de associada a alertas de SSD observou taxa mais baixa de mortalidade em compara&#231;&#227;o &#224; estrat&#233;gia educacional isolada.<xref ref-type="bibr" rid="B95">95</xref>
						</p>
            <p>Os SSD foram avaliados em estudos-piloto em Unidades B&#225;sicas de Sa&#250;de (UBS) brasileiras em interven&#231;&#227;o multifacetada. A ferramenta se mostrou fact&#237;vel para a APS em pacientes com hipertens&#227;o, diabetes e para o manejo do risco cardiovascular, com boa satisfa&#231;&#227;o dos profissionais e percep&#231;&#227;o de facilidade de uso,<xref ref-type="bibr" rid="B96">96</xref><sup>,</sup><xref ref-type="bibr" rid="B97">97</xref> mas com baixo preenchimento dos campos pelos profissionais.<xref ref-type="bibr" rid="B96">96</xref> Isso pode estar relacionado &#224; implanta&#231;&#227;o ainda incipiente do prontu&#225;rio eletr&#244;nico em UBS, o que gera necessidade de duplicar trabalho, fator inversamente relacionado ao sucesso da implementa&#231;&#227;o de SSD.<xref ref-type="bibr" rid="B98">98</xref> Novas iniciativas est&#227;o em andamento e visam avaliar o impacto em desfechos cl&#237;nicos, no controle de pacientes com hipertens&#227;o e diabetes no Vale do Mucuri, Minas Gerais, e no manejo de pacientes em uso de varfarina, anticoagulante ainda mais amplamente usado no SUS.</p>
          </sec>
          <sec>
            <title>2.2.3. Teleconsultorias</title>
            <p>As teleconsultorias t&#234;m grande aplica&#231;&#227;o na APS para apoio aos profissionais de sa&#250;de de &#225;reas remotas, qualificando e reduzindo o tempo para o diagn&#243;stico e tratamento. Como ferramenta com importante potencial para aumentar a resolubilidade da APS, deve estar incorporada ao fluxo de atendimento das unidades de sa&#250;de, sendo parte integrante do processo regulat&#243;rio do munic&#237;pio. Dessa forma, representa uma forma eficiente de reduzir as longas filas de espera para uma consulta presencial com um cardiologista. Embora a teleconsultoria tenha sido extensivamente estudada em nosso meio,<xref ref-type="bibr" rid="B99">99</xref> existem poucos estudos sobre o impacto da teleconsultoria nos resultados tradicionais de sa&#250;de da popula&#231;&#227;o, como risco e mortalidade. A revis&#227;o sistem&#225;tica de Liddy et al.,<xref ref-type="bibr" rid="B100">100</xref> reportou que o sistema de teleconsultoria &#233; altamente aceit&#225;vel para pacientes e profissionais de sa&#250;de e melhora o acesso ao cuidado especializado. Foi realizado um estudo randomizado em cardiologia que avaliou efeitos adversos como morte, infarto do mioc&#225;rdio, cateterismo e/ou angioplastia de urg&#234;ncia/emerg&#234;ncia e ida a unidades de urg&#234;ncia, comparando pacientes que receberam teleconsultoria e os que tiveram um referenciamento tradicional. O grupo que recebeu a teleconsultoria foi mais propenso a ter uma consulta com o cardiologista e teve menos entradas nas unidades de urg&#234;ncia.<xref ref-type="bibr" rid="B101">101</xref>
						</p>
          </sec>
          <sec>
            <title>2.2.4. Telerregula&#231;&#227;o</title>
            <p>A demanda para aten&#231;&#227;o especializada &#233; crescente em todo o mundo, superando a oferta de servi&#231;os, com acesso limitado aos especialistas e longas filas de espera.<xref ref-type="bibr" rid="B101">101</xref> Interven&#231;&#245;es de telessa&#250;de, particularmente envolvendo teleconsultoria para regula&#231;&#227;o, tem demonstrado grande impacto na redu&#231;&#227;o desse tempo de espera, com qualifica&#231;&#227;o do acesso ao especialista, evitando encaminhamentos desnecess&#225;rios e com menor custo. Igualmente, no Brasil, a experi&#234;ncia de teleconsultoria para regula&#231;&#227;o (ou telerregula&#231;&#227;o) tem mostrado redu&#231;&#227;o do tempo de espera para a consulta especializada, qualificando o acesso e otimizando a utiliza&#231;&#227;o dos recursos, al&#233;m de oferecer ao usu&#225;rio atendimento com maior conforto e menor impacto no seu cotidiano.<xref ref-type="bibr" rid="B102">102</xref><sup>-</sup><xref ref-type="bibr" rid="B104">104</xref> A telerregula&#231;&#227;o possibilita, ainda, a classifica&#231;&#227;o de risco da demanda de atendimento especializado. S&#227;o estabelecidos protocolos norteadores para o atendimento e a decis&#227;o final relativa ao encaminhamento &#233; definida conjuntamente com o m&#233;dico assistente e o m&#233;dico teleconsultor. Al&#233;m dos ganhos mencionados na perspectiva do usu&#225;rio, h&#225; o processo de educa&#231;&#227;o permanente e de qualifica&#231;&#227;o do profissional, aumentando a resolubilidade na aten&#231;&#227;o prim&#225;ria.<xref ref-type="bibr" rid="B101">101</xref><sup>-</sup><xref ref-type="bibr" rid="B104">104</xref>
						</p>
          </sec>
          <sec>
            <title>2.2.5. Telediagn&#243;stico</title>
            <p>A tele-eletrocardiografia representa a atividade mais frequente na telecardiologia, por ser uma tecnologia simples, de baixo custo, para transmiss&#227;o de um pequeno arquivo facilmente transmitido com pequena banda de Internet. Assim sendo, a tele-eletrocardiografia &#233; facilmente incorporada &#224; rotina da APS, por sua grande utilidade e por ser adequada &#224; infraestrutura prec&#225;ria da APS de &#225;reas pobres e remotas.<xref ref-type="bibr" rid="B105">105</xref><sup>,</sup><xref ref-type="bibr" rid="B106">106</xref> Est&#225; difundida tanto no meio p&#250;blico como no privado, com diversas empresas brasileiras oferecendo servi&#231;os de laudos 24 horas. O Minist&#233;rio da Sa&#250;de, em 2017, lan&#231;ou o Projeto Oferta Nacional de Telediagn&#243;stico (ONTD), que visa ampliar o servi&#231;o de diagn&#243;stico de exames realizados a dist&#226;ncia nas &#225;reas com maior necessidade do pa&#237;s. A tele-eletrocardiografia foi a primeira modalidade de telediagn&#243;stico a ser ofertada em n&#237;vel nacional por um n&#250;cleo de telessa&#250;de com expertise em telecardiologia. Esse projeto representa uma inova&#231;&#227;o na gest&#227;o de um modelo nacional de projeto de Telemedicina em larga escala e os bons resultados comprovam a facilidade de utiliza&#231;&#227;o da tecnologia e sua adequa&#231;&#227;o para &#225;reas remotas.<xref ref-type="bibr" rid="B107">107</xref> A aplica&#231;&#227;o de IA nos grandes bancos de dados dos exames agrega facilidades na realiza&#231;&#227;o dos laudos e aumenta a acur&#225;cia do exame.<xref ref-type="bibr" rid="B61">61</xref><sup>,</sup><xref ref-type="bibr" rid="B108">108</xref>
						</p>
            <p>Ainda na telecardiologia, a tele-ecocardiografia tem se mostrado uma estrat&#233;gia promissora para racionaliza&#231;&#227;o do acesso &#224; proped&#234;utica complementar, diagn&#243;stico precoce, prioriza&#231;&#227;o de encaminhamentos e organiza&#231;&#227;o de listas de espera nos sistemas de sa&#250;de. As evid&#234;ncias iniciais sobre sua utiliza&#231;&#227;o derivam de estudos populacionais de rastreamento, como o realizado em &#225;reas rurais da &#205;ndia, no qual mais de 1.000 ecocardiogramas foram realizados em cerca de 11 horas e enviados para sistema de computa&#231;&#227;o em nuvem para an&#225;lise por especialistas atrav&#233;s de Telemedicina.<xref ref-type="bibr" rid="B109">109</xref> A estrat&#233;gia se mostrou fact&#237;vel - inclusive com boa concord&#226;ncia entre os diagn&#243;sticos preliminares em campo e os laudos de especialistas (k = 0,85) - e uma alarmante taxa de 16% de altera&#231;&#245;es significativas (dentre as quais 32,9% de altera&#231;&#245;es valvares) foi observada.<xref ref-type="bibr" rid="B109">109</xref> Evid&#234;ncias sugerem tamb&#233;m que, mesmo em regi&#245;es de alta renda como o Reino Unido, o rastreamento ecocardiogr&#225;fico populacional na aten&#231;&#227;o prim&#225;ria realizado por n&#227;o especialistas se mostrou uma estrat&#233;gia atraente, tendo-se observado doen&#231;a valvar clinicamente significativa (moderada a grave) em 6,4% da popula&#231;&#227;o assintom&#225;tica com idade &#8805; 65 anos, com preval&#234;ncia associada a fatores socioecon&#244;micos.<xref ref-type="bibr" rid="B110">110</xref> A estrat&#233;gia pode ser especialmente &#250;til no Brasil, onde presumivelmente existe elevada carga de doen&#231;a cardiovascular n&#227;o diagnosticada e limita&#231;&#245;es na oferta de exames especializados, incluindo a ecocardiografia convencional. </p>
            <p>A estrat&#233;gia de tele-ecocardiografia foi inicialmente testada no pa&#237;s em um programa de rastreamento de cardiopatia reum&#225;tica (estudo PROVAR: Programa de RastreamentO da VAlvopatia Reum&#225;tica), no qual se estabeleceu, em n&#237;vel de pesquisa, uma rotina de aquisi&#231;&#227;o de protocolos de imagem simplificados com aparelhos port&#225;teis e ultraport&#225;teis por n&#227;o m&#233;dicos (enfermeiros e tecn&#243;logos), com upload para sistema dedicado de computa&#231;&#227;o em nuvem para armazenamento e interpreta&#231;&#227;o a dist&#226;ncia por especialistas.<xref ref-type="bibr" rid="B111">111</xref><sup>,</sup><xref ref-type="bibr" rid="B112">112</xref> Al&#233;m do diagn&#243;stico remoto, a Telemedicina foi utilizada tamb&#233;m para treinamento dos profissionais de sa&#250;de sobre princ&#237;pios b&#225;sicos da ecocardiografia, por meio de m&#243;dulos interativos <italic>on-line</italic>. Ap&#243;s o treinamento, os profissionais de sa&#250;de com diferentes forma&#231;&#245;es foram capazes de diagnosticar com acur&#225;cia a cardiopatia reum&#225;tica.<xref ref-type="bibr" rid="B111">111</xref> Neste projeto, observou-se uma elevada preval&#234;ncia de cardiopatia reum&#225;tica subcl&#237;nica (4,2%), um dado significativo considerando-se o impacto da doen&#231;a ainda hoje na sa&#250;de p&#250;blica.<xref ref-type="bibr" rid="B113">113</xref>
						</p>
            <p>Posteriormente, estrat&#233;gia semelhante foi levada &#224; aten&#231;&#227;o prim&#225;ria: profissionais de centros de sa&#250;de de regi&#245;es de baixa renda das regi&#245;es metropolitanas de Belo Horizonte e Montes Claros (m&#233;dicos, enfermeiros, t&#233;cnicos em enfermagem) receberam treinamento <italic>on-line</italic> e presencial para aquisi&#231;&#227;o de protocolo ecocardiogr&#225;fico simplificado com aparelhos ultraport&#225;teis, com suporte da equipe de campo do projeto. Foi realizado rastreamento ecocardiogr&#225;fico em indiv&#237;duos assintom&#225;ticos de tr&#234;s faixas et&#225;rias (17-20, 35-40 e 60-65 anos), al&#233;m da avalia&#231;&#227;o de pacientes em fila de espera por um ecocardiograma ou com solicita&#231;&#227;o do exame pela equipe de sa&#250;de da fam&#237;lia. Foi observado que: a) a estrat&#233;gia &#233; fact&#237;vel na realidade do Brasil, com potencial de expans&#227;o para outros cen&#225;rios; b) a preval&#234;ncia de altera&#231;&#245;es ecocardiogr&#225;ficas em popula&#231;&#245;es assintom&#225;ticas foi elevada, em geral superior a 20%; c) entre pacientes em fila de espera por ecocardiogramas, mais de 50% n&#227;o apresentavam altera&#231;&#245;es significativas ao eco de rastreamento; d) a correla&#231;&#227;o com o ecocardiograma convencional foi satisfat&#243;ria.<xref ref-type="bibr" rid="B112">112</xref> Adicionalmente, um escore de predi&#231;&#227;o tem sido desenvolvido a partir desses achados, incorporando dados cl&#237;nicos e vari&#225;veis do ecocardiograma simplificado.<xref ref-type="bibr" rid="B114">114</xref> Desta forma, a tele-ecocardiografia pode ser uma estrat&#233;gia para diagn&#243;stico precoce, mas principalmente uma ferramenta para prioriza&#231;&#227;o e organiza&#231;&#227;o de listas de espera em sistemas de sa&#250;de com disponibilidade limitada de exames e consultas especializadas. Entretanto, a incorpora&#231;&#227;o do modelo em pol&#237;ticas de sa&#250;de no Brasil depende de amplas discuss&#245;es regulat&#243;rias envolvendo autoridades, conselhos profissionais e sociedades m&#233;dicas - principalmente no que tange &#224; aquisi&#231;&#227;o das imagens simplificadas por n&#227;o m&#233;dicos.</p>
            <p>Existem potenciais vantagens da ado&#231;&#227;o do tele-ecocardiograma (<xref ref-type="table" rid="t18">Tabela 2.1</xref>) no atendimento a comunidades remotas desfavorecidas, por&#233;m o m&#233;todo ainda carece de valida&#231;&#227;o cient&#237;fica robusta com estudos prospectivos controlados que confirmem os benef&#237;cios &#224; sa&#250;de dos pacientes e sua custo-efetividade, entre outros desafios.</p>
            <table-wrap id="t18">
              <label>Tabela 2.1</label>
              <caption>
                <title>Potenciais vantagens e desafios para a ado&#231;&#227;o do tele-ecocardiograma no Brasil</title>
              </caption>
              <table frame="hsides" rules="groups">
                <colgroup>
                  <col width="50%"/>
                  <col width="50%"/>
                </colgroup>
                <thead>
                  <tr>
                    <th align="left">Vantagens</th>
                    <th align="center">Desafios</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td align="left">Permitir o acesso ao m&#233;todo em locais remotos</td>
                    <td align="center">Aus&#234;ncia de padroniza&#231;&#227;o dos componentes da tele-ecocardiografia</td>
                  </tr>
                  <tr>
                    <td align="left">Otimiza&#231;&#227;o de desfechos cl&#237;nicos</td>
                    <td align="center">Aus&#234;ncia de evid&#234;ncias cient&#237;ficas comprovando impacto sobre desfechos cl&#237;nicos </td>
                  </tr>
                  <tr>
                    <td align="left">Redu&#231;&#227;o do custo de transporte de recursos humanos para &#225;reas geograficamente distantes </td>
                    <td align="center">Aus&#234;ncia de evid&#234;ncias cient&#237;ficas comprovando custo-efetividade; d&#250;vidas sobre reembolso e custos do sistema </td>
                  </tr>
                  <tr>
                    <td align="left">Redu&#231;&#227;o do custo de transporte de pacientes at&#233; centros terci&#225;rios</td>
                    <td align="center">Incertezas quanto &#224; ades&#227;o pelos profissionais de sa&#250;de locais</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="4">Redu&#231;&#227;o do n&#250;mero de ecocardiogramas desnecess&#225;rios</td>
                    <td align="center">Veto da legisla&#231;&#227;o brasileira &#224; atua&#231;&#227;o de operadores (son&#243;grafos) n&#227;o m&#233;dicos</td>
                  </tr>
                  <tr>
                    <td align="center">Aus&#234;ncia de diretrizes para o treinamento de operadores </td>
                  </tr>
                  <tr>
                    <td align="center">Inseguran&#231;a m&#233;dico-legal</td>
                  </tr>
                  <tr>
                    <td align="center">Quest&#245;es de legisla&#231;&#227;o referentes &#224; licen&#231;a, armazenamento de dados, privacidade e confidencialidade</td>
                  </tr>
                </tbody>
              </table>
            </table-wrap>
          </sec>
          <sec>
            <title>2.2.6. Teleduca&#231;&#227;o</title>
            <p>Atividades educacionais a dist&#226;ncia em cardiologia para profissionais de sa&#250;de, com cursos, palestras e objetos de aprendizagem, tanto sobre temas cl&#237;nicos como em gest&#227;o do cuidado, t&#234;m como benef&#237;cio a melhoria da qualidade do atendimento. Atividades educacionais com foco no paciente devem ser estimuladas para seu empoderamento em sa&#250;de.</p>
            <p>Em munic&#237;pios de &#225;reas remotas com baixa popula&#231;&#227;o, muitas vezes a APS &#233; o &#250;nico n&#237;vel de aten&#231;&#227;o &#224; sa&#250;de local, e recebe pacientes com doen&#231;as cardiovasculares agudas em suas unidades de sa&#250;de. Dessa forma, a telecardiologia na APS deve n&#227;o s&#243; qualificar o atendimento de doen&#231;a cr&#244;nicas, mas tamb&#233;m atuar no suporte ao atendimento de urg&#234;ncia &#224;s doen&#231;as isqu&#234;micas e arritmias.</p>
            <p>Pelas in&#250;meras aplica&#231;&#245;es de ferramentas simples de Telemedicina, a cardiologia pode ser considerada uma das especialidades mais sens&#237;veis &#224; utiliza&#231;&#227;o de TIC. A tr&#237;ade teleconsultoria, telediagn&#243;stico e teleduca&#231;&#227;o, aplicada de forma integrada na APS e associada a ferramentas como os SSD, pode representar um diferencial na qualidade do atendimento &#224;s doen&#231;as cardiovasculares, em especial a hipertens&#227;o arterial, a FA, a insufici&#234;ncia card&#237;aca e o IAM. Finalmente, a telerregula&#231;&#227;o pode dar apoiar &#224; APS na resolubilidade neste n&#237;vel e na melhor qualifica&#231;&#227;o do acesso &#224; aten&#231;&#227;o especializada.</p>
          </sec>
        </sec>
        <sec>
          <title>2.7. Na Aten&#231;&#227;o Especializada</title>
          <sec>
            <title>2.7.1. Insufici&#234;ncia Card&#237;aca</title>
            <p>H&#225; extensa literatura sobre o uso de estrat&#233;gias de Telemedicina no acompanhamento de pacientes com insufici&#234;ncia card&#237;aca, com o objetivo de reduzir as hospitaliza&#231;&#245;es associadas ao aumento da morbidade, mortalidade e custos, al&#233;m de aumentar a ades&#227;o e participa&#231;&#227;o dos pacientes. As interven&#231;&#245;es variam desde o uso de tecnologias tradicionais, como suporte telef&#244;nico estruturado, telemonitoramento por tecnologias inovadoras, com dispositivos implant&#225;veis ou vest&#237;veis, SSD e aprendizado de m&#225;quina para predizer complica&#231;&#245;es.<xref ref-type="bibr" rid="B115">115</xref><sup>,</sup><xref ref-type="bibr" rid="B116">116</xref><sup>,</sup><xref ref-type="bibr" rid="B117">117</xref> Apesar de as evid&#234;ncias serem vari&#225;veis, em geral s&#227;o de benef&#237;cios. Entretanto, a aplica&#231;&#227;o dessas estrat&#233;gias na pr&#225;tica cl&#237;nica ainda &#233; muito limitada por quest&#245;es regulat&#243;rias, log&#237;sticas e financeiras.<xref ref-type="bibr" rid="B118">118</xref>
						</p>
            <p>O telemonitoramento pode ser invasivo ou n&#227;o invasivo. Os sensores s&#227;o ferramentas capazes de detectar, registrar e responder a dados espec&#237;ficos provenientes, por exemplo, dos dados vitais de um paciente, e est&#227;o cada vez mais incorporados em smartphones e outros dispositivos m&#243;veis. O registro por meio de sensores pode gerar grandes conjuntos de dados, que podem ser transmitidos em tempo real para profissionais de sa&#250;de.<xref ref-type="bibr" rid="B119">119</xref> Os programas de interven&#231;&#227;o multiprofissional geralmente t&#234;m barreiras geogr&#225;ficas, econ&#244;micas e burocr&#225;ticas, portanto o telemonitoramento pode ser uma solu&#231;&#227;o para promover o cuidado de pacientes com insufici&#234;ncia card&#237;aca.<xref ref-type="bibr" rid="B115">115</xref>
						</p>
            <p>As evid&#234;ncias acerca do suporte telef&#244;nico estruturado e telemonitoramento n&#227;o invasivo em pacientes com insufici&#234;ncia card&#237;aca foram sintetizadas em revis&#227;o sistem&#225;tica Cochrane, que incluiu 41 estudos. O suporte telef&#244;nico estruturado reduziu a mortalidade por todas as causas (RR 0,87, IC 95% 0,77-0,98; n = 9.222) e hospitaliza&#231;&#245;es relacionadas &#224; insufici&#234;ncia card&#237;aca (RR 0,85, IC 95% 0,77-0,93; n = 7.030), ambos com evid&#234;ncias de qualidade moderada. O telemonitoramento reduziu a mortalidade por todas as causas (RR 0,80, IC 95% 0,68-0,94; n = 3.740) e hospitaliza&#231;&#245;es relacionadas &#224; insufici&#234;ncia card&#237;aca (RR 0,71, IC 95% 0,60-0,83; n = 2.148), ambos com evid&#234;ncias de qualidade moderada.<xref ref-type="bibr" rid="B119">119</xref>
						</p>
            <p>Em outra metan&#225;lise<xref ref-type="bibr" rid="B120">120</xref> que avaliou 26 estudos, totalizando 2.506 pacientes seguidos por telemonitoramento, inclusive com transmiss&#227;o de sinais vitais, concluiu-se que o efeito &#233; tempo-dependente. O acompanhamento por um prazo mais curto, at&#233; 180 dias, demonstrou melhores resultados em desfechos duros como mortalidade, que n&#227;o foram atingidos com o seguimento por um per&#237;odo mais longo de um ano. No entanto, n&#227;o reduziu hospitaliza&#231;&#227;o, independentemente do per&#237;odo de seguimento. O aumento de visitas &#224; emerg&#234;ncia identificado no grupo em telemonitoramento levanta o questionamento de como uma interven&#231;&#227;o que n&#227;o reduz hospitaliza&#231;&#227;o impacta na redu&#231;&#227;o de mortalidade. Talvez a detec&#231;&#227;o precoce de sinais de descompensa&#231;&#227;o incentive a procura por atendimento mais frequente, mas pode ser prontamente tratada com diur&#233;tico e vasodilatadores, sem necessidade de terapia intensiva.</p>
            <p>O Minist&#233;rio da Sa&#250;de, na publica&#231;&#227;o de um de seus Protocolos Cl&#237;nicos e Diretrizes Terap&#234;uticas sobre Insufici&#234;ncia Card&#237;aca<xref ref-type="bibr" rid="B121">121</xref> contemplou a an&#225;lise dos benef&#237;cios do telemonitoramento baseado em seguimento telef&#244;nico, ap&#243;s analisar diversos estudos, e mostrou que os servi&#231;os de sa&#250;de devem considerar a realiza&#231;&#227;o de seguimento por suporte telef&#244;nico em pacientes com insufici&#234;ncia card&#237;aca ap&#243;s alta hospitalar, classe funcional da New York Heart Association (NYHA) III a IV. A an&#225;lise mostrou redu&#231;&#227;o de 18% na mortalidade geral no grupo sob monitoramento remoto em compara&#231;&#227;o com os cuidados usuais (RR 0,82, IC 95% 0,73-0,93). O telemonitoramento tamb&#233;m reduziu o risco de hospitaliza&#231;&#227;o por insufici&#234;ncia card&#237;aca em 23% (RR 0,77, IC 95% 0,68-0,88). &#201; importante ressaltar que a recomenda&#231;&#227;o deve ser direcionada para os pacientes que potencialmente obteriam maior benef&#237;cio. N&#227;o h&#225; um consenso sobre a intensidade e frequ&#234;ncias das abordagens de monitoramento, mas devem ser desenvolvidas com foco em orienta&#231;&#245;es cl&#237;nicas e educacionais.</p>
            <p>A evid&#234;ncia em rela&#231;&#227;o ao tempo de perman&#234;ncia hospitalar &#233; mais fr&#225;gil e controversa: de sete estudos sobre suporte telef&#244;nico estruturado e nove sobre telemonitoramento, apenas um sobre cada tipo de interven&#231;&#227;o reportou redu&#231;&#227;o significativa no tempo de perman&#234;ncia hospitalar. Nove de 11 estudos de suporte telef&#244;nico estruturado e 5 de 11 estudos de telemonitoramento relataram melhorias significativas na qualidade de vida. Tr&#234;s de nove estudos de suporte telef&#244;nico estruturado e um de seis estudos de telemonitoramento que avaliaram custos observaram redu&#231;&#227;o nos mesmos, enquanto dois estudos de telemonitoramento relataram aumentos no custo, devido ao custo da interven&#231;&#227;o e ao aumento do gerenciamento m&#233;dico. Sete dos nove estudos que avaliaram conhecimento sobre insufici&#234;ncia card&#237;aca e comportamentos de autocuidado observaram melhorias significativas. Apesar de ter sido observada aceita&#231;&#227;o entre 76 e 97% dos participantes, a redu&#231;&#227;o da ades&#227;o &#224; interven&#231;&#227;o com o tempo pode ser um desafio. Na revis&#227;o, foi reportada entre 55,1%-65,8% para suporte telef&#244;nico estruturado e 75-98,5% para telemonitoramento.<xref ref-type="bibr" rid="B119">119</xref>
						</p>
            <p>As t&#233;cnicas de aprendizado de m&#225;quina podem ser potencialmente valiosas no monitoramento remoto de pacientes com insufici&#234;ncia card&#237;aca de alto risco. As caracter&#237;sticas individuais desses pacientes, obtidas a partir da an&#225;lise de um grande n&#250;mero de prontu&#225;rios eletr&#244;nicos, podem permitir a identifica&#231;&#227;o dos que t&#234;m maior risco de evolu&#231;&#227;o desfavor&#225;vel e que poderiam se beneficiar de tratamentos m&#233;dicos individualizados.<xref ref-type="bibr" rid="B122">122</xref> O <italic>Seattle Heart Failure Model</italic> (SHFM), por exemplo, &#233; um <italic>framework</italic> baseado em aprendizado de m&#225;quina para calcular o risco de mortalidade na insufici&#234;ncia card&#237;aca. Ele considera v&#225;rios aspectos cl&#237;nicos obtidos de prontu&#225;rios eletr&#244;nicos para prever o progn&#243;stico da doen&#231;a e incorpora o impacto potencial das terapias nos desfechos dos pacientes. Esse sistema de apoio &#224; decis&#227;o se mostrou potencialmente &#250;til na identifica&#231;&#227;o de pacientes com insufici&#234;ncia card&#237;aca com maior risco de evolu&#231;&#227;o desfavor&#225;vel, mas apresentou barreiras &#224; implementa&#231;&#227;o: demorado, caro, exigia familiaridade do m&#233;dico com computadores e n&#227;o levava em conta outras vari&#225;veis cl&#237;nicas, n&#227;o inclu&#237;das como parte dos dados coletados.<xref ref-type="bibr" rid="B123">123</xref>
						</p>
            <p>As evid&#234;ncias do benef&#237;cio do telemonitoramento na insufici&#234;ncia card&#237;aca foram confirmadas recentemente pela publica&#231;&#227;o do estudo <italic>Telemedical Interventional Management in Heart Failure II</italic> (TIM-HF2). Trata-se de ensaio cl&#237;nico multic&#234;ntrico, prospectivo, randomizado, em que 1.571 pacientes com insufici&#234;ncia card&#237;aca na classe II ou III da NYHA ou internados no hospital por insufici&#234;ncia card&#237;aca no per&#237;odo de 12 meses antes da randomiza&#231;&#227;o e com fra&#231;&#227;o de eje&#231;&#227;o de 45% ou menor foram aleatoriamente designados para gerenciamento remoto ou apenas para o cuidado usual, com seguimento m&#225;ximo de 393 dias.<xref ref-type="bibr" rid="B124">124</xref>
						</p>
            <p>O percentual de dias perdidos devido a interna&#231;&#245;es hospitalares cardiovasculares n&#227;o planejadas e morte por todas as causas foi de 4,88% no grupo de controle remoto de pacientes e 6,64% no grupo de cuidados habituais (p = 0,04). Os pacientes designados para o manejo remoto perderam uma m&#233;dia de 17,8 dias (por ano, em compara&#231;&#227;o com 24,2 dias por ano para pacientes designados para o tratamento usual. A taxa de mortalidade por todas as causas apresentou <italic>harzard ratio</italic> (HR) 0,70 (IC 95% 0,50-0, 96; p = 0,0280) favor&#225;vel no grupo da teleconsultoria. Por&#233;m, a mortalidade e cardiovascular n&#227;o foi significativamente diferente entre os dois grupos (HR 0,671, IC 95% 0,45-1,01; p = 0,0560).<xref ref-type="bibr" rid="B124">124</xref>
						</p>
            <p>Novos dispositivos que monitoram as press&#245;es intracard&#237;acas disp&#245;em das evid&#234;ncias mais convincentes para o uso de telemonitoramento e est&#227;o relacionados com o uso de tecnologias mais avan&#231;adas. O CardioMEMS &#233; um dispositivo implantado via percut&#226;nea na art&#233;ria pulmonar que transmite os valores press&#243;ricos centrais para uma plataforma. Quando os n&#237;veis de press&#227;o na art&#233;ria pulmonar atingem valores acima de determinado limiar, o m&#233;dico recebe um alerta e um demonstrativo de tend&#234;ncias indicando congest&#227;o ou baixo d&#233;bito. Outros dispositivos para implante no ventr&#237;culo direito j&#225; est&#227;o em uso experimental. O estudo <italic>CardioMEMS Heart Sensor Allows Monitoring of Pressure to Improve Outcomes in NYHA Class III Heart Failure Patients</italic> (CHAMPION)<xref ref-type="bibr" rid="B125">125</xref> avaliou pacientes com insufici&#234;ncia card&#237;aca e em classe funcional III da NYHA em 64 centros americanos. Os pacientes foram randomizados atrav&#233;s de um sistema centralizado para um grupo de monitoramento com CardioMEMS ou um grupo controle. </p>
            <p>No grupo de monitoramento, os m&#233;dicos utilizavam dados di&#225;rios de aferi&#231;&#245;es de press&#227;o de art&#233;ria pulmonar para guiar o tratamento. No seguimento m&#233;dio de 15 meses, observou-se redu&#231;&#227;o de 37% na taxa de hospitaliza&#231;&#245;es relacionadas com insufici&#234;ncia card&#237;aca em compara&#231;&#227;o ao grupo controle. O seguimento de longo prazo do estudo CHAMPION com convers&#227;o do grupo controle para o monitoramento das press&#245;es pulmonares demonstrou que estes resultados se mantiveram significativos e clinicamente relevantes no decorrer do tempo.<xref ref-type="bibr" rid="B126">126</xref>
						</p>
          </sec>
          <sec>
            <title>2.7.2. Na Hipertens&#227;o Arterial Sist&#234;mica</title>
            <p>As estrat&#233;gias de telemonitoramento tamb&#233;m podem ser aplicadas para controle da PA, mas confundem-se com a abordagem de automonitoramento press&#243;rico. No TASMINH 4, 1.182 pacientes foram aleatoriamente alocados (1: 1: 1) para a titula&#231;&#227;o anti-hipertensiva com m&#233;dico generalista usando leituras cl&#237;nicas (grupo de cuidados habituais), realizando monitoramento sozinho (grupo de automonitoramento) ou usando automonitoramento com telemonitoramento (grupo de telemonitoramento). Foi verificado que o uso do automonitoramento da PA para titular a terapia anti-hipertensiva em hipertens&#227;o mal controlada na aten&#231;&#227;o prim&#225;ria resulta em menor PA sist&#243;lica sem aumentar a carga de trabalho da equipe cl&#237;nica. Ap&#243;s um ano, os pacientes cuja medica&#231;&#227;o foi ajustada usando automonitoramento, com ou sem telemonitoramento, tiveram press&#227;o arterial sist&#243;lica (PAS) significativamente menor do que aqueles que receberam tratamento ajustado usando a PA no consult&#243;rio. A PA no grupo de telemonitoramento para titula&#231;&#227;o de medica&#231;&#227;o tornou-se mais baixa mais rapidamente (aos seis meses) do que apenas o automonitoramento, um efeito que provavelmente reduz ainda mais os eventos cardiovasculares e pode melhorar o controle de longo prazo.<xref ref-type="bibr" rid="B127">127</xref><sup>,</sup><xref ref-type="bibr" rid="B128">128</xref>
						</p>
            <p>Diversos estudos tamb&#233;m demonstram que estrat&#233;gias de telemonitoramento de hipertens&#227;o arterial sist&#234;mica (HAS) com envolvimento de farmac&#234;utico cl&#237;nico reportaram impacto ben&#233;fico de curto e m&#233;dio prazo no controle da press&#227;o. Margolis et al.<xref ref-type="bibr" rid="B129">129</xref> avaliaram a durabilidade do efeito desta interven&#231;&#227;o ap&#243;s 54 meses de seguimento em estudo randomizado em <italic>clusters</italic> de 16 cl&#237;nicas de cuidados prim&#225;rios, envolvendo 450 pacientes (228 em telemonitoramento e 222 em cuidados habituais). A interven&#231;&#227;o intensiva baseada em telemonitoramento pode manter os efeitos por at&#233; 24 meses (12 meses ap&#243;s o t&#233;rmino da interven&#231;&#227;o), perdendo efic&#225;cia no longo prazo.<xref ref-type="bibr" rid="B129">129</xref>
						</p>
            <p>Um estudo de coorte observacional prospectivo monitorou o controle da PA antes e ap&#243;s uma interven&#231;&#227;o educacional e introdu&#231;&#227;o &#224; monitora&#231;&#227;o residencial da PA (MRPA). No grupo de interven&#231;&#227;o, 484 pacientes foram instru&#237;dos a rastrear sua PA usando um dispositivo de <italic>smartphone</italic> de tr&#234;s a sete vezes por semana. As taxas m&#233;dias de controle da PA melhoraram para os pacientes que receberam MRPA de 42% para 67% em compara&#231;&#227;o com os pacientes controle pareados, que melhoraram de 59% para 67% (p &lt; 0,01).<xref ref-type="bibr" rid="B130">130</xref>
						</p>
            <p>O estudo INTERACT foi um ensaio cl&#237;nico randomizado em que 303 pacientes usando medica&#231;&#227;o hipotensora e/ou hipolipemiante oral eram alocados para receber ou n&#227;o mensagens via SMS. O grupo que recebeu mensagem de texto melhorou o uso de medica&#231;&#227;o prescrita aos seis meses em compara&#231;&#227;o com o grupo que n&#227;o recebeu as mensagens. Houve melhoria geral na ades&#227;o &#224; medica&#231;&#227;o de 16%.<xref ref-type="bibr" rid="B129">129</xref><sup>,</sup><xref ref-type="bibr" rid="B131">131</xref>
						</p>
            <p>Uma revis&#227;o sistem&#225;tica na base de dados Cochrane<xref ref-type="bibr" rid="B132">132</xref> buscou estabelecer a efetividade das interven&#231;&#245;es realizadas por telefonia celular para melhorar a ades&#227;o aos medicamentos prescritos para a preven&#231;&#227;o prim&#225;ria de doen&#231;a cardiovascular em adultos. Os participantes foram recrutados de cl&#237;nicas de aten&#231;&#227;o prim&#225;ria ou ambulat&#243;rios de base comunit&#225;ria em pa&#237;ses de renda alta (Canad&#225;, Espanha) e pa&#237;ses de renda m&#233;dia-alta (&#193;frica do Sul, China), por&#233;m as interven&#231;&#245;es recebidas variaram amplamente. Um ensaio avaliou uma interven&#231;&#227;o focada na ades&#227;o &#224; medica&#231;&#227;o da PA, fornecida exclusivamente por meio de SMS, e uma interven&#231;&#227;o envolveu a monitora&#231;&#227;o da PA combinada com <italic>feedback</italic> fornecido via <italic>smartphone</italic>. Os autores julgaram o conjunto de evid&#234;ncias para o efeito de interven&#231;&#245;es baseadas no telefone celular em desfechos objetivos (PA e colesterol) de baixa qualidade. Dos dois estudos que avaliaram a ades&#227;o &#224; medica&#231;&#227;o juntamente com outras modifica&#231;&#245;es no estilo de vida, um relatou um pequeno efeito ben&#233;fico na redu&#231;&#227;o do colesterol de lipoprote&#237;na de baixa densidade e o outro n&#227;o encontrou benef&#237;cios. Outro estudo (1.372 participantes) sobre interven&#231;&#227;o baseada em mensagens de texto visando &#224; ades&#227;o mostrou uma pequena redu&#231;&#227;o na PAS para o grupo de interven&#231;&#227;o que entregou mensagens de texto apenas informativas, mas evid&#234;ncia incerta de benef&#237;cio para o segundo bra&#231;o de interven&#231;&#227;o que forneceu interatividade adicional. Um estudo examinou o efeito da monitoriza&#231;&#227;o da PAS combinada com mensagens do <italic>smartphone</italic> e relatou benef&#237;cios moderados de interven&#231;&#227;o na PAS e press&#227;o arterial diast&#243;lica (PAD). Houve evid&#234;ncias conflitantes de ensaios que visam ades&#227;o &#224; medica&#231;&#227;o com conselhos de estilo de vida por interven&#231;&#245;es multicomponentes. Outro estudo, ainda, encontrou grandes benef&#237;cios sobre n&#237;veis press&#243;ricos, enquanto outro estudo n&#227;o demonstrou tal efeito. Os autores da Cochrane conclu&#237;ram que h&#225; evid&#234;ncias de baixa qualidade relativas aos efeitos das interven&#231;&#245;es realizadas por telefone celular para aumentar a ades&#227;o aos medicamentos prescritos para a preven&#231;&#227;o prim&#225;ria. Com base nesta revis&#227;o, conclui-se que h&#225; atualmente incerteza em torno da efic&#225;cia dessas interven&#231;&#245;es.</p>
          </sec>
          <sec>
            <title>2.7.3. Servi&#231;os de Emerg&#234;ncia</title>
            <p>O Brasil tem um sistema de sa&#250;de geograficamente distribu&#237;do, onde as UBS, as unidades de pronto atendimento (UPA), os hospitais secund&#225;rios e as ambul&#226;ncias est&#227;o espalhados por todo o pa&#237;s, muitas vezes em pontos remotos. Os centros especializados est&#227;o em unidades de atendimento avan&#231;adas, como hospitais terci&#225;rios, localizados nas grandes cidades. Nesse contexto, ferramentas de Telemedicina podem melhorar o tratamento das emerg&#234;ncias.<xref ref-type="bibr" rid="B133">133</xref>
						</p>
            <p>A Telemedicina tem diferentes aplica&#231;&#245;es nos servi&#231;os de urg&#234;ncia, que envolvem desde a transmiss&#227;o do eletrocardiograma, associada ou n&#227;o a teleconsultorias s&#237;ncronas, para auxiliar no diagn&#243;stico precoce e manejo dos casos de s&#237;ndrome coronariana aguda (SCA), SSD cl&#237;nica para aux&#237;lio no diagn&#243;stico, manejo e predi&#231;&#227;o de complica&#231;&#245;es card&#237;acas em pacientes com SCA,<xref ref-type="bibr" rid="B133">133</xref> transmiss&#227;o de imagem de ultrassonografia &#224; beira do leito realizada no pr&#233;-hospitalar,<xref ref-type="bibr" rid="B134">134</xref> e transmiss&#227;o de imagem e suporte no diagn&#243;stico e manejo de pacientes com acidente vascular encef&#225;lico (AVE) agudo.<xref ref-type="bibr" rid="B135">135</xref> O uso de SSD poderia aumentar a ades&#227;o &#224;s recomenda&#231;&#245;es de diretrizes do manejo de pacientes com SCA, mas ainda faltam evid&#234;ncias acerca de seu impacto em desfechos cl&#237;nicos nesse contexto.<xref ref-type="bibr" rid="B135">135</xref>
						</p>
          </sec>
          <sec>
            <title>2.7.4. Na Linha de Cuidado do Infarto Agudo do Mioc&#225;rdio</title>
            <p>As linhas de cuidado do infarto visam integrar, de forma organizada, servi&#231;o pr&#233;-hospitalar, hospitais e servi&#231;os de hemodin&#226;mica que fazem parte do cuidado dos pacientes com IAM em determinada regi&#227;o, a fim de otimizar o manejo dos pacientes com suspeita cl&#237;nica. Elas se prop&#245;em a delinear um fluxo de atendimento ao paciente, envolvendo o diagn&#243;stico precoce, atendimento pr&#233;-hospitalar, tratamento inicial, uso de trombol&#237;ticos, encaminhamento para hospital especializado e acompanhamento p&#243;s-evento. Almejam um cuidado de alta qualidade, efetivo e seguro ao paciente com IAM otimizando recursos e reduzindo disparidades no acesso ao cuidado.<xref ref-type="bibr" rid="B133">133</xref><sup>,</sup><xref ref-type="bibr" rid="B136">136</xref>
						</p>
            <p>Servi&#231;os de Telemedicina podem desempenhar um papel crucial nas linhas de cuidado do IAM, pois facilitam a comunica&#231;&#227;o do m&#233;dico em unidade de emerg&#234;ncia ou hospital de baixa complexidade e atendimento pr&#233;-hospitalar com cardiologistas de um <italic>hub</italic> ou de hospital com centro de hemodin&#226;mica que ir&#225; receber o paciente. Os cardiologistas podem auxiliar: (i) na an&#225;lise e interpreta&#231;&#227;o do eletrocardiograma, para obter um diagn&#243;stico preciso e precoce de IAM com supradesnivelamento do segmento ST;<xref ref-type="bibr" rid="B132">132</xref><sup>,</sup><xref ref-type="bibr" rid="B137">137</xref> (ii) na orienta&#231;&#227;o da melhor conduta, incluindo indica&#231;&#227;o ou n&#227;o de trombol&#237;tico e demais medicamentos, atrav&#233;s de teleconsultorias s&#237;ncronas, isto &#233;, comunica&#231;&#227;o em tempo real entre o profissional que atende o paciente <italic>in locu</italic> e o especialista a dist&#226;ncia<xref ref-type="bibr" rid="B137">137</xref><sup>,</sup><xref ref-type="bibr" rid="B138">138</xref>; (iii) no acompanhamento do quadro cl&#237;nico do paciente por meio do telemonitoramento, com transmiss&#227;o s&#237;ncrona de dados.<xref ref-type="bibr" rid="B137">137</xref>
						</p>
            <p>Dessa forma, a inser&#231;&#227;o de ferramentas de Telemedicina nas linhas de cuidado do IAM &#233; uma tend&#234;ncia mundial. Uma metan&#225;lise recente que incluiu estudos na Europa (11), Am&#233;rica do Norte (8), Am&#233;rica do Sul (5), &#193;sia (9) e Austr&#225;lia (2), com um total de 16.960 pacientes, observou evid&#234;ncias consistentes de moderada qualidade que estrat&#233;gias de Telemedicina associadas ao cuidado usual nesse contexto reduzem em 37% a mortalidade hospitalar (RR 0,63, IC 95% 0,55-0,72), com n&#250;mero necess&#225;rio para tratar (NNT) de 29 (IC 95% 23-40) quando comparadas ao cuidado usual, sem Telemedicina. Al&#233;m disso, houve evid&#234;ncias de baixa qualidade que essa interven&#231;&#227;o pode reduzir o tempo porta-bal&#227;o (diferen&#231;a m&#233;dia 28 (IC 95% -35, -20) minutos, e a mortalidade em 30 dias (RR 0,62, IC 95% 0,43-0,85) e no longo prazo (RR 0,61 IC 95% 0,40-0,92).<xref ref-type="bibr" rid="B138">138</xref>
						</p>
            <p>No Brasil, foram publicadas iniciativas em Belo Horizonte, Campinas, Salvador, S&#227;o Paulo e na Regi&#227;o Norte de Minas Gerais, que engloba 89 munic&#237;pios.<xref ref-type="bibr" rid="B137">137</xref><sup>,</sup><xref ref-type="bibr" rid="B139">139</xref><sup>-</sup><xref ref-type="bibr" rid="B143">143</xref> Observou-se redu&#231;&#227;o do tempo de atraso do sistema e aumento de taxas de reperfus&#227;o nos casos de IAM com supradesnivelamento do segmento ST, com evid&#234;ncias de redu&#231;&#227;o da mortalidade hospitalar.<xref ref-type="bibr" rid="B139">139</xref><sup>,</sup><xref ref-type="bibr" rid="B143">143</xref><sup>,</sup><xref ref-type="bibr" rid="B144">144</xref>
						</p>
            <p>Um sistema de Telemedicina t&#237;pico consiste em um centro especializado (<italic>hub</italic>) e v&#225;rias unidades remotas de atendimento distribu&#237;das em uma regi&#227;o geogr&#225;fica (<italic>spoke centers</italic>) conectados bidirecionalmente com a ajuda de um canal de comunica&#231;&#227;o. O centro especializado pode ser um hospital de refer&#234;ncia em cardiologia, uma central de regula&#231;&#227;o do Servi&#231;o de Atendimento M&#243;vel de Urg&#234;ncia (SAMU) ou uma central de Telemedicina. Algumas linhas de cuidado do IAM s&#227;o compostas de mais de um centro especializado, cada um com determinadas unidades remotas, com abrang&#234;ncia regional.<xref ref-type="bibr" rid="B145">145</xref> A Diretriz de Telecardiologia no Cuidado de Pacientes com S&#237;ndrome Coronariana Aguda e Outras Doen&#231;as Card&#237;acas de 2015 detalha modelos de atendimento usando ferramentas de Telemedicina para o cuidado de pacientes com SCA.<xref ref-type="bibr" rid="B133">133</xref>
						</p>
          </sec>
          <sec>
            <title>2.7.5. No Controle do Uso de Anticoagulante</title>
            <p>A estrat&#233;gia de autogerenciamento foi associada com um risco significativamente menor de acidente vascular cerebral isqu&#234;mico e mortalidade por todas as causas em compara&#231;&#227;o com o tratamento com os anticoagulantes orais diretos, enquanto n&#227;o foram observadas diferen&#231;as significativas para grandes hemorragias e mortalidade. No entanto, a diminui&#231;&#227;o da vigil&#226;ncia apresenta um problema potencial na detec&#231;&#227;o de pacientes que n&#227;o s&#227;o capazes de cuidar de seu pr&#243;prio tratamento. &#201; necess&#225;rio um programa estruturado de educa&#231;&#227;o para pacientes e/ou seus cuidadores, al&#233;m dos profissionais de sa&#250;de relacionados e de controle de qualidade.<xref ref-type="bibr" rid="B146">146</xref><sup>-</sup><xref ref-type="bibr" rid="B148">148</xref>
						</p>
          </sec>
          <sec>
            <title>2.7.6. Reabilita&#231;&#227;o Card&#237;aca</title>
            <p>As diretrizes recomendam reabilita&#231;&#227;o card&#237;aca para pacientes ap&#243;s IAM, interven&#231;&#227;o coron&#225;ria percut&#226;nea (ICP) ou cirurgia de revasculariza&#231;&#227;o mioc&#225;rdica. Entretanto, ainda &#233; subutilizada, com apenas 14% a 31% dos pacientes eleg&#237;veis participantes. A dificuldade do paciente em participar das sess&#245;es e o custo s&#227;o importantes barreiras.<xref ref-type="bibr" rid="B149">149</xref> As interven&#231;&#245;es de telessa&#250;de que usam TIC para possibilitar programas remotos de reabilita&#231;&#227;o podem superar as barreiras comuns de acesso, preservando a supervis&#227;o cl&#237;nica e a prescri&#231;&#227;o individualizada de exerc&#237;cios.<xref ref-type="bibr" rid="B150">150</xref>
						</p>
            <p>Em revis&#227;o sistem&#225;tica que incluiu 11 estudos, o tipo de interven&#231;&#227;o foi vari&#225;vel, incluindo uso de aplicativos de celular ou em computador, biossensores e interven&#231;&#245;es por meio de telefone fixo. A interven&#231;&#227;o envolvia prescri&#231;&#227;o e/ou monitoramento do desempenho e ades&#227;o. Todas as interven&#231;&#245;es inclu&#237;ram <italic>feedback</italic>, educa&#231;&#227;o, apoio psicossocial e/ou mudan&#231;a de comportamento via telefone fixo, mensagens de celular, e-mail, site, tutorial <italic>on-line</italic> ou chat <italic>on-line</italic>.<xref ref-type="bibr" rid="B151">151</xref>
						</p>
            <p>O n&#237;vel de atividade f&#237;sica foi maior no grupo interven&#231;&#227;o em rela&#231;&#227;o ao cuidado usual. Em compara&#231;&#227;o &#224; reabilita&#231;&#227;o presencial, a interven&#231;&#227;o com ferramentas de telessa&#250;de foi mais eficaz para melhorar o n&#237;vel de atividade f&#237;sica, a ader&#234;ncia ao exerc&#237;cio, a PAD e o colesterol LDL, com evid&#234;ncias de baixa a moderada qualidade. A reabilita&#231;&#227;o com telessa&#250;de foi semelhante &#224; presencial na capacidade m&#225;xima de exerc&#237;cio aer&#243;bico e outros fatores de risco cardiovascular modific&#225;veis.<xref ref-type="bibr" rid="B151">151</xref>
						</p>
            <p>O estudo Telehab III foi um ensaio cl&#237;nico multic&#234;ntrico, prospectivo, randomizado, controlado com pacientes em reabilita&#231;&#227;o card&#237;aca. Foram 140 pacientes randomicamente alocados para um grupo de reabilita&#231;&#227;o convencional ou para um grupo com telerreabilita&#231;&#227;o via internet de 24 semanas associado a reabilita&#231;&#227;o convencional. O programa adicional de telerreabilita&#231;&#227;o mostrou melhora na aptid&#227;o f&#237;sica e na qualidade de vida e p&#244;de induzir benef&#237;cios persistentes para a sa&#250;de.<xref ref-type="bibr" rid="B152">152</xref>
						</p>
            <p>Em um ensaio cl&#237;nico realizado na China, 98 pacientes com insufici&#234;ncia card&#237;aca classe funcional da NYHA I-III foram randomizados para um programa de treinamento de exerc&#237;cios via teleconsulta por um per&#237;odo de oito semanas em casa ou em acompanhamento ambulatorial habitual. Observaram-se melhorias estatisticamente significativas no grupo experimental em rela&#231;&#227;o &#224; qualidade de vida e teste dos 6 minutos em compara&#231;&#227;o ao grupo controle. Os resultados corroboram que o treinamento f&#237;sico via teleconsultoria &#233; um m&#233;todo alternativo eficaz para a reabilita&#231;&#227;o card&#237;aca.<xref ref-type="bibr" rid="B153">153</xref>
						</p>
            <p>O estudo randomizado controlado de n&#227;o inferioridade REMOTE-CR que testou em 162 pacientes com insufici&#234;ncia card&#237;aca os efeitos e custos da reabilita&#231;&#227;o card&#237;aca por teleconsultoria em tempo real demonstrou que &#233; uma alternativa custo-efetiva e que pode aumentar o alcance da reabilita&#231;&#227;o.<xref ref-type="bibr" rid="B154">154</xref>
						</p>
            <p>Reabilita&#231;&#227;o card&#237;aca domiciliar pode ser uma alternativa para aumentar o engajamento de pacientes nesse programa por oferecer maior flexibilidade e op&#231;&#245;es para atividades, sendo ent&#227;o uma poss&#237;vel escolha de acordo com os valores e as prefer&#234;ncias do paciente, al&#233;m de poder ser implementada na sua rotina di&#225;ria.<xref ref-type="bibr" rid="B155">155</xref> A associa&#231;&#227;o da telerreabilita&#231;&#227;o card&#237;aca com a reabilita&#231;&#227;o convencional foi mais eficaz e eficiente quando comparada com o programa de reabilita&#231;&#227;o convencional sozinho, promovendo redu&#231;&#227;o na taxa de reinterna&#231;&#227;o hospitalar por causa cardiovascular e pelo ganho de qualidade de vida durante o tempo do estudo.<xref ref-type="bibr" rid="B156">156</xref>
						</p>
          </sec>
          <sec>
            <title>2.7.7. Monitora&#231;&#227;o Remota por Dispositivos Implant&#225;veis</title>
            <p>O telemonitoramento de marca-passos n&#227;o demonstrou melhora significativa em qualidade de vida e n&#250;mero de eventos cardiovasculares, mas os eventos foram detectados e tratados mais precocemente, reduzindo as hospitaliza&#231;&#245;es e visitas hospitalares (de rotina e de emerg&#234;ncia). Al&#233;m disso, proporcionaram custo mais baixo que o acompanhamento hospitalar.<xref ref-type="bibr" rid="B157">157</xref>
						</p>
            <p>Outra forma de monitoramento implant&#225;vel se faz pelo uso de cardiodesfibriladores implant&#225;veis (CDI) ou ressicronizadores. Alguns desses dispositivos podem possuir <italic>softwares</italic> de monitoramento multipar&#226;metros, como imped&#226;ncia tor&#225;cica e medidas das press&#245;es de enchimento de c&#226;meras direitas captadas pelo eletrodo posicionado no ventr&#237;culo direito. Estudo pioneiro publicado em 2008 sugeriu benef&#237;cio cl&#237;nico em paciente com insufici&#234;ncia card&#237;aca em classe funcional III da NYHA.<xref ref-type="bibr" rid="B158">158</xref> Posteriormente, o estudo <italic>IN-TIME</italic> testou estrat&#233;gia semelhante usando dispositivos (CDI e ressincronizadores) com capacidade de monitoramento multi-par&#226;metros. Neste estudo, os par&#226;metros estudados foram eventos como taquiarritmia ventricular e atrial, baixa percentagem de estimula&#231;&#227;o biventricular, aumento na frequ&#234;ncia de extrass&#237;stoles ventriculares, diminui&#231;&#227;o da atividade do paciente, e eletrograma intracard&#237;aco anormal. Altera&#231;&#245;es nestes par&#226;metros disparavam contato telef&#244;nico estruturado. O grupo alocado para telemonitoramento teve redu&#231;&#227;o significativa de desfecho cl&#237;nico combinado e de mortalidade total.<xref ref-type="bibr" rid="B159">159</xref> Outros estudos semelhantes tamb&#233;m demonstraram redu&#231;&#227;o de desfechos cl&#237;nicos combinados, muitas vezes relacionados com diminui&#231;&#227;o de necessidade de visitas presenciais.<xref ref-type="bibr" rid="B160">160</xref> Os resultados de estudo de coorte de popula&#231;&#227;o n&#227;o selecionada tamb&#233;m indicam benef&#237;cios do monitoramento remoto com informa&#231;&#245;es dos CDI/terapia de ressincroniza&#231;&#227;o card&#237;aca (TRC) sobre mortalidade.<xref ref-type="bibr" rid="B161">161</xref> Uma metan&#225;lise<xref ref-type="bibr" rid="B162">162</xref> com 11 estudos randomizados e que avaliou 5.703 pacientes, entretanto, n&#227;o demonstrou resultados consistentes sobre desfechos cl&#237;nicos. Nesta metan&#225;lise, o telemonitoramento por dispositivos foi associado com uma redu&#231;&#227;o no n&#250;mero total de visitas planejadas, n&#227;o planejadas, e na sala de emerg&#234;ncia (RR 0,56; IC 95% 0,43-0,73, p &lt; 0,001); por&#233;m as taxas de hospitaliza&#231;&#245;es de origem card&#237;aca (RR 0,96; IC 95% 0,82-1,12, p = 0,60) e os desfechos compostos de visitas &#224; emerg&#234;ncia, visitas hospitalares n&#227;o planejadas, ou hospitaliza&#231;&#245;es (RR 0,99; IC95% 0,68-1,43, p = 0,96) foram semelhantes entre os grupos. As mortalidades total e card&#237;aca tamb&#233;m foram semelhantes entre os grupos.<xref ref-type="bibr" rid="B162">162</xref>
						</p>
          </sec>
          <sec>
            <title>2.7.8. Fibrila&#231;&#227;o Atrial</title>
            <p>Pacientes com FA constituem um grupo especial, considerando - entre outras coisas - que a FA foi respons&#225;vel por aproximadamente 60% dos alertas em marca-passos e ressincronizadores/desfibriladores (CRT-D) e quase 10% dos alertas em CDIs num banco de dados mundial.<xref ref-type="bibr" rid="B163">163</xref> A monitoriza&#231;&#227;o remota tem excelente sensibilidade (95%) na detec&#231;&#227;o de FA, uma caracter&#237;stica que se torna mais importante pelo fato de que 90% dos epis&#243;dios detectados foram assintom&#225;ticos.<xref ref-type="bibr" rid="B164">164</xref><sup>,</sup><xref ref-type="bibr" rid="B165">165</xref> Os benef&#237;cios potenciais da monitoriza&#231;&#227;o remota incluem detec&#231;&#227;o e rea&#231;&#227;o precoce (por exemplo, terapia medicamentosa, reprograma&#231;&#227;o de dispositivo ou cardiovers&#227;o el&#233;trica) para prevenir a remodela&#231;&#227;o atrial e eventos adversos graves relacionados &#224; FA. O IMPACT Trial mostrou que a detec&#231;&#227;o de FA assintom&#225;tica via monitora&#231;&#227;o remota diminuiu consideravelmente o tempo para se iniciar a anticoagula&#231;&#227;o (3 dias <italic>versus</italic> 54 dias), mas as taxas de acidente vascular cerebral, embolia sist&#234;mica e sangramento n&#227;o foram significativamente reduzidas.<xref ref-type="bibr" rid="B166">166</xref>
						</p>
            <p>Na fase pr&#233;-cl&#237;nica da arritmia, a triagem com Telemedicina pode detectar casos assintom&#225;ticos de FA.<xref ref-type="bibr" rid="B89">89</xref> Em um estudo-piloto, a transmiss&#227;o transtelef&#244;nica di&#225;ria do eletrocardiograma (ECG) facilitou o diagn&#243;stico da FA parox&#237;stica assintom&#225;tica.<xref ref-type="bibr" rid="B90">90</xref> Em grandes coortes de pacientes, o servi&#231;o de telecardiologia melhorou o manuseio dos pacientes com FA e detectou novos casos da arritmia.<xref ref-type="bibr" rid="B167">167</xref>
						</p>
            <p>O suporte de Telemedicina pode melhorar o diagn&#243;stico da FA silenciosa.<xref ref-type="bibr" rid="B168">168</xref> Bilgi et al.<xref ref-type="bibr" rid="B169">169</xref> demonstraram que a avalia&#231;&#227;o em casa do ECG com suporte da telecardiologia, aumentou a sensibilidade do diagn&#243;stico de FA em idosos e foi &#250;til na identifica&#231;&#227;o domiciliar de indiv&#237;duos com FA e sintomas at&#237;picos.<xref ref-type="bibr" rid="B169">169</xref> O ECG era registrado e transmitido por celular para uma central de telecardiologia 24/7 e avaliado por um cardiologista. O suporte de telecardiologia aumentou a taxa de diagn&#243;stico da FA em domic&#237;lio em duas vezes (40 anos), para quatro vezes (60 anos) e sete vezes (70 anos).</p>
            <p>O SEARCH-AF mostrou que a utiliza&#231;&#227;o de uma deriva&#231;&#227;o de ECG (DI) pelo ECG do iPhone (iECG, AliveCor KardiaMobile) diagnostica com acur&#225;cia a FA, tornando essa tecnologia vi&#225;vel para a triagem de FA subcl&#237;nica na aten&#231;&#227;o prim&#225;ria e na comunidade.<xref ref-type="bibr" rid="B170">170</xref> O REHEARSE-AF foi um estudo randomizado para rastreio de FA que envolveu 1.001 participantes com idade &#8805; 65 anos e CHA<sub>2</sub>DS<sub>2</sub>-VASc &#8805; 2.<xref ref-type="bibr" rid="B171">171</xref> Os participantes foram randomizados para <italic>screening</italic> com AliveCor KardiaMobile (iECG) duas vezes por semana durante 12 meses (e ECG adicional no caso de sintomas) ou rotina habitual. A utiliza&#231;&#227;o do iECG aumentou o diagn&#243;stico de FA em quase quatro vezes (hazard ratio 3,9; p = 0,007).</p>
            <p><italic>Smartphones</italic>, aplicativos (&#8220;<italic>apps</italic>&#8221;) e a tecnologia de armazenamento em nuvem tem potencial para modificar profundamente a pr&#225;tica da Medicina e a forma como as decis&#245;es s&#227;o tomadas. Nas plataformas dos <italic>smartphones</italic>, os aplicativos m&#233;dicos ou de sa&#250;de podem analisar uma s&#233;rie de sinais vitais por meio de sensores embutidos, dispositivos interligados ou perif&#233;ricos.<xref ref-type="bibr" rid="B171">171</xref> O envio das imagens de ECG por mensagem multim&#237;dia pode ser um procedimento de telecardiologia pr&#225;tico e de baixo custo.<xref ref-type="bibr" rid="B172">172</xref> Essas novas tecnologias podem aumentar a capacidade de detec&#231;&#227;o das arritmias, mas o real valor desses novos m&#233;todos ainda precisa avaliado em estudos rigorosamente conduzidos.<xref ref-type="bibr" rid="B173">173</xref>
						</p>
          </sec>
          <sec>
            <title>2.7.9. Canolopatias</title>
            <p>S&#237;ndromes el&#233;tricas herdadas s&#227;o indica&#231;&#245;es menos frequentes para implante de CDI; no entanto, o seu gerenciamento pode ser desafiador porque estes dispositivos s&#227;o frequentemente implantados em pacientes mais jovens e menos propensos a participar de acompanhamento.<xref ref-type="bibr" rid="B174">174</xref> Anormalidades el&#233;tricas podem ocorrer nessas doen&#231;as, que predisp&#245;em os pacientes a choques desnecess&#225;rios e exigem uma programa&#231;&#227;o cuidadosa.<xref ref-type="bibr" rid="B175">175</xref> A popula&#231;&#227;o pedi&#225;trica, que frequentemente tem eletrodos epic&#225;rdicos implantados, &#233; mais vulner&#225;vel. O telemonitoramento pode, portanto, ter utilidade particular em tais pacientes para vigil&#226;ncia, detec&#231;&#227;o precoce e programa&#231;&#227;o preventiva.<xref ref-type="bibr" rid="B176">176</xref> No registro multic&#234;ntrico de Brugada, o n&#250;mero de visitas externas foi significativamente menor no grupo de telemonitoramento do que no grupo controle (p &lt; 0,001), e houve uma tend&#234;ncia sugerindo que o n&#250;mero de choques inapropriados tamb&#233;m foi reduzido.<xref ref-type="bibr" rid="B177">177</xref>
						</p>
          </sec>
          <sec>
            <title>2.7.10. Taquicardia e Fibrila&#231;&#227;o Ventricular</title>
            <p>O monitoramento remoto do paciente pode ser valioso para a pronta avalia&#231;&#227;o da adequa&#231;&#227;o da detec&#231;&#227;o e a efic&#225;cia da terapia administrada. Se o choque for apropriado e o estado cl&#237;nico for est&#225;vel, o m&#233;dico pode tranquilizar o paciente sem necessidade de visita hospitalar. Em estudo-piloto multic&#234;ntrico, 81% dos epis&#243;dios de taquiarritmia ventricular foram analisados remotamente e em 85% dos casos nenhuma outra a&#231;&#227;o foi necess&#225;ria.<xref ref-type="bibr" rid="B178">178</xref> O estudo TRUST demonstrou que o monitoramento remoto permite detec&#231;&#227;o precoce de taquiarritmias ventriculares em compara&#231;&#227;o com o seguimento padr&#227;o (1 dia vs. 36 dias para fibrila&#231;&#227;o ventricular e 1 dia versus 28 dias para taquicardia ventricular, p &lt; 0,001).<xref ref-type="bibr" rid="B179">179</xref> Outros benef&#237;cios potenciais do monitoramento remoto s&#227;o a preven&#231;&#227;o de choques inadequados e tamb&#233;m de choques apropriados, por&#233;m desnecess&#225;rios. Detec&#231;&#227;o inadequada devido a taquiarritmias supraventriculares (ou por <italic>oversensing</italic> da onda T) pode levar a notifica&#231;&#227;o do paciente para reprograma&#231;&#227;o intra-hospitalar ou outras interven&#231;&#245;es.<xref ref-type="bibr" rid="B180">180</xref> O fornecimento adequado de choque do CDI para taquicardias ventriculares est&#225;veis e lentas pode levar &#224; reprograma&#231;&#227;o do dispositivo com um uso mais amplo de terapias antitaquicardia indolores. A taquicardia ventricular r&#225;pida autolimitada recorrente e assintom&#225;tica, que entra na janela de fibrila&#231;&#227;o ventricular (que dispara alertas com alguns sistemas, independentemente da terapia administrada), pode ser detectada precocemente e uma interven&#231;&#227;o apropriada &#233; programada para evitar tempestades el&#233;tricas. Al&#233;m disso, o tratamento oportuno dessas taquicardias pode prevenir a deple&#231;&#227;o precoce da bateria causada pelas cargas recorrentes e administra&#231;&#227;o de choques.<xref ref-type="bibr" rid="B176">176</xref><sup>,</sup><xref ref-type="bibr" rid="B181">181</xref>
						</p>
          </sec>
          <sec>
            <title>2.7.11. Cardiopatia Cong&#234;nita</title>
            <p>O diagn&#243;stico precoce das cardiopatias cong&#234;nitas pode ser feito pela tele-ecocardiografia, de modo a guiar a conduta terap&#234;utica.<xref ref-type="bibr" rid="B182">182</xref> Um estudo norte-americano multic&#234;ntrico com 338 beb&#234;s pareados (com e sem acesso &#224; telemedicina) com nenhuma ou doen&#231;a card&#237;aca menor mostrou uma redu&#231;&#227;o estatisticamente significativa na porcentagem de beb&#234;s transferidos para um hospital terci&#225;rio (10% versus 5%) e no tempo total e de perman&#234;ncia na UTI.<xref ref-type="bibr" rid="B183">183</xref> A telemedicina aumenta a capacidade dos cardiologistas pedi&#225;tricos prestar cuidados de alta qualidade a um maior n&#250;mero de pacientes, por&#233;m faltam estudos de alta qualidade para avaliar o impacto dessa interven&#231;&#227;o.</p>
          </sec>
        </sec>
        <sec>
          <title>2.8. Teletomografia e Telerresson&#226;ncia Cardiovascular</title>
          <p>Apesar da aparente semelhan&#231;a entre a teleimagem e o servi&#231;o diagn&#243;stico local, h&#225; diverg&#234;ncias que atingem um quinto dos casos. Focando especificamente nas diverg&#234;ncias com impacto cl&#237;nico, atinge-se 1 a 3% dos casos. Podemos levantar hip&#243;teses de que as raz&#245;es para essa diverg&#234;ncia podem ser imagens com qualidade inadequada, indisponibilidade de dados cl&#237;nicos do paciente, como hist&#243;ria, exame f&#237;sico e antecedentes, falta de acesso a exames laboratoriais realizados, falta de acesso a outros exames de imagem realizados, fadiga e simples varia&#231;&#227;o interobservador.</p>
          <p>Pode ser dif&#237;cil distinguir entre o fluxo de trabalho no diagn&#243;stico de imagem no hospital local e o telediagn&#243;stico. As imagens geradas s&#227;o armazenadas no sistema de imagem (<italic>Picture Archiving and Communication System</italic> ou PACS, por exemplo). S&#227;o ent&#227;o analisadas pelo departamento de radiologia (al&#233;m de outras &#225;reas que lidam com imagens, como cardiologia e obstetr&#237;cia). Na teleimagem, a imagem &#233; transmitida para um centro externo e ent&#227;o analisada como seria localmente. S&#227;o necess&#225;rios estudos que comparem o desempenho da teleimagem com o diagn&#243;stico de imagem local. Pode at&#233; se supor que apresentem o mesmo desempenho, mas a evid&#234;ncia &#233; fundamental para se confirmarem nossas suposi&#231;&#245;es e pode determinar n&#227;o apenas se a teleimagem pode ser realizada, como tamb&#233;m as condi&#231;&#245;es &#243;timas para que se realize com seguran&#231;a, trazendo redu&#231;&#227;o de custos, sem preju&#237;zo ao paciente.</p>
          <sec>
            <title>2.8.1. Padr&#227;o DICOM</title>
            <p>Em 1993, foi apresentado um novo grupo de servi&#231;os, que j&#225; vinha sendo desenvolvido nos anos anteriores, o padr&#227;o <italic>Digital Imaging and Communications in Medicine</italic> (DICOM). O objetivo foi padronizar os dados e informa&#231;&#245;es obtidas por m&#233;todos de imagem, normatizando as regras com que as informa&#231;&#245;es m&#233;dicas s&#227;o transmitidas e armazenadas. Esse grupo de servi&#231;os tem como caracter&#237;stica a utiliza&#231;&#227;o de um formato digital que associa imagens &#224;s informa&#231;&#245;es, do tipo metadados, com capacidade de otimizar a busca, troca de informa&#231;&#227;o e utiliza&#231;&#227;o das imagens por softwares espec&#237;ficos. Al&#233;m disso, as especifica&#231;&#245;es DICOM s&#227;o atualizadas de tempos em tempos, sem que a funcionalidade j&#225; estabelecida seja abandonada.<xref ref-type="bibr" rid="B184">184</xref><sup>,</sup><xref ref-type="bibr" rid="B185">185</xref>
						</p>
          </sec>
          <sec>
            <title>2.8.2. RMC, TCC e Telemedicina</title>
            <p>Existem complexidades adicionais relacionadas aos exames de resson&#226;ncia magn&#233;tica contrastada (RMC) e tomografia computadorizada (TCC). Essas caracter&#237;sticas fazem com que alguns cuidados sejam necess&#225;rios nos servi&#231;os que contam com esses exames. Desde a marca&#231;&#227;o do exame, onde h&#225; a necessidade de definir a sua indica&#231;&#227;o precisa - ex.: estresse farmacol&#243;gico (dipiridamol, adenosina, dobutamina), avalia&#231;&#227;o de isquemia mioc&#225;rdica, viabilidade, valvopatias, cardiomiopatias espec&#237;ficas, entre outros -, passando pela necessidade de m&#233;dicos no local do exame devido ao uso frequente de contraste e medica&#231;&#245;es, t&#233;cnicos de enfermagem capazes de obter acesso venoso adequado, biom&#233;dicos e tecn&#243;logos com treinamento e experi&#234;ncia espec&#237;fica na aquisi&#231;&#227;o e p&#243;s-processamento das imagens de RMC e TCC, utilizando softwares dedicados a tais an&#225;lises.</p>
            <p>A an&#225;lise dos exames deve ser feita por m&#233;dicos especialistas experientes, com forma&#231;&#227;o espec&#237;fica nessa &#225;rea de atua&#231;&#227;o do diagn&#243;stico por imagem. Essa forma&#231;&#227;o demora em geral dois anos e n&#227;o tem uma oferta ampla em todo o territ&#243;rio nacional. Isso limita o n&#250;mero de especialistas com treinamento adequado para o exerc&#237;cio apropriado de RMC e TCC.</p>
            <p>A complexidade para a realiza&#231;&#227;o dos exames de RMC e TCC com orienta&#231;&#227;o e interpreta&#231;&#227;o a dist&#226;ncia, junto &#224; necessidade de especialistas para a an&#225;lise dos mesmos e a possibilidade de o exame ocorrer a qualquer momento, de acordo com a indica&#231;&#227;o cl&#237;nica, faz com que a Telemedicina seja cada vez mais importante nessa atividade. </p>
          </sec>
          <sec>
            <title>2.8.3. Conselho Federal de Medicina e Tele-TCC e Tele-RMC</title>
            <p>Em 2014 o CFM atualizou as normas para o exerc&#237;cio da tele-TCC/tele-RMC no Brasil.<xref ref-type="bibr" rid="B186">186</xref> Essas valem para a pr&#225;tica de transmiss&#227;o de imagens de pacientes entre diferentes locais para a produ&#231;&#227;o de um relat&#243;rio m&#233;dico, uma segunda opini&#227;o de especialista ou uma revis&#227;o cl&#237;nico-imagenol&#243;gica. As relacionadas ao t&#243;pico deste texto est&#227;o listadas abaixo:</p>
            <p>
              <list list-type="bullet">
                <list-item>
                  <p> Dados cl&#237;nicos - A transmiss&#227;o dos exames por tele-TCC/tele-RMC dever&#225; ser acompanhada dos dados cl&#237;nicos necess&#225;rios do paciente, colhidos pelo m&#233;dico solicitante, para a elabora&#231;&#227;o do relat&#243;rio.</p>
                </list-item>
                <list-item>
                  <p>Autoriza&#231;&#227;o do paciente - O paciente dever&#225; autorizar a transmiss&#227;o das suas imagens e dados por meio de consentimento informado, livre e esclarecido.</p>
                </list-item>
                <list-item>
                  <p> Especialista local e a dist&#226;ncia - A responsabilidade pela transmiss&#227;o de exames e relat&#243;rios a dist&#226;ncia ser&#225; assumida obrigatoriamente por m&#233;dico especialista na &#225;rea de RMC e TCC.</p>
                </list-item>
                <list-item>
                  <p> Limites para a pr&#225;tica a dist&#226;ncia - Em caso de exame de imagem n&#227;o contrastada (por exemplo, escore de c&#225;lcio - EC), e quando n&#227;o existir m&#233;dico especialista no estabelecimento de sa&#250;de, o m&#233;dico respons&#225;vel pelo paciente poder&#225; solicitar ao especialista o devido suporte diagn&#243;stico a dist&#226;ncia.</p>
                </list-item>
                <list-item>
                  <p> Especialista exigido - Deve haver obrigatoriamente um m&#233;dico especialista local nos servi&#231;os onde s&#227;o realizados exames de imagem contrastada, e tamb&#233;m onde s&#227;o realizados exames de RMC e TCC.</p>
                </list-item>
                <list-item>
                  <p> Responsabilidade partilhada - A responsabilidade profissional do atendimento cabe ao m&#233;dico especialista assistente do paciente que realizou o exame. O m&#233;dico especialista que emitiu o relat&#243;rio a dist&#226;ncia &#233; solid&#225;rio nesta responsabilidade.</p>
                </list-item>
                <list-item>
                  <p> Sede em territ&#243;rio brasileiro - As pessoas jur&#237;dicas que prestarem servi&#231;os em Tele-TCC/Tele-RMC dever&#227;o ter sede em territ&#243;rio brasileiro e estar inscritas no CRM de sua jurisdi&#231;&#227;o. No caso de o prestador ser pessoa f&#237;sica, ele dever&#225; ser m&#233;dico com compet&#234;ncia em RMC e TCC. </p>
                </list-item>
                <list-item>
                  <p> Normas operacionais - Foge ao escopo deste texto, mas informa&#231;&#245;es espec&#237;ficas podem ser encontradas em outro documento com as normas operacionais e requisitos m&#237;nimos para a transmiss&#227;o e manuseio dos exames e laudos de diagn&#243;stico por imagem a dist&#226;ncia.</p>
                </list-item>
                <list-item>
                  <p> Compress&#227;o e transmiss&#227;o das imagens - Os protocolos de comunica&#231;&#227;o, formato dos arquivos e algoritmos de compress&#227;o dever&#227;o estar de acordo com o padr&#227;o atual DICOM e HL7. A avalia&#231;&#227;o da taxa de compress&#227;o &#233; de responsabilidade do m&#233;dico especialista. </p>
                </list-item>
                <list-item>
                  <p> Visualiza&#231;&#227;o e processamento das imagens - &#201; de responsabilidade do m&#233;dico especialista garantir as caracter&#237;sticas t&#233;cnicas das esta&#231;&#245;es remotas de trabalho, monitores e condi&#231;&#245;es ergon&#244;micas que n&#227;o comprometam o diagn&#243;stico.</p>
                </list-item>
                <list-item>
                  <p> Seguran&#231;a e privacidade - Os sistemas informatizados utilizados para transmiss&#227;o e manuseio dos dados cl&#237;nicos, dos laudos de diagn&#243;stico por imagem, bem como para compartilhamento de imagens e informa&#231;&#245;es, devem obedecer &#224;s normativas do CFM. Especificamente para tele-TCC/tele-RMC, os sistemas devem atender aos requisitos obrigat&#243;rios do &#8220;N&#237;vel de Garantia de Seguran&#231;a 2 (NGS2)&#8221;, estabelecida no Manual de Certifica&#231;&#227;o para Sistemas de Registro Eletr&#244;nico em Sa&#250;de vigente, editado pelo CFM e pela Sociedade Brasileira de Inform&#225;tica em Sa&#250;de (SBIS).</p>
                </list-item>
              </list>
            </p>
          </sec>
          <sec>
            <title>2.8.4. Transmiss&#227;o dos Exames</title>
            <p>A transmiss&#227;o do exame deve respeitar as normas do CFM no que diz respeito a qualidade e seguran&#231;a, por&#233;m, nos exames de RMC e TCC, como geralmente o tamanho das imagens &#233; maior, se faz necess&#225;ria infraestrutura com banda de dados adequada capaz de fazer essa transmiss&#227;o. &#201; importante ressaltar que o m&#233;dico especialista respons&#225;vel pelo laudo vai precisar fazer o <italic>download</italic> dessas imagens. Dessa forma, a escolha das sequ&#234;ncias importantes ap&#243;s a aquisi&#231;&#227;o das imagens e o m&#233;todo de compress&#227;o s&#227;o fundamentais para o bom funcionamento desse fluxo.</p>
          </sec>
          <sec>
            <title>
              <bold>2.8.5. <italic>Softwares</italic> e <italic>Workstations</italic> para P&#243;s-Processamento</bold>
            </title>
            <p>Desde as imagens do ECG, at&#233; o bloco tridimensional das imagens de angiotomografia coronariana (ATC) passando para a grande variedade de sequ&#234;ncias da RMC, diversos par&#226;metros das imagens devem ser avaliados. Muitos desses v&#227;o precisar de softwares espec&#237;ficos para serem obtidos. </p>
            <p><italic>Avalia&#231;&#227;o do EC -</italic> A medida do EC &#233; feita atrav&#233;s de softwares que acompanham as esta&#231;&#245;es de trabalho, geralmente compradas em conjunto com os tom&#243;grafos, ou feita por outros programas ou &#8220;<italic>plugins</italic>&#8221; independentes. Geralmente &#233; informado no laudo o valor obtido da calcifica&#231;&#227;o por cada art&#233;ria, o valor total do EC e o percentil para o sexo e idade de cada paciente, baseado em v&#225;rios estudos populacionais, sendo um dos mais utilizados e recomendados o estudo MESA (<italic>MultiEthnic Study of Atherosclerosis</italic>).<xref ref-type="bibr" rid="B187">187</xref><sup>,</sup><xref ref-type="bibr" rid="B188">188</xref> Outros dados como a idade arterial e a varia&#231;&#227;o do risco global cardiovascular do paciente, tendo como base o ECG tamb&#233;m podem ser descritos.</p>
            <p><italic>Avalia&#231;&#227;o da ATC -</italic> Ap&#243;s a fase de aquisi&#231;&#227;o adequada visando &#224; melhor resolu&#231;&#227;o temporal e espacial das coron&#225;rias, e a edi&#231;&#227;o do ECG feita geralmente no pr&#243;prio tom&#243;grafo, outras aplica&#231;&#245;es auxiliam o diagn&#243;stico.</p>
            <p><italic>Softwares</italic> com capacidade de estender as art&#233;rias coron&#225;rias em um &#250;nico plano (<italic>Curved Planar Reconstruction</italic> ou CPR), visualizar imagens em tr&#234;s dimens&#245;es renderizada (utilizando t&#233;cnica de 3D-Volume-Rendering), visualizar imagens 2D com imagens em m&#250;ltiplos planos obl&#237;quos (<italic>Multiplanar Reconstruction</italic> ou MPR) e a caracteriza&#231;&#227;o das placas coron&#225;rias, assim como a medida objetiva das estenoses, podem ajudar muito na interpreta&#231;&#227;o dos achados at&#233; a demonstra&#231;&#227;o de forma mais clara para o m&#233;dico solicitante.<xref ref-type="bibr" rid="B189">189</xref>
						</p>
            <p><italic>Avalia&#231;&#227;o da RMC -</italic> A RMC &#233; um dos m&#233;todos de imagem mais vers&#225;teis dispon&#237;veis. Tem uma grande capacidade de produzir imagens em praticamente qualquer plano anat&#244;mico e fornece um amplo leque de sequ&#234;ncias de pulso que geram imagens com caracter&#237;sticas espec&#237;ficas e permitem desde a avalia&#231;&#227;o e fun&#231;&#227;o ventricular at&#233; a caracteriza&#231;&#227;o tecidual do mioc&#225;rdio.<xref ref-type="bibr" rid="B190">190</xref> Dessa forma, existe uma grande quantidade de aplica&#231;&#245;es dispon&#237;veis por softwares, e apenas como exemplos limitados podemos citar:</p>
            <p>
              <list list-type="bullet">
                <list-item>
                  <p> avalia&#231;&#227;o dos volumes, massa ventricular e da fun&#231;&#227;o card&#237;aca direita e esquerda;</p>
                </list-item>
                <list-item>
                  <p> an&#225;lise dos fluxos intracard&#237;acos para medida do QP-QS, <italic>shunts</italic> e disfun&#231;&#227;o orovalvares;</p>
                </list-item>
                <list-item>
                  <p> p&#243;s-processamento de angioresson&#226;ncia com medida dos di&#226;metros vasculares;</p>
                </list-item>
                <list-item>
                  <p> caracteriza&#231;&#227;o tecidual visando quantificar a perfus&#227;o, a massa com necrose/fibrose, o dep&#243;sito de ferro por avalia&#231;&#227;o do T2*, assim como os mapas param&#233;tricos dos valores de T1, T2 e T2*.</p>
                </list-item>
              </list>
            </p>
            <p>A utiliza&#231;&#227;o de programas de <italic>software</italic> junto aos exames de RMC e TCC &#233; fortemente recomendada e pode melhorar o tempo necess&#225;rio para se avaliar um exame, tornar essa avalia&#231;&#227;o mais precisa e demonstrar esses achados no laudo de forma mais clara.</p>
          </sec>
          <sec>
            <title>2.8.6. Banco de Dados, Comunica&#231;&#227;o e Arquivamento de Imagens</title>
            <p>A integra&#231;&#227;o entre o RIS (<italic>Radiology Information System</italic>) e o PACS possibilita um registro &#250;nico dos pacientes otimizando as informa&#231;&#245;es ao se combinarem imagens com dados cl&#237;nicos. Isso torna o processo mais &#225;gil e seguro. &#201; um formato cada vez mais utilizado nos servi&#231;os de sa&#250;de, geralmente oferece acesso remoto, facilitando a tele-TCC/tele-RMC, e melhora os processos administrativos e a comunica&#231;&#227;o.</p>
            <p>Existem v&#225;rias solu&#231;&#245;es no mercado, inclusive com base na nuvem utilizando a plataforma na web. Esse acesso remoto a imagens e a capacidade de distribuir a informa&#231;&#227;o do laudo em um sistema universal padr&#227;o ajudam muito no fluxo de trabalho.</p>
            <p>O laudo nada mais &#233; do que uma forma de comunica&#231;&#227;o, que tem como principal objetivo transmitir a avalia&#231;&#227;o das imagens analisadas por em especialista a outro m&#233;dico que precisa dessa informa&#231;&#227;o para o processo decis&#243;rio. Quanto mais completa e mais clara a informa&#231;&#227;o transmitida, mais importante se torna o exame solicitado. Existe uma tend&#234;ncia ao desenvolvimento de laudos estruturados que unem a informa&#231;&#227;o escrita a tabelas, figuras e fotos, todos em conjunto para que a informa&#231;&#227;o fique a mais clara e precisa poss&#237;vel.</p>
            <p>Assim como descrito anteriormente, o laudo pode ser disponibilizado por meio de sistemas avan&#231;ados como o RIS, por&#233;m outras formas de transmiss&#227;o dessa informa&#231;&#227;o, incluindo aplicativos de mensagem instant&#226;nea como o Whatsapp, tamb&#233;m podem ser utilizadas. De acordo com o CFM,<xref ref-type="bibr" rid="B191">191</xref> o WhatsApp e plataformas similares podem ser usados para comunica&#231;&#227;o entre m&#233;dicos e seus pacientes, bem como entre m&#233;dicos e m&#233;dicos em car&#225;ter privativo para enviar dados ou tirar d&#250;vidas com colegas, ou em grupos fechados de especialistas ou do corpo cl&#237;nico de uma institui&#231;&#227;o ou c&#225;tedra, com a ressalva de que todas as informa&#231;&#245;es passadas t&#234;m absoluto car&#225;ter confidencial e n&#227;o podem extrapolar os limites do pr&#243;prio grupo, tampouco circular em grupos recreativos, mesmo que compostos apenas por m&#233;dicos.</p>
          </sec>
          <sec>
            <title>2.8.7. Indica&#231;&#245;es Cl&#237;nicas da RMC e TCC</title>
            <p>Interessantemente, n&#227;o existe na literatura nenhum trabalho do impacto cl&#237;nico da aplica&#231;&#227;o da tele-RMC ou tele-TCC. Desta forma, as indica&#231;&#245;es cl&#237;nicas presentes nesta diretriz recebem todas as indica&#231;&#245;es com n&#237;vel de evid&#234;ncia C, como opini&#227;o de especialistas em consenso, sem trabalhos que avaliem desfechos ou custo-efetividade. Conhecendo essa limita&#231;&#227;o, citamos no final desse documento as principais indica&#231;&#245;es do uso da tele-TCC/tele-RMC nesta sub&#225;rea da imagem cardiovascular.<xref ref-type="bibr" rid="B192">192</xref>
						</p>
            <p>Os exames de RMC e TCC s&#227;o cada vez mais frequentes e possuem caracter&#237;sticas que tornam sua utiliza&#231;&#227;o pela Telemedicina muito interessante, em particular em pa&#237;ses continentais como o Brasil e com limitado n&#250;mero de especialistas em RMC e TCC dispon&#237;veis. A possibilidade de um especialista estar acess&#237;vel potencialmente a qualquer momento pode ajudar no manejo dos pacientes e diminuir custos na sa&#250;de, seja pela otimiza&#231;&#227;o do tempo dos especialistas dispon&#237;veis, seja na agilidade dos laudos para pacientes internados que podem abreviar sua perman&#234;ncia nos hospitais, al&#233;m de outros exemplos relacionados a essa evolu&#231;&#227;o dentro da Medicina.</p>
          </sec>
        </sec>
      </sec>
      <sec>
        <title>3. Telerrob&#243;tica Aplicada &#224; Cardiologia</title>
        <sec>
          <title>3.1. Telecirurgia Rob&#243;tica</title>
          <p>O conceito de telecirurgia surgiu no in&#237;cio dos anos 70, iniciado pela NASA.<xref ref-type="bibr" rid="B193">193</xref> O objetivo do projeto original era fornecer assist&#234;ncia m&#233;dica aos astronautas durante sua miss&#227;o remota. </p>
          <p>Dispositivos de telecirurgia rob&#243;tica s&#227;o aplica&#231;&#245;es em que o cirurgi&#227;o controla remotamente um rob&#244; executando a opera&#231;&#227;o. O sistema da Vinci&#174; (da Vinci&#174; surgical system; Intuitive Surgical, Sunnyvale, CA, USA), a plataforma rob&#243;tica de maior uso atualmente, segue essa abordagem. O cirurgi&#227;o trabalha em um console separado do campo operat&#243;rio e seus movimentos da m&#227;o s&#227;o percebidos e transmitidos para os instrumentos ao lado do paciente. H&#225; um grande benef&#237;cio ergon&#244;mico para o cirurgi&#227;o al&#233;m da incorpora&#231;&#227;o de fun&#231;&#245;es como o cancelamento do tremor das m&#227;os ou amplia&#231;&#227;o &#224; vis&#227;o do campo (em tr&#234;s dimens&#245;es) em que o cirurgi&#227;o est&#225; interessado. No entanto, essas plataformas n&#227;o incorporam muita automa&#231;&#227;o e requerem o envolvimento cont&#237;nuo do operador humano (cirurgi&#227;o) por quest&#245;es regulat&#243;rias.</p>
          <p>O primeiro rob&#244; cir&#250;rgico para procedimentos card&#237;acos criado foi o sistema ARTEMIS.<xref ref-type="bibr" rid="B194">194</xref> Projetado como um sistema de tele cirurgia e tele presen&#231;a para procedimentos card&#237;acos, foi usado para treinamento, planejamento e execu&#231;&#227;o de procedimentos minimamente invasivos. </p>
          <p>Atualmente a cirurgia card&#237;aca rob&#243;tica tem sido usada principalmente para reparo da v&#225;lvula mitral e revasculariza&#231;&#227;o do mioc&#225;rdio, autorizados pelo <italic>Food and Drug Administration</italic> (FDA) em 2002 e 2000, respectivamente. T&#233;cnicas mais recentes auxiliam nos procedimentos de manipula&#231;&#227;o do cora&#231;&#227;o por meio da compensa&#231;&#227;o de seus movimentos. No entanto, a implementa&#231;&#227;o dessa t&#233;cnica em larga escala encontra barreiras devido ao seu alto custo<xref ref-type="bibr" rid="B195">195</xref> e aus&#234;ncia de estudos randomizados que demonstrem superioridade sobre as t&#233;cnicas minimamente invasivas tradicionais, com ou sem procedimentos h&#237;bridos.<xref ref-type="bibr" rid="B196">196</xref>
					</p>
          <p>A primeira cirurgia card&#237;aca rob&#243;tica de v&#225;lvula mitral foi realizada em 1998 por Carpentier, na Fran&#231;a, e por Mohr na Alemanha. Nesse mesmo ano, Carpentier realizou a primeira cirurgia de revasculariza&#231;&#227;o do mioc&#225;rdio, em Paris, e Reichenspurner realizou a cirurgia de revasculariza&#231;&#227;o com o <italic>ZEUS Robotic Surgical System</italic> (Computer Motion, Goleta, CA), controlado por voz, em Munique.<xref ref-type="bibr" rid="B196">196</xref><sup>,</sup><xref ref-type="bibr" rid="B197">197</xref> Desde ent&#227;o, essa t&#233;cnica vem sendo popularizada por proporcionar menor agress&#227;o cir&#250;rgica, menor tempo de circula&#231;&#227;o extracorp&#243;rea e clampeamento da aorta, e menor tempo de interna&#231;&#227;o quando comparada com a t&#233;cnica aberta convencional.<xref ref-type="bibr" rid="B197">197</xref>
					</p>
          <p>A incorpora&#231;&#227;o do sistema rob&#243;tico DaVinci<sup>&#174;</sup> permitiu melhor visualiza&#231;&#227;o do campo cir&#250;rgico pela captura tridimensional e magnifica&#231;&#227;o de dez vezes, resultando em maior precis&#227;o do procedimento cir&#250;rgico com menores incis&#245;es, ap&#243;s estabelecimento de curva de aprendizado.<xref ref-type="bibr" rid="B198">198</xref><sup>,</sup><xref ref-type="bibr" rid="B199">199</xref> Adicionalmente, houve redu&#231;&#227;o das taxas de todas as complica&#231;&#245;es, notadamente de infec&#231;&#227;o, transfus&#227;o de sangue, e retorno &#224;s atividades laborativas, com impacto nos custos totais do procedimento. Esse fato foi observado especialmente entre pacientes de alto risco, como idosos, aqueles que apresentam fra&#231;&#227;o de eje&#231;&#227;o menor que 20%, portadores de diabetes de dif&#237;cil controle e doen&#231;a pulmonar obstrutiva cr&#244;nica grave.<xref ref-type="bibr" rid="B200">200</xref> Outro benef&#237;cio foi nas cirurgias h&#237;bridas, angioplastia e minimamente invasivas em pacientes com doen&#231;a arterial coronariana obstrutiva multilateral.<xref ref-type="bibr" rid="B201">201</xref>
					</p>
          <p>A Cirurgia Integrada por Computador e a Telemedicina est&#227;o se tornando populares no mundo desenvolvido. O avan&#231;o da tecnologia rob&#243;tica associado ao progresso da tecnologia da informa&#231;&#227;o, como a Internet das Coisas, permite que os bra&#231;os rob&#243;ticos sejam controlados a dist&#226;ncia, viabilizando a telecirurgia rob&#243;tica. A telecirurgia, portanto, permite aos cirurgi&#245;es realizar opera&#231;&#245;es em lugares remotos, longe de seus pacientes, melhorando o acesso e, potencialmente, a qualidade do tratamento m&#233;dico.</p>
          <p>Como em outras ferramentas da Telemedicina, a telecirurgia pode ampliar o acesso a interven&#231;&#245;es em &#225;reas remotas ou centros onde os especialistas em determinada cirurgia n&#227;o est&#227;o presentes, por exemplo. A import&#226;ncia da Telemedicina, telecirurgia e cirurgia a dist&#226;ncia n&#227;o se restringe &#224; capacidade de realizar procedimentos m&#233;dicos em &#225;reas onde estes n&#227;o est&#227;o dispon&#237;veis e pode ser estendida &#224; telementoria, que envolve a forma&#231;&#227;o de profissionais m&#233;dicos na realiza&#231;&#227;o desses procedimentos.<xref ref-type="bibr" rid="B202">202</xref> Nesse dom&#237;nio, a telecirurgia poderia beneficiar, ainda, pacientes que requerem interven&#231;&#245;es de grande complexidade e pequena preval&#234;ncia, casos em que a expertise medico-cir&#250;rgica n&#227;o est&#225; amplamente dispon&#237;vel. A aquisi&#231;&#227;o de expertise por especialistas em novas tecnologias tem sido acompanhada por programas de mentoria - <italic>proctors</italic>. A Telemedicina, na cirurgia rob&#243;tica, pode prover um treinamento com <italic>proctors</italic> a dist&#226;ncia, conectados remotamente (telementoria), ampliando o acesso &#224;s tecnologias inovadoras.<xref ref-type="bibr" rid="B203">203</xref><sup>,</sup><xref ref-type="bibr" rid="B204">204</xref>
					</p>
          <p>Os resultados das cirurgias rob&#243;ticas ainda carecem de an&#225;lises de longo prazo, tanto em rela&#231;&#227;o aos desfechos duros, como morte por todas as causas ou morte cardiovascular, infarto do mioc&#225;rdio fatal, AVE, necessidade de nova revasculariza&#231;&#227;o, e pat&#234;ncia dos enxertos vasculares. Como nas cirurgias tradicionais, a sele&#231;&#227;o dos pacientes &#233; fundamental, e o objetivo deve ser a revasculariza&#231;&#227;o completa, lembrando que a insufla&#231;&#227;o de CO<sub>2</sub> diminui o retorno venoso pelo aumento da press&#227;o intrator&#225;cica, podendo comprometer os par&#226;metros hemodin&#226;micos de pacientes com disfun&#231;&#227;o ventricular esquerda e portadores de doen&#231;a obstrutiva cr&#244;nica, que teriam os maiores benef&#237;cios com a cirurgia minimamente invasiva. S&#227;o relatados estudos com s&#233;ries de casos, com cerca de 110 pacientes, reportando sucesso cir&#250;rgico de 90% em 30 dias, sem necessidade de cirurgia aberta, e seguimento m&#225;ximo de cinco anos.<xref ref-type="bibr" rid="B205">205</xref><sup>-</sup><xref ref-type="bibr" rid="B207">207</xref>
					</p>
          <p>A maior experi&#234;ncia foi relatada por Cavallaro et al.,<xref ref-type="bibr" rid="B208">208</xref> que descreveram a morbimortalidade pela cirurgia rob&#243;tica de revasculariza&#231;&#227;o do mioc&#225;rdio em 2.582 pacientes entre 2008 e 2010, concluindo que houve menores taxas de complica&#231;&#245;es p&#243;s-operat&#243;rias em pacientes selecionados, mas que esses benef&#237;cios diminu&#237;ram em pacientes multilaterais.<xref ref-type="bibr" rid="B208">208</xref>
					</p>
          <p>Nos EUA, s&#227;o realizadas anualmente aproximadamente 1.700 cirurgias card&#237;acas rob&#243;ticas, dos quais 35,5% s&#227;o para reparo de v&#225;lvula mitral.<xref ref-type="bibr" rid="B209">209</xref> O FDA introduziu em 2011 um plano de vigil&#226;ncia ap&#243;s-comercializa&#231;&#227;o conhecido como <italic>Medical Device Epidemiology Network</italic>, aproveitando a IA para an&#225;lise de dados do mundo real, incluindo registros internacionais e dados eletr&#244;nicos de registos m&#233;dicos, para preencher a lacuna de obten&#231;&#227;o de evid&#234;ncias concomitante &#224; implementa&#231;&#227;o da inova&#231;&#227;o tecnol&#243;gica, sem comprometer a seguran&#231;a do paciente.<xref ref-type="bibr" rid="B210">210</xref>
					</p>
          <p>&#201; importante mencionar que nenhuma das t&#233;cnicas de cirurgia rob&#243;tica faz parte do rol de pol&#237;ticas p&#250;blicas do Brasil, tampouco est&#227;o inclu&#237;das no Rol de Procedimentos e Eventos em Sa&#250;de da Ag&#234;ncia Nacional de Sa&#250;de.<xref ref-type="bibr" rid="B210">210</xref> Nesse sentido, o CFM, por interm&#233;dio da Resolu&#231;&#227;o 2.227/2018, revogada, havia regulado a telecirurgia rob&#243;tica, justamente antevendo a amplia&#231;&#227;o dos benef&#237;cios da t&#233;cnica e facilitando o acompanhamento da curva de aprendizado por <italic>proctors</italic> em locais remotos. Assim, uma cirurgia rob&#243;tica no Brasil poderia ser assistida remotamente por especialista em um grande centro de outro pa&#237;s. Embora o CFM tivesse permitido o emprego da telecirurgia rob&#243;tica no Brasil, restringiu o m&#233;todo aos profissionais habilitados para exercer a Medicina no pa&#237;s.<xref ref-type="bibr" rid="B39">39</xref> Cabe ressaltar que, no Brasil, os programas de mentoria/proctor n&#227;o foram regulamentos mais amplamente, exceto no Estado da Para&#237;ba, onde o CRM, por interm&#233;dio da Res CRM-PB 182/2018, definiu regras que disciplinam a pr&#225;tica e conferem seguran&#231;a jur&#237;dica ao ato m&#233;dico.<xref ref-type="bibr" rid="B39">39</xref>
					</p>
          <p>Al&#233;m do que foi discutido acima, h&#225; tamb&#233;m uma falta de sincroniza&#231;&#227;o entre o vasto potencial dessas tecnologias e o aparato &#233;tico e legal vigente. Ao contr&#225;rio de uma pol&#237;tica nacional abrangente, existe um cen&#225;rio geral de fragmenta&#231;&#227;o caracterizado pela exist&#234;ncia de diferentes normas e padr&#245;es emitidos por diversos &#243;rg&#227;os e com focos distintos.<xref ref-type="bibr" rid="B7">7</xref> Mesmo que um &#250;nico instrumento dificilmente alcan&#231;asse esses objetivos, a fragmenta&#231;&#227;o &#233; mais um obst&#225;culo a ser superado para se alcan&#231;ar o potencial da Telemedicina e da telecirurgia em nosso meio.</p>
          <p>Entre outras barreiras ao seu uso pr&#225;tico, deve-se mencionar a escassez de recursos e conhecimentos t&#233;cnicos, al&#233;m de quest&#245;es de infraestrutura. O Brasil &#233; um pa&#237;s de distribui&#231;&#227;o regional desigual em termos de disponibilidade de banda larga.<xref ref-type="bibr" rid="B7">7</xref> Isso significa que a infraestrutura da rede de dados em banda larga &#233; um dos fatores mais limitantes para a expans&#227;o da Telemedicina em geral e da telecirurgia em particular, em especial no interior do Brasil.</p>
        </sec>
        <sec>
          <title>3.2. Angioplastia Rob&#243;tica</title>
          <p>Pode-se afirmar que a ICP &#233; um tratamento minimamente invasivo de alta previsibilidade e seguran&#231;a. Entretanto, trata-se de procedimento de execu&#231;&#227;o manual, operador-dependente, cuja execu&#231;&#227;o &#233; obrigatoriamente presencial, demandando a a&#231;&#227;o f&#237;sica dos m&#233;dicos. &#201; sabido que em cen&#225;rios de interven&#231;&#245;es de alta complexidade e alta tecnologia, a profici&#234;ncia plena somente &#233; alcan&#231;ada em ambientes de alto volume. Ressalta-se tamb&#233;m que a angioplastia coron&#225;ria &#233; realizada obrigatoriamente atrav&#233;s da exposi&#231;&#227;o de radia&#231;&#227;o ionizante, tanto para profissionais quanto pacientes. Em consequ&#234;ncia, s&#227;o altos os riscos potenciais de danos ocupacionais &#224; sa&#250;de decorrentes n&#227;o s&#243; da radia&#231;&#227;o, mas tamb&#233;m da necessidade de prote&#231;&#227;o individual<xref ref-type="bibr" rid="B211">211</xref><sup>-</sup><xref ref-type="bibr" rid="B213">213</xref> (p.e. avental de chumbo com peso m&#233;dio de 7 kg).</p>
          <p>Recentemente foi desenvolvida a interven&#231;&#227;o coron&#225;ria assistida por rob&#244; como alternativa para reduzir a depend&#234;ncia da opera&#231;&#227;o manual,<xref ref-type="bibr" rid="B214">214</xref><sup>-</sup><xref ref-type="bibr" rid="B224">224</xref> potencialmente reduzindo os danos relativos &#224; exposi&#231;&#227;o de radia&#231;&#227;o.<xref ref-type="bibr" rid="B225">225</xref> Estudos cl&#237;nicos demonstram a seguran&#231;a e efic&#225;cia do sistema rob&#243;tico, que j&#225; possui aprova&#231;&#227;o para utiliza&#231;&#227;o rotineira nos EUA e na Comunidade Europeia. Entretanto, apesar de animador, o conjunto de evid&#234;ncias cient&#237;ficas atuais &#233; inicial e limitado ao n&#250;mero de pacientes tratados, n&#227;o permitindo maiores considera&#231;&#245;es sobre eventuais riscos e benef&#237;cios da t&#233;cnica, sobretudo com rela&#231;&#245;es &#224;s particularidades de sua aplica&#231;&#227;o em subgrupos de interesse cl&#237;nico.</p>
        </sec>
      </sec>
      <sec sec-type="supplementary-material">
        <title>4. Telemedicina como Presta&#231;&#227;o de Servi&#231;os e na Sa&#250;de Suplementar</title>
        <sec>
          <title>4.1. Presta&#231;&#227;o de Servi&#231;os</title>
          <p>Atualmente, estima-se que mais de 60% de todas as institui&#231;&#245;es de sa&#250;de, e entre 40% e 50% de todos os hospitais norte-americanos usam alguma forma de transmiss&#227;o de dados por meio digital.<xref ref-type="bibr" rid="B226">226</xref> Em 2016, uma institui&#231;&#227;o de sa&#250;de norte-americana reportou que a comunica&#231;&#227;o de dados digitais em sa&#250;de (e-mail, telefone e v&#237;deo) excedeu as consultas f&#237;sicas.<xref ref-type="bibr" rid="B227">227</xref>
					</p>
          <p>&#201; importante ressaltar, entretanto, que a despeito dos novos modais de transmiss&#227;o e meios de comunica&#231;&#227;o entre m&#233;dicos e pacientes, as responsabilidades &#233;ticas e legais permanecem iguais &#224;s que regem as formas tradicionais de relacionamento entre m&#233;dicos e pacientes.<xref ref-type="bibr" rid="B228">228</xref> Os cardiologistas devem informar seus pacientes sobre os servi&#231;os prestados pela Telemedicina e suas limita&#231;&#245;es, a capacidade de seguimento tardio, atrav&#233;s do encorajamento do envio de informa&#231;&#245;es regulares para seus m&#233;dicos assistentes, e como os pacientes podem receber informa&#231;&#245;es eletr&#244;nicas que promovam a sa&#250;de. </p>
          <p>O reembolso &#233; determinante-chave para o sucesso de interven&#231;&#245;es cl&#237;nicas. O movimento em dire&#231;&#227;o ao reembolso baseado em valor, em vez do pagamento por servi&#231;o, que fornece incentivos para a presta&#231;&#227;o de cuidados nos ambientes com menor custo, a identifica&#231;&#227;o e a intera&#231;&#227;o com pessoas de alto risco antes do in&#237;cio da doen&#231;a, e o uso eficiente de equipes integradas de cuidados, todos fornecem incentivos para o crescimento da Telemedicina. Compreender o efeito do reembolso dentro do contexto de modelos alternativos de pagamento &#233; uma prioridade. </p>
          <p>Embora a trajet&#243;ria do reembolso baseado em valor seja incerta, a efici&#234;ncia na presta&#231;&#227;o de cuidados ser&#225; inevitavelmente uma prioridade em qualquer cen&#225;rio. Uma quest&#227;o relacionada &#233; assegurar que essas tecnologias sejam usadas para pacientes que satisfazem os requisitos cl&#237;nicos apropriados. Nos EUA, o reembolso dos servi&#231;os m&#233;dicos por Telemedicina vem se expandindo gradualmente, passando de uma cobertura dos servi&#231;os prestados em locais rurais para um programa mais amplo (<italic>Medicare Access and CHIP Reauthorization Act</italic>).<xref ref-type="bibr" rid="B229">229</xref> No Brasil, foram criados projetos de capacita&#231;&#227;o e de educa&#231;&#227;o m&#233;dica continuada com especial aten&#231;&#227;o para o modelo de atendimento SAMU/UPA, desenvolvidos pelo Minist&#233;rio da Sa&#250;de e Hospitais privados.<xref ref-type="bibr" rid="B230">230</xref>
					</p>
          <p>No que se refere ao pagamento dos servi&#231;os de Telemedicina e telessa&#250;de no Brasil, como j&#225; destacado, deve-se considerar que a principal fonte de recursos tem sido o setor p&#250;blico, por meio de:<xref ref-type="bibr" rid="B231">231</xref><sup>-</sup><xref ref-type="bibr" rid="B233">233</xref>
					</p>
          <p>
            <list list-type="bullet">
              <list-item>
                <p> editais de ag&#234;ncias de fomento &#224; pesquisa e inova&#231;&#227;o nacionais (como o Conselho Nacional de Desenvolvimento Cient&#237;fico e Tecnol&#243;gico - CNPq e a Financiadora de Estudos e Projetos - FINEP) e regionais (funda&#231;&#245;es estaduais de amparo &#224; pesquisa); </p>
              </list-item>
              <list-item>
                <p> conv&#234;nios ou transfer&#234;ncia direta de recursos para Universidades e Secretarias de Sa&#250;de, no bojo do Programa Telessa&#250;de Brasil, depois Telessa&#250;de Brasil Redes;</p>
              </list-item>
              <list-item>
                <p> contratos de presta&#231;&#227;o de servi&#231;o entre os gestores p&#250;blicos e centros de telessa&#250;de dos n&#250;cleos universit&#225;rios;<xref ref-type="bibr" rid="B232">232</xref>
								</p>
              </list-item>
              <list-item>
                <p> projetos no &#226;mbito dos hospitais agraciados com a ren&#250;ncia fiscal pelo programa PRO-ADI SUS, do Minist&#233;rio da Sa&#250;de.<xref ref-type="bibr" rid="B215">215</xref>
								</p>
              </list-item>
            </list>
          </p>
          <p>Observa-se que muitos desses investimentos ocorreram numa fase inicial do desenvolvimento da tecnologia no pa&#237;s e apenas alguns dos n&#250;cleos fomentados se transformaram em servi&#231;os ativos sustent&#225;veis.<xref ref-type="bibr" rid="B232">232</xref> &#201; clara a necessidade de incluir os procedimentos de telessa&#250;de no rol de procedimentos remunerados pelo SUS, de forma a regulamentar e fomentar seu uso rotineiro no sistema de sa&#250;de.</p>
          <p>A sa&#250;de suplementar, por sua vez, carece de mecanismos formais de remunera&#231;&#227;o e reembolso das atividades de telessa&#250;de, de modo que as a&#231;&#245;es de Telemedicina, neste setor, t&#234;m sido voltadas para a otimiza&#231;&#227;o do cuidado e redu&#231;&#227;o dos custos, e muitas vezes associadas a condi&#231;&#245;es espec&#237;ficas, como o acidente vascular cerebral.<xref ref-type="bibr" rid="B231">231</xref>
					</p>
          <p>Cabe registrar que a Secretaria de Ci&#234;ncia, Tecnologia e Insumos Estrat&#233;gicos do Minist&#233;rio da Sa&#250;de, por interm&#233;dio da Portaria 26, de 2 de agosto de 2017, tornou p&#250;blica a decis&#227;o de incorporar a tecnologia de monitoramento remoto para avalia&#231;&#227;o de pacientes portadores de dispositivos card&#237;acos eletr&#244;nicos implant&#225;veis (DCEI) no &#226;mbito do SUS. Trata-se de in&#233;dita incorpora&#231;&#227;o de tecnologia de monitoramento remoto decorrente de demanda da ind&#250;stria. O demandante avaliou o impacto or&#231;ament&#225;rio da tecnologia em cinco anos, considerando, no caso-base, apenas os gastos diretos com a compra do dispositivo de monitoramento remoto e da oferta do monitoramento convencional. Um segundo cen&#225;rio analisado usou um modelo din&#226;mico de estados transicionais para levar em conta custos de oportunidade de ambas as tecnologias, explorando vantagens e desvantagens de cada estrat&#233;gia. A decis&#227;o implica, obrigatoriamente, a inclus&#227;o da tecnologia no SUS em 180 dias ap&#243;s a publica&#231;&#227;o da portaria de incorpora&#231;&#227;o pelo Secret&#225;rio de Ci&#234;ncia, Tecnologia e Insumos Estrat&#233;gicos, mas at&#233; o presente n&#227;o houve divulga&#231;&#227;o do Protocolo Cl&#237;nico e Diretriz Terap&#234;utica (PC/DT), disponibilizando-a no SUS.<xref ref-type="bibr" rid="B234">234</xref>
					</p>
          <p>Infelizmente ainda existem v&#225;rias lacunas no processo de reconhecimento dos servi&#231;os m&#233;dicos de Telemedicina no quesito reembolso. O exemplo acima &#233; o &#250;nico que se encontra deliberado para a sa&#250;de p&#250;blica. O processo de codifica&#231;&#227;o em classifica&#231;&#245;es hierarquizadas ou outras modalidades de pagamentos para os diversos servi&#231;os em Telemedicina ainda n&#227;o est&#225; devidamente estruturado. </p>
          <p>Um conjunto mais completo e estruturado de c&#243;digos tamb&#233;m permitiria fornecer dados mais precisos para abordar a escassez de avalia&#231;&#227;o econ&#244;mica sistem&#225;tica dos benef&#237;cios da Telemedicina tanto em modelos de pagamento por servi&#231;o como baseado em valor.<xref ref-type="bibr" rid="B235">235</xref> Preencher essa lacuna &#233; essencial para orientar os provedores p&#250;blicos e privados de atendimento em sa&#250;de, os compradores e investidores de tecnologia, enquanto tomam decis&#245;es sobre o retorno do investimento nesse campo.</p>
        </sec>
        <sec>
          <title>4.2. A Telemedicina na Sa&#250;de Suplementar</title>
          <p>O Brasil, em 1988, optou pela institui&#231;&#227;o de um sistema de sa&#250;de de acesso universal, integral e gratuito, nos termos do art. 196 da Constitui&#231;&#227;o Federal. No entanto, a assist&#234;ncia &#224; sa&#250;de &#233; livre &#224; iniciativa privada, o par&#225;grafo 1<sup>o</sup> do art. 199 da Carta Magna estabelece a abrang&#234;ncia da participa&#231;&#227;o da inciativa privada: &#8220;As institui&#231;&#245;es privadas poder&#227;o participar de forma complementar do SUS, segundo diretrizes deste, mediante contrato de direito p&#250;blico ou conv&#234;nio, tendo prefer&#234;ncia as entidades filantr&#243;picas e as sem fins lucrativos.&#8221;<xref ref-type="bibr" rid="B236">236</xref>
					</p>
          <p>A Sa&#250;de Suplementar assiste a mais de 47 milh&#245;es de benefici&#225;rios no Brasil, regida por legisla&#231;&#227;o pr&#243;pria, cuja regula&#231;&#227;o compete &#224; ANS. Trata-se de um sistema de sa&#250;de com carater&#237;sticas pr&#243;prias e marco regulat&#243;rio disciplinado em legisla&#231;&#227;o espec&#237;fica (Lei n&#186; 9.656/ 1998). Os benef&#237;cios auferidos com o desenvolvimento not&#225;vel das TIC, igualmente, s&#227;o aplic&#225;veis &#224; sa&#250;de suplementar. No entanto, deve-se real&#231;ar que, em virtude das peculiaridades da legisla&#231;&#227;o que rege o setor, as operadoras de planos de sa&#250;de s&#227;o obrigadas a ofertar uma mir&#237;ade de procedimentos inclu&#237;dos no Rol de Procedimentos e Eventos em Sa&#250;de da ANS.<xref ref-type="bibr" rid="B237">237</xref>
					</p>
          <p>Vale dizer, ainda, que ao contratar um plano de sa&#250;de se busca prioridade no acesso &#224; m&#233;dicos e &#224;s terapias que suplementem o Rol de Pol&#237;ticas ofertadas no SUS. A maior parte dos benefici&#225;rios da sa&#250;de suplementar reside em grandes centros, mais 35 milh&#245;es de benefici&#225;rios da sa&#250;de suplementar nas regi&#245;es Sudeste (28.650.281) e Sul (6.912.748), mais de 18 milh&#245;es est&#227;o nas capitais. Ao analisar o cruzamento dos dados demogr&#225;ficos dos benefici&#225;rios da sa&#250;de suplementar e dos m&#233;dicos brasileiros, inclusive cardiologistas, nota-se que nessas regi&#245;es a propor&#231;&#227;o de m&#233;dicos por habitantes (benefici&#225;rios da sa&#250;de suplementar) &#233; diversa da verificada na sa&#250;de p&#250;blica, onde h&#225;, verdadeiramente, &#225;reas remotas sem cobertura. Torna-se imperioso considerar que a rela&#231;&#227;o presencial m&#233;dico-paciente &#233; a regra na sa&#250;de suplementar, sem preju&#237;zo da possibilidade de se disponibilizarem recursos de Telemedicina.<xref ref-type="bibr" rid="B238">238</xref>
					</p>
          <p>Nessa senda, os diversos servi&#231;os prestados no &#226;mbito da Telemedicina s&#227;o plenamente aplic&#225;veis na sa&#250;de suplementar; contudo, prover consultas presenciais, inclusive com especialistas, em vez da sua vers&#227;o &#8220;tele&#8221;, &#233; uma imposi&#231;&#227;o legal. Os recursos de TIC n&#227;o devem ser ofertados para substituir o presencial, mas ser op&#231;&#227;o no aprimoramento da assist&#234;ncia, tamb&#233;m no contexto da sa&#250;de suplementar.</p>
          <p>Aumentar a efici&#234;ncia nos cuidados de sa&#250;de exigir&#225; melhorias na qualidade, bem como redu&#231;&#245;es de custos.<xref ref-type="bibr" rid="B239">239</xref> A integra&#231;&#227;o da Telemedicina em ambulat&#243;rios e hospitais, inclusive no &#226;mbito da sa&#250;de suplementar, pode ajudar a alcan&#231;ar ambos objetivos.<xref ref-type="bibr" rid="B240">240</xref>
					</p>
          <p>A assist&#234;ncia m&#233;dica &#233;, sem d&#250;vida, um dos mais - se n&#227;o o mais - complexos setores da economia. Capital consider&#225;vel, al&#233;m de persist&#234;ncia por anos, ser&#227;o necess&#225;rios para a constru&#231;&#227;o de um sistema efetivo de Telemedicina. A ado&#231;&#227;o difundida desse tipo de pr&#225;tica exigir&#225; adapta&#231;&#245;es comportamentais por parte de muitos m&#233;dicos, organiza&#231;&#245;es e pacientes.<xref ref-type="bibr" rid="B241">241</xref> Ainda h&#225; a necessidade de regular melhor o setor nessa &#225;rea. </p>
          <p>A Telemedicina pode ser uma alternativa acess&#237;vel para atender &#224;s necessidades de sa&#250;de de popula&#231;&#245;es vulner&#225;veis &#8203;&#8203;que t&#234;m m&#250;ltiplas comorbidades, exigindo frequentes servi&#231;os de sa&#250;de.<xref ref-type="bibr" rid="B242">242</xref> Melhorando o envolvimento do paciente, a Telemedicina pode fornecer uma plataforma eficaz para os pacientes se envolverem em suas pr&#243;prias decis&#245;es.<xref ref-type="bibr" rid="B243">243</xref> Por exemplo, a <italic>Veterans Health Administration</italic>, nos EUA, introduziu um programa nacional de Telemedicina, o <italic>Care Coordination-Home Telehealth</italic>. Esse modelo permite que os pacientes gerenciem suas pr&#243;prias condi&#231;&#245;es.<xref ref-type="bibr" rid="B244">244</xref> Alguns estudos importantes demonstraram que o modelo de decis&#245;es compartilhadas reduziu as taxas de hospitaliza&#231;&#227;o.<xref ref-type="bibr" rid="B245">245</xref>
					</p>
          <p>O acesso desigual &#224; sa&#250;de, mesmo na sa&#250;de suplementar, persiste no Brasil e exige grandes investimentos para melhorar a organiza&#231;&#227;o dos sistemas de sa&#250;de. Mesmo quando os servi&#231;os de sa&#250;de e orienta&#231;&#245;es baseadas em evid&#234;ncias est&#227;o dispon&#237;veis para condi&#231;&#245;es comuns e relevantes, como hipertens&#227;o e diabetes, a lacuna de implementa&#231;&#227;o &#233; gigantesca e as melhores pr&#225;ticas n&#227;o s&#227;o absorvidas pelos profissionais de sa&#250;de ou medidas recomendadas n&#227;o s&#227;o implementadas pelos pacientes e suas fam&#237;lias. A ci&#234;ncia da implementa&#231;&#227;o revelou-se, nas &#250;ltimas d&#233;cadas, t&#227;o importante quanto a an&#225;lise de dados para o reconhecimento de gargalos que impedem o uso completo de medidas preventivas e terap&#234;uticas que assegurem benef&#237;cios aos pacientes, que podem viver mais e melhor, beneficiando-se de todo o conhecimento dispon&#237;vel,<xref ref-type="bibr" rid="B246">246</xref> reduzindo custos e aumentando a efici&#234;ncia dos sistemas privados de sa&#250;de. </p>
          <p>A teleconsulta direta de m&#233;dico para paciente, ainda n&#227;o regulamentada no Brasil, representa o modelo mais frequentemente utilizado. Um relat&#243;rio dos EUA demonstrou que a telecardiologia foi &#250;til tanto para avaliar os novos encaminhamentos quanto os p&#243;s-operat&#243;rios recentes, com o potencial benef&#237;cio da transfer&#234;ncia de conhecimento para a aten&#231;&#227;o prim&#225;ria local. No Canad&#225;, a teleconsulta tem sido &#250;til para avalia&#231;&#227;o de novos pacientes com s&#237;ncope e taquicardia supraventricular.<xref ref-type="bibr" rid="B247">247</xref> No Reino Unido, uma ampla gama de servi&#231;os de telecardiologia em pacientes internados e ambulatoriais est&#225; dispon&#237;vel nos hospitais distritais usando v&#225;rias tecnologias.<xref ref-type="bibr" rid="B248">248</xref> Essa abordagem melhorou o acesso, foi custo-neutra e aumentou a satisfa&#231;&#227;o dos pacientes. Os autores enfatizaram que tal abordagem complementava, mas n&#227;o substitu&#237;a, as consultas regulares. </p>
          <p>Existe um crescimento exponencial na demanda por cuidados domiciliares atrav&#233;s de aplica&#231;&#245;es diretas ao consumidor baseadas na web, que incluem aplicativos para <italic>tablets</italic> e <italic>smartphones</italic>.<xref ref-type="bibr" rid="B249">249</xref> Muitos provedores de sa&#250;de no exterior est&#227;o adotando essa tecnologia como uma maneira de fornecer cuidados de baixo custo para problemas comuns que poderiam resultar em uma visita ao departamento de emerg&#234;ncia.<xref ref-type="bibr" rid="B250">250</xref> A maioria dessas aplica&#231;&#245;es depende exclusivamente de conex&#245;es de v&#237;deo e &#225;udio com <italic>software</italic> adicional para agendamento, faturamento, compartilhamento de imagens fixas e documenta&#231;&#227;o. Al&#233;m disso, alguns perif&#233;ricos, como dispositivos de detec&#231;&#227;o de ritmo card&#237;aco compat&#237;veis com <italic>smartphone</italic>,<xref ref-type="bibr" rid="B251">251</xref> est&#227;o dispon&#237;veis para compra por um pre&#231;o decrescente. </p>
          <p>A exiguidade de capital para a aquisi&#231;&#227;o e manuten&#231;&#227;o de equipamentos e infraestrutura em Telemedicina continua a ser uma barreira para a implementa&#231;&#227;o mais difundida.<xref ref-type="bibr" rid="B252">252</xref> Isso &#233; particularmente verdadeiro para muitos provedores de redes de sa&#250;de ou pequenos sistemas que podem carecer dos recursos necess&#225;rios e frequentemente t&#234;m demandas conflitantes por fundos dispon&#237;veis. Outros custos associados a um programa de Telemedicina incluem sal&#225;rio, apoio administrativo e suprimentos, custos de desenvolvimento e atualiza&#231;&#227;o de <italic>softwares</italic> e aplicativos, programas de treinamento e iniciativas para promover o programa aos pacientes.<xref ref-type="bibr" rid="B253">253</xref> Com o aumento da conectividade m&#243;vel, dos <italic>smartphones</italic> e da compacta&#231;&#227;o de v&#237;deo, os custos para implementar intera&#231;&#245;es simples de Telemedicina diminu&#237;ram.</p>
          <p>Atualmente, nenhum dos procedimentos utilizados em Telemedicina integram o Rol de Procedimentos e Eventos em Sa&#250;de da Sa&#250;de Suplementar, ou seja, h&#225; um vazio regulat&#243;rio que coloca a Telemedicina em um terreno de conjecturas e expectativas frustradas dissociado do interesse do setor regulamentado. Tamb&#233;m n&#227;o h&#225; evid&#234;ncias cient&#237;ficas concretas dispon&#237;veis que sustentem o emprego formal dessa tecnologia.<xref ref-type="bibr" rid="B38">38</xref>
					</p>
          <p>A Telemedicina &#233; uma inova&#231;&#227;o disruptiva com potencial para mudar a sa&#250;de, e &#233; prov&#225;vel que sua influ&#234;ncia aumente rapidamente. Guiada pelo que &#233; melhor para os pacientes, a Telemedicina, se aplicada adequadamente, ajudar&#225; a inaugurar uma nova era para aten&#231;&#227;o &#224; sa&#250;de, que ser&#225; constru&#237;da por pacientes e m&#233;dicos, identificando novas maneiras de cuidados, aumentando a qualidade e racionalizando o custo tamb&#233;m no &#226;mbito da sa&#250;de suplementar.<xref ref-type="bibr" rid="B240">240</xref>
					</p>
        </sec>
      </sec>
      <sec>
        <title>5. Avalia&#231;&#227;o Econ&#244;mica e Impacto Or&#231;ament&#225;rio da Incorpora&#231;&#227;o da Telemedicina Aplic&#225;vel &#224; Cardiologia no Brasil</title>
        <sec>
          <title>5.1. Conceitos de Avalia&#231;&#227;o Econ&#244;mica em Telemedicina</title>
          <p>A implementa&#231;&#227;o de servi&#231;os de Telemedicina busca fornecer cuidados de sa&#250;de de qualidade e de f&#225;cil acesso a um baixo custo.<xref ref-type="bibr" rid="B254">254</xref> Desde a d&#233;cada de 1990, &#224; medida que a capacidade tecnol&#243;gica de comunica&#231;&#227;o avan&#231;ava, os servi&#231;os de Telemedicina come&#231;aram a se fazer mais presentes.<xref ref-type="bibr" rid="B255">255</xref>
					</p>
          <p>O surgimento de novas capacidades relacionadas &#224; Telemedicina e sua integra&#231;&#227;o em sistemas de presta&#231;&#227;o de cuidados oferece oportunidades para melhorar o atendimento cl&#237;nico baseado em valor, a promo&#231;&#227;o da sa&#250;de e a preven&#231;&#227;o de doen&#231;as.<xref ref-type="bibr" rid="B256">256</xref>
					</p>
          <p>Entre os valores associados &#224; ado&#231;&#227;o de servi&#231;os de Telemedicina, tem-se a colabora&#231;&#227;o com a acessibilidade &#225;gil dos pacientes aos centros de alta complexidade<xref ref-type="bibr" rid="B257">257</xref> a redu&#231;&#227;o de mortalidade<xref ref-type="bibr" rid="B258">258</xref> e a redu&#231;&#227;o da frequ&#234;ncia de interna&#231;&#245;es dos pacientes.<xref ref-type="bibr" rid="B259">259</xref>
					</p>
          <p>Na cardiologia, recentes publica&#231;&#245;es retratam servi&#231;os de Telemedicina e teleconsultoria como eficazes na gest&#227;o de pacientes com insufici&#234;ncia card&#237;aca cr&#244;nica,<xref ref-type="bibr" rid="B260">260</xref><sup>,</sup><xref ref-type="bibr" rid="B261">261</xref> realiza&#231;&#227;o de laudos de eletrocardiogramas, orienta&#231;&#227;o aos pacientes atrav&#233;s de aplicativos m&#243;veis,<xref ref-type="bibr" rid="B262">262</xref> reabilita&#231;&#227;o card&#237;aca,<xref ref-type="bibr" rid="B263">263</xref> entre outros. </p>
          <p>Atrav&#233;s das experi&#234;ncias relatadas, &#233; consenso que a Telemedicina oferece benef&#237;cios interessantes para melhorar a acessibilidade e a qualidade dos cuidados de sa&#250;de.<xref ref-type="bibr" rid="B264">264</xref> No entanto, os investimentos cient&#237;ficos e financeiros necess&#225;rios para introduzir essas tecnologias no sistema de sa&#250;de s&#227;o altos,<xref ref-type="bibr" rid="B265">265</xref> o que potenciliza a import&#226;ncia de que estudos acurados de an&#225;lise econ&#244;mica sejam conduzidos a fim de orientar decis&#245;es de implementa&#231;&#227;o de servi&#231;os de Telemedicina.<xref ref-type="bibr" rid="B265">265</xref><sup>,</sup><xref ref-type="bibr" rid="B266">266</xref>
					</p>
          <p>A an&#225;lise econ&#244;mica &#233; um dos pilares da avalia&#231;&#227;o da sa&#250;de que tem por objetivo apoiar e orientar a tomada de decis&#227;o. Para que uma nova tecnologia seja aplicada a um processo, ela deve substituir as alternativas existentes com igual ou melhor resultado. Ou seja, deve ser efetiva. Al&#233;m disso, os resultados assim obtidos devem ter um custo inferior &#224;s alternativas ou apresentar valores razo&#225;veis em rela&#231;&#227;o aos benef&#237;cios, ou seja, serem custo-efetivas. </p>
          <p>No entanto, a avalia&#231;&#227;o econ&#244;mica das estrat&#233;gias de Telemedicina apresenta algumas especificidades: mudan&#231;a constante de tecnologia, falta de desenho de estudo adequado para gerenciar amostras subdimensionadas, inadequa&#231;&#227;o das t&#233;cnicas convencionais de avalia&#231;&#227;o econ&#244;mica e problema de avalia&#231;&#227;o de resultados de sa&#250;de e n&#227;o diretamente relacionadas &#224; sa&#250;de.<xref ref-type="bibr" rid="B267">267</xref> Como consequ&#234;ncia, diferentes tipos de an&#225;lise de custos ganharam um papel importante na avalia&#231;&#227;o de servi&#231;os de Telemedicina.</p>
        </sec>
        <sec>
          <title>5.2. M&#233;todos Econ&#244;micos Aplicados</title>
          <p>Diferentes abordagens t&#234;m sido usadas para avaliar o impacto econ&#244;mico da ado&#231;&#227;o de servi&#231;os de Telemedicina com diversos n&#237;veis de aceitabilidade. Basicamente, existem cinco m&#233;todos para calcular a rela&#231;&#227;o custo-efic&#225;cia entre interven&#231;&#245;es convencionais e Telemedicina: an&#225;lise de minimiza&#231;&#227;o de custos, an&#225;lise de custo-benef&#237;cio, an&#225;lise de custo-efetividade, an&#225;lise custo-utilidade. Al&#233;m disso, o retorno do investimento tem sido usado em projetos de Telemedicina.<xref ref-type="bibr" rid="B268">268</xref>
					</p>
          <p>A an&#225;lise de minimiza&#231;&#227;o de custos pressup&#245;e que ambas as alternativas (convencional e Telemedicina) tenham a mesma efic&#225;cia em termos de resultados de sa&#250;de, mas que sejam diferentes em termos de custos. Na an&#225;lise de minimiza&#231;&#227;o de custo, mudan&#231;as s&#227;o consideradas, mas os resultados na sa&#250;de s&#227;o mantidos inalterados. Por exemplo, a telecardiologia para laudo de eletrocardiograma assume o mesmo resultado, mas tem custos diferentes. Consequentemente, os gestores t&#234;m que considerar apenas as diferen&#231;as nos custos para decidir qual alternativa &#233; menos dispendiosa.<xref ref-type="bibr" rid="B269">269</xref>
					</p>
          <p>A an&#225;lise custo-benef&#237;cio reconhece que diferentes projetos s&#227;o igualmente eficazes, mas os resultados e custos mudam. Mudan&#231;as nos custos e desfechos de sa&#250;de s&#227;o consideradas simultaneamente e d&#227;o um valor monet&#225;rio ou num&#233;rico n&#227;o apenas aos custos, mas tamb&#233;m aos resultados de sa&#250;de, a fim de expressar a rela&#231;&#227;o n&#227;o dimensional US$ de custo/US$ de benef&#237;cio. No entanto, a ideia de dar valores monet&#225;rios aos resultados de sa&#250;de, como anos de vida, nem sempre &#233; aceit&#225;vel para os tomadores de decis&#227;o na &#225;rea da sa&#250;de. </p>
          <p>A an&#225;lise de custo-efetividade aparece como uma solu&#231;&#227;o quando os custos e resultados s&#227;o considerados simultaneamente, sem dar valores monet&#225;rios aos resultados. Cada resultado &#233; definido de acordo com sua unidade espec&#237;fica, de modo que os &#237;ndices finais demonstram uma rela&#231;&#227;o entre os resultados econ&#244;micos e de sa&#250;de. Portanto, a decis&#227;o final depender&#225; da rela&#231;&#227;o que o tomador de decis&#227;o considera melhor. Essa rela&#231;&#227;o (rela&#231;&#227;o custo-efetividade incremental (do ingl&#234;s <italic>incremental cost-effectiveness ratio</italic>) - ICER representa o custo para cada unidade de resultado adicional.<xref ref-type="bibr" rid="B252">252</xref>
					</p>
          <p>A an&#225;lise custo-utilidade considera a qualidade de vida das pessoas e o tempo de vida que elas obter&#227;o como resultado de uma interven&#231;&#227;o. &#201; um caso particular de custo efetividade, em que os resultados s&#227;o medidos em termos de anos de vida plena vividos, geralmente expressos em anos de vida ajustados pela qualidade (<italic>quality-adjusted life-year</italic> - QALYs) ou anos de vida ajustados por incapacidade (<italic>disability-adjusted life-year</italic> - DALY). A OMS recomenda um valor para o DALY equivalente a tr&#234;s vezes o Produto Interno Bruto (PIB) <italic>per capita</italic>. </p>
          <p>O retorno do investimento &#233; uma rela&#231;&#227;o n&#227;o dimensional entre o valor monet&#225;rio investido e os ganhos monet&#225;rios resultantes desses investimentos e mede a efici&#234;ncia do investimento.<xref ref-type="bibr" rid="B270">270</xref>
					</p>
        </sec>
        <sec>
          <title>5.3. Revis&#227;o da Literatura</title>
          <p>Uma revis&#227;o sistem&#225;tica da literatura de estudos de revis&#227;o de avalia&#231;&#245;es de custos e benef&#237;cios da ado&#231;&#227;o de servi&#231;os de Telemedicina foi conduzida pela Universidade Federal de Minas Gerais (UFMG) em 2016, reunindo as publica&#231;&#245;es de 2000 a 2016.<xref ref-type="bibr" rid="B105">105</xref> Considerando as palavras-chave empregadas no estudo, atualizou-se a busca da revis&#227;o na base Pubmed e o crit&#233;rio de inclus&#227;o era apenas estudos relacionados &#224; cardiologia. Al&#233;m disso, acrescentaram-se outras revis&#245;es buscadas manualmente em bases e/ou revistas da &#225;rea. Dessa forma, a busca contemplou artigos de revis&#227;o da literatura sobre a avalia&#231;&#227;o da incorpora&#231;&#227;o de servi&#231;os de Telemedicina em cardiologia do per&#237;odo de 2000 at&#233; abril de 2019. </p>
          <p>As vari&#225;veis de informa&#231;&#245;es de m&#233;todo de an&#225;lise econ&#244;mica, objetivo do servi&#231;o de Telemedicina em cardiologia, efetividade cl&#237;nica e redu&#231;&#227;o de custos foram extra&#237;das dos estudos. Para a efetividade, foram avaliados o impacto em redu&#231;&#227;o de mortalidade, a redu&#231;&#227;o de interna&#231;&#245;es, a melhora no manejo de medica&#231;&#245;es e a antecipa&#231;&#227;o de diagn&#243;stico.</p>
          <p>A partir das buscas e aplica&#231;&#227;o dos crit&#233;rios de exclus&#227;o, 35 artigos foram analisados na &#237;ntegra por dois pesquisadores (AE e BZ) para extra&#231;&#227;o das vari&#225;veis. A <xref ref-type="fig" rid="f12">figura 5.1</xref> apresenta o fluxo de sele&#231;&#227;o dos artigos. </p>
          <p>
            <fig id="f12">
              <label>Figura 5.1</label>
              <caption>
                <title>Fluxo de sele&#231;&#227;o dos artigos de an&#225;lise econ&#244;mica em telemedicina aplicada a cardiologia.</title>
              </caption>
              <graphic xlink:href="1678-4170-abc-113-05-1006-90205-gf06-pt.jpg"/></fig>
          </p>
          <p>O n&#250;mero de estudos voltados &#224; Telemedicina, especialmente no acompanhamento de doen&#231;as cr&#244;nicas, aumentou na &#250;ltima d&#233;cada. Dos 35 estudos identificados, 19 foram publicados ap&#243;s 2015. A <xref ref-type="table" rid="t19">Tabela 5.1</xref> apresenta um resumo das caracter&#237;sticas dos artigos.</p>
          <table-wrap id="t19">
            <label>Tabela 5.1</label>
            <caption>
              <title>Estudos de avalia&#231;&#245;es econ&#244;micas de Telemedicina em cardiologia</title>
            </caption>
            <table frame="hsides" rules="rows">
              <colgroup>
                <col width="11%"/>
                <col width="11%"/>
                <col width="11%"/>
                <col width="11%"/>
                <col width="11%"/>
                <col width="11%"/>
                <col width="11%"/>
                <col width="11%"/>
                <col width="11%"/>
              </colgroup>
              <tbody>
                <tr>
                  <td align="left">
                    <bold>#ID</bold>
                  </td>
                  <td align="center">
                    <bold>Autores</bold>
                  </td>
                  <td align="center">
                    <bold>Ano</bold>
                  </td>
                  <td align="center">
                    <bold>N&#250;mero de artigos avaliados</bold>
                  </td>
                  <td align="center">
                    <bold>Categoria dos servi&#231;os de Telemedicina</bold>
                  </td>
                  <td align="center">
                    <bold>Foco do servi&#231;o</bold>
                  </td>
                  <td align="center">
                    <bold>Redu&#231;&#227;o de mortalidade</bold>
                  </td>
                  <td align="center">
                    <bold>Redu&#231;&#227;o no n&#250;mero de interna&#231;&#245;es</bold>
                  </td>
                  <td align="center">
                    <bold>Redu&#231;&#227;o do per&#237;odo de interna&#231;&#227;o</bold>
                  </td>
                </tr>
                <tr>
                  <td align="left">1</td>
                  <td align="center">L&#243;pez-Villegas A, Catal&#225;n-Matamoros D, Mart&#237;n-Saborido C, Villegas-Tripiana I, Robles-Musso E.<xref ref-type="bibr" rid="B284">284</xref>
									</td>
                  <td align="center">2016</td>
                  <td align="center">7</td>
                  <td align="center">Telemonitoramento (<italic>mHealth</italic>)</td>
                  <td align="center">Insufici&#234;ncia card&#237;aca</td>
                  <td align="center">NA</td>
                  <td align="center">NA</td>
                  <td align="center">Sim</td>
                </tr>
                <tr>
                  <td align="left">2</td>
                  <td align="center">Cajita MI, Gleason KT, Han HR.<xref ref-type="bibr" rid="B271">271</xref>
									</td>
                  <td align="center">2016</td>
                  <td align="center">10</td>
                  <td align="center">Telemonitoramento (<italic>mHealth</italic>)</td>
                  <td align="center">Insufici&#234;ncia card&#237;aca</td>
                  <td align="center">NA</td>
                  <td align="center">NA</td>
                  <td align="center">NA</td>
                </tr>
                <tr>
                  <td align="left">3</td>
                  <td align="center">Louis AA Turner T Gretton M Baksh A Cleland JG.<xref ref-type="bibr" rid="B270">270</xref>
									</td>
                  <td align="center">2003</td>
                  <td align="center">24</td>
                  <td align="center">Telemonitoramento (<italic>mHealth</italic>)</td>
                  <td align="center">Insufici&#234;ncia card&#237;aca</td>
                  <td align="center">Sim</td>
                  <td align="center">Sim</td>
                  <td align="center">Sim</td>
                </tr>
                <tr>
                  <td align="left">4</td>
                  <td align="center">Kassavou A, Sutton S.<xref ref-type="bibr" rid="B254">254</xref>
									</td>
                  <td align="center">2018</td>
                  <td align="center">17</td>
                  <td align="center">Comunica&#231;&#227;o mobile e automatizada</td>
                  <td align="center">Orienta&#231;&#227;o de uso de medica&#231;&#227;o</td>
                  <td align="center">NA</td>
                  <td align="center">NA</td>
                  <td align="center">NA</td>
                </tr>
                <tr>
                  <td align="left">5</td>
                  <td align="center">Lin MH, Yuan WL, Huang TC, Zhang HF, Mai JT, Wang JF.<xref ref-type="bibr" rid="B264">264</xref>
									</td>
                  <td align="center">2017</td>
                  <td align="center">39</td>
                  <td align="center">Telemonitoramento (<italic>mHealth</italic>)</td>
                  <td align="center">Insufici&#234;ncia card&#237;aca cr&#244;nica</td>
                  <td align="center">Sim</td>
                  <td align="center">Sim</td>
                  <td align="center">Sim</td>
                </tr>
                <tr>
                  <td align="left">6</td>
                  <td align="center">Kotb A Cameron C Hsieh S Wells G.<xref ref-type="bibr" rid="B285">285</xref>
									</td>
                  <td align="center">2015</td>
                  <td align="center">30</td>
                  <td align="center">Compara&#231;&#227;o entre servi&#231;os de teleconsultoria por telefone</td>
                  <td align="center">Insufici&#234;ncia card&#237;aca</td>
                  <td align="center">Sim</td>
                  <td align="center">Sim</td>
                  <td align="center">Sim</td>
                </tr>
                <tr>
                  <td align="left">7</td>
                  <td align="center">Yun JE, Park JE, Park HY, Lee HY, Park DA.<xref ref-type="bibr" rid="B286">286</xref>
									</td>
                  <td align="center">2018</td>
                  <td align="center">37</td>
                  <td align="center">Telemonitoramento (<italic>mHealth</italic>)</td>
                  <td align="center">Insufici&#234;ncia card&#237;aca</td>
                  <td align="center">Sim</td>
                  <td align="center">Sim</td>
                  <td align="center">NA</td>
                </tr>
                <tr>
                  <td align="left">8</td>
                  <td align="center">Seto E.<xref ref-type="bibr" rid="B269">269</xref>
									</td>
                  <td align="center">2008</td>
                  <td align="center">9</td>
                  <td align="center">Telemonitoramento (<italic>mHealth</italic>)</td>
                  <td align="center">Insufici&#234;ncia card&#237;aca</td>
                  <td align="center">NA</td>
                  <td align="center">NA</td>
                  <td align="center">NA</td>
                </tr>
                <tr>
                  <td align="left">9</td>
                  <td align="center">Grustam AS, Severens JL, van Nijnatten J, Koymans R, Vrijhoef HJ.<xref ref-type="bibr" rid="B260">260</xref>
									</td>
                  <td align="center">2014</td>
                  <td align="center">22</td>
                  <td align="center">Telemedicina</td>
                  <td align="center">Insufici&#234;ncia card&#237;aca cr&#244;nica</td>
                  <td align="center">Sim</td>
                  <td align="center">Sim</td>
                  <td align="center">NA</td>
                </tr>
                <tr>
                  <td align="left">10</td>
                  <td align="center">Lee M, Wang M, Liu J, Holbrook A.<xref ref-type="bibr" rid="B287">287</xref>
									</td>
                  <td align="center">2018</td>
                  <td align="center">7</td>
                  <td align="center">Teleconsultoria</td>
                  <td align="center">Orienta&#231;&#227;o de uso de medica&#231;&#227;o</td>
                  <td align="center">Sim</td>
                  <td align="center">NA</td>
                  <td align="center">NA</td>
                </tr>
                <tr>
                  <td align="left">11</td>
                  <td align="center">Klersy C, De Silvestri A, Gabutti G, Raisaro A, Curti M, Regoli F, et al.<xref ref-type="bibr" rid="B288">288</xref>
									</td>
                  <td align="center">2011</td>
                  <td align="center">17</td>
                  <td align="center">Telemonitoramento (<italic>mHealth</italic>)</td>
                  <td align="center">Insufici&#234;ncia card&#237;aca</td>
                  <td align="center">NA</td>
                  <td align="center">Sim</td>
                  <td align="center">N&#227;o</td>
                </tr>
                <tr>
                  <td align="left">12</td>
                  <td align="center">Conway A Inglis SC Clark RA.;<xref ref-type="bibr" rid="B289">289</xref>
									</td>
                  <td align="center">2014</td>
                  <td align="center">25</td>
                  <td align="center">Telemonitoramento (<italic>mHealth</italic>)</td>
                  <td align="center">Hipertens&#227;o</td>
                  <td align="center">Sim</td>
                  <td align="center">SIm</td>
                  <td align="center">Sim</td>
                </tr>
                <tr>
                  <td align="left">13</td>
                  <td align="center">Duan Y, Xie Z, Dong F, Wu Z, Lin Z, Sun N, Xu J.<xref ref-type="bibr" rid="B290">290</xref>
									</td>
                  <td align="center">2017</td>
                  <td align="center">46</td>
                  <td align="center">Telemonitoramento (<italic>mHealth</italic>)</td>
                  <td align="center">Hipertens&#227;o</td>
                  <td align="center">NA</td>
                  <td align="center">Sim</td>
                  <td align="center">NA</td>
                </tr>
                <tr>
                  <td align="left">14</td>
                  <td align="center">Kitsiou S Par&#233; G Jaana M.;<xref ref-type="bibr" rid="B291">291</xref>
									</td>
                  <td align="center">2015</td>
                  <td align="center">15</td>
                  <td align="center">Telemonitoramento (<italic>mHealth</italic>)</td>
                  <td align="center">Insufici&#234;ncia card&#237;aca cr&#244;nica</td>
                  <td align="center">Sim</td>
                  <td align="center">NA</td>
                  <td align="center">NA</td>
                </tr>
                <tr>
                  <td align="left">#ID</td>
                  <td align="center">Redu&#231;&#227;o do per&#237;odo de interna&#231;&#227;o</td>
                  <td align="center">Diagn&#243;stico antecipado</td>
                  <td align="center">Maio ades&#227;o &#224; terapia</td>
                  <td align="center">N&#227;o se mostrou conclusivo</td>
                  <td align="center">Redu&#231;&#227;o de custos</td>
                  <td align="center" colspan="3">M&#233;todo de an&#225;lise econ&#244;mica mais<break/>frequente entre os artigos</td>
                </tr>
                <tr>
                  <td align="left">1</td>
                  <td align="center">Sim</td>
                  <td align="center">Sim</td>
                  <td align="center">NA</td>
                  <td align="center">NA</td>
                  <td align="center">Sim</td>
                  <td align="center" colspan="3">Custo-efetividade</td>
                </tr>
                <tr>
                  <td align="left">2</td>
                  <td align="center">NA</td>
                  <td align="center">NA</td>
                  <td align="center">NA</td>
                  <td align="center">Sim</td>
                  <td align="center">NA</td>
                  <td align="center" colspan="3">NA</td>
                </tr>
                <tr>
                  <td align="left">3</td>
                  <td align="center">Sim</td>
                  <td align="center">Sim</td>
                  <td align="center">NA</td>
                  <td align="center">NA</td>
                  <td align="center">Sim</td>
                  <td align="center" colspan="3">Custo-efetividade</td>
                </tr>
                <tr>
                  <td align="left">4</td>
                  <td align="center">NA</td>
                  <td align="center">NA</td>
                  <td align="center">Sim</td>
                  <td align="center">NA</td>
                  <td align="center">NA</td>
                  <td align="center" colspan="3">NA</td>
                </tr>
                <tr>
                  <td align="left">5</td>
                  <td align="center">Sim</td>
                  <td align="center">NA</td>
                  <td align="center">NA</td>
                  <td align="center">NA</td>
                  <td align="center">NA</td>
                  <td align="center" colspan="3">NA</td>
                </tr>
                <tr>
                  <td align="left">6</td>
                  <td align="center">Sim</td>
                  <td align="center">NA</td>
                  <td align="center">NA</td>
                  <td align="center">NA</td>
                  <td align="center">NA</td>
                  <td align="center" colspan="3">NA</td>
                </tr>
                <tr>
                  <td align="left">7</td>
                  <td align="center">NA</td>
                  <td align="center">NA</td>
                  <td align="center">Sim</td>
                  <td align="center">NA</td>
                  <td align="center">NA</td>
                  <td align="center" colspan="3">NA</td>
                </tr>
                <tr>
                  <td align="left">8</td>
                  <td align="center">NA</td>
                  <td align="center">NA</td>
                  <td align="center">NA</td>
                  <td align="center">NA</td>
                  <td align="center">Sim</td>
                  <td align="center" colspan="3">Custo-minimiza&#231;&#227;o</td>
                </tr>
                <tr>
                  <td align="left">9</td>
                  <td align="center">NA</td>
                  <td align="center">NA</td>
                  <td align="center">NA</td>
                  <td align="center">NA</td>
                  <td align="center">Sim</td>
                  <td align="center" colspan="3">Custo-efetividade</td>
                </tr>
                <tr>
                  <td align="left">10</td>
                  <td align="center">NA</td>
                  <td align="center">Sim</td>
                  <td align="center">NA</td>
                  <td align="center">NA</td>
                  <td align="center">NA</td>
                  <td align="center" colspan="3">NA</td>
                </tr>
                <tr>
                  <td align="left">11</td>
                  <td align="center">N&#227;o</td>
                  <td align="center">NA</td>
                  <td align="center">NA</td>
                  <td align="center">NA</td>
                  <td align="center">Sim</td>
                  <td align="center" colspan="3">Custo-efetividade</td>
                </tr>
                <tr>
                  <td align="left">12</td>
                  <td align="center">Sim</td>
                  <td align="center">NA</td>
                  <td align="center">NA</td>
                  <td align="center">NA</td>
                  <td align="center">NA</td>
                  <td align="center" colspan="3">NA</td>
                </tr>
                <tr>
                  <td align="left">13</td>
                  <td align="center">NA</td>
                  <td align="center">Sim</td>
                  <td align="center">NA</td>
                  <td align="center">NA</td>
                  <td align="center">NA</td>
                  <td align="center" colspan="3">NA</td>
                </tr>
                <tr>
                  <td align="left">14</td>
                  <td align="center">NA</td>
                  <td align="center">NA</td>
                  <td align="center">NA</td>
                  <td align="center">NA</td>
                  <td align="center">Sim</td>
                  <td align="center" colspan="3">NA</td>
                </tr>
                <tr>
                  <td align="left">#ID</td>
                  <td align="center">Autores</td>
                  <td align="center">Ano</td>
                  <td align="center">N&#250;mero de artigos avaliados</td>
                  <td align="center">Categoria dos servi&#231;os de Telemedicina</td>
                  <td align="center">Foco do servi&#231;o</td>
                  <td align="center">Redu&#231;&#227;o de mortalidade</td>
                  <td align="center">Redu&#231;&#227;o no n&#250;mero de interna&#231;&#245;es</td>
                  <td align="center">Redu&#231;&#227;o do per&#237;odo de interna&#231;&#227;o</td>
                </tr>
                <tr>
                  <td align="left">15</td>
                  <td align="center">Polisena J Tran K Cimon K Hutton B McGill S Palmer K<xref ref-type="bibr" rid="B292">292</xref>
									</td>
                  <td align="center">2010</td>
                  <td align="center">21</td>
                  <td align="center">Telemonitoramento (<italic>mHealth</italic>)</td>
                  <td align="center">Insufici&#234;ncia card&#237;aca congestiva</td>
                  <td align="center">Sim</td>
                  <td align="center">Sim</td>
                  <td align="center">SIm</td>
                </tr>
                <tr>
                  <td align="left">16</td>
                  <td align="center">Pandor A Thokala P Gomersall T Baalbaki H Stevens JW Wang J.<xref ref-type="bibr" rid="B266">266</xref>
									</td>
                  <td align="center">2013</td>
                  <td align="center">2</td>
                  <td align="center">Telemonitoramento (<italic>mHealth</italic>)</td>
                  <td align="center">Insufici&#234;ncia card&#237;aca</td>
                  <td align="center">Sim</td>
                  <td align="center">Sim</td>
                  <td align="center">NA</td>
                </tr>
                <tr>
                  <td align="left">17</td>
                  <td align="center">Inglis SC Conway A Clark RA.; Cleland JG<xref ref-type="bibr" rid="B285">285</xref>
									</td>
                  <td align="center">2015</td>
                  <td align="center">27</td>
                  <td align="center">Teleconsultoria</td>
                  <td align="center">Insufici&#234;ncia card&#237;aca</td>
                  <td align="center">Sim</td>
                  <td align="center">SIm</td>
                  <td align="center">NA</td>
                </tr>
                <tr>
                  <td align="left">18</td>
                  <td align="center">Liu S, Feng W, Chhatbar PY, Liu Y, Ji X, Ovbiagele B.<xref ref-type="bibr" rid="B286">286</xref>
									</td>
                  <td align="center">2015</td>
                  <td align="center">13</td>
                  <td align="center">Telemonitoramento (<italic>mHealth</italic>)</td>
                  <td align="center">Risco de acidente vascular encef&#225;lico</td>
                  <td align="center">Sim</td>
                  <td align="center">NA</td>
                  <td align="center">NA</td>
                </tr>
                <tr>
                  <td align="left">19</td>
                  <td align="center">Knox L, Rahman RJ, Beedie C.<xref ref-type="bibr" rid="B287">287</xref>
									</td>
                  <td align="center">2017</td>
                  <td align="center">26</td>
                  <td align="center">Telemonitoramento (<italic>mHealth</italic>)</td>
                  <td align="center">Insufici&#234;ncia card&#237;aca cr&#244;nica</td>
                  <td align="center">Sim</td>
                  <td align="center">Sim</td>
                  <td align="center">Sim</td>
                </tr>
                <tr>
                  <td align="left">20</td>
                  <td align="center">Pandor A Gomersall T Stevens JW Wang J Al-Mohammad A Bakhai A.<xref ref-type="bibr" rid="B288">288</xref>
									</td>
                  <td align="center">2013</td>
                  <td align="center">21</td>
                  <td align="center">Telemonitoramento (<italic>mHealth</italic>)</td>
                  <td align="center">Insufici&#234;ncia card&#237;aca</td>
                  <td align="center">NA</td>
                  <td align="center">Sim</td>
                  <td align="center">NA</td>
                </tr>
                <tr>
                  <td align="left">21</td>
                  <td align="center">Hamilton SJ, Mills B, Birch EM, Thompson SC.<xref ref-type="bibr" rid="B255">255</xref>
									</td>
                  <td align="center">2018</td>
                  <td align="center">9</td>
                  <td align="center">Telemonitoramento (<italic>mHealth</italic>)</td>
                  <td align="center">Reabilita&#231;&#227;o card&#237;aca e Insufici&#234;ncia card&#237;aca</td>
                  <td align="center">NA</td>
                  <td align="center">NA</td>
                  <td align="center">NA</td>
                </tr>
                <tr>
                  <td align="left">22</td>
                  <td align="center">Inglis SC Clark RA Dierckx R Prieto-Merino D Cleland JG.<xref ref-type="bibr" rid="B289">289</xref>
									</td>
                  <td align="center">2015</td>
                  <td align="center">25</td>
                  <td align="center">Telemonitoramento (<italic>mHealth</italic>)</td>
                  <td align="center">Insufici&#234;ncia card&#237;aca</td>
                  <td align="center">Sim</td>
                  <td align="center">Sim</td>
                  <td align="center">NA</td>
                </tr>
                <tr>
                  <td align="left">23</td>
                  <td align="center">Par&#233; G Jaana M Sicotte C.;<xref ref-type="bibr" rid="B290">290</xref>
									</td>
                  <td align="center">2007</td>
                  <td align="center">16</td>
                  <td align="center">Telemonitoramento (<italic>mHealth</italic>)</td>
                  <td align="center">Hipertens&#227;o e doen&#231;as card&#237;acas</td>
                  <td align="center">NA</td>
                  <td align="center">Sim</td>
                  <td align="center">Sim</td>
                </tr>
                <tr>
                  <td align="left">24</td>
                  <td align="center">Shah A Clarke M Sharma U.;<xref ref-type="bibr" rid="B291">291</xref>
									</td>
                  <td align="center">2011</td>
                  <td align="center">13</td>
                  <td align="center">Telemonitoramento (<italic>mHealth</italic>)</td>
                  <td align="center">Insufici&#234;ncia card&#237;aca congestiva</td>
                  <td align="center">NA</td>
                  <td align="center">N&#227;o</td>
                  <td align="center">N&#227;o</td>
                </tr>
                <tr>
                  <td align="left">25</td>
                  <td align="center">Rawstorn JC, Gant N, Direito A, Beckmann C, Maddison R.<xref ref-type="bibr" rid="B151">151</xref>
									</td>
                  <td align="center">2016</td>
                  <td align="center">11</td>
                  <td align="center">Teleconsultoria</td>
                  <td align="center">Reabilita&#231;&#227;o card&#237;aca</td>
                  <td align="center">Sim</td>
                  <td align="center">NA</td>
                  <td align="center">NA</td>
                </tr>
                <tr>
                  <td align="left">26</td>
                  <td align="center">Neubeck L Redfern J Fernandez R Briffa T Bauman A.<xref ref-type="bibr" rid="B292">292</xref>
									</td>
                  <td align="center">2009</td>
                  <td align="center">11</td>
                  <td align="center">Telemonitoramento (<italic>mHealth</italic>)</td>
                  <td align="center">Doen&#231;a coronariana</td>
                  <td align="center">Sim</td>
                  <td align="center">NA</td>
                  <td align="center">NA</td>
                </tr>
                <tr>
                  <td align="left">#ID</td>
                  <td align="center">Diagn&#243;stico antecipado</td>
                  <td align="center" colspan="2">Maior ades&#227;o &#224; terapia</td>
                  <td align="center" colspan="2">N&#227;o se mostrou conclusivo</td>
                  <td align="center">Redu&#231;&#227;o de custos</td>
                  <td align="center" colspan="2">M&#233;todo de an&#225;lise econ&#244;mica mais frequente entre os artigos</td>
                </tr>
                <tr>
                  <td align="left">15</td>
                  <td align="center">NA</td>
                  <td align="center" colspan="2">NA</td>
                  <td align="center" colspan="2">NA</td>
                  <td align="center">NA</td>
                  <td align="center" colspan="2">NA</td>
                </tr>
                <tr>
                  <td align="left">16</td>
                  <td align="center">NA</td>
                  <td align="center" colspan="2">NA</td>
                  <td align="center" colspan="2">NA</td>
                  <td align="center">Sim</td>
                  <td align="center" colspan="2">Custo-efetividade</td>
                </tr>
                <tr>
                  <td align="left">17</td>
                  <td align="center">NA</td>
                  <td align="center" colspan="2">NA</td>
                  <td align="center" colspan="2">NA</td>
                  <td align="center">NA</td>
                  <td align="center" colspan="2">NA</td>
                </tr>
                <tr>
                  <td align="left">18</td>
                  <td align="center">Sim</td>
                  <td align="center" colspan="2">NA</td>
                  <td align="center" colspan="2">NA</td>
                  <td align="center">NA</td>
                  <td align="center" colspan="2">NA</td>
                </tr>
                <tr>
                  <td align="left">19</td>
                  <td align="center">Sim</td>
                  <td align="center" colspan="2">NA</td>
                  <td align="center" colspan="2">NA</td>
                  <td align="center">NA</td>
                  <td align="center" colspan="2">NA</td>
                </tr>
                <tr>
                  <td align="left">20</td>
                  <td align="center">NA</td>
                  <td align="center" colspan="2">NA</td>
                  <td align="center" colspan="2">NA</td>
                  <td align="center">NA</td>
                  <td align="center" colspan="2">NA</td>
                </tr>
                <tr>
                  <td align="left">21</td>
                  <td align="center">Sim</td>
                  <td align="center" colspan="2">Sim</td>
                  <td align="center" colspan="2">NA</td>
                  <td align="center">NA</td>
                  <td align="center" colspan="2">Custo-efetividade</td>
                </tr>
                <tr>
                  <td align="left">22</td>
                  <td align="center">Sim</td>
                  <td align="center" colspan="2">NA</td>
                  <td align="center" colspan="2">NA</td>
                  <td align="center">N&#227;o</td>
                  <td align="center" colspan="2">NA</td>
                </tr>
                <tr>
                  <td align="left">23</td>
                  <td align="center">Sim</td>
                  <td align="center" colspan="2">NA</td>
                  <td align="center" colspan="2">NA</td>
                  <td align="center">N&#227;o</td>
                  <td align="center" colspan="2">NA</td>
                </tr>
                <tr>
                  <td align="left">24</td>
                  <td align="center">NA</td>
                  <td align="center" colspan="2">NA</td>
                  <td align="center" colspan="2">NA</td>
                  <td align="center">Sim</td>
                  <td align="center" colspan="2">NA</td>
                </tr>
                <tr>
                  <td align="left">25</td>
                  <td align="center">Sim</td>
                  <td align="center" colspan="2">NA</td>
                  <td align="center" colspan="2">NA</td>
                  <td align="center">NA</td>
                  <td align="center" colspan="2">NA</td>
                </tr>
                <tr>
                  <td align="left">26</td>
                  <td align="center">Sim</td>
                  <td align="center" colspan="2">NA</td>
                  <td align="center" colspan="2">NA</td>
                  <td align="center">Sim</td>
                  <td align="center" colspan="2">NA</td>
                </tr>
                <tr>
                  <td align="left">#ID</td>
                  <td align="center">Autores</td>
                  <td align="center">Ano</td>
                  <td align="center">N&#250;mero de artigos avaliados</td>
                  <td align="center">Categoria dos servi&#231;os de Telemedicina</td>
                  <td align="center">Foco do servi&#231;o</td>
                  <td align="center">Redu&#231;&#227;o de mortalidade</td>
                  <td align="center">Redu&#231;&#227;o no n&#250;mero de interna&#231;&#245;es</td>
                  <td align="center">Redu&#231;&#227;o do per&#237;odo de interna&#231;&#227;o</td>
                </tr>
                <tr>
                  <td align="left">27</td>
                  <td align="center">Huang K Liu W He D Huang B Xiao D Peng Y.<xref ref-type="bibr" rid="B301">301</xref>
									</td>
                  <td align="center">2015</td>
                  <td align="center">9</td>
                  <td align="center">Teleconsultoria</td>
                  <td align="center">Doen&#231;a coronariana</td>
                  <td align="center">Sim</td>
                  <td align="center">NA</td>
                  <td align="center">NA</td>
                </tr>
                <tr>
                  <td align="left">28</td>
                  <td align="center">Purcell R McInnes S Halcomb EJ.<xref ref-type="bibr" rid="B302">302</xref>
									</td>
                  <td align="center">2014</td>
                  <td align="center">13</td>
                  <td align="center">Telemonitoramento (<italic>mHealth</italic>)</td>
                  <td align="center">Insufici&#234;ncia card&#237;aca cr&#244;nica</td>
                  <td align="center">Sim</td>
                  <td align="center">Sim</td>
                  <td align="center">NA</td>
                </tr>
                <tr>
                  <td align="left">29</td>
                  <td align="center">Chaudhry SI Phillips CO Stewart SS Riegel B Mattera JA Jerant AF Krumholz HM.<xref ref-type="bibr" rid="B303">303</xref>
									</td>
                  <td align="center">2007</td>
                  <td align="center">9</td>
                  <td align="center">Telemonitoramento (<italic>mHealth</italic>)</td>
                  <td align="center">Insufici&#234;ncia Card&#237;aca</td>
                  <td align="center">NA</td>
                  <td align="center">Sim</td>
                  <td align="center">Sim</td>
                </tr>
                <tr>
                  <td align="left">30</td>
                  <td align="center">Pfaeffli Dale L, Dobson R, Whittaker R, Maddison R.<xref ref-type="bibr" rid="B304">304</xref>
									</td>
                  <td align="center">2016</td>
                  <td align="center">7</td>
                  <td align="center">Telemonitoramento (<italic>mHealth</italic>)</td>
                  <td align="center">Doen&#231;as cardiovasculares</td>
                  <td align="center">NA</td>
                  <td align="center">NA</td>
                  <td align="center">NA</td>
                </tr>
                <tr>
                  <td align="left">31</td>
                  <td align="center">Rush KL Hatt L Janke R Burton L Ferrier M Tetrault M.;<xref ref-type="bibr" rid="B262">262</xref>
									</td>
                  <td align="center">2018</td>
                  <td align="center">16</td>
                  <td align="center">Teleduca&#231;&#227;o</td>
                  <td align="center">Insufici&#234;ncia card&#237;aca cr&#244;nica</td>
                  <td align="center">NA</td>
                  <td align="center">Sim</td>
                  <td align="center">Sim</td>
                </tr>
                <tr>
                  <td align="left">32</td>
                  <td align="center">Hameed AS, Sauermann S, Schreier G.<xref ref-type="bibr" rid="B305">305</xref>
									</td>
                  <td align="center">2014</td>
                  <td align="center">9</td>
                  <td align="center">Compara&#231;&#227;o entre servi&#231;os de teleconsultoria por telefone</td>
                  <td align="center">Insufici&#234;ncia Card&#237;aca</td>
                  <td align="center">NA</td>
                  <td align="center">NA</td>
                  <td align="center">NA</td>
                </tr>
                <tr>
                  <td align="left">33</td>
                  <td align="center">Feltner C Jones CD Feltner C Zheng ZJ Sueta CA Coker-Schwimmer EJ Arvanitis M.<xref ref-type="bibr" rid="B259">259</xref>
									</td>
                  <td align="center">2014</td>
                  <td align="center">47</td>
                  <td align="center">Telemonitoramento (<italic>mHealth</italic>)</td>
                  <td align="center">Insufici&#234;ncia Card&#237;aca</td>
                  <td align="center">NA</td>
                  <td align="center">Sim</td>
                  <td align="center">NA</td>
                </tr>
                <tr>
                  <td align="left">34</td>
                  <td align="center">Beatty AL, Fukuoka Y, Whooley MA.<xref ref-type="bibr" rid="B150">150</xref>
									</td>
                  <td align="center">2013</td>
                  <td align="center">3</td>
                  <td align="center">Telemonitoramento (<italic>mHealth</italic>)</td>
                  <td align="center">Reabilita&#231;&#227;o card&#237;aca</td>
                  <td align="center">NA</td>
                  <td align="center">NA</td>
                  <td align="center">NA</td>
                </tr>
                <tr>
                  <td align="left">35</td>
                  <td align="center">Driscoll A, Meagher S, Kennedy R, Hay M, Banerji J, Campbell D, Cox N, Gascard D, Hare D, Page K, Nadurata V, Sanders R, Patsamanis H.<xref ref-type="bibr" rid="B258">258</xref>
									</td>
                  <td align="center">2016</td>
                  <td align="center">29</td>
                  <td align="center">Telemonitoramento (<italic>mHealth</italic>)</td>
                  <td align="center">Insufici&#234;ncia card&#237;aca</td>
                  <td align="center">Sim</td>
                  <td align="center">Sim</td>
                  <td align="center">Sim</td>
                </tr>
                <tr>
                  <td align="left">#ID</td>
                  <td align="center">Diagn&#243;stico antecipado</td>
                  <td align="center" colspan="2">Maior ades&#227;o &#224; terapia</td>
                  <td align="center" colspan="2">N&#227;o se mostrou conclusivo</td>
                  <td align="center">Redu&#231;&#227;o de custos</td>
                  <td align="center" colspan="2">M&#233;todo de an&#225;lise econ&#244;mica mais frequente entre os artigos</td>
                </tr>
                <tr>
                  <td align="left">27</td>
                  <td align="center">Sim</td>
                  <td align="center" colspan="2">NA</td>
                  <td align="center" colspan="2">NA</td>
                  <td align="center">NA</td>
                  <td align="center" colspan="2">NA</td>
                </tr>
                <tr>
                  <td align="left">28</td>
                  <td align="center">Sim</td>
                  <td align="center" colspan="2">NA</td>
                  <td align="center" colspan="2">NA</td>
                  <td align="center">Sim</td>
                  <td align="center" colspan="2">NA</td>
                </tr>
                <tr>
                  <td align="left">29</td>
                  <td align="center">NA</td>
                  <td align="center" colspan="2">NA</td>
                  <td align="center" colspan="2">NA</td>
                  <td align="center">Sim</td>
                  <td align="center" colspan="2">Custo-efetividade</td>
                </tr>
                <tr>
                  <td align="left">30</td>
                  <td align="center">NA</td>
                  <td align="center" colspan="2">Sim</td>
                  <td align="center" colspan="2">NA</td>
                  <td align="center">Sim</td>
                  <td align="center" colspan="2">NA</td>
                </tr>
                <tr>
                  <td align="left">31</td>
                  <td align="center">Sim</td>
                  <td align="center" colspan="2">Sim</td>
                  <td align="center" colspan="2">NA</td>
                  <td align="center">Sim</td>
                  <td align="center" colspan="2">NA</td>
                </tr>
                <tr>
                  <td align="left">32</td>
                  <td align="center">Sim</td>
                  <td align="center" colspan="2">Sim</td>
                  <td align="center" colspan="2">NA</td>
                  <td align="center">N&#227;o</td>
                  <td align="center" colspan="2">NA</td>
                </tr>
                <tr>
                  <td align="left">33</td>
                  <td align="center">NA</td>
                  <td align="center" colspan="2">NA</td>
                  <td align="center" colspan="2">NA</td>
                  <td align="center">NA</td>
                  <td align="center" colspan="2">NA</td>
                </tr>
                <tr>
                  <td align="left">34</td>
                  <td align="center">Sim</td>
                  <td align="center" colspan="2">Sim</td>
                  <td align="center" colspan="2">NA</td>
                  <td align="center">NA</td>
                  <td align="center" colspan="2">NA</td>
                </tr>
                <tr>
                  <td align="left">35</td>
                  <td align="center">NA</td>
                  <td align="center" colspan="2">NA</td>
                  <td align="center" colspan="2">NA</td>
                  <td align="center">NA</td>
                  <td align="center" colspan="2">NA</td>
                </tr>
              </tbody>
            </table>
          </table-wrap>
          <p>Dentre os estudos, 26 avaliaram o servi&#231;o de Telemedicina de telemonitoramento <italic>mHealth</italic> como a interven&#231;&#227;o prim&#225;ria <italic>versus</italic> tratamento usual presencial. Entre as justificativas dos autores, &#233; frequente a facilidade de uso dos celulares m&#243;veis, por meio de aplicativos, para acompanhamento remoto e &#225;gil comunica&#231;&#227;o com os pacientes.<xref ref-type="bibr" rid="B271">271</xref>
					</p>
          <p>Os desfechos mais comuns entre os estudos avaliados foram: redu&#231;&#227;o de mortalidade (54% das revis&#245;es avaliadas) e redu&#231;&#227;o no n&#250;mero de reinterna&#231;&#245;es hospitalares (57% das revis&#245;es avaliadas), sendo que ao menos um desses desfechos apareceu em 26 estudos. Outros resultados esperados foram em redu&#231;&#227;o no per&#237;odo de interna&#231;&#227;o, diagn&#243;stico precoce e melhor ades&#227;o aos medicamentos. </p>
          <p>Por outro lado, as avalia&#231;&#245;es econ&#244;micas foram menos frequentes. Apenas 16 revis&#245;es encontraram resultados conclusivos sobre a inclus&#227;o de an&#225;lises de custos, destas, 13 afirmaram que o servi&#231;o de Telemedicina representou uma economia para a fonte pagadora por causar redu&#231;&#227;o de custos. Oito revis&#245;es apresentaram discuss&#245;es sobre a inclus&#227;o de alguma avalia&#231;&#227;o econ&#244;mica da incorpora&#231;&#227;o da Telemedicina na cardiologia, sendo custo-efetividade o m&#233;todo mais presente (sete estudos) e um estudo de custo-minimiza&#231;&#227;o. Um estudo sugeriu que as poucas avalia&#231;&#245;es econ&#244;micas existentes ainda s&#227;o de baixo rigor metodol&#243;gico, n&#227;o permitindo uma conclus&#227;o assertiva sobre a viabilidade econ&#244;mica da implementa&#231;&#227;o.<xref ref-type="bibr" rid="B264">264</xref><sup>,</sup><xref ref-type="bibr" rid="B271">271</xref>
					</p>
          <p>De modo resumido, estudos de telemonitoramento de insufici&#234;ncia card&#237;aca mostraram que as estrat&#233;gias de apoio (v&#237;deo confer&#234;ncia ou telefone) s&#227;o custo ben&#233;ficas, ou seja, tem um potencial de retorno financeiro. Estudos que avaliaram monitoriza&#231;&#227;o atrav&#233;s de dispositivos card&#237;acos mostraram uma rela&#231;&#227;o custo-efetividade incremental de US$ 13.979 por QALYs. Em uma metan&#225;lise, o telemonitoramento por dispositivos mostrou uma redu&#231;&#227;o de 44% nas visitas hospitalares, sem efeito na mortalidade, mas com economia de 15-50% dos custos diretos em sa&#250;de.<xref ref-type="bibr" rid="B272">272</xref> Os resultados econ&#244;micos de telemonitoriza&#231;&#227;o n&#227;o invasiva s&#227;o ainda mais heterog&#234;neos. Alguns ensaios cl&#237;nicos demostraram resultados neutros, outros uma redu&#231;&#227;o significativa de readmiss&#245;es por insufici&#234;ncia card&#237;aca e uma redu&#231;&#227;o de custo total direto de &#8364; 3.546 por paciente por seis meses de seguimento.<xref ref-type="bibr" rid="B273">273</xref> Em um ensaio cl&#237;nico Holand&#234;s, o TEHAF trial, a probabilidade de monitoramento remoto ser custo-efetivo foi de 48% (limiar de &#8364; 50.000/QALY), provavelmente pelas diferen&#231;as entre as institui&#231;&#245;es. Um dos estudos mais detalhados foi desenvolvido para perspectiva do sistema de sa&#250;de da Inglaterra, atrav&#233;s de modelo de Markov, comparando tratamento usual, suporte por telefone ou telemonitoramento a dist&#226;ncia para pacientes com insufici&#234;ncia card&#237;aca ap&#243;s alta hospitalar. Assumindo custos mensais de &#163; 27 para atendimento usual, &#163; 179 para suporte por telefone e &#163; 175 para telemonitoramento em hor&#225;rio comercial, a estrat&#233;gia com melhor rela&#231;&#227;o de custo-efetividade foi o telemonitoramento, com valores menores que &#163; 20.000 por QALY. A estrat&#233;gia de suporte por telefone foi muito desfavor&#225;vel, com um ICER de &#163; 228.035/QALY comparada com telemonitoramento.<xref ref-type="bibr" rid="B274">274</xref>
					</p>
          <p>As vari&#225;veis de avalia&#231;&#227;o de efetividade se repetem entre os estudos, merecendo destaque a redu&#231;&#227;o da mortalidade e da frequ&#234;ncia de interna&#231;&#245;es. Por&#233;m, m&#233;todos acurados de coleta de custos, defini&#231;&#227;o de quais vari&#225;veis de custos devem ser coletadas e a aplica&#231;&#227;o de modelos econ&#244;micos ainda carece de uma orienta&#231;&#227;o padr&#227;o na literatura. Mais de 70% dos estudos n&#227;o levaram em considera&#231;&#227;o pelo menos uma categoria: custo para o sistema de sa&#250;de, despesas com pacientes e familiares, ou perda de produtividade. Muitos falham por n&#227;o incluir sal&#225;rios e benef&#237;cios, tempo de treinamento, investimentos com capital amortizado, opera&#231;&#245;es de apoio de dados e acompanhamento e despesas fixas (<italic>overhead</italic>). Al&#233;m disso, um limitador importante nessas an&#225;lises econ&#244;micas tem sido a grande heterogeneidade da tecnologia (interven&#231;&#227;o) e mesmo o grupo controle (alternativas). A velocidade de avan&#231;o nas tecnologias que suportam servi&#231;os de Telemedicina &#233; impressionante, partindo de estruturas complexas e grandes investimentos, h&#225; menos de dez anos, para solu&#231;&#245;es efetivas de baixo custo baseadas em celulares e dispositivos m&#243;veis.<xref ref-type="bibr" rid="B256">256</xref><sup>,</sup><xref ref-type="bibr" rid="B263">263</xref> Trata-se de servi&#231;os distintos com maior investimento inicial, mas cuja maioria dos dados aponta um retorno do investimento ao longo do tempo pelo volume de pacientes que consegue evitar o consumo do sistema de sa&#250;de tradicional.<xref ref-type="bibr" rid="B260">260</xref><sup>,</sup><xref ref-type="bibr" rid="B269">269</xref> Isto requer que m&#233;todos de avalia&#231;&#227;o econ&#244;mica acompanhem o comportamento do servi&#231;o, incluindo desfecho dos pacientes atendidos ou monitorados pelo servi&#231;o de Telemedicina ao longo do tempo. Pela diversidade de benef&#237;cios alcan&#231;ados, metodologias de custos empregadas, dados dedicados que reflitam realidades locais do sistema de sa&#250;de precisam ser avaliados para entender a custo-efetividade dessas tecnologias.</p>
        </sec>
        <sec>
          <title>5.4. Avalia&#231;&#245;es Econ&#244;micas de Telemedicina no Brasil</title>
          <p>Gradativamente, essas novas tecnologias v&#234;m sendo introduzidas na rotina dos hospitais, cl&#237;nicas e consult&#243;rios, seja no setor privado ou no p&#250;blico no Brasil. A primeira dessas tecnologias a ser utilizada foi a transmiss&#227;o de dados de ECG para laudos a dist&#226;ncia. Em 1994, iniciou-se a utiliza&#231;&#227;o dessa tecnologia pela empresa Telecardio, transmitindo os exames via telefone, e em 1995 o Instituto do Cora&#231;&#227;o (InCor) criou um servi&#231;o chamado de ECG-FAX. Posteriormente, em 2005, foi implementado no Hospital das Cl&#237;nicas da UFMG o sistema de telecardiologia, ou projeto Minas Telecardio.<xref ref-type="bibr" rid="B275">275</xref> Em 2007, o Minist&#233;rio da Sa&#250;de, com o objetivo de desenvolver a&#231;&#245;es de apoio &#224;s equipes de aten&#231;&#227;o b&#225;sica por meio da educa&#231;&#227;o permanente e de tecnologias virtuais, instituiu o Programa Telessa&#250;de Brasil, mais tarde denominado Telessa&#250;de Brasil Redes. Inicialmente, foram constitu&#237;dos nove N&#250;cleos de Telessa&#250;de no Brasil, tendo in&#237;cio a oferta de teleconsultorias (consulta entre profissionais) e telediagn&#243;sticos (ECG) no setor p&#250;blico. Atualmente, diversas empresas oferecem servi&#231;os de laudos de monitoramento ambulatorial da press&#227;o arterial (MAPA), Holter e ecocardiograma a dist&#226;ncia e an&#225;lise de imagens. A IA j&#225; &#233; atualmente utilizada em teleconsultorias e encontra-se em est&#225;gio avan&#231;ado na elabora&#231;&#227;o de laudos de exames diagn&#243;sticos. Telemonitoramento de pacientes com insufici&#234;ncia card&#237;aca tamb&#233;m &#233; realidade no Brasil. </p>
          <p>A utiliza&#231;&#227;o rotineira dessas tecnologias no Brasil mostra indiretamente suas respectivas efetividades, e a exist&#234;ncia perene das empresas que atuam no setor constitui uma medida indireta de custo-efetividade, muito embora sejam poucos os estudos formais sobre o assunto no Brasil. </p>
          <p>No entanto, pelo menos duas iniciativas de aplica&#231;&#227;o de novas tecnologias em cardiologia no Brasil foram o foco desses estudos de custo-efetividade: 1) o servi&#231;o de Telemedicina e monitoramento a dist&#226;ncia de pacientes do InCor da Faculdade de Medicina da Universidade de S&#227;o Paulo; 2) o sistema de telediagn&#243;stico e teleconsultoria da Rede de Teleassist&#234;ncia de Minas Gerais (RTMG) do Hospital da Cl&#237;nicas da UFMG.</p>
          <p>Como complemento aos resultados encontrados nos servi&#231;os de telemedicina de cardiologia, uma an&#225;lise de estimativa de economia gerada ao Estado do Rio Grande do Sul atrav&#233;s do projeto Telessa&#250;deRS, que oferece servi&#231;o de teleconsultoria de 20 especialidades cl&#237;nicas, foi conduzida e apresentada nesse cap&#237;tulo como uma terceira abordagem para avaliar economicamente um servi&#231;o de Telemedicina no Brasil. </p>
        </sec>
        <sec>
          <title>5.5. Servi&#231;o de Telemedicina e Monitoramento de Pacientes do InCor-FMUSP</title>
          <p>Stevens et al. avaliaram o impacto das quatro principais condi&#231;&#245;es card&#237;acas - insufici&#234;ncia card&#237;aca, IAM, FA e hipertens&#227;o - no Brasil em 2015 sob o aspecto financeiro e desabilidade dos pacientes.<xref ref-type="bibr" rid="B276">276</xref> Especificamente para a hipertens&#227;o, compararam os cuidados convencionais com os proporcionados pela Telemedicina e por meio de um sistema de suporte estruturado por telefone para avaliar o custo-efetividade dessas duas tecnologias em um horizonte temporal de 30 anos a partir de 2015. Um resumo dos resultados encontrados &#233; mostrado na <xref ref-type="table" rid="t20">tabela 5.2</xref>.</p>
          <table-wrap id="t20">
            <label>Tabela 5.2</label>
            <caption>
              <title>Resultados da compara&#231;&#227;o de tratamento de pacientes com hipertens&#227;o com cuidados convencional, por meio de Telemedicina e por meio de um sistema de suporte estruturado por telefone em um horizonte temporal de 30 anos a partir de 2015</title>
            </caption>
            <table frame="hsides" rules="rows">
              <colgroup>
                <col width="25%"/>
                <col width="25%"/>
                <col width="25%"/>
                <col width="25%"/>
              </colgroup>
              <thead>
                <tr>
                  <th align="left">
									</th>
                  <th align="center">Cuidado convencional</th>
                  <th align="center">Telemedicina</th>
                  <th align="center">Suporte estruturado por telefone</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left">Custo total (R$)</td>
                  <td align="center">5.832</td>
                  <td align="center">55.930</td>
                  <td align="center">49.870</td>
                </tr>
                <tr>
                  <td align="left">Custo incremental (R$)</td>
                  <td align="center">
									</td>
                  <td align="center">50.098</td>
                  <td align="center">44.038</td>
                </tr>
                <tr>
                  <td align="left">Anos de vida adicionais<sup><xref ref-type="table-fn" rid="TFN6">1</xref></sup></td>
                  <td align="center">
									</td>
                  <td align="center">1,89</td>
                  <td align="center">1,61</td>
                </tr>
                <tr>
                  <td align="left">Custo por ano de vida adicional (R$/ano)</td>
                  <td align="center">
									</td>
                  <td align="center">26.437</td>
                  <td align="center">27.281</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="TFN6">
                <label>1</label>
                <p>Anos de vida adicionais significa o impacto na longevidade com qualidade de vida para o paciente.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p>Assumindo um referencial da OMS, uma interven&#231;&#227;o que tenha um custo por ano de vida entre um e tr&#234;s vezes o PIB <italic>per capita</italic> por QALY &#233; considerada custo-efetiva, as duas tecnologias foram consideradas custo-efetivas pelos autores. No entanto, as autoridades sanit&#225;rias brasileiras ainda n&#227;o definiram qual o valor do ICER que deve ser considerado no pa&#237;s. Assim, n&#227;o se pode inferir com seguran&#231;a se os procedimentos empregados em Telemedicina, no &#226;mbito do SUS, seriam custo-efetivos ou n&#227;o dentro dos cen&#225;rios avaliados. A legisla&#231;&#227;o brasileira imp&#245;e que os produtos, f&#225;rmacos ou procedimentos inclu&#237;dos nos protocolos do SUS devam ser avaliados quanto &#224; seguran&#231;a, efic&#225;cia, efetividade e custo-efetividade, assim, carecemos de uma refer&#234;ncia efetiva para validar a avalia&#231;&#227;o econ&#244;mica em quest&#227;o.<xref ref-type="bibr" rid="B277">277</xref>
					</p>
        </sec>
        <sec>
          <title>5.6. Sistema de Telediagn&#243;stico e Teleconsultoria da Rede de Teleassist&#234;ncia de Minas Gerais (RTMG) do Hospital das Cl&#237;nicas da UFMG</title>
          <p>O Centro de Telessa&#250;de (CTS HC/UFMG) coordena a RTMG, uma rede colaborativa constitu&#237;da em 2005 por sete universidades p&#250;blicas de Minas Gerais: UFMG, Universidade Federal de Uberl&#226;ndia (UFU), Universidade Federal do Tri&#226;ngulo Mineiro (UFTM), Universidade Federal de Juiz de Fora (UFJF), Universidade Federal de S&#227;o Jo&#227;o Del Rei (UFSJ), Universidade Estadual de Montes Claros (Unimontes) e Universidade Federal dos Vales do Jequitinhonha e Mucuri (UFVJM). </p>
          <p>As atividades de teleassist&#234;ncia s&#227;o teleconsultorias e telediagn&#243;stico. As teleconsultorias s&#227;o majoritariamente ass&#237;ncronas por meio de plant&#245;es reguladores em Medicina, enfermagem, odontologia, fisioterapia, farm&#225;cia, psicologia, nutri&#231;&#227;o e fonoaudiologia. O telediagn&#243;stico consiste em an&#225;lise e laudos de eletrocardiogramas, MAPA, Holter e retinografia e teleconsultorias s&#237;ncronas em cardiologia para suporte aos casos cl&#237;nicos cr&#237;ticos. O servi&#231;o est&#225; registrado no CRM do Estado de Minas Gerais.</p>
          <p>A RTMG iniciou suas atividades por meio do projeto de pesquisa &#8220;Minas Telecardio&#8221; em 2006, implantando um servi&#231;o de telecardiologia com laudos de ECG e teleconsultorias em 82 munic&#237;pios de Minas Gerais. Ao longo do tempo, expandiu suas atividades e, atualmente, est&#227;o conectados &#224; Rede 814 munic&#237;pios com mais de 1.000 pontos de telessa&#250;de em Minas Gerais. Dentro do projeto do Minist&#233;rio da Sa&#250;de ONTD, iniciou em setembro de 2017 a oferta de servi&#231;os de telecardiologia em n&#237;vel nacional, atendendo atualmente 90 munic&#237;pios nos Estados do Acre, Bahia, Cear&#225;, Mato Grosso e Roraima. Essa expans&#227;o foi em parte resultante dos estudos que demonstraram a custo-efetividade do sistema para os principais financiadores da RTMG (Minist&#233;rio da Sa&#250;de e Secretaria de Estado da Sa&#250;de de Minas Gerais). </p>
          <p>Andrade et al.,<xref ref-type="bibr" rid="B278">278</xref> utilizando-se dos resultados do Projeto Minas Telecardio, compararam a rela&#231;&#227;o custo-benef&#237;cio da realiza&#231;&#227;o do laudo de ECG a dist&#226;ncia, considerando a hip&#243;tese de que h&#225; benef&#237;cio econ&#244;mico na realiza&#231;&#227;o do eletrocardiograma atrav&#233;s da telecardiologia, em compara&#231;&#227;o com o encaminhamento do paciente para realiza&#231;&#227;o do exame em outras localidades de refer&#234;ncia.<xref ref-type="bibr" rid="B278">278</xref> O estudo foi realizado entre junho de 2006 e novembro de 2008 em 82 munic&#237;pios do interior do estado de Minas Gerais. Cada munic&#237;pio recebeu um microcomputador com eletrocardi&#243;grafo digital, com possibilidade de envio dos tra&#231;ados e comunica&#231;&#227;o com plant&#227;o de cardiologia em hospitais universit&#225;rios da RTMG. Os gastos com o projeto foram divididos em duas categorias: com implanta&#231;&#227;o e com manuten&#231;&#227;o do sistema de telecardiologia. O custo de deslocamento dos pacientes foi avaliado incluindo o custo de transporte (a cargo da prefeitura) e os custos com alimenta&#231;&#227;o durante o per&#237;odo de aus&#234;ncia do domic&#237;lio e o custo de oportunidade do indiv&#237;duo por perder o dia de trabalho (ambos custeados pelo paciente). Avaliou-se o custo-benef&#237;cio sem inclus&#227;o (perspectiva do servi&#231;o p&#250;blico de sa&#250;de) e com inclus&#227;o (perspectiva da sociedade) dos custos dos pacientes. Para a situa&#231;&#227;o presencial, acrescentou-se ainda o custo do ECG e o custo da consulta, R$ 5,15 e R$ 10,00 respectivamente (Tabela SUS). As fontes de dados para a an&#225;lise foram principalmente a Pesquisa Nacional de Amostra de Domic&#237;lios (PNAD), Sistema de Informa&#231;&#245;es Ambulatorial SIA-SUS e CNES.</p>
          <p>Considerando-se os custos de implanta&#231;&#227;o e manuten&#231;&#227;o do projeto de R$ 1.818.282,87 e o n&#250;mero de exames realizados no per&#237;odo de 30 meses (62.865 exames entre agosto de 2006 a dezembro de 2008), o custo unit&#225;rio de cada laudo a dist&#226;ncia foi de R$ 28,92. Um resumo dos resultados &#233; mostrado na <xref ref-type="table" rid="t21">tabela 5.3</xref>.</p>
          <table-wrap id="t21">
            <label>Tabela 5.3</label>
            <caption>
              <title>Compara&#231;&#227;o de custos entre as alternativas laudo a dist&#226;ncia e laudo presencial no Projeto Minas Telecardio<xref ref-type="bibr" rid="B278">278</xref>
							</title>
            </caption>
            <table frame="hsides" rules="rows">
              <colgroup>
                <col width="33%"/>
                <col width="33%"/>
                <col width="33%"/>
              </colgroup>
              <thead>
                <tr>
                  <th align="left">Situa&#231;&#227;o</th>
                  <th align="center">Valor (R$)</th>
                  <th align="center">Diferen&#231;a (R$)</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left">1. Laudo a dist&#226;ncia</td>
                  <td align="center">28,92</td>
                  <td align="center">
									</td>
                </tr>
                <tr>
                  <td align="left">2. Laudo presencial sem custos deslocamento do paciente</td>
                  <td align="center">30,91</td>
                  <td align="center">1,99</td>
                </tr>
                <tr>
                  <td align="left">3. Laudo presencial com custos deslocamento do paciente</td>
                  <td align="center">49,83</td>
                  <td align="center">20,91</td>
                </tr>
              </tbody>
            </table>
          </table-wrap>
          <p>Uma an&#225;lise de sensibilidade mostrou que os resultados s&#227;o sens&#237;veis ao custo de deslocamento do paciente, particularmente em rela&#231;&#227;o ao sal&#225;rio do motorista e n&#250;mero de pacientes por ve&#237;culo. Tendo em vista a pequena diferen&#231;a entre as situa&#231;&#245;es 1 e 2, pode-se concluir que, em algumas situa&#231;&#245;es, a telecardiologia pode n&#227;o ser mais econ&#244;mica sob o ponto de vista do servi&#231;o p&#250;blico de sa&#250;de. </p>
          <p>&#201; importante observar que, naquele momento, a escala do sistema era relativamente baixa e, como suas atividades possuem elevado custo fixo, resultou em um alto custo do laudo a dist&#226;ncia. &#192; medida que o sistema foi estendido para outros munic&#237;pios, o custo das atividades foi sendo sucessivamente reduzido, tornando o sistema cada vez mais custo-efetivo.</p>
          <p>Em 2007, o Minist&#233;rio da Sa&#250;de, com recursos da OPAS, contratou com o CTS HC/UFMG o projeto &#8220;An&#225;lise da Gest&#227;o Financeira de Servi&#231;os de Telessa&#250;de Aplicados na Aten&#231;&#227;o B&#225;sica&#8221;. Nesse projeto, a an&#225;lise de sustentabilidade econ&#244;mica da aplica&#231;&#227;o da telessa&#250;de na Aten&#231;&#227;o B&#225;sica foi baseada na compara&#231;&#227;o de custos entre duas situa&#231;&#245;es:</p>
          <p>I. atendimento presencial: quando o paciente &#233; atendido na Aten&#231;&#227;o B&#225;sica e necessita posteriormente ser encaminhado para o n&#237;vel secund&#225;rio;</p>
          <p>II. atendimento a dist&#226;ncia: quando o m&#233;dico na Aten&#231;&#227;o B&#225;sica recebe suporte a dist&#226;ncia por meio de um servi&#231;o de telessa&#250;de e esse suporte evita o encaminhamento do paciente.</p>
          <p>Os resultados se referem a 20 munic&#237;pios participantes do Projeto Nacional de Telessa&#250;de com dados confi&#225;veis, localizados nas Regi&#245;es Norte/Nordeste e Vale do Jequitinhonha em Minas Gerais, considerada uma das regi&#245;es mais pobres do Estado. Os principais resultados do projeto s&#227;o mostrados na <xref ref-type="table" rid="t22">tabela 5.4</xref>.<xref ref-type="bibr" rid="B279">279</xref><sup>,</sup><xref ref-type="bibr" rid="B280">280</xref>
					</p>
          <table-wrap id="t22">
            <label>Tabela 5.4</label>
            <caption>
              <title>Compara&#231;&#227;o de custos m&#233;dios (R$/m&#234;s/munic&#237;pio) entre o atendimento presencial e o atendimento a dist&#226;ncia encontrados no projeto "An&#225;lise da Gest&#227;o Financeira de Servi&#231;os de Telessa&#250;de Aplicados na Aten&#231;&#227;o B&#225;sica"<xref ref-type="bibr" rid="B279">279</xref><sup>,</sup><xref ref-type="bibr" rid="B280">280</xref>
							</title>
            </caption>
            <table frame="hsides" rules="rows">
              <colgroup>
                <col width="33%"/>
                <col width="33%"/>
                <col width="33%"/>
              </colgroup>
              <thead>
                <tr>
                  <th align="left">Item de custo (R$/m&#234;s)</th>
                  <th align="center">Atendimento presencial</th>
                  <th align="center">Atendimento a dist&#226;ncia</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left">Encaminhamento de pacientes</td>
                  <td align="center">2.399,58</td>
                  <td align="center">697,78</td>
                </tr>
                <tr>
                  <td align="left">Implementa&#231;&#227;o do sistema</td>
                  <td align="center">
									</td>
                  <td align="center">56,03</td>
                </tr>
                <tr>
                  <td align="left">Deprecia&#231;&#227;o de equipamentos no munic&#237;pio</td>
                  <td align="center">
									</td>
                  <td align="center">101,97</td>
                </tr>
                <tr>
                  <td align="left">Manuten&#231;&#227;o de equipamentos no munic&#237;pio</td>
                  <td align="center">
									</td>
                  <td align="center">40,79</td>
                </tr>
                <tr>
                  <td align="left">Custo de capital de equipamentos</td>
                  <td align="center">
									</td>
                  <td align="center">51,92</td>
                </tr>
                <tr>
                  <td align="left">Atividades de atendimento a dist&#226;ncia<xref ref-type="table-fn" rid="TFN7">*</xref>
									</td>
                  <td align="center">
									</td>
                  <td align="center">210,80</td>
                </tr>
                <tr>
                  <td align="left">Total</td>
                  <td align="center">2.398,58</td>
                  <td align="center">1.159,29</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="TFN7">
                <label>*</label>
                <p>Laudo ECG, discuss&#227;o de casos e teleconsultoria.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p>Esse projeto apresentou resultados mais realistas em rela&#231;&#227;o ao anterior pois coletou informa&#231;&#245;es sobre o custo de encaminhamento do paciente diretamente nos munic&#237;pios. No entanto, manteve a amostragem dos munic&#237;pios participantes concentrada em uma mesma regi&#227;o do Estado, o Vale do Jequitinhonha, de baixo &#237;ndice de desenvolvimento humano (IDH). Em 2009, o Projeto &#8220;Expans&#227;o Minas Telecardio&#8221; levou o servi&#231;o para regi&#245;es de IDH mais elevados, para uma amostra final de outros 66 munic&#237;pios. Os resultados foram similares aquele encontrados no projeto anterior e s&#227;o mostrados na <xref ref-type="table" rid="t23">tabela 5.5</xref>.<xref ref-type="bibr" rid="B281">281</xref><sup>-</sup><xref ref-type="bibr" rid="B283">283</xref>
					</p>
          <table-wrap id="t23">
            <label>Tabela 5.5</label>
            <caption>
              <title>Principais resultados do projeto "Estudo de An&#225;lise Econ&#244;mica e de impacto da Aplica&#231;&#227;o de Servi&#231;os de Telessa&#250;de na Aten&#231;&#227;o B&#225;sica em Munic&#237;pios de Minas Gerais"<xref ref-type="bibr" rid="B282">282</xref>
							</title>
            </caption>
            <table frame="hsides" rules="rows">
              <colgroup>
                <col width="80%"/>
                <col width="20%"/>
              </colgroup>
              <tbody>
                <tr>
                  <td align="left">Custo m&#233;dio de cada atividade de telessa&#250;de em 2010</td>
                  <td align="center">R$ 10,68</td>
                </tr>
                <tr>
                  <td align="left">Custo fixo m&#233;dio do encaminhamento/paciente</td>
                  <td align="center">R$ 41,77</td>
                </tr>
                <tr>
                  <td align="left">Economia para o munic&#237;pio por encaminhamento evitado</td>
                  <td align="center">R$ 71,11</td>
                </tr>
                <tr>
                  <td align="left">N&#250;mero m&#237;nimo mensal de redu&#231;&#227;o de encaminhamentos por munic&#237;pio para viabilizar o sistema</td>
                  <td align="center">4,28</td>
                </tr>
                <tr>
                  <td align="left">N&#250;mero m&#237;nimo mensal de atividades por munic&#237;pio para viabilizar o sistema</td>
                  <td align="center">5,5</td>
                </tr>
                <tr>
                  <td align="left">N&#250;mero m&#233;dio mensal de atividades por munic&#237;pio em 2010</td>
                  <td align="center">28,5</td>
                </tr>
                <tr>
                  <td align="left">Investimento realizado pela SES/MG (2005-2009)</td>
                  <td align="center">R$ 11.599.638,00</td>
                </tr>
                <tr>
                  <td align="left">Economia para o sistema de sa&#250;de (de junho/2006 a julho/2011)</td>
                  <td align="center">R$ 31.970.549,13</td>
                </tr>
                <tr>
                  <td align="left">Retorno do investimento (ROI) (economia:investimento)</td>
                  <td align="center">2,76:1</td>
                </tr>
                <tr>
                  <td align="left">% de encaminhamentos evitados</td>
                  <td align="center">78%</td>
                </tr>
                <tr>
                  <td align="left">Dist&#226;ncia m&#237;nima de encaminhamento para viabilidade do sistema (aproximada)</td>
                  <td align="center">54 Km</td>
                </tr>
                <tr>
                  <td align="left">Custo m&#233;dio de cada atividade de telessa&#250;de em 2010<xref ref-type="table-fn" rid="TFN8">*</xref>
									</td>
                  <td align="center">R$ 10,68</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="TFN8">
                <label>*</label>
                <p>Laudo ECG, discuss&#227;o de casos e teleconsultoria.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p>Recentemente, foi feito um estudo, a ser publicado, relativo ao custo-efetividade da ONTD. A ONTD &#233; um projeto do Minist&#233;rio da Sa&#250;de para ofertar servi&#231;os de telecardiologia (laudos de ECG e teleconsultorias) para todos os Estados brasileiros para o qual o CTS HC/UFMG foi escolhido como N&#250;cleo Especialista, ou seja, provedor do servi&#231;o. Os N&#250;cleos Estaduais de Telessa&#250;de recebem financiamento do Minist&#233;rio da Sa&#250;de para treinar e implantar o servi&#231;o em munic&#237;pios de seu Estado, previamente acordados com as Secretarias Estaduais da Sa&#250;de, que enviam suas solicita&#231;&#245;es de exame e teleconsultorias para o N&#250;cleo Especialista em regime 24/7. As solicita&#231;&#245;es podem ser eletivas ou de urg&#234;ncia. O laudo &#233; disponibilizado em uma plataforma e, quando necess&#225;rio, os m&#233;dicos locais podem tirar d&#250;vidas em teleconsultorias. Um sistema de alerta informa m&#233;dicos e enfermeiros quando h&#225; situa&#231;&#245;es cr&#237;ticas. A efetividade do sistema foi comprovada por meio de indicadores de performance (tempo para envio dos exames, tempo de espera para an&#225;lise de laudos urgentes/eletivos, tempo da primeira visualiza&#231;&#227;o do laudo, n&#250;mero de exames solicitados por munic&#237;pio etc.) e satisfa&#231;&#227;o dos usu&#225;rios. Os resultados comprovaram a efetividade do sistema em substitui&#231;&#227;o &#224;s alternativas dispon&#237;veis anteriormente para obten&#231;&#227;o do exame/laudo (encaminhamento do paciente, visitas peri&#243;dicas do cardiologista ao munic&#237;pio e terceiriza&#231;&#227;o do exame para empresas/cl&#237;nicas privadas). Em rela&#231;&#227;o a essas alternativas, o custo do exame pela ONTD &#233; cerca de cinco vezes mais baixo, o que demonstra custo-efetividade.</p>
        </sec>
        <sec>
          <title>5.7. An&#225;lise de Impacto Econ&#244;mico do Servi&#231;o de Teleconsultoria do Telessa&#250;deRS</title>
          <p>A an&#225;lise econ&#244;mica conduzida no servi&#231;o do TelessaudeRS foi realizada para avaliar resultados financeiros do servi&#231;o gerada ao Estado. S&#227;o oferecidas teleconsultorias para diversas especialidades, al&#233;m da contribui&#231;&#227;o com a regula&#231;&#227;o da fila de atendimento para o estado do RS. Selecionaram-se teleconsultorias de endocrinologia, gastroenterologia, proctologia, reumatologia e urologia como amostra. </p>
          <p>O custo por teleconsultoria (R$ 110,29) foi avaliado considerando dados de oito meses de servi&#231;o e contemplou custos de estrutura f&#237;sica do servi&#231;o (alugu&#233;is, energia, deprecia&#231;&#227;o, capacidade de servidor, entre outros) e pagamento de profissionais. Foi adotado como premissa que todas as teleconsultorias e regula&#231;&#245;es que geraram como resultado o cancelamento da consulta presencial representam, para o Estado, economia de transporte do paciente para Porto Alegre (vari&#225;vel de acordo com o munic&#237;pio de origem) e de pagamento da consulta presencial ao munic&#237;pio (R$ 100,00). A economia estimada foi calculada pela diferen&#231;a entre o custo para realizar as teleconsultorias canceladas e o custo do atendimento presencial.</p>
          <p>A an&#225;lise identificou que, ao longo de 21 meses (outubro de 2016 a junho de 2018), o Estado economizou R$ 2.287.121,78, sendo 47% pelo valor de consulta e 53% de transporte. Para as teleconsultorias, identificou-se que o servi&#231;o &#233; atrativo at&#233; o valor de pagamento por consulta de R$ 38,95, considerando o custo m&#233;dio de transporte. Os munic&#237;pios com maiores dist&#226;ncias de Porto Alegre apresentam maior economia, exceto quatro munic&#237;pios vizinhos a Porto Alegre que possuem um volume de teleconsultas evitadas maior do que a m&#233;dia dos demais. </p>
          <p>Destaca-se que o uso desses resultados para fins de compara&#231;&#227;o com outros Estados e servi&#231;os deve considerar que o servi&#231;o do Telessa&#250;de &#233; composto por profissionais bolsistas e celetistas e, por isso, consegue operar com menor custo por teleconsultoria. O funcionamento de servi&#231;o similar, apenas com funcion&#225;rios celetistas, representaria um aumento do custo unit&#225;rio por teleconsultoria e demandaria an&#225;lise econ&#244;micas adicionais.</p>
          <p>A OMS considera custo-efetivas as interven&#231;&#245;es cujo ICER esteja entre 1 e 3 vezes o PIB <italic>per capita</italic> por ano de vida salvo ajustado ao QALY.</p>
        </sec>
      </sec>
      <sec>
        <title>6. Recomenda&#231;&#245;es</title>
        <p>A SBC, em virtude do crescente interesse suscitado pela utiliza&#231;&#227;o da Telemedicina na amplia&#231;&#227;o da aten&#231;&#227;o &#224; sa&#250;de, em particular no cen&#225;rio da cardiologia, edita essa diretriz com objetivo de esclarecer a categoria m&#233;dica e a sociedade em geral sobre as bases cient&#237;ficas e aplica&#231;&#245;es da Telemedicina no cen&#225;rio atual. </p>
        <p>Embora seja crescente o entusiasmo com a democratiza&#231;&#227;o das tecnologias de informa&#231;&#227;o e comunica&#231;&#227;o, &#233; importante apontar que persistem barreiras para a implementa&#231;&#227;o no pa&#237;s, as quais precisam ser enfrentadas. Pode-se citar como mais significativas:</p>
        <p>
          <list list-type="bullet">
            <list-item>
              <p> atualiza&#231;&#227;o da legisla&#231;&#227;o e regulamenta&#231;&#245;es aplic&#225;veis pelas autoridades sanit&#225;rias e CFM;</p>
            </list-item>
            <list-item>
              <p> disponibiliza&#231;&#227;o de infraestrutura m&#237;nima de telecomunica&#231;&#227;o nas unidades de sa&#250;de, sobretudo nas &#225;reas ditas remotas;</p>
            </list-item>
            <list-item>
              <p> custo da tecnologia;</p>
            </list-item>
            <list-item>
              <p> necessidade de capacita&#231;&#227;o e treinamento dos recursos humanos;</p>
            </list-item>
            <list-item>
              <p> incorpora&#231;&#227;o das tecnologias no rol de pol&#237;ticas p&#250;bicas do SUS e no Rol de Procedimentos e Eventos e Sa&#250;de da ANS.</p>
            </list-item>
          </list>
        </p>
        <p>Ao trazer &#224; luz a discuss&#227;o sobre a aplica&#231;&#227;o da Telemedicina, al&#233;m da sua midi&#225;tica repercuss&#227;o, busca-se oferecer o suporte t&#233;cnico-cient&#237;fico para a elabora&#231;&#227;o de pol&#237;ticas de sa&#250;de consent&#226;neas com o emprego dessa tecnologia. Nesse sentido, se faz necess&#225;ria a incorpora&#231;&#227;o formal, ap&#243;s a devida avalia&#231;&#227;o da CONITEC, das diversas modalidades de possibilidades hoje dispon&#237;veis vinculadas aos respectivos protocolos cl&#237;nicos e diretrizes terap&#234;uticas (PCDT). No mesmo sentido, observa-se no &#226;mbito da sa&#250;de suplementar, a necessidade de inclus&#227;o, no Rol de Procedimentos e Eventos da ANS, daqueles que tenham reconhecimento cient&#237;fico e sejam autorizados para uso corrente no pa&#237;s.</p>
        <p>Conforme discutido nessa diretriz, salvo raras exce&#231;&#245;es, n&#227;o h&#225; previs&#227;o na Classifica&#231;&#227;o Brasileira Hierarquizada de Procedimentos M&#233;dicos, condi&#231;&#227;o para inclus&#227;o no rol de coberturas da ANS, para os procedimentos de uso corrente na Telemedicina. Recorre-se a codifica&#231;&#245;es gen&#233;ricas, com descri&#231;&#245;es que s&#227;o amplas e por natureza permitem a utiza&#231;&#227;o por verossimilhan&#231;a, a exemplo do c&#243;digo 2.01.01.20-1 (avalia&#231;&#227;o cl&#237;nica e eletr&#244;nica de paciente portador de marca-passo ou sincronizador ou desfibrilador, card&#237;acos). No entanto, o reembolso desse servi&#231;o decorrer&#225; da mera liberalidade da operadora de plano de sa&#250;de. Tal fato limita a aplicabilidade da Telemedicina no &#226;mbito da sa&#250;de suplementar, com as consequ&#234;ncias vinculadas.</p>
        <p>Em 2015, a SBC, por interm&#233;dio da Diretriz de Telecardiologia no Cuidado de Pacientes com S&#237;ndrome Coronariana Aguda e outras Doen&#231;as Card&#237;acas,<xref ref-type="bibr" rid="B133">133</xref> fez recomenda&#231;&#245;es acerca do tema. Contudo, na atual vers&#227;o da diretriz, mais abrangente, abordam-se novas aplica&#231;&#245;es da telecardiologia, sobretudo as j&#225; incorporadas ao sistema de sa&#250;de. Ainda versa sobre as perspectivas futuras como o emprego de telerrob&#243;tica e IA. Os autores, com foco na evid&#234;ncia cient&#237;fica atual e seu custo-efetividade, atualizaram as recomenda&#231;&#245;es a fim de orientar os provedores de sa&#250;de p&#250;blicos e privados no judicioso emprego das aplica&#231;&#245;es da Telemedicina no Brasil.</p>
        <p>A <xref ref-type="table" rid="t24">tabela 6.1</xref> sumariza as recomenda&#231;&#245;es apontadas nessa diretriz.</p>
        <table-wrap id="t24">
          <label>Tabela 6.1</label>
          <caption>
            <title>Recomenda&#231;&#245;es para a pr&#225;tica da Telemedicina no Brasil</title>
          </caption>
          <table frame="hsides" rules="rows">
            <colgroup>
              <col width="40%"/>
              <col width="20%"/>
              <col width="20%"/>
              <col width="20%"/>
            </colgroup>
            <thead>
              <tr>
                <th align="left">Indica&#231;&#227;o cl&#237;nica</th>
                <th align="center">Classe de indica&#231;&#227;o</th>
                <th align="center">Nivel de evid&#234;ncia</th>
                <th align="center">Refer&#234;ncias</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left">
                  <bold>Teleconsultoria</bold>
                </td>
                <td align="center">
								</td>
                <td align="center">
								</td>
                <td align="center">
								</td>
              </tr>
              <tr>
                <td align="left">A teleconsultoria auxilia os m&#233;dicos generalistas de &#225;reas remotas na avalia&#231;&#227;o cl&#237;nica de pacientes com suspeita ou doen&#231;a cardiovascular estabelecida, sendo custo-efetiva, na perspectiva do SUS.</td>
                <td align="center">IIa</td>
                <td align="center">B</td>
                <td align="center">
                  <xref ref-type="bibr" rid="B76">76</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B99">99</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B100">100</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B101">101</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B278">278</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B279">279</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B280">280</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B281">281</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B282">282</xref>
                </td>
              </tr>
              <tr>
                <td align="left">A teleconsultoria auxilia os m&#233;dicos que atuam no atendimento a urg&#234;ncias e emerg&#234;ncias na condu&#231;&#227;o de casos de doen&#231;as cardiovasculares agudas</td>
                <td align="center">IIa</td>
                <td align="center">C</td>
                <td align="center">
                  <xref ref-type="bibr" rid="B133">133</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B134">134</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B137">137</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B138">138</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B139">139</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B140">140</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B141">141</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B142">142</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B143">143</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B144">144</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B145">145</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B149">149</xref>
                </td>
              </tr>
              <tr>
                <td align="left">A teleconsultoria auxilia na regula&#231;&#227;o do acesso &#224; aten&#231;&#227;o especializada nos pacientes com suspeita ou doen&#231;a cardiovascular estabelecida</td>
                <td align="center">IIa</td>
                <td align="center">C</td>
                <td align="center">
                  <xref ref-type="bibr" rid="B101">101</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B102">102</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B103">103</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B104">104</xref>
                </td>
              </tr>
              <tr>
                <td align="left">
                  <bold>Telediagn&#243;stico</bold>
                </td>
                <td align="center">
								</td>
                <td align="center">
								</td>
                <td align="center">
								</td>
              </tr>
              <tr>
                <td align="left">A tele-eletrocardiografia &#233; uma alternativa fact&#237;vel e efetiva de oferta do exame nos sistemas de sa&#250;de, sendo particularmente &#250;til e custo-efetiva na aten&#231;&#227;o b&#225;sica e em localidades remotas </td>
                <td align="center">I</td>
                <td align="center">B</td>
                <td align="center">
                  <xref ref-type="bibr" rid="B61">61</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B105">105</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B106">106</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B107">107</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B278">278</xref>
                </td>
              </tr>
              <tr>
                <td align="left">O uso da Telemedicina com envio do laudo do eletrocardiograma no atendimento pr&#233;-hospitalar do paciente com suspeita de infarto agudo do mioc&#225;rdio reduz desfechos cardiovasculares e mortalidade precoce e tardia</td>
                <td align="center">I</td>
                <td align="center">B</td>
                <td align="center">
                  <xref ref-type="bibr" rid="B87">87</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B137">137</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B138">138</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B139">139</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B140">140</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B141">141</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B142">142</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B143">143</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B144">144</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B145">145</xref>
                  <sup>,</sup>
                </td>
              </tr>
              <tr>
                <td align="left">A tele-ecocardiografia com teleconsultoria &#233; efetiva na detec&#231;&#227;o precoce de cardiopatia cong&#234;nita em rec&#233;m-nascidos</td>
                <td align="center">IIa</td>
                <td align="center">B</td>
                <td align="center">
                  <xref ref-type="bibr" rid="B182">182</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B183">183</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B306">306</xref>
                </td>
              </tr>
              <tr>
                <td align="left">A tele-ecocardiografia permite a detec&#231;&#227;o precoce de casos subcl&#237;nicos de cardiopatia reum&#225;tica em crian&#231;as e adolescentes </td>
                <td align="center">IIa</td>
                <td align="center">B</td>
                <td align="center">
                  <xref ref-type="bibr" rid="B111">111</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B112">112</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B307">307</xref>
                </td>
              </tr>
              <tr>
                <td align="left">A tele-ecocardiografia na aten&#231;&#227;o prim&#225;ria permite a detec&#231;&#227;o precoce de casos de cardiopatia e pode auxiliar na prioriza&#231;&#227;o de encaminhamentos para o cuidado especializado</td>
                <td align="center">IIb</td>
                <td align="center">C</td>
                <td align="center">
                  <xref ref-type="bibr" rid="B109">109</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B110">110</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B112">112</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B114">114</xref>
                </td>
              </tr>
              <tr>
                <td align="left" colspan="2">A transfer&#234;ncia de imagens de tomografia e resson&#226;ncia card&#237;aca por Telemedicina pode ser realizada: </td>
                <td align="center">
								</td>
                <td align="center">
								</td>
              </tr>
              <tr>
                <td align="left">- para obten&#231;&#227;o de segunda opini&#227;o</td>
                <td align="center">IIa</td>
                <td align="center">C</td>
                <td align="center">
                  <xref ref-type="bibr" rid="B190">190</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B192">192</xref>
                </td>
              </tr>
              <tr>
                <td align="left">- para discuss&#227;o em "Heart Teams"</td>
                <td align="center">IIa</td>
                <td align="center">C</td>
                <td align="center">
                  <xref ref-type="bibr" rid="B190">190</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B192">192</xref>
                </td>
              </tr>
              <tr>
                <td align="left">- para suporte a dist&#226;ncia para casos de urg&#234;ncia</td>
                <td align="center">IIa</td>
                <td align="center">C</td>
                <td align="center">
                  <xref ref-type="bibr" rid="B190">190</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B192">192</xref>
                </td>
              </tr>
              <tr>
                <td align="left">- em casos de rotina espor&#225;dicos</td>
                <td align="center">IIa</td>
                <td align="center">C</td>
                <td align="center">
                  <xref ref-type="bibr" rid="B190">190</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B192">192</xref>
                </td>
              </tr>
              <tr>
                <td align="left">- para transmiss&#227;o de rotina de todos os exames de imagem cardiovascular para centros ou grupos especializados</td>
                <td align="center">IIb</td>
                <td align="center">C</td>
                <td align="center">
                  <xref ref-type="bibr" rid="B190">190</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B192">192</xref>
                </td>
              </tr>
              <tr>
                <td align="left">
                  <bold>Telemonitoramento</bold>
                </td>
                <td align="center">
								</td>
                <td align="center">
								</td>
                <td align="center">
								</td>
              </tr>
              <tr>
                <td align="left">O automonitoramento da press&#227;o arterial com telemonitoramento auxilia no controle e ader&#234;ncia ao tratamento</td>
                <td align="center">IIa</td>
                <td align="center">B</td>
                <td align="center">
                  <xref ref-type="bibr" rid="B75">75</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B77">77</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B78">78</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B127">127</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B128">128</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B129">129</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B130">130</xref>
                </td>
              </tr>
              <tr>
                <td align="left">Estrat&#233;gias de telemonitoramento n&#227;o invasivo com suporte telef&#244;nico estruturado s&#227;o efetivas para redu&#231;&#227;o de hospitaliza&#231;&#245;es na insufici&#234;ncia card&#237;ada</td>
                <td align="center">I</td>
                <td align="center">A</td>
                <td align="center">
                  <xref ref-type="bibr" rid="B115">115</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B116">116</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B118">118</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B119">119</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B120">120</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B123">123</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B124">124</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B125">125</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B126">126</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B158">158</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B159">159</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B161">161</xref>
                </td>
              </tr>
              <tr>
                <td align="left">Estrat&#233;gias de telemonitoramento n&#227;o invasivo com suporte telef&#244;nico estruturado s&#227;o efetivas para redu&#231;&#227;o de mortalidade na insufici&#234;ncia card&#237;aca</td>
                <td align="center">IIa</td>
                <td align="center">A</td>
                <td align="center">
                  <xref ref-type="bibr" rid="B115">115</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B116">116</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B118">118</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B119">119</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B120">120</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B123">123</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B124">124</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B125">125</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B126">126</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B158">158</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B159">159</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B161">161</xref>
                </td>
              </tr>
              <tr>
                <td align="left">A monitora&#231;&#227;o remota para acompanhamento de pacientes com arritmias e dispositivos el&#233;tricos implant&#225;veis, em adi&#231;&#227;o &#224;s avalia&#231;&#245;es telem&#233;tricas regulares, &#233; efetiva em reduzir visitas ambulatoriais e na detec&#231;&#227;o precoce de disfun&#231;&#227;o de dispositivos</td>
                <td align="center">IIa</td>
                <td align="center">B</td>
                <td align="center">
                  <xref ref-type="bibr" rid="B157">157</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B160">160</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B162">162</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B163">163</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B164">164</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B165">165</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B166">166</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B167">167</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B168">168</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B169">169</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B170">170</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B174">174</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B175">175</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B177">177</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B178">178</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B179">179</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B180">180</xref>
                </td>
              </tr>
              <tr>
                <td align="left">A tele-reabilita&#231;&#227;o em pacientes eleg&#237;veis com insufici&#234;ncia card&#237;aca, disfun&#231;&#227;o do ventr&#237;culo esquerdo ou n&#227;o, com classe funcional NYHA I-III, &#233; efetiva em melhorar ader&#234;ncia ao programa, aumentar a qualidade de vida e performance no teste de 6 minutos</td>
                <td align="center">IIa</td>
                <td align="center">B</td>
                <td align="center">
                  <xref ref-type="bibr" rid="B148">148</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B149">149</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B150">150</xref>
                  <xref ref-type="bibr" rid="B151">151</xref>
                  <sup>,</sup>
                  <xref ref-type="bibr" rid="B152">152</xref>
                </td>
              </tr>
              <tr>
                <td align="left">Comunica&#231;&#227;o entre m&#233;dicos e m&#233;dicos, em car&#225;ter privativo, para enviar dados ou tirar d&#250;vidas, bem como em grupos fechados de especialistas ou do corpo cl&#237;nico de uma institui&#231;&#227;o ou c&#225;tedra, resguardando-se o sigilo profissional</td>
                <td align="center">I</td>
                <td align="center">C</td>
                <td align="center">
                  <xref ref-type="bibr" rid="B191">191</xref>
                </td>
              </tr>
              <tr>
                <td align="left">Comunica&#231;&#227;o entre m&#233;dicos e seus pacientes, em car&#225;ter privativo, por interm&#233;dio de plataformas de comunica&#231;&#227;o, para enviar dados ou tirar d&#250;vidas, resguardado o sigilo profissional</td>
                <td align="center">IIa</td>
                <td align="center">C</td>
                <td align="center">
                  <xref ref-type="bibr" rid="B191">191</xref>
                </td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
      </sec>
    </body>
  </sub-article>
</article>
